data_2jvz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jvz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 15.0 m -133.54 115.18 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.502 0.668 . . . . 0.0 111.525 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -115.28 141.33 48.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.487 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 39.5 mt-10 -109.77 136.04 49.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.555 0.693 . . . . 0.0 112.504 -174.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.0 148.22 29.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.07 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 68.3 mtp -101.49 129.18 47.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.151 0.5 . . . . 0.0 111.56 -174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.669 HD11 ' HB2' ' A' ' 51' ' ' LEU . 3.9 mp -105.54 107.29 58.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.301 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 12' ' ' LYS . 8.1 Cg_exo -74.64 152.23 42.43 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.211 2.607 . . . . 0.0 111.429 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.61 129.43 40.53 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.47 -15.4 24.77 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.538 ' HD2' ' O ' ' A' ' 71' ' ' LEU . 71.0 mmtt -112.66 9.27 19.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.045 0.45 . . . . 0.0 110.132 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.67 99.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.95 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.6 -15.72 66.72 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.175 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.874 HD13 ' HB2' ' A' ' 73' ' ' GLU . 24.7 mt -87.32 -58.61 2.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 120.81 0.338 . . . . 0.0 110.719 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.665 HG11 HG12 ' A' ' 8' ' ' ILE . 85.3 t -81.68 -48.83 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.438 HG21 HD12 ' A' ' 37' ' ' LEU . 39.8 pt -91.52 -26.78 4.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.917 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.35 33.92 13.18 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.457 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm 57.65 29.66 17.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.977 0.511 . . . . 0.0 112.093 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.1 -33.47 0.61 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 119.951 -1.119 . . . . 0.0 113.304 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 157.07 -6.33 0.19 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 119.908 -1.139 . . . . 0.0 113.792 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.74 -46.57 67.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.964 0.382 . . . . 0.0 111.549 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.474 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 86.0 m -73.36 -42.9 61.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.23 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.71 HD13 ' HB2' ' A' ' 35' ' ' MET . 5.8 tp -62.35 -26.1 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.75 -174.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 89.3 mttt -53.54 -56.89 13.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.945 0.879 . . . . 0.0 109.96 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.68 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 22.8 mt-30 -73.96 -27.69 61.12 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.607 -174.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 91.8 mt -66.59 -27.64 67.88 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.236 0.541 . . . . 0.0 109.853 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.668 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.4 mt-30 -85.41 -46.42 10.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.019 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -79.82 -62.44 1.68 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 3.0 ttm180 -62.34 -38.37 89.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.395 -173.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.866 ' HB3' ' HE2' ' A' ' 66' ' ' MET . . . -87.51 -26.46 23.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.825 0.345 . . . . 0.0 111.634 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.4 70.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.76 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.5 m -127.41 156.06 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -94.25 109.37 21.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.793 ' HB3' HD23 ' A' ' 51' ' ' LEU . 48.8 mtt -100.24 114.04 27.18 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.172 0.51 . . . . 0.0 109.64 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.4 tt -111.72 113.8 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.982 0.896 . . . . 0.0 109.932 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 1.1 pt? -132.6 141.19 48.56 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.197 -175.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.669 HD11 ' HG2' ' A' ' 50' ' ' PRO . 2.1 mp -59.43 102.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.421 0.629 . . . . 0.0 111.012 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 19.46 17.73 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.6 123.37 25.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.405 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.763 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . -79.59 -0.97 85.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.225 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.6 m -90.09 -26.35 20.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.086 0.443 . . . . 0.0 110.865 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -115.79 -81.53 0.61 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.282 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.56 ' HB2' ' CG2' ' A' ' 38' ' ' ILE . 15.0 m120 -96.76 67.31 2.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.94 0.4 . . . . 0.0 110.994 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.763 ' HB ' ' HA2' ' A' ' 41' ' ' GLY . 1.9 t -83.44 -56.49 3.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.315 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.482 ' H ' HG22 ' A' ' 45' ' ' THR . 4.4 m-20 -94.3 -21.8 18.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.124 0.488 . . . . 0.0 110.856 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.11 158.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.755 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.2 148.0 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.442 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -122.86 133.86 24.71 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.018 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.669 ' HG2' HD11 ' A' ' 38' ' ' ILE . 94.7 Cg_endo -86.98 119.91 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.421 2.081 . . . . 0.0 112.649 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.793 HD23 ' HB3' ' A' ' 35' ' ' MET . 2.0 tt -88.06 111.11 21.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.675 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 2.6 mtp85 -96.73 100.12 11.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.722 0.296 . . . . 0.0 110.544 177.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 59.9 mt -80.83 112.61 19.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.23 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.4 mt -104.43 121.24 55.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.34 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.63 -171.01 44.21 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.23 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -69.05 153.1 96.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.5 -54.98 4.36 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.217 2.612 . . . . 0.0 114.227 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -65.68 -26.87 67.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 110.811 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 87.6 mttt -69.67 -51.06 38.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.112 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.91 -29.0 46.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.321 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.36 -56.18 16.14 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.516 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.881 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -65.04 -37.2 86.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.647 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -67.33 -46.67 72.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.356 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.9 t -55.68 -36.64 67.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.074 0.464 . . . . 0.0 110.447 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -63.95 -50.72 67.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.148 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.866 ' HE2' ' HB3' ' A' ' 31' ' ' ALA . 8.2 ptt? -68.69 -38.96 80.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.951 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 63' ' ' ALA . 61.6 t -57.53 -41.83 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.567 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.0 mtp -68.33 -25.71 65.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.306 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.671 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 11.8 t70 -84.54 -54.46 4.73 Favored 'General case' 0 C--O 1.219 -0.5 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.692 -176.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -71.51 -21.04 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.997 -174.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.612 HD12 HG23 ' A' ' 16' ' ' VAL . 5.1 tt -76.34 -16.82 59.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.069 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.692 ' HD2' ' HG2' ' A' ' 74' ' ' ARG . 10.9 ptp180 -56.7 -36.6 69.83 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.874 ' HB2' HD13 ' A' ' 15' ' ' LEU . 1.3 tm-20 65.85 98.98 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.853 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.692 ' HG2' ' HD2' ' A' ' 72' ' ' ARG . 43.2 mtt180 -96.36 -27.8 14.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.378 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -151.65 29.1 0.61 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.129 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.705 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 37.86 35.67 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.004 0.921 . . . . 0.0 112.827 -169.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.47 -44.26 0.79 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.611 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 65.03 25.57 70.93 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.698 -0.287 . . . . 0.0 112.876 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 67.8 -50.93 0.52 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.622 0.769 . . . . 0.0 111.889 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 111.34 99.15 2.48 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -174.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.68 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 0.7 OUTLIER 72.59 -66.38 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.02 0.482 . . . . 0.0 109.91 -169.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.627 ' HB3' ' NH1' ' A' ' 82' ' ' ARG . 0.8 OUTLIER 170.17 -42.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.328 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 57.95 78.11 0.26 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.213 0.53 . . . . 0.0 110.765 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 1.028 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.6 tt0 -174.91 -68.27 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.288 -175.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 1.1 p90 -141.32 -69.22 0.38 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 120.689 -1.257 . . . . 0.0 112.367 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.45 75.39 0.52 Allowed Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.288 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.622 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 9.6 m 74.86 -38.74 0.39 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.541 0.736 . . . . 0.0 112.71 176.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.695 ' HG2' ' HD2' ' A' ' 127' ' ' LYS . 3.9 mpt_? -66.21 -88.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.617 ' O ' ' HB3' ' A' ' 85' ' ' TYR . 10.5 mm -111.65 88.82 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.1 -174.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.39 91.01 0.08 OUTLIER Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.496 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.57 93.79 0.29 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.836 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 112.41 165.13 16.98 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 -174.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 1.028 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 45.6 pt -94.15 155.71 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 117.125 0.463 . . . . 0.0 111.967 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.495 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 2.1 p30 -96.35 147.16 24.1 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.649 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 40.6 t -136.51 99.72 10.52 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.473 ' HA ' HD11 ' A' ' 137' ' ' ILE . 38.6 Cg_endo -71.07 106.7 1.95 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.113 1.875 . . . . 0.0 111.412 170.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.557 HG23 HD22 ' A' ' 158' ' ' LEU . 13.4 p -109.65 131.32 21.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.58 144.51 51.93 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.447 2.765 . . . . 0.0 112.747 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -64.49 -22.13 66.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.772 -172.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -86.35 -4.48 59.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 110.516 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 105' ' ' VAL . 16.4 m -114.85 -29.61 6.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.1 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.21 -39.96 70.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.12 -27.12 74.11 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.071 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.95 -33.62 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.08 0.467 . . . . 0.0 109.745 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 101' ' ' SER . 94.3 t -60.19 -39.8 81.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.171 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.6 mm -72.2 -59.05 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.467 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.4 -137.72 14.26 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -98.42 -57.34 2.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.222 0.511 . . . . 0.0 110.014 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 m -105.65 -24.27 12.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.612 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 136.81 20.54 0.59 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.469 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 1.8 mp0 -49.75 -43.68 48.12 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.1 0.476 . . . . 0.0 110.991 -176.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.66 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.2 tpt -76.37 -52.7 9.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.584 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.617 HD12 HG23 ' A' ' 124' ' ' ILE . 20.1 tt -69.92 -26.26 29.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.743 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.23 -29.28 63.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.552 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 112' ' ' MET . 16.5 ptpt -80.04 -22.59 42.2 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.265 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.36 -45.68 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -69.26 -25.29 64.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.625 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -79.39 -39.46 32.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.046 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -78.98 -54.08 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.404 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.437 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -88.23 -15.29 36.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.06 57.46 6.95 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.129 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.9 m -131.62 174.21 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.872 0.368 . . . . 0.0 111.314 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.785 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 86.6 mtt180 -125.04 151.41 45.65 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.617 HG23 HD12 ' A' ' 113' ' ' ILE . 47.8 mm -112.23 136.35 48.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.079 0.466 . . . . 0.0 111.155 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.666 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 3.9 tp-100 -130.72 110.99 11.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.309 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -80.97 102.89 10.43 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.113 171.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.909 ' HE2' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -99.2 164.67 12.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.847 -178.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.426 ' CD ' HH21 ' A' ' 88' ' ' ARG . 4.9 pt20 . . . . . 0 C--O 1.236 0.382 0 O-C-N 124.146 0.904 . . . . 0.0 110.52 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 CA--C 1.532 0.407 0 N-CA-C 114.393 0.882 . . . . 0.0 114.393 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.17 148.87 21.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.619 . . . . 0.0 111.757 -172.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.464 ' O ' HG13 ' A' ' 97' ' ' VAL . 60.3 mttm -127.46 123.21 35.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.894 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.909 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 6.4 mm -74.13 107.67 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.35 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -99.4 104.71 16.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.666 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 60.7 t-80 -73.32 133.73 43.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.0 0.428 . . . . 0.0 111.485 -172.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.692 HD11 ' HB2' ' A' ' 150' ' ' ALA . 95.9 mt -101.2 111.83 32.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.887 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.785 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 37.6 ttm -97.19 137.36 36.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.936 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.82 -161.21 29.45 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.011 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.412 ' C ' ' HG ' ' A' ' 147' ' ' CYS . 14.2 Cg_exo -71.39 139.12 34.15 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.982 2.455 . . . . 0.0 111.344 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.94 -47.21 10.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.037 3.158 . . . . 0.0 113.964 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.53 -39.6 91.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 111.155 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 57.7 mtt180 -76.16 -28.29 57.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.178 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.836 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 73.1 m -56.92 -59.74 4.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.202 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.686 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 31.3 mt-10 -61.58 -39.82 92.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.464 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -54.79 -31.41 58.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.393 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.692 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -78.34 -34.74 48.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.974 0.416 . . . . 0.0 110.635 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' A' ' 93' ' ' ILE . . . -71.73 -21.39 61.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.286 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.686 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 8.2 mpt_? -76.74 -30.42 56.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.587 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 58.1 mt -70.13 -51.29 40.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.591 175.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.538 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 67.1 mt -59.04 -44.83 92.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.091 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.28 -32.2 72.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.386 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.86 -35.51 67.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 47.3 mt -62.0 -38.2 87.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.001 176.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.557 HD22 HG23 ' A' ' 97' ' ' VAL . 22.2 mt . . . . . 0 C--N 1.333 -0.15 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.691 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.43 ' HB ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 111.405 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 38.0 t -125.03 113.62 36.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.5 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -107.32 146.98 30.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.449 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 42.5 mt-10 -109.03 120.49 42.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.136 0.493 . . . . 0.0 111.507 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.8 mm -108.55 127.17 65.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.038 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 ttm -79.64 119.85 23.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.137 0.494 . . . . 0.0 111.525 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.439 HG12 HG12 ' A' ' 16' ' ' VAL . 1.6 mp -100.48 119.01 59.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.171 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.65 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 50.4 Cg_exo -61.74 148.41 93.13 Favored 'Trans proline' 0 N--CA 1.476 0.451 0 C-N-CA 123.761 2.974 . . . . 0.0 112.609 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.99 135.45 52.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.7 -45.8 1.69 Allowed Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -170.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.813 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -71.41 -34.01 69.96 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.665 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.25 -41.27 60.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.106 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.818 ' HA3' ' HE3' ' A' ' 19' ' ' LYS . . . -61.19 -32.25 79.88 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.957 -0.565 . . . . 0.0 113.221 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.4 pp -91.59 -22.2 20.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.001 0.401 . . . . 0.0 111.401 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.439 HG12 HG12 ' A' ' 8' ' ' ILE . 70.6 t -81.32 -46.56 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.656 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 13' ' ' ALA . 25.0 pt -91.6 -27.29 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.193 0.52 . . . . 0.0 110.383 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.7 132.6 6.43 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.818 ' HE3' ' HA3' ' A' ' 14' ' ' GLY . 30.9 mmtp -63.96 -17.81 63.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.122 0.461 . . . . 0.0 110.693 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.45 13.83 8.26 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.87 -1.09 74.07 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.977 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -53.9 -52.85 59.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.2 m -62.32 -36.45 82.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.822 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.686 HD13 HD11 ' A' ' 27' ' ' LEU . 2.6 tp -66.7 -33.28 62.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.897 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -57.24 -41.7 80.06 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.433 0.635 . . . . 0.0 110.375 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.64 ' HA ' ' HB2' ' A' ' 30' ' ' ARG . 10.7 mt-30 -71.86 -26.37 62.33 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.229 -176.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.686 HD11 HD13 ' A' ' 24' ' ' ILE . 74.2 mt -81.14 -34.36 32.53 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.08 0.467 . . . . 0.0 110.857 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.816 HE22 ' HB2' ' A' ' 35' ' ' MET . 18.6 mm-40 -84.83 -59.12 2.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.271 0.558 . . . . 0.0 110.843 -176.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.89 -46.17 10.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.722 -172.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.95 HH12 ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -65.84 -52.6 49.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 111.09 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -71.5 -28.95 64.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.642 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.72 17.36 54.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.054 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.5 m -118.39 171.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HD2' ' OE1' ' A' ' 28' ' ' GLN . 52.7 tptt -114.53 109.47 18.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.832 0.825 . . . . 0.0 109.723 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.816 ' HB2' HE22 ' A' ' 28' ' ' GLN . 48.3 mtt -94.68 112.64 24.38 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.452 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.624 HG22 ' HB2' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -111.01 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.905 0.859 . . . . 0.0 109.219 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.682 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 1.8 pt? -133.46 142.5 48.31 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.041 -173.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.513 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 3.2 mp -66.28 105.13 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.563 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.487 ' HG2' HG21 ' A' ' 17' ' ' ILE . 49.1 mt-30 -85.67 -57.84 2.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.925 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -174.43 118.59 0.22 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.86 -49.86 0.36 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.997 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.3 p -72.16 -75.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.904 0.352 . . . . 0.0 111.616 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -157.55 -35.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.189 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -79.62 67.32 5.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.443 0.639 . . . . 0.0 110.207 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 p -83.34 -57.76 3.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.918 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.19 -14.3 27.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.442 0.639 . . . . 0.0 110.239 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.04 158.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.7 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.89 150.36 16.71 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.394 0.434 . . . . 0.0 110.49 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 64.8 mttt -127.33 123.56 23.33 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.24 -167.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.19 124.44 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.81 2.34 . . . . 0.0 112.891 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.682 ' HA ' ' HB3' ' A' ' 37' ' ' LEU . 7.2 tt -98.98 118.6 36.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.697 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.624 ' HB2' HG22 ' A' ' 36' ' ' ILE . 3.9 mpt_? -97.52 119.4 36.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.644 0.259 . . . . 0.0 110.53 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 56.4 mt -92.46 110.16 22.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.021 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.465 HG12 HG21 ' A' ' 3' ' ' VAL . 27.5 mt -104.55 120.84 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.53 -171.08 44.09 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.028 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.494 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 9.5 t70 -60.73 135.49 92.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 O-C-N 123.786 0.345 . . . . 0.0 110.782 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HA ' HG23 ' A' ' 2' ' ' THR . 97.2 Cg_exo -43.48 -46.73 9.73 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.174 2.582 . . . . 0.0 114.262 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.469 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 87.3 t80 -64.81 -40.39 95.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.296 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.756 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 52.0 mttp -67.52 -42.26 83.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.281 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 2' ' ' THR . 98.9 t -60.16 -33.49 53.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.674 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.71 -50.1 53.54 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 12.5 mm100 -65.37 -39.68 92.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.223 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.517 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -63.56 -43.45 97.02 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.773 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.2 m -56.93 -44.36 82.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.761 0.315 . . . . 0.0 110.356 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.99 -42.16 99.76 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.905 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.602 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 5.6 ptt? -77.51 -34.22 54.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.406 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.489 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 54.1 t -61.62 -38.69 80.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 110.243 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.8 mtt -69.98 -21.84 63.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.542 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.59 ' HB2' HH21 ' A' ' 82' ' ' ARG . 31.9 t70 -84.84 -59.25 2.4 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.789 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -68.44 -20.04 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.069 -174.013 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.813 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 6.5 tt -76.51 -10.26 59.26 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.309 175.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -65.58 -17.37 64.53 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.917 0.389 . . . . 0.0 110.351 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HB3' HD22 ' A' ' 15' ' ' LEU . 10.5 tp10 -56.83 128.43 36.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.522 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -96.7 -20.18 18.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.013 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -122.46 36.63 4.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.648 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 65.08 105.43 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.247 173.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.69 -104.23 0.22 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.759 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 91.26 33.43 8.11 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.541 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.446 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 21.0 m-85 67.89 -56.68 0.47 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.215 0.606 . . . . 0.0 111.871 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 115.28 105.79 2.56 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -172.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.558 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 2.5 t70 73.39 -61.34 0.5 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.673 0.389 . . . . 0.0 110.354 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.798 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 8.6 ttm180 169.72 -21.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.564 1.165 . . . . 0.0 108.712 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.608 ' HA ' ' OD1' ' A' ' 94' ' ' ASP . 0.2 OUTLIER 66.1 31.89 8.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.611 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 1.034 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 34.4 tt0 -141.07 -40.05 0.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.157 -173.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 20.0 p90 -159.98 -44.07 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.95 ' HA3' HH12 ' A' ' 30' ' ' ARG . . . 65.12 72.74 0.67 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.572 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.756 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 49.7 m 67.67 -37.89 0.34 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 175.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.422 ' HB3' ' H ' ' A' ' 89' ' ' ILE . 2.8 tmt_? -68.53 -81.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.941 HD12 ' HG2' ' A' ' 125' ' ' GLN . 31.5 mm -65.97 -80.35 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -168.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.96 73.47 0.75 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -170.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.522 ' H ' ' HD2' ' A' ' 85' ' ' TYR . . . 118.75 161.12 11.66 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.805 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 89.34 -146.66 19.11 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.144 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 1.034 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 43.4 pt -149.24 162.02 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 172.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.608 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 2.3 p-10 -107.4 140.51 40.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 138' ' ' ALA . 17.2 m -132.91 95.24 19.4 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.466 0.65 . . . . 0.0 111.472 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 95' ' ' VAL . 12.3 Cg_endo -58.47 108.68 0.42 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.191 2.594 . . . . 0.0 111.899 173.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.716 HG12 HD21 ' A' ' 158' ' ' LEU . 89.8 t -98.2 118.64 63.32 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.447 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.584 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 59.9 Cg_exo -41.35 132.57 3.38 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.518 2.812 . . . . 0.0 112.217 172.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -61.19 -26.47 67.74 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.019 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -92.21 6.73 45.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.4 m -122.63 -29.14 4.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.553 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.439 ' HA ' HG13 ' A' ' 97' ' ' VAL . 14.1 p -51.55 -30.75 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.08 -44.7 96.14 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.098 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.08 -35.0 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.865 0.364 . . . . 0.0 110.448 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.93 -42.54 95.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.979 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.667 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 48.2 mm -75.49 -45.35 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.892 0.377 . . . . 0.0 110.612 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.12 -147.64 16.86 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.654 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 109' ' ' SER . 14.9 ptm180 -108.68 -44.52 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.056 0.455 . . . . 0.0 110.274 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.509 ' HB2' ' HG3' ' A' ' 111' ' ' GLU . 46.2 m -106.6 10.35 31.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.197 0.522 . . . . 0.0 109.748 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.03 28.05 59.23 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.325 -176.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -92.48 -20.35 21.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.362 0.125 . . . . 0.0 111.203 -178.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.424 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 16.7 tpt -74.41 -43.22 57.28 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.667 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 6.2 tp -63.84 -28.24 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.222 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.689 ' HA ' ' HG2' ' A' ' 117' ' ' GLN . 98.8 mttt -78.68 -19.12 53.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.63 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 63.6 mttm -64.76 -31.82 73.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.8 mm -67.78 -38.61 80.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.245 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.689 ' HG2' ' HA ' ' A' ' 114' ' ' LYS . 2.7 mm100 -72.39 -27.23 62.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.04 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.18 -38.63 35.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.399 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -81.29 -54.99 5.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.357 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.0 -5.06 51.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -172.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.88 29.23 67.23 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.727 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.7 m -95.82 177.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.168 0.508 . . . . 0.0 111.549 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -129.41 133.87 47.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.062 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.531 HG12 HE22 ' A' ' 117' ' ' GLN . 47.7 mm -99.72 127.23 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.336 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.941 ' HG2' HD12 ' A' ' 89' ' ' ILE . 5.3 tp-100 -122.64 97.13 5.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.513 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -74.94 106.39 6.43 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.757 ' HZ1' ' HB2' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -125.62 132.3 52.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.157 -177.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.757 ' HB2' ' HZ1' ' A' ' 127' ' ' LYS . 29.0 mm-40 . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.463 -0.283 0 CA-C-O 120.941 0.309 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.584 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 5.3 mp0 -114.24 161.95 17.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.962 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -110.46 110.93 21.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 34.1 mm -68.24 102.18 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.181 0.515 . . . . 0.0 111.287 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.8 ' HB2' HG23 ' A' ' 95' ' ' VAL . . . -80.82 141.05 35.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 57.7 t-80 -106.33 115.02 29.49 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.877 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.738 HD13 HD13 ' A' ' 154' ' ' ILE . 83.7 mt -80.14 110.75 16.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 27.7 ttp -109.06 123.69 49.56 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.018 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.72 -161.12 34.9 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.418 ' HG2' ' CZ ' ' A' ' 146' ' ' ARG . 18.2 Cg_exo -67.58 141.14 54.23 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.689 2.259 . . . . 0.0 111.531 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -44.31 -51.11 7.2 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.799 2.999 . . . . 0.0 114.343 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.58 -38.31 86.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.411 0.624 . . . . 0.0 110.559 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.418 ' CZ ' ' HG2' ' A' ' 143' ' ' PRO . 12.1 ttm180 -72.49 -30.44 64.53 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.253 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.805 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 77.5 m -56.35 -57.97 10.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.913 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.487 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 6.4 mm-40 -64.28 -27.75 69.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.679 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -65.92 -29.78 70.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.176 0.512 . . . . 0.0 110.373 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.671 ' HB1' HD12 ' A' ' 140' ' ' ILE . . . -78.2 -34.97 49.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.261 0.553 . . . . 0.0 109.903 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -17.03 64.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.408 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -76.19 -42.1 47.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 0.0 110.193 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.85 -42.28 82.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.952 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.738 HD13 HD13 ' A' ' 140' ' ' ILE . 73.4 mt -67.57 -34.96 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.472 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -62.46 -48.81 77.99 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.8 -44.58 70.29 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.094 176.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.11 -52.95 62.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.415 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.716 HD21 HG12 ' A' ' 97' ' ' VAL . 86.1 mt . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.372 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 47.5 t -126.95 112.72 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.676 171.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -113.41 144.91 42.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.056 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.553 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 41.2 mt-10 -109.52 111.77 23.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.243 0.544 . . . . 0.0 111.654 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 6' ' ' ILE . 3.3 mp -105.2 139.07 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.2 mtp -95.71 123.73 39.41 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.265 0.555 . . . . 0.0 110.645 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.713 HG12 HG12 ' A' ' 16' ' ' VAL . 1.6 mp -96.98 114.8 65.24 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.725 -175.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 37.9 Cg_exo -63.84 147.94 92.06 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.771 2.981 . . . . 0.0 113.007 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.36 132.37 47.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 168.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.53 -44.16 1.59 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -170.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 9' ' ' PRO . 14.2 mptt -72.05 -26.32 62.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.008 0.432 . . . . 0.0 110.003 173.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.577 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.31 -32.55 25.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.472 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' HA2' ' A' ' 18' ' ' GLY . . . -60.98 -38.53 95.65 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.566 -0.825 . . . . 0.0 112.903 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.766 HD23 ' HB2' ' A' ' 73' ' ' GLU . 3.5 pp -91.01 -27.23 18.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.405 0.602 . . . . 0.0 111.419 176.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.713 HG12 HG12 ' A' ' 8' ' ' ILE . 75.8 t -70.04 -58.93 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 13' ' ' ALA . 37.9 pt -91.77 -22.64 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.67 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . 84.42 19.41 60.43 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.561 ' H ' HG13 ' A' ' 17' ' ' ILE . 32.9 mmtp 65.6 -68.76 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.671 0.788 . . . . 0.0 111.314 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.55 5.9 79.47 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.69 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.78 10.09 58.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.769 177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 27.7 tt0 -66.25 -39.15 89.29 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.809 -0.23 . . . . 0.0 111.513 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 15' ' ' LEU . 20.5 m -77.25 -33.88 55.95 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.317 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -67.06 -29.99 48.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.901 178.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 10.7 ttmm -49.68 -55.23 14.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.66 0.743 . . . . 0.0 109.098 168.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.52 HE21 ' NH1' ' A' ' 30' ' ' ARG . 35.9 mt-30 -70.32 -39.3 74.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.493 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 32.1 mt -66.61 -25.61 66.69 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.945 -0.472 . . . . 0.0 111.488 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 43.8 mt-30 -85.73 -41.17 15.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.732 0.301 . . . . 0.0 111.352 173.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 25' ' ' LYS . 12.4 mm-40 -86.66 -55.25 3.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -175.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.685 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 6.9 ttm180 -67.1 -50.59 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.198 0.523 . . . . 0.0 110.865 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 87' ' ' SER . . . -70.13 -9.99 57.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.415 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.54 23.0 60.01 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.999 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 53' ' ' ILE . 34.2 m -132.2 155.57 41.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -89.98 109.1 20.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.577 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 58.4 mtt -96.71 116.03 28.43 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.421 ' C ' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -109.58 107.12 22.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 122.322 1.058 . . . . 0.0 108.79 178.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.96 HD13 HD12 ' A' ' 51' ' ' LEU . 1.3 pt? -133.47 144.85 49.71 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.013 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.847 HG22 ' HB2' ' A' ' 42' ' ' SER . 2.5 mp -56.95 122.08 5.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 123.507 0.504 . . . . 0.0 110.145 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -129.91 -159.58 0.97 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.64 99.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.536 0.684 . . . . 0.0 110.346 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.84 -39.24 0.5 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.847 ' HB2' HG22 ' A' ' 38' ' ' ILE . 16.8 m -88.31 171.92 9.81 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -89.84 -13.74 35.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.884 0.373 . . . . 0.0 111.486 -171.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.792 ' HB2' HG23 ' A' ' 38' ' ' ILE . 94.8 m-20 -87.68 34.9 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -176.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -64.97 -46.13 82.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -85.26 -14.44 46.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.594 0.711 . . . . 0.0 109.76 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 35.5 t -79.66 156.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.462 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.81 131.13 45.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 173.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.655 ' HD2' ' O ' ' A' ' 38' ' ' ILE . 26.8 mtmm -121.68 125.97 26.59 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -165.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 38' ' ' ILE . 88.3 Cg_endo -80.57 130.67 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.581 2.187 . . . . 0.0 112.313 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.96 HD12 HD13 ' A' ' 37' ' ' LEU . 6.8 tt -108.37 128.59 54.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.695 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.553 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.1 mpt_? -97.62 118.94 35.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.481 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.681 HG22 HG22 ' A' ' 33' ' ' VAL . 59.9 mt -88.08 109.51 19.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.44 HG12 HG23 ' A' ' 3' ' ' VAL . 29.4 mt -110.39 119.12 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.518 ' HA3' HG13 ' A' ' 33' ' ' VAL . . . 171.86 -170.61 43.54 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.834 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.469 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 7.5 t70 -64.72 137.79 97.25 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 122.781 0.432 . . . . 0.0 110.914 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HA ' HG23 ' A' ' 2' ' ' THR . 76.3 Cg_exo -40.3 -49.13 3.97 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.601 2.867 . . . . 0.0 113.964 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -63.46 -45.42 90.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.765 0.317 . . . . 0.0 110.724 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.469 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 46.2 mttm -62.95 -43.74 97.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.848 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 53' ' ' ILE . 90.9 t -63.52 -29.25 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.633 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.521 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -80.5 -46.28 16.1 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -173.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -66.99 -32.57 73.89 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.46 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.735 ' HA ' ' SD ' ' A' ' 66' ' ' MET . . . -70.42 -45.02 66.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' A' ' 61' ' ' GLN . 26.5 p -63.02 -27.23 69.27 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.311 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.05 -47.54 28.43 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.202 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.735 ' SD ' ' HA ' ' A' ' 63' ' ' ALA . 6.6 ptm -69.13 -38.58 78.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.439 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 26.9 m -63.4 -31.79 54.18 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-N 117.961 0.346 . . . . 0.0 111.326 -178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.7 mtt -81.18 -20.75 40.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.402 0.62 . . . . 0.0 109.959 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 21.1 t70 -83.16 -52.62 6.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.214 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.857 HG23 ' HB2' ' A' ' 79' ' ' PHE . 2.7 pp -72.51 -21.43 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 111.363 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.52 ' N ' HD11 ' A' ' 70' ' ' ILE . 6.1 tt -85.9 -4.18 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.55 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 12.3 ptm180 -51.87 -42.02 62.33 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.912 ' HG3' ' HA ' ' A' ' 76' ' ' GLN . 26.0 tt0 60.93 101.53 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.449 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.2 ttm105 -101.64 -36.92 8.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.037 170.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -119.81 8.32 11.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.128 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.912 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . 44.6 tt0 68.57 12.29 8.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.789 0.804 . . . . 0.0 110.915 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.06 -19.56 6.74 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 64.15 -102.64 0.61 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.857 ' HB2' HG23 ' A' ' 70' ' ' ILE . 87.8 m-85 -135.83 -29.23 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.231 0.515 . . . . 0.0 110.624 173.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.42 79.91 1.47 Allowed Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.685 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER 71.18 -60.52 0.51 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 124.499 0.764 . . . . 0.0 110.353 -172.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.401 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 4.8 ttm-85 142.65 91.74 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 126.204 1.802 . . . . 0.0 108.117 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -67.92 52.04 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.038 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 33.4 mt-10 -152.13 -45.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.747 -176.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 88' ' ' ARG . 33.1 p90 -177.44 144.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 111.306 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.505 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -128.51 -94.34 0.79 Allowed Glycine 0 C--O 1.221 -0.659 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 174.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.658 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 19.6 p -87.52 13.27 10.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.17 0.509 . . . . 0.0 110.2 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.67 ' CG ' ' HD3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -143.23 174.63 10.55 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.329 -170.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.765 HG12 ' CD2' ' A' ' 139' ' ' HIS . 8.9 mt 59.46 -80.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.768 173.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.73 41.07 89.73 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 141' ' ' MET . . . 151.38 66.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.722 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 168.22 -142.79 7.69 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.932 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 38.9 pt -142.7 143.83 25.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 117.277 0.538 . . . . 0.0 111.262 176.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.95 126.77 35.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.541 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 70.2 t -116.38 95.22 44.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.553 ' HA ' HD13 ' A' ' 137' ' ' ILE . 38.1 Cg_endo -71.28 106.51 1.94 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 121.4 1.4 . . . . 0.0 111.276 169.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 136' ' ' LYS . 10.7 p -104.47 129.39 25.12 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 121.229 0.538 . . . . 0.0 110.169 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.625 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 52.9 Cg_exo -52.79 128.83 30.04 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.221 2.614 . . . . 0.0 112.624 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 0.6 OUTLIER -57.43 -25.57 59.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.904 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -92.09 16.36 11.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.605 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.534 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 2.7 p -155.97 12.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 p -77.01 -20.57 14.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.464 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.13 -33.59 86.31 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.92 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.496 ' O ' ' HG2' ' A' ' 112' ' ' MET . 7.3 p -74.99 -24.02 17.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.063 0.459 . . . . 0.0 110.412 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.432 HG23 HG21 ' A' ' 97' ' ' VAL . 30.9 t -72.88 -37.62 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.064 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 46.7 mm -84.26 -38.99 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.425 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.29 -133.56 11.65 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -102.4 -74.03 0.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.915 0.388 . . . . 0.0 110.443 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.514 ' HB2' ' OE1' ' A' ' 111' ' ' GLU . 30.5 m -89.38 -4.73 57.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.894 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 113' ' ' ILE . . . 114.01 6.74 20.35 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.06 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.514 ' OE1' ' HB2' ' A' ' 109' ' ' SER . 1.1 mp0 -65.16 -24.02 67.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' A' ' 104' ' ' VAL . 15.8 tpt -76.49 -40.61 49.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.402 . . . . 0.0 110.907 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.613 HD13 HG21 ' A' ' 124' ' ' ILE . 6.6 tp -70.02 -32.34 51.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 88.7 mttt -71.29 -29.32 64.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.429 0.633 . . . . 0.0 109.642 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.494 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 7.0 ttmt -66.28 -36.85 84.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.746 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.5 mt -65.1 -39.72 86.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.148 0.499 . . . . 0.0 109.709 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.583 HE21 ' HB ' ' A' ' 124' ' ' ILE . 79.2 mt-30 -63.93 -24.84 67.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.428 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -87.01 -50.54 6.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.235 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.02 -40.06 32.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.153 -172.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.58 -16.69 20.91 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.266 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.7 42.11 62.81 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.4 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.9 150.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.09 0.471 . . . . 0.0 111.628 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -96.74 122.35 39.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.56 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 113' ' ' ILE . 50.0 mm -109.44 141.85 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.942 0.401 . . . . 0.0 111.998 -170.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.75 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 1.9 pt20 -158.89 144.13 16.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -96.82 107.5 19.99 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.744 -0.597 . . . . 0.0 109.741 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.67 ' HD3' ' CG ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -112.55 134.0 54.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.458 -171.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 . . . . . 0 N--CA 1.467 0.406 0 O-C-N 123.962 0.789 . . . . 0.0 112.892 174.636 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.5 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 20.5 Cg_endo . . . . . 0 CA--C 1.529 0.271 0 N-CA-C 112.508 0.157 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.625 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 0.4 OUTLIER -86.13 155.6 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.833 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.607 ' O ' HG12 ' A' ' 97' ' ' VAL . 74.0 mttt -110.96 113.56 26.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.199 -175.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.653 HG21 ' HZ2' ' A' ' 127' ' ' LYS . 4.9 mm -79.19 115.1 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.186 0.517 . . . . 0.0 111.711 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . . . -87.31 142.34 27.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.666 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.765 ' CD2' HG12 ' A' ' 89' ' ' ILE . 2.9 t-80 -86.95 107.69 18.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.12 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 150' ' ' ALA . 23.1 mt -105.42 121.99 58.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 172.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.704 ' HE3' ' HE1' ' A' ' 139' ' ' HIS . 43.7 ttp -129.82 139.71 51.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 -176.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.5 -155.01 25.92 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.3 139.25 37.93 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.475 2.117 . . . . 0.0 111.174 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.29 -47.93 8.53 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 123.691 2.927 . . . . 0.0 113.229 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.28 -48.2 82.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.484 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -66.86 -29.97 70.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.837 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.722 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 66.9 m -59.31 -62.43 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.72 -42.79 89.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.882 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.508 ' O ' HG13 ' A' ' 153' ' ' ILE . 11.9 t-160 -58.49 -24.75 61.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.235 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.612 ' HB2' HD12 ' A' ' 140' ' ' ILE . . . -81.06 -52.36 7.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.27 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.05 -26.14 68.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -79.66 -19.04 50.01 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.798 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 149' ' ' HIS . 78.4 mt -72.06 -42.53 67.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 167.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.677 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 71.1 mt -61.07 -49.95 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.358 176.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -53.12 -40.22 64.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.529 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.25 -43.73 95.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.883 0.373 . . . . 0.0 110.564 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.03 -39.81 94.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.406 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 33.3 mt . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.564 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 78.8 t -127.91 125.95 65.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.077 0.465 . . . . 0.0 111.186 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -122.43 145.16 48.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.837 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 67.3 mt-10 -111.84 126.7 55.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.48 0.657 . . . . 0.0 112.222 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.442 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -119.74 126.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 173.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 ttm -82.34 125.08 30.6 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.019 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.623 HG12 HG13 ' A' ' 16' ' ' VAL . 1.6 mp -101.05 119.37 58.23 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.617 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.642 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 51.2 Cg_exo -60.27 154.5 52.04 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.582 2.854 . . . . 0.0 113.047 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 129.76 39.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.63 -38.6 3.04 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -170.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.652 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -70.6 -30.76 67.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.582 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -54.67 -35.08 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.618 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.51 -32.57 73.52 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.157 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.736 ' HB3' ' HA ' ' A' ' 76' ' ' GLN . 0.8 OUTLIER -91.48 -25.91 19.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 117.069 0.435 . . . . 0.0 111.433 177.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.623 HG13 HG12 ' A' ' 8' ' ' ILE . 85.5 t -77.32 -48.84 23.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.704 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.618 HG13 ' H ' ' A' ' 19' ' ' LYS . 36.8 pt -91.93 -15.42 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.199 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 90.51 5.47 69.3 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.618 ' H ' HG13 ' A' ' 17' ' ' ILE . 13.6 tptm 65.27 -64.4 0.18 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.31 1.044 . . . . 0.0 110.645 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.09 -6.76 88.77 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 108.11 3.14 33.8 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.663 174.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.719 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 34.9 tt0 -62.41 -45.37 93.44 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.434 0.617 . . . . 0.0 111.981 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.474 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 25.7 m -71.27 -37.81 71.89 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.566 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.698 HD13 HD13 ' A' ' 27' ' ' LEU . 4.9 tp -64.76 -25.55 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.802 0.334 . . . . 0.0 110.381 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.719 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 76.0 mttt -58.77 -46.95 86.32 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.63 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -68.33 -39.07 82.06 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.917 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.698 HD13 HD13 ' A' ' 24' ' ' ILE . 39.1 mt -66.63 -26.89 67.29 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.135 -0.353 . . . . 0.0 110.922 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.722 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 79.7 mt-30 -85.52 -52.1 6.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -86.58 -55.29 3.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.54 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.625 HH22 ' HA ' ' A' ' 83' ' ' ASN . 2.7 mtp180 -62.61 -47.88 81.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.169 0.509 . . . . 0.0 111.269 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 27' ' ' LEU . . . -78.16 -2.81 39.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.695 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.12 22.02 41.27 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.765 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.3 m -133.74 153.66 37.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -93.55 109.24 20.86 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.936 ' HB3' HD21 ' A' ' 51' ' ' LEU . 46.9 mtt -93.47 113.89 26.14 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.411 ' C ' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -109.96 107.96 24.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 122.46 1.124 . . . . 0.0 109.464 -177.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.672 HD11 HD23 ' A' ' 51' ' ' LEU . 1.1 pt? -133.36 142.81 48.59 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.014 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.9 mm -64.5 98.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.115 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.409 ' HG2' HG23 ' A' ' 17' ' ' ILE . 26.0 mt-30 -82.03 -59.8 2.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -122.12 -176.94 3.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.636 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.619 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . 105.6 157.37 22.49 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -82.24 28.97 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -105.41 -96.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -100.28 58.5 0.98 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.639 HG23 ' H ' ' A' ' 46' ' ' ASN . 1.6 t -61.95 -61.19 2.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.508 -174.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.639 ' H ' HG23 ' A' ' 45' ' ' THR . 66.1 t30 -96.03 -22.43 17.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.834 -0.541 . . . . 0.0 111.316 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 m -83.85 -168.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -169.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.14 147.97 23.33 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.347 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -135.14 133.98 21.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.887 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.07 111.13 1.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.691 2.261 . . . . 0.0 111.578 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.936 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.0 tm? -88.46 111.76 22.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.239 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' A' ' 35' ' ' MET . 5.3 mpt_? -98.69 111.02 23.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.923 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.2 mt -85.95 110.42 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.537 HG12 HG21 ' A' ' 3' ' ' VAL . 21.1 mt -110.18 119.93 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.202 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.504 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.72 -170.44 43.36 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.032 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.934 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 7.3 m-20 -61.56 141.9 94.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 122.487 0.315 . . . . 0.0 110.646 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 54.1 Cg_exo -50.53 -51.69 10.54 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.403 2.736 . . . . 0.0 114.174 -169.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -57.02 -44.55 82.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.065 0.459 . . . . 0.0 110.44 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.934 ' HE2' ' HB2' ' A' ' 56' ' ' ASP . 42.1 mtmt -68.58 -40.57 80.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.759 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.3 t -61.93 -35.65 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.463 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.03 -54.25 28.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -65.43 -27.48 68.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.546 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.573 ' HA ' ' HE3' ' A' ' 66' ' ' MET . . . -79.7 -36.53 37.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 68' ' ' MET . 38.1 t -56.82 -42.4 79.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.075 0.464 . . . . 0.0 110.005 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.47 -26.69 38.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.448 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.624 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 9.9 ptp -66.37 -48.02 71.49 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.462 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.624 ' N ' ' HG3' ' A' ' 66' ' ' MET . 91.9 t -59.83 -47.61 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.815 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 64' ' ' CYS . 19.9 ptp -70.57 -20.59 62.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.924 0.392 . . . . 0.0 111.12 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 25.3 t70 -85.98 -44.2 12.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -81.82 -21.37 10.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.901 -0.719 . . . . 0.0 111.053 -177.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.607 ' HA ' HD12 ' A' ' 15' ' ' LEU . 3.2 pp -77.02 -2.71 35.36 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.229 174.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 8.4 ptp180 -63.88 -19.95 65.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.278 0.561 . . . . 0.0 109.531 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.576 ' HG2' ' N ' ' A' ' 77' ' ' GLY . 9.5 tp10 -52.47 144.17 13.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.338 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -87.63 -60.1 2.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.013 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -113.61 55.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.7 -173.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.736 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 62.2 tt0 69.39 114.09 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.739 0.78 . . . . 0.0 112.545 173.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.576 ' N ' ' HG2' ' A' ' 73' ' ' GLU . . . 157.3 -96.35 0.15 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.476 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.7 -99.2 1.48 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.588 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -141.29 -41.42 0.38 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.868 0.366 . . . . 0.0 110.053 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 91.25 91.62 1.35 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -171.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 3.4 t70 70.57 -69.89 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -165.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.587 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 20.8 ttm-85 171.62 -40.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.763 0.825 . . . . 0.0 109.129 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.625 ' HA ' HH22 ' A' ' 30' ' ' ARG . 4.7 t30 61.87 59.13 1.79 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.629 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 1.05 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 44.9 tt0 -173.95 -38.5 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.275 -173.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.4 ' HB3' ' H ' ' A' ' 90' ' ' GLY . 5.6 p90 -168.4 90.16 0.27 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.626 166.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' HA2' ' CE ' ' A' ' 66' ' ' MET . . . -83.87 96.94 2.01 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 170.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.605 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 61.3 p 66.84 -53.69 0.45 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.112 1.365 . . . . 0.0 111.896 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 6.0 mmt180 -97.42 -167.2 1.5 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.019 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.653 HG23 ' ND1' ' A' ' 139' ' ' HIS . 71.0 mt 75.52 -66.44 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 124.083 0.864 . . . . 0.0 111.085 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 50.42 61.03 6.23 Favored Glycine 0 N--CA 1.451 -0.352 0 O-C-N 123.691 0.619 . . . . 0.0 112.497 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.34 88.89 1.02 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.878 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.616 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 154.36 -128.06 2.27 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 1.05 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 31.1 pt -148.37 154.39 10.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -89.03 128.05 35.71 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 53.5 t -119.1 96.72 50.3 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.872 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.543 ' HA ' HD11 ' A' ' 137' ' ' ILE . 60.1 Cg_endo -77.38 107.54 2.42 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.786 1.657 . . . . 0.0 110.941 174.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 102' ' ' VAL . 21.7 t -100.64 124.43 42.4 Favored Pre-proline 0 C--N 1.319 -0.74 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.205 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.1 129.53 22.01 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.589 2.193 . . . . 0.0 110.742 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -57.57 -28.51 63.64 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -172.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -80.67 -7.26 59.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.752 0.311 . . . . 0.0 110.877 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 m -113.31 -27.27 8.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.71 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.423 ' HA ' HG13 ' A' ' 97' ' ' VAL . 12.1 p -57.44 -30.08 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 111.596 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.49 -34.72 89.95 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.091 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.8 t -74.14 -29.42 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.024 0.44 . . . . 0.0 110.273 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -34.99 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.149 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.9 mm -84.13 -47.89 17.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.2 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.39 -116.42 5.51 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.549 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -128.7 -54.31 1.23 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.141 0.496 . . . . 0.0 110.009 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 m -105.1 20.55 18.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.297 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.1 18.15 76.26 Favored Glycine 0 C--O 1.224 -0.475 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.46 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 6.0 tp10 -68.49 -37.06 79.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.993 0.425 . . . . 0.0 111.092 -174.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.6 tpt -69.68 -43.39 72.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.693 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.427 HD13 ' CB ' ' A' ' 124' ' ' ILE . 19.8 tt -67.31 -27.03 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.155 0.502 . . . . 0.0 111.032 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 50.4 mtpt -65.12 -32.03 73.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.421 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -72.3 -32.33 66.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 113' ' ' ILE . 10.8 mm -63.98 -50.59 76.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -62.84 -29.72 70.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.287 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -79.84 -38.7 32.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.601 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -79.5 -38.91 33.31 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.786 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.45 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -96.65 -11.25 25.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 111.49 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.4 23.35 75.8 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.592 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.03 173.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.337 . . . . 0.0 111.425 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 31.6 mtp180 -136.24 141.04 43.91 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 173.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.427 ' CB ' HD13 ' A' ' 113' ' ' ILE . 36.5 mm -110.26 138.67 37.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.524 0.678 . . . . 0.0 112.561 -171.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 138.17 44.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.148 171.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -84.86 105.28 15.52 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.712 ' HE2' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -94.82 -166.13 1.42 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.298 -169.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.444 ' H ' ' HB2' ' A' ' 127' ' ' LYS . 27.7 tp60 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.618 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 N--CA 1.454 -0.82 0 N-CA-C 113.185 0.417 . . . . 0.0 113.185 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -143.8 165.84 26.57 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.356 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -123.08 118.21 27.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.728 0.299 . . . . 0.0 110.353 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.712 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 18.8 mm -70.14 124.22 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 111.966 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -102.39 140.66 36.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.298 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.653 ' ND1' HG23 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -83.54 112.09 19.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.602 178.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.733 HD12 ' HB3' ' A' ' 150' ' ' ALA . 24.7 mt -91.81 123.76 44.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.66 169.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.486 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 44.5 ttm -102.71 136.75 41.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.75 -169.98 24.16 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.126 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 14.5 Cg_exo -70.29 139.1 37.61 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.109 2.539 . . . . 0.0 111.166 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 147' ' ' CYS . 87.0 Cg_exo -48.6 -32.92 22.52 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.24 3.293 . . . . 0.0 114.456 -174.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.1 -43.1 68.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.001 0.429 . . . . 0.0 110.781 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 49.8 mtt180 -72.36 -26.34 61.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.062 0.458 . . . . 0.0 110.03 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.601 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 92.7 m -55.91 -58.04 9.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.801 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.85 -30.02 71.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.911 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.421 ' O ' HG13 ' A' ' 153' ' ' ILE . 4.2 t60 -57.86 -35.73 71.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.311 0.577 . . . . 0.0 110.214 176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.733 ' HB3' HD12 ' A' ' 140' ' ' ILE . . . -78.6 -38.35 40.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.905 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.82 -25.16 67.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.58 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -79.15 -25.0 42.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.237 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.436 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 42.1 mt -73.35 -37.74 52.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 57.3 mt -71.77 -33.33 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.176 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -63.68 -40.52 97.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.746 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.29 -30.45 71.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.703 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 26.9 mt -66.08 -32.15 73.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.981 0.42 . . . . 0.0 110.096 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.879 176.686 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 89.1 t -133.91 131.34 56.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.458 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -134.52 149.2 50.65 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 46.4 mt-10 -106.49 135.76 47.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.23 0.538 . . . . 0.0 111.741 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.0 mp -119.22 148.15 22.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.446 ' HA ' ' HE1' ' A' ' 7' ' ' MET . 2.2 mmt -92.33 114.25 26.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.707 0.289 . . . . 0.0 111.369 -177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 51' ' ' LEU . 2.3 mp -100.14 108.01 50.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.101 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 12' ' ' LYS . 7.3 Cg_exo -75.92 155.0 38.65 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.939 2.426 . . . . 0.0 111.474 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.17 128.97 38.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.04 -34.56 5.36 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -169.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 10.0 mptt -94.53 -4.39 48.09 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.129 0.49 . . . . 0.0 110.747 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.67 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -61.61 -43.06 99.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.548 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.25 -11.15 55.08 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.831 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.596 ' CD1' ' HB3' ' A' ' 73' ' ' GLU . 34.1 mt -84.84 -47.8 9.99 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.474 HG22 ' CG1' ' A' ' 8' ' ' ILE . 65.1 t -78.06 -44.58 27.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.989 -176.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.782 HG13 ' H ' ' A' ' 19' ' ' LYS . 23.3 pt -90.77 -15.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 121.54 -0.725 . . . . 0.0 110.468 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.45 -1.19 89.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.783 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.782 ' H ' HG13 ' A' ' 17' ' ' ILE . 14.3 tptm 72.9 -44.04 0.58 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.015 0.926 . . . . 0.0 110.702 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.95 -11.04 55.72 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.914 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.81 -9.03 29.84 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.447 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.49 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 10.5 mp0 -54.09 -49.29 69.41 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.954 0.502 . . . . 0.0 112.33 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 15' ' ' LEU . 26.4 m -70.11 -43.42 71.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.444 HD12 HD12 ' A' ' 27' ' ' LEU . 6.0 tp -61.99 -25.9 38.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.331 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 42.6 mttm -62.68 -42.59 99.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.496 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.49 ' HB3' ' HD3' ' A' ' 30' ' ' ARG . 49.2 mt-30 -83.55 -29.16 28.07 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.003 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.566 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 82.7 mt -65.89 -24.8 66.93 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.541 -0.725 . . . . 0.0 109.683 171.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.754 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.2 mt-30 -86.1 -55.42 3.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.618 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -80.76 -45.4 17.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.591 ' NH2' ' HA ' ' A' ' 83' ' ' ASN . 11.4 mtp180 -76.06 -42.08 48.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.631 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -82.87 -9.07 59.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.122 0.486 . . . . 0.0 110.425 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.04 20.95 71.32 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.456 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 31.4 m -134.7 163.1 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -100.24 110.28 22.52 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.994 ' HB3' HD11 ' A' ' 51' ' ' LEU . 51.4 mtt -93.59 114.52 26.88 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.426 ' C ' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -110.85 108.02 24.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 122.399 1.095 . . . . 0.0 109.302 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.608 HD12 HD13 ' A' ' 51' ' ' LEU . 1.3 pt? -133.68 142.64 48.11 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.262 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.436 ' H ' HD11 ' A' ' 38' ' ' ILE . 3.5 mp -64.31 101.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.208 0.528 . . . . 0.0 111.107 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -99.29 -58.47 1.93 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -95.42 159.81 14.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.429 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.58 117.03 3.36 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.072 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 t -74.28 78.73 1.83 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.313 0.578 . . . . 0.0 110.775 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -142.65 -54.46 0.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.783 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.58 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 14.5 m120 -118.58 39.79 3.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.659 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 p -70.71 -61.5 1.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.832 0.349 . . . . 0.0 111.232 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -91.29 -4.08 56.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.498 0.666 . . . . 0.0 109.968 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 39.3 t -90.72 160.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.328 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -58.3 145.65 37.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.165 0.507 . . . . 0.0 109.706 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 128.21 26.04 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.704 -169.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.42 113.29 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.793 2.329 . . . . 0.0 112.13 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.994 HD11 ' HB3' ' A' ' 35' ' ' MET . 48.7 tp -85.58 105.34 16.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.226 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.52 101.6 14.28 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.33 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.4 mt -83.63 109.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.5 mt -107.95 119.47 57.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.152 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.51 ' HA3' HG13 ' A' ' 33' ' ' VAL . . . 171.77 -169.97 42.98 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.265 -1.445 . . . . 0.0 113.697 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.478 ' HB3' ' HD2' ' A' ' 59' ' ' LYS . 13.1 t70 -55.02 136.05 67.18 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 114.642 -0.779 . . . . 0.0 110.642 174.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 33.0 Cg_exo -57.34 -34.32 97.7 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.496 2.797 . . . . 0.0 113.813 -173.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 68.4 t80 -72.37 -35.64 68.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.556 0.693 . . . . 0.0 109.419 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HD2' ' HB3' ' A' ' 56' ' ' ASP . 53.3 mttp -76.84 -41.62 43.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.768 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.402 HG23 HG23 ' A' ' 53' ' ' ILE . 95.1 t -59.72 -36.61 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.11 176.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -56.55 17.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.45 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 12.4 mm100 -67.05 -34.52 77.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.067 -176.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -69.98 -44.77 68.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.21 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.9 t -56.74 -35.05 68.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.498 0.666 . . . . 0.0 109.584 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -72.61 -33.83 66.95 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.013 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.685 ' HA ' ' HE ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -74.98 -37.52 61.87 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.347 177.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.612 ' N ' ' HG3' ' A' ' 66' ' ' MET . 85.0 t -56.34 -52.35 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.277 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.3 mtp -62.57 -21.01 65.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.892 0.377 . . . . 0.0 111.077 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 30.6 t70 -79.37 -56.18 4.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.614 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.815 HG22 ' H ' ' A' ' 82' ' ' ARG . 2.1 pp -81.7 -21.38 10.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.514 ' O ' HD22 ' A' ' 71' ' ' LEU . 6.4 tt -84.8 -10.64 57.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.333 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 4.4 ptp180 -66.15 -11.44 49.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.078 0.466 . . . . 0.0 110.342 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.596 ' HB3' ' CD1' ' A' ' 15' ' ' LEU . 10.0 tp10 -50.64 142.22 11.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.13 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -80.77 -49.39 11.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.469 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -171.98 20.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.828 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -109.6 -86.46 0.53 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.079 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -151.56 -24.56 0.05 OUTLIER Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.774 -1.203 . . . . 0.0 114.543 -173.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.37 -127.23 8.78 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.826 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.464 ' HD2' HG23 ' A' ' 70' ' ' ILE . 70.3 m-85 -133.1 -60.28 0.86 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.962 0.411 . . . . 0.0 110.121 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.52 76.78 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 26' ' ' GLN . 3.9 m-20 54.6 44.38 28.77 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.119 0.962 . . . . 0.0 109.184 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.815 ' H ' HG22 ' A' ' 70' ' ' ILE . 30.8 ttm-85 69.06 -45.52 0.55 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.624 -1.625 . . . . 0.0 112.353 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.591 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 6.2 t30 61.21 63.64 1.2 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.616 0.722 . . . . 0.0 109.233 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 1.061 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 37.0 tt0 -177.17 -41.72 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.428 -170.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.0 p90 175.08 151.36 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.643 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.34 -12.96 1.75 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.88 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 6.3 p -172.88 -57.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.809 0.814 . . . . 0.0 108.815 -174.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.449 ' HD3' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -73.5 -178.44 3.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.473 170.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.775 HG22 ' H ' ' A' ' 91' ' ' GLY . 68.1 mt 74.13 -82.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 167.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.03 41.49 94.49 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.649 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.775 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 153.45 91.15 0.08 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.681 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.668 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 158.63 -132.96 3.25 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 175.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 1.061 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 27.7 pt -147.19 165.94 6.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 169.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.547 ' HB3' ' CG2' ' A' ' 137' ' ' ILE . 19.8 m-20 -111.36 132.18 54.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.835 HG22 ' HB1' ' A' ' 138' ' ' ALA . 2.6 m -120.86 95.28 48.97 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 120.965 0.412 . . . . 0.0 111.015 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.77 108.73 1.95 Allowed 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 122.99 2.46 . . . . 0.0 110.946 173.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.607 HG23 HG22 ' A' ' 105' ' ' VAL . 14.0 p -116.64 127.58 26.63 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.861 0.363 . . . . 0.0 111.123 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.425 ' N ' ' HG2' ' A' ' 135' ' ' GLU . 6.9 Cg_endo -50.42 131.56 32.52 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.385 2.723 . . . . 0.0 112.406 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.425 ' O ' HG12 ' A' ' 102' ' ' VAL . 15.7 ptt180 -64.22 -25.45 68.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.51 -171.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.84 -4.77 57.28 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.373 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.0 m -123.82 -10.14 7.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.758 0.313 . . . . 0.0 111.548 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 99' ' ' ARG . 12.5 p -63.83 -28.07 44.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 110.387 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.66 -30.03 71.31 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.957 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.0 t -76.53 -36.44 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.41 . . . . 0.0 110.079 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.607 HG22 HG23 ' A' ' 97' ' ' VAL . 54.2 t -69.7 -37.45 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.446 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.724 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 45.7 mm -76.55 -46.92 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.177 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.28 170.23 25.91 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -70.94 -53.15 16.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.103 0.478 . . . . 0.0 110.188 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -87.88 -6.93 57.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.182 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.69 29.06 27.66 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.687 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 78.7 mm-40 -88.99 -25.73 21.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.659 0.266 . . . . 0.0 110.743 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.512 ' SD ' ' HD2' ' A' ' 115' ' ' LYS . 17.4 tpt -68.79 -40.61 79.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.902 0.382 . . . . 0.0 110.328 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.724 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.6 tp -65.79 -27.33 41.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.297 0.57 . . . . 0.0 109.912 177.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -76.41 -30.33 57.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.522 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.512 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 99.2 mttt -62.77 -35.87 81.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.191 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.2 mm -60.88 -45.45 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.491 0.662 . . . . 0.0 109.295 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.34 -34.6 76.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.6 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -79.49 -42.17 25.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.729 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.58 -54.26 6.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.34 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -85.44 -14.37 46.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.859 0.361 . . . . 0.0 111.466 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.51 32.6 57.46 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.168 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -106.27 171.81 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.191 0.519 . . . . 0.0 111.532 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 27.2 mtm180 -122.13 140.49 52.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.354 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.436 HG22 HD12 ' A' ' 113' ' ' ILE . 50.8 mm -103.45 141.57 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 111.653 -172.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 24.5 tt0 -144.08 106.92 4.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.794 177.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -82.82 148.54 27.7 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.633 ' HD2' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -151.07 93.43 1.92 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -168.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 124.539 1.136 . . . . 0.0 112.313 178.897 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.316 0.465 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 98' ' ' PRO . 25.6 mt-10 -128.06 147.34 50.52 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.801 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -109.38 118.13 35.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.614 -168.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.633 ' O ' ' HD2' ' A' ' 127' ' ' LYS . 5.5 mm -78.7 99.5 3.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.55 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.835 ' HB1' HG22 ' A' ' 95' ' ' VAL . . . -91.95 141.94 28.09 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.878 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.519 ' CE1' HG23 ' A' ' 89' ' ' ILE . 6.7 t-160 -95.55 123.49 39.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.006 0.431 . . . . 0.0 110.504 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.599 ' HB ' ' CG1' ' A' ' 93' ' ' ILE . 37.0 mt -97.33 114.85 35.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.284 170.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.492 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 52.7 ttm -101.77 134.59 44.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.179 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.55 -165.24 31.39 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.447 ' HD2' ' HD2' ' A' ' 146' ' ' ARG . 20.5 Cg_exo -66.41 148.32 83.95 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.67 2.246 . . . . 0.0 111.658 176.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.39 -53.98 3.88 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.541 2.828 . . . . 0.0 113.645 -176.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.24 -44.77 96.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.084 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.447 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 53.8 mtt180 -64.84 -39.12 93.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.99 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.453 ' HB3' HG12 ' A' ' 93' ' ' ILE . 75.7 m -58.06 -59.21 5.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.003 0.43 . . . . 0.0 110.654 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.633 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 35.0 mm-40 -61.83 -34.73 76.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.836 -176.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -67.95 -29.06 68.02 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.798 0.333 . . . . 0.0 110.73 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.59 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -77.72 -34.23 52.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.086 0.47 . . . . 0.0 110.3 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -60.87 -31.38 70.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.749 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.633 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 7.3 mpt_? -77.7 -19.94 54.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.723 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.6 mt -73.22 -40.98 58.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 84.5 mt -68.96 -45.27 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.236 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -56.73 -32.39 65.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.789 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.39 -41.7 90.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.188 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.42 HD22 ' HE3' ' A' ' 112' ' ' MET . 3.1 mm? -63.89 -44.58 92.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.223 0.535 . . . . 0.0 110.485 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.5 HD23 HG22 ' A' ' 97' ' ' VAL . 17.2 mt . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.152 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.549 HG22 ' HA ' ' A' ' 57' ' ' PRO . 10.7 m . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.099 0.476 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 44.5 t -132.16 113.02 20.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.609 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -108.64 142.25 39.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.964 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 48.7 mt-10 -104.27 129.58 52.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.424 ' N ' HD11 ' A' ' 6' ' ' ILE . 4.1 mp -115.9 141.42 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 96.6 mmm -90.69 104.84 17.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.973 0.416 . . . . 0.0 110.965 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.539 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -91.85 118.86 68.49 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.764 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 43.4 Cg_exo -63.21 140.3 76.92 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.655 2.904 . . . . 0.0 112.809 176.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.94 123.61 21.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 170.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.08 -36.97 3.75 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -168.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 74' ' ' ARG . 11.6 mptt -74.11 -19.48 60.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.54 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -47.53 -41.02 20.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.164 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.24 -36.9 92.04 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.622 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.654 HD21 ' HB3' ' A' ' 73' ' ' GLU . 3.9 pp -91.42 -23.88 19.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.883 0.341 . . . . 0.0 111.518 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.539 HG11 HG12 ' A' ' 8' ' ' ILE . 86.7 t -82.24 -55.04 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 13' ' ' ALA . 40.6 pt -91.79 -14.99 8.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.367 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.677 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 92.18 6.56 64.72 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.841 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER 64.98 -68.35 0.11 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.874 0.869 . . . . 0.0 110.204 -176.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.83 -1.09 90.13 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.237 -0.506 . . . . 0.0 111.918 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.59 -5.92 29.71 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.409 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.616 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 57.4 mm-40 -50.87 -51.95 46.42 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.677 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 27.6 m -71.87 -39.31 69.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -174.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.599 HD11 HD12 ' A' ' 27' ' ' LEU . 2.6 tp -66.17 -27.64 41.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.08 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.338 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.616 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 22.0 mttm -56.29 -59.2 5.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.453 0.644 . . . . 0.0 109.561 172.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 18.9 mt-30 -63.51 -37.53 87.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.559 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.599 HD12 HD11 ' A' ' 24' ' ' ILE . 95.7 mt -63.2 -33.64 75.93 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.921 -0.487 . . . . 0.0 110.815 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.742 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 46.7 mt-30 -85.11 -44.77 12.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.905 0.384 . . . . 0.0 111.512 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.61 -51.47 5.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -65.78 -52.41 51.13 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.063 0.459 . . . . 0.0 109.975 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.66 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.57 -28.62 63.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.74 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.35 3.55 86.85 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.116 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.2 m -101.2 149.29 6.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -87.66 110.7 20.6 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.627 ' HE2' HG13 ' A' ' 67' ' ' VAL . 32.0 mmm -92.14 111.87 23.6 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.652 HG22 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tp -112.22 104.97 17.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.816 0.817 . . . . 0.0 109.379 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.706 ' HB3' HD22 ' A' ' 51' ' ' LEU . 1.2 pt? -132.76 127.25 34.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.561 -175.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.524 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.2 mp -68.78 99.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.497 ' HA ' ' HD2' ' A' ' 49' ' ' LYS . 7.2 tp-100 -123.76 -34.06 3.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.049 0.452 . . . . 0.0 110.29 -174.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -127.85 42.54 3.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.545 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.17 -156.76 8.4 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.127 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -90.52 -164.42 1.17 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.164 0.186 . . . . 0.0 111.214 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 71.62 -79.47 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.229 0.612 . . . . 0.0 111.008 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.537 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 5.7 m-20 -116.74 94.65 4.69 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 p -85.53 -61.87 1.66 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.021 0.438 . . . . 0.0 111.615 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -94.33 -8.7 38.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.926 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.543 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 17.3 t -85.89 164.81 2.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.908 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.48 142.59 26.86 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.997 0.427 . . . . 0.0 110.29 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 46.1 mtmt -131.6 131.18 22.67 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.75 -167.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.58 131.86 9.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.858 2.372 . . . . 0.0 113.382 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.706 HD22 ' HB3' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -111.73 124.59 52.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.494 178.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.652 ' HB2' HG22 ' A' ' 36' ' ' ILE . 4.7 mpt_? -101.11 119.69 39.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.017 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.536 HG12 ' SD ' ' A' ' 35' ' ' MET . 57.9 mt -91.19 115.28 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 173.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.1 mt -104.74 120.72 55.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.381 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.45 -170.92 43.94 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.495 -0.859 . . . . 0.0 113.149 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.702 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 13.8 t70 -72.12 143.5 86.21 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.549 ' HA ' HG22 ' A' ' 2' ' ' THR . 74.6 Cg_exo -40.49 -50.32 3.8 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.756 2.971 . . . . 0.0 114.983 -175.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -62.12 -38.94 90.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 111.221 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.887 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 19.4 ptmt -79.64 -35.42 39.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -175.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.17 -31.42 52.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.215 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -68.77 -55.84 9.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.806 0.336 . . . . 0.0 110.356 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.567 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 15.2 mm100 -59.55 -35.86 75.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.643 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.52 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -73.13 -43.61 61.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.614 ' O ' ' HG3' ' A' ' 68' ' ' MET . 36.0 t -59.11 -42.54 90.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.004 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.87 -32.54 67.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.599 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.903 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 14.7 ptt? -78.69 -38.67 38.64 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.91 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.627 HG13 ' HE2' ' A' ' 35' ' ' MET . 33.7 m -61.8 -22.11 27.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 120.649 0.261 . . . . 0.0 110.602 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 48.7 mtt -81.71 -39.94 23.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.069 0.462 . . . . 0.0 110.167 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.73 -26.58 29.61 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -171.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -87.13 -20.93 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 120.865 -1.147 . . . . 0.0 109.714 173.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.48 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 5.2 tt -75.86 -18.04 59.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.045 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -60.5 -14.24 18.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.213 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.654 ' HB3' HD21 ' A' ' 15' ' ' LEU . 8.2 tp10 -47.01 -41.49 16.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.423 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.803 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 45.1 ttp180 74.62 -67.53 0.25 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.501 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.46 62.05 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -171.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 67.38 127.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.787 0.68 . . . . 0.0 112.63 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.497 ' H ' ' HB3' ' A' ' 15' ' ' LEU . . . 137.84 -103.83 0.43 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.683 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 73.6 24.8 73.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.368 174.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 68.4 -54.57 0.53 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.514 0.726 . . . . 0.0 111.962 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 110.91 102.45 2.68 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -173.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.667 ' H ' HG22 ' A' ' 23' ' ' THR . 2.7 t70 71.38 -69.37 0.19 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -169.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.903 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 50.9 ttt85 162.13 -33.54 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.846 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.35 32.93 14.31 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.33 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.873 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 23.5 tt0 -130.73 -57.97 1.04 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.869 -174.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 9.9 p90 -146.79 -26.32 0.41 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.202 -0.936 . . . . 0.0 113.149 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.589 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 65.63 -89.16 0.11 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.816 -176.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.887 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 29.3 m -147.83 22.27 1.12 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.271 0.558 . . . . 0.0 109.606 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -96.41 -86.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.188 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -94.44 -164.08 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.251 175.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.594 ' H ' HG23 ' A' ' 89' ' ' ILE . . . -141.92 2.43 1.88 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.711 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.82 125.17 3.34 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.838 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 103.5 163.34 25.32 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.873 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 46.3 pt -97.85 157.11 3.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.017 0.437 . . . . 0.0 111.732 -174.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.552 ' CG ' ' HZ1' ' A' ' 127' ' ' LYS . 13.1 m-20 -99.11 117.47 33.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.611 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 25.0 t -107.56 105.73 56.7 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -172.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HA ' HD13 ' A' ' 137' ' ' ILE . 48.6 Cg_endo -72.48 108.02 2.43 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.826 1.684 . . . . 0.0 110.897 169.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.666 HG22 HD21 ' A' ' 158' ' ' LEU . 11.0 p -124.91 131.14 24.06 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.122 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 87.2 Cg_exo -45.52 134.01 12.83 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.389 2.726 . . . . 0.0 113.437 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.418 ' O ' HG12 ' A' ' 102' ' ' VAL . 10.3 ptm180 -55.85 -33.22 64.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.854 -174.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -86.04 -15.18 42.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.103 0.477 . . . . 0.0 110.416 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 16.0 m -95.28 -28.45 14.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.85 -176.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 106' ' ' ILE . 13.6 p -63.49 -28.21 44.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.399 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.84 -28.06 72.92 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.811 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.06 -30.49 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.189 0.519 . . . . 0.0 109.765 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.6 t -68.82 -34.37 64.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.225 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 102' ' ' VAL . 37.0 mm -80.45 -50.25 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.166 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.59 -117.8 5.47 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -126.8 -53.97 1.42 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.1 m -102.18 -15.77 16.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.036 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.51 14.53 6.86 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.85 -24.61 67.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.873 0.368 . . . . 0.0 110.987 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.604 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.0 tpt -86.15 -42.82 13.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.882 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.59 HD11 HG13 ' A' ' 124' ' ' ILE . 15.5 tt -74.01 -35.85 43.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.572 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -69.71 -23.87 63.49 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.495 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 112' ' ' MET . 16.9 ptpt -75.35 -21.96 57.96 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.364 175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 mm -65.41 -40.94 89.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.632 ' HG3' ' O ' ' A' ' 122' ' ' VAL . 1.8 mp0 -63.78 -31.28 72.41 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.268 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.09 -53.43 7.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.541 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -79.4 -51.26 9.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.113 -172.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.08 -22.42 31.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.866 0.365 . . . . 0.0 111.425 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.01 41.42 40.37 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.088 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.632 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 27.4 m -121.08 160.23 22.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 111.72 -173.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.769 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 83.3 mtp180 -111.11 151.12 28.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.633 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 113' ' ' ILE . 48.9 mm -114.4 130.99 67.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.082 0.468 . . . . 0.0 111.333 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 5.4 tp-100 -128.2 110.44 12.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.545 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -82.45 107.12 14.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.128 0.49 . . . . 0.0 110.014 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.552 ' HZ1' ' CG ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -123.15 -174.67 3.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.07 -174.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 . . . . . 0 N--CA 1.467 0.424 0 O-C-N 123.442 0.464 . . . . 0.0 111.101 177.448 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 88.1 Cg_exo . . . . . 0 CA--C 1.528 0.211 0 N-CA-C 113.501 0.539 . . . . 0.0 113.501 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 98' ' ' PRO . 36.1 mt-10 -120.7 137.64 54.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.794 0.33 . . . . 0.0 111.101 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -110.97 133.11 53.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.128 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 6.8 mm -78.17 105.64 7.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.192 0.52 . . . . 0.0 111.45 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.611 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -100.78 109.11 21.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 170.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 28.3 t60 -73.64 132.42 42.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.955 0.407 . . . . 0.0 111.119 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.653 HD13 ' HB2' ' A' ' 150' ' ' ALA . 80.5 mt -104.13 107.16 21.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.501 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.769 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 41.1 ttm -93.42 143.4 26.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.076 -174.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.44 -165.45 26.74 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.586 ' HD2' ' HD2' ' A' ' 146' ' ' ARG . 32.2 Cg_exo -60.51 136.8 69.81 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.648 2.232 . . . . 0.0 110.523 172.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.9 -32.19 55.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.034 3.156 . . . . 0.0 113.236 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.09 -51.92 58.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.293 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.586 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 98.1 mtt180 -60.4 -40.73 92.01 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.479 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.838 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 73.2 m -52.33 -59.35 4.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.316 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.16 -39.61 93.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.871 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -56.6 -29.83 62.56 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.3 0.572 . . . . 0.0 110.558 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 140' ' ' ILE . . . -79.97 -36.08 36.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.848 -175.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.75 -19.66 65.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.589 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -77.83 -36.66 49.85 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.9 mt -66.87 -40.49 85.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.833 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.595 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 54.3 mt -66.46 -41.74 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.456 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -60.31 -39.87 88.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.176 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -55.92 -41.01 73.94 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.103 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.588 HD21 ' HE2' ' A' ' 112' ' ' MET . 96.5 mt -62.31 -47.57 83.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.266 175.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.666 HD21 HG22 ' A' ' 97' ' ' VAL . 24.8 mt . . . . . 0 N--CA 1.465 0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.798 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 30.0 m -131.37 137.13 56.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.165 0.507 . . . . 0.0 111.417 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -130.35 150.65 51.49 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 73.8 mt-10 -106.19 123.86 48.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 111.57 -173.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.3 mp -112.33 140.21 33.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.8 tpp -89.15 113.41 24.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.722 0.296 . . . . 0.0 110.909 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.726 HG12 HG13 ' A' ' 16' ' ' VAL . 1.7 mp -98.61 111.14 59.48 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.065 0.459 . . . . 0.0 110.526 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.559 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 51.5 Cg_exo -60.22 139.6 87.9 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.307 2.672 . . . . 0.0 112.713 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.3 125.78 25.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 169.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.16 -46.25 1.2 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -167.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.849 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.7 -32.7 64.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.651 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.21 -31.89 21.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.55 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.16 -44.99 88.75 Favored Glycine 0 C--O 1.223 -0.593 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.49 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 73' ' ' GLU . 3.3 pp -90.09 -18.13 26.45 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.69 -0.3 . . . . 0.0 111.651 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.726 HG13 HG12 ' A' ' 8' ' ' ILE . 91.6 t -82.73 -49.01 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.781 0.324 . . . . 0.0 111.682 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.651 HG12 ' O ' ' A' ' 13' ' ' ALA . 10.1 pt -91.36 -21.67 6.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.944 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.748 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 96.16 13.12 50.21 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.597 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? 67.36 -57.7 0.43 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.961 0.904 . . . . 0.0 110.922 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.53 2.58 46.11 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 109.39 13.23 17.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.088 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.726 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 33.7 tt0 -68.32 -43.59 77.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.841 0.353 . . . . 0.0 111.736 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.748 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 59.3 m -71.06 -40.34 71.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.502 -177.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 35' ' ' MET . 7.3 tp -64.08 -21.53 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.83 0.348 . . . . 0.0 110.529 -176.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.726 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 47.9 mttm -59.0 -48.31 82.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.288 0.566 . . . . 0.0 110.136 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -79.33 -29.83 42.49 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.505 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.42 -27.25 66.03 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 121.844 -0.535 . . . . 0.0 110.449 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.661 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.4 mt-30 -84.27 -45.52 12.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.337 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.82 -39.23 15.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.507 ' HD3' ' OD2' ' A' ' 94' ' ' ASP . 4.0 ttm180 -75.29 -46.48 33.23 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.217 -176.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.796 ' HB3' ' HE2' ' A' ' 66' ' ' MET . . . -81.56 -27.0 34.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.28 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.01 21.7 60.66 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.677 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.3 m -121.97 147.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.91 0.386 . . . . 0.0 111.195 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -90.54 110.38 21.52 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.755 ' HB2' HD12 ' A' ' 24' ' ' ILE . 60.3 mtt -95.09 124.0 38.9 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.3 tp -110.93 100.81 11.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 122.156 0.979 . . . . 0.0 110.451 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.734 HD13 HD13 ' A' ' 51' ' ' LEU . 1.4 pt? -134.93 142.87 46.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.889 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.575 ' H ' HD11 ' A' ' 38' ' ' ILE . 4.2 mp -65.83 99.94 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 111.188 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -101.56 -29.04 12.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.004 176.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.19 175.03 7.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.524 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.12 48.13 3.28 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.363 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.0 t -90.21 -157.81 0.5 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -55.82 -61.37 2.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.577 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.6 m-20 -85.58 48.63 1.62 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.99 0.424 . . . . 0.0 111.218 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -76.95 -47.94 19.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -93.51 -17.01 23.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.419 0.628 . . . . 0.0 110.068 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 23.1 t -79.4 151.35 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.377 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 9' ' ' PRO . 6.6 m-20 -58.97 145.14 42.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -114.63 125.72 28.78 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-O 121.029 0.442 . . . . 0.0 111.989 -162.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.8 125.5 3.23 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.825 2.35 . . . . 0.0 111.15 174.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.734 HD13 HD13 ' A' ' 37' ' ' LEU . 7.3 tt -106.51 120.67 42.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.93 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 36' ' ' ILE . 5.1 mpt_? -102.93 120.74 41.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 71.8 mt -91.1 115.47 30.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.108 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.448 HG12 ' CG1' ' A' ' 3' ' ' VAL . 24.7 mt -104.16 121.39 55.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.98 -170.83 43.76 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.37 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.82 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 1.9 m-20 -57.42 149.08 51.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 123.171 0.589 . . . . 0.0 110.472 175.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.13 -50.28 10.19 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.842 2.361 . . . . 0.0 113.332 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 50.4 p90 -67.89 -42.53 81.04 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.82 ' HG2' ' HB2' ' A' ' 56' ' ' ASP . 16.8 ptpt -72.12 -29.91 64.54 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.969 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.87 -34.57 70.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.447 . . . . 0.0 110.051 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.563 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 59.2 tp60 -77.03 -45.91 25.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.522 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 14.4 mm100 -63.0 -27.18 69.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.079 0.466 . . . . 0.0 110.131 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.615 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -84.6 -41.81 16.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.784 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.599 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.8 p -61.1 -34.45 74.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.594 0.235 . . . . 0.0 111.595 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.77 -30.64 32.25 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.745 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.796 ' HE2' ' HB3' ' A' ' 31' ' ' ALA . 17.4 ptt? -76.02 -34.97 59.7 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.446 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 27.2 m -68.8 -22.68 26.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.636 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.599 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 49.3 mtt -82.21 -24.5 34.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.664 0.745 . . . . 0.0 109.394 172.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.459 ' CG ' HH21 ' A' ' 72' ' ' ARG . 10.0 t70 -84.58 -53.3 5.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.594 -171.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 1.059 HG22 ' HA ' ' A' ' 82' ' ' ARG . 2.6 pp -76.17 -20.77 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.412 0.625 . . . . 0.0 111.455 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.849 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 2.0 tt -76.06 -9.25 58.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.072 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.511 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 15.0 ptp180 -52.39 -53.5 44.15 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.595 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER 53.97 144.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 176.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.595 ' HD2' ' O ' ' A' ' 73' ' ' GLU . 13.0 mmm180 -121.14 -30.31 4.36 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.723 -0.611 . . . . 0.0 110.247 172.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -147.19 41.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.643 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.406 ' H ' ' CG ' ' A' ' 73' ' ' GLU . 49.6 mt-30 62.77 30.73 16.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.373 0.606 . . . . 0.0 110.068 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.68 82.7 0.35 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.199 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.36 175.94 44.69 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.646 ' CD1' HG23 ' A' ' 70' ' ' ILE . 92.8 m-85 -81.45 4.29 21.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.097 0.949 . . . . 0.0 112.348 -173.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 23' ' ' THR . . . 78.03 -3.94 59.72 Favored Glycine 0 N--CA 1.461 0.35 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.638 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.406 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -177.49 -61.57 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -178.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 1.059 ' HA ' HG22 ' A' ' 70' ' ' ILE . 2.9 ttp-105 162.47 -34.59 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 124.616 1.197 . . . . 0.0 109.45 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.74 ' HA ' ' OD1' ' A' ' 94' ' ' ASP . 2.2 t-20 57.98 58.99 3.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.931 0.872 . . . . 0.0 110.173 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 1.029 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 0.8 OUTLIER -171.95 -136.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.878 -178.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.5 ' HB3' ' H ' ' A' ' 90' ' ' GLY . 1.3 p90 -59.19 -74.42 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.689 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 85.02 -38.57 2.97 Favored Glycine 0 C--O 1.226 -0.379 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.415 ' OG ' ' HB3' ' A' ' 59' ' ' LYS . 13.0 t -170.92 -37.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.907 -0.647 . . . . 0.0 109.352 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.433 ' HG3' ' CB ' ' A' ' 127' ' ' LYS . 6.5 mmt180 -94.64 149.12 21.56 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.381 -176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.747 HD11 ' HB2' ' A' ' 141' ' ' MET . 39.8 mm 75.48 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 124.083 0.864 . . . . 0.0 111.377 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.5 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 72.11 43.6 47.53 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.46 -174.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.16 73.7 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.532 ' O ' ' HG2' ' A' ' 84' ' ' GLU . . . 147.8 159.37 8.37 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -171.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 1.029 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 9.7 pt -91.14 165.86 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -167.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.74 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 0.6 OUTLIER -99.8 148.17 24.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.865 176.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 38.7 t -135.0 96.18 14.63 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -174.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.408 ' HA ' HD13 ' A' ' 137' ' ' ILE . 35.9 Cg_endo -69.48 107.2 1.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.549 1.5 . . . . 0.0 110.504 168.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.728 HG23 HD22 ' A' ' 158' ' ' LEU . 14.9 p -117.37 128.95 25.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.584 0.231 . . . . 0.0 110.683 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.427 ' HB2' ' OG ' ' A' ' 101' ' ' SER . 64.1 Cg_exo -39.25 132.84 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.997 3.131 . . . . 0.0 113.443 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -56.99 -30.13 63.86 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.476 -171.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -90.1 -12.17 39.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.839 0.352 . . . . 0.0 111.497 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 14.8 m -96.57 -17.16 20.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.758 -173.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 106' ' ' ILE . 7.4 p -59.49 -34.7 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.13 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.38 -31.01 79.43 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.447 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.63 -37.05 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 109.952 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 97' ' ' VAL . 52.9 t -63.27 -39.87 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.294 176.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.703 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.6 mm -72.41 -42.68 64.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.309 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.98 35.94 7.44 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.788 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 63.25 -78.06 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.03 0.532 . . . . 0.0 111.857 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -69.71 -15.28 63.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.768 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.473 ' HA2' HG23 ' A' ' 106' ' ' ILE . . . 90.99 17.26 52.1 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.839 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -7.9 51.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.865 0.364 . . . . 0.0 110.968 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 14.8 tpt -90.24 -41.43 11.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.966 0.412 . . . . 0.0 109.918 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.703 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 8.9 tp -64.31 -22.43 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.207 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 99.3 mttt -81.74 -21.79 37.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.029 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -67.74 -40.24 84.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.008 0.432 . . . . 0.0 109.901 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 153' ' ' ILE . 22.1 mt -60.85 -43.65 96.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.78 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -73.71 -18.9 60.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.165 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -87.96 -45.39 10.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.824 0.345 . . . . 0.0 110.882 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -78.49 -46.67 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.512 ' O ' ' HG2' ' A' ' 146' ' ' ARG . . . -87.16 -17.46 32.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.842 0.354 . . . . 0.0 111.258 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.65 23.96 77.3 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.697 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 120' ' ' ALA . 17.4 m -95.47 177.8 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.912 0.387 . . . . 0.0 111.273 -175.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.681 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 98.5 mtt180 -129.24 131.93 47.13 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.606 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.618 HG23 HD11 ' A' ' 113' ' ' ILE . 47.0 mm -98.6 118.69 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.974 0.416 . . . . 0.0 111.02 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.672 ' HB3' HD13 ' A' ' 89' ' ' ILE . 50.6 tp60 -116.23 109.94 18.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.838 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -82.58 140.7 33.1 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.5 ' HD2' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -146.61 -172.36 3.95 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.067 -171.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 . . . . . 0 C--O 1.236 0.38 0 CA-C-O 120.859 0.361 . . . . 0.0 110.404 175.165 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo . . . . . 0 N--CA 1.461 -0.44 0 CA-C-O 120.844 0.268 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -125.83 155.82 40.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.038 0.447 . . . . 0.0 111.301 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.408 ' O ' HG11 ' A' ' 97' ' ' VAL . 23.8 mtpp -110.42 123.91 50.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.222 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.5 ' O ' ' HD2' ' A' ' 127' ' ' LYS . 15.2 mm -72.91 102.31 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.007 0.432 . . . . 0.0 112.005 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.51 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -92.72 140.96 28.99 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 169.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.501 ' HB3' ' CG1' ' A' ' 89' ' ' ILE . 2.2 m80 -106.33 138.24 42.87 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.197 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.746 HD12 ' HB1' ' A' ' 150' ' ' ALA . 87.8 mt -107.4 107.25 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.325 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.747 ' HB2' HD11 ' A' ' 89' ' ' ILE . 47.4 ttm -85.83 124.43 32.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.824 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.92 -177.82 34.49 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.131 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.64 147.74 86.45 Favored 'Trans proline' 0 C--O 1.224 -0.177 0 C-N-CA 122.913 2.409 . . . . 0.0 111.389 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.636 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 87.5 Cg_exo -45.16 -46.66 13.34 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.286 2.657 . . . . 0.0 114.132 -174.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -60.53 -34.55 74.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.764 0.316 . . . . 0.0 110.889 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 120' ' ' ALA . 7.0 mtm180 -86.79 -34.48 19.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.188 -176.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.959 ' HG ' HG23 ' A' ' 93' ' ' ILE . 25.7 p -61.42 -47.14 87.13 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -69.6 -35.64 75.48 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.597 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -54.56 -32.92 59.3 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.149 0.5 . . . . 0.0 110.942 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.746 ' HB1' HD12 ' A' ' 140' ' ' ILE . . . -78.86 -28.77 44.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.089 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.77 -23.65 63.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.955 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -78.08 -25.02 47.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.322 . . . . 0.0 110.412 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.532 HD11 HG21 ' A' ' 116' ' ' ILE . 62.1 mt -73.87 -42.84 53.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.242 0.544 . . . . 0.0 109.868 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.3 mt -68.81 -39.39 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.469 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -58.86 -36.75 75.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.486 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.21 -42.03 93.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.173 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.44 -35.23 80.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.49 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.728 HD22 HG23 ' A' ' 97' ' ' VAL . 35.5 mt . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.219 0.533 . . . . 0.0 110.323 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.955 0.407 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 38.5 t -130.35 112.52 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.439 173.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -110.87 146.93 35.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.57 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 38.4 mt-10 -110.91 116.9 32.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.219 0.533 . . . . 0.0 112.033 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.2 mm -110.16 132.28 58.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 173.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.0 ttm -90.41 119.4 30.66 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.516 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.827 HG12 HG13 ' A' ' 16' ' ' VAL . 1.8 mp -92.95 115.63 65.24 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.252 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.468 ' HA ' ' OD1' ' A' ' 48' ' ' ASP . 59.6 Cg_exo -57.12 142.14 94.32 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.598 2.865 . . . . 0.0 112.404 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.38 121.37 13.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.6 -54.2 0.6 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -167.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HE2' ' OE2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -64.69 -29.77 70.77 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 172.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.693 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -50.33 -33.82 21.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.03 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.73 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -59.56 -41.47 97.27 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.731 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.789 HD21 ' HA ' ' A' ' 76' ' ' GLN . 0.5 OUTLIER -89.39 -31.07 17.93 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.957 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.827 HG13 HG12 ' A' ' 8' ' ' ILE . 78.4 t -67.29 -47.91 79.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.699 HG13 ' H ' ' A' ' 19' ' ' LYS . 21.6 pt -91.03 -21.68 6.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.281 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.489 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 98.4 -2.5 59.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.859 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.73 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 6.1 tptm 69.78 -50.59 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 111.047 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.57 4.96 69.92 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 172.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.7 3.62 64.25 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.801 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 46.7 mt-10 -65.05 -34.31 78.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.489 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 26.7 m -85.37 -40.93 15.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.92 -175.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.504 HD11 HD13 ' A' ' 27' ' ' LEU . 3.3 tp -67.19 -26.39 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 63.7 tttt -52.73 -50.99 62.32 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.83 169.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.461 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 28.4 mt-30 -74.43 -36.5 63.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.363 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.621 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 88.0 mt -66.13 -28.23 68.64 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.173 -0.329 . . . . 0.0 111.135 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 24.3 mt-30 -85.6 -43.64 13.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.793 0.33 . . . . 0.0 111.503 176.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.59 -52.0 6.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.513 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 29.6 ttm180 -70.35 -53.35 17.03 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -65.68 -26.2 67.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.349 0.595 . . . . 0.0 110.711 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.93 0.38 75.29 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.998 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 35.3 m -103.88 151.38 6.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -92.51 110.3 21.72 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 1.082 ' HB3' HD22 ' A' ' 51' ' ' LEU . 56.8 mtt -97.24 115.38 27.5 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.361 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.93 104.42 17.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 122.334 1.064 . . . . 0.0 109.664 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.717 ' HB3' HD21 ' A' ' 51' ' ' LEU . 1.2 pt? -134.26 142.5 47.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.859 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.533 ' H ' HD11 ' A' ' 38' ' ' ILE . 4.0 mp -69.29 100.11 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.465 HE22 HG22 ' A' ' 24' ' ' ILE . 70.2 mt-30 -80.76 -67.12 0.8 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -130.54 101.65 5.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.972 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.535 ' O ' HG22 ' A' ' 45' ' ' THR . . . -155.86 149.51 20.57 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 p -69.76 71.87 0.36 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.12 0.485 . . . . 0.0 111.58 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -169.85 -56.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.411 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.529 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 90.1 m-20 -126.9 60.55 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.898 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 41' ' ' GLY . 2.2 p -83.86 -59.87 2.29 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.637 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.13 -14.92 39.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.354 0.597 . . . . 0.0 109.727 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 47.2 t -79.77 146.06 8.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.833 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.468 ' OD1' ' HA ' ' A' ' 9' ' ' PRO . 42.7 m-20 -58.81 149.91 25.33 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.565 0.541 . . . . 0.0 109.615 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -115.97 122.18 32.82 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.936 -166.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.43 121.34 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.47 2.113 . . . . 0.0 111.537 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 1.082 HD22 ' HB3' ' A' ' 35' ' ' MET . 2.1 tm? -106.19 125.17 50.66 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.299 -174.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 1.7 mpt_? -103.42 121.25 42.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.378 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 62.9 mt -89.81 109.09 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.9 mt -105.94 119.7 55.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.992 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.505 ' HA3' HG11 ' A' ' 33' ' ' VAL . . . 172.18 -171.14 44.04 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.432 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.05 146.72 97.41 Favored Pre-proline 0 C--N 1.327 -0.397 0 O-C-N 123.67 0.276 . . . . 0.0 110.522 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.12 -51.89 8.68 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.367 2.711 . . . . 0.0 114.186 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -58.2 -44.19 87.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.233 0.54 . . . . 0.0 110.457 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 86.5 mttt -62.82 -46.72 86.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.486 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.13 -34.21 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.52 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -69.63 -50.04 48.1 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.794 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -65.88 -33.5 75.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.341 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.557 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -69.7 -47.78 61.96 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.079 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 83.3 m -56.27 -37.82 70.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.171 0.51 . . . . 0.0 110.304 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -70.08 -41.92 73.45 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.888 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.894 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 10.5 ptt? -78.31 -35.69 47.44 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.425 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.542 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 26.9 m -59.44 -47.02 92.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.492 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.1 mtm -65.16 -24.29 67.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 110.479 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -83.32 -41.97 17.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.514 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -86.99 -32.65 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.442 -179.235 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.508 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -82.66 -11.66 58.19 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.348 -175.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -40.67 97.96 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 175.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' OE2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 37.21 -156.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.622 1.201 . . . . 0.0 113.431 175.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -165.12 -19.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.492 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 77' ' ' GLY . 13.7 t70 -163.2 63.93 0.18 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.894 169.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.789 ' HA ' HD21 ' A' ' 15' ' ' LEU . 65.2 tt0 70.94 -18.81 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.59 0.756 . . . . 0.0 112.619 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 75' ' ' ASP . . . -73.09 86.03 0.58 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.327 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.664 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -121.25 35.29 3.68 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.468 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 65.97 -60.78 0.29 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.626 0.77 . . . . 0.0 112.258 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 106.62 107.53 3.22 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -172.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 1.9 t70 70.64 -72.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -168.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.894 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 47.5 ttt-85 165.03 -27.79 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.825 1.25 . . . . 0.0 108.532 172.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 67.04 26.19 9.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.282 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 1.012 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 13.9 tt0 -130.52 -66.79 0.75 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.188 0.518 . . . . 0.0 110.191 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 13.3 p90 -144.84 86.9 1.81 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.771 0.796 . . . . 0.0 110.348 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.754 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -74.18 71.45 1.47 Allowed Glycine 0 C--N 1.315 -0.617 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.748 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.587 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 47.4 m 66.23 2.41 2.35 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -85.17 -86.11 0.14 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.212 0.529 . . . . 0.0 110.448 174.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.903 HD11 ' HG2' ' A' ' 125' ' ' GLN . 1.7 mt -88.75 -167.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.814 ' H ' HG21 ' A' ' 89' ' ' ILE . . . -144.57 39.62 1.21 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HE1' ' A' ' 139' ' ' HIS . . . -177.42 124.41 0.94 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.638 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 96.9 165.41 32.84 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 1.012 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 43.3 pt -94.06 156.22 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 117.292 0.546 . . . . 0.0 112.412 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.488 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 2.2 m-20 -95.88 114.14 25.84 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 175.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.603 HG21 HD11 ' A' ' 140' ' ' ILE . 44.1 t -111.65 104.81 56.45 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.514 ' HA ' HD13 ' A' ' 137' ' ' ILE . 46.1 Cg_endo -71.32 115.26 4.21 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.349 2.033 . . . . 0.0 112.341 171.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.645 HG21 HD22 ' A' ' 158' ' ' LEU . 10.5 p -117.43 126.22 27.55 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.398 0.618 . . . . 0.0 110.277 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 24.3 Cg_exo -61.79 143.06 95.7 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.306 2.671 . . . . 0.0 112.501 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -59.2 -33.96 71.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.273 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -85.27 20.94 1.83 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -149.55 -24.52 0.28 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.415 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 106' ' ' ILE . 10.6 p -60.57 -26.55 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 120.694 0.283 . . . . 0.0 110.696 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.84 -35.89 84.65 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.255 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.79 -35.18 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 110.055 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 97' ' ' VAL . 41.5 t -63.25 -38.66 82.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.569 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.785 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 44.7 mm -73.87 -40.87 53.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.197 0.522 . . . . 0.0 110.07 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.46 -149.52 19.36 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -75.73 -83.27 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 m -95.92 21.74 8.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.214 0.53 . . . . 0.0 110.645 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.657 ' O ' ' HD3' ' A' ' 114' ' ' LYS . . . 91.79 47.67 3.36 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -170.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -94.26 -54.14 3.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.846 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.2 tpt -67.67 -34.29 76.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.882 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.785 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 7.9 tp -67.13 -31.96 55.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.546 -177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.657 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 5.7 mptp? -79.51 -23.47 42.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.124 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HB3' ' HE3' ' A' ' 115' ' ' LYS . 22.9 mmmt -66.07 -37.27 85.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.8 mm -60.34 -42.87 92.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.519 0.675 . . . . 0.0 109.281 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -67.58 -33.13 74.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.916 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -79.29 -46.58 17.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.514 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -42.23 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.928 -172.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.402 ' HB1' HG23 ' A' ' 122' ' ' VAL . . . -92.54 -13.51 29.66 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.286 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.62 23.26 75.69 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.651 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.402 HG23 ' HB1' ' A' ' 120' ' ' ALA . 21.8 m -99.94 175.28 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.131 0.491 . . . . 0.0 111.432 -176.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.431 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 71.1 mtm180 -129.0 141.36 51.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.039 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.548 HG21 HD11 ' A' ' 113' ' ' ILE . 49.5 mm -102.38 130.0 52.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.024 0.44 . . . . 0.0 110.8 -175.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.903 ' HG2' HD11 ' A' ' 89' ' ' ILE . 6.1 tp-100 -126.62 96.86 4.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.868 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -75.55 112.78 12.25 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 169.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.762 ' NZ ' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -134.57 163.98 28.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.768 -168.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 171.477 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.44 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 36.6 Cg_endo . . . . . 0 C--O 1.234 0.284 0 N-CA-C 114.242 0.824 . . . . 0.0 114.242 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -133.61 148.52 51.57 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.391 0.615 . . . . 0.0 112.089 -168.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 97' ' ' VAL . 30.7 mttm -123.44 117.28 24.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.937 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.762 ' HB ' ' NZ ' ' A' ' 127' ' ' LYS . 12.2 mm -71.93 102.22 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.123 0.487 . . . . 0.0 110.676 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.529 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -87.37 98.26 11.26 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.695 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 63.9 t-80 -72.1 127.72 33.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.056 0.455 . . . . 0.0 110.634 -172.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.607 HD12 ' HB1' ' A' ' 150' ' ' ALA . 93.9 mt -98.65 107.66 20.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.174 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.482 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 38.6 ttm -92.95 137.72 32.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.876 -176.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.26 -160.92 28.61 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.703 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.83 140.6 35.6 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.739 2.293 . . . . 0.0 111.507 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -41.54 -49.64 5.07 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.891 3.061 . . . . 0.0 114.249 -174.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -59.42 -52.1 67.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.335 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -61.61 -35.51 78.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.35 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.638 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 72.9 m -56.96 -59.46 5.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.856 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -66.92 -33.73 76.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.971 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.435 ' O ' HG13 ' A' ' 153' ' ' ILE . 4.2 t60 -60.02 -33.17 71.65 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.211 0.529 . . . . 0.0 110.018 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.607 ' HB1' HD12 ' A' ' 140' ' ' ILE . . . -78.09 -45.93 22.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.906 -176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.57 -20.74 66.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.06 0.457 . . . . 0.0 110.244 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -28.2 52.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.089 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 149' ' ' HIS . 71.6 mt -77.62 -44.93 29.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.132 0.492 . . . . 0.0 109.829 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.477 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 73.2 mt -65.49 -41.15 90.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.01 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -57.04 -42.6 80.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.346 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.95 -36.87 80.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.92 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.15 -42.18 99.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 109.989 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 97' ' ' VAL . 17.6 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.99 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 18.6 m -123.47 120.6 60.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.327 0.584 . . . . 0.0 111.098 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 4' ' ' GLN . 11.7 mm-40 -106.32 139.13 41.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.844 174.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.792 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 61.9 mt-10 -110.99 116.11 30.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.28 0.562 . . . . 0.0 111.54 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.471 ' N ' HD11 ' A' ' 6' ' ' ILE . 3.9 mp -105.79 140.13 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.43 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 86.7 mmm -87.02 106.31 17.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.996 0.426 . . . . 0.0 110.901 -176.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.464 ' CG1' HG23 ' A' ' 16' ' ' VAL . 1.8 mp -90.62 109.49 34.69 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.985 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 12' ' ' LYS . 13.3 Cg_exo -72.85 165.75 31.9 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 123.322 2.681 . . . . 0.0 111.695 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.97 148.78 34.07 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.583 ' O ' ' HB3' ' A' ' 76' ' ' GLN . . . 84.65 -58.1 5.0 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.145 -172.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.646 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 7.5 mptt -60.98 -31.0 70.6 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.644 0.259 . . . . 0.0 111.268 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.671 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.7 -38.03 53.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' HA2' ' HG2' ' A' ' 19' ' ' LYS . . . -63.26 -37.51 94.99 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.946 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 3.8 pp -80.97 -24.28 38.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.98 0.39 . . . . 0.0 110.133 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.464 HG23 ' CG1' ' A' ' 8' ' ' ILE . 96.2 t -79.77 -52.34 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.311 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.675 HG13 ' H ' ' A' ' 19' ' ' LYS . 27.8 pt -77.64 -27.45 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.287 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.436 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 95.49 8.19 58.67 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.35 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.675 ' H ' HG13 ' A' ' 17' ' ' ILE . 54.3 mmtt 42.47 58.22 3.15 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.678 0.752 . . . . 0.0 110.955 -176.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.17 -27.52 1.56 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.398 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.69 -8.02 10.18 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.127 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.678 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 32.8 tt0 -49.96 -59.21 4.09 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.436 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 23.5 m -67.27 -38.19 84.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 35' ' ' MET . 3.4 tp -65.25 -27.19 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.197 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.678 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 35.0 mttm -57.97 -54.46 46.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.19 0.519 . . . . 0.0 109.797 171.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 25.6 mt-30 -68.88 -34.28 75.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.475 -176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.675 HD13 ' HE1' ' A' ' 35' ' ' MET . 32.6 mt -70.69 -25.7 63.09 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.343 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.752 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 27.0 mt-30 -85.75 -44.07 12.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.691 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -86.11 -54.01 4.73 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.636 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 28.0 ttm180 -71.44 -42.18 68.55 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.972 0.415 . . . . 0.0 110.44 -175.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.652 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -83.32 -9.18 59.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.824 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.12 23.49 66.14 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.886 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 20.6 m -129.02 152.11 36.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.982 0.391 . . . . 0.0 110.426 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 49.9 tptt -87.74 110.19 20.27 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.675 ' HE1' HD13 ' A' ' 27' ' ' LEU . 27.9 mmm -92.7 116.39 28.97 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 52' ' ' ARG . 4.7 tp -110.08 111.66 37.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.978 0.894 . . . . 0.0 110.214 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.474 HD11 HD21 ' A' ' 51' ' ' LEU . 3.1 mm? -99.29 135.68 40.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.759 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.469 HG23 ' HD2' ' A' ' 50' ' ' PRO . 13.0 tt -86.79 99.87 8.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.839 0.828 . . . . 0.0 109.755 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.49 32.88 0.13 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.761 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.15 -29.27 16.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.444 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.66 -177.82 16.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.26 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 m -79.37 69.85 5.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.329 0.585 . . . . 0.0 110.737 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -134.52 -63.32 0.72 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.036 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.476 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 13.1 m120 -124.78 28.2 6.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.532 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -82.1 -36.17 27.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.132 0.491 . . . . 0.0 109.768 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -93.72 -11.99 30.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.533 0.682 . . . . 0.0 109.676 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 38.0 t -104.19 164.75 3.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.201 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.425 ' N ' HG11 ' A' ' 47' ' ' VAL . 4.1 p30 -55.88 151.33 11.7 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.028 170.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -130.86 125.59 21.37 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.735 -168.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HD2' HG23 ' A' ' 38' ' ' ILE . 66.3 Cg_endo -74.27 103.89 1.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.144 1.896 . . . . 0.0 110.831 172.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.792 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -84.7 127.46 34.11 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.975 -175.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.573 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.5 mpt_? -102.42 113.39 26.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.004 0.43 . . . . 0.0 110.728 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.642 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 59.1 mt -83.84 112.41 21.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.512 172.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 34' ' ' LYS . 52.0 mt -104.22 120.28 54.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.17 -170.58 43.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.681 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.592 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 9.5 m-20 -68.12 152.57 96.37 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 122.688 0.395 . . . . 0.0 111.139 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.8 -54.71 3.92 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.256 2.637 . . . . 0.0 114.394 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -62.22 -48.46 79.87 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.707 0.289 . . . . 0.0 111.594 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.592 ' HD2' ' H ' ' A' ' 56' ' ' ASP . 16.8 ptpt -68.57 -34.11 75.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.771 -175.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 56' ' ' ASP . 76.7 t -65.3 -30.06 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 0.0 110.189 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.23 -48.55 12.92 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 15.6 mm100 -63.35 -39.92 95.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.433 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.672 ' HA ' ' CG ' ' A' ' 66' ' ' MET . . . -70.02 -41.22 74.59 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.842 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.1 t -55.53 -43.5 75.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.47 0.652 . . . . 0.0 109.631 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -65.16 -48.56 73.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.232 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.672 ' CG ' ' HA ' ' A' ' 63' ' ' ALA . 2.0 ppp? -67.01 -42.56 84.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.472 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.653 HG12 HD21 ' A' ' 71' ' ' LEU . 75.3 t -58.47 -49.97 80.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 122.971 0.17 . . . . 0.0 110.924 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.4 mtt -58.64 -29.86 66.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.165 0.507 . . . . 0.0 110.425 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.543 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 8.7 t70 -85.54 -35.63 20.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.044 -173.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.726 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.7 pp -86.87 -21.57 7.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.985 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.653 HD21 HG12 ' A' ' 67' ' ' VAL . 3.0 pp -86.35 2.2 48.3 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.341 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 7.4 ptp180 -64.07 -14.24 53.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.989 0.423 . . . . 0.0 109.86 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HG2' ' C ' ' A' ' 77' ' ' GLY . 8.0 tp10 -51.57 146.75 7.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.452 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -64.01 -36.58 84.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.552 -174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -168.1 112.77 0.65 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.375 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HA ' HD22 ' A' ' 15' ' ' LEU . 22.4 pt20 37.64 63.48 0.76 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.347 1.059 . . . . 0.0 113.84 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.499 ' C ' ' HG2' ' A' ' 73' ' ' GLU . . . -152.73 29.15 0.84 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.165 176.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.69 171.25 34.49 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.282 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.726 ' HD1' HG22 ' A' ' 70' ' ' ILE . 80.0 m-85 -65.81 -20.42 66.24 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 84.31 98.68 0.63 Allowed Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.636 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 4.0 t70 71.57 -82.94 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -168.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.63 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 44.4 ttt85 169.36 -36.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.197 0.599 . . . . 0.0 109.616 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 62.38 36.34 14.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.515 0.674 . . . . 0.0 110.218 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.991 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.6 tt0 -142.35 -49.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.455 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.558 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 13.1 p90 -177.04 135.47 0.2 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.96 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -115.27 -72.49 0.53 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.704 174.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.612 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 18.5 t -108.08 -4.83 17.38 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.16 0.505 . . . . 0.0 110.429 176.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.734 ' HB2' ' HZ1' ' A' ' 127' ' ' LYS . 1.4 mpt_? -129.81 172.52 11.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.662 -172.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.625 HG12 ' HB2' ' A' ' 139' ' ' HIS . 35.7 mt 73.21 -78.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 123.813 0.695 . . . . 0.0 112.243 171.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.27 44.54 96.42 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.231 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.28 78.05 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.162 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 140' ' ' ILE . . . 158.56 -129.28 2.24 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.991 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 29.4 pt -149.99 160.79 4.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 117.081 0.44 . . . . 0.0 109.847 173.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.5 125.73 45.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.342 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 39.9 t -126.2 101.88 27.96 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.443 ' HA ' HD12 ' A' ' 137' ' ' ILE . 55.9 Cg_endo -74.65 107.36 2.45 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.021 1.814 . . . . 0.0 112.057 172.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.469 HG23 HG11 ' A' ' 95' ' ' VAL . 37.8 t -98.89 128.51 32.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.006 0.432 . . . . 0.0 111.449 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.578 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 5.5 Cg_endo -47.4 129.26 16.02 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.852 3.034 . . . . 0.0 112.215 174.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.698 ' HD3' ' HB2' ' A' ' 134' ' ' PRO . 23.1 ptt180 -57.49 -32.06 66.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.372 -174.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -87.92 11.34 16.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.734 0.302 . . . . 0.0 111.196 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 m -127.89 -30.14 2.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.383 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.39 -33.13 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.36 66.31 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.533 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.69 -37.1 12.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.08 0.467 . . . . 0.0 110.08 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.97 -41.79 93.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.713 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.637 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 34.1 mm -77.1 -45.69 29.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.518 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.64 -124.79 8.36 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.553 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -112.36 -70.39 0.81 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.028 0.442 . . . . 0.0 110.1 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.7 m -99.04 20.4 13.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.56 37.2 35.89 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.794 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -93.88 -33.4 13.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.643 0.258 . . . . 0.0 110.466 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 17.1 tpt -68.43 -41.84 79.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.403 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.638 HD13 HD12 ' A' ' 116' ' ' ILE . 10.1 tp -63.65 -21.69 29.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.614 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -80.61 -19.22 45.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -68.2 -28.97 67.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.167 0.508 . . . . 0.0 110.166 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.638 HD12 HD13 ' A' ' 113' ' ' ILE . 27.1 mt -71.67 -33.64 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.682 0.754 . . . . 0.0 109.172 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -72.18 -23.93 61.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.292 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -79.86 -40.93 27.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.564 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.4 -56.27 4.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.469 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -86.94 -23.73 25.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 111.597 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.16 26.65 43.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.703 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 141' ' ' MET . 29.8 m -95.2 164.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.669 0.271 . . . . 0.0 111.225 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 13.8 mmt180 -118.33 139.1 51.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 139' ' ' HIS . 48.5 mm -114.64 141.88 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.653 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 1.1 tp-100 -155.23 106.06 2.56 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.248 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.483 ' CE1' HD11 ' A' ' 106' ' ' ILE . 18.2 m-85 -73.39 105.0 4.58 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.888 176.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.734 ' HZ1' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -107.25 96.25 6.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.119 -174.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 C--O 1.236 0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.759 179.637 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.698 ' HB2' ' HD3' ' A' ' 99' ' ' ARG . 5.8 Cg_exo . . . . . 0 CA--C 1.528 0.177 0 CA-C-O 121.153 0.397 . . . . 0.0 112.414 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 1.4 mp0 -83.92 147.59 27.41 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.273 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -108.91 120.9 43.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.555 -174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 7.0 mm -73.55 123.61 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.016 0.436 . . . . 0.0 111.294 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -99.0 126.77 44.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.608 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.653 ' HB3' ' O ' ' A' ' 125' ' ' GLN . 1.5 t60 -73.87 126.85 31.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.707 HD12 ' HB2' ' A' ' 150' ' ' ALA . 82.9 mt -113.98 142.74 25.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.78 172.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.444 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 51.0 ttm -132.09 131.35 42.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.552 0.215 . . . . 0.0 110.562 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.8 -167.97 30.52 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.82 142.63 76.87 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.537 2.158 . . . . 0.0 111.477 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.91 -46.69 18.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.215 2.61 . . . . 0.0 113.529 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.46 -36.87 79.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.083 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' A' ' 149' ' ' HIS . 53.1 mtt180 -80.1 -26.43 39.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.86 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.58 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 69.9 m -60.65 -56.1 25.35 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.68 -31.42 72.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.599 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.53 ' O ' HG13 ' A' ' 153' ' ' ILE . 11.9 t60 -59.75 -33.38 71.6 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.145 0.497 . . . . 0.0 110.258 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.707 ' HB2' HD12 ' A' ' 140' ' ' ILE . . . -78.37 -42.39 30.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.388 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 93' ' ' ILE . . . -63.53 -28.42 69.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.08 0.466 . . . . 0.0 110.275 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -25.71 52.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.297 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 149' ' ' HIS . 75.3 mt -74.64 -47.6 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.666 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.1 mt -61.36 -46.18 97.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.822 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -54.45 -44.06 72.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.356 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.39 -36.13 83.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.405 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 73.5 mt -63.54 -45.55 90.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.085 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 20.7 mt . . . . . 0 N--CA 1.462 0.17 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.27 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 5.0 m . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 4.2 p -140.79 140.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.519 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -125.69 140.66 52.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.258 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 13.0 mp0 -102.39 119.99 39.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.168 0.508 . . . . 0.0 111.623 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.685 HG13 HG23 ' A' ' 67' ' ' VAL . 39.1 mm -113.08 146.62 17.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.027 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.447 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 42.3 mtp -105.38 116.46 31.99 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.482 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.675 HG12 HG12 ' A' ' 16' ' ' VAL . 2.1 mp -97.39 109.14 48.72 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.883 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.782 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 50.8 Cg_exo -61.4 152.78 70.53 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.364 2.709 . . . . 0.0 112.558 175.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.67 144.39 57.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.17 -45.54 2.64 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -171.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.782 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -69.19 -15.65 63.44 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 110.274 174.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.53 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -54.23 -38.64 65.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.511 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 18' ' ' GLY . . . -65.89 -31.17 78.81 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.925 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.679 ' CD1' ' HA ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -91.92 -29.48 16.65 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.446 -0.443 . . . . 0.0 112.157 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 8' ' ' ILE . 89.2 t -83.78 -56.66 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 13' ' ' ALA . 32.0 pt -93.05 -21.12 6.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.864 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . 103.77 -61.74 0.43 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 23.1 tptp 169.31 -35.91 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 170.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.92 -0.36 7.08 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.224 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.647 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 133.11 0.54 4.21 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.189 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.47 ' HB2' ' HA3' ' A' ' 18' ' ' GLY . 36.3 mp0 -51.08 -54.7 22.5 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.072 0.549 . . . . 0.0 112.08 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 15' ' ' LEU . 87.3 m -81.67 -26.12 34.97 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.508 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.73 HD11 HD11 ' A' ' 27' ' ' LEU . 2.7 tp -67.75 -22.9 28.76 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.156 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.647 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 7.8 mtpm? -56.03 -54.76 41.07 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.555 169.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.614 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 45.0 mt-30 -60.6 -44.12 96.65 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.659 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.73 HD11 HD11 ' A' ' 24' ' ' ILE . 50.7 mt -64.38 -28.59 69.8 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.264 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.728 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 47.1 mt-30 -86.88 -49.09 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 111.664 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.41 -54.24 4.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.707 -171.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 94' ' ' ASP . 10.5 ttt180 -63.8 -51.82 63.06 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.781 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -70.9 -26.79 63.38 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.754 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.79 16.83 80.43 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.876 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.9 m -120.11 160.7 20.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -98.11 110.44 23.02 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.677 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 1.08 ' HB3' HD11 ' A' ' 51' ' ' LEU . 43.5 mtt -101.43 125.75 48.11 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.622 HG22 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tt -122.53 115.09 44.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.856 0.836 . . . . 0.0 110.733 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.631 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -134.69 145.18 48.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.332 -175.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.774 HG23 ' HB2' ' A' ' 42' ' ' SER . 33.5 mm -59.9 99.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.469 0.652 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -155.45 23.47 0.41 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.972 175.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -111.34 -63.78 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.269 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.43 20.67 0.27 Allowed Glycine 0 CA--C 1.517 0.206 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.736 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.774 ' HB2' HG23 ' A' ' 38' ' ' ILE . 54.6 m -90.95 -166.22 1.53 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.279 0.539 . . . . 0.0 110.781 177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.28 -27.25 24.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.546 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.4 m-20 -79.58 56.58 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.028 0.442 . . . . 0.0 110.698 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.9 p -83.1 -50.98 7.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.425 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -90.55 -21.47 21.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.525 0.678 . . . . 0.0 109.683 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 23.0 t -79.15 158.82 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.267 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -60.32 153.53 22.41 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.184 0.516 . . . . 0.0 110.525 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -123.88 135.05 25.83 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.766 -163.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.22 104.0 0.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.891 2.394 . . . . 0.0 111.843 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 1.08 HD11 ' HB3' ' A' ' 35' ' ' MET . 29.5 tp -87.6 129.44 35.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.027 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.622 ' HB2' HG22 ' A' ' 36' ' ' ILE . 7.7 mpt_? -106.73 117.61 34.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.407 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.1 mt -92.79 109.34 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.851 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.9 mt -106.11 121.54 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.72 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 177.82 -171.21 43.75 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.668 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.654 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 11.4 m-20 -64.78 156.28 79.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 122.412 0.285 . . . . 0.0 110.882 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -48.03 -54.85 4.64 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.148 2.565 . . . . 0.0 113.851 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -63.57 -31.54 72.73 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.946 0.403 . . . . 0.0 110.287 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.654 ' HD2' ' H ' ' A' ' 56' ' ' ASP . 89.7 mttt -66.84 -52.39 44.26 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.566 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.31 -28.76 45.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.299 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -79.85 -41.65 25.89 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.438 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.784 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -72.52 -25.21 61.31 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.831 178.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.704 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -83.42 -40.43 19.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.61 -33.29 72.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.574 0.702 . . . . 0.0 109.246 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.27 -47.22 62.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.681 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.704 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 2.3 ppp? -66.91 -42.13 85.93 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.58 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.685 HG23 HG13 ' A' ' 6' ' ' ILE . 27.0 m -59.63 -42.84 89.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.927 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.3 mtt -68.75 -24.76 64.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.678 ' HA ' ' HE ' ' A' ' 72' ' ' ARG . 52.3 m-20 -81.67 -40.91 22.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.818 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.857 HG23 ' HD2' ' A' ' 79' ' ' PHE . 2.8 pp -88.07 -31.58 5.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.679 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 1.6 tt -75.71 -15.26 60.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.849 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.678 ' HE ' ' HA ' ' A' ' 69' ' ' ASP . 16.4 ptp180 -60.94 -53.6 55.23 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.542 ' HG2' ' CD2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER 40.35 -169.73 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 174.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -162.09 -30.25 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.0 -1.455 . . . . 0.0 109.214 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -129.16 32.66 4.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.556 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.493 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 39.4 mt-30 64.42 16.74 10.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.062 0.458 . . . . 0.0 111.351 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -114.11 86.44 0.42 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 80' ' ' GLY . . . -98.82 40.61 2.41 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.183 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.857 ' HD2' HG23 ' A' ' 70' ' ' ILE . 24.7 m-85 69.28 -32.11 0.22 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.918 0.887 . . . . 0.0 112.818 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 93.83 95.95 1.55 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.614 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 4.1 t70 72.31 -67.15 0.27 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -170.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.774 ' HA ' HG22 ' A' ' 70' ' ' ILE . 48.0 ttt-85 178.03 -1.93 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.214 169.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 47.5 t30 67.85 -58.65 0.44 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.213 0.605 . . . . 0.0 111.64 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.801 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 36.1 mt-10 -72.92 -23.19 60.67 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -174.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.617 ' CB ' ' HB ' ' A' ' 89' ' ' ILE . 44.7 p90 172.12 140.17 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 122.912 0.485 . . . . 0.0 111.136 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.781 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -112.25 97.33 0.9 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 168.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . 21.8 t 71.62 -38.15 0.41 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.422 ' HG3' HH11 ' A' ' 88' ' ' ARG . 0.2 OUTLIER -89.73 -167.87 1.98 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.74 HG13 ' CG ' ' A' ' 139' ' ' HIS . 1.5 mp 67.19 -75.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 123.671 0.607 . . . . 0.0 112.3 171.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 80.23 -31.91 2.32 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.459 -0.401 . . . . 0.0 112.781 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 89' ' ' ILE . . . -148.42 118.61 0.99 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.01 -146.18 17.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.801 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 44.4 pt -140.98 160.61 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.904 0.352 . . . . 0.0 110.258 174.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.558 ' OD2' ' HA ' ' A' ' 85' ' ' TYR . 32.8 m-20 -108.04 117.88 35.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.03 174.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.793 HG21 ' HB3' ' A' ' 138' ' ' ALA . 20.7 m -117.03 106.03 48.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -176.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.493 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 32.4 Cg_endo -66.29 107.83 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.455 2.103 . . . . 0.0 111.311 172.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.85 127.96 28.89 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.936 0.398 . . . . 0.0 110.85 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.658 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 7.3 Cg_endo -52.73 129.3 31.92 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.185 2.59 . . . . 0.0 112.677 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.536 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -44.77 -40.9 6.46 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 113.988 -1.46 . . . . 0.0 113.268 -176.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.514 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 16.6 p80 -82.45 -4.87 58.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.732 -173.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.518 ' O ' HG12 ' A' ' 104' ' ' VAL . 22.6 t -124.49 8.18 8.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.327 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.45 -26.39 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.155 0.503 . . . . 0.0 110.224 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.63 -39.58 67.26 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.906 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 101' ' ' SER . 6.0 p -64.35 -24.71 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.083 0.468 . . . . 0.0 110.458 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 101' ' ' SER . 48.9 t -74.23 -45.47 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.46 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.19 -36.4 37.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.428 0.633 . . . . 0.0 110.578 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.07 -72.68 2.55 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -171.2 -71.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.8 m -95.66 20.63 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.442 0.639 . . . . 0.0 110.088 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.401 ' HA2' HG21 ' A' ' 113' ' ' ILE . . . 84.96 2.37 88.44 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.876 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -57.4 -24.8 57.67 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 15.1 tpt -89.54 -51.51 5.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.69 0.281 . . . . 0.0 110.852 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.883 HD11 HG13 ' A' ' 124' ' ' ILE . 19.5 tt -67.68 -31.54 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.735 -174.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 117' ' ' GLN . 98.0 mttt -68.65 -19.16 64.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.673 0.273 . . . . 0.0 111.201 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -74.65 -31.06 61.83 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.107 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.0 mm -63.37 -38.4 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.703 HE22 HG12 ' A' ' 124' ' ' ILE . 4.9 mm100 -64.1 -32.21 73.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.629 -1.168 . . . . 0.0 110.704 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -87.16 -41.9 13.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.458 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.15 -48.09 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -89.13 -16.22 31.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.152 0.501 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 53.79 6.31 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.122 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 141' ' ' MET . 29.1 m -133.46 170.81 19.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -172.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.657 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 85.9 mtt180 -132.36 153.27 50.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.883 HG13 HD11 ' A' ' 113' ' ' ILE . 49.6 mm -114.71 140.44 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -172.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.969 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 52.0 tp60 -143.95 101.19 3.7 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.521 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -73.14 116.35 13.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.997 0.427 . . . . 0.0 110.574 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.66 ' O ' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -139.03 129.42 25.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.689 -177.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 172.118 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.473 ' HG2' ' HD2' ' A' ' 99' ' ' ARG . 10.3 Cg_endo . . . . . 0 N--CA 1.453 -0.866 0 CA-C-O 120.875 0.281 . . . . 0.0 112.143 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.658 ' OE2' ' HA ' ' A' ' 98' ' ' PRO . 0.8 OUTLIER -81.52 152.27 27.38 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.256 0.551 . . . . 0.0 111.026 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -110.53 114.8 28.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.582 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.66 ' HB ' ' O ' ' A' ' 127' ' ' LYS . 12.5 mm -70.32 105.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.306 0.574 . . . . 0.0 110.357 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.793 ' HB3' HG21 ' A' ' 95' ' ' VAL . . . -94.3 126.95 39.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.969 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 7.3 t-160 -77.8 117.37 19.11 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.099 173.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.596 ' HB ' ' CG1' ' A' ' 93' ' ' ILE . 48.7 mt -97.98 106.57 18.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.657 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 52.9 ttm -85.73 126.63 34.12 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.219 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.15 157.81 8.5 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.496 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.98 149.78 19.92 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.699 2.266 . . . . 0.0 111.741 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.759 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 50.7 Cg_exo -39.12 -44.42 2.64 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 124.037 3.158 . . . . 0.0 114.457 -175.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.32 -40.77 87.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.079 0.466 . . . . 0.0 111.484 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -78.62 -50.61 11.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.512 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.759 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 18.8 p -61.33 -52.36 64.99 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.667 -175.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.56 -30.47 71.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.735 0.302 . . . . 0.0 111.685 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -70.83 -25.08 62.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.231 0.539 . . . . 0.0 110.461 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.522 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -79.28 -42.91 24.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.964 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.89 -30.23 68.87 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -19.95 54.44 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.915 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.5 mt -80.18 -45.13 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.54 HD13 HD12 ' A' ' 140' ' ' ILE . 61.6 mt -64.11 -45.01 97.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.342 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -56.06 -37.35 69.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.305 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.85 -43.61 90.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 110.305 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 70.3 mt -63.14 -40.33 97.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.425 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 7.7 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.039 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 57' ' ' PRO . 37.1 m . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.869 0.366 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 70.5 t -122.52 116.63 49.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.044 0.449 . . . . 0.0 111.027 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -107.77 163.03 13.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 49.0 mt-10 -127.82 120.09 27.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.079 0.466 . . . . 0.0 111.768 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 6' ' ' ILE . 3.7 mp -111.36 140.52 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.535 -0.757 . . . . 0.0 108.969 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.488 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 39.0 ttm -90.12 122.44 33.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.811 0.339 . . . . 0.0 110.808 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 51' ' ' LEU . 1.7 mp -95.88 110.78 53.4 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.751 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.746 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 32.6 Cg_exo -65.82 146.66 83.95 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.463 2.775 . . . . 0.0 111.909 172.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.42 130.72 44.84 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.63 -40.31 2.59 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.746 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 1.3 mptm? -84.36 -30.68 25.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.952 173.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.594 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -49.54 -45.45 47.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.855 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.0 -39.59 92.12 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.467 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.651 HD22 ' HA ' ' A' ' 76' ' ' GLN . 3.5 pp -84.87 -36.39 21.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.069 0.434 . . . . 0.0 110.918 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.646 HG22 HD13 ' A' ' 71' ' ' LEU . 59.9 t -65.94 -42.79 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.682 0.277 . . . . 0.0 111.727 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.806 HG13 ' H ' ' A' ' 19' ' ' LYS . 13.9 pt -92.25 -27.13 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.033 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 99.88 0.17 56.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.643 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.806 ' H ' HG13 ' A' ' 17' ' ' ILE . 7.2 tptm 74.28 -35.66 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.139 0.975 . . . . 0.0 111.423 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.99 2.55 17.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.945 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.78 -2.76 38.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.608 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 6.8 mp0 -55.52 -44.94 77.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.555 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 88.5 m -74.16 -46.95 39.1 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.496 -177.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 35' ' ' MET . 7.6 tp -62.83 -26.58 41.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 1.3 tmtm? -55.41 -44.83 76.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.212 173.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -85.36 -20.55 29.75 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.707 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.901 HD21 ' HE3' ' A' ' 66' ' ' MET . 33.8 mt -79.38 -24.25 42.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.44 0.638 . . . . 0.0 109.494 176.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.5 mt-30 -86.03 -38.88 17.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.892 174.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -86.73 -63.06 1.37 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HD3' ' CG ' ' A' ' 94' ' ' ASP . 13.7 ttm180 -65.96 -34.21 77.59 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 110.778 -174.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -87.63 -9.74 53.38 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.024 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.01 22.7 55.84 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.484 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.6 m -126.95 148.99 31.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -89.75 109.01 20.03 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.925 ' HB3' HD13 ' A' ' 51' ' ' LEU . 7.4 mtm -98.29 117.26 32.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 52' ' ' ARG . 5.1 tp -111.29 104.7 17.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.928 0.87 . . . . 0.0 110.5 -173.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.541 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -133.98 142.28 47.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.915 -178.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.694 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 3.9 mp -68.31 100.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.159 0.504 . . . . 0.0 110.604 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 12.2 mt-30 -96.58 -56.05 2.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -121.54 95.9 4.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.089 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.44 158.56 24.95 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.829 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.7 t -88.82 85.35 6.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.972 0.415 . . . . 0.0 110.453 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -164.46 -79.07 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.021 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.445 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 3.2 m-20 -118.52 66.2 0.77 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.51 -56.3 3.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.717 -174.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -93.73 -6.01 47.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.208 1.004 . . . . 0.0 108.519 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 56.5 t -86.42 158.74 3.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.952 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -60.32 148.79 35.66 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 110.323 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.694 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 52.0 mttt -128.62 134.73 26.6 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.024 -166.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.7 121.64 3.34 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.665 2.244 . . . . 0.0 112.125 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.925 HD13 ' HB3' ' A' ' 35' ' ' MET . 53.3 tp -98.03 111.68 23.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.794 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.54 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.9 mpt_? -98.22 116.22 29.98 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.506 175.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 49.8 mt -92.14 111.19 23.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.553 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.9 mt -106.6 120.26 57.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.767 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.15 -171.51 44.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.42 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.636 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 3.7 m-20 -65.14 141.69 98.35 Favored Pre-proline 0 C--N 1.33 -0.239 0 C-N-CA 122.149 0.18 . . . . 0.0 111.332 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.49 ' HA ' HG22 ' A' ' 2' ' ' THR . 96.7 Cg_exo -43.39 -54.2 3.73 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.873 3.049 . . . . 0.0 114.234 -174.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -61.13 -41.82 97.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.666 0.27 . . . . 0.0 111.579 -174.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.963 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 18.3 ptpt -77.44 -27.16 52.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.381 -173.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 56' ' ' ASP . 91.4 t -64.56 -32.06 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.986 175.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -73.04 -52.81 12.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -61.98 -37.84 86.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.554 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.557 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -72.25 -39.15 68.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.725 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.407 ' HA ' HG22 ' A' ' 67' ' ' VAL . 42.5 t -57.73 -35.29 70.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.268 0.556 . . . . 0.0 110.076 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.63 -40.93 76.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.774 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.901 ' HE3' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -78.11 -34.95 49.8 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.494 -176.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 33.1 m -67.92 -26.3 34.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 120.811 0.338 . . . . 0.0 110.614 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.42 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 66.3 mtt -81.4 -21.36 39.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.011 0.434 . . . . 0.0 109.897 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.85 -55.31 4.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.944 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.536 ' HB ' ' H ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -70.01 -19.71 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.397 0.617 . . . . 0.0 110.48 -177.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.646 HD13 HG22 ' A' ' 16' ' ' VAL . 3.1 tt -85.77 -16.33 39.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.19 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 68' ' ' MET . 8.2 ptm180 -69.83 -8.29 47.16 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.902 -0.136 . . . . 0.0 111.306 -174.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 10.3 tp10 -59.21 -94.87 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 O-C-N 123.586 0.554 . . . . 0.0 111.99 -172.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 37.8 ttp180 159.59 -59.74 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -86.97 147.15 25.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.272 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.651 ' HA ' HD22 ' A' ' 15' ' ' LEU . 29.7 tt0 -54.12 99.87 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.162 0.506 . . . . 0.0 110.834 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.39 -78.6 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.308 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 59.48 -117.26 10.57 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.536 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 90.7 m-85 -127.73 -55.32 1.31 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.497 ' O ' HG13 ' A' ' 70' ' ' ILE . . . 135.98 -79.97 0.31 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 82' ' ' ARG . 6.2 p-10 -103.25 2.78 34.74 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.828 0.823 . . . . 0.0 109.237 170.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 20.4 ttt180 86.86 -31.21 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.587 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.4 t30 51.5 71.99 0.41 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 18.0 tt0 -176.36 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.003 -171.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.841 ' HA ' HD13 ' A' ' 89' ' ' ILE . 34.8 p90 -171.88 -37.63 0.02 OUTLIER 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 175.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.57 -91.69 0.58 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.818 -175.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.963 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 46.1 p -117.16 -11.68 10.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.588 0.708 . . . . 0.0 111.01 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.694 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 46.9 mtt180 -113.65 -163.98 0.9 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.571 -169.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 85' ' ' TYR . 75.6 mt 60.66 -84.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.678 0.611 . . . . 0.0 112.274 168.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.17 45.4 81.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.857 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.447 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 150.82 90.62 0.08 OUTLIER Glycine 0 CA--C 1.518 0.261 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.46 -149.64 18.71 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.721 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 23.7 pt -136.77 167.14 24.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 117.605 0.703 . . . . 0.0 111.107 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.513 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . 2.1 p30 -105.43 141.8 36.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.373 173.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.845 HG22 ' HB1' ' A' ' 138' ' ' ALA . 6.2 m -136.92 102.86 9.14 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.076 0.465 . . . . 0.0 111.451 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HB3' HD13 ' A' ' 137' ' ' ILE . 36.1 Cg_endo -67.2 107.86 1.44 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.893 2.395 . . . . 0.0 111.739 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.629 HG22 HG21 ' A' ' 105' ' ' VAL . 7.6 p -105.79 131.2 21.95 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.247 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.448 ' HD2' HD21 ' A' ' 158' ' ' LEU . 84.6 Cg_exo -45.28 125.91 7.66 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.673 2.915 . . . . 0.0 113.104 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -61.46 -21.03 63.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.947 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -92.04 8.11 39.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.704 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 105' ' ' VAL . 41.7 m -141.88 0.44 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 106' ' ' ILE . 10.1 p -66.84 -33.37 62.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.393 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.18 -29.9 76.49 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.894 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.08 -40.22 58.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 109.988 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.629 HG21 HG22 ' A' ' 97' ' ' VAL . 40.4 t -64.22 -41.6 92.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.303 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.723 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.1 mm -67.07 -49.28 74.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.487 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.38 69.16 1.42 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.126 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 57.43 -88.85 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.522 0.729 . . . . 0.0 112.309 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.0 t -97.69 18.81 14.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.987 0.422 . . . . 0.0 110.971 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.66 22.92 41.16 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.057 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -72.91 -43.91 61.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.047 0.451 . . . . 0.0 110.839 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.449 ' HE2' HD13 ' A' ' 157' ' ' LEU . 16.6 tpt -74.05 -40.29 62.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.632 -177.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.723 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.5 tp -66.47 -32.67 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.815 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -80.85 -22.63 39.72 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.991 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -37.25 84.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.9 mt -63.28 -40.97 91.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 75.1 mt-30 -63.05 -32.85 74.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.29 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -84.6 -40.1 17.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.987 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.78 -42.04 28.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.361 -172.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.66 2.41 47.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.513 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.98 32.49 82.31 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.464 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.91 171.6 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.008 0.432 . . . . 0.0 111.263 -175.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.832 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 3.2 mmp_? -124.1 152.28 42.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.6 mm -117.08 133.47 63.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.087 0.47 . . . . 0.0 111.65 -175.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.572 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 23.8 tp60 -139.37 99.63 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.368 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -74.9 140.6 43.91 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 121.932 -0.48 . . . . 0.0 109.792 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.579 ' HD3' HH11 ' A' ' 88' ' ' ARG . 0.7 OUTLIER -153.11 138.2 17.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.146 -175.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.405 ' HB2' ' NH1' ' A' ' 88' ' ' ARG . 14.2 mm100 . . . . . 0 N--CA 1.467 0.416 0 O-C-N 123.438 0.461 . . . . 0.0 111.254 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 N--CA 1.464 -0.257 0 CA-C-O 120.883 0.285 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 98' ' ' PRO . 5.3 mp0 -121.86 159.93 25.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.043 0.449 . . . . 0.0 111.019 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -121.77 117.53 26.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.542 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 30.1 mm -71.42 102.45 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.244 0.545 . . . . 0.0 111.968 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.845 ' HB1' HG22 ' A' ' 95' ' ' VAL . . . -90.5 142.48 27.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.558 176.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.584 ' NE2' HG23 ' A' ' 89' ' ' ILE . 6.0 t-160 -91.23 115.66 28.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.689 HD12 ' HB3' ' A' ' 150' ' ' ALA . 47.3 mt -94.15 113.98 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.25 172.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.832 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 43.8 ttm -98.95 132.84 43.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.575 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.17 -175.14 31.74 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.925 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.93 145.91 75.9 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.681 2.254 . . . . 0.0 111.592 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.603 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 96.8 Cg_exo -44.68 -48.63 10.23 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.523 2.816 . . . . 0.0 113.869 -173.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.9 -38.69 79.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.936 0.398 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.56 -37.33 21.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.874 -174.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.603 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 29.4 p -57.74 -47.83 81.34 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -69.22 -32.95 72.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.683 0.277 . . . . 0.0 110.655 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -64.69 -27.78 69.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.689 ' HB3' HD12 ' A' ' 140' ' ' ILE . . . -77.19 -29.77 54.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.9 0.381 . . . . 0.0 110.704 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.69 -25.32 66.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.839 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -78.29 -20.32 51.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.469 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.5 mt -79.77 -39.89 20.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.28 0.562 . . . . 0.0 109.56 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.559 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 53.2 mt -71.17 -51.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.824 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -58.07 -32.21 67.82 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.995 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.24 -32.29 72.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.245 0.545 . . . . 0.0 110.462 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.449 HD13 ' HE2' ' A' ' 112' ' ' MET . 86.6 mt -78.8 -44.44 23.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.814 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 57.6 mt . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.117 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 14.0 m . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.853 0.358 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 22.4 m -124.85 145.77 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.27 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 73.1 mm-40 -130.42 150.78 51.49 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.523 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 43.6 mt-10 -111.21 121.93 46.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.908 0.385 . . . . 0.0 111.505 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.426 ' N ' HD11 ' A' ' 6' ' ' ILE . 4.4 mp -106.06 140.58 23.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.37 110.09 20.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.444 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.67 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -98.36 111.48 59.9 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.151 0.5 . . . . 0.0 111.084 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -62.55 151.87 80.83 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.707 2.938 . . . . 0.0 112.789 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.36 133.45 46.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.4 -49.9 1.02 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -167.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.5 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 13.9 mptt -69.08 -32.71 72.35 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 170.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.672 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -50.99 -35.09 31.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.415 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' CA ' ' HG2' ' A' ' 19' ' ' LYS . . . -64.3 -38.05 95.34 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.489 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.3 pp -89.06 -21.17 23.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.711 0.255 . . . . 0.0 111.18 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.67 HG11 HG12 ' A' ' 8' ' ' ILE . 96.6 t -82.58 -41.35 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.849 HG22 ' HG3' ' A' ' 39' ' ' GLN . 11.2 pt -92.25 -22.68 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 121.52 -0.738 . . . . 0.0 110.912 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.631 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 92.69 16.55 48.37 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.377 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 66.0 mmtt 48.64 50.82 16.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.911 0.484 . . . . 0.0 111.297 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.91 -28.49 1.57 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.096 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.25 -13.94 2.78 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.006 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.755 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 1.2 mm-40 -43.7 -55.28 4.49 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.631 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 73.8 m -75.11 -35.11 61.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.49 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.774 HD13 HD21 ' A' ' 37' ' ' LEU . 1.7 tp -68.35 -26.78 34.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.613 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.755 ' HD3' ' HA ' ' A' ' 22' ' ' GLU . 14.3 mtpp -55.04 -51.89 64.88 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.483 0.659 . . . . 0.0 109.998 174.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.414 ' HB2' ' CG ' ' A' ' 81' ' ' ASP . 23.1 mt-30 -81.63 -31.72 32.27 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.887 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.623 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 83.8 mt -66.83 -23.43 66.04 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.742 -0.599 . . . . 0.0 110.479 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.621 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 24.1 mt-30 -84.81 -46.46 11.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.13 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.44 -56.69 3.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -175.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.467 ' HA ' ' OE1' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -57.87 -41.97 83.58 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.144 0.497 . . . . 0.0 110.223 -178.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.683 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -86.79 -6.46 58.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.533 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.23 23.22 52.46 Favored Glycine 0 CA--C 1.517 0.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 113.52 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.0 m -132.21 153.88 39.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.893 0.377 . . . . 0.0 110.449 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -90.93 109.52 20.75 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.623 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 47.8 mtt -95.37 113.51 25.19 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 tp -110.96 106.87 21.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 122.027 0.918 . . . . 0.0 110.152 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.804 HD22 ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -132.99 142.12 48.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.254 -177.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.756 HG22 ' HB2' ' A' ' 43' ' ' GLN . 71.8 mt -86.14 101.6 10.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.726 0.298 . . . . 0.0 111.09 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.849 ' HG3' HG22 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -134.69 -26.51 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.291 177.018 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -88.16 -34.13 17.95 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.4 146.78 34.88 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.75 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -79.71 38.8 0.39 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.756 ' HB2' HG22 ' A' ' 38' ' ' ILE . 48.8 mt-30 -106.38 -49.6 3.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.111 0.482 . . . . 0.0 110.345 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -131.45 30.96 4.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.488 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -70.58 -40.28 73.37 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.022 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -93.84 -26.17 17.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.094 0.473 . . . . 0.0 110.288 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.3 169.57 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.629 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.28 151.95 26.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.985 0.421 . . . . 0.0 110.415 172.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 11.6 mptt -108.64 130.87 22.22 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.024 -171.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -88.88 103.95 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.685 2.257 . . . . 0.0 111.4 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.804 ' HG ' HD22 ' A' ' 37' ' ' LEU . 5.7 tt -87.92 109.7 19.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.868 -174.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.3 mpt_? -97.23 115.43 27.6 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.697 0.284 . . . . 0.0 110.51 175.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 72.7 mt -87.71 115.67 28.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.054 175.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.415 HG12 ' CG1' ' A' ' 3' ' ' VAL . 32.5 mt -104.13 120.74 54.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 172.22 -170.78 43.76 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.62 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.421 ' HB3' ' HD2' ' A' ' 59' ' ' LYS . 5.5 t70 -65.79 140.42 97.29 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.229 174.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -43.39 -49.45 7.52 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.252 2.635 . . . . 0.0 114.308 -176.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.38 -36.55 84.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.409 0.623 . . . . 0.0 110.204 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.568 ' HG2' ' HB2' ' A' ' 87' ' ' SER . 45.8 mttp -68.95 -44.0 73.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.9 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -59.3 -34.41 53.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.047 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.543 HE21 ' C ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -72.15 -52.2 17.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.545 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.773 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -59.93 -32.35 70.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.251 0.548 . . . . 0.0 110.477 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.73 -44.54 14.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.057 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.651 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.9 p -59.5 -33.9 71.92 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 111.272 -175.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.28 -32.78 61.13 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.239 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.569 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 14.2 ptt? -84.4 -32.82 23.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.344 -175.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.655 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 34.9 m -61.0 -31.79 50.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.425 175.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 36.6 mtm -81.26 -35.36 31.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 175.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.569 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 30.8 t70 -64.66 -40.66 95.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.205 -175.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.55 HG21 ' O ' ' A' ' 66' ' ' MET . 0.2 OUTLIER -87.79 -22.21 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.009 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.655 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -83.93 -24.41 30.72 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.298 -178.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.4 1.17 3.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 9.8 tp10 -58.07 150.5 20.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.799 173.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 74' ' ' ARG . 44.3 ttt-85 -79.49 59.43 2.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.312 0.577 . . . . 0.0 110.187 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.475 ' CG ' ' HZ1' ' A' ' 12' ' ' LYS . 48.5 m-20 64.38 75.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.439 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -156.98 -71.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.931 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.432 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . -172.93 -36.53 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.768 -177.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.01 -97.99 2.22 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.988 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.51 -35.31 1.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.872 0.368 . . . . 0.0 111.039 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.55 67.61 0.64 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.414 ' CG ' ' HB2' ' A' ' 26' ' ' GLN . 5.8 m-20 61.97 30.7 18.09 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 122.026 0.917 . . . . 0.0 109.998 -174.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.512 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 35.5 ttt85 73.99 -40.23 0.45 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.035 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 t30 66.79 11.56 8.33 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.383 0.611 . . . . 0.0 110.601 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.705 ' HG3' ' O ' ' A' ' 92' ' ' GLY . 42.7 tt0 -115.83 -39.49 3.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.033 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.619 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 4.7 p90 -176.13 -157.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.697 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -176.2 -28.58 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.568 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 20.4 p -165.41 -48.63 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -73.66 173.36 9.88 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.034 169.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.792 ' HA ' ' CE1' ' A' ' 139' ' ' HIS . 65.5 mt 74.49 -77.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 O-C-N 123.538 0.524 . . . . 0.0 111.539 178.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.71 40.94 49.55 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.367 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.634 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 144.93 98.79 0.25 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.741 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 135.9 -138.79 10.19 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.689 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 29.6 pt -143.67 158.35 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 117.109 0.454 . . . . 0.0 110.493 173.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.609 ' OD2' HG23 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -93.4 117.84 30.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.021 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.934 HG22 HD13 ' A' ' 140' ' ' ILE . 75.2 t -116.8 95.29 46.19 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.719 -168.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.543 ' HA ' HD11 ' A' ' 137' ' ' ILE . 50.8 Cg_endo -72.22 113.51 3.72 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.037 1.825 . . . . 0.0 111.893 172.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.601 HG23 HG22 ' A' ' 105' ' ' VAL . 10.4 p -116.84 133.84 23.03 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -48.43 128.98 18.75 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.202 2.602 . . . . 0.0 112.226 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.851 ' HG2' ' HG3' ' A' ' 136' ' ' LYS . 14.7 mtp180 -63.5 -44.1 95.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.414 -171.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.02 6.44 3.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.871 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.444 ' O ' HG11 ' A' ' 104' ' ' VAL . 4.4 m -132.51 1.92 3.77 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.834 0.35 . . . . 0.0 110.761 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 99' ' ' ARG . 10.9 p -75.42 -19.7 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 110.671 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.77 -40.67 95.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.842 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 101' ' ' SER . 8.5 p -73.15 -29.03 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.337 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 97' ' ' VAL . 64.6 t -66.94 -41.75 87.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.775 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.744 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 40.7 mm -72.51 -38.11 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.935 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.5 38.65 5.24 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.039 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.7 ttp-105 66.33 -75.36 0.05 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.215 0.606 . . . . 0.0 111.821 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.3 p -99.99 12.5 36.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.091 0.472 . . . . 0.0 110.694 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.72 40.49 7.18 Favored Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.203 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -91.91 -32.07 15.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.116 0.484 . . . . 0.0 110.412 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.544 ' O ' HG12 ' A' ' 116' ' ' ILE . 5.9 tpt -89.64 -41.56 11.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.521 -171.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.744 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 6.2 tp -59.81 -25.99 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.33 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' A' ' 114' ' ' LYS . 10.1 mmpt? -73.32 -45.33 55.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.924 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.95 -22.44 60.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.917 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 112' ' ' MET . 37.0 mm -59.42 -44.29 92.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.583 HE21 ' HB ' ' A' ' 124' ' ' ILE . 65.0 mt-30 -68.01 -25.5 65.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.26 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.7 -46.75 16.52 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.025 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -78.44 -52.68 8.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.317 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.551 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -81.07 -19.34 43.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.367 -176.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.35 26.35 63.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.629 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.3 m -95.84 161.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.377 0.608 . . . . 0.0 112.109 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.804 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 6.7 mpt_? -108.68 135.15 50.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.642 HG22 HD12 ' A' ' 113' ' ' ILE . 43.2 mm -116.29 129.83 72.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 1.048 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -143.51 169.56 17.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.186 168.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -117.29 104.28 10.99 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.871 ' HD2' ' HG3' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -94.83 -12.91 26.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -165.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.871 ' HG3' ' HD2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 123.675 0.79 . . . . 0.0 109.055 173.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 87.6 Cg_endo . . . . . 0 N--CA 1.462 -0.326 0 CA-C-O 120.963 0.318 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -130.89 156.43 45.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.932 0.396 . . . . 0.0 111.028 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.851 ' HG3' ' HG2' ' A' ' 99' ' ' ARG . 48.9 mttm -110.03 118.51 36.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.485 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 10.6 mm -77.34 120.53 28.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.041 0.448 . . . . 0.0 112.207 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.69 36.18 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.47 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 1.048 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 12.7 t-160 -85.15 104.71 15.28 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.934 HD13 HG22 ' A' ' 95' ' ' VAL . 60.5 mt -88.35 118.27 33.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.221 170.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.804 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 41.4 ttm -109.49 127.39 54.39 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 158.56 -160.59 31.12 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 16.3 Cg_exo -68.73 139.99 45.52 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.786 2.324 . . . . 0.0 110.855 174.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 143' ' ' PRO . 75.8 Cg_exo -50.56 -32.54 35.58 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.138 3.225 . . . . 0.0 114.139 -172.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.82 -44.61 66.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.789 0.328 . . . . 0.0 110.556 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.551 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 55.7 mtt-85 -70.76 -27.72 64.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.291 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.741 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 71.2 m -57.41 -56.05 26.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.27 175.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.08 -31.81 68.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.36 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 146' ' ' ARG . 30.9 t60 -55.95 -33.1 64.43 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.265 0.555 . . . . 0.0 110.313 173.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.689 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -78.24 -45.01 24.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.506 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.19 -24.56 67.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.403 0.621 . . . . 0.0 110.304 176.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -76.58 -26.27 54.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.106 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.564 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 68.5 mt -78.21 -40.89 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.503 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 73.6 mt -59.55 -43.17 90.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.064 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -57.06 -39.34 74.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.011 0.434 . . . . 0.0 110.666 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -69.91 -33.09 71.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.303 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 70.3 mt -66.61 -40.41 88.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.087 0.47 . . . . 0.0 110.335 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 56.3 mt . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.854 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.492 HG21 ' HA ' ' A' ' 57' ' ' PRO . 24.0 m . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 121.302 0.572 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 12.1 p -125.65 121.98 61.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.858 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -109.99 150.74 28.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.759 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.763 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 39.1 mt-10 -116.06 123.36 47.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.439 0.638 . . . . 0.0 111.959 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -114.11 144.46 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.992 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.401 ' SD ' ' HB2' ' A' ' 48' ' ' ASP . 33.3 tpp -87.91 124.11 33.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.963 0.411 . . . . 0.0 111.514 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.602 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.7 mp -104.24 109.05 61.94 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.86 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.598 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 52.7 Cg_exo -61.29 147.25 96.08 Favored 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 123.596 2.864 . . . . 0.0 112.962 175.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.7 124.92 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.65 -39.14 2.99 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -169.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.598 ' HB2' ' HB2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -79.71 -31.75 41.23 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.104 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -53.67 -34.34 58.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.881 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.03 -39.12 91.53 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.581 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.1 pp -89.7 -22.84 22.03 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.553 -0.381 . . . . 0.0 111.075 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 71' ' ' LEU . 96.6 t -78.52 -46.83 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 13' ' ' ALA . 22.0 pt -91.2 -21.14 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.086 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.436 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.78 -0.73 59.44 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.759 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.656 ' H ' HG13 ' A' ' 17' ' ' ILE . 15.6 tptp 70.0 -52.33 0.63 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.975 0.91 . . . . 0.0 110.557 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.72 8.68 73.99 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.16 5.4 76.54 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.194 -0.526 . . . . 0.0 113.082 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.895 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 10.2 pt-20 -73.31 -27.57 61.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 80' ' ' GLY . 90.3 m -77.43 -43.67 31.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.899 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.534 ' HA ' HD13 ' A' ' 27' ' ' LEU . 6.2 tp -62.81 -24.21 35.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 CA-C-O 120.834 0.349 . . . . 0.0 110.525 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.895 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 77.9 mttt -60.85 -50.66 72.55 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.141 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.446 ' CB ' ' HB2' ' A' ' 81' ' ' ASP . 39.2 mt-30 -71.54 -31.75 67.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.107 -177.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.646 HD11 ' HE2' ' A' ' 35' ' ' MET . 47.7 mt -68.44 -27.58 66.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 110.611 176.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.1 mt-30 -84.65 -47.55 10.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.295 0.569 . . . . 0.0 110.565 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -84.02 -53.37 5.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.206 -171.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.662 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 26.3 ttm180 -65.6 -44.47 86.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.877 ' HB3' ' HE2' ' A' ' 66' ' ' MET . . . -80.66 -7.19 59.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.316 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.77 9.34 38.74 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.763 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.2 m -109.15 172.16 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.95 0.375 . . . . 0.0 110.362 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -113.43 109.98 19.56 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.844 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -95.19 112.82 24.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.477 HG22 ' HB2' ' A' ' 52' ' ' ARG . 6.1 tp -111.11 100.67 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 122.392 1.091 . . . . 0.0 110.667 -177.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.873 ' HG ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -134.38 143.91 47.9 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.634 178.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.619 ' H ' HD13 ' A' ' 38' ' ' ILE . 4.0 mp -62.51 100.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.886 0.374 . . . . 0.0 110.237 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -87.36 -77.21 0.34 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -104.85 86.68 2.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.224 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . -144.28 163.12 27.85 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.021 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 m -62.54 -28.74 70.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -82.16 -78.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.39 . . . . 0.0 111.77 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.621 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 76.2 m-20 -110.34 56.25 0.63 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.874 -171.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 9.3 t -80.19 -45.43 18.08 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -94.01 -26.52 16.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.824 0.821 . . . . 0.0 109.026 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 57.3 t -78.89 159.86 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.009 -175.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.401 ' HB2' ' SD ' ' A' ' 7' ' ' MET . 3.3 p-10 -55.94 151.33 11.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -126.71 129.83 23.98 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.509 -166.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.06 112.99 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.846 2.364 . . . . 0.0 112.108 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.873 HD22 ' HG ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -81.37 110.52 16.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.973 -176.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.543 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.6 mpt_? -98.77 107.46 19.91 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.42 174.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.3 mt -91.43 113.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.053 176.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.0 mt -103.77 123.12 57.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.806 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.4 -171.45 44.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.267 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 9.7 t70 -71.34 139.14 84.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.492 ' HA ' HG21 ' A' ' 2' ' ' THR . 30.3 Cg_exo -34.82 -47.06 0.62 Allowed 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 124.07 3.18 . . . . 0.0 114.99 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -61.81 -40.64 95.95 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.821 0.344 . . . . 0.0 111.281 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 56' ' ' ASP . 19.7 ptpt -82.14 -31.04 30.76 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.95 -175.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.98 -30.68 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.546 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -52.21 14.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.878 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -65.59 -23.68 66.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.708 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -81.21 -51.32 8.55 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.997 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.496 ' SG ' HD13 ' A' ' 53' ' ' ILE . 94.5 m -54.11 -40.81 67.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.272 0.558 . . . . 0.0 109.978 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -58.54 -53.28 60.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.822 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.877 ' HE2' ' HB3' ' A' ' 31' ' ' ALA . 6.6 ptt? -64.43 -40.81 96.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.89 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 63' ' ' ALA . 86.9 t -56.53 -47.64 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.531 0.205 . . . . 0.0 110.812 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.1 mtt -69.87 -26.9 64.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.956 0.408 . . . . 0.0 110.89 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.526 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -85.36 -27.91 25.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.745 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.7 pp -90.14 -32.64 5.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 O-C-N 121.71 -0.619 . . . . 0.0 111.788 175.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.573 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 4.2 tt -71.98 -12.5 61.27 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.604 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -67.36 -10.42 50.91 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.256 -0.278 . . . . 0.0 111.22 177.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.828 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 9.2 tp10 -56.57 131.13 47.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.136 0.494 . . . . 0.0 110.297 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -66.67 -44.57 81.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.888 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.1 t0 172.88 92.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.869 0.73 . . . . 0.0 109.54 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -176.19 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.926 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.828 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . 160.78 131.25 1.2 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.169 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -87.89 58.55 4.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.154 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.605 ' HD2' HG22 ' A' ' 70' ' ' ILE . 78.5 m-85 57.72 8.84 0.73 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.212 0.605 . . . . 0.0 112.416 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.473 ' C ' HG22 ' A' ' 23' ' ' THR . . . 70.06 7.34 59.41 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.581 -0.342 . . . . 0.0 113.087 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.662 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.2 OUTLIER 170.71 -62.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.107 0.479 . . . . 0.0 109.781 -172.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.745 ' HA ' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER 163.71 -45.02 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.446 -173.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 57.63 72.37 0.52 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.388 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 1.022 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 24.8 tt0 -171.34 -68.56 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.749 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.34 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.634 ' H ' ' HD2' ' A' ' 82' ' ' ARG . 0.9 OUTLIER -136.18 -95.7 0.24 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.527 -0.733 . . . . 0.0 111.926 178.011 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . 84.96 92.03 0.79 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 38.0 t 65.49 6.34 3.7 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.709 0.404 . . . . 0.0 110.893 -175.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.748 ' HG3' ' HD2' ' A' ' 127' ' ' LYS . 3.0 mmp_? -132.66 171.61 13.62 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.102 -173.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.953 HD12 ' HG2' ' A' ' 125' ' ' GLN . 24.3 mm 28.95 -83.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 125.725 1.891 . . . . 0.0 115.144 169.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.515 ' HA2' ' CD1' ' A' ' 85' ' ' TYR . . . 86.49 36.18 9.85 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -172.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.18 98.23 0.11 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.783 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 112.0 161.66 16.22 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -174.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 1.022 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 40.0 pt -93.98 158.77 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -172.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.456 ' CG ' HG23 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -102.55 108.07 19.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.015 179.481 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 27.5 t -101.11 105.12 37.07 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.426 ' CA ' HD11 ' A' ' 137' ' ' ILE . 56.9 Cg_endo -75.06 108.12 2.64 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.047 1.832 . . . . 0.0 111.885 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.701 HG12 HD22 ' A' ' 158' ' ' LEU . 47.2 t -101.65 127.76 30.58 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.997 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.602 ' HD2' HD23 ' A' ' 158' ' ' LEU . 74.3 Cg_exo -41.59 132.97 3.72 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.803 3.002 . . . . 0.0 112.734 171.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.515 ' HD3' ' HB2' ' A' ' 134' ' ' PRO . 32.6 ptt180 -51.34 -34.92 35.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.562 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -92.5 4.69 53.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.352 -177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 98' ' ' PRO . 19.6 m -122.44 -18.55 6.68 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.622 ' HA ' HG13 ' A' ' 97' ' ' VAL . 14.2 p -59.1 -34.1 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.623 0.249 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.53 -30.0 75.74 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.798 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.78 -33.79 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.055 0.455 . . . . 0.0 109.868 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.53 -36.09 76.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.01 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.735 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 37.7 mm -75.23 -46.04 39.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.266 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.45 -127.19 7.49 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.448 ' HA ' ' NE ' ' A' ' 108' ' ' ARG . 4.2 mmp_? -100.39 -65.38 0.97 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.7 m -105.64 -20.96 13.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.514 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.17 50.18 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.127 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -93.86 -57.78 2.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.703 0.287 . . . . 0.0 110.472 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.565 ' HA ' ' HD3' ' A' ' 115' ' ' LYS . 14.2 tpt -59.82 -36.43 76.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.367 -174.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.735 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.6 tp -65.78 -32.39 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -86.43 -19.76 29.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.308 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' A' ' 112' ' ' MET . 26.5 mtpp -66.79 -35.68 80.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.297 174.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 112' ' ' MET . 30.1 mm -62.89 -38.51 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.198 0.523 . . . . 0.0 109.629 175.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -64.69 -34.01 77.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.675 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -82.36 -38.64 23.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.277 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.9 -55.8 4.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.002 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.85 -25.38 22.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.558 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.97 32.9 19.77 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.981 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 m -114.69 164.1 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.094 0.473 . . . . 0.0 111.449 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -109.87 163.17 13.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.601 HG22 HD12 ' A' ' 113' ' ' ILE . 45.3 mm -123.76 124.36 69.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.048 0.452 . . . . 0.0 111.492 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.953 ' HG2' HD12 ' A' ' 89' ' ' ILE . 50.5 tp60 -115.18 112.96 23.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.034 177.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -87.64 106.04 17.76 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.365 0.602 . . . . 0.0 109.566 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.748 ' HD2' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -107.46 -159.28 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.753 -178.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 128' ' ' GLN . 7.2 tp-100 . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 121.298 0.57 . . . . 0.0 112.099 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.515 ' HB2' ' HD3' ' A' ' 99' ' ' ARG . 92.4 Cg_endo . . . . . 0 N--CA 1.461 -0.39 0 CA-C-O 120.941 0.309 . . . . 0.0 112.771 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -75.37 149.24 38.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 111.131 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -124.93 123.16 39.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.996 -175.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 40.0 mm -65.43 111.25 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.954 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -90.84 91.07 8.2 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 164.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.624 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 28.0 t60 -71.18 115.86 10.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.228 0.537 . . . . 0.0 111.08 -169.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.761 HD13 HD13 ' A' ' 154' ' ' ILE . 96.4 mt -79.74 107.79 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.222 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.482 ' HB2' ' HD2' ' A' ' 139' ' ' HIS . 21.9 ttp -103.96 128.12 51.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.13 -172.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.26 -156.4 27.21 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.41 137.79 44.22 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.669 2.246 . . . . 0.0 111.705 177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -45.56 -55.07 3.81 Favored 'Trans proline' 0 N--CA 1.474 0.378 0 C-N-CA 123.543 2.828 . . . . 0.0 113.978 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -64.52 -32.86 74.68 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.798 0.333 . . . . 0.0 111.03 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -72.5 -36.06 68.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.783 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 74.5 m -60.72 -54.5 44.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.44 174.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.565 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 4.7 mm-40 -54.97 -42.04 71.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.739 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -59.65 -31.61 69.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.401 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.705 ' HB2' HD12 ' A' ' 140' ' ' ILE . . . -79.22 -35.15 42.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.365 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -70.71 -18.71 62.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.644 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.565 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 9.8 mpt_? -77.57 -17.3 58.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.977 0.418 . . . . 0.0 109.975 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.93 -50.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.913 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.761 HD13 HD13 ' A' ' 140' ' ' ILE . 38.7 mt -71.64 -57.18 8.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.734 -173.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -59.07 -28.65 66.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.881 0.372 . . . . 0.0 110.813 -177.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.93 -47.32 80.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.428 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 4.4 pp -76.59 -20.91 56.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.326 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.701 HD22 HG12 ' A' ' 97' ' ' VAL . 33.6 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.198 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 57' ' ' PRO . 6.6 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 29.3 m -130.98 124.56 56.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 0.0 110.8 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -105.42 153.75 21.26 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.573 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 51.9 mt-10 -123.86 109.06 13.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.457 0.646 . . . . 0.0 111.677 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -105.59 139.02 28.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.7 tpp -91.01 122.35 33.6 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.716 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.682 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -95.53 113.76 62.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.749 -177.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -61.78 153.87 64.72 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.628 2.886 . . . . 0.0 112.459 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.74 144.66 55.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 171.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.42 -53.15 3.46 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -170.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -63.36 -35.11 79.29 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.372 172.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -49.12 -34.37 13.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.839 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.466 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -60.06 -44.34 97.37 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.615 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 75' ' ' ASP . 4.1 pp -85.48 -23.95 27.58 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.081 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.682 HG11 HG12 ' A' ' 8' ' ' ILE . 97.7 t -73.69 -42.9 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 13' ' ' ALA . 21.2 pt -91.56 -25.24 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 121.679 -0.638 . . . . 0.0 111.083 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.586 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 100.49 3.77 55.17 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.904 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.624 ' H ' HG13 ' A' ' 17' ' ' ILE . 7.6 tptm 53.82 48.13 22.05 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.542 0.687 . . . . 0.0 110.462 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.57 -1.48 0.52 Allowed Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.945 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.34 26.46 13.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.605 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -84.11 -60.12 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.988 0.423 . . . . 0.0 110.555 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.586 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 54.4 m -61.33 -44.52 97.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.359 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.564 HD11 HE21 ' A' ' 28' ' ' GLN . 0.3 OUTLIER -60.69 -31.4 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.032 0.444 . . . . 0.0 110.19 -177.2 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -39.01 93.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.264 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 30' ' ' ARG . 24.3 mt-30 -77.85 -39.53 43.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.269 0.557 . . . . 0.0 109.61 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.614 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 74.8 mt -64.0 -23.85 67.49 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.81 0.338 . . . . 0.0 110.61 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 68.8 mt-30 -85.89 -58.37 2.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.808 0.337 . . . . 0.0 111.751 174.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -82.59 -42.26 18.51 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -172.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.543 ' HG3' HG13 ' A' ' 137' ' ' ILE . 1.9 mtp180 -73.7 -38.72 64.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.83 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.637 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -84.39 -12.22 54.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.209 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.75 75.09 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.992 175.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 23.3 m -128.15 153.15 37.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.844 0.354 . . . . 0.0 110.675 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -90.13 110.14 21.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 1.01 ' HB3' HD22 ' A' ' 51' ' ' LEU . 48.9 mtt -96.25 124.58 40.31 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.433 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 6.1 tp -119.09 111.12 32.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.776 0.798 . . . . 0.0 110.217 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.699 ' HB3' HD21 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -134.15 144.35 48.48 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.829 -174.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.486 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 43.8 mm -68.19 104.48 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.05 0.452 . . . . 0.0 111.207 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 1.3 pp0? -146.71 20.85 1.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.64 0.733 . . . . 0.0 109.868 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.27 23.15 0.29 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.702 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . 82.33 -55.59 4.96 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.223 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.4 t -90.53 -157.9 0.51 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 62.04 -132.27 0.59 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.304 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.402 ' H ' HG21 ' A' ' 38' ' ' ILE . 93.8 m-20 -80.88 69.51 7.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.487 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 4.0 t -79.58 -44.96 20.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.904 0.383 . . . . 0.0 110.801 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -93.27 -3.54 53.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.161 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.11 159.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.913 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.02 156.22 36.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 18.2 mttm -131.06 128.35 22.24 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.301 -161.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.53 125.35 8.25 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.435 2.09 . . . . 0.0 112.021 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 1.01 HD22 ' HB3' ' A' ' 35' ' ' MET . 2.5 tm? -105.88 120.42 41.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.603 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.573 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.7 mpt_? -102.98 121.61 42.9 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.395 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.9 mt -90.5 109.92 21.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.421 HG12 ' CG1' ' A' ' 3' ' ' VAL . 36.8 mt -104.92 119.33 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.514 ' HA3' HG11 ' A' ' 33' ' ' VAL . . . 172.45 -170.74 43.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.921 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -67.24 142.03 96.55 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.487 ' HA ' HG22 ' A' ' 2' ' ' THR . 87.4 Cg_exo -46.29 -47.68 14.6 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.129 2.553 . . . . 0.0 113.931 -172.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.473 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 46.1 t80 -59.23 -40.71 86.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.151 0.5 . . . . 0.0 110.647 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -67.99 -45.49 73.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.093 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.6 t -58.33 -34.08 49.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.558 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -73.99 -40.51 62.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.737 0.303 . . . . 0.0 111.377 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.636 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 13.4 mm100 -72.99 -29.02 62.73 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.139 0.495 . . . . 0.0 110.268 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.642 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -85.65 -36.59 20.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.8 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.7 p -55.56 -43.4 75.83 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.96 0.41 . . . . 0.0 111.146 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.642 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 9.4 pt-20 -68.53 -38.85 81.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.593 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.778 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 4.9 ptt? -71.49 -34.27 70.0 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.598 -176.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 63' ' ' ALA . 89.4 t -56.99 -36.17 49.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 174.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.642 ' HE2' ' HA ' ' A' ' 65' ' ' GLU . 36.2 mtm -82.0 -28.34 32.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.449 0.642 . . . . 0.0 110.19 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 36.5 t70 -75.87 -41.29 52.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.311 -171.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 82' ' ' ARG . 2.8 pp -89.63 -26.3 5.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.536 HD11 HG13 ' A' ' 8' ' ' ILE . 5.8 tt -69.6 -24.27 63.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.673 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -19.94 59.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.591 -177.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -51.19 -90.31 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.557 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 61.9 ttt180 168.08 -82.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.1 p-10 -168.52 12.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.828 172.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -86.46 -76.26 0.36 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.501 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -140.43 83.65 0.23 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.792 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -91.83 24.07 22.85 Favored Glycine 0 C--O 1.226 -0.388 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 175.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.698 ' HD2' HG21 ' A' ' 70' ' ' ILE . 54.6 m-85 69.05 -23.86 0.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.394 1.078 . . . . 0.0 113.56 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.479 ' C ' HG22 ' A' ' 23' ' ' THR . . . 84.14 15.4 69.61 Favored Glycine 0 C--N 1.328 0.129 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.399 177.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.407 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER 173.89 -65.69 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -174.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.898 ' HA ' HG23 ' A' ' 70' ' ' ILE . 32.3 ttt180 166.88 -18.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.906 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.647 ' HB2' ' HB3' ' A' ' 79' ' ' PHE . 0.3 OUTLIER 67.66 42.7 1.98 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.025 176.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 28.9 tt0 -160.64 -52.56 0.05 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.472 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.631 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 46.0 p90 -176.71 171.7 2.22 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 110.075 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.674 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -132.95 -11.13 1.88 Allowed Glycine 0 CA--C 1.523 0.57 0 O-C-N 123.726 0.641 . . . . 0.0 112.28 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.636 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 18.0 p 178.28 -55.97 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.583 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 1.4 mpt_? -70.08 179.1 2.46 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.752 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.66 HG12 ' CG ' ' A' ' 139' ' ' HIS . 54.2 mt 78.36 -74.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.64 0.587 . . . . 0.0 111.136 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 46.91 46.73 19.65 Favored Glycine 0 C--N 1.337 0.609 0 O-C-N 123.41 0.444 . . . . 0.0 112.582 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.435 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 142.85 99.88 0.34 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.66 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 113.69 166.11 16.03 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -174.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.721 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 2.8 pp -93.66 -178.43 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.223 0.535 . . . . 0.0 112.253 -173.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.57 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 1.7 p-10 -109.74 147.01 33.96 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.142 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.88 HG23 ' HB2' ' A' ' 138' ' ' ALA . 3.5 m -137.56 97.14 10.48 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 121.229 0.537 . . . . 0.0 111.666 173.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.542 ' HD3' ' OD2' ' A' ' 94' ' ' ASP . 37.2 Cg_endo -67.04 108.55 1.53 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.155 2.57 . . . . 0.0 111.692 173.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 102' ' ' VAL . 99.0 t -103.52 120.1 52.78 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.818 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -46.32 128.02 11.77 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.768 2.312 . . . . 0.0 110.872 170.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.71 -31.5 37.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -173.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -82.12 -9.76 59.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.968 0.413 . . . . 0.0 110.809 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -107.06 -19.1 13.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.487 ' HA ' HG11 ' A' ' 97' ' ' VAL . 94.6 t -48.31 -45.39 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.491 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.87 -22.13 61.9 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.986 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.7 t -86.51 -38.78 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.89 0.376 . . . . 0.0 110.075 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.6 t -66.61 -38.77 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 121.345 0.593 . . . . 0.0 109.904 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.745 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 38.9 mm -70.54 -43.36 77.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.562 174.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.92 66.92 1.39 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.726 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 108' ' ' ARG . 4.0 mpt_? 57.81 -94.81 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.061 0.544 . . . . 0.0 112.055 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.1 m -77.21 -13.29 59.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.399 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.534 ' HA2' HG21 ' A' ' 106' ' ' ILE . . . 109.11 22.38 6.9 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.992 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 12.8 pt-20 -85.45 -10.81 55.63 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.737 -0.272 . . . . 0.0 111.689 -176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.453 ' HE1' HD21 ' A' ' 157' ' ' LEU . 16.9 tpt -89.94 -40.8 12.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 0.0 110.421 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.745 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 11.0 tp -62.19 -25.32 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.449 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 45.6 mtpt -85.93 -22.05 27.61 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.605 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 61.1 mttp -68.51 -32.95 73.28 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.519 HG23 HD11 ' A' ' 153' ' ' ILE . 29.8 mt -63.65 -37.02 78.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.505 0.669 . . . . 0.0 109.43 174.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -73.04 -26.33 61.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.858 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -87.56 -41.24 13.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.024 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.1 -51.33 10.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.185 -174.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.582 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -92.77 -11.05 34.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.084 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.42 31.65 68.37 Favored Glycine 0 C--O 1.229 -0.196 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.484 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.65 -177.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.036 0.446 . . . . 0.0 111.909 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 55.1 ttt180 -132.57 143.2 49.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.177 176.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.555 HG21 HD11 ' A' ' 113' ' ' ILE . 47.0 mm -110.86 142.84 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.041 0.448 . . . . 0.0 112.164 -171.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 2.2 tt0 -148.34 114.38 5.8 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.281 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -79.45 111.21 15.48 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.803 -0.56 . . . . 0.0 109.635 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -121.34 112.91 19.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.369 -174.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.426 HE21 ' HB3' ' A' ' 128' ' ' GLN . 9.2 mm100 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 121.224 0.535 . . . . 0.0 110.984 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.476 0.483 0 N-CA-C 115.249 1.211 . . . . 0.0 115.249 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -94.46 134.66 36.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.581 0.705 . . . . 0.0 112.358 -169.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -110.88 120.8 43.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.804 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.543 HG13 ' HG3' ' A' ' 30' ' ' ARG . 9.1 mm -72.34 116.37 14.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.808 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.88 ' HB2' HG23 ' A' ' 95' ' ' VAL . . . -105.09 143.12 33.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.199 0.523 . . . . 0.0 111.417 174.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.66 ' CG ' HG12 ' A' ' 89' ' ' ILE . 10.4 t-160 -86.38 125.58 33.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.902 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.644 HD12 HD12 ' A' ' 93' ' ' ILE . 30.6 mt -106.91 107.8 23.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.805 170.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.603 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 37.0 ttm -95.59 129.69 42.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.151 -175.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.64 -167.79 36.56 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.633 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.12 143.44 78.15 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.489 2.126 . . . . 0.0 110.811 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.32 -48.17 8.41 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 124.023 3.148 . . . . 0.0 113.758 -173.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -61.79 -47.81 83.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.32 0.581 . . . . 0.0 110.945 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.582 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 49.7 mtt180 -69.51 -22.38 63.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.307 -176.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.66 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 77.8 m -59.22 -52.31 66.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.249 0.547 . . . . 0.0 110.003 174.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -74.39 -31.71 62.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.731 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 146' ' ' ARG . 9.4 t60 -62.49 -29.91 70.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.243 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.561 ' HB2' HG22 ' A' ' 140' ' ' ILE . . . -80.17 -38.85 30.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.506 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.3 -23.82 66.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.302 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 149' ' ' HIS . 13.5 ptt180 -76.62 -25.14 53.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -174.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.559 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 62.5 mt -68.82 -41.46 82.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.529 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.8 -40.74 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.057 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -57.8 -45.79 85.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.458 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -57.84 -37.31 73.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.926 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 77.4 mt -65.36 -50.77 64.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.545 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 mt . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 121.217 0.532 . . . . 0.0 110.192 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 20.6 t -142.8 112.65 2.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.688 166.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 16.6 mm100 -123.85 159.59 29.27 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 176.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 48.7 mt-10 -116.88 129.15 55.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.17 0.51 . . . . 0.0 111.35 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.72 HD11 ' HA ' ' A' ' 64' ' ' CYS . 74.5 mt -111.43 145.97 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.54 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.21 110.29 20.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.835 0.35 . . . . 0.0 111.427 -175.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.514 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.9 mp -106.42 106.39 57.33 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.276 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.82 163.95 37.3 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.793 2.329 . . . . 0.0 111.342 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.85 145.3 56.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.47 -56.57 2.0 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -172.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -68.93 -27.91 66.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.827 0.346 . . . . 0.0 110.481 175.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.613 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -53.52 -35.37 60.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.133 174.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.672 ' HA3' ' HE3' ' A' ' 19' ' ' LYS . . . -63.37 -47.69 85.36 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.846 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.743 HD22 ' HB2' ' A' ' 73' ' ' GLU . 2.7 pp -78.68 -19.16 53.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.2 0.5 . . . . 0.0 111.407 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.8 t -78.41 -40.24 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.764 0.316 . . . . 0.0 111.151 175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 13' ' ' ALA . 30.9 pt -88.86 -29.48 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.075 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.493 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.9 16.8 32.18 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.672 ' HE3' ' HA3' ' A' ' 14' ' ' GLY . 33.4 mmtp 55.44 47.07 21.93 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.006 0.522 . . . . 0.0 110.867 -175.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.11 -35.83 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.35 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 152.87 -12.43 0.62 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.295 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.506 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 20.1 mm-40 -45.26 -49.81 12.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.493 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 26.1 m -81.29 -34.89 31.69 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.435 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.485 HG21 ' O ' ' A' ' 21' ' ' GLY . 7.3 tp -64.91 -26.92 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.012 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.506 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 84.4 mttt -55.19 -53.6 54.0 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.913 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 23.2 mt-30 -66.14 -45.08 82.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.592 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.593 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 95.7 mt -59.87 -29.13 68.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.897 0.38 . . . . 0.0 111.124 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 27.5 mt-30 -85.89 -49.81 7.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.147 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.63 -51.78 5.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.643 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 15.2 ttm180 -65.14 -42.83 93.44 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.913 ' HB2' ' HG ' ' A' ' 87' ' ' SER . . . -80.89 -29.66 35.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.557 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.73 0.92 85.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.351 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 34.6 m -112.87 151.45 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -91.39 109.66 20.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.6 ' HB3' HD23 ' A' ' 51' ' ' LEU . 41.6 mtt -95.61 114.05 25.77 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.615 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.5 tp -113.12 109.63 29.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.99 0.9 . . . . 0.0 109.532 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.834 HD12 HD11 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -124.11 136.86 54.52 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.45 -174.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.693 HG22 ' HD2' ' A' ' 50' ' ' PRO . 10.8 tp -76.15 100.8 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 122.012 0.91 . . . . 0.0 110.014 -174.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.456 ' C ' ' H ' ' A' ' 41' ' ' GLY . 21.6 tm0? -132.09 135.1 46.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.084 -173.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 t70 72.52 -23.81 0.2 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.82 0.848 . . . . 0.0 111.874 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 39' ' ' GLN . . . -68.24 155.81 53.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.203 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -74.28 76.17 1.84 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.066 0.46 . . . . 0.0 111.415 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -160.98 -62.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.158 176.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -131.68 53.71 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 110.439 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -83.08 -41.53 18.5 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.714 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -91.61 -4.2 55.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.386 0.612 . . . . 0.0 109.875 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 48' ' ' ASP . 40.3 t -108.45 165.03 5.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.519 -173.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.421 ' N ' HG11 ' A' ' 47' ' ' VAL . 5.0 p-10 -58.14 150.58 20.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.123 0.487 . . . . 0.0 110.289 171.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -126.99 127.43 24.37 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.101 -169.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.693 ' HD2' HG22 ' A' ' 38' ' ' ILE . 83.3 Cg_endo -81.18 108.18 1.98 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.74 2.294 . . . . 0.0 112.09 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.834 HD11 HD12 ' A' ' 37' ' ' LEU . 9.6 tt -84.17 117.55 23.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.841 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.615 ' HB2' HG23 ' A' ' 36' ' ' ILE . 1.5 mpt_? -91.42 112.22 24.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.107 0.254 . . . . 0.0 110.964 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.75 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 62.5 mt -89.12 113.02 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.057 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.712 HG12 HG22 ' A' ' 3' ' ' VAL . 30.3 mt -104.55 118.17 51.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.496 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 176.52 -170.9 43.83 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.393 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.46 ' O ' HG22 ' A' ' 60' ' ' VAL . 9.3 m-20 -65.11 147.38 98.58 Favored Pre-proline 0 N--CA 1.462 0.156 0 C-N-CA 122.46 0.304 . . . . 0.0 110.507 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.89 -52.41 8.94 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.112 2.542 . . . . 0.0 114.613 -173.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 17.5 p90 -63.17 -27.07 69.12 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.949 0.404 . . . . 0.0 110.571 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.803 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 91.7 mttt -72.46 -50.52 25.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.555 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 56' ' ' ASP . 22.0 t -59.93 -34.95 57.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.03 -176.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -66.3 -51.19 59.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 12.2 mm100 -64.83 -37.71 88.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 110.38 -177.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.588 ' HB1' ' OG ' ' A' ' 87' ' ' SER . . . -69.19 -40.38 78.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.751 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.72 ' HA ' HD11 ' A' ' 6' ' ' ILE . 54.0 t -52.41 -43.4 64.77 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.209 0.528 . . . . 0.0 110.208 177.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.1 -46.14 62.32 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.587 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.781 ' HE3' ' HB3' ' A' ' 31' ' ' ALA . 3.8 ptt? -65.35 -39.69 92.69 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.494 -171.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.731 HG12 HD22 ' A' ' 71' ' ' LEU . 90.4 t -62.32 -50.19 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.367 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.565 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 56.4 mtp -63.32 -30.29 71.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.05 0.452 . . . . 0.0 110.586 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 0.9 OUTLIER -73.37 -40.24 64.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.898 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 82' ' ' ARG . 2.9 pp -86.67 -24.29 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.684 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.731 HD22 HG12 ' A' ' 67' ' ' VAL . 3.6 pp -83.09 -0.38 48.83 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.37 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.586 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 11.9 ptm180 -50.92 -42.8 59.74 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.743 ' HB2' HD22 ' A' ' 15' ' ' LEU . 27.1 tt0 60.07 110.84 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 124.373 1.046 . . . . 0.0 113.107 174.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -107.67 -39.17 5.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -140.66 50.58 1.66 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 59.49 68.2 0.82 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.18 0.514 . . . . 0.0 111.571 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.32 -40.62 0.24 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.652 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 76.48 -96.7 1.15 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.182 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.588 ' HD2' ' HA ' ' A' ' 70' ' ' ILE . 97.2 m-85 -144.47 -29.95 0.47 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.851 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.72 100.48 0.64 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.463 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 27.1 t70 68.79 -72.75 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -169.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.835 ' HA ' HG22 ' A' ' 70' ' ' ILE . 26.6 ttt180 178.26 -29.36 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.483 169.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t30 66.96 16.04 10.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.195 0.998 . . . . 0.0 109.479 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.98 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 74.6 mt-10 -129.12 -31.29 2.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.787 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.722 ' CB ' ' HB ' ' A' ' 89' ' ' ILE . 30.0 p90 176.98 152.68 0.2 Allowed 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.385 172.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.557 ' C ' ' HA ' ' A' ' 31' ' ' ALA . . . -117.53 106.31 1.38 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.404 168.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.913 ' HG ' ' HB2' ' A' ' 31' ' ' ALA . 43.4 m 51.51 35.64 14.94 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.673 ' HB3' HD12 ' A' ' 89' ' ' ILE . 11.8 mtt180 -166.12 -162.36 0.54 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.722 ' HB ' ' CB ' ' A' ' 85' ' ' TYR . 2.8 mp 63.97 -77.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 124.039 0.837 . . . . 0.0 111.806 173.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.42 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 57.51 48.06 83.76 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.628 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 144.91 81.27 0.05 OUTLIER Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.292 -0.48 . . . . 0.0 111.92 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 141.37 -150.16 21.65 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.98 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 47.9 pt -136.56 167.34 24.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 116.9 0.35 . . . . 0.0 111.219 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.643 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 3.5 p30 -108.59 139.22 43.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 171.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.878 HG21 ' HB1' ' A' ' 138' ' ' ALA . 11.8 m -133.35 95.48 18.19 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 121.107 0.48 . . . . 0.0 111.277 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.484 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 19.9 Cg_endo -62.54 108.31 0.7 Allowed 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.692 2.261 . . . . 0.0 111.071 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.457 ' HA ' ' HD2' ' A' ' 98' ' ' PRO . 12.8 p -110.27 125.02 31.85 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.955 0.407 . . . . 0.0 111.102 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 97' ' ' VAL . 5.5 Cg_endo -48.64 124.06 10.4 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.221 2.614 . . . . 0.0 111.774 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -63.64 -20.94 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.706 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -83.7 -0.87 52.61 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.785 0.326 . . . . 0.0 110.775 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.9 m -129.63 -2.43 4.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.653 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.95 -24.78 24.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 110.592 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.96 -28.88 66.82 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.394 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.1 t -77.14 -37.61 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.083 0.468 . . . . 0.0 110.388 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.1 t -71.02 -37.31 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.609 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.6 mm -80.19 -38.87 18.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.52 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.68 -104.33 2.9 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.037 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -138.32 -66.58 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.704 0.288 . . . . 0.0 110.395 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.7 m -88.76 -3.78 58.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.344 0.592 . . . . 0.0 110.297 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.95 31.08 7.9 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.41 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -92.81 -26.81 17.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.765 0.317 . . . . 0.0 110.358 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.514 ' SD ' ' HD3' ' A' ' 115' ' ' LYS . 16.3 tpt -69.63 -36.55 76.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.375 0.607 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.416 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 4.6 tp -70.36 -32.93 52.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.913 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.471 ' HZ1' ' HB3' ' A' ' 114' ' ' LYS . 9.4 mtpm? -73.53 -28.31 61.82 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.508 0.67 . . . . 0.0 109.421 173.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.514 ' HD3' ' SD ' ' A' ' 112' ' ' MET . 21.0 tttp -68.77 -31.87 71.21 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.65 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.5 mm -62.28 -36.87 76.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.679 0.752 . . . . 0.0 109.055 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.599 HE21 HG12 ' A' ' 124' ' ' ILE . 66.2 mt-30 -72.56 -22.19 61.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.557 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 115' ' ' LYS . 92.1 m-20 -79.52 -30.57 41.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.945 0.403 . . . . 0.0 110.803 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.36 -55.86 4.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.587 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -101.02 -28.97 12.43 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.922 -176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 117' ' ' GLN . . . 88.23 74.29 1.28 Allowed Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.681 -175.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 150' ' ' ALA . 18.6 m -134.23 166.95 27.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.683 0.278 . . . . 0.0 110.927 -175.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.794 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 23.5 ttt180 -122.27 138.81 54.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.599 HG12 HE21 ' A' ' 117' ' ' GLN . 50.8 mm -112.81 136.3 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -169.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.761 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 3.9 tp-100 -132.43 138.45 47.65 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.365 174.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -111.68 113.88 26.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.54 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -128.55 152.78 47.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.929 -173.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 . . . . . 0 C--O 1.235 0.316 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.723 177.32 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 C--O 1.234 0.293 0 CA-C-O 121.033 0.347 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 98' ' ' PRO . 3.0 mp0 -111.48 153.98 25.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.899 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -109.96 113.23 25.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.367 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.54 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 17.5 mm -68.86 105.71 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.113 0.482 . . . . 0.0 111.123 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.878 ' HB1' HG21 ' A' ' 95' ' ' VAL . . . -94.77 141.4 28.67 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.368 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.761 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -96.65 113.61 25.19 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.182 176.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.665 HD12 ' HB1' ' A' ' 150' ' ' ALA . 48.0 mt -93.22 119.6 41.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.634 173.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.794 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 38.0 ttm -105.89 137.77 43.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.445 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.48 179.34 26.17 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.318 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.36 149.17 23.69 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.927 2.418 . . . . 0.0 111.824 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.52 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 76.8 Cg_exo -51.34 -27.69 24.58 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.684 2.923 . . . . 0.0 113.684 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 12.5 t70 -76.97 -46.42 24.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.06 0.457 . . . . 0.0 109.84 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.45 -47.3 86.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.912 -177.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.545 ' HA ' ' CG2' ' A' ' 140' ' ' ILE . 17.7 p -57.58 -56.5 21.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.777 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -68.45 -23.46 64.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.814 0.34 . . . . 0.0 111.463 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.46 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 4.6 t60 -70.41 -30.37 67.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.134 0.492 . . . . 0.0 109.673 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 140' ' ' ILE . . . -79.09 -41.66 28.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.926 -177.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.22 -32.02 69.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.04 0.448 . . . . 0.0 110.857 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -76.98 -19.48 57.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.381 -177.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 149' ' ' HIS . 63.3 mt -81.08 -43.06 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.309 0.576 . . . . 0.0 109.575 174.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.3 mt -63.42 -46.94 93.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.572 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -60.14 -35.63 75.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.384 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.42 -40.45 86.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.14 0.495 . . . . 0.0 110.125 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.39 -41.0 81.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.625 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 51.2 mt . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 121.151 0.501 . . . . 0.0 110.579 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 57' ' ' PRO . 16.2 m . . . . . 0 C--O 1.223 -0.295 0 CA-C-O 121.189 0.519 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 17.9 m -101.06 134.58 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.34 0.591 . . . . 0.0 111.196 -177.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -125.63 155.39 40.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.904 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 46.8 mt-10 -113.45 117.27 31.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.328 0.585 . . . . 0.0 112.104 -173.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -105.68 142.4 18.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.754 175.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.523 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 48.0 tpp -91.94 125.51 36.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.681 0.277 . . . . 0.0 110.899 -176.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.924 HD13 ' HB2' ' A' ' 51' ' ' LEU . 3.5 mp -96.84 106.02 27.6 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.644 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.773 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 23.9 Cg_exo -67.37 148.37 79.46 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.936 2.424 . . . . 0.0 111.531 175.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.59 134.39 54.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 76' ' ' GLN . . . 102.99 -36.25 4.44 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -170.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.897 ' HG3' HD11 ' A' ' 15' ' ' LEU . 12.6 mptt -82.42 8.46 11.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.961 0.41 . . . . 0.0 110.363 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -59.02 -39.84 83.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.914 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.459 ' O ' ' HA2' ' A' ' 18' ' ' GLY . . . -69.15 -15.34 69.68 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.265 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.897 HD11 ' HG3' ' A' ' 12' ' ' LYS . 16.2 mt -90.67 -40.93 11.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.917 -0.142 . . . . 0.0 111.235 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.68 HG23 HG13 ' A' ' 8' ' ' ILE . 61.8 t -92.84 -51.16 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.658 HG13 ' H ' ' A' ' 19' ' ' LYS . 17.3 pt -91.51 -28.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.075 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . 89.84 15.81 57.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.185 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.658 ' H ' HG13 ' A' ' 17' ' ' ILE . 66.6 mmtt 67.36 -58.28 0.42 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.417 0.687 . . . . 0.0 111.704 -177.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.19 -5.9 75.68 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.501 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.94 4.36 54.37 Favored Glycine 0 C--O 1.229 -0.213 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.757 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.728 ' HA ' ' CD ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -73.39 -28.77 62.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -175.148 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 15' ' ' LEU . 91.5 m -71.53 -41.27 69.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.252 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' A' ' 35' ' ' MET . 6.9 tp -65.56 -27.45 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.151 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.728 ' CD ' ' HA ' ' A' ' 22' ' ' GLU . 11.9 mtpp -57.79 -49.5 76.42 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -72.84 -35.99 67.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.102 -175.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 98.1 mt -66.01 -27.69 68.31 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 121.837 -0.539 . . . . 0.0 110.382 176.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.741 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.6 mt-30 -84.88 -52.88 5.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.421 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -84.28 -56.38 3.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -174.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.47 HH22 ' HB3' ' A' ' 82' ' ' ARG . 3.5 ttp180 -56.27 -42.28 77.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.864 0.364 . . . . 0.0 110.461 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -87.65 -29.83 20.88 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.368 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.47 10.37 70.76 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.26 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.6 m -117.31 152.04 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.743 0.306 . . . . 0.0 110.3 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -96.56 110.98 23.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 46.4 mtt -94.81 125.79 39.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' A' ' 52' ' ' ARG . 5.0 tp -117.6 114.5 45.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.886 0.85 . . . . 0.0 109.941 -177.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.691 HD23 ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -132.82 142.94 49.23 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.676 -175.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.416 HD12 ' HG2' ' A' ' 50' ' ' PRO . 2.0 mp -61.62 112.84 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.17 0.51 . . . . 0.0 110.882 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.403 ' OE1' HD13 ' A' ' 17' ' ' ILE . 22.2 mm-40 -125.26 -53.51 1.61 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.067 176.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.29 72.17 9.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.541 0.686 . . . . 0.0 109.588 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.13 106.02 0.24 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.563 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.9 t -79.2 65.22 4.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.588 0.708 . . . . 0.0 111.103 -173.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -131.41 -52.25 1.01 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.187 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.632 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.7 m-20 -113.32 47.09 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.358 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 p -78.37 -48.55 15.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.991 0.424 . . . . 0.0 110.825 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -93.23 -11.8 31.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.587 0.708 . . . . 0.0 109.417 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.632 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 50.1 t -88.92 162.65 2.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.815 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.85 154.12 26.9 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.463 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 39.4 mttp -127.28 144.31 50.25 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.874 -170.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HG2' HD12 ' A' ' 38' ' ' ILE . 83.3 Cg_endo -92.08 122.11 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.81 2.34 . . . . 0.0 112.886 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.924 ' HB2' HD13 ' A' ' 8' ' ' ILE . 8.4 tt -101.56 126.23 48.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.7 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.546 ' HB2' HG21 ' A' ' 36' ' ' ILE . 3.3 mpt_? -107.92 121.1 44.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.691 0.282 . . . . 0.0 110.287 174.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 61.6 mt -89.47 117.3 32.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.174 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.4 mt -103.84 120.31 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.97 -171.05 43.93 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.336 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.553 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 18.9 m-20 -71.63 146.77 91.57 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 122.459 0.303 . . . . 0.0 110.504 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.598 ' HA ' HG22 ' A' ' 2' ' ' THR . 99.8 Cg_exo -44.33 -51.24 7.07 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.463 2.775 . . . . 0.0 113.7 -175.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -60.58 -49.61 76.85 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.756 0.312 . . . . 0.0 111.223 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 1.015 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 5.3 ptpp? -72.73 -23.55 60.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.926 -175.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 2' ' ' THR . 71.4 t -71.22 -43.04 74.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -58.17 9.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.78 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.72 -21.62 66.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.598 -174.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -85.36 -39.17 17.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.463 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 68' ' ' MET . 37.9 t -56.59 -50.56 71.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.606 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.54 -33.54 75.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.083 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.804 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 18.2 ptt? -79.57 -36.21 38.58 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.738 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 63' ' ' ALA . 69.9 t -56.27 -44.57 79.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 57.1 mtp -66.63 -32.57 73.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.566 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 35.2 t70 -85.24 -28.71 25.2 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -88.82 -21.69 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.098 -1.001 . . . . 0.0 110.438 173.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.489 HD13 ' CG2' ' A' ' 16' ' ' VAL . 5.8 tt -82.08 -26.29 33.78 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.354 178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.439 ' NH2' ' HA ' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -61.05 -13.95 20.3 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.611 ' HG3' ' H ' ' A' ' 75' ' ' ASP . 9.0 tp10 -55.47 135.28 50.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.217 0.532 . . . . 0.0 111.684 -175.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -75.72 -19.1 59.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.587 0.708 . . . . 0.0 109.578 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.611 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 10.8 m-20 -106.39 -174.8 2.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.632 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 11' ' ' GLY . 48.2 mt-30 -94.91 41.03 1.09 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.85 45.4 1.17 Allowed Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.705 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.603 ' H ' HD23 ' A' ' 15' ' ' LEU . . . -67.33 178.63 17.26 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 172.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.401 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 86.5 m-85 -68.32 -31.57 71.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.283 0.541 . . . . 0.0 111.581 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 23' ' ' THR . . . 101.45 -2.64 53.74 Favored Glycine 0 CA--C 1.508 -0.348 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 82' ' ' ARG . 1.6 p30 -179.17 -63.54 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.804 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 6.8 ttt85 173.41 -29.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.241 165.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.507 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 4.1 t30 52.33 65.77 1.41 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.937 0.399 . . . . 0.0 110.373 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 1.022 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 30.5 tt0 176.28 -47.54 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.754 0.787 . . . . 0.0 109.844 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.79 ' HA ' ' NE2' ' A' ' 139' ' ' HIS . 36.4 p90 -173.78 157.98 3.17 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.43 175.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -143.03 95.42 0.18 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 1.015 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 67.8 m 70.75 -52.64 0.67 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.678 ' HD3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -67.6 -82.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.078 0.466 . . . . 0.0 111.738 -175.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.678 HD12 ' HD3' ' A' ' 88' ' ' ARG . 41.3 mm -54.34 -88.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -168.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.73 78.42 1.33 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -169.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.24 94.2 2.1 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.232 -0.508 . . . . 0.0 112.063 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.712 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 148.94 -144.06 11.69 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 1.022 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 49.9 pt -152.43 158.13 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 117.476 0.638 . . . . 0.0 110.057 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.507 ' OD2' ' HA ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -105.27 140.71 38.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.981 0.42 . . . . 0.0 110.53 175.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 2.8 t -137.45 116.72 10.17 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.659 -176.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.61 107.75 2.25 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.013 1.809 . . . . 0.0 111.629 169.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 102' ' ' VAL . 40.9 t -99.17 126.14 39.05 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.945 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.679 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 74.1 Cg_exo -43.69 130.68 7.47 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.662 2.908 . . . . 0.0 113.13 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.552 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 33.1 ptt180 -60.24 -24.22 64.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.025 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -92.81 20.34 6.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.729 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 105' ' ' VAL . 14.6 t -145.79 -31.46 0.38 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.126 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.413 ' HA ' HG13 ' A' ' 97' ' ' VAL . 7.3 p -49.38 -37.66 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.24 -28.95 63.06 Favored Glycine 0 C--O 1.235 0.178 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.925 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.7 t -75.11 -35.07 33.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.027 0.441 . . . . 0.0 109.873 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 101' ' ' SER . 66.9 t -59.59 -40.05 81.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.905 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.765 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.3 mm -72.95 -37.71 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.389 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.93 34.57 21.17 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 65.66 -76.73 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.514 0.725 . . . . 0.0 111.399 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.2 p -93.73 9.62 36.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.868 0.366 . . . . 0.0 111.662 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.34 8.12 60.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.892 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -65.26 -32.2 73.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 110.913 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 15.4 tpt -89.93 -37.85 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.817 -176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.2 tp -64.98 -27.97 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.084 0.469 . . . . 0.0 110.382 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -72.58 -21.86 61.08 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.182 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -71.57 -33.84 69.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.732 0.301 . . . . 0.0 110.543 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.545 HG22 HD12 ' A' ' 153' ' ' ILE . 32.3 mt -67.92 -40.38 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 0.0 109.469 176.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -70.02 -28.21 65.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.437 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -79.52 -37.52 36.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.9 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -79.57 -55.16 5.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.578 -176.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.96 -15.01 26.75 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.55 32.5 57.5 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.881 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 146' ' ' ARG . 14.9 m -102.98 159.15 4.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.216 0.531 . . . . 0.0 112.103 -173.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.895 ' HB2' ' HB2' ' A' ' 141' ' ' MET . 65.3 mtm180 -101.26 144.09 30.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.223 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.513 HG23 HD13 ' A' ' 113' ' ' ILE . 51.2 mm -116.79 121.54 67.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.567 ' HB2' ' SD ' ' A' ' 141' ' ' MET . 5.9 tp-100 -123.94 111.14 15.69 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.597 ' CE1' HD12 ' A' ' 106' ' ' ILE . 27.4 m-85 -87.53 133.26 33.8 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.561 0.696 . . . . 0.0 110.104 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.718 ' HD3' ' HD1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -157.03 -166.25 2.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.381 -171.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 128' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.491 0 O-C-N 123.426 0.454 . . . . 0.0 111.813 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.552 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 14.2 Cg_exo . . . . . 0 N--CA 1.464 -0.234 0 CA-C-O 120.893 0.289 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.679 ' OE2' ' HA ' ' A' ' 98' ' ' PRO . 1.3 mp0 -94.73 154.17 17.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.972 0.415 . . . . 0.0 111.248 -174.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.409 ' HZ2' ' HG3' ' A' ' 136' ' ' LYS . 0.9 OUTLIER -119.79 124.73 46.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.328 0.585 . . . . 0.0 111.359 -178.039 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 44.8 mm -63.3 115.8 2.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.295 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.75 132.45 38.12 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 164.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.79 ' NE2' ' HA ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -108.34 115.24 29.74 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.676 -177.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.697 HD11 ' HB1' ' A' ' 150' ' ' ALA . 82.7 mt -83.85 137.58 20.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.522 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.895 ' HB2' ' HB2' ' A' ' 123' ' ' ARG . 31.2 mtp -120.42 129.26 53.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.066 -176.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.75 -167.03 28.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.635 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.745 ' HB2' ' HD3' ' A' ' 146' ' ' ARG . 32.8 Cg_exo -61.0 147.28 96.19 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.085 2.524 . . . . 0.0 112.195 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.702 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 52.0 Cg_exo -57.04 -18.65 29.46 Favored 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 123.955 3.104 . . . . 0.0 113.817 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.94 -30.17 26.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.326 0.584 . . . . 0.0 110.178 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.745 ' HD3' ' HB2' ' A' ' 143' ' ' PRO . 8.4 mpt_? -84.13 -44.12 14.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.408 -174.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.702 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 10.6 p -53.85 -55.1 29.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.011 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.414 ' OE2' HG23 ' A' ' 93' ' ' ILE . 38.5 mm-40 -62.65 -37.87 88.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.48 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.409 ' O ' HG13 ' A' ' 153' ' ' ILE . 15.7 t60 -65.49 -26.76 68.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.223 0.535 . . . . 0.0 110.316 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.697 ' HB1' HD11 ' A' ' 140' ' ' ILE . . . -79.98 -40.26 28.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.005 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 93' ' ' ILE . . . -65.94 -24.92 66.92 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.366 0.603 . . . . 0.0 110.149 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -18.94 59.56 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.538 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.545 HD12 HG22 ' A' ' 116' ' ' ILE . 63.1 mt -81.76 -45.06 20.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.316 172.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.466 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.9 mt -62.21 -40.77 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.006 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -58.84 -37.33 76.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.71 -34.16 77.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 34.1 mt -68.87 -33.87 74.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.824 -178.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.529 HD22 ' HD2' ' A' ' 98' ' ' PRO . 18.4 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.357 0.599 . . . . 0.0 110.127 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.4 ' O ' HG21 ' A' ' 60' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.642 0 CA-C-O 120.944 0.402 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 27.7 m -123.5 130.39 74.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.159 175.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -118.47 142.72 47.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.625 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 45.3 mt-10 -108.01 116.74 32.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.361 0.6 . . . . 0.0 111.775 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 6' ' ' ILE . 3.9 mp -106.82 142.82 18.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 87.6 mmm -92.88 116.09 28.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.937 0.399 . . . . 0.0 110.704 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.497 HG12 HG11 ' A' ' 16' ' ' VAL . 1.8 mp -91.36 113.77 59.55 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.586 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 75.1 Cg_exo -55.77 152.15 36.51 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.425 2.75 . . . . 0.0 112.775 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.616 ' HA ' ' NZ ' ' A' ' 49' ' ' LYS . . . -59.62 129.93 44.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 172.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.58 -39.21 2.94 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.81 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.728 ' HG3' HD21 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -65.38 -19.68 66.05 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.805 0.335 . . . . 0.0 111.249 -177.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.643 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -58.38 -24.04 58.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.863 0.363 . . . . 0.0 110.374 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.55 ' CA ' ' HD3' ' A' ' 19' ' ' LYS . . . -61.29 -41.15 99.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.246 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.728 HD21 ' HG3' ' A' ' 12' ' ' LYS . 0.5 OUTLIER -90.42 -23.84 20.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.811 0.305 . . . . 0.0 110.992 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.617 HG21 HD11 ' A' ' 71' ' ' LEU . 77.1 t -82.63 -52.05 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.692 HD11 ' HG3' ' A' ' 39' ' ' GLN . 19.2 pt -91.53 -20.09 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 121.526 -0.734 . . . . 0.0 110.155 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.602 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.19 17.09 32.97 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -175.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.55 ' HD3' ' CA ' ' A' ' 14' ' ' GLY . 13.6 tptp 55.66 31.81 18.08 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.421 0.688 . . . . 0.0 110.428 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.77 -40.17 0.3 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.551 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.593 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 158.1 -8.84 0.2 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.157 -1.02 . . . . 0.0 114.07 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 44.4 tt0 -58.64 -43.37 89.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.504 0.652 . . . . 0.0 112.377 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.602 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 55.2 m -78.3 -36.73 46.19 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.195 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 35' ' ' MET . 5.6 tp -64.6 -20.1 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.937 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 27.6 mtpp -58.36 -59.45 5.33 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.42 0.629 . . . . 0.0 109.503 170.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -67.22 -35.23 79.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.91 -174.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 87.7 mt -65.1 -32.91 74.85 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 122.037 -0.415 . . . . 0.0 110.835 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.719 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 47.9 mt-30 -85.5 -46.61 10.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.062 0.458 . . . . 0.0 111.41 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -88.16 -35.36 17.45 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.503 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 5.5 ttm180 -82.87 -43.42 16.6 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.746 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.803 ' HB2' ' HE1' ' A' ' 66' ' ' MET . . . -83.18 -22.29 33.26 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.982 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.69 68.16 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.097 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 34.2 m -128.15 150.69 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 110.846 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -90.72 109.99 21.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 1.073 ' HB3' HD12 ' A' ' 51' ' ' LEU . 48.4 mtt -100.29 123.31 44.36 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 tt -121.02 113.87 41.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.799 0.809 . . . . 0.0 110.768 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.628 HD23 HD11 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -134.86 143.57 47.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.948 -177.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.527 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 3.7 mp -73.34 101.18 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.307 0.575 . . . . 0.0 111.351 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.692 ' HG3' HD11 ' A' ' 17' ' ' ILE . 4.9 mm-40 -131.36 15.68 5.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.44 170.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.03 -30.74 62.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.825 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.527 ' HA2' ' CG2' ' A' ' 45' ' ' THR . . . 113.56 8.28 19.04 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.036 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 m -61.77 -49.9 74.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.678 0.275 . . . . 0.0 111.688 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -164.44 -42.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.851 0.358 . . . . 0.0 111.091 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.624 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 13.3 m120 -78.98 51.49 1.14 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.926 0.393 . . . . 0.0 111.266 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.527 ' CG2' ' HA2' ' A' ' 41' ' ' GLY . 14.3 p -86.09 -61.77 1.67 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.178 0.513 . . . . 0.0 110.867 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -92.33 -6.82 49.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.455 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.624 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 48.9 t -93.38 156.27 3.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.944 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.4 149.4 38.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.619 ' HE3' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -111.21 124.15 33.45 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.816 -174.397 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.12 112.89 2.34 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.452 2.101 . . . . 0.0 111.825 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 1.073 HD12 ' HB3' ' A' ' 35' ' ' MET . 21.2 tp -92.98 121.1 33.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.775 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 2.7 mpt_? -102.05 114.14 28.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.853 0.358 . . . . 0.0 110.657 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 70.0 mt -89.42 110.63 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.229 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.4 mt -106.13 122.08 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.376 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.87 -171.43 44.51 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.956 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.518 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . 3.2 m-20 -61.58 148.75 85.96 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 122.282 0.233 . . . . 0.0 110.536 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.65 -55.61 3.82 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.119 2.546 . . . . 0.0 114.188 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -66.73 -26.91 67.23 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.926 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.846 ' HG2' ' HB2' ' A' ' 87' ' ' SER . 93.2 mttt -66.67 -53.02 38.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.187 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 2' ' ' THR . 46.4 t -59.89 -32.51 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.589 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.22 -54.91 30.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.823 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -69.88 -34.1 73.12 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.051 -178.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.552 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -69.88 -47.5 62.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.431 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.2 t -55.95 -38.36 70.23 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.19 0.519 . . . . 0.0 109.862 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -64.53 -52.82 55.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.695 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.803 ' HE1' ' HB2' ' A' ' 31' ' ' ALA . 8.4 ptt? -65.69 -36.07 82.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.472 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.484 HG21 HD13 ' A' ' 53' ' ' ILE . 53.5 t -57.06 -48.38 81.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.245 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 69.4 mtm -69.78 -25.35 63.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.184 0.516 . . . . 0.0 110.214 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.48 -37.82 42.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.926 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' HB ' ' H ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -90.22 -30.77 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.86 176.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.617 HD11 HG21 ' A' ' 16' ' ' VAL . 5.2 tt -70.93 -26.45 63.2 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -63.9 0.95 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.176 0.298 . . . . 0.0 110.404 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.995 ' HG2' ' H ' ' A' ' 74' ' ' ARG . 23.6 tt0 42.31 -159.83 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 169.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.995 ' H ' ' HG2' ' A' ' 73' ' ' GLU . 20.9 mmt180 -145.54 -47.06 0.22 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.807 0.843 . . . . 0.0 108.751 167.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -173.66 102.23 0.11 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.011 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 61.66 69.49 0.64 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.459 0.647 . . . . 0.0 111.399 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.41 -5.52 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.372 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.22 150.78 48.88 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.669 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.53 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 74.5 m-85 -76.99 3.53 12.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -170.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 23' ' ' THR . . . 73.14 4.13 62.62 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.723 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.443 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.5 OUTLIER 175.89 -62.91 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.745 ' HB3' ' CZ ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER 154.13 -35.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 O-C-N 125.1 1.5 . . . . 0.0 109.101 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 55.81 73.51 0.43 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.371 0.419 . . . . 0.0 110.399 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.924 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 70.4 tt0 -175.71 -51.13 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.665 -173.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.705 ' HA ' HD11 ' A' ' 89' ' ' ILE . 4.5 p90 -151.04 -75.89 0.14 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.654 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 101.15 -43.38 1.74 Allowed Glycine 0 C--O 1.229 -0.198 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.846 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 32.5 p -171.06 -57.16 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -69.98 -177.23 1.28 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.379 167.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.705 HD11 ' HA ' ' A' ' 85' ' ' TYR . 59.8 mt 70.57 -74.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.09 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.12 47.21 49.92 Favored Glycine 0 C--N 1.336 0.552 0 O-C-N 123.727 0.642 . . . . 0.0 112.501 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.25 99.36 0.4 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -176.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.813 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 135.79 -138.51 9.98 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -174.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.924 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.8 pt -145.53 159.59 12.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 171.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.572 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . 1.9 p30 -99.22 132.58 44.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 31.3 t -126.65 106.2 23.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -171.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 135' ' ' GLU . 42.8 Cg_endo -68.79 121.44 8.33 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.234 1.956 . . . . 0.0 111.389 171.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.64 HG11 HD21 ' A' ' 158' ' ' LEU . 51.3 t -117.71 124.9 28.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.653 0.263 . . . . 0.0 111.216 177.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 86.1 Cg_exo -44.62 130.51 9.54 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.753 2.968 . . . . 0.0 113.475 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 134' ' ' PRO . 35.2 mtp180 -51.63 -37.92 52.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.151 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.476 ' CE1' ' HB3' ' A' ' 98' ' ' PRO . 0.7 OUTLIER -92.26 6.43 46.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.655 -174.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 98' ' ' PRO . 9.8 m -130.03 -25.52 2.5 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.607 -173.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.4 p -53.15 -26.26 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.742 0.306 . . . . 0.0 111.592 172.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.3 -44.96 89.41 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.947 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 101' ' ' SER . 7.6 p -77.38 -25.23 15.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.208 0.528 . . . . 0.0 110.587 -178.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.1 t -69.68 -33.14 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.85 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.546 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 49.6 mm -87.12 -65.06 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.352 176.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.82 52.19 3.39 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.696 -173.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 108' ' ' ARG . 45.2 mtp180 54.77 -89.84 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.71 0.804 . . . . 0.0 112.375 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -72.75 -8.82 57.25 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.594 0.711 . . . . 0.0 110.348 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.26 45.72 2.52 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.587 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.37 -43.88 80.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.8 0.3 . . . . 0.0 110.942 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.454 ' O ' HG13 ' A' ' 116' ' ' ILE . 15.3 tpt -83.59 -38.55 21.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.848 0.356 . . . . 0.0 110.641 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.637 HD12 HG23 ' A' ' 124' ' ' ILE . 8.9 tp -63.91 -31.08 51.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.5 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -82.73 -20.12 36.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.657 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.545 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -71.23 -37.44 72.01 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 112' ' ' MET . 23.1 mt -64.64 -37.27 79.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.201 0.524 . . . . 0.0 109.603 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 86.6 mt-30 -66.6 -27.36 67.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.724 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -85.65 -46.26 10.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.039 0.447 . . . . 0.0 111.045 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -79.33 -55.36 5.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.778 -173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.14 -26.96 39.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.058 0.456 . . . . 0.0 110.293 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.96 19.98 62.02 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.138 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.76 144.88 9.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 111.879 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.774 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 7.7 tpp180 -91.34 143.41 26.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.637 HG23 HD12 ' A' ' 113' ' ' ILE . 34.3 mm -129.01 142.21 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -170.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 1.012 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 3.8 pt20 -149.54 167.8 25.29 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 167.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.496 ' CE1' HD11 ' A' ' 106' ' ' ILE . 31.7 m-85 -121.95 133.55 54.83 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -152.66 128.16 10.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.352 -171.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.052 0.453 . . . . 0.0 111.216 179.664 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.55 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 15.0 Cg_exo . . . . . 0 CA--C 1.528 0.19 0 N-CA-C 114.734 1.013 . . . . 0.0 114.734 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 51.1 mt-10 -127.18 141.35 51.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -114.02 130.62 56.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.478 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.572 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 23.5 mm -74.62 131.54 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -105.88 141.47 37.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.358 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 1.012 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -89.27 110.15 20.96 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.187 175.17 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 150' ' ' ALA . 68.5 mt -94.26 135.84 27.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.463 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.774 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 41.6 ttm -122.92 124.55 43.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.056 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.59 -170.66 34.11 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.91 149.02 91.54 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.713 2.276 . . . . 0.0 111.986 174.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.4 -50.71 6.53 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 123.314 2.676 . . . . 0.0 113.665 -177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.66 -47.53 79.6 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.13 0.49 . . . . 0.0 110.224 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -60.0 -41.93 93.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.631 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.813 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 66.7 m -56.26 -60.53 3.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.224 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.631 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 38.2 mt-10 -66.82 -33.17 75.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.287 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -26.88 68.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.707 ' HB3' HD11 ' A' ' 140' ' ' ILE . . . -78.13 -37.19 46.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.826 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.27 67.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.409 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.631 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -76.56 -31.48 57.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.287 -178.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.44 -44.58 83.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.197 0.522 . . . . 0.0 109.644 174.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.669 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 70.4 mt -63.03 -53.38 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.741 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.576 HD21 HD12 ' A' ' 158' ' ' LEU . 12.0 m120 -55.47 -38.29 68.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.476 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -59.87 -44.1 94.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 110.756 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.12 -39.48 89.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.594 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 68.4 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.941 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.5 m -132.1 133.4 60.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.105 0.478 . . . . 0.0 111.179 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 5.4 mm-40 -108.09 145.08 34.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.909 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.728 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 42.1 mt-10 -112.05 104.28 12.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.329 0.585 . . . . 0.0 111.343 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.0 mp -105.65 141.97 19.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.01 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.518 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 45.5 ttm -100.56 114.58 28.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.911 0.386 . . . . 0.0 110.646 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.459 ' HA ' HD11 ' A' ' 71' ' ' LEU . 1.8 mp -83.22 110.07 21.46 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.043 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.833 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 31.3 Cg_exo -62.26 137.25 64.65 Favored 'Trans proline' 0 CA--C 1.519 -0.259 0 C-N-CA 122.81 2.34 . . . . 0.0 111.273 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.59 114.88 3.22 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.56 -34.78 3.66 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -169.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.833 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -89.29 3.78 50.97 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 172.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' HB3' HD13 ' A' ' 17' ' ' ILE . . . -60.73 -41.19 94.85 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.545 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.82 -14.29 50.94 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.702 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.652 ' O ' HG21 ' A' ' 23' ' ' THR . 22.6 mt -89.56 -57.04 3.01 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.539 0.169 . . . . 0.0 111.187 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.423 HG21 HD12 ' A' ' 71' ' ' LEU . 61.8 t -79.58 -54.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.545 HD13 ' HB3' ' A' ' 13' ' ' ALA . 12.7 pt -92.47 -10.7 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.699 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 69.64 31.47 70.65 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 19' ' ' LYS . 44.1 tptt 73.27 -58.08 0.61 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.097 0.959 . . . . 0.0 111.356 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.2 24.48 5.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.874 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 24' ' ' ILE . . . 116.06 -13.21 16.86 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.684 174.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.486 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 35.8 mm-40 -56.95 -46.67 81.94 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.652 HG21 ' O ' ' A' ' 15' ' ' LEU . 55.4 m -80.33 -34.24 36.82 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.265 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.498 HD12 HD21 ' A' ' 37' ' ' LEU . 5.2 tp -62.28 -24.96 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 83.6 mttt -57.25 -58.89 6.25 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.102 170.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.46 ' CB ' ' HB3' ' A' ' 81' ' ' ASP . 42.7 mt-30 -67.57 -20.25 65.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.206 -174.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.828 HD21 ' HE3' ' A' ' 66' ' ' MET . 85.3 mt -79.74 -30.85 40.97 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.22 173.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.441 ' HG3' ' HE1' ' A' ' 35' ' ' MET . 79.8 mt-30 -84.31 -32.26 24.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.569 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.62 -63.38 1.33 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.606 0.241 . . . . 0.0 111.285 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.48 ' HB3' HH22 ' A' ' 82' ' ' ARG . 10.6 ttm180 -66.66 -31.45 72.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.162 -172.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -96.38 -27.17 15.05 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.37 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' HA3' ' NE2' ' A' ' 128' ' ' GLN . . . 78.56 2.89 85.98 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.774 -0.726 . . . . 0.0 113.286 175.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.67 HG22 ' SD ' ' A' ' 35' ' ' MET . 27.6 m -101.08 161.91 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -103.99 109.49 21.28 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.326 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.67 ' SD ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -92.12 121.09 33.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 52' ' ' ARG . 6.2 tp -113.56 102.34 13.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.964 0.888 . . . . 0.0 109.219 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -132.31 142.21 49.26 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.819 -176.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.619 HG21 ' H ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -60.77 122.24 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.403 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.2 -37.23 0.57 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.299 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.85 -48.11 55.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.121 0.486 . . . . 0.0 110.398 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.63 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 137.14 34.48 0.2 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.335 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -78.99 -22.32 45.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.037 0.446 . . . . 0.0 110.829 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.519 ' HB3' HG12 ' A' ' 38' ' ' ILE . 54.1 tp60 -136.72 -80.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.781 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.619 ' H ' HG21 ' A' ' 38' ' ' ILE . 96.7 m-20 -107.56 87.31 2.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.168 0.509 . . . . 0.0 110.757 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.63 ' HB ' ' HA2' ' A' ' 41' ' ' GLY . 1.8 t -81.51 -42.67 19.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.262 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -94.17 -35.45 12.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.746 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.72 160.33 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.386 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.604 ' OD1' ' HA ' ' A' ' 9' ' ' PRO . 61.7 m-20 -49.53 139.93 11.52 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.391 0.432 . . . . 0.0 111.05 177.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 65.2 mttt -113.06 128.52 25.52 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.163 -165.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -84.8 140.29 7.96 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.798 2.332 . . . . 0.0 113.376 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.749 ' HA ' ' HB3' ' A' ' 37' ' ' LEU . 9.0 tt -117.92 139.81 50.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.361 -174.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.545 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.3 mpt_? -123.35 123.42 40.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.453 0.168 . . . . 0.0 110.589 170.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.4 mt -93.82 116.77 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.7 mt -103.67 120.34 53.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.653 0.263 . . . . 0.0 111.281 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.09 -170.76 43.51 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.372 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' HE2' ' A' ' 59' ' ' LYS . 9.9 t70 -60.57 138.81 92.78 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.847 -0.677 . . . . 0.0 110.675 172.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.42 -28.83 9.06 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.967 3.111 . . . . 0.0 114.676 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -73.17 -52.05 15.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.949 0.404 . . . . 0.0 110.225 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.749 ' HB3' ' HZ1' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -68.83 -30.14 68.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.468 -177.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.6 -32.87 51.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.448 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.447 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 0.8 OUTLIER -70.23 -52.45 23.1 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -65.01 -23.2 67.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.358 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.665 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -86.6 -43.97 12.25 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.949 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 68' ' ' MET . 30.4 p -61.9 -30.98 71.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.692 0.282 . . . . 0.0 111.447 -174.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.415 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 6.0 pt-20 -83.43 -30.51 27.24 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.794 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.828 ' HE3' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -79.3 -34.34 42.5 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.326 -176.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.08 -27.45 42.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.924 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 44.8 mtm -82.95 -35.95 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 0.0 109.607 171.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.531 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 36.0 t70 -62.97 -43.76 97.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.782 -175.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.851 HG23 ' HA ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -87.05 -21.5 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.37 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 8' ' ' ILE . 3.5 tt -84.29 -24.69 29.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.64 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -35.55 76.39 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.146 -0.222 . . . . 0.0 110.537 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 1.1 pt-20 37.83 -145.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.199 0.937 . . . . 0.0 112.867 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.436 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 8.1 ptm180 173.26 -12.67 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.264 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -154.87 35.62 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.531 -173.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? 58.54 76.13 0.36 Allowed 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.614 0.721 . . . . 0.0 109.404 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.66 116.78 0.72 Allowed Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.257 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . -99.37 -75.32 1.18 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.264 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -144.53 -58.38 0.37 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.768 0.794 . . . . 0.0 109.028 176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.42 -91.3 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.46 ' HB3' ' CB ' ' A' ' 26' ' ' GLN . 5.7 p-10 -90.52 -44.75 9.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 164.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.851 ' HA ' HG23 ' A' ' 70' ' ' ILE . 0.0 OUTLIER 170.37 -51.46 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.689 -172.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.493 ' HA ' ' HB2' ' A' ' 94' ' ' ASP . 18.8 m120 57.45 53.41 7.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 171.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 0.7 OUTLIER -174.36 2.99 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 177.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.823 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -161.66 -71.53 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.987 -1.071 . . . . 0.0 110.959 174.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.484 ' CA ' ' HA ' ' A' ' 31' ' ' ALA . . . 53.67 65.67 3.27 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.581 -174.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.511 ' C ' ' HD2' ' A' ' 88' ' ' ARG . 17.0 t 74.31 -21.62 0.27 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.692 0.797 . . . . 0.0 112.086 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.569 ' HG3' ' HB2' ' A' ' 127' ' ' LYS . 2.6 mmm180 -119.05 -166.32 1.24 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -172.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.823 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 55.6 mt 70.59 -83.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 167.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.573 ' HA2' ' HD2' ' A' ' 85' ' ' TYR . . . 62.87 54.97 29.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.126 -173.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 128.96 58.71 0.11 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.513 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 89' ' ' ILE . . . 164.59 163.28 17.34 Favored Glycine 0 C--O 1.207 -1.572 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.0 pt -90.31 154.26 3.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 119.14 1.47 . . . . 0.0 112.39 -169.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 83' ' ' ASN . 36.2 m-20 -90.38 117.48 29.13 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.836 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.65 HG23 HD13 ' A' ' 140' ' ' ILE . 1.3 t -116.69 95.1 45.48 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.874 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.17 108.53 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.52 2.146 . . . . 0.0 111.782 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 102' ' ' VAL . 86.0 t -94.77 118.75 66.74 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.443 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.619 ' HD2' HD23 ' A' ' 158' ' ' LEU . 47.0 Cg_exo -38.11 123.6 0.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.014 2.476 . . . . 0.0 111.478 171.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -34.46 -58.55 0.48 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -168.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -71.92 -23.71 61.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 t -78.63 -15.1 58.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.594 0.235 . . . . 0.0 111.143 -172.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.619 ' HA ' HG13 ' A' ' 97' ' ' VAL . 58.1 t -54.82 -37.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.154 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.51 -36.03 82.87 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.701 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.18 -37.83 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.353 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.33 -34.28 69.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.346 0.593 . . . . 0.0 110.36 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.708 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 39.7 mm -76.45 -43.57 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.29 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.56 34.87 8.21 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.477 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 65.65 -75.28 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.357 0.663 . . . . 0.0 111.673 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 m -87.49 2.79 49.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 114' ' ' LYS . . . 92.52 14.08 56.06 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.877 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -65.89 -40.86 91.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.751 0.31 . . . . 0.0 111.297 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 55.7 tpp -78.23 -36.34 47.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.708 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.0 tp -68.18 -29.66 45.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.816 0.341 . . . . 0.0 110.157 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 110' ' ' GLY . 42.2 mmtm -70.16 -34.73 73.37 Favored 'General case' 0 CA--C 1.523 -0.086 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 173.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 112' ' ' MET . 25.5 mmmt -61.61 -38.7 88.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.981 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.12 -43.04 95.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.26 0.552 . . . . 0.0 109.552 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 60.5 mt-30 -69.04 -26.81 65.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.733 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -86.22 -45.54 11.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.073 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.17 -36.42 47.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.986 -173.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 146' ' ' ARG . . . -103.98 -20.35 13.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.96 37.96 31.81 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.886 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.409 HG12 HG22 ' A' ' 140' ' ' ILE . 33.1 m -112.79 154.23 14.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.959 0.409 . . . . 0.0 111.944 -173.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.547 ' HD3' ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -108.25 135.18 50.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.607 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.547 ' N ' ' HD3' ' A' ' 123' ' ' ARG . 45.3 mm -99.58 143.66 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.087 0.47 . . . . 0.0 111.957 -170.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 5.5 tt0 -147.79 104.95 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.682 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -74.29 111.42 9.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.061 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.569 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -125.22 156.32 38.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.181 -173.715 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . 0.519 ' NE2' ' HA3' ' A' ' 32' ' ' GLY . 12.0 mm100 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.848 175.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.46 -0.494 0 CA-C-O 121.237 0.432 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -131.24 152.79 50.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.913 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.513 ' HD2' HG22 ' A' ' 102' ' ' VAL . 82.8 mttt -110.7 113.36 25.91 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.496 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 1.7 mm -72.55 112.57 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.194 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 95' ' ' VAL . . . -96.29 135.8 37.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.802 173.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.779 ' CE1' HG22 ' A' ' 89' ' ' ILE . 1.5 t60 -86.87 109.04 19.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.903 174.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 150' ' ' ALA . 41.0 mt -91.19 123.25 43.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 170.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.451 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 13.9 ttp -112.53 131.41 55.61 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -171.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.32 -178.11 27.98 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.68 147.13 96.04 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.859 1.706 . . . . 0.0 110.764 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -41.16 -44.27 5.32 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.475 2.783 . . . . 0.0 112.834 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.31 -40.96 62.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.789 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 9.3 mtm180 -84.53 -38.89 19.48 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.509 ' HA ' ' CG2' ' A' ' 140' ' ' ILE . 61.2 m -58.59 -61.32 2.69 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 111.002 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.67 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 6.2 mm-40 -58.02 -40.85 81.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.182 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -57.58 -31.96 66.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.903 0.382 . . . . 0.0 111.282 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.687 ' HB3' HD11 ' A' ' 140' ' ' ILE . . . -78.46 -36.79 44.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.972 0.415 . . . . 0.0 110.915 -176.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.17 -24.1 66.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.798 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.67 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 11.3 mpt_? -78.59 -28.04 45.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.755 0.312 . . . . 0.0 110.424 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.3 mt -70.15 -47.93 64.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.233 0.539 . . . . 0.0 109.551 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.505 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.0 mt -63.18 -42.99 98.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.705 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -57.84 -39.21 77.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.982 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.55 -32.58 74.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.772 0.32 . . . . 0.0 110.302 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 44.0 mt -67.64 -47.95 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.969 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.619 HD23 ' HD2' ' A' ' 98' ' ' PRO . 13.3 mt . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.896 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 57' ' ' PRO . 1.6 m . . . . . 0 N--CA 1.451 -0.409 0 CA-C-O 120.958 0.408 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 12.0 m -124.12 128.79 74.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.09 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -114.15 133.95 55.23 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.543 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.578 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 43.5 mt-10 -103.04 126.12 50.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.223 0.535 . . . . 0.0 111.869 -175.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.421 ' N ' HD11 ' A' ' 6' ' ' ILE . 4.2 mp -117.8 144.52 25.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 174.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.4 mtp -93.1 112.44 24.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.158 0.504 . . . . 0.0 110.777 -176.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.521 HG12 HG13 ' A' ' 16' ' ' VAL . 1.7 mp -95.21 114.93 64.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.706 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 41.8 Cg_exo -61.72 152.42 74.23 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.449 2.766 . . . . 0.0 112.815 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.73 131.51 45.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.61 -42.01 2.13 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -169.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 9' ' ' PRO . 13.1 tptt -68.7 -32.48 72.31 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.703 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -52.39 -31.75 35.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.315 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.617 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -59.0 -42.09 96.73 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.431 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.906 HD22 ' HA ' ' A' ' 76' ' ' GLN . 3.8 pp -89.67 -17.95 27.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.756 0.278 . . . . 0.0 111.663 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.521 HG13 HG12 ' A' ' 8' ' ' ILE . 82.9 t -83.5 -48.69 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 13' ' ' ALA . 13.3 pt -90.52 -24.79 5.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.516 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 100.91 11.58 39.66 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.669 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.617 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 5.4 tptm 52.33 44.2 30.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.324 0.583 . . . . 0.0 110.353 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.83 -24.4 0.55 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.474 -173.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.99 -11.53 7.34 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.331 175.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -59.32 -34.32 72.19 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -174.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 15' ' ' LEU . 28.3 m -84.23 -41.57 16.8 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.316 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 35' ' ' MET . 8.3 tp -66.44 -32.4 57.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -47.91 -48.14 31.83 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.58 170.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 49.4 mt-30 -73.8 -42.07 61.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.657 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.533 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 81.6 mt -60.65 -28.1 68.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.179 0.514 . . . . 0.0 110.709 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 87.6 mt-30 -85.58 -53.75 4.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.567 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -82.23 -49.75 9.75 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -172.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.507 ' HD3' ' OD2' ' A' ' 81' ' ' ASP . 21.3 ttt180 -67.61 -51.75 46.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 110.01 -176.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.634 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -70.31 -29.05 65.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.934 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.07 3.23 87.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.832 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.1 m -103.44 -179.34 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.039 0.447 . . . . 0.0 110.376 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -121.5 114.25 20.97 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.67 ' HB2' HD11 ' A' ' 24' ' ' ILE . 51.6 mtt -100.66 121.1 41.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tp -114.02 110.99 34.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.915 0.864 . . . . 0.0 110.213 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.822 HD11 HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -133.22 144.42 49.78 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.319 -174.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.6 mm -60.76 100.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.134 0.492 . . . . 0.0 110.615 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.528 ' HG2' HG22 ' A' ' 17' ' ' ILE . 42.4 mt-30 -105.4 -42.73 5.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.526 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.74 -19.65 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.511 -177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.04 49.46 3.53 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.199 174.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 m -59.83 -71.37 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.832 0.349 . . . . 0.0 110.847 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -117.85 -26.0 6.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.146 0.498 . . . . 0.0 110.832 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -107.56 75.35 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.985 0.422 . . . . 0.0 110.823 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 p -83.29 -63.22 1.4 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.927 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -94.96 -4.47 46.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.289 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.24 158.21 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.004 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.46 144.77 16.13 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.49 0.494 . . . . 0.0 110.872 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -117.46 127.98 26.31 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.796 -171.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.88 116.76 3.49 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.248 1.966 . . . . 0.0 112.141 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.822 HD12 HD11 ' A' ' 37' ' ' LEU . 8.4 tt -98.48 119.89 37.95 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.483 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.578 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.4 mpt_? -100.11 116.27 31.75 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 176.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.503 ' CG2' HG23 ' A' ' 60' ' ' VAL . 27.7 mt -89.43 118.37 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.444 HG12 ' CG1' ' A' ' 3' ' ' VAL . 27.5 mt -104.67 121.32 56.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 177.49 -177.92 48.32 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.483 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.578 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 13.8 t70 -62.04 139.98 95.9 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.602 ' HA ' HG22 ' A' ' 2' ' ' THR . 69.7 Cg_exo -38.7 -45.86 2.51 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.912 3.075 . . . . 0.0 115.157 -175.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -74.43 -33.51 62.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.251 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.982 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 19.0 ptpt -79.2 -41.68 27.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -175.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.503 HG23 ' CG2' ' A' ' 53' ' ' ILE . 8.0 p -67.36 -24.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.503 0.668 . . . . 0.0 109.935 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -66.88 -57.89 6.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.24 178.066 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -61.45 -33.16 73.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -69.51 -45.73 68.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.745 177.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.437 ' HA ' HG21 ' A' ' 67' ' ' VAL . 42.8 t -58.97 -35.63 73.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.52 0.676 . . . . 0.0 109.632 177.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.25 -37.08 84.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.616 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.822 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 15.5 ptt? -84.95 -33.47 22.65 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.975 -176.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 35.1 m -62.37 -28.96 45.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.299 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.6 mtm -81.6 -21.03 38.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 110.32 174.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -83.2 -46.26 12.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.894 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.697 HG23 ' HD1' ' A' ' 79' ' ' PHE . 2.6 pp -83.22 -26.7 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.333 . . . . 0.0 111.743 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 6.0 tt -75.72 -18.35 59.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.876 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -53.39 -42.1 66.61 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.505 ' HG2' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER 56.07 137.73 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 170.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.415 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 72.7 mtp180 -112.43 -13.45 13.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 161.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.505 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 36.1 t70 -163.18 135.06 5.1 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.544 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.906 ' HA ' HD22 ' A' ' 15' ' ' LEU . 78.4 mt-30 -43.81 106.65 0.07 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.289 1.042 . . . . 0.0 112.188 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.469 ' N ' ' HB3' ' A' ' 15' ' ' LEU . . . 150.82 -34.38 0.95 Allowed Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.103 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.95 -111.23 3.61 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.697 ' HD1' HG23 ' A' ' 70' ' ' ILE . 97.3 m-85 -127.78 -13.77 5.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.74 0.305 . . . . 0.0 110.609 174.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.561 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 81.23 91.92 0.52 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -174.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.561 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 5.7 t70 71.22 -75.04 0.08 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -170.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.822 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 24.9 ttt180 173.17 -35.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 O-C-N 124.18 0.925 . . . . 0.0 110.332 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 69.19 13.54 8.62 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.65 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.792 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 84.9 tt0 -123.96 -34.43 2.99 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.608 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 25.6 p90 171.27 127.31 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.139 175.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.747 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -82.99 -66.69 1.51 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.946 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.982 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 45.2 m -144.98 22.56 1.57 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.776 0.798 . . . . 0.0 109.125 176.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 1.8 mpt_? -133.84 -164.16 1.46 Allowed 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.043 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.608 ' HB ' ' HB3' ' A' ' 85' ' ' TYR . 23.9 mt 64.71 -81.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.45 50.71 57.86 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 132.96 85.02 0.26 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.286 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 153.94 -143.76 10.48 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.792 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.9 pt -144.97 160.55 13.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 117.302 0.551 . . . . 0.0 110.844 175.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.464 ' OD1' HD13 ' A' ' 89' ' ' ILE . 5.0 m-20 -107.0 119.68 40.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.949 173.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.803 HG21 ' HB1' ' A' ' 138' ' ' ALA . 6.2 m -113.35 104.88 55.56 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.169 0.509 . . . . 0.0 112.172 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.518 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 51.8 Cg_endo -72.34 108.6 2.54 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.816 2.344 . . . . 0.0 111.634 173.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.634 HG13 HD22 ' A' ' 158' ' ' LEU . 46.9 t -102.35 124.92 37.87 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.071 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.588 ' HD2' HD23 ' A' ' 158' ' ' LEU . 78.7 Cg_exo -44.54 133.65 9.8 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.636 2.89 . . . . 0.0 112.783 173.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -58.59 -30.6 67.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.651 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -89.88 1.36 56.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.424 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.474 ' O ' HG21 ' A' ' 105' ' ' VAL . 25.1 m -119.56 -27.97 5.41 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.54 ' HA ' HG11 ' A' ' 97' ' ' VAL . 11.2 p -52.33 -34.43 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.38 -37.76 94.19 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.85 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.9 -37.14 53.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 0.0 110.36 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 101' ' ' SER . 48.0 t -65.35 -38.67 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.326 0.584 . . . . 0.0 110.669 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.793 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 13.7 mt -81.03 -26.33 10.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.238 0.542 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.4 48.44 5.94 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 59.02 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.83 0.852 . . . . 0.0 112.244 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.9 m -75.08 -24.49 58.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 111.065 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.402 ' HA2' ' CG2' ' A' ' 106' ' ' ILE . . . 130.41 50.7 0.11 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.725 177.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.546 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 40.4 mt-10 -93.42 -58.98 2.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.882 0.373 . . . . 0.0 110.302 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.504 ' SD ' HD11 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -68.37 -31.54 70.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.163 -173.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.793 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.0 tp -65.46 -22.88 31.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.253 0.549 . . . . 0.0 110.675 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -82.32 -26.06 33.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.046 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 111' ' ' GLU . 2.7 mptp? -65.24 -38.13 89.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.504 HD11 ' SD ' ' A' ' 112' ' ' MET . 28.9 mm -59.12 -43.12 88.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.491 175.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.452 HE21 HG12 ' A' ' 124' ' ' ILE . 59.7 mt-30 -67.04 -33.61 75.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.744 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -79.26 -42.32 26.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.613 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.64 -40.62 33.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.464 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.17 18.47 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.93 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.19 46.35 8.25 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.464 HG12 HG22 ' A' ' 140' ' ' ILE . 1.9 t -118.02 143.75 27.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.109 -0.546 . . . . 0.0 111.678 -169.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.475 ' HD3' ' SD ' ' A' ' 141' ' ' MET . 79.4 mtp180 -103.53 148.68 25.67 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.452 HG12 HE21 ' A' ' 117' ' ' GLN . 46.2 mm -114.63 135.03 55.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.189 0.519 . . . . 0.0 111.937 -171.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.571 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 24.1 tt0 -137.32 105.67 5.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.219 176.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 33.6 m-85 -80.76 106.53 12.84 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 121.942 -0.474 . . . . 0.0 109.949 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.827 ' HE2' ' O ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.47 127.28 48.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.235 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 . . . . . 0 N--CA 1.466 0.353 0 CA-C-O 121.384 0.612 . . . . 0.0 111.589 175.567 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.476 0.445 0 N-CA-C 115.091 1.15 . . . . 0.0 115.091 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -132.74 146.35 51.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.358 0.599 . . . . 0.0 111.525 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -119.47 115.94 25.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.747 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.572 HG21 ' NZ ' ' A' ' 127' ' ' LYS . 18.0 mm -72.84 108.32 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.569 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.803 ' HB1' HG21 ' A' ' 95' ' ' VAL . . . -96.79 141.4 30.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.671 175.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.593 ' CG ' HG12 ' A' ' 89' ' ' ILE . 3.2 t-160 -91.52 117.52 29.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.879 0.371 . . . . 0.0 110.414 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.684 HD12 ' HB1' ' A' ' 150' ' ' ALA . 37.9 mt -97.17 118.24 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.248 171.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.475 ' SD ' ' HD3' ' A' ' 123' ' ' ARG . 46.3 ttm -102.13 121.61 42.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 -174.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 164.33 170.26 29.02 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.16 150.83 82.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.585 2.19 . . . . 0.0 111.6 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.691 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 87.2 Cg_exo -42.3 -40.02 6.65 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.931 3.087 . . . . 0.0 114.999 -172.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.3 -32.07 64.4 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.998 -0.439 . . . . 0.0 110.855 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -85.0 -35.17 22.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.778 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.691 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 27.7 p -62.99 -51.08 68.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.594 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 28.3 mt-10 -66.38 -29.01 69.09 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.935 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -55.49 -36.08 66.26 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.116 0.484 . . . . 0.0 110.136 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.684 ' HB1' HD12 ' A' ' 140' ' ' ILE . . . -79.14 -35.04 42.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.922 -174.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' A' ' 93' ' ' ILE . . . -67.15 -24.93 65.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.594 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 2.9 mpt_? -77.84 -18.5 56.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.981 0.42 . . . . 0.0 110.314 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.5 mt -82.41 -44.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 66.7 mt -65.94 -52.51 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.347 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -60.74 -30.21 69.85 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.251 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.63 -39.48 93.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.996 0.427 . . . . 0.0 110.013 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.424 HD11 ' HE1' ' A' ' 112' ' ' MET . 82.7 mt -67.07 -44.06 81.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.776 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.634 HD22 HG13 ' A' ' 97' ' ' VAL . 71.3 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.776 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.683 HG21 ' HA ' ' A' ' 57' ' ' PRO . 36.5 m . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 17.5 m -132.28 141.4 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.699 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -123.52 141.72 51.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.732 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 45.6 mt-10 -112.23 121.38 44.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.363 0.601 . . . . 0.0 111.703 -175.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.625 HG13 HG22 ' A' ' 67' ' ' VAL . 44.7 mm -110.52 150.08 13.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.665 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.481 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 50.4 tpp -101.37 117.03 34.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.881 0.372 . . . . 0.0 110.848 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.743 HG12 HG12 ' A' ' 16' ' ' VAL . 3.0 mp -99.37 104.39 26.56 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.185 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 7' ' ' MET . 21.2 Cg_exo -67.52 159.45 52.44 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 123.08 2.52 . . . . 0.0 111.82 177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.51 141.56 57.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.14 -51.42 1.89 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -172.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.78 -25.01 64.49 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.004 0.431 . . . . 0.0 110.411 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.738 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -52.11 -37.47 54.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.67 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.546 ' HA3' ' OE1' ' A' ' 76' ' ' GLN . . . -63.03 -38.46 96.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.984 -178.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 1.051 HD23 ' HA ' ' A' ' 76' ' ' GLN . 2.9 pp -89.93 -15.82 31.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.98 0.39 . . . . 0.0 111.656 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.743 HG12 HG12 ' A' ' 8' ' ' ILE . 70.8 t -90.2 -49.94 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.738 HG12 ' O ' ' A' ' 13' ' ' ALA . 17.6 pt -87.51 -23.42 6.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.321 -0.551 . . . . 0.0 109.895 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.713 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 89.92 17.95 52.33 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.719 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 29.7 mmtp 65.05 -63.36 0.19 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.667 0.787 . . . . 0.0 111.658 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.75 19.35 47.56 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.257 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 92.82 8.04 62.33 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.025 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.604 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 28.6 tt0 -63.01 -48.34 79.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.687 0.28 . . . . 0.0 111.594 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.713 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 78.9 m -67.23 -39.45 86.23 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.204 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.626 HD11 HD11 ' A' ' 27' ' ' LEU . 1.3 tp -64.6 -22.1 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.67 0.272 . . . . 0.0 110.899 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.604 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 49.8 mttm -56.79 -57.86 10.62 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.619 0.723 . . . . 0.0 109.981 173.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -69.31 -26.98 65.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.963 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.907 HD21 ' HE3' ' A' ' 66' ' ' MET . 36.6 mt -75.03 -30.14 61.0 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.045 -0.409 . . . . 0.0 111.019 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.695 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.2 mt-30 -84.83 -42.45 15.1 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.032 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -88.07 -62.1 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.634 HH21 ' HA3' ' A' ' 86' ' ' GLY . 2.2 ttp180 -58.47 -43.75 89.02 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.933 0.397 . . . . 0.0 110.891 -176.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -75.45 -22.39 57.36 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.356 0.598 . . . . 0.0 111.178 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.99 78.4 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.778 -0.647 . . . . 0.0 112.672 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 28.6 m -121.75 151.0 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.843 0.354 . . . . 0.0 110.455 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -89.19 109.49 20.36 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 1.041 ' HB3' HD11 ' A' ' 51' ' ' LEU . 59.4 mtt -98.2 114.43 26.67 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.671 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.9 tp -110.44 112.25 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 122.006 0.908 . . . . 0.0 109.677 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -132.29 143.38 49.85 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.95 -175.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 78.7 mt -54.37 107.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 124.01 0.819 . . . . 0.0 111.892 -173.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -126.37 -14.55 5.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.837 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.28 158.61 20.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.676 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.29 69.11 0.88 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.966 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.4 t -89.38 -62.89 1.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -175.6 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.393 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -86.75 62.5 7.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.114 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 p -83.29 -61.13 1.93 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.81 0.338 . . . . 0.0 111.347 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -93.39 -17.08 23.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.283 0.563 . . . . 0.0 109.819 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 11.9 t -79.15 166.17 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.886 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.4 p30 -47.84 140.91 6.13 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.159 0.504 . . . . 0.0 111.282 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 16.6 mtmm -130.1 137.46 30.92 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.087 -170.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.53 133.21 5.22 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.597 2.198 . . . . 0.0 112.4 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 1.041 HD11 ' HB3' ' A' ' 35' ' ' MET . 22.4 tp -108.05 120.18 41.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.813 -177.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.671 ' HB2' HG23 ' A' ' 36' ' ' ILE . 5.1 mpt_? -96.27 115.57 27.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.37 174.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.3 mt -91.47 110.1 22.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.786 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.442 HG12 ' CG1' ' A' ' 3' ' ' VAL . 35.3 mt -108.06 121.04 60.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.452 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.512 ' HA3' HG13 ' A' ' 33' ' ' VAL . . . 172.86 -170.2 43.33 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.986 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 1.003 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . 2.1 m-20 -51.03 146.75 10.11 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.647 0.263 . . . . 0.0 110.514 175.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.683 ' HA ' HG21 ' A' ' 2' ' ' THR . 51.3 Cg_exo -54.72 -52.62 7.66 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 121.909 1.739 . . . . 0.0 112.773 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -61.03 -30.65 70.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.638 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 1.003 ' HG3' ' HB2' ' A' ' 56' ' ' ASP . 46.1 mttp -64.77 -47.97 76.22 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.294 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.31 -39.0 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.165 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.19 -51.88 67.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.564 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.877 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -68.7 -35.43 77.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 -178.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -72.31 -42.48 65.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.89 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 47.3 t -57.35 -36.76 71.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.358 0.599 . . . . 0.0 109.568 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -67.49 -45.63 75.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.21 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.907 ' HE3' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -73.94 -37.7 64.48 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.837 -175.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.625 HG22 HG13 ' A' ' 6' ' ' ILE . 35.9 m -62.49 -35.18 68.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.678 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.72 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 66.2 mtt -71.24 -21.22 62.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.737 0.303 . . . . 0.0 110.632 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.597 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 8.9 t70 -85.59 -41.51 15.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.967 0.413 . . . . 0.0 111.04 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.839 HG23 ' HD1' ' A' ' 79' ' ' PHE . 2.1 pp -86.85 -23.99 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.922 0.392 . . . . 0.0 111.856 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.612 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 3.6 tt -86.47 -20.06 28.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.551 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.72 ' HB3' ' O ' ' A' ' 68' ' ' MET . 5.3 ptm180 -61.55 -11.36 10.81 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.85 0.357 . . . . 0.0 111.076 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 1.029 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 16.0 tp10 -50.98 138.79 18.65 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.401 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -66.7 -30.08 70.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.827 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.448 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 29.1 t70 -135.23 -89.32 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.716 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 1.051 ' HA ' HD23 ' A' ' 15' ' ' LEU . 9.3 tt0 -153.66 61.45 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.544 0.688 . . . . 0.0 110.296 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 1.029 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . -137.64 30.49 2.58 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.8 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.75 158.27 40.73 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.839 ' HD1' HG23 ' A' ' 70' ' ' ILE . 4.5 m-85 -60.59 -45.51 93.7 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.82 -75.49 0.42 Allowed Glycine 0 CA--C 1.496 -1.099 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 169.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.525 ' HA ' HD23 ' A' ' 27' ' ' LEU . 19.2 p-10 -92.33 -15.61 27.12 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.418 -0.891 . . . . 0.0 110.473 174.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.44 ' CB ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER 84.58 64.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.635 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 28.8 t-20 -49.54 102.93 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.709 176.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 1.07 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.7 tt0 162.65 -41.97 0.0 OUTLIER 'General case' 0 C--O 1.232 0.157 0 O-C-N 124.572 1.17 . . . . 0.0 108.32 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 53.2 p90 -175.03 151.27 1.3 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.449 -177.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.61 80.04 0.18 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.877 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 40.1 m 72.38 -20.41 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.107 0.479 . . . . 0.0 111.001 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.566 ' HD3' ' H ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -103.96 154.03 20.13 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.733 171.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.686 HG23 ' CE1' ' A' ' 139' ' ' HIS . 33.3 mm 62.58 -88.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.119 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.03 46.45 1.73 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.661 -172.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.464 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 151.71 164.82 12.48 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.739 -0.545 . . . . 0.0 111.739 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.742 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 86.13 -122.02 5.91 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.081 -0.581 . . . . 0.0 111.724 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 1.07 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 28.7 pt -155.43 178.5 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 122.921 0.489 . . . . 0.0 109.852 171.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.476 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -120.22 137.04 54.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.694 170.364 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 29.2 t -124.12 98.06 39.55 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.073 -175.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.485 ' HA ' HD12 ' A' ' 137' ' ' ILE . 38.2 Cg_endo -69.98 107.75 1.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.671 1.581 . . . . 0.0 110.92 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 105' ' ' VAL . 14.8 p -116.02 126.75 27.35 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.014 0.435 . . . . 0.0 110.574 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.528 ' HA ' ' HG2' ' A' ' 135' ' ' GLU . 73.6 Cg_exo -46.96 136.17 17.54 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.499 2.799 . . . . 0.0 112.546 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -54.77 -29.13 53.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.343 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -92.29 10.55 29.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.895 0.379 . . . . 0.0 111.354 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.403 ' O ' HG21 ' A' ' 105' ' ' VAL . 46.1 m -128.64 -15.19 4.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.761 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 106' ' ' ILE . 7.6 p -64.51 -35.28 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.267 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.73 -28.56 73.5 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.184 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.29 -37.97 39.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.653 HG22 HG21 ' A' ' 97' ' ' VAL . 62.1 t -59.78 -41.09 84.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.919 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.76 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 46.0 mm -67.39 -46.3 83.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.245 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.06 33.26 9.02 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.611 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 108' ' ' ARG . 27.9 mtp180 64.9 -78.28 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.264 0.626 . . . . 0.0 111.914 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.428 ' HB2' ' HG3' ' A' ' 111' ' ' GLU . 18.0 m -81.81 11.32 5.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.878 0.37 . . . . 0.0 110.815 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.51 22.12 76.0 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.919 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 109' ' ' SER . 41.0 mt-10 -71.46 -50.47 31.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.895 0.378 . . . . 0.0 110.916 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.536 ' O ' HG12 ' A' ' 116' ' ' ILE . 13.6 tpt -68.49 -39.11 81.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.081 -173.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.76 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.3 tp -65.96 -32.37 57.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.608 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.41 -30.58 33.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.203 0.525 . . . . 0.0 109.731 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -66.15 -38.74 88.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.945 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 112' ' ' MET . 45.6 mm -62.15 -39.04 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.354 0.597 . . . . 0.0 109.651 174.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 77.6 mt-30 -65.8 -32.22 73.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.833 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -79.8 -42.4 24.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.567 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -79.46 -43.58 22.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.65 -18.94 20.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.929 0.395 . . . . 0.0 111.671 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.53 47.42 8.03 Favored Glycine 0 C--O 1.228 -0.223 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.886 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.438 ' HB ' HG23 ' A' ' 140' ' ' ILE . 27.1 m -122.17 179.58 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 111.653 -173.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.735 ' HB3' ' HG2' ' A' ' 141' ' ' MET . 43.1 ttt180 -145.68 145.78 31.04 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.548 HG13 HD11 ' A' ' 113' ' ' ILE . 44.9 mm -107.68 138.46 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -168.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.758 HE21 ' HA ' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -138.48 94.92 2.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.866 175.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 138' ' ' ALA . 44.2 m-85 -73.72 105.97 5.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.687 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -102.04 -166.74 1.32 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.076 -173.451 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -169.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--O 1.237 0.45 0 CA-C-O 121.519 0.55 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 98' ' ' PRO . 45.7 mt-10 -129.36 151.03 50.45 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.872 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.501 ' O ' HG13 ' A' ' 97' ' ' VAL . 66.9 mttm -109.38 113.82 26.97 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -175.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 14.9 mm -67.13 109.86 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.864 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.481 ' HB2' ' CE1' ' A' ' 126' ' ' PHE . . . -97.79 135.14 39.98 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 170.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.686 ' CE1' HG23 ' A' ' 89' ' ' ILE . 13.2 t60 -86.69 123.43 31.85 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.979 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.568 HD11 ' HB3' ' A' ' 150' ' ' ALA . 32.3 mt -103.24 126.15 57.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.275 171.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.735 ' HG2' ' HB3' ' A' ' 123' ' ' ARG . 16.8 ptp -107.23 165.49 11.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.958 0.409 . . . . 0.0 110.665 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.76 172.96 13.26 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.475 ' HD2' ' HD3' ' A' ' 146' ' ' ARG . 38.1 Cg_exo -58.89 143.5 99.36 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.415 2.076 . . . . 0.0 111.765 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.66 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 72.5 Cg_exo -41.59 -43.97 6.24 Favored 'Trans proline' 0 N--CA 1.476 0.466 0 C-N-CA 124.006 3.137 . . . . 0.0 114.497 -173.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 11.4 t70 -57.59 -42.93 84.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.612 0.244 . . . . 0.0 111.417 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.475 ' HD3' ' HD2' ' A' ' 143' ' ' PRO . 18.3 mtp180 -79.75 -39.15 31.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.52 -172.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.66 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 12.2 p -63.11 -50.65 69.64 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.652 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 5.7 mm-40 -62.21 -38.88 90.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.664 0.269 . . . . 0.0 110.718 176.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 18.6 t60 -57.66 -32.31 67.18 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.953 0.406 . . . . 0.0 111.076 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 140' ' ' ILE . . . -77.91 -34.02 51.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.778 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.505 ' HB2' HH11 ' A' ' 152' ' ' ARG . . . -67.47 -25.26 65.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.396 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.652 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 10.9 mpt_? -77.83 -32.73 52.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.845 0.355 . . . . 0.0 110.264 -177.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.444 ' O ' HD12 ' A' ' 157' ' ' LEU . 63.4 mt -65.4 -46.36 90.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.813 176.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.626 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 68.3 mt -62.41 -37.48 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.294 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.85 -31.3 69.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.462 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.08 -37.48 38.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.14 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 153' ' ' ILE . 7.8 mp -53.49 -42.29 67.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 25.5 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.424 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.807 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m -79.51 125.08 29.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.886 0.343 . . . . 0.0 110.201 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 15.0 m -133.54 115.18 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.502 0.668 . . . . 0.0 111.525 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -115.28 141.33 48.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.487 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 39.5 mt-10 -109.77 136.04 49.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.555 0.693 . . . . 0.0 112.504 -174.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.0 148.22 29.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.07 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 68.3 mtp -101.49 129.18 47.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.151 0.5 . . . . 0.0 111.56 -174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.669 HD11 ' HB2' ' A' ' 51' ' ' LEU . 3.9 mp -105.54 107.29 58.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.301 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.469 ' HD2' ' HG3' ' A' ' 12' ' ' LYS . 8.1 Cg_exo -74.64 152.23 42.43 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.211 2.607 . . . . 0.0 111.429 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.61 129.43 40.53 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.47 -15.4 24.77 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.538 ' HD2' ' O ' ' A' ' 71' ' ' LEU . 71.0 mmtt -112.66 9.27 19.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.045 0.45 . . . . 0.0 110.132 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.67 99.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.95 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.6 -15.72 66.72 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.175 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.874 HD13 ' HB2' ' A' ' 73' ' ' GLU . 24.7 mt -87.32 -58.61 2.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 120.81 0.338 . . . . 0.0 110.719 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.665 HG11 HG12 ' A' ' 8' ' ' ILE . 85.3 t -81.68 -48.83 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.438 HG21 HD12 ' A' ' 37' ' ' LEU . 39.8 pt -91.52 -26.78 4.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.917 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.35 33.92 13.18 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.457 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm 57.65 29.66 17.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.977 0.511 . . . . 0.0 112.093 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.1 -33.47 0.61 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 119.951 -1.119 . . . . 0.0 113.304 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.521 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 157.07 -6.33 0.19 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 119.908 -1.139 . . . . 0.0 113.792 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.74 -46.57 67.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.964 0.382 . . . . 0.0 111.549 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.474 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 86.0 m -73.36 -42.9 61.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.23 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.71 HD13 ' HB2' ' A' ' 35' ' ' MET . 5.8 tp -62.35 -26.1 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.75 -174.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 89.3 mttt -53.54 -56.89 13.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.945 0.879 . . . . 0.0 109.96 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.68 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 22.8 mt-30 -73.96 -27.69 61.12 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.607 -174.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 91.8 mt -66.59 -27.64 67.88 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.236 0.541 . . . . 0.0 109.853 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.668 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.4 mt-30 -85.41 -46.42 10.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.019 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -79.82 -62.44 1.68 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.495 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 3.0 ttm180 -62.34 -38.37 89.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.395 -173.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.866 ' HB3' ' HE2' ' A' ' 66' ' ' MET . . . -87.51 -26.46 23.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.825 0.345 . . . . 0.0 111.634 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.4 70.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.76 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.668 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.5 m -127.41 156.06 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -94.25 109.37 21.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.793 ' HB3' HD23 ' A' ' 51' ' ' LEU . 48.8 mtt -100.24 114.04 27.18 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.172 0.51 . . . . 0.0 109.64 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.4 tt -111.72 113.8 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.982 0.896 . . . . 0.0 109.932 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 1.1 pt? -132.6 141.19 48.56 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.197 -175.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.669 HD11 ' HG2' ' A' ' 50' ' ' PRO . 2.1 mp -59.43 102.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.421 0.629 . . . . 0.0 111.012 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 19.46 17.73 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.6 123.37 25.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.405 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.763 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . -79.59 -0.97 85.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.225 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.6 m -90.09 -26.35 20.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.086 0.443 . . . . 0.0 110.865 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -115.79 -81.53 0.61 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.282 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.56 ' HB2' ' CG2' ' A' ' 38' ' ' ILE . 15.0 m120 -96.76 67.31 2.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.94 0.4 . . . . 0.0 110.994 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.763 ' HB ' ' HA2' ' A' ' 41' ' ' GLY . 1.9 t -83.44 -56.49 3.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.315 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.482 ' H ' HG22 ' A' ' 45' ' ' THR . 4.4 m-20 -94.3 -21.8 18.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.124 0.488 . . . . 0.0 110.856 -178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.11 158.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.755 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.2 148.0 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.442 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -122.86 133.86 24.71 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.018 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.669 ' HG2' HD11 ' A' ' 38' ' ' ILE . 94.7 Cg_endo -86.98 119.91 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.421 2.081 . . . . 0.0 112.649 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.793 HD23 ' HB3' ' A' ' 35' ' ' MET . 2.0 tt -88.06 111.11 21.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.675 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 2.6 mtp85 -96.73 100.12 11.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.722 0.296 . . . . 0.0 110.544 177.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 59.9 mt -80.83 112.61 19.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.23 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.4 mt -104.43 121.24 55.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.34 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.63 -171.01 44.21 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.23 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -69.05 153.1 96.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.5 -54.98 4.36 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.217 2.612 . . . . 0.0 114.227 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -65.68 -26.87 67.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 110.811 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 87.6 mttt -69.67 -51.06 38.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.112 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.91 -29.0 46.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.321 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.36 -56.18 16.14 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.516 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.881 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -65.04 -37.2 86.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.647 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -67.33 -46.67 72.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.356 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.9 t -55.68 -36.64 67.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.074 0.464 . . . . 0.0 110.447 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -63.95 -50.72 67.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.148 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.866 ' HE2' ' HB3' ' A' ' 31' ' ' ALA . 8.2 ptt? -68.69 -38.96 80.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.951 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 63' ' ' ALA . 61.6 t -57.53 -41.83 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.567 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.0 mtp -68.33 -25.71 65.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.306 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.671 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 11.8 t70 -84.54 -54.46 4.73 Favored 'General case' 0 C--O 1.219 -0.5 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.692 -176.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -71.51 -21.04 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.997 -174.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.612 HD12 HG23 ' A' ' 16' ' ' VAL . 5.1 tt -76.34 -16.82 59.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.069 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.692 ' HD2' ' HG2' ' A' ' 74' ' ' ARG . 10.9 ptp180 -56.7 -36.6 69.83 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.874 ' HB2' HD13 ' A' ' 15' ' ' LEU . 1.3 tm-20 65.85 98.98 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.853 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.692 ' HG2' ' HD2' ' A' ' 72' ' ' ARG . 43.2 mtt180 -96.36 -27.8 14.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.378 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -151.65 29.1 0.61 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.129 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.705 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 37.86 35.67 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.004 0.921 . . . . 0.0 112.827 -169.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.47 -44.26 0.79 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.611 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 65.03 25.57 70.93 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.698 -0.287 . . . . 0.0 112.876 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 67.8 -50.93 0.52 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.622 0.769 . . . . 0.0 111.889 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 111.34 99.15 2.48 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -174.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.68 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 0.7 OUTLIER 72.59 -66.38 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.02 0.482 . . . . 0.0 109.91 -169.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.627 ' HB3' ' NH1' ' A' ' 82' ' ' ARG . 0.8 OUTLIER 170.17 -42.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.328 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 57.95 78.11 0.26 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.213 0.53 . . . . 0.0 110.765 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 1.028 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.6 tt0 -174.91 -68.27 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.288 -175.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 1.1 p90 -141.32 -69.22 0.38 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 120.689 -1.257 . . . . 0.0 112.367 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.45 75.39 0.52 Allowed Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.288 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.622 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 9.6 m 74.86 -38.74 0.39 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.541 0.736 . . . . 0.0 112.71 176.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.695 ' HG2' ' HD2' ' A' ' 127' ' ' LYS . 3.9 mpt_? -66.21 -88.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.617 ' O ' ' HB3' ' A' ' 85' ' ' TYR . 10.5 mm -111.65 88.82 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.1 -174.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.39 91.01 0.08 OUTLIER Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.496 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.57 93.79 0.29 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.836 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 112.41 165.13 16.98 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 -174.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.028 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 45.6 pt -94.15 155.71 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 117.125 0.463 . . . . 0.0 111.967 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.495 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 2.1 p30 -96.35 147.16 24.1 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.649 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 40.6 t -136.51 99.72 10.52 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.473 ' HA ' HD11 ' A' ' 137' ' ' ILE . 38.6 Cg_endo -71.07 106.7 1.95 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.113 1.875 . . . . 0.0 111.412 170.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.557 HG23 HD22 ' A' ' 158' ' ' LEU . 13.4 p -109.65 131.32 21.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.58 144.51 51.93 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.447 2.765 . . . . 0.0 112.747 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -64.49 -22.13 66.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.772 -172.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -86.35 -4.48 59.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 110.516 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 105' ' ' VAL . 16.4 m -114.85 -29.61 6.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.1 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.21 -39.96 70.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.12 -27.12 74.11 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.071 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.519 HG11 HD23 ' A' ' 161' ' ' LEU . 62.1 t -77.95 -33.62 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.08 0.467 . . . . 0.0 109.745 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 101' ' ' SER . 94.3 t -60.19 -39.8 81.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.171 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 33.6 mm -72.2 -59.05 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.467 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.4 -137.72 14.26 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -98.42 -57.34 2.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.222 0.511 . . . . 0.0 110.014 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 m -105.65 -24.27 12.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.612 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 136.81 20.54 0.59 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.469 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 1.8 mp0 -49.75 -43.68 48.12 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.1 0.476 . . . . 0.0 110.991 -176.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.66 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.2 tpt -76.37 -52.7 9.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.584 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.617 HD12 HG23 ' A' ' 124' ' ' ILE . 20.1 tt -69.92 -26.26 29.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.743 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.23 -29.28 63.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.552 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 112' ' ' MET . 16.5 ptpt -80.04 -22.59 42.2 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.265 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.36 -45.68 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -69.26 -25.29 64.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.625 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -79.39 -39.46 32.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.046 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -78.98 -54.08 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.404 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.437 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -88.23 -15.29 36.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.06 57.46 6.95 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.129 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.9 m -131.62 174.21 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.872 0.368 . . . . 0.0 111.314 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.785 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 86.6 mtt180 -125.04 151.41 45.65 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.617 HG23 HD12 ' A' ' 113' ' ' ILE . 47.8 mm -112.23 136.35 48.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.079 0.466 . . . . 0.0 111.155 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.666 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 3.9 tp-100 -130.72 110.99 11.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.309 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -80.97 102.89 10.43 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.113 171.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.909 ' HE2' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -99.2 164.67 12.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.847 -178.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.426 ' CD ' HH21 ' A' ' 88' ' ' ARG . 4.9 pt20 -46.32 100.26 0.02 OUTLIER 'General case' 0 C--O 1.236 0.382 0 O-C-N 124.146 0.904 . . . . 0.0 110.52 173.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -64.35 149.06 49.02 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.754 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.81 116.45 2.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.189 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.87 75.43 0.74 Allowed Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.861 0.726 . . . . 0.0 113.555 -167.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 20.2 p -124.63 -32.32 3.12 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.685 0.279 . . . . 0.0 110.765 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 123.33 -69.44 0.45 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.405 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.22 -65.22 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.394 2.73 . . . . 0.0 114.393 -174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.17 148.87 21.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.619 . . . . 0.0 111.757 -172.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.464 ' O ' HG13 ' A' ' 97' ' ' VAL . 60.3 mttm -127.46 123.21 35.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.894 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.909 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 6.4 mm -74.13 107.67 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.35 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.649 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -99.4 104.71 16.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.666 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 60.7 t-80 -73.32 133.73 43.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.0 0.428 . . . . 0.0 111.485 -172.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.692 HD11 ' HB2' ' A' ' 150' ' ' ALA . 95.9 mt -101.2 111.83 32.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.887 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.785 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 37.6 ttm -97.19 137.36 36.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.936 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.82 -161.21 29.45 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.011 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.412 ' C ' ' HG ' ' A' ' 147' ' ' CYS . 14.2 Cg_exo -71.39 139.12 34.15 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.982 2.455 . . . . 0.0 111.344 175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.94 -47.21 10.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.037 3.158 . . . . 0.0 113.964 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.53 -39.6 91.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 111.155 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 57.7 mtt180 -76.16 -28.29 57.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.178 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.836 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 73.1 m -56.92 -59.74 4.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.202 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.686 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 31.3 mt-10 -61.58 -39.82 92.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.464 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -54.79 -31.41 58.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.393 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.692 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -78.34 -34.74 48.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.974 0.416 . . . . 0.0 110.635 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' A' ' 93' ' ' ILE . . . -71.73 -21.39 61.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.286 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.686 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 8.2 mpt_? -76.74 -30.42 56.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.587 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 58.1 mt -70.13 -51.29 40.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.591 175.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.538 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 67.1 mt -59.04 -44.83 92.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.091 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.28 -32.2 72.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.386 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.86 -35.51 67.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 47.3 mt -62.0 -38.2 87.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.001 176.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.557 HD22 HG23 ' A' ' 97' ' ' VAL . 22.2 mt -61.08 -41.28 96.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.691 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.25 -32.13 66.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.949 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 34.7 t -64.84 -40.93 95.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.027 0.441 . . . . 0.0 109.906 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.519 HD23 HG11 ' A' ' 104' ' ' VAL . 93.3 mt -74.19 -22.52 59.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.972 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -73.4 -22.1 60.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.429 173.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.3 m -93.05 93.93 8.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.859 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.443 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.504 -177.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.43 ' HB ' HG23 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -79.4 95.99 5.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.971 0.415 . . . . 0.0 111.405 179.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 38.0 t -125.03 113.62 36.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.5 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -107.32 146.98 30.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.449 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 42.5 mt-10 -109.03 120.49 42.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.136 0.493 . . . . 0.0 111.507 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.8 mm -108.55 127.17 65.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.038 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 ttm -79.64 119.85 23.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.137 0.494 . . . . 0.0 111.525 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.439 HG12 HG12 ' A' ' 16' ' ' VAL . 1.6 mp -100.48 119.01 59.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.171 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.65 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 50.4 Cg_exo -61.74 148.41 93.13 Favored 'Trans proline' 0 N--CA 1.476 0.451 0 C-N-CA 123.761 2.974 . . . . 0.0 112.609 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.99 135.45 52.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.7 -45.8 1.69 Allowed Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -170.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.813 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -71.41 -34.01 69.96 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.665 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.25 -41.27 60.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.106 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.818 ' HA3' ' HE3' ' A' ' 19' ' ' LYS . . . -61.19 -32.25 79.88 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.957 -0.565 . . . . 0.0 113.221 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.4 pp -91.59 -22.2 20.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.001 0.401 . . . . 0.0 111.401 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.439 HG12 HG12 ' A' ' 8' ' ' ILE . 70.6 t -81.32 -46.56 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.656 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 13' ' ' ALA . 25.0 pt -91.6 -27.29 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.193 0.52 . . . . 0.0 110.383 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.7 132.6 6.43 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.818 ' HE3' ' HA3' ' A' ' 14' ' ' GLY . 30.9 mmtp -63.96 -17.81 63.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.122 0.461 . . . . 0.0 110.693 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.45 13.83 8.26 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.87 -1.09 74.07 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.977 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -53.9 -52.85 59.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.2 m -62.32 -36.45 82.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.822 -175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.686 HD13 HD11 ' A' ' 27' ' ' LEU . 2.6 tp -66.7 -33.28 62.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.897 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -57.24 -41.7 80.06 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.433 0.635 . . . . 0.0 110.375 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.64 ' HA ' ' HB2' ' A' ' 30' ' ' ARG . 10.7 mt-30 -71.86 -26.37 62.33 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.229 -176.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.686 HD11 HD13 ' A' ' 24' ' ' ILE . 74.2 mt -81.14 -34.36 32.53 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.08 0.467 . . . . 0.0 110.857 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.816 HE22 ' HB2' ' A' ' 35' ' ' MET . 18.6 mm-40 -84.83 -59.12 2.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.271 0.558 . . . . 0.0 110.843 -176.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.89 -46.17 10.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.722 -172.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.95 HH12 ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -65.84 -52.6 49.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 111.09 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.495 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -71.5 -28.95 64.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.642 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.72 17.36 54.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.054 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.5 m -118.39 171.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HD2' ' OE1' ' A' ' 28' ' ' GLN . 52.7 tptt -114.53 109.47 18.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.832 0.825 . . . . 0.0 109.723 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.816 ' HB2' HE22 ' A' ' 28' ' ' GLN . 48.3 mtt -94.68 112.64 24.38 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.452 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.624 HG22 ' HB2' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -111.01 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.905 0.859 . . . . 0.0 109.219 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.682 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 1.8 pt? -133.46 142.5 48.31 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.041 -173.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.513 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 3.2 mp -66.28 105.13 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.563 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.487 ' HG2' HG21 ' A' ' 17' ' ' ILE . 49.1 mt-30 -85.67 -57.84 2.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.925 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -174.43 118.59 0.22 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.86 -49.86 0.36 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.997 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.3 p -72.16 -75.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.904 0.352 . . . . 0.0 111.616 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -157.55 -35.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.189 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -79.62 67.32 5.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.443 0.639 . . . . 0.0 110.207 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 p -83.34 -57.76 3.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.918 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.19 -14.3 27.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.442 0.639 . . . . 0.0 110.239 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.04 158.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.7 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.89 150.36 16.71 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.394 0.434 . . . . 0.0 110.49 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 64.8 mttt -127.33 123.56 23.33 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.24 -167.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.19 124.44 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.81 2.34 . . . . 0.0 112.891 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.682 ' HA ' ' HB3' ' A' ' 37' ' ' LEU . 7.2 tt -98.98 118.6 36.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.697 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.624 ' HB2' HG22 ' A' ' 36' ' ' ILE . 3.9 mpt_? -97.52 119.4 36.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.644 0.259 . . . . 0.0 110.53 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 56.4 mt -92.46 110.16 22.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.021 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.465 HG12 HG21 ' A' ' 3' ' ' VAL . 27.5 mt -104.55 120.84 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.53 -171.08 44.09 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.028 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.494 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 9.5 t70 -60.73 135.49 92.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 O-C-N 123.786 0.345 . . . . 0.0 110.782 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HA ' HG23 ' A' ' 2' ' ' THR . 97.2 Cg_exo -43.48 -46.73 9.73 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.174 2.582 . . . . 0.0 114.262 -174.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.469 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 87.3 t80 -64.81 -40.39 95.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.296 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.756 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 52.0 mttp -67.52 -42.26 83.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.281 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.43 HG23 ' HB ' ' A' ' 2' ' ' THR . 98.9 t -60.16 -33.49 53.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.674 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.71 -50.1 53.54 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 12.5 mm100 -65.37 -39.68 92.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.223 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.517 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -63.56 -43.45 97.02 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.773 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.2 m -56.93 -44.36 82.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.761 0.315 . . . . 0.0 110.356 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.99 -42.16 99.76 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.905 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.602 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 5.6 ptt? -77.51 -34.22 54.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.406 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.489 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 54.1 t -61.62 -38.69 80.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 110.243 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.8 mtt -69.98 -21.84 63.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.542 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.59 ' HB2' HH21 ' A' ' 82' ' ' ARG . 31.9 t70 -84.84 -59.25 2.4 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.789 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.759 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -68.44 -20.04 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.069 -174.013 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.813 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 6.5 tt -76.51 -10.26 59.26 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.309 175.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -65.58 -17.37 64.53 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.917 0.389 . . . . 0.0 110.351 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HB3' HD22 ' A' ' 15' ' ' LEU . 10.5 tp10 -56.83 128.43 36.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.522 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -96.7 -20.18 18.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.013 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -122.46 36.63 4.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.648 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 65.08 105.43 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.247 173.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.69 -104.23 0.22 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.759 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 91.26 33.43 8.11 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.541 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.446 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 21.0 m-85 67.89 -56.68 0.47 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.215 0.606 . . . . 0.0 111.871 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 115.28 105.79 2.56 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -172.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.558 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 2.5 t70 73.39 -61.34 0.5 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.673 0.389 . . . . 0.0 110.354 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.798 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 8.6 ttm180 169.72 -21.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.564 1.165 . . . . 0.0 108.712 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.608 ' HA ' ' OD1' ' A' ' 94' ' ' ASP . 0.2 OUTLIER 66.1 31.89 8.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.611 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 1.034 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 34.4 tt0 -141.07 -40.05 0.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.157 -173.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 20.0 p90 -159.98 -44.07 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.95 ' HA3' HH12 ' A' ' 30' ' ' ARG . . . 65.12 72.74 0.67 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.572 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.756 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 49.7 m 67.67 -37.89 0.34 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 175.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.422 ' HB3' ' H ' ' A' ' 89' ' ' ILE . 2.8 tmt_? -68.53 -81.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.941 HD12 ' HG2' ' A' ' 125' ' ' GLN . 31.5 mm -65.97 -80.35 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -168.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.96 73.47 0.75 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -170.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.522 ' H ' ' HD2' ' A' ' 85' ' ' TYR . . . 118.75 161.12 11.66 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.805 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 89.34 -146.66 19.11 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.144 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.034 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 43.4 pt -149.24 162.02 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 172.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.608 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 2.3 p-10 -107.4 140.51 40.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' A' ' 138' ' ' ALA . 17.2 m -132.91 95.24 19.4 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.466 0.65 . . . . 0.0 111.472 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 95' ' ' VAL . 12.3 Cg_endo -58.47 108.68 0.42 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.191 2.594 . . . . 0.0 111.899 173.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.716 HG12 HD21 ' A' ' 158' ' ' LEU . 89.8 t -98.2 118.64 63.32 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.447 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.584 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 59.9 Cg_exo -41.35 132.57 3.38 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.518 2.812 . . . . 0.0 112.217 172.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -61.19 -26.47 67.74 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.019 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -92.21 6.73 45.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.684 ' HG ' HD13 ' A' ' 161' ' ' LEU . 22.4 m -122.63 -29.14 4.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.553 -176.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.439 ' HA ' HG13 ' A' ' 97' ' ' VAL . 14.1 p -51.55 -30.75 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.08 -44.7 96.14 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.098 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.08 -35.0 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.865 0.364 . . . . 0.0 110.448 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.93 -42.54 95.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.979 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.667 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 48.2 mm -75.49 -45.35 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.892 0.377 . . . . 0.0 110.612 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.12 -147.64 16.86 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.654 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 109' ' ' SER . 14.9 ptm180 -108.68 -44.52 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.056 0.455 . . . . 0.0 110.274 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.509 ' HB2' ' HG3' ' A' ' 111' ' ' GLU . 46.2 m -106.6 10.35 31.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.197 0.522 . . . . 0.0 109.748 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.03 28.05 59.23 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.325 -176.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -92.48 -20.35 21.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.362 0.125 . . . . 0.0 111.203 -178.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.424 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 16.7 tpt -74.41 -43.22 57.28 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.667 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 6.2 tp -63.84 -28.24 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.222 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.689 ' HA ' ' HG2' ' A' ' 117' ' ' GLN . 98.8 mttt -78.68 -19.12 53.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.63 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 63.6 mttm -64.76 -31.82 73.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.8 mm -67.78 -38.61 80.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.245 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.689 ' HG2' ' HA ' ' A' ' 114' ' ' LYS . 2.7 mm100 -72.39 -27.23 62.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.04 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.18 -38.63 35.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.399 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -81.29 -54.99 5.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.357 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.0 -5.06 51.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -172.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.88 29.23 67.23 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.727 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.7 m -95.82 177.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.168 0.508 . . . . 0.0 111.549 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -129.41 133.87 47.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.062 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.531 HG12 HE22 ' A' ' 117' ' ' GLN . 47.7 mm -99.72 127.23 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.336 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.941 ' HG2' HD12 ' A' ' 89' ' ' ILE . 5.3 tp-100 -122.64 97.13 5.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.513 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -74.94 106.39 6.43 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.757 ' HZ1' ' HB2' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -125.62 132.3 52.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.157 -177.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.757 ' HB2' ' HZ1' ' A' ' 127' ' ' LYS . 29.0 mm-40 54.66 -171.83 0.05 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 170.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 67.54 -34.9 0.25 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.302 1.041 . . . . 0.0 113.263 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 128' ' ' GLN . 10.1 t0 -58.18 119.59 7.14 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.452 0.301 . . . . 0.0 110.599 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.87 -37.81 3.31 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.446 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.3 t -91.79 -13.43 31.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.931 0.396 . . . . 0.0 110.546 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.89 173.64 19.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.06 -27.11 4.76 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.113 2.542 . . . . 0.0 112.368 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.584 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 5.3 mp0 -114.24 161.95 17.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.962 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -110.46 110.93 21.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 34.1 mm -68.24 102.18 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.181 0.515 . . . . 0.0 111.287 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.8 ' HB2' HG23 ' A' ' 95' ' ' VAL . . . -80.82 141.05 35.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.73 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 57.7 t-80 -106.33 115.02 29.49 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.877 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.738 HD13 HD13 ' A' ' 154' ' ' ILE . 83.7 mt -80.14 110.75 16.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 27.7 ttp -109.06 123.69 49.56 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.018 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.72 -161.12 34.9 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.418 ' HG2' ' CZ ' ' A' ' 146' ' ' ARG . 18.2 Cg_exo -67.58 141.14 54.23 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.689 2.259 . . . . 0.0 111.531 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -44.31 -51.11 7.2 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.799 2.999 . . . . 0.0 114.343 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.58 -38.31 86.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.411 0.624 . . . . 0.0 110.559 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.418 ' CZ ' ' HG2' ' A' ' 143' ' ' PRO . 12.1 ttm180 -72.49 -30.44 64.53 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.253 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.805 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 77.5 m -56.35 -57.97 10.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.913 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.487 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 6.4 mm-40 -64.28 -27.75 69.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.679 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -65.92 -29.78 70.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.176 0.512 . . . . 0.0 110.373 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.671 ' HB1' HD12 ' A' ' 140' ' ' ILE . . . -78.2 -34.97 49.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.261 0.553 . . . . 0.0 109.903 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -17.03 64.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.408 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -76.19 -42.1 47.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 0.0 110.193 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.85 -42.28 82.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.952 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.738 HD13 HD13 ' A' ' 140' ' ' ILE . 73.4 mt -67.57 -34.96 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.472 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 159' ' ' GLN . 21.2 t-20 -62.46 -48.81 77.99 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.8 -44.58 70.29 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.094 176.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.11 -52.95 62.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.415 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.716 HD21 HG12 ' A' ' 97' ' ' VAL . 86.1 mt -62.45 -29.5 70.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.372 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 155' ' ' ASN . 26.6 mm-40 -81.55 -42.94 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.963 0.411 . . . . 0.0 111.131 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.7 p -67.51 -43.39 80.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.912 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.684 HD13 ' HG ' ' A' ' 101' ' ' SER . 4.5 pp -70.48 -17.58 62.97 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -175.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -100.44 12.25 37.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.05 0.452 . . . . 0.0 110.699 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.9 m -153.59 -167.97 2.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.286 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.673 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -83.64 93.48 7.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 47.5 t -126.95 112.72 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.676 171.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -113.41 144.91 42.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.056 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.553 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 41.2 mt-10 -109.52 111.77 23.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.243 0.544 . . . . 0.0 111.654 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 6' ' ' ILE . 3.3 mp -105.2 139.07 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.2 mtp -95.71 123.73 39.41 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.265 0.555 . . . . 0.0 110.645 -174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.713 HG12 HG12 ' A' ' 16' ' ' VAL . 1.6 mp -96.98 114.8 65.24 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.725 -175.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 37.9 Cg_exo -63.84 147.94 92.06 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.771 2.981 . . . . 0.0 113.007 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.36 132.37 47.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 168.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.53 -44.16 1.59 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -170.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 9' ' ' PRO . 14.2 mptt -72.05 -26.32 62.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.008 0.432 . . . . 0.0 110.003 173.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.577 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.31 -32.55 25.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.472 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.454 ' O ' ' HA2' ' A' ' 18' ' ' GLY . . . -60.98 -38.53 95.65 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.566 -0.825 . . . . 0.0 112.903 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.766 HD23 ' HB2' ' A' ' 73' ' ' GLU . 3.5 pp -91.01 -27.23 18.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.405 0.602 . . . . 0.0 111.419 176.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.713 HG12 HG12 ' A' ' 8' ' ' ILE . 75.8 t -70.04 -58.93 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 13' ' ' ALA . 37.9 pt -91.77 -22.64 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.67 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . 84.42 19.41 60.43 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.561 ' H ' HG13 ' A' ' 17' ' ' ILE . 32.9 mmtp 65.6 -68.76 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.671 0.788 . . . . 0.0 111.314 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.55 5.9 79.47 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.69 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.78 10.09 58.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.769 177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.541 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 27.7 tt0 -66.25 -39.15 89.29 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.809 -0.23 . . . . 0.0 111.513 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 15' ' ' LEU . 20.5 m -77.25 -33.88 55.95 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.317 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -67.06 -29.99 48.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.901 178.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 10.7 ttmm -49.68 -55.23 14.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.66 0.743 . . . . 0.0 109.098 168.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.52 HE21 ' NH1' ' A' ' 30' ' ' ARG . 35.9 mt-30 -70.32 -39.3 74.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.493 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 32.1 mt -66.61 -25.61 66.69 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.945 -0.472 . . . . 0.0 111.488 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 43.8 mt-30 -85.73 -41.17 15.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.732 0.301 . . . . 0.0 111.352 173.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 25' ' ' LYS . 12.4 mm-40 -86.66 -55.25 3.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -175.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.685 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 6.9 ttm180 -67.1 -50.59 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.198 0.523 . . . . 0.0 110.865 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 87' ' ' SER . . . -70.13 -9.99 57.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.415 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.54 23.0 60.01 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.999 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.681 HG22 HG22 ' A' ' 53' ' ' ILE . 34.2 m -132.2 155.57 41.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -89.98 109.1 20.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.577 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 58.4 mtt -96.71 116.03 28.43 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.421 ' C ' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -109.58 107.12 22.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 122.322 1.058 . . . . 0.0 108.79 178.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.96 HD13 HD12 ' A' ' 51' ' ' LEU . 1.3 pt? -133.47 144.85 49.71 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.013 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.847 HG22 ' HB2' ' A' ' 42' ' ' SER . 2.5 mp -56.95 122.08 5.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 123.507 0.504 . . . . 0.0 110.145 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -129.91 -159.58 0.97 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.64 99.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.536 0.684 . . . . 0.0 110.346 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.84 -39.24 0.5 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.847 ' HB2' HG22 ' A' ' 38' ' ' ILE . 16.8 m -88.31 171.92 9.81 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -89.84 -13.74 35.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.884 0.373 . . . . 0.0 111.486 -171.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.792 ' HB2' HG23 ' A' ' 38' ' ' ILE . 94.8 m-20 -87.68 34.9 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -176.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -64.97 -46.13 82.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -85.26 -14.44 46.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.594 0.711 . . . . 0.0 109.76 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 35.5 t -79.66 156.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.462 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.81 131.13 45.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 173.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.655 ' HD2' ' O ' ' A' ' 38' ' ' ILE . 26.8 mtmm -121.68 125.97 26.59 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -165.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 38' ' ' ILE . 88.3 Cg_endo -80.57 130.67 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.581 2.187 . . . . 0.0 112.313 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.96 HD12 HD13 ' A' ' 37' ' ' LEU . 6.8 tt -108.37 128.59 54.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.695 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.1 mpt_? -97.62 118.94 35.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.481 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.681 HG22 HG22 ' A' ' 33' ' ' VAL . 59.9 mt -88.08 109.51 19.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.44 HG12 HG23 ' A' ' 3' ' ' VAL . 29.4 mt -110.39 119.12 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' HA3' HG13 ' A' ' 33' ' ' VAL . . . 171.86 -170.61 43.54 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.834 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.469 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 7.5 t70 -64.72 137.79 97.25 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 122.781 0.432 . . . . 0.0 110.914 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HA ' HG23 ' A' ' 2' ' ' THR . 76.3 Cg_exo -40.3 -49.13 3.97 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.601 2.867 . . . . 0.0 113.964 -176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -63.46 -45.42 90.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.765 0.317 . . . . 0.0 110.724 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.469 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 46.2 mttm -62.95 -43.74 97.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.848 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 53' ' ' ILE . 90.9 t -63.52 -29.25 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.633 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.521 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -80.5 -46.28 16.1 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -173.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -66.99 -32.57 73.89 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.46 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.735 ' HA ' ' SD ' ' A' ' 66' ' ' MET . . . -70.42 -45.02 66.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' A' ' 61' ' ' GLN . 26.5 p -63.02 -27.23 69.27 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.311 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.05 -47.54 28.43 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.202 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.735 ' SD ' ' HA ' ' A' ' 63' ' ' ALA . 6.6 ptm -69.13 -38.58 78.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.439 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 26.9 m -63.4 -31.79 54.18 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-N 117.961 0.346 . . . . 0.0 111.326 -178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.7 mtt -81.18 -20.75 40.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.402 0.62 . . . . 0.0 109.959 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 21.1 t70 -83.16 -52.62 6.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.214 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.857 HG23 ' HB2' ' A' ' 79' ' ' PHE . 2.7 pp -72.51 -21.43 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 111.363 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.52 ' N ' HD11 ' A' ' 70' ' ' ILE . 6.1 tt -85.9 -4.18 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.55 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 12.3 ptm180 -51.87 -42.02 62.33 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.912 ' HG3' ' HA ' ' A' ' 76' ' ' GLN . 26.0 tt0 60.93 101.53 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.449 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.2 ttm105 -101.64 -36.92 8.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.037 170.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -119.81 8.32 11.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.128 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.912 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . 44.6 tt0 68.57 12.29 8.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.789 0.804 . . . . 0.0 110.915 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.06 -19.56 6.74 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 64.15 -102.64 0.61 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.857 ' HB2' HG23 ' A' ' 70' ' ' ILE . 87.8 m-85 -135.83 -29.23 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.231 0.515 . . . . 0.0 110.624 173.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.42 79.91 1.47 Allowed Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.685 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER 71.18 -60.52 0.51 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 124.499 0.764 . . . . 0.0 110.353 -172.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.401 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 4.8 ttm-85 142.65 91.74 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 126.204 1.802 . . . . 0.0 108.117 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -67.92 52.04 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.038 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 33.4 mt-10 -152.13 -45.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.747 -176.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 88' ' ' ARG . 33.1 p90 -177.44 144.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 111.306 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.505 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -128.51 -94.34 0.79 Allowed Glycine 0 C--O 1.221 -0.659 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 174.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.658 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 19.6 p -87.52 13.27 10.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.17 0.509 . . . . 0.0 110.2 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.67 ' CG ' ' HD3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -143.23 174.63 10.55 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.329 -170.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.765 HG12 ' CD2' ' A' ' 139' ' ' HIS . 8.9 mt 59.46 -80.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.768 173.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.73 41.07 89.73 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 141' ' ' MET . . . 151.38 66.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.722 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 168.22 -142.79 7.69 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.932 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 38.9 pt -142.7 143.83 25.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 117.277 0.538 . . . . 0.0 111.262 176.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.95 126.77 35.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.541 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 70.2 t -116.38 95.22 44.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.553 ' HA ' HD13 ' A' ' 137' ' ' ILE . 38.1 Cg_endo -71.28 106.51 1.94 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 121.4 1.4 . . . . 0.0 111.276 169.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 136' ' ' LYS . 10.7 p -104.47 129.39 25.12 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 121.229 0.538 . . . . 0.0 110.169 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.625 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 52.9 Cg_exo -52.79 128.83 30.04 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.221 2.614 . . . . 0.0 112.624 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 0.6 OUTLIER -57.43 -25.57 59.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.904 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -92.09 16.36 11.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.605 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.534 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 2.7 p -155.97 12.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 p -77.01 -20.57 14.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.464 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.13 -33.59 86.31 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.92 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.79 ' HB ' HD13 ' A' ' 161' ' ' LEU . 7.3 p -74.99 -24.02 17.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.063 0.459 . . . . 0.0 110.412 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.432 HG23 HG21 ' A' ' 97' ' ' VAL . 30.9 t -72.88 -37.62 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.064 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 46.7 mm -84.26 -38.99 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.425 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.29 -133.56 11.65 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -102.4 -74.03 0.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.915 0.388 . . . . 0.0 110.443 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.514 ' HB2' ' OE1' ' A' ' 111' ' ' GLU . 30.5 m -89.38 -4.73 57.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.894 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 113' ' ' ILE . . . 114.01 6.74 20.35 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.06 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.514 ' OE1' ' HB2' ' A' ' 109' ' ' SER . 1.1 mp0 -65.16 -24.02 67.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' A' ' 104' ' ' VAL . 15.8 tpt -76.49 -40.61 49.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.402 . . . . 0.0 110.907 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.613 HD13 HG21 ' A' ' 124' ' ' ILE . 6.6 tp -70.02 -32.34 51.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 88.7 mttt -71.29 -29.32 64.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.429 0.633 . . . . 0.0 109.642 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.494 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 7.0 ttmt -66.28 -36.85 84.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.746 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.5 mt -65.1 -39.72 86.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.148 0.499 . . . . 0.0 109.709 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.583 HE21 ' HB ' ' A' ' 124' ' ' ILE . 79.2 mt-30 -63.93 -24.84 67.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.428 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -87.01 -50.54 6.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.235 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.02 -40.06 32.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.153 -172.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.58 -16.69 20.91 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.266 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.7 42.11 62.81 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.4 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.9 150.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.09 0.471 . . . . 0.0 111.628 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -96.74 122.35 39.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.56 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 113' ' ' ILE . 50.0 mm -109.44 141.85 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.942 0.401 . . . . 0.0 111.998 -170.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.75 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 1.9 pt20 -158.89 144.13 16.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -96.82 107.5 19.99 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.744 -0.597 . . . . 0.0 109.741 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.67 ' HD3' ' CG ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -112.55 134.0 54.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.458 -171.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 61.55 -78.83 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.962 0.789 . . . . 0.0 112.892 174.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.441 ' HA ' ' OG1' ' A' ' 132' ' ' THR . 10.4 m-20 -76.59 72.01 3.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.32 0.581 . . . . 0.0 112.04 -171.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -142.06 98.6 3.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.07 -7.45 81.6 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.988 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.441 ' OG1' ' HA ' ' A' ' 129' ' ' ASP . 33.8 p -90.65 -38.01 13.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.171 0.51 . . . . 0.0 110.52 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.77 -178.11 15.21 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.532 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.5 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 20.5 Cg_endo -64.31 -61.96 0.1 Allowed 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.424 2.083 . . . . 0.0 112.508 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.625 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 0.4 OUTLIER -86.13 155.6 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.833 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.607 ' O ' HG12 ' A' ' 97' ' ' VAL . 74.0 mttt -110.96 113.56 26.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.199 -175.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.653 HG21 ' HZ2' ' A' ' 127' ' ' LYS . 4.9 mm -79.19 115.1 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.186 0.517 . . . . 0.0 111.711 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.433 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . . . -87.31 142.34 27.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.666 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.765 ' CD2' HG12 ' A' ' 89' ' ' ILE . 2.9 t-80 -86.95 107.69 18.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.12 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 150' ' ' ALA . 23.1 mt -105.42 121.99 58.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 172.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.704 ' HE3' ' HE1' ' A' ' 139' ' ' HIS . 43.7 ttp -129.82 139.71 51.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 -176.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.5 -155.01 25.92 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.3 139.25 37.93 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.475 2.117 . . . . 0.0 111.174 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.29 -47.93 8.53 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 123.691 2.927 . . . . 0.0 113.229 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.28 -48.2 82.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.484 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -66.86 -29.97 70.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.837 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.722 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 66.9 m -59.31 -62.43 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.72 -42.79 89.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.882 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.508 ' O ' HG13 ' A' ' 153' ' ' ILE . 11.9 t-160 -58.49 -24.75 61.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.235 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.612 ' HB2' HD12 ' A' ' 140' ' ' ILE . . . -81.06 -52.36 7.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.27 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.05 -26.14 68.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -79.66 -19.04 50.01 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.798 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 149' ' ' HIS . 78.4 mt -72.06 -42.53 67.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 167.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.677 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 71.1 mt -61.07 -49.95 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.358 176.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -53.12 -40.22 64.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.529 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.25 -43.73 95.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.883 0.373 . . . . 0.0 110.564 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.03 -39.81 94.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.406 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 33.3 mt -65.48 -36.57 84.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.564 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -79.36 -15.99 57.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.416 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 33.6 t -79.38 -36.43 39.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.131 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.79 HD13 ' HB ' ' A' ' 104' ' ' VAL . 38.5 mt -88.07 -41.36 13.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.852 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 68.93 -73.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.078 0.862 . . . . 0.0 110.451 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.7 t -136.87 126.23 24.93 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.677 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.622 179.101 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.9 m -85.81 119.97 26.71 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 78.8 t -127.91 125.95 65.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.077 0.465 . . . . 0.0 111.186 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -122.43 145.16 48.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.837 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 67.3 mt-10 -111.84 126.7 55.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.48 0.657 . . . . 0.0 112.222 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.442 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -119.74 126.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 173.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 ttm -82.34 125.08 30.6 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.019 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.623 HG12 HG13 ' A' ' 16' ' ' VAL . 1.6 mp -101.05 119.37 58.23 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.617 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.642 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 51.2 Cg_exo -60.27 154.5 52.04 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.582 2.854 . . . . 0.0 113.047 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 129.76 39.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.63 -38.6 3.04 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -170.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.652 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -70.6 -30.76 67.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.582 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -54.67 -35.08 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.618 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.51 -32.57 73.52 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.157 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.736 ' HB3' ' HA ' ' A' ' 76' ' ' GLN . 0.8 OUTLIER -91.48 -25.91 19.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 117.069 0.435 . . . . 0.0 111.433 177.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.623 HG13 HG12 ' A' ' 8' ' ' ILE . 85.5 t -77.32 -48.84 23.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.704 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.618 HG13 ' H ' ' A' ' 19' ' ' LYS . 36.8 pt -91.93 -15.42 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.199 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 90.51 5.47 69.3 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.618 ' H ' HG13 ' A' ' 17' ' ' ILE . 13.6 tptm 65.27 -64.4 0.18 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.31 1.044 . . . . 0.0 110.645 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.09 -6.76 88.77 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 108.11 3.14 33.8 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.663 174.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.719 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 34.9 tt0 -62.41 -45.37 93.44 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.434 0.617 . . . . 0.0 111.981 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.474 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 25.7 m -71.27 -37.81 71.89 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.566 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.698 HD13 HD13 ' A' ' 27' ' ' LEU . 4.9 tp -64.76 -25.55 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.802 0.334 . . . . 0.0 110.381 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.719 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 76.0 mttt -58.77 -46.95 86.32 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.63 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -68.33 -39.07 82.06 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.917 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.698 HD13 HD13 ' A' ' 24' ' ' ILE . 39.1 mt -66.63 -26.89 67.29 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.135 -0.353 . . . . 0.0 110.922 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.722 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 79.7 mt-30 -85.52 -52.1 6.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -86.58 -55.29 3.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.54 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.625 HH22 ' HA ' ' A' ' 83' ' ' ASN . 2.7 mtp180 -62.61 -47.88 81.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.169 0.509 . . . . 0.0 111.269 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 27' ' ' LEU . . . -78.16 -2.81 39.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.695 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.12 22.02 41.27 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.765 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.3 m -133.74 153.66 37.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -93.55 109.24 20.86 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.936 ' HB3' HD21 ' A' ' 51' ' ' LEU . 46.9 mtt -93.47 113.89 26.14 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.411 ' C ' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -109.96 107.96 24.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 122.46 1.124 . . . . 0.0 109.464 -177.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.672 HD11 HD23 ' A' ' 51' ' ' LEU . 1.1 pt? -133.36 142.81 48.59 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.014 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.9 mm -64.5 98.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.115 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.409 ' HG2' HG23 ' A' ' 17' ' ' ILE . 26.0 mt-30 -82.03 -59.8 2.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -122.12 -176.94 3.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.636 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.619 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . 105.6 157.37 22.49 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -82.24 28.97 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -105.41 -96.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -100.28 58.5 0.98 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.639 HG23 ' H ' ' A' ' 46' ' ' ASN . 1.6 t -61.95 -61.19 2.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.508 -174.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.639 ' H ' HG23 ' A' ' 45' ' ' THR . 66.1 t30 -96.03 -22.43 17.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.834 -0.541 . . . . 0.0 111.316 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 m -83.85 -168.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -169.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.14 147.97 23.33 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.347 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -135.14 133.98 21.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.887 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.07 111.13 1.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.691 2.261 . . . . 0.0 111.578 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.936 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.0 tm? -88.46 111.76 22.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.239 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' A' ' 35' ' ' MET . 5.3 mpt_? -98.69 111.02 23.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.923 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.2 mt -85.95 110.42 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.537 HG12 HG21 ' A' ' 3' ' ' VAL . 21.1 mt -110.18 119.93 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.202 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.504 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.72 -170.44 43.36 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.032 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.934 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 7.3 m-20 -61.56 141.9 94.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 122.487 0.315 . . . . 0.0 110.646 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 54.1 Cg_exo -50.53 -51.69 10.54 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.403 2.736 . . . . 0.0 114.174 -169.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -57.02 -44.55 82.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.065 0.459 . . . . 0.0 110.44 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.934 ' HE2' ' HB2' ' A' ' 56' ' ' ASP . 42.1 mtmt -68.58 -40.57 80.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.759 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.3 t -61.93 -35.65 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.463 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.03 -54.25 28.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -65.43 -27.48 68.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.546 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.573 ' HA ' ' HE3' ' A' ' 66' ' ' MET . . . -79.7 -36.53 37.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 68' ' ' MET . 38.1 t -56.82 -42.4 79.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.075 0.464 . . . . 0.0 110.005 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.47 -26.69 38.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.448 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.624 ' HG3' ' N ' ' A' ' 67' ' ' VAL . 9.9 ptp -66.37 -48.02 71.49 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.462 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.624 ' N ' ' HG3' ' A' ' 66' ' ' MET . 91.9 t -59.83 -47.61 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.815 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 64' ' ' CYS . 19.9 ptp -70.57 -20.59 62.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.924 0.392 . . . . 0.0 111.12 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 25.3 t70 -85.98 -44.2 12.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -81.82 -21.37 10.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.901 -0.719 . . . . 0.0 111.053 -177.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.607 ' HA ' HD12 ' A' ' 15' ' ' LEU . 3.2 pp -77.02 -2.71 35.36 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.229 174.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 8.4 ptp180 -63.88 -19.95 65.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.278 0.561 . . . . 0.0 109.531 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.576 ' HG2' ' N ' ' A' ' 77' ' ' GLY . 9.5 tp10 -52.47 144.17 13.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.338 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -87.63 -60.1 2.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.013 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -113.61 55.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.7 -173.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.736 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 62.2 tt0 69.39 114.09 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.739 0.78 . . . . 0.0 112.545 173.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.576 ' N ' ' HG2' ' A' ' 73' ' ' GLU . . . 157.3 -96.35 0.15 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.476 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.7 -99.2 1.48 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.588 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -141.29 -41.42 0.38 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.868 0.366 . . . . 0.0 110.053 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 91.25 91.62 1.35 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -171.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 3.4 t70 70.57 -69.89 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -165.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.587 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 20.8 ttm-85 171.62 -40.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.763 0.825 . . . . 0.0 109.129 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.625 ' HA ' HH22 ' A' ' 30' ' ' ARG . 4.7 t30 61.87 59.13 1.79 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.629 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 1.05 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 44.9 tt0 -173.95 -38.5 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.275 -173.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.4 ' HB3' ' H ' ' A' ' 90' ' ' GLY . 5.6 p90 -168.4 90.16 0.27 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.626 166.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' HA2' ' CE ' ' A' ' 66' ' ' MET . . . -83.87 96.94 2.01 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 170.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.605 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 61.3 p 66.84 -53.69 0.45 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.112 1.365 . . . . 0.0 111.896 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 6.0 mmt180 -97.42 -167.2 1.5 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.019 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.653 HG23 ' ND1' ' A' ' 139' ' ' HIS . 71.0 mt 75.52 -66.44 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 124.083 0.864 . . . . 0.0 111.085 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 50.42 61.03 6.23 Favored Glycine 0 N--CA 1.451 -0.352 0 O-C-N 123.691 0.619 . . . . 0.0 112.497 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.34 88.89 1.02 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.878 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.616 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 154.36 -128.06 2.27 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.05 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 31.1 pt -148.37 154.39 10.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -89.03 128.05 35.71 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 53.5 t -119.1 96.72 50.3 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.872 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.543 ' HA ' HD11 ' A' ' 137' ' ' ILE . 60.1 Cg_endo -77.38 107.54 2.42 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.786 1.657 . . . . 0.0 110.941 174.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 102' ' ' VAL . 21.7 t -100.64 124.43 42.4 Favored Pre-proline 0 C--N 1.319 -0.74 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.205 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.1 129.53 22.01 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.589 2.193 . . . . 0.0 110.742 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -57.57 -28.51 63.64 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -172.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -80.67 -7.26 59.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.752 0.311 . . . . 0.0 110.877 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 m -113.31 -27.27 8.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.71 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.423 ' HA ' HG13 ' A' ' 97' ' ' VAL . 12.1 p -57.44 -30.08 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 111.596 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.49 -34.72 89.95 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.091 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.601 HG22 HD22 ' A' ' 161' ' ' LEU . 43.8 t -74.14 -29.42 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.024 0.44 . . . . 0.0 110.273 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -34.99 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.149 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.9 mm -84.13 -47.89 17.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.2 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.39 -116.42 5.51 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.549 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -128.7 -54.31 1.23 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.141 0.496 . . . . 0.0 110.009 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 m -105.1 20.55 18.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.297 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.1 18.15 76.26 Favored Glycine 0 C--O 1.224 -0.475 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.46 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 6.0 tp10 -68.49 -37.06 79.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.993 0.425 . . . . 0.0 111.092 -174.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.6 tpt -69.68 -43.39 72.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.693 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.427 HD13 ' CB ' ' A' ' 124' ' ' ILE . 19.8 tt -67.31 -27.03 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.155 0.502 . . . . 0.0 111.032 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 50.4 mtpt -65.12 -32.03 73.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.421 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -72.3 -32.33 66.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' A' ' 113' ' ' ILE . 10.8 mm -63.98 -50.59 76.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -62.84 -29.72 70.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.287 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -79.84 -38.7 32.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.601 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -79.5 -38.91 33.31 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.786 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.45 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -96.65 -11.25 25.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 111.49 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.4 23.35 75.8 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.592 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.03 173.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.337 . . . . 0.0 111.425 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 31.6 mtp180 -136.24 141.04 43.91 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 173.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.427 ' CB ' HD13 ' A' ' 113' ' ' ILE . 36.5 mm -110.26 138.67 37.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.524 0.678 . . . . 0.0 112.561 -171.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 138.17 44.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.148 171.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -84.86 105.28 15.52 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.712 ' HE2' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -94.82 -166.13 1.42 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.298 -169.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.444 ' H ' ' HB2' ' A' ' 127' ' ' LYS . 27.7 tp60 -69.17 75.55 0.34 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.618 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.482 ' OD2' ' HA ' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -163.79 81.35 0.43 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.377 172.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.51 53.8 2.92 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.743 0.783 . . . . 0.0 109.377 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.61 81.1 1.0 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.198 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.6 p -82.67 1.04 40.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.31 0.576 . . . . 0.0 110.662 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.48 -64.33 0.93 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.608 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -87.56 -84.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.677 2.251 . . . . 0.0 113.185 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -143.8 165.84 26.57 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.356 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -123.08 118.21 27.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.728 0.299 . . . . 0.0 110.353 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.712 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 18.8 mm -70.14 124.22 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 111.966 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -102.39 140.66 36.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.298 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.653 ' ND1' HG23 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -83.54 112.09 19.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.602 178.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.733 HD12 ' HB3' ' A' ' 150' ' ' ALA . 24.7 mt -91.81 123.76 44.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.66 169.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.486 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 44.5 ttm -102.71 136.75 41.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.75 -169.98 24.16 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.126 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 14.5 Cg_exo -70.29 139.1 37.61 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.109 2.539 . . . . 0.0 111.166 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 147' ' ' CYS . 87.0 Cg_exo -48.6 -32.92 22.52 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.24 3.293 . . . . 0.0 114.456 -174.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.1 -43.1 68.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.001 0.429 . . . . 0.0 110.781 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 49.8 mtt180 -72.36 -26.34 61.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.062 0.458 . . . . 0.0 110.03 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.601 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 92.7 m -55.91 -58.04 9.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.801 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.85 -30.02 71.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.911 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.421 ' O ' HG13 ' A' ' 153' ' ' ILE . 4.2 t60 -57.86 -35.73 71.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.311 0.577 . . . . 0.0 110.214 176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.733 ' HB3' HD12 ' A' ' 140' ' ' ILE . . . -78.6 -38.35 40.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.905 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.82 -25.16 67.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.58 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -79.15 -25.0 42.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.237 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.436 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 42.1 mt -73.35 -37.74 52.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 57.3 mt -71.77 -33.33 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.176 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -63.68 -40.52 97.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.746 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.29 -30.45 71.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.703 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 26.9 mt -66.08 -32.15 73.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.981 0.42 . . . . 0.0 110.096 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.44 -35.69 81.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.879 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -73.15 -36.97 66.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.921 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.6 p -71.34 -21.06 62.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.588 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.601 HD22 HG22 ' A' ' 104' ' ' VAL . 70.1 mt -77.01 17.85 0.41 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -87.91 -5.06 58.75 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.8 t -122.44 144.34 49.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.956 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.731 -177.239 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.6 m -79.27 135.29 36.72 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 89.1 t -133.91 131.34 56.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.458 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -134.52 149.2 50.65 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.69 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 46.4 mt-10 -106.49 135.76 47.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.23 0.538 . . . . 0.0 111.741 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.0 mp -119.22 148.15 22.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.446 ' HA ' ' HE1' ' A' ' 7' ' ' MET . 2.2 mmt -92.33 114.25 26.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.707 0.289 . . . . 0.0 111.369 -177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 51' ' ' LEU . 2.3 mp -100.14 108.01 50.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.101 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 12' ' ' LYS . 7.3 Cg_exo -75.92 155.0 38.65 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.939 2.426 . . . . 0.0 111.474 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.17 128.97 38.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.04 -34.56 5.36 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -169.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 10.0 mptt -94.53 -4.39 48.09 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.129 0.49 . . . . 0.0 110.747 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.67 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -61.61 -43.06 99.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.548 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.25 -11.15 55.08 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.831 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.596 ' CD1' ' HB3' ' A' ' 73' ' ' GLU . 34.1 mt -84.84 -47.8 9.99 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.474 HG22 ' CG1' ' A' ' 8' ' ' ILE . 65.1 t -78.06 -44.58 27.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.989 -176.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.782 HG13 ' H ' ' A' ' 19' ' ' LYS . 23.3 pt -90.77 -15.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 121.54 -0.725 . . . . 0.0 110.468 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.45 -1.19 89.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.783 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.782 ' H ' HG13 ' A' ' 17' ' ' ILE . 14.3 tptm 72.9 -44.04 0.58 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.015 0.926 . . . . 0.0 110.702 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.95 -11.04 55.72 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.914 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.81 -9.03 29.84 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.447 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 10.5 mp0 -54.09 -49.29 69.41 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.954 0.502 . . . . 0.0 112.33 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 15' ' ' LEU . 26.4 m -70.11 -43.42 71.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.444 HD12 HD12 ' A' ' 27' ' ' LEU . 6.0 tp -61.99 -25.9 38.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.331 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 42.6 mttm -62.68 -42.59 99.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.496 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.49 ' HB3' ' HD3' ' A' ' 30' ' ' ARG . 49.2 mt-30 -83.55 -29.16 28.07 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.003 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.566 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 82.7 mt -65.89 -24.8 66.93 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.541 -0.725 . . . . 0.0 109.683 171.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.754 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.2 mt-30 -86.1 -55.42 3.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.618 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -80.76 -45.4 17.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.591 ' NH2' ' HA ' ' A' ' 83' ' ' ASN . 11.4 mtp180 -76.06 -42.08 48.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.631 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . -82.87 -9.07 59.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.122 0.486 . . . . 0.0 110.425 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.04 20.95 71.32 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.456 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 31.4 m -134.7 163.1 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -100.24 110.28 22.52 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.994 ' HB3' HD11 ' A' ' 51' ' ' LEU . 51.4 mtt -93.59 114.52 26.88 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.426 ' C ' HD11 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -110.85 108.02 24.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 122.399 1.095 . . . . 0.0 109.302 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.608 HD12 HD13 ' A' ' 51' ' ' LEU . 1.3 pt? -133.68 142.64 48.11 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.262 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.436 ' H ' HD11 ' A' ' 38' ' ' ILE . 3.5 mp -64.31 101.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.208 0.528 . . . . 0.0 111.107 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -99.29 -58.47 1.93 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -95.42 159.81 14.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.429 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.58 117.03 3.36 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.072 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 t -74.28 78.73 1.83 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.313 0.578 . . . . 0.0 110.775 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -142.65 -54.46 0.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.783 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.58 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 14.5 m120 -118.58 39.79 3.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.659 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 p -70.71 -61.5 1.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.832 0.349 . . . . 0.0 111.232 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -91.29 -4.08 56.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.498 0.666 . . . . 0.0 109.968 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 39.3 t -90.72 160.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.328 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -58.3 145.65 37.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.165 0.507 . . . . 0.0 109.706 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 128.21 26.04 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.704 -169.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.42 113.29 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.793 2.329 . . . . 0.0 112.13 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.994 HD11 ' HB3' ' A' ' 35' ' ' MET . 48.7 tp -85.58 105.34 16.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.226 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.52 101.6 14.28 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.33 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.4 mt -83.63 109.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.5 mt -107.95 119.47 57.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.152 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.51 ' HA3' HG13 ' A' ' 33' ' ' VAL . . . 171.77 -169.97 42.98 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.265 -1.445 . . . . 0.0 113.697 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.478 ' HB3' ' HD2' ' A' ' 59' ' ' LYS . 13.1 t70 -55.02 136.05 67.18 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 114.642 -0.779 . . . . 0.0 110.642 174.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 33.0 Cg_exo -57.34 -34.32 97.7 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.496 2.797 . . . . 0.0 113.813 -173.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.451 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 68.4 t80 -72.37 -35.64 68.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.556 0.693 . . . . 0.0 109.419 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HD2' ' HB3' ' A' ' 56' ' ' ASP . 53.3 mttp -76.84 -41.62 43.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.768 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.402 HG23 HG23 ' A' ' 53' ' ' ILE . 95.1 t -59.72 -36.61 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.11 176.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -56.55 17.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.45 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 12.4 mm100 -67.05 -34.52 77.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.067 -176.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -69.98 -44.77 68.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.21 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.9 t -56.74 -35.05 68.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.498 0.666 . . . . 0.0 109.584 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -72.61 -33.83 66.95 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.013 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.685 ' HA ' ' HE ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -74.98 -37.52 61.87 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.347 177.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.612 ' N ' ' HG3' ' A' ' 66' ' ' MET . 85.0 t -56.34 -52.35 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.277 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.3 mtp -62.57 -21.01 65.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.892 0.377 . . . . 0.0 111.077 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 30.6 t70 -79.37 -56.18 4.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.614 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.815 HG22 ' H ' ' A' ' 82' ' ' ARG . 2.1 pp -81.7 -21.38 10.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.514 ' O ' HD22 ' A' ' 71' ' ' LEU . 6.4 tt -84.8 -10.64 57.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.333 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 4.4 ptp180 -66.15 -11.44 49.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.078 0.466 . . . . 0.0 110.342 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.596 ' HB3' ' CD1' ' A' ' 15' ' ' LEU . 10.0 tp10 -50.64 142.22 11.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.13 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -80.77 -49.39 11.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.469 -175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -171.98 20.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.828 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -109.6 -86.46 0.53 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.079 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -151.56 -24.56 0.05 OUTLIER Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.774 -1.203 . . . . 0.0 114.543 -173.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.37 -127.23 8.78 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.826 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.464 ' HD2' HG23 ' A' ' 70' ' ' ILE . 70.3 m-85 -133.1 -60.28 0.86 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.962 0.411 . . . . 0.0 110.121 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.52 76.78 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 26' ' ' GLN . 3.9 m-20 54.6 44.38 28.77 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.119 0.962 . . . . 0.0 109.184 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.815 ' H ' HG22 ' A' ' 70' ' ' ILE . 30.8 ttm-85 69.06 -45.52 0.55 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.624 -1.625 . . . . 0.0 112.353 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.591 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 6.2 t30 61.21 63.64 1.2 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.616 0.722 . . . . 0.0 109.233 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 1.061 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 37.0 tt0 -177.17 -41.72 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.428 -170.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.0 p90 175.08 151.36 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.643 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.34 -12.96 1.75 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.88 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 6.3 p -172.88 -57.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.809 0.814 . . . . 0.0 108.815 -174.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.449 ' HD3' ' HB2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -73.5 -178.44 3.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.473 170.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.775 HG22 ' H ' ' A' ' 91' ' ' GLY . 68.1 mt 74.13 -82.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 167.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.03 41.49 94.49 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.649 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.775 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 153.45 91.15 0.08 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.681 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.668 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 158.63 -132.96 3.25 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 175.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.061 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 27.7 pt -147.19 165.94 6.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 169.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.547 ' HB3' ' CG2' ' A' ' 137' ' ' ILE . 19.8 m-20 -111.36 132.18 54.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.835 HG22 ' HB1' ' A' ' 138' ' ' ALA . 2.6 m -120.86 95.28 48.97 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 120.965 0.412 . . . . 0.0 111.015 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.77 108.73 1.95 Allowed 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 122.99 2.46 . . . . 0.0 110.946 173.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.607 HG23 HG22 ' A' ' 105' ' ' VAL . 14.0 p -116.64 127.58 26.63 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.861 0.363 . . . . 0.0 111.123 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.425 ' N ' ' HG2' ' A' ' 135' ' ' GLU . 6.9 Cg_endo -50.42 131.56 32.52 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.385 2.723 . . . . 0.0 112.406 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.425 ' O ' HG12 ' A' ' 102' ' ' VAL . 15.7 ptt180 -64.22 -25.45 68.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.51 -171.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.84 -4.77 57.28 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.373 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.0 m -123.82 -10.14 7.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.758 0.313 . . . . 0.0 111.548 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 99' ' ' ARG . 12.5 p -63.83 -28.07 44.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 110.387 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.66 -30.03 71.31 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.957 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.0 t -76.53 -36.44 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.41 . . . . 0.0 110.079 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.607 HG22 HG23 ' A' ' 97' ' ' VAL . 54.2 t -69.7 -37.45 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.446 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.724 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 45.7 mm -76.55 -46.92 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.177 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.28 170.23 25.91 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -70.94 -53.15 16.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.103 0.478 . . . . 0.0 110.188 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -87.88 -6.93 57.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.182 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.69 29.06 27.66 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.687 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 78.7 mm-40 -88.99 -25.73 21.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.659 0.266 . . . . 0.0 110.743 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.512 ' SD ' ' HD2' ' A' ' 115' ' ' LYS . 17.4 tpt -68.79 -40.61 79.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.902 0.382 . . . . 0.0 110.328 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.724 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.6 tp -65.79 -27.33 41.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.297 0.57 . . . . 0.0 109.912 177.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -76.41 -30.33 57.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.522 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.512 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 99.2 mttt -62.77 -35.87 81.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.191 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.2 mm -60.88 -45.45 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.491 0.662 . . . . 0.0 109.295 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.34 -34.6 76.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.6 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -79.49 -42.17 25.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.729 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.58 -54.26 6.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.34 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -85.44 -14.37 46.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.859 0.361 . . . . 0.0 111.466 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.51 32.6 57.46 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.168 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -106.27 171.81 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.191 0.519 . . . . 0.0 111.532 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.473 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 27.2 mtm180 -122.13 140.49 52.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.354 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.436 HG22 HD12 ' A' ' 113' ' ' ILE . 50.8 mm -103.45 141.57 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 111.653 -172.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 24.5 tt0 -144.08 106.92 4.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.794 177.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -82.82 148.54 27.7 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.633 ' HD2' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -151.07 93.43 1.92 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -168.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 45.26 40.73 5.42 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.539 1.136 . . . . 0.0 112.313 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.609 ' HB2' ' HA ' ' A' ' 136' ' ' LYS . 2.4 p30 -106.04 -6.06 19.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.607 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.607 ' HA ' ' HE3' ' A' ' 136' ' ' LYS . 29.9 t70 -78.8 92.82 4.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.048 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.36 -15.78 62.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.879 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.6 p -67.71 -32.23 72.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.785 0.326 . . . . 0.0 111.397 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -140.62 -176.73 15.45 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.307 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.62 -27.17 18.86 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.05 2.5 . . . . 0.0 111.736 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 98' ' ' PRO . 25.6 mt-10 -128.06 147.34 50.52 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.801 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.609 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 36.6 mtpt -109.38 118.13 35.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.614 -168.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.633 ' O ' ' HD2' ' A' ' 127' ' ' LYS . 5.5 mm -78.7 99.5 3.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.55 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.835 ' HB1' HG22 ' A' ' 95' ' ' VAL . . . -91.95 141.94 28.09 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.878 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.519 ' CE1' HG23 ' A' ' 89' ' ' ILE . 6.7 t-160 -95.55 123.49 39.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.006 0.431 . . . . 0.0 110.504 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.599 ' HB ' ' CG1' ' A' ' 93' ' ' ILE . 37.0 mt -97.33 114.85 35.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.284 170.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.492 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 52.7 ttm -101.77 134.59 44.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.179 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.55 -165.24 31.39 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.447 ' HD2' ' HD2' ' A' ' 146' ' ' ARG . 20.5 Cg_exo -66.41 148.32 83.95 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.67 2.246 . . . . 0.0 111.658 176.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.39 -53.98 3.88 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.541 2.828 . . . . 0.0 113.645 -176.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.24 -44.77 96.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.084 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.447 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 53.8 mtt180 -64.84 -39.12 93.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.99 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.453 ' HB3' HG12 ' A' ' 93' ' ' ILE . 75.7 m -58.06 -59.21 5.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.003 0.43 . . . . 0.0 110.654 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.633 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 35.0 mm-40 -61.83 -34.73 76.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.836 -176.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -67.95 -29.06 68.02 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.798 0.333 . . . . 0.0 110.73 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.59 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -77.72 -34.23 52.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.086 0.47 . . . . 0.0 110.3 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -60.87 -31.38 70.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.749 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.633 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 7.3 mpt_? -77.7 -19.94 54.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.723 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.6 mt -73.22 -40.98 58.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 84.5 mt -68.96 -45.27 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.236 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -56.73 -32.39 65.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.789 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.39 -41.7 90.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.188 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.42 HD22 ' HE3' ' A' ' 112' ' ' MET . 3.1 mm? -63.89 -44.58 92.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.223 0.535 . . . . 0.0 110.485 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.5 HD23 HG22 ' A' ' 97' ' ' VAL . 17.2 mt -69.27 -33.07 72.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.152 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -64.98 -29.62 70.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.939 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.5 t -66.31 -26.07 67.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.981 0.42 . . . . 0.0 110.322 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.6 mt -89.28 5.38 45.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.678 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -121.12 109.44 15.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.693 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.4 m -82.34 24.72 0.66 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.968 0.413 . . . . 0.0 111.859 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.978 -179.003 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.549 HG22 ' HA ' ' A' ' 57' ' ' PRO . 10.7 m -81.48 105.78 12.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.099 0.476 . . . . 0.0 111.325 -173.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 44.5 t -132.16 113.02 20.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.609 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -108.64 142.25 39.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.964 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 48.7 mt-10 -104.27 129.58 52.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.424 ' N ' HD11 ' A' ' 6' ' ' ILE . 4.1 mp -115.9 141.42 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 96.6 mmm -90.69 104.84 17.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.973 0.416 . . . . 0.0 110.965 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.539 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -91.85 118.86 68.49 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.764 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 43.4 Cg_exo -63.21 140.3 76.92 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.655 2.904 . . . . 0.0 112.809 176.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.94 123.61 21.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 170.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.08 -36.97 3.75 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -168.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 74' ' ' ARG . 11.6 mptt -74.11 -19.48 60.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.54 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -47.53 -41.02 20.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.164 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.24 -36.9 92.04 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.622 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.654 HD21 ' HB3' ' A' ' 73' ' ' GLU . 3.9 pp -91.42 -23.88 19.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.883 0.341 . . . . 0.0 111.518 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.539 HG11 HG12 ' A' ' 8' ' ' ILE . 86.7 t -82.24 -55.04 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 13' ' ' ALA . 40.6 pt -91.79 -14.99 8.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.367 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.677 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 92.18 6.56 64.72 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.841 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER 64.98 -68.35 0.11 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.874 0.869 . . . . 0.0 110.204 -176.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.83 -1.09 90.13 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.237 -0.506 . . . . 0.0 111.918 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.59 -5.92 29.71 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.409 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.616 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 57.4 mm-40 -50.87 -51.95 46.42 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.677 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 27.6 m -71.87 -39.31 69.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -174.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.599 HD11 HD12 ' A' ' 27' ' ' LEU . 2.6 tp -66.17 -27.64 41.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.08 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.338 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.616 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 22.0 mttm -56.29 -59.2 5.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.453 0.644 . . . . 0.0 109.561 172.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 18.9 mt-30 -63.51 -37.53 87.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.559 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.599 HD12 HD11 ' A' ' 24' ' ' ILE . 95.7 mt -63.2 -33.64 75.93 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.921 -0.487 . . . . 0.0 110.815 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.742 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 46.7 mt-30 -85.11 -44.77 12.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.905 0.384 . . . . 0.0 111.512 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.61 -51.47 5.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -65.78 -52.41 51.13 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.063 0.459 . . . . 0.0 109.975 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.66 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.57 -28.62 63.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.74 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.35 3.55 86.85 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.116 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.2 m -101.2 149.29 6.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -87.66 110.7 20.6 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.627 ' HE2' HG13 ' A' ' 67' ' ' VAL . 32.0 mmm -92.14 111.87 23.6 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.652 HG22 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tp -112.22 104.97 17.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.816 0.817 . . . . 0.0 109.379 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.706 ' HB3' HD22 ' A' ' 51' ' ' LEU . 1.2 pt? -132.76 127.25 34.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.561 -175.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.524 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.2 mp -68.78 99.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.497 ' HA ' ' HD2' ' A' ' 49' ' ' LYS . 7.2 tp-100 -123.76 -34.06 3.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.049 0.452 . . . . 0.0 110.29 -174.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -127.85 42.54 3.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.545 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.17 -156.76 8.4 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.127 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -90.52 -164.42 1.17 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.164 0.186 . . . . 0.0 111.214 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 71.62 -79.47 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.229 0.612 . . . . 0.0 111.008 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.537 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 5.7 m-20 -116.74 94.65 4.69 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 p -85.53 -61.87 1.66 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.021 0.438 . . . . 0.0 111.615 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -94.33 -8.7 38.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.926 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.543 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 17.3 t -85.89 164.81 2.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.908 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -54.48 142.59 26.86 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.997 0.427 . . . . 0.0 110.29 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 46.1 mtmt -131.6 131.18 22.67 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.75 -167.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.58 131.86 9.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.858 2.372 . . . . 0.0 113.382 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.706 HD22 ' HB3' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -111.73 124.59 52.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.494 178.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.652 ' HB2' HG22 ' A' ' 36' ' ' ILE . 4.7 mpt_? -101.11 119.69 39.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.017 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.536 HG12 ' SD ' ' A' ' 35' ' ' MET . 57.9 mt -91.19 115.28 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 173.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.1 mt -104.74 120.72 55.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.381 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.45 -170.92 43.94 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.495 -0.859 . . . . 0.0 113.149 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.702 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 13.8 t70 -72.12 143.5 86.21 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.549 ' HA ' HG22 ' A' ' 2' ' ' THR . 74.6 Cg_exo -40.49 -50.32 3.8 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.756 2.971 . . . . 0.0 114.983 -175.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -62.12 -38.94 90.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 111.221 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.887 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 19.4 ptmt -79.64 -35.42 39.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -175.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.17 -31.42 52.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.215 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -68.77 -55.84 9.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.806 0.336 . . . . 0.0 110.356 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.567 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 15.2 mm100 -59.55 -35.86 75.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.643 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.52 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -73.13 -43.61 61.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.614 ' O ' ' HG3' ' A' ' 68' ' ' MET . 36.0 t -59.11 -42.54 90.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.004 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.87 -32.54 67.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.599 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.903 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 14.7 ptt? -78.69 -38.67 38.64 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.91 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.627 HG13 ' HE2' ' A' ' 35' ' ' MET . 33.7 m -61.8 -22.11 27.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 120.649 0.261 . . . . 0.0 110.602 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 48.7 mtt -81.71 -39.94 23.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.069 0.462 . . . . 0.0 110.167 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.73 -26.58 29.61 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -171.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -87.13 -20.93 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 120.865 -1.147 . . . . 0.0 109.714 173.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.48 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 5.2 tt -75.86 -18.04 59.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.045 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -60.5 -14.24 18.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.213 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.654 ' HB3' HD21 ' A' ' 15' ' ' LEU . 8.2 tp10 -47.01 -41.49 16.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.423 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.803 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 45.1 ttp180 74.62 -67.53 0.25 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.501 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.46 62.05 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -171.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 67.38 127.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.787 0.68 . . . . 0.0 112.63 170.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.497 ' H ' ' HB3' ' A' ' 15' ' ' LEU . . . 137.84 -103.83 0.43 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.683 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 73.6 24.8 73.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.368 174.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 68.4 -54.57 0.53 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.514 0.726 . . . . 0.0 111.962 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 110.91 102.45 2.68 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -173.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.667 ' H ' HG22 ' A' ' 23' ' ' THR . 2.7 t70 71.38 -69.37 0.19 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -169.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.903 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 50.9 ttt85 162.13 -33.54 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.846 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.35 32.93 14.31 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.33 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.873 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 23.5 tt0 -130.73 -57.97 1.04 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.869 -174.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 9.9 p90 -146.79 -26.32 0.41 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.202 -0.936 . . . . 0.0 113.149 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.589 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 65.63 -89.16 0.11 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.816 -176.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.887 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 29.3 m -147.83 22.27 1.12 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.271 0.558 . . . . 0.0 109.606 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.496 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -96.41 -86.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.188 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -94.44 -164.08 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.251 175.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.594 ' H ' HG23 ' A' ' 89' ' ' ILE . . . -141.92 2.43 1.88 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.711 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.82 125.17 3.34 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.838 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 103.5 163.34 25.32 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.873 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 46.3 pt -97.85 157.11 3.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.017 0.437 . . . . 0.0 111.732 -174.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.552 ' CG ' ' HZ1' ' A' ' 127' ' ' LYS . 13.1 m-20 -99.11 117.47 33.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.611 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 25.0 t -107.56 105.73 56.7 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -172.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HA ' HD13 ' A' ' 137' ' ' ILE . 48.6 Cg_endo -72.48 108.02 2.43 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.826 1.684 . . . . 0.0 110.897 169.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.666 HG22 HD21 ' A' ' 158' ' ' LEU . 11.0 p -124.91 131.14 24.06 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.122 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 87.2 Cg_exo -45.52 134.01 12.83 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.389 2.726 . . . . 0.0 113.437 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' O ' HG12 ' A' ' 102' ' ' VAL . 10.3 ptm180 -55.85 -33.22 64.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.854 -174.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -86.04 -15.18 42.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.103 0.477 . . . . 0.0 110.416 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.449 ' HB3' HD21 ' A' ' 161' ' ' LEU . 16.0 m -95.28 -28.45 14.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.85 -176.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 106' ' ' ILE . 13.6 p -63.49 -28.21 44.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.399 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.84 -28.06 72.92 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.811 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.06 -30.49 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.189 0.519 . . . . 0.0 109.765 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.6 t -68.82 -34.37 64.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.225 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 102' ' ' VAL . 37.0 mm -80.45 -50.25 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.166 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.59 -117.8 5.47 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -126.8 -53.97 1.42 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.1 m -102.18 -15.77 16.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.036 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.51 14.53 6.86 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.85 -24.61 67.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.873 0.368 . . . . 0.0 110.987 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.604 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.0 tpt -86.15 -42.82 13.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.882 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.59 HD11 HG13 ' A' ' 124' ' ' ILE . 15.5 tt -74.01 -35.85 43.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.572 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -69.71 -23.87 63.49 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.495 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 112' ' ' MET . 16.9 ptpt -75.35 -21.96 57.96 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.364 175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 mm -65.41 -40.94 89.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.632 ' HG3' ' O ' ' A' ' 122' ' ' VAL . 1.8 mp0 -63.78 -31.28 72.41 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.268 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.09 -53.43 7.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.541 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -79.4 -51.26 9.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.113 -172.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.08 -22.42 31.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.866 0.365 . . . . 0.0 111.425 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.01 41.42 40.37 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.088 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.632 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 27.4 m -121.08 160.23 22.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 111.72 -173.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.769 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 83.3 mtp180 -111.11 151.12 28.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.633 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 113' ' ' ILE . 48.9 mm -114.4 130.99 67.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.082 0.468 . . . . 0.0 111.333 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.727 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 5.4 tp-100 -128.2 110.44 12.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.545 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -82.45 107.12 14.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.128 0.49 . . . . 0.0 110.014 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.552 ' HZ1' ' CG ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -123.15 -174.67 3.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.07 -174.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -49.94 131.37 22.67 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.442 0.464 . . . . 0.0 111.101 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.456 ' HA ' HG12 ' A' ' 137' ' ' ILE . 24.2 m-20 -87.7 -173.31 4.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.796 -176.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -73.55 -8.52 56.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.007 0.432 . . . . 0.0 111.071 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.39 1.36 83.83 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.855 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.7 p -80.55 -66.72 0.85 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.923 0.392 . . . . 0.0 110.954 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . 134.18 -58.05 0.69 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.579 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.532 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 88.1 Cg_exo -49.15 -39.19 41.88 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.082 2.521 . . . . 0.0 113.501 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 98' ' ' PRO . 36.1 mt-10 -120.7 137.64 54.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.794 0.33 . . . . 0.0 111.101 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -110.97 133.11 53.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.128 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.579 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 6.8 mm -78.17 105.64 7.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.192 0.52 . . . . 0.0 111.45 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.611 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -100.78 109.11 21.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 170.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 28.3 t60 -73.64 132.42 42.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.955 0.407 . . . . 0.0 111.119 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.653 HD13 ' HB2' ' A' ' 150' ' ' ALA . 80.5 mt -104.13 107.16 21.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.501 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.769 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 41.1 ttm -93.42 143.4 26.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.076 -174.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.44 -165.45 26.74 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.586 ' HD2' ' HD2' ' A' ' 146' ' ' ARG . 32.2 Cg_exo -60.51 136.8 69.81 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.648 2.232 . . . . 0.0 110.523 172.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.9 -32.19 55.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.034 3.156 . . . . 0.0 113.236 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.09 -51.92 58.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.293 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.586 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 98.1 mtt180 -60.4 -40.73 92.01 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.479 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.838 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 73.2 m -52.33 -59.35 4.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.316 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.16 -39.61 93.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.871 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -56.6 -29.83 62.56 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.3 0.572 . . . . 0.0 110.558 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.653 ' HB2' HD13 ' A' ' 140' ' ' ILE . . . -79.97 -36.08 36.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.848 -175.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.75 -19.66 65.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.589 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -77.83 -36.66 49.85 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.9 mt -66.87 -40.49 85.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.833 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.595 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 54.3 mt -66.46 -41.74 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.456 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.55 ' O ' ' HG2' ' A' ' 159' ' ' GLN . 7.6 m-80 -60.31 -39.87 88.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.176 176.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -55.92 -41.01 73.94 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.103 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.588 HD21 ' HE2' ' A' ' 112' ' ' MET . 96.5 mt -62.31 -47.57 83.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.266 175.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.666 HD21 HG22 ' A' ' 97' ' ' VAL . 24.8 mt -61.02 -23.83 65.71 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.798 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 155' ' ' ASN . 13.1 mm100 -83.36 -48.6 10.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.161 0.505 . . . . 0.0 110.556 175.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.1 m -67.48 -33.55 75.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.306 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 157' ' ' LEU . 4.4 pp -78.02 -6.07 53.35 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.145 -0.347 . . . . 0.0 111.897 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -68.28 -37.16 80.39 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.9 p -87.56 -51.63 5.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.456 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.868 176.444 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.571 -0.611 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 t -94.53 152.42 18.57 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 30.0 m -131.37 137.13 56.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.165 0.507 . . . . 0.0 111.417 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -130.35 150.65 51.49 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 73.8 mt-10 -106.19 123.86 48.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 111.57 -173.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.3 mp -112.33 140.21 33.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.8 tpp -89.15 113.41 24.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.722 0.296 . . . . 0.0 110.909 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.726 HG12 HG13 ' A' ' 16' ' ' VAL . 1.7 mp -98.61 111.14 59.48 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.065 0.459 . . . . 0.0 110.526 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.559 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 51.5 Cg_exo -60.22 139.6 87.9 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.307 2.672 . . . . 0.0 112.713 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.3 125.78 25.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 169.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.16 -46.25 1.2 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -167.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.849 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.7 -32.7 64.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.651 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.21 -31.89 21.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.55 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.16 -44.99 88.75 Favored Glycine 0 C--O 1.223 -0.593 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.49 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' A' ' 73' ' ' GLU . 3.3 pp -90.09 -18.13 26.45 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.69 -0.3 . . . . 0.0 111.651 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.726 HG13 HG12 ' A' ' 8' ' ' ILE . 91.6 t -82.73 -49.01 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.781 0.324 . . . . 0.0 111.682 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.651 HG12 ' O ' ' A' ' 13' ' ' ALA . 10.1 pt -91.36 -21.67 6.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.944 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.748 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 96.16 13.12 50.21 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.597 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? 67.36 -57.7 0.43 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.961 0.904 . . . . 0.0 110.922 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.53 2.58 46.11 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 109.39 13.23 17.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.088 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.726 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 33.7 tt0 -68.32 -43.59 77.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.841 0.353 . . . . 0.0 111.736 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.748 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 59.3 m -71.06 -40.34 71.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.502 -177.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.755 HD12 ' HB2' ' A' ' 35' ' ' MET . 7.3 tp -64.08 -21.53 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.83 0.348 . . . . 0.0 110.529 -176.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.726 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 47.9 mttm -59.0 -48.31 82.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.288 0.566 . . . . 0.0 110.136 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -79.33 -29.83 42.49 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.505 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.42 -27.25 66.03 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 121.844 -0.535 . . . . 0.0 110.449 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.661 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.4 mt-30 -84.27 -45.52 12.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.337 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.82 -39.23 15.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.507 ' HD3' ' OD2' ' A' ' 94' ' ' ASP . 4.0 ttm180 -75.29 -46.48 33.23 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.217 -176.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.796 ' HB3' ' HE2' ' A' ' 66' ' ' MET . . . -81.56 -27.0 34.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.28 177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.01 21.7 60.66 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.677 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.3 m -121.97 147.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.91 0.386 . . . . 0.0 111.195 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -90.54 110.38 21.52 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.755 ' HB2' HD12 ' A' ' 24' ' ' ILE . 60.3 mtt -95.09 124.0 38.9 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.3 tp -110.93 100.81 11.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 122.156 0.979 . . . . 0.0 110.451 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.734 HD13 HD13 ' A' ' 51' ' ' LEU . 1.4 pt? -134.93 142.87 46.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.889 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.575 ' H ' HD11 ' A' ' 38' ' ' ILE . 4.2 mp -65.83 99.94 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 111.188 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -101.56 -29.04 12.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.004 176.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.19 175.03 7.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.524 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.12 48.13 3.28 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.363 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.0 t -90.21 -157.81 0.5 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -55.82 -61.37 2.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.577 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.6 m-20 -85.58 48.63 1.62 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.99 0.424 . . . . 0.0 111.218 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -76.95 -47.94 19.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -93.51 -17.01 23.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.419 0.628 . . . . 0.0 110.068 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 23.1 t -79.4 151.35 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.377 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.559 ' OD2' ' HA ' ' A' ' 9' ' ' PRO . 6.6 m-20 -58.97 145.14 42.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -114.63 125.72 28.78 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-O 121.029 0.442 . . . . 0.0 111.989 -162.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.8 125.5 3.23 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.825 2.35 . . . . 0.0 111.15 174.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.734 HD13 HD13 ' A' ' 37' ' ' LEU . 7.3 tt -106.51 120.67 42.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.93 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 36' ' ' ILE . 5.1 mpt_? -102.93 120.74 41.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 71.8 mt -91.1 115.47 30.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.108 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.448 HG12 ' CG1' ' A' ' 3' ' ' VAL . 24.7 mt -104.16 121.39 55.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.98 -170.83 43.76 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.37 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.82 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 1.9 m-20 -57.42 149.08 51.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 123.171 0.589 . . . . 0.0 110.472 175.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.13 -50.28 10.19 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.842 2.361 . . . . 0.0 113.332 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.432 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 50.4 p90 -67.89 -42.53 81.04 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.82 ' HG2' ' HB2' ' A' ' 56' ' ' ASP . 16.8 ptpt -72.12 -29.91 64.54 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.969 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.87 -34.57 70.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.447 . . . . 0.0 110.051 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.563 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 59.2 tp60 -77.03 -45.91 25.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.522 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 14.4 mm100 -63.0 -27.18 69.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.079 0.466 . . . . 0.0 110.131 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.615 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -84.6 -41.81 16.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.784 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.599 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.8 p -61.1 -34.45 74.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.594 0.235 . . . . 0.0 111.595 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.77 -30.64 32.25 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.745 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.796 ' HE2' ' HB3' ' A' ' 31' ' ' ALA . 17.4 ptt? -76.02 -34.97 59.7 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.446 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 27.2 m -68.8 -22.68 26.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.636 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.599 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 49.3 mtt -82.21 -24.5 34.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.664 0.745 . . . . 0.0 109.394 172.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.459 ' CG ' HH21 ' A' ' 72' ' ' ARG . 10.0 t70 -84.58 -53.3 5.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.594 -171.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 1.059 HG22 ' HA ' ' A' ' 82' ' ' ARG . 2.6 pp -76.17 -20.77 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.412 0.625 . . . . 0.0 111.455 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.849 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 2.0 tt -76.06 -9.25 58.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.072 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.511 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 15.0 ptp180 -52.39 -53.5 44.15 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.595 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER 53.97 144.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 176.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.595 ' HD2' ' O ' ' A' ' 73' ' ' GLU . 13.0 mmm180 -121.14 -30.31 4.36 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.723 -0.611 . . . . 0.0 110.247 172.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -147.19 41.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.643 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.406 ' H ' ' CG ' ' A' ' 73' ' ' GLU . 49.6 mt-30 62.77 30.73 16.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.373 0.606 . . . . 0.0 110.068 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.68 82.7 0.35 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.199 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.36 175.94 44.69 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.646 ' CD1' HG23 ' A' ' 70' ' ' ILE . 92.8 m-85 -81.45 4.29 21.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.097 0.949 . . . . 0.0 112.348 -173.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 23' ' ' THR . . . 78.03 -3.94 59.72 Favored Glycine 0 N--CA 1.461 0.35 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.638 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.406 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -177.49 -61.57 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -178.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 1.059 ' HA ' HG22 ' A' ' 70' ' ' ILE . 2.9 ttp-105 162.47 -34.59 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 124.616 1.197 . . . . 0.0 109.45 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.74 ' HA ' ' OD1' ' A' ' 94' ' ' ASP . 2.2 t-20 57.98 58.99 3.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.931 0.872 . . . . 0.0 110.173 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 1.029 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 0.8 OUTLIER -171.95 -136.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.878 -178.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.5 ' HB3' ' H ' ' A' ' 90' ' ' GLY . 1.3 p90 -59.19 -74.42 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.689 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 85.02 -38.57 2.97 Favored Glycine 0 C--O 1.226 -0.379 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.415 ' OG ' ' HB3' ' A' ' 59' ' ' LYS . 13.0 t -170.92 -37.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.907 -0.647 . . . . 0.0 109.352 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.433 ' HG3' ' CB ' ' A' ' 127' ' ' LYS . 6.5 mmt180 -94.64 149.12 21.56 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.381 -176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.747 HD11 ' HB2' ' A' ' 141' ' ' MET . 39.8 mm 75.48 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 124.083 0.864 . . . . 0.0 111.377 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.5 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 72.11 43.6 47.53 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.46 -174.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.16 73.7 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.532 ' O ' ' HG2' ' A' ' 84' ' ' GLU . . . 147.8 159.37 8.37 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -171.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.029 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 9.7 pt -91.14 165.86 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -167.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.74 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 0.6 OUTLIER -99.8 148.17 24.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.865 176.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 38.7 t -135.0 96.18 14.63 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -174.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.408 ' HA ' HD13 ' A' ' 137' ' ' ILE . 35.9 Cg_endo -69.48 107.2 1.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.549 1.5 . . . . 0.0 110.504 168.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.728 HG23 HD22 ' A' ' 158' ' ' LEU . 14.9 p -117.37 128.95 25.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.584 0.231 . . . . 0.0 110.683 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.427 ' HB2' ' OG ' ' A' ' 101' ' ' SER . 64.1 Cg_exo -39.25 132.84 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.997 3.131 . . . . 0.0 113.443 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -56.99 -30.13 63.86 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.476 -171.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -90.1 -12.17 39.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.839 0.352 . . . . 0.0 111.497 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.427 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 14.8 m -96.57 -17.16 20.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.758 -173.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.474 ' O ' HG12 ' A' ' 106' ' ' ILE . 7.4 p -59.49 -34.7 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.13 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.38 -31.01 79.43 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.447 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.63 -37.05 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 109.952 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 97' ' ' VAL . 52.9 t -63.27 -39.87 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.294 176.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.703 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.6 mm -72.41 -42.68 64.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.309 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.98 35.94 7.44 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.788 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 63.25 -78.06 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.03 0.532 . . . . 0.0 111.857 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -69.71 -15.28 63.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.768 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.473 ' HA2' HG23 ' A' ' 106' ' ' ILE . . . 90.99 17.26 52.1 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.839 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -7.9 51.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.865 0.364 . . . . 0.0 110.968 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 14.8 tpt -90.24 -41.43 11.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.966 0.412 . . . . 0.0 109.918 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.703 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 8.9 tp -64.31 -22.43 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.207 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 99.3 mttt -81.74 -21.79 37.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.029 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -67.74 -40.24 84.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.008 0.432 . . . . 0.0 109.901 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 153' ' ' ILE . 22.1 mt -60.85 -43.65 96.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.78 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -73.71 -18.9 60.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.165 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -87.96 -45.39 10.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.824 0.345 . . . . 0.0 110.882 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -78.49 -46.67 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.512 ' O ' ' HG2' ' A' ' 146' ' ' ARG . . . -87.16 -17.46 32.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.842 0.354 . . . . 0.0 111.258 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.65 23.96 77.3 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.697 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 120' ' ' ALA . 17.4 m -95.47 177.8 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.912 0.387 . . . . 0.0 111.273 -175.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.681 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 98.5 mtt180 -129.24 131.93 47.13 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.606 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.618 HG23 HD11 ' A' ' 113' ' ' ILE . 47.0 mm -98.6 118.69 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.974 0.416 . . . . 0.0 111.02 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.672 ' HB3' HD13 ' A' ' 89' ' ' ILE . 50.6 tp60 -116.23 109.94 18.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.838 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -82.58 140.7 33.1 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.5 ' HD2' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -146.61 -172.36 3.95 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.067 -171.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -52.23 121.3 6.61 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.859 0.361 . . . . 0.0 110.404 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.01 170.97 14.94 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.31 -45.07 41.95 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.278 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.8 -21.02 10.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.49 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 89.2 m -76.63 -38.54 54.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.158 0.504 . . . . 0.0 110.301 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.24 173.77 37.87 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -86.39 17.82 1.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.857 2.371 . . . . 0.0 112.661 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -125.83 155.82 40.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.038 0.447 . . . . 0.0 111.301 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.408 ' O ' HG11 ' A' ' 97' ' ' VAL . 23.8 mtpp -110.42 123.91 50.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.222 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.5 ' O ' ' HD2' ' A' ' 127' ' ' LYS . 15.2 mm -72.91 102.31 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.007 0.432 . . . . 0.0 112.005 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.51 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -92.72 140.96 28.99 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 169.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.501 ' HB3' ' CG1' ' A' ' 89' ' ' ILE . 2.2 m80 -106.33 138.24 42.87 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.197 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.746 HD12 ' HB1' ' A' ' 150' ' ' ALA . 87.8 mt -107.4 107.25 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.325 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.747 ' HB2' HD11 ' A' ' 89' ' ' ILE . 47.4 ttm -85.83 124.43 32.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.824 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.92 -177.82 34.49 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.131 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.64 147.74 86.45 Favored 'Trans proline' 0 C--O 1.224 -0.177 0 C-N-CA 122.913 2.409 . . . . 0.0 111.389 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.636 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 87.5 Cg_exo -45.16 -46.66 13.34 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.286 2.657 . . . . 0.0 114.132 -174.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -60.53 -34.55 74.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.764 0.316 . . . . 0.0 110.889 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 120' ' ' ALA . 7.0 mtm180 -86.79 -34.48 19.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.188 -176.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.959 ' HG ' HG23 ' A' ' 93' ' ' ILE . 25.7 p -61.42 -47.14 87.13 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -69.6 -35.64 75.48 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.597 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -54.56 -32.92 59.3 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.149 0.5 . . . . 0.0 110.942 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.746 ' HB1' HD12 ' A' ' 140' ' ' ILE . . . -78.86 -28.77 44.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.089 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.77 -23.65 63.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.955 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -78.08 -25.02 47.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.322 . . . . 0.0 110.412 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.532 HD11 HG21 ' A' ' 116' ' ' ILE . 62.1 mt -73.87 -42.84 53.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.242 0.544 . . . . 0.0 109.868 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.3 mt -68.81 -39.39 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.469 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -58.86 -36.75 75.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.486 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.21 -42.03 93.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.173 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.44 -35.23 80.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.49 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.728 HD22 HG23 ' A' ' 97' ' ' VAL . 35.5 mt -62.52 -28.95 70.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.219 0.533 . . . . 0.0 110.323 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -85.21 -47.19 10.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.705 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.2 t -66.08 -22.62 66.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.477 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.62 -15.0 57.02 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -59.82 -34.92 73.7 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.285 0.564 . . . . 0.0 109.874 173.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.4 p -101.99 54.52 0.8 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.747 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.322 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.36 107.27 12.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.955 0.407 . . . . 0.0 111.589 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 38.5 t -130.35 112.52 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.439 173.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -110.87 146.93 35.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.57 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 38.4 mt-10 -110.91 116.9 32.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.219 0.533 . . . . 0.0 112.033 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.2 mm -110.16 132.28 58.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 173.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.0 ttm -90.41 119.4 30.66 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.516 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.827 HG12 HG13 ' A' ' 16' ' ' VAL . 1.8 mp -92.95 115.63 65.24 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.252 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.468 ' HA ' ' OD1' ' A' ' 48' ' ' ASP . 59.6 Cg_exo -57.12 142.14 94.32 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.598 2.865 . . . . 0.0 112.404 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.38 121.37 13.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.6 -54.2 0.6 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -167.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HE2' ' OE2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -64.69 -29.77 70.77 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 172.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.693 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -50.33 -33.82 21.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.03 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.73 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -59.56 -41.47 97.27 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.731 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.789 HD21 ' HA ' ' A' ' 76' ' ' GLN . 0.5 OUTLIER -89.39 -31.07 17.93 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.957 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.827 HG13 HG12 ' A' ' 8' ' ' ILE . 78.4 t -67.29 -47.91 79.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.699 HG13 ' H ' ' A' ' 19' ' ' LYS . 21.6 pt -91.03 -21.68 6.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.281 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.489 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 98.4 -2.5 59.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.859 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.73 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 6.1 tptm 69.78 -50.59 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 111.047 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.57 4.96 69.92 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 172.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.7 3.62 64.25 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.801 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 46.7 mt-10 -65.05 -34.31 78.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.489 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 26.7 m -85.37 -40.93 15.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.92 -175.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.504 HD11 HD13 ' A' ' 27' ' ' LEU . 3.3 tp -67.19 -26.39 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 63.7 tttt -52.73 -50.99 62.32 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.83 169.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.461 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 28.4 mt-30 -74.43 -36.5 63.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.363 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.621 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 88.0 mt -66.13 -28.23 68.64 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.173 -0.329 . . . . 0.0 111.135 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 24.3 mt-30 -85.6 -43.64 13.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.793 0.33 . . . . 0.0 111.503 176.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.59 -52.0 6.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.513 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 29.6 ttm180 -70.35 -53.35 17.03 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.754 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -65.68 -26.2 67.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.349 0.595 . . . . 0.0 110.711 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.93 0.38 75.29 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.998 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 35.3 m -103.88 151.38 6.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -92.51 110.3 21.72 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 1.082 ' HB3' HD22 ' A' ' 51' ' ' LEU . 56.8 mtt -97.24 115.38 27.5 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.361 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.93 104.42 17.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 122.334 1.064 . . . . 0.0 109.664 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.717 ' HB3' HD21 ' A' ' 51' ' ' LEU . 1.2 pt? -134.26 142.5 47.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.859 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.533 ' H ' HD11 ' A' ' 38' ' ' ILE . 4.0 mp -69.29 100.11 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.465 HE22 HG22 ' A' ' 24' ' ' ILE . 70.2 mt-30 -80.76 -67.12 0.8 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -130.54 101.65 5.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.972 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.535 ' O ' HG22 ' A' ' 45' ' ' THR . . . -155.86 149.51 20.57 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 p -69.76 71.87 0.36 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.12 0.485 . . . . 0.0 111.58 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -169.85 -56.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.411 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.529 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 90.1 m-20 -126.9 60.55 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.898 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 41' ' ' GLY . 2.2 p -83.86 -59.87 2.29 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.637 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.13 -14.92 39.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.354 0.597 . . . . 0.0 109.727 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 47.2 t -79.77 146.06 8.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.833 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' OD1' ' HA ' ' A' ' 9' ' ' PRO . 42.7 m-20 -58.81 149.91 25.33 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.565 0.541 . . . . 0.0 109.615 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -115.97 122.18 32.82 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.936 -166.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.43 121.34 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.47 2.113 . . . . 0.0 111.537 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 1.082 HD22 ' HB3' ' A' ' 35' ' ' MET . 2.1 tm? -106.19 125.17 50.66 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.299 -174.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.57 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 1.7 mpt_? -103.42 121.25 42.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.378 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 62.9 mt -89.81 109.09 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.9 mt -105.94 119.7 55.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.992 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.505 ' HA3' HG11 ' A' ' 33' ' ' VAL . . . 172.18 -171.14 44.04 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.432 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.05 146.72 97.41 Favored Pre-proline 0 C--N 1.327 -0.397 0 O-C-N 123.67 0.276 . . . . 0.0 110.522 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.12 -51.89 8.68 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.367 2.711 . . . . 0.0 114.186 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -58.2 -44.19 87.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.233 0.54 . . . . 0.0 110.457 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 86.5 mttt -62.82 -46.72 86.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.486 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.13 -34.21 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.52 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -69.63 -50.04 48.1 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.794 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -65.88 -33.5 75.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.341 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.557 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -69.7 -47.78 61.96 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.079 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 83.3 m -56.27 -37.82 70.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.171 0.51 . . . . 0.0 110.304 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -70.08 -41.92 73.45 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.888 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.894 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 10.5 ptt? -78.31 -35.69 47.44 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.425 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.542 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 26.9 m -59.44 -47.02 92.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.492 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.1 mtm -65.16 -24.29 67.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 110.479 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -83.32 -41.97 17.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.514 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -86.99 -32.65 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.442 -179.235 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.508 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -82.66 -11.66 58.19 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.348 -175.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -40.67 97.96 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 175.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' OE2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 37.21 -156.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.622 1.201 . . . . 0.0 113.431 175.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -165.12 -19.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.492 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 77' ' ' GLY . 13.7 t70 -163.2 63.93 0.18 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.894 169.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.789 ' HA ' HD21 ' A' ' 15' ' ' LEU . 65.2 tt0 70.94 -18.81 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.59 0.756 . . . . 0.0 112.619 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 75' ' ' ASP . . . -73.09 86.03 0.58 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.327 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.664 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -121.25 35.29 3.68 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.468 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 65.97 -60.78 0.29 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.626 0.77 . . . . 0.0 112.258 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 106.62 107.53 3.22 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -172.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 1.9 t70 70.64 -72.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -168.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.894 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 47.5 ttt-85 165.03 -27.79 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.825 1.25 . . . . 0.0 108.532 172.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 67.04 26.19 9.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.282 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 1.012 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 13.9 tt0 -130.52 -66.79 0.75 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.188 0.518 . . . . 0.0 110.191 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 13.3 p90 -144.84 86.9 1.81 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.771 0.796 . . . . 0.0 110.348 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.754 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -74.18 71.45 1.47 Allowed Glycine 0 C--N 1.315 -0.617 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.748 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.587 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 47.4 m 66.23 2.41 2.35 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -85.17 -86.11 0.14 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.212 0.529 . . . . 0.0 110.448 174.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.903 HD11 ' HG2' ' A' ' 125' ' ' GLN . 1.7 mt -88.75 -167.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.814 ' H ' HG21 ' A' ' 89' ' ' ILE . . . -144.57 39.62 1.21 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HE1' ' A' ' 139' ' ' HIS . . . -177.42 124.41 0.94 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.638 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 96.9 165.41 32.84 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.012 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 43.3 pt -94.06 156.22 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 117.292 0.546 . . . . 0.0 112.412 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.488 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 2.2 m-20 -95.88 114.14 25.84 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 175.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.603 HG21 HD11 ' A' ' 140' ' ' ILE . 44.1 t -111.65 104.81 56.45 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.514 ' HA ' HD13 ' A' ' 137' ' ' ILE . 46.1 Cg_endo -71.32 115.26 4.21 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.349 2.033 . . . . 0.0 112.341 171.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.645 HG21 HD22 ' A' ' 158' ' ' LEU . 10.5 p -117.43 126.22 27.55 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.398 0.618 . . . . 0.0 110.277 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.44 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 24.3 Cg_exo -61.79 143.06 95.7 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.306 2.671 . . . . 0.0 112.501 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -59.2 -33.96 71.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.273 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -85.27 20.94 1.83 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -149.55 -24.52 0.28 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.415 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 106' ' ' ILE . 10.6 p -60.57 -26.55 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 120.694 0.283 . . . . 0.0 110.696 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.84 -35.89 84.65 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.255 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.79 -35.18 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 110.055 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.501 HG22 HG22 ' A' ' 97' ' ' VAL . 41.5 t -63.25 -38.66 82.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.569 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.785 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 44.7 mm -73.87 -40.87 53.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.197 0.522 . . . . 0.0 110.07 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.46 -149.52 19.36 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -75.73 -83.27 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 m -95.92 21.74 8.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.214 0.53 . . . . 0.0 110.645 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.657 ' O ' ' HD3' ' A' ' 114' ' ' LYS . . . 91.79 47.67 3.36 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -170.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -94.26 -54.14 3.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.846 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.2 tpt -67.67 -34.29 76.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.882 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.785 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 7.9 tp -67.13 -31.96 55.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.546 -177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.657 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 5.7 mptp? -79.51 -23.47 42.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.124 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HB3' ' HE3' ' A' ' 115' ' ' LYS . 22.9 mmmt -66.07 -37.27 85.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.8 mm -60.34 -42.87 92.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.519 0.675 . . . . 0.0 109.281 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -67.58 -33.13 74.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.916 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -79.29 -46.58 17.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.514 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -42.23 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.928 -172.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.402 ' HB1' HG23 ' A' ' 122' ' ' VAL . . . -92.54 -13.51 29.66 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.286 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.62 23.26 75.69 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.651 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.402 HG23 ' HB1' ' A' ' 120' ' ' ALA . 21.8 m -99.94 175.28 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.131 0.491 . . . . 0.0 111.432 -176.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.431 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 71.1 mtm180 -129.0 141.36 51.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.039 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.548 HG21 HD11 ' A' ' 113' ' ' ILE . 49.5 mm -102.38 130.0 52.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.024 0.44 . . . . 0.0 110.8 -175.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.903 ' HG2' HD11 ' A' ' 89' ' ' ILE . 6.1 tp-100 -126.62 96.86 4.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.868 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -75.55 112.78 12.25 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 169.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.762 ' NZ ' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -134.57 163.98 28.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.768 -168.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 40.76 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' OD2' HG12 ' A' ' 137' ' ' ILE . 0.6 OUTLIER -58.87 123.54 16.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.399 0.618 . . . . 0.0 111.562 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -123.14 -68.65 0.87 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.804 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.49 44.56 1.48 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.2 p -67.62 -13.83 62.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.328 -0.436 . . . . 0.0 111.714 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 119.56 -103.19 0.95 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.679 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.44 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 36.6 Cg_endo -65.75 -43.69 9.38 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.052 2.501 . . . . 0.0 114.242 -173.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -133.61 148.52 51.57 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.391 0.615 . . . . 0.0 112.089 -168.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 97' ' ' VAL . 30.7 mttm -123.44 117.28 24.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.937 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.762 ' HB ' ' NZ ' ' A' ' 127' ' ' LYS . 12.2 mm -71.93 102.22 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.123 0.487 . . . . 0.0 110.676 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.529 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -87.37 98.26 11.26 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.695 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 63.9 t-80 -72.1 127.72 33.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.056 0.455 . . . . 0.0 110.634 -172.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.607 HD12 ' HB1' ' A' ' 150' ' ' ALA . 93.9 mt -98.65 107.66 20.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.174 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.482 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 38.6 ttm -92.95 137.72 32.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.876 -176.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.26 -160.92 28.61 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.703 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.83 140.6 35.6 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.739 2.293 . . . . 0.0 111.507 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -41.54 -49.64 5.07 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.891 3.061 . . . . 0.0 114.249 -174.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -59.42 -52.1 67.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.335 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -61.61 -35.51 78.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.35 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.638 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 72.9 m -56.96 -59.46 5.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.856 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -66.92 -33.73 76.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.971 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.435 ' O ' HG13 ' A' ' 153' ' ' ILE . 4.2 t60 -60.02 -33.17 71.65 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.211 0.529 . . . . 0.0 110.018 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.607 ' HB1' HD12 ' A' ' 140' ' ' ILE . . . -78.09 -45.93 22.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.906 -176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.57 -20.74 66.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.06 0.457 . . . . 0.0 110.244 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -28.2 52.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.089 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 149' ' ' HIS . 71.6 mt -77.62 -44.93 29.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.132 0.492 . . . . 0.0 109.829 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.477 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 73.2 mt -65.49 -41.15 90.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.01 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -57.04 -42.6 80.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.346 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.95 -36.87 80.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.92 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.15 -42.18 99.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 109.989 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 97' ' ' VAL . 17.6 mt -66.55 -42.59 86.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.99 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -67.56 -34.81 77.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.888 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.2 t -65.83 -31.67 72.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.963 0.411 . . . . 0.0 110.377 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.16 19.26 4.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.564 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -91.76 44.44 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.98 0.419 . . . . 0.0 110.052 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.8 t -86.22 71.34 10.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.27 0.557 . . . . 0.0 109.718 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.4 -176.304 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 m -79.57 111.51 15.92 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 18.6 m -123.47 120.6 60.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.327 0.584 . . . . 0.0 111.098 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 4' ' ' GLN . 11.7 mm-40 -106.32 139.13 41.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.844 174.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.792 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 61.9 mt-10 -110.99 116.11 30.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.28 0.562 . . . . 0.0 111.54 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.471 ' N ' HD11 ' A' ' 6' ' ' ILE . 3.9 mp -105.79 140.13 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.43 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 86.7 mmm -87.02 106.31 17.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.996 0.426 . . . . 0.0 110.901 -176.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.464 ' CG1' HG23 ' A' ' 16' ' ' VAL . 1.8 mp -90.62 109.49 34.69 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.985 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 12' ' ' LYS . 13.3 Cg_exo -72.85 165.75 31.9 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 123.322 2.681 . . . . 0.0 111.695 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.97 148.78 34.07 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.583 ' O ' ' HB3' ' A' ' 76' ' ' GLN . . . 84.65 -58.1 5.0 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.145 -172.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.646 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 7.5 mptt -60.98 -31.0 70.6 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.644 0.259 . . . . 0.0 111.268 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.671 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.7 -38.03 53.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' HA2' ' HG2' ' A' ' 19' ' ' LYS . . . -63.26 -37.51 94.99 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.946 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 3.8 pp -80.97 -24.28 38.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.98 0.39 . . . . 0.0 110.133 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.464 HG23 ' CG1' ' A' ' 8' ' ' ILE . 96.2 t -79.77 -52.34 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.311 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.675 HG13 ' H ' ' A' ' 19' ' ' LYS . 27.8 pt -77.64 -27.45 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.287 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 95.49 8.19 58.67 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.35 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.675 ' H ' HG13 ' A' ' 17' ' ' ILE . 54.3 mmtt 42.47 58.22 3.15 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.678 0.752 . . . . 0.0 110.955 -176.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.17 -27.52 1.56 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.398 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.69 -8.02 10.18 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.127 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.678 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 32.8 tt0 -49.96 -59.21 4.09 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.436 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 23.5 m -67.27 -38.19 84.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 35' ' ' MET . 3.4 tp -65.25 -27.19 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.197 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.678 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 35.0 mttm -57.97 -54.46 46.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.19 0.519 . . . . 0.0 109.797 171.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.472 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 25.6 mt-30 -68.88 -34.28 75.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.475 -176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.675 HD13 ' HE1' ' A' ' 35' ' ' MET . 32.6 mt -70.69 -25.7 63.09 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.343 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.752 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 27.0 mt-30 -85.75 -44.07 12.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.691 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -86.11 -54.01 4.73 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.636 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 28.0 ttm180 -71.44 -42.18 68.55 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.972 0.415 . . . . 0.0 110.44 -175.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.652 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -83.32 -9.18 59.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.824 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.12 23.49 66.14 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.886 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 20.6 m -129.02 152.11 36.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.982 0.391 . . . . 0.0 110.426 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 49.9 tptt -87.74 110.19 20.27 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.675 ' HE1' HD13 ' A' ' 27' ' ' LEU . 27.9 mmm -92.7 116.39 28.97 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 52' ' ' ARG . 4.7 tp -110.08 111.66 37.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.978 0.894 . . . . 0.0 110.214 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.474 HD11 HD21 ' A' ' 51' ' ' LEU . 3.1 mm? -99.29 135.68 40.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.759 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.469 HG23 ' HD2' ' A' ' 50' ' ' PRO . 13.0 tt -86.79 99.87 8.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.839 0.828 . . . . 0.0 109.755 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.49 32.88 0.13 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.761 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.15 -29.27 16.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.444 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.66 -177.82 16.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.26 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 m -79.37 69.85 5.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.329 0.585 . . . . 0.0 110.737 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -134.52 -63.32 0.72 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.036 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.476 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 13.1 m120 -124.78 28.2 6.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.532 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -82.1 -36.17 27.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.132 0.491 . . . . 0.0 109.768 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -93.72 -11.99 30.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.533 0.682 . . . . 0.0 109.676 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 38.0 t -104.19 164.75 3.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.201 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.425 ' N ' HG11 ' A' ' 47' ' ' VAL . 4.1 p30 -55.88 151.33 11.7 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.028 170.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -130.86 125.59 21.37 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.735 -168.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HD2' HG23 ' A' ' 38' ' ' ILE . 66.3 Cg_endo -74.27 103.89 1.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.144 1.896 . . . . 0.0 110.831 172.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.792 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -84.7 127.46 34.11 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.975 -175.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.573 ' N ' HD23 ' A' ' 51' ' ' LEU . 3.5 mpt_? -102.42 113.39 26.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.004 0.43 . . . . 0.0 110.728 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.642 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 59.1 mt -83.84 112.41 21.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.512 172.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 34' ' ' LYS . 52.0 mt -104.22 120.28 54.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.17 -170.58 43.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.681 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.592 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 9.5 m-20 -68.12 152.57 96.37 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 122.688 0.395 . . . . 0.0 111.139 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.8 -54.71 3.92 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.256 2.637 . . . . 0.0 114.394 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -62.22 -48.46 79.87 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.707 0.289 . . . . 0.0 111.594 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.592 ' HD2' ' H ' ' A' ' 56' ' ' ASP . 16.8 ptpt -68.57 -34.11 75.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.771 -175.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 56' ' ' ASP . 76.7 t -65.3 -30.06 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 0.0 110.189 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.23 -48.55 12.92 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 15.6 mm100 -63.35 -39.92 95.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.433 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.672 ' HA ' ' CG ' ' A' ' 66' ' ' MET . . . -70.02 -41.22 74.59 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.842 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.1 t -55.53 -43.5 75.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.47 0.652 . . . . 0.0 109.631 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -65.16 -48.56 73.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.232 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.672 ' CG ' ' HA ' ' A' ' 63' ' ' ALA . 2.0 ppp? -67.01 -42.56 84.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.472 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.653 HG12 HD21 ' A' ' 71' ' ' LEU . 75.3 t -58.47 -49.97 80.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 122.971 0.17 . . . . 0.0 110.924 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.4 mtt -58.64 -29.86 66.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.165 0.507 . . . . 0.0 110.425 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.543 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 8.7 t70 -85.54 -35.63 20.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.044 -173.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.726 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.7 pp -86.87 -21.57 7.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.985 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.653 HD21 HG12 ' A' ' 67' ' ' VAL . 3.0 pp -86.35 2.2 48.3 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.341 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 7.4 ptp180 -64.07 -14.24 53.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.989 0.423 . . . . 0.0 109.86 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HG2' ' C ' ' A' ' 77' ' ' GLY . 8.0 tp10 -51.57 146.75 7.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.452 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -64.01 -36.58 84.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.552 -174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -168.1 112.77 0.65 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.375 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HA ' HD22 ' A' ' 15' ' ' LEU . 22.4 pt20 37.64 63.48 0.76 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.347 1.059 . . . . 0.0 113.84 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.499 ' C ' ' HG2' ' A' ' 73' ' ' GLU . . . -152.73 29.15 0.84 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.165 176.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.69 171.25 34.49 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.282 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.726 ' HD1' HG22 ' A' ' 70' ' ' ILE . 80.0 m-85 -65.81 -20.42 66.24 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 84.31 98.68 0.63 Allowed Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.636 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 4.0 t70 71.57 -82.94 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -168.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.63 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 44.4 ttt85 169.36 -36.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.197 0.599 . . . . 0.0 109.616 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 62.38 36.34 14.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.515 0.674 . . . . 0.0 110.218 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.991 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.6 tt0 -142.35 -49.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.455 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.558 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 13.1 p90 -177.04 135.47 0.2 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.96 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -115.27 -72.49 0.53 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.704 174.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.612 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 18.5 t -108.08 -4.83 17.38 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.16 0.505 . . . . 0.0 110.429 176.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.734 ' HB2' ' HZ1' ' A' ' 127' ' ' LYS . 1.4 mpt_? -129.81 172.52 11.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.662 -172.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.625 HG12 ' HB2' ' A' ' 139' ' ' HIS . 35.7 mt 73.21 -78.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 123.813 0.695 . . . . 0.0 112.243 171.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.27 44.54 96.42 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.231 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.28 78.05 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.162 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 140' ' ' ILE . . . 158.56 -129.28 2.24 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.991 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 29.4 pt -149.99 160.79 4.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 117.081 0.44 . . . . 0.0 109.847 173.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.5 125.73 45.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.342 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 39.9 t -126.2 101.88 27.96 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.443 ' HA ' HD12 ' A' ' 137' ' ' ILE . 55.9 Cg_endo -74.65 107.36 2.45 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.021 1.814 . . . . 0.0 112.057 172.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.469 HG23 HG11 ' A' ' 95' ' ' VAL . 37.8 t -98.89 128.51 32.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.006 0.432 . . . . 0.0 111.449 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.578 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 5.5 Cg_endo -47.4 129.26 16.02 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.852 3.034 . . . . 0.0 112.215 174.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.698 ' HD3' ' HB2' ' A' ' 134' ' ' PRO . 23.1 ptt180 -57.49 -32.06 66.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.372 -174.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -87.92 11.34 16.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.734 0.302 . . . . 0.0 111.196 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.664 ' HB3' HD22 ' A' ' 161' ' ' LEU . 9.3 m -127.89 -30.14 2.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.383 -176.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.39 -33.13 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.36 66.31 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.533 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.69 -37.1 12.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.08 0.467 . . . . 0.0 110.08 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.97 -41.79 93.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.713 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.637 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 34.1 mm -77.1 -45.69 29.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.518 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.64 -124.79 8.36 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.553 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -112.36 -70.39 0.81 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.028 0.442 . . . . 0.0 110.1 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.7 m -99.04 20.4 13.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.56 37.2 35.89 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.794 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -93.88 -33.4 13.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.643 0.258 . . . . 0.0 110.466 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 17.1 tpt -68.43 -41.84 79.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.403 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.638 HD13 HD12 ' A' ' 116' ' ' ILE . 10.1 tp -63.65 -21.69 29.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.614 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -80.61 -19.22 45.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -68.2 -28.97 67.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.167 0.508 . . . . 0.0 110.166 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.638 HD12 HD13 ' A' ' 113' ' ' ILE . 27.1 mt -71.67 -33.64 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.682 0.754 . . . . 0.0 109.172 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -72.18 -23.93 61.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.292 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -79.86 -40.93 27.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.564 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.4 -56.27 4.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.469 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.481 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -86.94 -23.73 25.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 111.597 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.16 26.65 43.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.703 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 141' ' ' MET . 29.8 m -95.2 164.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.669 0.271 . . . . 0.0 111.225 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.426 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 13.8 mmt180 -118.33 139.1 51.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 139' ' ' HIS . 48.5 mm -114.64 141.88 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.653 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 1.1 tp-100 -155.23 106.06 2.56 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.248 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.483 ' CE1' HD11 ' A' ' 106' ' ' ILE . 18.2 m-85 -73.39 105.0 4.58 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.888 176.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.734 ' HZ1' ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -107.25 96.25 6.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.119 -174.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 65.83 -168.63 0.21 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.759 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.26 -179.6 3.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.421 ' HA ' HD13 ' A' ' 137' ' ' ILE . 13.5 t70 -67.32 -40.6 85.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.307 0.575 . . . . 0.0 110.46 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.27 -44.69 1.75 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.6 m -66.1 -36.06 82.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.358 0.599 . . . . 0.0 110.281 175.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -146.15 178.86 23.57 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.727 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.698 ' HB2' ' HD3' ' A' ' 99' ' ' ARG . 5.8 Cg_exo -79.61 19.93 0.92 Allowed 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 123.551 2.834 . . . . 0.0 112.414 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 1.4 mp0 -83.92 147.59 27.41 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.273 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -108.91 120.9 43.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.555 -174.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 7.0 mm -73.55 123.61 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.016 0.436 . . . . 0.0 111.294 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -99.0 126.77 44.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.608 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.653 ' HB3' ' O ' ' A' ' 125' ' ' GLN . 1.5 t60 -73.87 126.85 31.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.707 HD12 ' HB2' ' A' ' 150' ' ' ALA . 82.9 mt -113.98 142.74 25.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.78 172.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.444 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 51.0 ttm -132.09 131.35 42.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.552 0.215 . . . . 0.0 110.562 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.8 -167.97 30.52 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.82 142.63 76.87 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.537 2.158 . . . . 0.0 111.477 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.91 -46.69 18.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.215 2.61 . . . . 0.0 113.529 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.46 -36.87 79.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.083 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.485 ' HA ' ' HB3' ' A' ' 149' ' ' HIS . 53.1 mtt180 -80.1 -26.43 39.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.86 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.58 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 69.9 m -60.65 -56.1 25.35 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.68 -31.42 72.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.599 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.53 ' O ' HG13 ' A' ' 153' ' ' ILE . 11.9 t60 -59.75 -33.38 71.6 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.145 0.497 . . . . 0.0 110.258 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.707 ' HB2' HD12 ' A' ' 140' ' ' ILE . . . -78.37 -42.39 30.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.388 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 93' ' ' ILE . . . -63.53 -28.42 69.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.08 0.466 . . . . 0.0 110.275 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -25.71 52.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.297 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 149' ' ' HIS . 75.3 mt -74.64 -47.6 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.666 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.1 mt -61.36 -46.18 97.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.822 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -54.45 -44.06 72.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.356 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.39 -36.13 83.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.405 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 73.5 mt -63.54 -45.55 90.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.085 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 20.7 mt -62.57 -30.02 71.01 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -79.63 -33.72 41.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.881 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.3 t -79.06 -29.06 43.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.271 -172.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.664 HD22 ' HB3' ' A' ' 101' ' ' SER . 3.2 pp -81.01 19.8 0.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -172.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -78.55 47.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.796 0.331 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.8 m -122.99 -7.23 8.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.756 0.313 . . . . 0.0 110.636 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.785 -177.437 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 5.0 m -111.83 110.6 21.03 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 4.2 p -140.79 140.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.519 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -125.69 140.66 52.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.258 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 13.0 mp0 -102.39 119.99 39.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.168 0.508 . . . . 0.0 111.623 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.685 HG13 HG23 ' A' ' 67' ' ' VAL . 39.1 mm -113.08 146.62 17.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.027 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.447 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 42.3 mtp -105.38 116.46 31.99 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.482 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.675 HG12 HG12 ' A' ' 16' ' ' VAL . 2.1 mp -97.39 109.14 48.72 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.883 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.782 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 50.8 Cg_exo -61.4 152.78 70.53 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.364 2.709 . . . . 0.0 112.558 175.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.67 144.39 57.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.17 -45.54 2.64 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -171.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.782 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -69.19 -15.65 63.44 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 110.274 174.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.53 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -54.23 -38.64 65.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.511 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 18' ' ' GLY . . . -65.89 -31.17 78.81 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.925 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.679 ' CD1' ' HA ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -91.92 -29.48 16.65 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.446 -0.443 . . . . 0.0 112.157 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 8' ' ' ILE . 89.2 t -83.78 -56.66 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 13' ' ' ALA . 32.0 pt -93.05 -21.12 6.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.864 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . 103.77 -61.74 0.43 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 23.1 tptp 169.31 -35.91 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 170.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.92 -0.36 7.08 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.224 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.647 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 133.11 0.54 4.21 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.189 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.47 ' HB2' ' HA3' ' A' ' 18' ' ' GLY . 36.3 mp0 -51.08 -54.7 22.5 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.072 0.549 . . . . 0.0 112.08 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 15' ' ' LEU . 87.3 m -81.67 -26.12 34.97 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.508 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.73 HD11 HD11 ' A' ' 27' ' ' LEU . 2.7 tp -67.75 -22.9 28.76 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.156 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.647 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 7.8 mtpm? -56.03 -54.76 41.07 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.555 169.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.614 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 45.0 mt-30 -60.6 -44.12 96.65 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.659 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.73 HD11 HD11 ' A' ' 24' ' ' ILE . 50.7 mt -64.38 -28.59 69.8 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.264 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.728 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 47.1 mt-30 -86.88 -49.09 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 111.664 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.41 -54.24 4.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.707 -171.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 94' ' ' ASP . 10.5 ttt180 -63.8 -51.82 63.06 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.781 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -70.9 -26.79 63.38 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.754 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.79 16.83 80.43 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.876 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.728 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.9 m -120.11 160.7 20.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -98.11 110.44 23.02 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.677 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 1.08 ' HB3' HD11 ' A' ' 51' ' ' LEU . 43.5 mtt -101.43 125.75 48.11 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.622 HG22 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tt -122.53 115.09 44.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.856 0.836 . . . . 0.0 110.733 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.631 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -134.69 145.18 48.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.332 -175.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.774 HG23 ' HB2' ' A' ' 42' ' ' SER . 33.5 mm -59.9 99.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.469 0.652 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -155.45 23.47 0.41 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.972 175.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -111.34 -63.78 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.269 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.43 20.67 0.27 Allowed Glycine 0 CA--C 1.517 0.206 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.736 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.774 ' HB2' HG23 ' A' ' 38' ' ' ILE . 54.6 m -90.95 -166.22 1.53 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.279 0.539 . . . . 0.0 110.781 177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.28 -27.25 24.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.546 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.4 m-20 -79.58 56.58 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.028 0.442 . . . . 0.0 110.698 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.9 p -83.1 -50.98 7.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.425 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -90.55 -21.47 21.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.525 0.678 . . . . 0.0 109.683 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 23.0 t -79.15 158.82 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.267 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -60.32 153.53 22.41 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.184 0.516 . . . . 0.0 110.525 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -123.88 135.05 25.83 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.766 -163.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.22 104.0 0.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.891 2.394 . . . . 0.0 111.843 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 1.08 HD11 ' HB3' ' A' ' 35' ' ' MET . 29.5 tp -87.6 129.44 35.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.027 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.622 ' HB2' HG22 ' A' ' 36' ' ' ILE . 7.7 mpt_? -106.73 117.61 34.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.407 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.1 mt -92.79 109.34 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.851 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.9 mt -106.11 121.54 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.72 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 177.82 -171.21 43.75 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.668 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.654 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 11.4 m-20 -64.78 156.28 79.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 122.412 0.285 . . . . 0.0 110.882 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -48.03 -54.85 4.64 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.148 2.565 . . . . 0.0 113.851 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -63.57 -31.54 72.73 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.946 0.403 . . . . 0.0 110.287 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.654 ' HD2' ' H ' ' A' ' 56' ' ' ASP . 89.7 mttt -66.84 -52.39 44.26 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.566 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.31 -28.76 45.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.299 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -79.85 -41.65 25.89 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.438 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.784 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -72.52 -25.21 61.31 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.831 178.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.704 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -83.42 -40.43 19.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.61 -33.29 72.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.574 0.702 . . . . 0.0 109.246 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.27 -47.22 62.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.681 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.704 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 2.3 ppp? -66.91 -42.13 85.93 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.58 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.685 HG23 HG13 ' A' ' 6' ' ' ILE . 27.0 m -59.63 -42.84 89.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.927 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.3 mtt -68.75 -24.76 64.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.678 ' HA ' ' HE ' ' A' ' 72' ' ' ARG . 52.3 m-20 -81.67 -40.91 22.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.818 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.857 HG23 ' HD2' ' A' ' 79' ' ' PHE . 2.8 pp -88.07 -31.58 5.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.679 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 1.6 tt -75.71 -15.26 60.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.849 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.678 ' HE ' ' HA ' ' A' ' 69' ' ' ASP . 16.4 ptp180 -60.94 -53.6 55.23 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.542 ' HG2' ' CD2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER 40.35 -169.73 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 174.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -162.09 -30.25 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.0 -1.455 . . . . 0.0 109.214 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -129.16 32.66 4.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.556 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.493 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 39.4 mt-30 64.42 16.74 10.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.062 0.458 . . . . 0.0 111.351 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -114.11 86.44 0.42 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 80' ' ' GLY . . . -98.82 40.61 2.41 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.183 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.857 ' HD2' HG23 ' A' ' 70' ' ' ILE . 24.7 m-85 69.28 -32.11 0.22 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.918 0.887 . . . . 0.0 112.818 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 93.83 95.95 1.55 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.614 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 4.1 t70 72.31 -67.15 0.27 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -170.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.774 ' HA ' HG22 ' A' ' 70' ' ' ILE . 48.0 ttt-85 178.03 -1.93 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.214 169.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 47.5 t30 67.85 -58.65 0.44 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.213 0.605 . . . . 0.0 111.64 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.801 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 36.1 mt-10 -72.92 -23.19 60.67 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -174.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.617 ' CB ' ' HB ' ' A' ' 89' ' ' ILE . 44.7 p90 172.12 140.17 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 122.912 0.485 . . . . 0.0 111.136 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.781 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -112.25 97.33 0.9 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 168.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 31' ' ' ALA . 21.8 t 71.62 -38.15 0.41 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.422 ' HG3' HH11 ' A' ' 88' ' ' ARG . 0.2 OUTLIER -89.73 -167.87 1.98 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.74 HG13 ' CG ' ' A' ' 139' ' ' HIS . 1.5 mp 67.19 -75.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 123.671 0.607 . . . . 0.0 112.3 171.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 80.23 -31.91 2.32 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.459 -0.401 . . . . 0.0 112.781 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 89' ' ' ILE . . . -148.42 118.61 0.99 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.01 -146.18 17.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.801 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 44.4 pt -140.98 160.61 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.904 0.352 . . . . 0.0 110.258 174.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.558 ' OD2' ' HA ' ' A' ' 85' ' ' TYR . 32.8 m-20 -108.04 117.88 35.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.03 174.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.793 HG21 ' HB3' ' A' ' 138' ' ' ALA . 20.7 m -117.03 106.03 48.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -176.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.493 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 32.4 Cg_endo -66.29 107.83 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.455 2.103 . . . . 0.0 111.311 172.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.85 127.96 28.89 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.936 0.398 . . . . 0.0 110.85 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.658 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 7.3 Cg_endo -52.73 129.3 31.92 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.185 2.59 . . . . 0.0 112.677 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.536 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -44.77 -40.9 6.46 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 113.988 -1.46 . . . . 0.0 113.268 -176.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.514 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 16.6 p80 -82.45 -4.87 58.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.732 -173.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.518 ' O ' HG12 ' A' ' 104' ' ' VAL . 22.6 t -124.49 8.18 8.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.327 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.45 -26.39 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.155 0.503 . . . . 0.0 110.224 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.63 -39.58 67.26 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.906 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 101' ' ' SER . 6.0 p -64.35 -24.71 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.083 0.468 . . . . 0.0 110.458 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 101' ' ' SER . 48.9 t -74.23 -45.47 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.46 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.19 -36.4 37.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.428 0.633 . . . . 0.0 110.578 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.07 -72.68 2.55 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -171.2 -71.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.8 m -95.66 20.63 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.442 0.639 . . . . 0.0 110.088 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.401 ' HA2' HG21 ' A' ' 113' ' ' ILE . . . 84.96 2.37 88.44 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.876 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -57.4 -24.8 57.67 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 15.1 tpt -89.54 -51.51 5.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.69 0.281 . . . . 0.0 110.852 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.883 HD11 HG13 ' A' ' 124' ' ' ILE . 19.5 tt -67.68 -31.54 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.735 -174.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.534 ' HA ' ' HG2' ' A' ' 117' ' ' GLN . 98.0 mttt -68.65 -19.16 64.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.673 0.273 . . . . 0.0 111.201 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -74.65 -31.06 61.83 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.107 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.0 mm -63.37 -38.4 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.703 HE22 HG12 ' A' ' 124' ' ' ILE . 4.9 mm100 -64.1 -32.21 73.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.629 -1.168 . . . . 0.0 110.704 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -87.16 -41.9 13.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.458 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.15 -48.09 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -89.13 -16.22 31.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.152 0.501 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 53.79 6.31 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.122 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 141' ' ' MET . 29.1 m -133.46 170.81 19.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -172.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.657 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 85.9 mtt180 -132.36 153.27 50.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.883 HG13 HD11 ' A' ' 113' ' ' ILE . 49.6 mm -114.71 140.44 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -172.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.969 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 52.0 tp60 -143.95 101.19 3.7 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.521 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -73.14 116.35 13.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.997 0.427 . . . . 0.0 110.574 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.66 ' O ' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -139.03 129.42 25.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.689 -177.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 61.53 -171.23 0.15 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 172.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.17 168.63 21.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.141 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.23 -11.54 54.65 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -171.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.44 -46.07 3.36 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.862 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.8 t -83.89 -1.36 54.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.362 0.601 . . . . 0.0 109.846 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -156.21 177.92 32.99 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.384 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.473 ' HG2' ' HD2' ' A' ' 99' ' ' ARG . 10.3 Cg_endo -93.43 30.27 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.711 2.94 . . . . 0.0 112.143 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.658 ' OE2' ' HA ' ' A' ' 98' ' ' PRO . 0.8 OUTLIER -81.52 152.27 27.38 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.256 0.551 . . . . 0.0 111.026 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -110.53 114.8 28.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.582 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.66 ' HB ' ' O ' ' A' ' 127' ' ' LYS . 12.5 mm -70.32 105.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.306 0.574 . . . . 0.0 110.357 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.793 ' HB3' HG21 ' A' ' 95' ' ' VAL . . . -94.3 126.95 39.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.969 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 7.3 t-160 -77.8 117.37 19.11 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.099 173.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.596 ' HB ' ' CG1' ' A' ' 93' ' ' ILE . 48.7 mt -97.98 106.57 18.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.657 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 52.9 ttm -85.73 126.63 34.12 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.219 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.15 157.81 8.5 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.496 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.98 149.78 19.92 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.699 2.266 . . . . 0.0 111.741 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.759 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 50.7 Cg_exo -39.12 -44.42 2.64 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 124.037 3.158 . . . . 0.0 114.457 -175.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.32 -40.77 87.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.079 0.466 . . . . 0.0 111.484 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -78.62 -50.61 11.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.512 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.759 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 18.8 p -61.33 -52.36 64.99 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.667 -175.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.56 -30.47 71.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.735 0.302 . . . . 0.0 111.685 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -70.83 -25.08 62.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.231 0.539 . . . . 0.0 110.461 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.522 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -79.28 -42.91 24.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.964 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.89 -30.23 68.87 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -19.95 54.44 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.915 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.5 mt -80.18 -45.13 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.54 HD13 HD12 ' A' ' 140' ' ' ILE . 61.6 mt -64.11 -45.01 97.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.342 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -56.06 -37.35 69.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.305 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.85 -43.61 90.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 110.305 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 70.3 mt -63.14 -40.33 97.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.425 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 7.7 mt -62.5 -40.83 97.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.039 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.403 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . 17.9 mt-30 -68.37 -28.9 67.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.855 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.7 t -73.72 -33.16 64.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.376 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.1 mt -92.15 19.62 6.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.391 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 159' ' ' GLN . 39.8 mmt180 -79.76 68.64 5.9 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.4 p -69.72 93.72 0.75 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.33 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.348 -175.209 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.868 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 57' ' ' PRO . 37.1 m -152.67 96.21 2.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.869 0.366 . . . . 0.0 110.155 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 70.5 t -122.52 116.63 49.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.044 0.449 . . . . 0.0 111.027 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -107.77 163.03 13.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 49.0 mt-10 -127.82 120.09 27.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.079 0.466 . . . . 0.0 111.768 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 6' ' ' ILE . 3.7 mp -111.36 140.52 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.535 -0.757 . . . . 0.0 108.969 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.488 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 39.0 ttm -90.12 122.44 33.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.811 0.339 . . . . 0.0 110.808 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 51' ' ' LEU . 1.7 mp -95.88 110.78 53.4 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.751 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.746 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 32.6 Cg_exo -65.82 146.66 83.95 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.463 2.775 . . . . 0.0 111.909 172.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.42 130.72 44.84 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.63 -40.31 2.59 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.746 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 1.3 mptm? -84.36 -30.68 25.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.952 173.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.594 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -49.54 -45.45 47.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.855 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.0 -39.59 92.12 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.467 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.651 HD22 ' HA ' ' A' ' 76' ' ' GLN . 3.5 pp -84.87 -36.39 21.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.069 0.434 . . . . 0.0 110.918 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.646 HG22 HD13 ' A' ' 71' ' ' LEU . 59.9 t -65.94 -42.79 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.682 0.277 . . . . 0.0 111.727 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.806 HG13 ' H ' ' A' ' 19' ' ' LYS . 13.9 pt -92.25 -27.13 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.033 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 99.88 0.17 56.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.643 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.806 ' H ' HG13 ' A' ' 17' ' ' ILE . 7.2 tptm 74.28 -35.66 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.139 0.975 . . . . 0.0 111.423 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.99 2.55 17.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.945 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.78 -2.76 38.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.608 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 6.8 mp0 -55.52 -44.94 77.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.555 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 88.5 m -74.16 -46.95 39.1 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.496 -177.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 35' ' ' MET . 7.6 tp -62.83 -26.58 41.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 1.3 tmtm? -55.41 -44.83 76.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.212 173.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -85.36 -20.55 29.75 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.707 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.901 HD21 ' HE3' ' A' ' 66' ' ' MET . 33.8 mt -79.38 -24.25 42.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.44 0.638 . . . . 0.0 109.494 176.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.5 mt-30 -86.03 -38.88 17.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.892 174.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -86.73 -63.06 1.37 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HD3' ' CG ' ' A' ' 94' ' ' ASP . 13.7 ttm180 -65.96 -34.21 77.59 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 110.778 -174.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -87.63 -9.74 53.38 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.024 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.01 22.7 55.84 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.484 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.6 m -126.95 148.99 31.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -89.75 109.01 20.03 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.925 ' HB3' HD13 ' A' ' 51' ' ' LEU . 7.4 mtm -98.29 117.26 32.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 52' ' ' ARG . 5.1 tp -111.29 104.7 17.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.928 0.87 . . . . 0.0 110.5 -173.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.541 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -133.98 142.28 47.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.915 -178.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.694 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 3.9 mp -68.31 100.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.159 0.504 . . . . 0.0 110.604 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 12.2 mt-30 -96.58 -56.05 2.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -121.54 95.9 4.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.089 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.44 158.56 24.95 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.829 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.7 t -88.82 85.35 6.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.972 0.415 . . . . 0.0 110.453 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -164.46 -79.07 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.021 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.445 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 3.2 m-20 -118.52 66.2 0.77 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.51 -56.3 3.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.717 -174.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -93.73 -6.01 47.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.208 1.004 . . . . 0.0 108.519 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 56.5 t -86.42 158.74 3.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.952 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -60.32 148.79 35.66 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 110.323 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.694 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 52.0 mttt -128.62 134.73 26.6 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.024 -166.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.7 121.64 3.34 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.665 2.244 . . . . 0.0 112.125 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.925 HD13 ' HB3' ' A' ' 35' ' ' MET . 53.3 tp -98.03 111.68 23.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.794 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.54 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.9 mpt_? -98.22 116.22 29.98 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.506 175.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 49.8 mt -92.14 111.19 23.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.553 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.9 mt -106.6 120.26 57.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.767 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.15 -171.51 44.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.42 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.636 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 3.7 m-20 -65.14 141.69 98.35 Favored Pre-proline 0 C--N 1.33 -0.239 0 C-N-CA 122.149 0.18 . . . . 0.0 111.332 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.49 ' HA ' HG22 ' A' ' 2' ' ' THR . 96.7 Cg_exo -43.39 -54.2 3.73 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.873 3.049 . . . . 0.0 114.234 -174.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -61.13 -41.82 97.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.666 0.27 . . . . 0.0 111.579 -174.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.963 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 18.3 ptpt -77.44 -27.16 52.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.381 -173.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 56' ' ' ASP . 91.4 t -64.56 -32.06 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.986 175.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -73.04 -52.81 12.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -61.98 -37.84 86.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.554 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.557 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -72.25 -39.15 68.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.725 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.407 ' HA ' HG22 ' A' ' 67' ' ' VAL . 42.5 t -57.73 -35.29 70.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.268 0.556 . . . . 0.0 110.076 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.63 -40.93 76.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.774 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.901 ' HE3' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -78.11 -34.95 49.8 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.494 -176.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 33.1 m -67.92 -26.3 34.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 120.811 0.338 . . . . 0.0 110.614 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.42 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 66.3 mtt -81.4 -21.36 39.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.011 0.434 . . . . 0.0 109.897 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.85 -55.31 4.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.944 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.536 ' HB ' ' H ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -70.01 -19.71 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.397 0.617 . . . . 0.0 110.48 -177.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.646 HD13 HG22 ' A' ' 16' ' ' VAL . 3.1 tt -85.77 -16.33 39.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.19 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 68' ' ' MET . 8.2 ptm180 -69.83 -8.29 47.16 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.902 -0.136 . . . . 0.0 111.306 -174.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 10.3 tp10 -59.21 -94.87 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 O-C-N 123.586 0.554 . . . . 0.0 111.99 -172.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 37.8 ttp180 159.59 -59.74 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -86.97 147.15 25.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.272 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.651 ' HA ' HD22 ' A' ' 15' ' ' LEU . 29.7 tt0 -54.12 99.87 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.162 0.506 . . . . 0.0 110.834 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.39 -78.6 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.308 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 59.48 -117.26 10.57 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.536 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 90.7 m-85 -127.73 -55.32 1.31 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.497 ' O ' HG13 ' A' ' 70' ' ' ILE . . . 135.98 -79.97 0.31 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 82' ' ' ARG . 6.2 p-10 -103.25 2.78 34.74 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.828 0.823 . . . . 0.0 109.237 170.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.483 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 20.4 ttt180 86.86 -31.21 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.587 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.4 t30 51.5 71.99 0.41 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 18.0 tt0 -176.36 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.003 -171.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.841 ' HA ' HD13 ' A' ' 89' ' ' ILE . 34.8 p90 -171.88 -37.63 0.02 OUTLIER 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 175.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.57 -91.69 0.58 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.818 -175.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.963 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 46.1 p -117.16 -11.68 10.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.588 0.708 . . . . 0.0 111.01 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.694 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 46.9 mtt180 -113.65 -163.98 0.9 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.571 -169.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.841 HD13 ' HA ' ' A' ' 85' ' ' TYR . 75.6 mt 60.66 -84.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.678 0.611 . . . . 0.0 112.274 168.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.17 45.4 81.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.857 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.447 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 150.82 90.62 0.08 OUTLIER Glycine 0 CA--C 1.518 0.261 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.46 -149.64 18.71 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.721 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 23.7 pt -136.77 167.14 24.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 117.605 0.703 . . . . 0.0 111.107 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.513 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . 2.1 p30 -105.43 141.8 36.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.373 173.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.845 HG22 ' HB1' ' A' ' 138' ' ' ALA . 6.2 m -136.92 102.86 9.14 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.076 0.465 . . . . 0.0 111.451 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HB3' HD13 ' A' ' 137' ' ' ILE . 36.1 Cg_endo -67.2 107.86 1.44 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.893 2.395 . . . . 0.0 111.739 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.629 HG22 HG21 ' A' ' 105' ' ' VAL . 7.6 p -105.79 131.2 21.95 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.247 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.46 ' HG3' ' NH2' ' A' ' 162' ' ' ARG . 84.6 Cg_exo -45.28 125.91 7.66 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.673 2.915 . . . . 0.0 113.104 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -61.46 -21.03 63.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.947 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -92.04 8.11 39.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.704 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 105' ' ' VAL . 41.7 m -141.88 0.44 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 106' ' ' ILE . 10.1 p -66.84 -33.37 62.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.393 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.18 -29.9 76.49 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.894 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.08 -40.22 58.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 109.988 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.629 HG21 HG22 ' A' ' 97' ' ' VAL . 40.4 t -64.22 -41.6 92.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.303 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.723 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.1 mm -67.07 -49.28 74.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.487 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.38 69.16 1.42 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.126 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 57.43 -88.85 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.522 0.729 . . . . 0.0 112.309 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.0 t -97.69 18.81 14.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.987 0.422 . . . . 0.0 110.971 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.66 22.92 41.16 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.057 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -72.91 -43.91 61.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.047 0.451 . . . . 0.0 110.839 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.449 ' HE2' HD13 ' A' ' 157' ' ' LEU . 16.6 tpt -74.05 -40.29 62.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.632 -177.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.723 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.5 tp -66.47 -32.67 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.815 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -80.85 -22.63 39.72 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.991 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -37.25 84.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.9 mt -63.28 -40.97 91.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 75.1 mt-30 -63.05 -32.85 74.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.29 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -84.6 -40.1 17.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.987 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.78 -42.04 28.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.361 -172.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.66 2.41 47.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.513 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.98 32.49 82.31 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.464 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.91 171.6 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.008 0.432 . . . . 0.0 111.263 -175.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.832 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 3.2 mmp_? -124.1 152.28 42.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.6 mm -117.08 133.47 63.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.087 0.47 . . . . 0.0 111.65 -175.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.572 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 23.8 tp60 -139.37 99.63 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.368 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -74.9 140.6 43.91 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 121.932 -0.48 . . . . 0.0 109.792 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.579 ' HD3' HH11 ' A' ' 88' ' ' ARG . 0.7 OUTLIER -153.11 138.2 17.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.146 -175.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.405 ' HB2' ' NH1' ' A' ' 88' ' ' ARG . 14.2 mm100 51.48 -164.65 0.06 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.438 0.461 . . . . 0.0 111.254 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 46.28 39.63 6.52 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.024 0.827 . . . . 0.0 111.777 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -102.0 80.54 2.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.812 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.09 -14.9 44.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.051 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.8 p -64.06 -66.62 0.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.133 0.492 . . . . 0.0 111.125 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -99.24 -174.03 31.41 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.494 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.69 -21.61 14.45 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.858 2.372 . . . . 0.0 112.204 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 98' ' ' PRO . 5.3 mp0 -121.86 159.93 25.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.043 0.449 . . . . 0.0 111.019 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -121.77 117.53 26.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.542 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 30.1 mm -71.42 102.45 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.244 0.545 . . . . 0.0 111.968 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.845 ' HB1' HG22 ' A' ' 95' ' ' VAL . . . -90.5 142.48 27.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.558 176.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.584 ' NE2' HG23 ' A' ' 89' ' ' ILE . 6.0 t-160 -91.23 115.66 28.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.689 HD12 ' HB3' ' A' ' 150' ' ' ALA . 47.3 mt -94.15 113.98 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.25 172.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.832 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 43.8 ttm -98.95 132.84 43.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.575 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.17 -175.14 31.74 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.925 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.93 145.91 75.9 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.681 2.254 . . . . 0.0 111.592 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.603 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 96.8 Cg_exo -44.68 -48.63 10.23 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.523 2.816 . . . . 0.0 113.869 -173.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.9 -38.69 79.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.936 0.398 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.56 -37.33 21.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.874 -174.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.603 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 29.4 p -57.74 -47.83 81.34 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -69.22 -32.95 72.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.683 0.277 . . . . 0.0 110.655 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -64.69 -27.78 69.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.689 ' HB3' HD12 ' A' ' 140' ' ' ILE . . . -77.19 -29.77 54.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.9 0.381 . . . . 0.0 110.704 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.69 -25.32 66.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.839 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -78.29 -20.32 51.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.469 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.5 mt -79.77 -39.89 20.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.28 0.562 . . . . 0.0 109.56 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.559 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 53.2 mt -71.17 -51.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.824 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -58.07 -32.21 67.82 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.995 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.24 -32.29 72.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.245 0.545 . . . . 0.0 110.462 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.449 HD13 ' HE2' ' A' ' 112' ' ' MET . 86.6 mt -78.8 -44.44 23.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.814 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.868 ' HA ' HD22 ' A' ' 161' ' ' LEU . 57.6 mt -64.12 -26.61 68.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.117 -174.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -74.22 -15.28 61.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.831 0.348 . . . . 0.0 110.732 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.571 ' HB3' HD11 ' A' ' 161' ' ' LEU . 20.5 t -79.68 -60.3 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.464 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.868 HD22 ' HA ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -73.98 21.51 0.09 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.46 ' NH2' ' HG3' ' A' ' 98' ' ' PRO . 35.1 mmt180 -97.63 40.66 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 169.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.3 m -67.23 132.87 48.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.806 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.316 178.21 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 14.0 m -92.86 89.38 6.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.853 0.358 . . . . 0.0 110.148 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 22.4 m -124.85 145.77 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.27 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 73.1 mm-40 -130.42 150.78 51.49 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.523 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 43.6 mt-10 -111.21 121.93 46.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.908 0.385 . . . . 0.0 111.505 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.426 ' N ' HD11 ' A' ' 6' ' ' ILE . 4.4 mp -106.06 140.58 23.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.37 110.09 20.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.444 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.67 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -98.36 111.48 59.9 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.151 0.5 . . . . 0.0 111.084 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -62.55 151.87 80.83 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.707 2.938 . . . . 0.0 112.789 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.36 133.45 46.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.4 -49.9 1.02 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -167.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.5 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 13.9 mptt -69.08 -32.71 72.35 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 170.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.672 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -50.99 -35.09 31.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.415 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.41 ' CA ' ' HG2' ' A' ' 19' ' ' LYS . . . -64.3 -38.05 95.34 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.489 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.3 pp -89.06 -21.17 23.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.711 0.255 . . . . 0.0 111.18 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.67 HG11 HG12 ' A' ' 8' ' ' ILE . 96.6 t -82.58 -41.35 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.849 HG22 ' HG3' ' A' ' 39' ' ' GLN . 11.2 pt -92.25 -22.68 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 121.52 -0.738 . . . . 0.0 110.912 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.631 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 92.69 16.55 48.37 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.377 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 66.0 mmtt 48.64 50.82 16.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.911 0.484 . . . . 0.0 111.297 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.91 -28.49 1.57 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.096 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.25 -13.94 2.78 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.006 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.755 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 1.2 mm-40 -43.7 -55.28 4.49 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.631 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 73.8 m -75.11 -35.11 61.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.49 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.774 HD13 HD21 ' A' ' 37' ' ' LEU . 1.7 tp -68.35 -26.78 34.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.613 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.755 ' HD3' ' HA ' ' A' ' 22' ' ' GLU . 14.3 mtpp -55.04 -51.89 64.88 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.483 0.659 . . . . 0.0 109.998 174.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.414 ' HB2' ' CG ' ' A' ' 81' ' ' ASP . 23.1 mt-30 -81.63 -31.72 32.27 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.887 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.623 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 83.8 mt -66.83 -23.43 66.04 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.742 -0.599 . . . . 0.0 110.479 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.621 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 24.1 mt-30 -84.81 -46.46 11.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.13 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.739 ' HB3' ' O ' ' A' ' 130' ' ' ASP . 15.2 mm-40 -86.44 -56.69 3.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -175.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.467 ' HA ' ' OE1' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -57.87 -41.97 83.58 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.144 0.497 . . . . 0.0 110.223 -178.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.683 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -86.79 -6.46 58.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.533 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.23 23.22 52.46 Favored Glycine 0 CA--C 1.517 0.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 113.52 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.0 m -132.21 153.88 39.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.893 0.377 . . . . 0.0 110.449 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -90.93 109.52 20.75 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.623 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 47.8 mtt -95.37 113.51 25.19 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 tp -110.96 106.87 21.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 122.027 0.918 . . . . 0.0 110.152 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.804 HD22 ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -132.99 142.12 48.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.254 -177.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.756 HG22 ' HB2' ' A' ' 43' ' ' GLN . 71.8 mt -86.14 101.6 10.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.726 0.298 . . . . 0.0 111.09 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.849 ' HG3' HG22 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -134.69 -26.51 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.291 177.018 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -88.16 -34.13 17.95 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.4 146.78 34.88 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.75 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -79.71 38.8 0.39 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.756 ' HB2' HG22 ' A' ' 38' ' ' ILE . 48.8 mt-30 -106.38 -49.6 3.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.111 0.482 . . . . 0.0 110.345 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -131.45 30.96 4.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.488 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -70.58 -40.28 73.37 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.022 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -93.84 -26.17 17.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.094 0.473 . . . . 0.0 110.288 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.3 169.57 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.629 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.28 151.95 26.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.985 0.421 . . . . 0.0 110.415 172.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 11.6 mptt -108.64 130.87 22.22 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.024 -171.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -88.88 103.95 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.685 2.257 . . . . 0.0 111.4 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.804 ' HG ' HD22 ' A' ' 37' ' ' LEU . 5.7 tt -87.92 109.7 19.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.868 -174.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.3 mpt_? -97.23 115.43 27.6 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.697 0.284 . . . . 0.0 110.51 175.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 72.7 mt -87.71 115.67 28.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.054 175.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.415 HG12 ' CG1' ' A' ' 3' ' ' VAL . 32.5 mt -104.13 120.74 54.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 172.22 -170.78 43.76 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.62 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.421 ' HB3' ' HD2' ' A' ' 59' ' ' LYS . 5.5 t70 -65.79 140.42 97.29 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.229 174.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -43.39 -49.45 7.52 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.252 2.635 . . . . 0.0 114.308 -176.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.38 -36.55 84.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.409 0.623 . . . . 0.0 110.204 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.568 ' HG2' ' HB2' ' A' ' 87' ' ' SER . 45.8 mttp -68.95 -44.0 73.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.9 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -59.3 -34.41 53.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.047 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.543 HE21 ' C ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -72.15 -52.2 17.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.545 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.773 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -59.93 -32.35 70.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.251 0.548 . . . . 0.0 110.477 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.73 -44.54 14.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.057 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.651 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.9 p -59.5 -33.9 71.92 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 111.272 -175.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.28 -32.78 61.13 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.239 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.569 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 14.2 ptt? -84.4 -32.82 23.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.344 -175.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.655 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 34.9 m -61.0 -31.79 50.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.425 175.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.651 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 36.6 mtm -81.26 -35.36 31.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 175.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.569 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 30.8 t70 -64.66 -40.66 95.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.205 -175.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.55 HG21 ' O ' ' A' ' 66' ' ' MET . 0.2 OUTLIER -87.79 -22.21 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.009 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.655 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -83.93 -24.41 30.72 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.298 -178.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.4 1.17 3.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 9.8 tp10 -58.07 150.5 20.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.799 173.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 74' ' ' ARG . 44.3 ttt-85 -79.49 59.43 2.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.312 0.577 . . . . 0.0 110.187 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.475 ' CG ' ' HZ1' ' A' ' 12' ' ' LYS . 48.5 m-20 64.38 75.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.439 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -156.98 -71.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.931 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . -172.93 -36.53 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.768 -177.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.01 -97.99 2.22 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.988 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.51 -35.31 1.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.872 0.368 . . . . 0.0 111.039 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.55 67.61 0.64 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.414 ' CG ' ' HB2' ' A' ' 26' ' ' GLN . 5.8 m-20 61.97 30.7 18.09 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 122.026 0.917 . . . . 0.0 109.998 -174.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.512 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 35.5 ttt85 73.99 -40.23 0.45 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.035 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 t30 66.79 11.56 8.33 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.383 0.611 . . . . 0.0 110.601 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.705 ' HG3' ' O ' ' A' ' 92' ' ' GLY . 42.7 tt0 -115.83 -39.49 3.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.033 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.619 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 4.7 p90 -176.13 -157.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.697 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -176.2 -28.58 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.568 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 20.4 p -165.41 -48.63 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -73.66 173.36 9.88 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.034 169.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.792 ' HA ' ' CE1' ' A' ' 139' ' ' HIS . 65.5 mt 74.49 -77.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 O-C-N 123.538 0.524 . . . . 0.0 111.539 178.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.71 40.94 49.55 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.367 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.634 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 144.93 98.79 0.25 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.741 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 135.9 -138.79 10.19 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.689 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 29.6 pt -143.67 158.35 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 117.109 0.454 . . . . 0.0 110.493 173.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.609 ' OD2' HG23 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -93.4 117.84 30.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.021 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.934 HG22 HD13 ' A' ' 140' ' ' ILE . 75.2 t -116.8 95.29 46.19 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.719 -168.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.543 ' HA ' HD11 ' A' ' 137' ' ' ILE . 50.8 Cg_endo -72.22 113.51 3.72 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.037 1.825 . . . . 0.0 111.893 172.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.601 HG23 HG22 ' A' ' 105' ' ' VAL . 10.4 p -116.84 133.84 23.03 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -48.43 128.98 18.75 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.202 2.602 . . . . 0.0 112.226 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.851 ' HG2' ' HG3' ' A' ' 136' ' ' LYS . 14.7 mtp180 -63.5 -44.1 95.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.414 -171.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.02 6.44 3.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.871 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.444 ' O ' HG11 ' A' ' 104' ' ' VAL . 4.4 m -132.51 1.92 3.77 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.834 0.35 . . . . 0.0 110.761 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 99' ' ' ARG . 10.9 p -75.42 -19.7 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 110.671 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.77 -40.67 95.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.842 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 101' ' ' SER . 8.5 p -73.15 -29.03 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.337 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 97' ' ' VAL . 64.6 t -66.94 -41.75 87.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.775 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.744 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 40.7 mm -72.51 -38.11 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.935 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.5 38.65 5.24 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.039 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.7 ttp-105 66.33 -75.36 0.05 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.215 0.606 . . . . 0.0 111.821 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.3 p -99.99 12.5 36.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.091 0.472 . . . . 0.0 110.694 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.72 40.49 7.18 Favored Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.203 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -91.91 -32.07 15.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.116 0.484 . . . . 0.0 110.412 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.544 ' O ' HG12 ' A' ' 116' ' ' ILE . 5.9 tpt -89.64 -41.56 11.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.521 -171.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.744 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 6.2 tp -59.81 -25.99 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.33 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' A' ' 114' ' ' LYS . 10.1 mmpt? -73.32 -45.33 55.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.924 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.95 -22.44 60.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.917 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 112' ' ' MET . 37.0 mm -59.42 -44.29 92.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.583 HE21 ' HB ' ' A' ' 124' ' ' ILE . 65.0 mt-30 -68.01 -25.5 65.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.26 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.7 -46.75 16.52 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.025 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -78.44 -52.68 8.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.317 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.551 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -81.07 -19.34 43.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.367 -176.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.35 26.35 63.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.629 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.3 m -95.84 161.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.377 0.608 . . . . 0.0 112.109 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.804 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 6.7 mpt_? -108.68 135.15 50.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.642 HG22 HD12 ' A' ' 113' ' ' ILE . 43.2 mm -116.29 129.83 72.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 1.048 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -143.51 169.56 17.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.186 168.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -117.29 104.28 10.99 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.871 ' HD2' ' HG3' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -94.83 -12.91 26.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -165.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.871 ' HG3' ' HD2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER 166.73 140.45 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.675 0.79 . . . . 0.0 109.055 173.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.57 ' OD2' ' HG2' ' A' ' 136' ' ' LYS . 1.3 m-20 -90.59 46.29 1.32 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.987 0.179 . . . . 0.0 111.059 -174.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.739 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 30.8 t70 56.57 -90.98 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -167.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 139.79 -22.66 2.81 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.499 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.5 p -113.22 -36.4 5.04 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.802 0.334 . . . . 0.0 110.334 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -87.31 159.24 30.8 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.393 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 87.6 Cg_endo -87.73 36.53 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.321 2.68 . . . . 0.0 112.656 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -130.89 156.43 45.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.932 0.396 . . . . 0.0 111.028 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.851 ' HG3' ' HG2' ' A' ' 99' ' ' ARG . 48.9 mttm -110.03 118.51 36.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.485 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 10.6 mm -77.34 120.53 28.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.041 0.448 . . . . 0.0 112.207 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.69 36.18 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.47 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 1.048 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 12.7 t-160 -85.15 104.71 15.28 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.934 HD13 HG22 ' A' ' 95' ' ' VAL . 60.5 mt -88.35 118.27 33.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.221 170.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.804 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 41.4 ttm -109.49 127.39 54.39 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 158.56 -160.59 31.12 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 16.3 Cg_exo -68.73 139.99 45.52 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.786 2.324 . . . . 0.0 110.855 174.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 143' ' ' PRO . 75.8 Cg_exo -50.56 -32.54 35.58 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.138 3.225 . . . . 0.0 114.139 -172.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.82 -44.61 66.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.789 0.328 . . . . 0.0 110.556 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.551 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 55.7 mtt-85 -70.76 -27.72 64.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.291 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.741 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 71.2 m -57.41 -56.05 26.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.27 175.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.08 -31.81 68.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.36 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.535 ' HB3' ' HA ' ' A' ' 146' ' ' ARG . 30.9 t60 -55.95 -33.1 64.43 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.265 0.555 . . . . 0.0 110.313 173.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.689 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -78.24 -45.01 24.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.506 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.19 -24.56 67.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.403 0.621 . . . . 0.0 110.304 176.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -76.58 -26.27 54.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.106 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.564 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 68.5 mt -78.21 -40.89 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.503 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 73.6 mt -59.55 -43.17 90.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.064 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -57.06 -39.34 74.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.011 0.434 . . . . 0.0 110.666 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -69.91 -33.09 71.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.303 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 70.3 mt -66.61 -40.41 88.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.087 0.47 . . . . 0.0 110.335 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 56.3 mt -66.56 -28.73 68.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.854 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -83.36 -16.12 47.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.673 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 44.4 m -73.25 -20.6 60.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.557 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.43 0.46 1.04 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.845 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -68.92 -50.81 46.13 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.6 m -162.81 117.27 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.514 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.474 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.318 -179.65 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 112.071 -0.412 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.492 HG21 ' HA ' ' A' ' 57' ' ' PRO . 24.0 m -82.05 92.88 6.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.302 0.572 . . . . 0.0 110.945 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 12.1 p -125.65 121.98 61.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.858 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -109.99 150.74 28.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.759 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.763 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 39.1 mt-10 -116.06 123.36 47.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.439 0.638 . . . . 0.0 111.959 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -114.11 144.46 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.992 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.401 ' SD ' ' HB2' ' A' ' 48' ' ' ASP . 33.3 tpp -87.91 124.11 33.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.963 0.411 . . . . 0.0 111.514 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.602 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.7 mp -104.24 109.05 61.94 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.86 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.598 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 52.7 Cg_exo -61.29 147.25 96.08 Favored 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 123.596 2.864 . . . . 0.0 112.962 175.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.7 124.92 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.65 -39.14 2.99 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -169.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.598 ' HB2' ' HB2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -79.71 -31.75 41.23 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.104 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -53.67 -34.34 58.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.881 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.03 -39.12 91.53 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.581 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.1 pp -89.7 -22.84 22.03 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.553 -0.381 . . . . 0.0 111.075 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.532 HG21 HD13 ' A' ' 71' ' ' LEU . 96.6 t -78.52 -46.83 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 13' ' ' ALA . 22.0 pt -91.2 -21.14 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.086 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.78 -0.73 59.44 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.759 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.656 ' H ' HG13 ' A' ' 17' ' ' ILE . 15.6 tptp 70.0 -52.33 0.63 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.975 0.91 . . . . 0.0 110.557 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.72 8.68 73.99 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.16 5.4 76.54 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.194 -0.526 . . . . 0.0 113.082 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.895 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 10.2 pt-20 -73.31 -27.57 61.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.473 HG22 ' C ' ' A' ' 80' ' ' GLY . 90.3 m -77.43 -43.67 31.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.899 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.534 ' HA ' HD13 ' A' ' 27' ' ' LEU . 6.2 tp -62.81 -24.21 35.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 CA-C-O 120.834 0.349 . . . . 0.0 110.525 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.895 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 77.9 mttt -60.85 -50.66 72.55 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.141 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.446 ' CB ' ' HB2' ' A' ' 81' ' ' ASP . 39.2 mt-30 -71.54 -31.75 67.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.107 -177.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.646 HD11 ' HE2' ' A' ' 35' ' ' MET . 47.7 mt -68.44 -27.58 66.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 110.611 176.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.1 mt-30 -84.65 -47.55 10.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.295 0.569 . . . . 0.0 110.565 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.912 ' HB3' ' HA3' ' A' ' 131' ' ' GLY . 21.4 mm-40 -84.02 -53.37 5.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.206 -171.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.662 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 26.3 ttm180 -65.6 -44.47 86.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.877 ' HB3' ' HE2' ' A' ' 66' ' ' MET . . . -80.66 -7.19 59.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.316 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.77 9.34 38.74 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.763 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.2 m -109.15 172.16 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.95 0.375 . . . . 0.0 110.362 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -113.43 109.98 19.56 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.844 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -95.19 112.82 24.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.477 HG22 ' HB2' ' A' ' 52' ' ' ARG . 6.1 tp -111.11 100.67 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 122.392 1.091 . . . . 0.0 110.667 -177.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.873 ' HG ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -134.38 143.91 47.9 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.634 178.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.619 ' H ' HD13 ' A' ' 38' ' ' ILE . 4.0 mp -62.51 100.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.886 0.374 . . . . 0.0 110.237 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -87.36 -77.21 0.34 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -104.85 86.68 2.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.224 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . -144.28 163.12 27.85 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.021 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 m -62.54 -28.74 70.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -82.16 -78.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.39 . . . . 0.0 111.77 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.621 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 76.2 m-20 -110.34 56.25 0.63 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.874 -171.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 9.3 t -80.19 -45.43 18.08 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -94.01 -26.52 16.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.824 0.821 . . . . 0.0 109.026 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.621 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 57.3 t -78.89 159.86 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.009 -175.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.401 ' HB2' ' SD ' ' A' ' 7' ' ' MET . 3.3 p-10 -55.94 151.33 11.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -126.71 129.83 23.98 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.509 -166.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.06 112.99 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.846 2.364 . . . . 0.0 112.108 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.873 HD22 ' HG ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -81.37 110.52 16.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.973 -176.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.543 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.6 mpt_? -98.77 107.46 19.91 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.42 174.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.3 mt -91.43 113.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.053 176.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.0 mt -103.77 123.12 57.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.806 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.4 -171.45 44.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.267 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 9.7 t70 -71.34 139.14 84.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.492 ' HA ' HG21 ' A' ' 2' ' ' THR . 30.3 Cg_exo -34.82 -47.06 0.62 Allowed 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 124.07 3.18 . . . . 0.0 114.99 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -61.81 -40.64 95.95 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.821 0.344 . . . . 0.0 111.281 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 56' ' ' ASP . 19.7 ptpt -82.14 -31.04 30.76 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.95 -175.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.98 -30.68 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.546 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -52.21 14.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.878 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -65.59 -23.68 66.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.708 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.665 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -81.21 -51.32 8.55 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.997 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.496 ' SG ' HD13 ' A' ' 53' ' ' ILE . 94.5 m -54.11 -40.81 67.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.272 0.558 . . . . 0.0 109.978 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -58.54 -53.28 60.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.822 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.877 ' HE2' ' HB3' ' A' ' 31' ' ' ALA . 6.6 ptt? -64.43 -40.81 96.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.89 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 63' ' ' ALA . 86.9 t -56.53 -47.64 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.531 0.205 . . . . 0.0 110.812 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.1 mtt -69.87 -26.9 64.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.956 0.408 . . . . 0.0 110.89 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.526 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -85.36 -27.91 25.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.745 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.7 pp -90.14 -32.64 5.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 O-C-N 121.71 -0.619 . . . . 0.0 111.788 175.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.573 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 4.2 tt -71.98 -12.5 61.27 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.604 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -67.36 -10.42 50.91 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.256 -0.278 . . . . 0.0 111.22 177.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.828 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 9.2 tp10 -56.57 131.13 47.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.136 0.494 . . . . 0.0 110.297 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -66.67 -44.57 81.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.888 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.1 t0 172.88 92.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.869 0.73 . . . . 0.0 109.54 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -176.19 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.926 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.828 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . 160.78 131.25 1.2 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.169 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -87.89 58.55 4.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.154 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.605 ' HD2' HG22 ' A' ' 70' ' ' ILE . 78.5 m-85 57.72 8.84 0.73 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.212 0.605 . . . . 0.0 112.416 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.473 ' C ' HG22 ' A' ' 23' ' ' THR . . . 70.06 7.34 59.41 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.581 -0.342 . . . . 0.0 113.087 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.662 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.2 OUTLIER 170.71 -62.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.107 0.479 . . . . 0.0 109.781 -172.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.745 ' HA ' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER 163.71 -45.02 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.446 -173.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 57.63 72.37 0.52 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.388 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 1.022 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 24.8 tt0 -171.34 -68.56 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.749 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.34 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.634 ' H ' ' HD2' ' A' ' 82' ' ' ARG . 0.9 OUTLIER -136.18 -95.7 0.24 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.527 -0.733 . . . . 0.0 111.926 178.011 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . 84.96 92.03 0.79 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 38.0 t 65.49 6.34 3.7 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.709 0.404 . . . . 0.0 110.893 -175.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.748 ' HG3' ' HD2' ' A' ' 127' ' ' LYS . 3.0 mmp_? -132.66 171.61 13.62 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.102 -173.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.953 HD12 ' HG2' ' A' ' 125' ' ' GLN . 24.3 mm 28.95 -83.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 125.725 1.891 . . . . 0.0 115.144 169.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.515 ' HA2' ' CD1' ' A' ' 85' ' ' TYR . . . 86.49 36.18 9.85 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -172.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.18 98.23 0.11 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.783 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 112.0 161.66 16.22 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -174.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.022 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 40.0 pt -93.98 158.77 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -172.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.456 ' CG ' HG23 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -102.55 108.07 19.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.015 179.481 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 27.5 t -101.11 105.12 37.07 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.426 ' CA ' HD11 ' A' ' 137' ' ' ILE . 56.9 Cg_endo -75.06 108.12 2.64 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.047 1.832 . . . . 0.0 111.885 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.701 HG12 HD22 ' A' ' 158' ' ' LEU . 47.2 t -101.65 127.76 30.58 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.997 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.602 ' HD2' HD23 ' A' ' 158' ' ' LEU . 74.3 Cg_exo -41.59 132.97 3.72 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.803 3.002 . . . . 0.0 112.734 171.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.515 ' HD3' ' HB2' ' A' ' 134' ' ' PRO . 32.6 ptt180 -51.34 -34.92 35.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.562 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -92.5 4.69 53.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.352 -177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 98' ' ' PRO . 19.6 m -122.44 -18.55 6.68 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.622 ' HA ' HG13 ' A' ' 97' ' ' VAL . 14.2 p -59.1 -34.1 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.623 0.249 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.53 -30.0 75.74 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.798 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.78 -33.79 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.055 0.455 . . . . 0.0 109.868 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.53 -36.09 76.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.01 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.735 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 37.7 mm -75.23 -46.04 39.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.266 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.45 -127.19 7.49 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.448 ' HA ' ' NE ' ' A' ' 108' ' ' ARG . 4.2 mmp_? -100.39 -65.38 0.97 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.7 m -105.64 -20.96 13.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.514 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.17 50.18 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.127 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -93.86 -57.78 2.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.703 0.287 . . . . 0.0 110.472 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.565 ' HA ' ' HD3' ' A' ' 115' ' ' LYS . 14.2 tpt -59.82 -36.43 76.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.367 -174.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.735 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.6 tp -65.78 -32.39 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -86.43 -19.76 29.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.308 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' A' ' 112' ' ' MET . 26.5 mtpp -66.79 -35.68 80.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.297 174.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 112' ' ' MET . 30.1 mm -62.89 -38.51 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.198 0.523 . . . . 0.0 109.629 175.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -64.69 -34.01 77.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.675 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -82.36 -38.64 23.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.277 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.9 -55.8 4.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.002 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.85 -25.38 22.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.558 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.97 32.9 19.77 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.981 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 m -114.69 164.1 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.094 0.473 . . . . 0.0 111.449 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -109.87 163.17 13.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.601 HG22 HD12 ' A' ' 113' ' ' ILE . 45.3 mm -123.76 124.36 69.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.048 0.452 . . . . 0.0 111.492 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.953 ' HG2' HD12 ' A' ' 89' ' ' ILE . 50.5 tp60 -115.18 112.96 23.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.034 177.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -87.64 106.04 17.76 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.365 0.602 . . . . 0.0 109.566 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.748 ' HD2' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -107.46 -159.28 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.753 -178.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 128' ' ' GLN . 7.2 tp-100 -71.65 63.66 0.43 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.298 0.57 . . . . 0.0 112.099 -176.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.492 ' OD2' ' HG2' ' A' ' 136' ' ' LYS . 0.9 OUTLIER 48.84 -163.82 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 170.035 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.557 ' OD2' HG22 ' A' ' 132' ' ' THR . 16.3 t70 -88.05 -65.53 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.368 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.912 ' HA3' ' HB3' ' A' ' 29' ' ' GLU . . . 132.3 -48.12 0.98 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.775 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.557 HG22 ' OD2' ' A' ' 130' ' ' ASP . 13.9 t -72.57 -12.23 60.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.413 0.607 . . . . 0.0 111.11 -173.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -163.92 -156.15 8.64 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.779 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.515 ' HB2' ' HD3' ' A' ' 99' ' ' ARG . 92.4 Cg_endo -81.33 9.49 3.84 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.802 2.335 . . . . 0.0 112.771 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -75.37 149.24 38.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 111.131 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.492 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 60.1 mttm -124.93 123.16 39.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.996 -175.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.686 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 40.0 mm -65.43 111.25 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.954 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -90.84 91.07 8.2 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 164.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.624 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 28.0 t60 -71.18 115.86 10.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.228 0.537 . . . . 0.0 111.08 -169.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.761 HD13 HD13 ' A' ' 154' ' ' ILE . 96.4 mt -79.74 107.79 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.222 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.482 ' HB2' ' HD2' ' A' ' 139' ' ' HIS . 21.9 ttp -103.96 128.12 51.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.13 -172.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.26 -156.4 27.21 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.41 137.79 44.22 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.669 2.246 . . . . 0.0 111.705 177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -45.56 -55.07 3.81 Favored 'Trans proline' 0 N--CA 1.474 0.378 0 C-N-CA 123.543 2.828 . . . . 0.0 113.978 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -64.52 -32.86 74.68 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.798 0.333 . . . . 0.0 111.03 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -72.5 -36.06 68.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.783 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 74.5 m -60.72 -54.5 44.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.44 174.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.565 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 4.7 mm-40 -54.97 -42.04 71.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.739 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -59.65 -31.61 69.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.401 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.705 ' HB2' HD12 ' A' ' 140' ' ' ILE . . . -79.22 -35.15 42.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.365 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -70.71 -18.71 62.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.644 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.565 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 9.8 mpt_? -77.57 -17.3 58.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.977 0.418 . . . . 0.0 109.975 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.93 -50.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.913 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.761 HD13 HD13 ' A' ' 140' ' ' ILE . 38.7 mt -71.64 -57.18 8.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.734 -173.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 159' ' ' GLN . 3.9 m-20 -59.07 -28.65 66.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.881 0.372 . . . . 0.0 110.813 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.93 -47.32 80.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.428 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 4.4 pp -76.59 -20.91 56.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.326 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.701 HD22 HG12 ' A' ' 97' ' ' VAL . 33.6 mt -67.91 -33.64 75.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.198 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 155' ' ' ASN . 61.9 mm-40 -67.66 -30.49 70.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 109.67 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 157' ' ' LEU . 49.8 m -64.12 -23.08 67.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.596 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.5 mt -111.1 2.77 18.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.934 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -111.24 59.38 0.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.095 0.474 . . . . 0.0 110.783 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.1 m -83.96 -10.49 57.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.341 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.0 176.49 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.487 HG22 ' HA ' ' A' ' 57' ' ' PRO . 6.6 m -129.31 104.35 7.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 29.3 m -130.98 124.56 56.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 0.0 110.8 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -105.42 153.75 21.26 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.573 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 51.9 mt-10 -123.86 109.06 13.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.457 0.646 . . . . 0.0 111.677 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mp -105.59 139.02 28.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.7 tpp -91.01 122.35 33.6 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.716 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.682 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -95.53 113.76 62.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.749 -177.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -61.78 153.87 64.72 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.628 2.886 . . . . 0.0 112.459 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.74 144.66 55.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 171.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.42 -53.15 3.46 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -170.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -63.36 -35.11 79.29 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.372 172.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.663 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -49.12 -34.37 13.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.839 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.466 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -60.06 -44.34 97.37 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.615 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 75' ' ' ASP . 4.1 pp -85.48 -23.95 27.58 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.081 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.682 HG11 HG12 ' A' ' 8' ' ' ILE . 97.7 t -73.69 -42.9 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 13' ' ' ALA . 21.2 pt -91.56 -25.24 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 121.679 -0.638 . . . . 0.0 111.083 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 100.49 3.77 55.17 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.904 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.624 ' H ' HG13 ' A' ' 17' ' ' ILE . 7.6 tptm 53.82 48.13 22.05 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.542 0.687 . . . . 0.0 110.462 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.57 -1.48 0.52 Allowed Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.945 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.34 26.46 13.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.605 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -84.11 -60.12 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.988 0.423 . . . . 0.0 110.555 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.586 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 54.4 m -61.33 -44.52 97.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.359 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.564 HD11 HE21 ' A' ' 28' ' ' GLN . 0.3 OUTLIER -60.69 -31.4 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.032 0.444 . . . . 0.0 110.19 -177.2 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -39.01 93.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.264 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 30' ' ' ARG . 24.3 mt-30 -77.85 -39.53 43.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.269 0.557 . . . . 0.0 109.61 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.614 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 74.8 mt -64.0 -23.85 67.49 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.81 0.338 . . . . 0.0 110.61 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 68.8 mt-30 -85.89 -58.37 2.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.808 0.337 . . . . 0.0 111.751 174.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -82.59 -42.26 18.51 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -172.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.543 ' HG3' HG13 ' A' ' 137' ' ' ILE . 1.9 mtp180 -73.7 -38.72 64.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.83 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.637 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -84.39 -12.22 54.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.209 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.75 75.09 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.992 175.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.683 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 23.3 m -128.15 153.15 37.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.844 0.354 . . . . 0.0 110.675 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -90.13 110.14 21.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 1.01 ' HB3' HD22 ' A' ' 51' ' ' LEU . 48.9 mtt -96.25 124.58 40.31 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.433 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 6.1 tp -119.09 111.12 32.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.776 0.798 . . . . 0.0 110.217 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.699 ' HB3' HD21 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -134.15 144.35 48.48 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.829 -174.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.486 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 43.8 mm -68.19 104.48 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.05 0.452 . . . . 0.0 111.207 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 1.3 pp0? -146.71 20.85 1.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.64 0.733 . . . . 0.0 109.868 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.27 23.15 0.29 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.702 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . 82.33 -55.59 4.96 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.223 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.4 t -90.53 -157.9 0.51 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 62.04 -132.27 0.59 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.304 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.402 ' H ' HG21 ' A' ' 38' ' ' ILE . 93.8 m-20 -80.88 69.51 7.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.487 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 4.0 t -79.58 -44.96 20.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.904 0.383 . . . . 0.0 110.801 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -93.27 -3.54 53.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.161 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.11 159.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.913 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.02 156.22 36.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 18.2 mttm -131.06 128.35 22.24 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.301 -161.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.53 125.35 8.25 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.435 2.09 . . . . 0.0 112.021 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 1.01 HD22 ' HB3' ' A' ' 35' ' ' MET . 2.5 tm? -105.88 120.42 41.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.603 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.573 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.7 mpt_? -102.98 121.61 42.9 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.395 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.9 mt -90.5 109.92 21.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.421 HG12 ' CG1' ' A' ' 3' ' ' VAL . 36.8 mt -104.92 119.33 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.514 ' HA3' HG11 ' A' ' 33' ' ' VAL . . . 172.45 -170.74 43.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.921 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -67.24 142.03 96.55 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.487 ' HA ' HG22 ' A' ' 2' ' ' THR . 87.4 Cg_exo -46.29 -47.68 14.6 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.129 2.553 . . . . 0.0 113.931 -172.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.473 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 46.1 t80 -59.23 -40.71 86.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.151 0.5 . . . . 0.0 110.647 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -67.99 -45.49 73.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.093 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.6 t -58.33 -34.08 49.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.558 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -73.99 -40.51 62.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.737 0.303 . . . . 0.0 111.377 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.636 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 13.4 mm100 -72.99 -29.02 62.73 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.139 0.495 . . . . 0.0 110.268 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.642 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -85.65 -36.59 20.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.8 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.7 p -55.56 -43.4 75.83 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.96 0.41 . . . . 0.0 111.146 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.642 ' HA ' ' HE2' ' A' ' 68' ' ' MET . 9.4 pt-20 -68.53 -38.85 81.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.593 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.778 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 4.9 ptt? -71.49 -34.27 70.0 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.598 -176.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 63' ' ' ALA . 89.4 t -56.99 -36.17 49.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 174.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.642 ' HE2' ' HA ' ' A' ' 65' ' ' GLU . 36.2 mtm -82.0 -28.34 32.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.449 0.642 . . . . 0.0 110.19 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.452 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 36.5 t70 -75.87 -41.29 52.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.311 -171.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 82' ' ' ARG . 2.8 pp -89.63 -26.3 5.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.536 HD11 HG13 ' A' ' 8' ' ' ILE . 5.8 tt -69.6 -24.27 63.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.673 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -19.94 59.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.591 -177.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -51.19 -90.31 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -176.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.557 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 61.9 ttt180 168.08 -82.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.1 p-10 -168.52 12.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.828 172.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -86.46 -76.26 0.36 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.501 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -140.43 83.65 0.23 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.792 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -91.83 24.07 22.85 Favored Glycine 0 C--O 1.226 -0.388 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 175.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.698 ' HD2' HG21 ' A' ' 70' ' ' ILE . 54.6 m-85 69.05 -23.86 0.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.394 1.078 . . . . 0.0 113.56 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.479 ' C ' HG22 ' A' ' 23' ' ' THR . . . 84.14 15.4 69.61 Favored Glycine 0 C--N 1.328 0.129 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.399 177.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.407 ' HA ' ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER 173.89 -65.69 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -174.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.898 ' HA ' HG23 ' A' ' 70' ' ' ILE . 32.3 ttt180 166.88 -18.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.906 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.647 ' HB2' ' HB3' ' A' ' 79' ' ' PHE . 0.3 OUTLIER 67.66 42.7 1.98 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.025 176.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 28.9 tt0 -160.64 -52.56 0.05 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.472 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.631 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 46.0 p90 -176.71 171.7 2.22 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 110.075 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.674 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -132.95 -11.13 1.88 Allowed Glycine 0 CA--C 1.523 0.57 0 O-C-N 123.726 0.641 . . . . 0.0 112.28 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.636 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 18.0 p 178.28 -55.97 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.583 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 1.4 mpt_? -70.08 179.1 2.46 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.752 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.66 HG12 ' CG ' ' A' ' 139' ' ' HIS . 54.2 mt 78.36 -74.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.64 0.587 . . . . 0.0 111.136 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 46.91 46.73 19.65 Favored Glycine 0 C--N 1.337 0.609 0 O-C-N 123.41 0.444 . . . . 0.0 112.582 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.435 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 142.85 99.88 0.34 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.66 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 113.69 166.11 16.03 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -174.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.721 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 2.8 pp -93.66 -178.43 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.223 0.535 . . . . 0.0 112.253 -173.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.57 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 1.7 p-10 -109.74 147.01 33.96 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.142 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.88 HG23 ' HB2' ' A' ' 138' ' ' ALA . 3.5 m -137.56 97.14 10.48 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 121.229 0.537 . . . . 0.0 111.666 173.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.542 ' HD3' ' OD2' ' A' ' 94' ' ' ASP . 37.2 Cg_endo -67.04 108.55 1.53 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.155 2.57 . . . . 0.0 111.692 173.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 102' ' ' VAL . 99.0 t -103.52 120.1 52.78 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.818 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -46.32 128.02 11.77 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.768 2.312 . . . . 0.0 110.872 170.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.71 -31.5 37.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -173.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -82.12 -9.76 59.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.968 0.413 . . . . 0.0 110.809 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -107.06 -19.1 13.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.487 ' HA ' HG11 ' A' ' 97' ' ' VAL . 94.6 t -48.31 -45.39 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.491 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.87 -22.13 61.9 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.986 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.7 t -86.51 -38.78 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.89 0.376 . . . . 0.0 110.075 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.6 t -66.61 -38.77 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 121.345 0.593 . . . . 0.0 109.904 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.745 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 38.9 mm -70.54 -43.36 77.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.562 174.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.92 66.92 1.39 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.726 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 108' ' ' ARG . 4.0 mpt_? 57.81 -94.81 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.061 0.544 . . . . 0.0 112.055 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.1 m -77.21 -13.29 59.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.399 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.534 ' HA2' HG21 ' A' ' 106' ' ' ILE . . . 109.11 22.38 6.9 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.992 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 12.8 pt-20 -85.45 -10.81 55.63 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.737 -0.272 . . . . 0.0 111.689 -176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.453 ' HE1' HD21 ' A' ' 157' ' ' LEU . 16.9 tpt -89.94 -40.8 12.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 0.0 110.421 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.745 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 11.0 tp -62.19 -25.32 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.449 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 45.6 mtpt -85.93 -22.05 27.61 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.605 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 61.1 mttp -68.51 -32.95 73.28 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.519 HG23 HD11 ' A' ' 153' ' ' ILE . 29.8 mt -63.65 -37.02 78.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.505 0.669 . . . . 0.0 109.43 174.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -73.04 -26.33 61.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.858 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -87.56 -41.24 13.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.024 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.1 -51.33 10.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.185 -174.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.582 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -92.77 -11.05 34.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.084 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.42 31.65 68.37 Favored Glycine 0 C--O 1.229 -0.196 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.484 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.65 -177.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.036 0.446 . . . . 0.0 111.909 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.603 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 55.1 ttt180 -132.57 143.2 49.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.177 176.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.555 HG21 HD11 ' A' ' 113' ' ' ILE . 47.0 mm -110.86 142.84 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.041 0.448 . . . . 0.0 112.164 -171.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 2.2 tt0 -148.34 114.38 5.8 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.281 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -79.45 111.21 15.48 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.803 -0.56 . . . . 0.0 109.635 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.528 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -121.34 112.91 19.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.369 -174.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.426 HE21 ' HB3' ' A' ' 128' ' ' GLN . 9.2 mm100 59.69 -167.46 0.17 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.224 0.535 . . . . 0.0 110.984 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.575 ' OD1' ' HG2' ' A' ' 136' ' ' LYS . 5.7 m-20 -135.93 171.68 14.11 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.505 ' OD1' HG23 ' A' ' 132' ' ' THR . 15.5 t70 -84.72 139.6 31.88 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -63.08 -10.46 33.7 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 114.268 -171.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.649 HG22 ' HD2' ' A' ' 134' ' ' PRO . 14.5 t -77.44 -26.28 51.41 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.566 0.683 . . . . 0.0 110.358 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 118.67 -70.61 0.32 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.714 -0.755 . . . . 0.0 114.267 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.649 ' HD2' HG22 ' A' ' 132' ' ' THR . 9.3 Cg_endo -51.67 -50.1 15.08 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.708 2.939 . . . . 0.0 115.249 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -94.46 134.66 36.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.581 0.705 . . . . 0.0 112.358 -169.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.575 ' HG2' ' OD1' ' A' ' 129' ' ' ASP . 48.3 mttm -110.88 120.8 43.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.804 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.543 HG13 ' HG3' ' A' ' 30' ' ' ARG . 9.1 mm -72.34 116.37 14.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.808 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.88 ' HB2' HG23 ' A' ' 95' ' ' VAL . . . -105.09 143.12 33.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.199 0.523 . . . . 0.0 111.417 174.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.66 ' CG ' HG12 ' A' ' 89' ' ' ILE . 10.4 t-160 -86.38 125.58 33.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.902 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.644 HD12 HD12 ' A' ' 93' ' ' ILE . 30.6 mt -106.91 107.8 23.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.805 170.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.603 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 37.0 ttm -95.59 129.69 42.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.151 -175.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.64 -167.79 36.56 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.633 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.12 143.44 78.15 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.489 2.126 . . . . 0.0 110.811 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.32 -48.17 8.41 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 124.023 3.148 . . . . 0.0 113.758 -173.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -61.79 -47.81 83.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.32 0.581 . . . . 0.0 110.945 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.582 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 49.7 mtt180 -69.51 -22.38 63.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.307 -176.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.66 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 77.8 m -59.22 -52.31 66.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.249 0.547 . . . . 0.0 110.003 174.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -74.39 -31.71 62.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.731 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 146' ' ' ARG . 9.4 t60 -62.49 -29.91 70.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.243 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.561 ' HB2' HG22 ' A' ' 140' ' ' ILE . . . -80.17 -38.85 30.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.506 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.3 -23.82 66.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.302 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 149' ' ' HIS . 13.5 ptt180 -76.62 -25.14 53.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -174.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.559 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 62.5 mt -68.82 -41.46 82.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.529 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.8 -40.74 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.057 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -57.8 -45.79 85.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.458 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -57.84 -37.31 73.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.926 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 77.4 mt -65.36 -50.77 64.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.545 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 mt -63.91 -37.13 86.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.217 0.532 . . . . 0.0 110.192 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -69.86 -34.1 73.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.799 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.2 t -69.12 -22.64 63.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.985 0.421 . . . . 0.0 110.492 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 81.9 mt -84.05 -4.33 58.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.248 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -76.2 135.6 39.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.6 t -73.92 103.17 4.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.101 0.477 . . . . 0.0 109.833 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.244 -174.846 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 0.9 OUTLIER -161.32 -42.01 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.384 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 20.6 t -142.8 112.65 2.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.688 166.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 16.6 mm100 -123.85 159.59 29.27 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 176.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 48.7 mt-10 -116.88 129.15 55.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.17 0.51 . . . . 0.0 111.35 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.72 HD11 ' HA ' ' A' ' 64' ' ' CYS . 74.5 mt -111.43 145.97 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.54 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.21 110.29 20.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.835 0.35 . . . . 0.0 111.427 -175.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.514 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.9 mp -106.42 106.39 57.33 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.276 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.82 163.95 37.3 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.793 2.329 . . . . 0.0 111.342 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.85 145.3 56.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.47 -56.57 2.0 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -172.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -68.93 -27.91 66.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.827 0.346 . . . . 0.0 110.481 175.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.613 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -53.52 -35.37 60.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.133 174.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.672 ' HA3' ' HE3' ' A' ' 19' ' ' LYS . . . -63.37 -47.69 85.36 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.846 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.743 HD22 ' HB2' ' A' ' 73' ' ' GLU . 2.7 pp -78.68 -19.16 53.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.2 0.5 . . . . 0.0 111.407 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.8 t -78.41 -40.24 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.764 0.316 . . . . 0.0 111.151 175.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 13' ' ' ALA . 30.9 pt -88.86 -29.48 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.075 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.493 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.9 16.8 32.18 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.672 ' HE3' ' HA3' ' A' ' 14' ' ' GLY . 33.4 mmtp 55.44 47.07 21.93 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.006 0.522 . . . . 0.0 110.867 -175.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.11 -35.83 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.35 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 152.87 -12.43 0.62 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.295 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.506 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 20.1 mm-40 -45.26 -49.81 12.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.493 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 26.1 m -81.29 -34.89 31.69 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.435 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.485 HG21 ' O ' ' A' ' 21' ' ' GLY . 7.3 tp -64.91 -26.92 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.012 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.506 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 84.4 mttt -55.19 -53.6 54.0 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.913 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 23.2 mt-30 -66.14 -45.08 82.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.592 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.593 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 95.7 mt -59.87 -29.13 68.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.897 0.38 . . . . 0.0 111.124 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 27.5 mt-30 -85.89 -49.81 7.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.147 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.63 -51.78 5.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.643 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 15.2 ttm180 -65.14 -42.83 93.44 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.913 ' HB2' ' HG ' ' A' ' 87' ' ' SER . . . -80.89 -29.66 35.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.557 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.73 0.92 85.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.351 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 34.6 m -112.87 151.45 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -91.39 109.66 20.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.6 ' HB3' HD23 ' A' ' 51' ' ' LEU . 41.6 mtt -95.61 114.05 25.77 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.615 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.5 tp -113.12 109.63 29.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.99 0.9 . . . . 0.0 109.532 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.834 HD12 HD11 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -124.11 136.86 54.52 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.45 -174.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.693 HG22 ' HD2' ' A' ' 50' ' ' PRO . 10.8 tp -76.15 100.8 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 122.012 0.91 . . . . 0.0 110.014 -174.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.456 ' C ' ' H ' ' A' ' 41' ' ' GLY . 21.6 tm0? -132.09 135.1 46.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.084 -173.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 t70 72.52 -23.81 0.2 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.82 0.848 . . . . 0.0 111.874 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 39' ' ' GLN . . . -68.24 155.81 53.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.203 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -74.28 76.17 1.84 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.066 0.46 . . . . 0.0 111.415 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -160.98 -62.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.158 176.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -131.68 53.71 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 110.439 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -83.08 -41.53 18.5 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.714 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -91.61 -4.2 55.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.386 0.612 . . . . 0.0 109.875 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 48' ' ' ASP . 40.3 t -108.45 165.03 5.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.519 -173.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.421 ' N ' HG11 ' A' ' 47' ' ' VAL . 5.0 p-10 -58.14 150.58 20.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.123 0.487 . . . . 0.0 110.289 171.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -126.99 127.43 24.37 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.101 -169.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.693 ' HD2' HG22 ' A' ' 38' ' ' ILE . 83.3 Cg_endo -81.18 108.18 1.98 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.74 2.294 . . . . 0.0 112.09 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.834 HD11 HD12 ' A' ' 37' ' ' LEU . 9.6 tt -84.17 117.55 23.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.841 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.615 ' HB2' HG23 ' A' ' 36' ' ' ILE . 1.5 mpt_? -91.42 112.22 24.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.107 0.254 . . . . 0.0 110.964 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.75 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 62.5 mt -89.12 113.02 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.057 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.712 HG12 HG22 ' A' ' 3' ' ' VAL . 30.3 mt -104.55 118.17 51.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.496 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 176.52 -170.9 43.83 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.393 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.46 ' O ' HG22 ' A' ' 60' ' ' VAL . 9.3 m-20 -65.11 147.38 98.58 Favored Pre-proline 0 N--CA 1.462 0.156 0 C-N-CA 122.46 0.304 . . . . 0.0 110.507 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' A' ' 1' ' ' GLY . 83.2 Cg_exo -49.89 -52.41 8.94 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.112 2.542 . . . . 0.0 114.613 -173.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 17.5 p90 -63.17 -27.07 69.12 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.949 0.404 . . . . 0.0 110.571 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.803 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 91.7 mttt -72.46 -50.52 25.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.555 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 56' ' ' ASP . 22.0 t -59.93 -34.95 57.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.03 -176.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -66.3 -51.19 59.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 12.2 mm100 -64.83 -37.71 88.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 110.38 -177.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.588 ' HB1' ' OG ' ' A' ' 87' ' ' SER . . . -69.19 -40.38 78.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.751 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.72 ' HA ' HD11 ' A' ' 6' ' ' ILE . 54.0 t -52.41 -43.4 64.77 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.209 0.528 . . . . 0.0 110.208 177.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.1 -46.14 62.32 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.587 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.781 ' HE3' ' HB3' ' A' ' 31' ' ' ALA . 3.8 ptt? -65.35 -39.69 92.69 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.494 -171.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.731 HG12 HD22 ' A' ' 71' ' ' LEU . 90.4 t -62.32 -50.19 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.367 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.565 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 56.4 mtp -63.32 -30.29 71.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.05 0.452 . . . . 0.0 110.586 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 0.9 OUTLIER -73.37 -40.24 64.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.898 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 82' ' ' ARG . 2.9 pp -86.67 -24.29 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.684 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.731 HD22 HG12 ' A' ' 67' ' ' VAL . 3.6 pp -83.09 -0.38 48.83 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.37 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.586 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 11.9 ptm180 -50.92 -42.8 59.74 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.743 ' HB2' HD22 ' A' ' 15' ' ' LEU . 27.1 tt0 60.07 110.84 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 124.373 1.046 . . . . 0.0 113.107 174.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -107.67 -39.17 5.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -140.66 50.58 1.66 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 59.49 68.2 0.82 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.18 0.514 . . . . 0.0 111.571 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.32 -40.62 0.24 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.652 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 76.48 -96.7 1.15 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.182 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.588 ' HD2' ' HA ' ' A' ' 70' ' ' ILE . 97.2 m-85 -144.47 -29.95 0.47 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.851 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.72 100.48 0.64 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.463 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 27.1 t70 68.79 -72.75 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -169.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.835 ' HA ' HG22 ' A' ' 70' ' ' ILE . 26.6 ttt180 178.26 -29.36 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.483 169.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t30 66.96 16.04 10.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.195 0.998 . . . . 0.0 109.479 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.98 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 74.6 mt-10 -129.12 -31.29 2.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.787 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.722 ' CB ' ' HB ' ' A' ' 89' ' ' ILE . 30.0 p90 176.98 152.68 0.2 Allowed 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.385 172.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.557 ' C ' ' HA ' ' A' ' 31' ' ' ALA . . . -117.53 106.31 1.38 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.404 168.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.913 ' HG ' ' HB2' ' A' ' 31' ' ' ALA . 43.4 m 51.51 35.64 14.94 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.673 ' HB3' HD12 ' A' ' 89' ' ' ILE . 11.8 mtt180 -166.12 -162.36 0.54 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.722 ' HB ' ' CB ' ' A' ' 85' ' ' TYR . 2.8 mp 63.97 -77.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 124.039 0.837 . . . . 0.0 111.806 173.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 57.51 48.06 83.76 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.628 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 144.91 81.27 0.05 OUTLIER Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.292 -0.48 . . . . 0.0 111.92 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 141.37 -150.16 21.65 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.98 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 47.9 pt -136.56 167.34 24.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 116.9 0.35 . . . . 0.0 111.219 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.643 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 3.5 p30 -108.59 139.22 43.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 171.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.878 HG21 ' HB1' ' A' ' 138' ' ' ALA . 11.8 m -133.35 95.48 18.19 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 121.107 0.48 . . . . 0.0 111.277 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.484 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 19.9 Cg_endo -62.54 108.31 0.7 Allowed 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.692 2.261 . . . . 0.0 111.071 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.457 ' HA ' ' HD2' ' A' ' 98' ' ' PRO . 12.8 p -110.27 125.02 31.85 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.955 0.407 . . . . 0.0 111.102 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 97' ' ' VAL . 5.5 Cg_endo -48.64 124.06 10.4 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.221 2.614 . . . . 0.0 111.774 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -63.64 -20.94 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.706 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -83.7 -0.87 52.61 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.785 0.326 . . . . 0.0 110.775 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.651 ' HB3' HD23 ' A' ' 161' ' ' LEU . 18.9 m -129.63 -2.43 4.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.653 -175.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.95 -24.78 24.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 110.592 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.96 -28.88 66.82 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.394 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.1 t -77.14 -37.61 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.083 0.468 . . . . 0.0 110.388 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.1 t -71.02 -37.31 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.609 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.6 mm -80.19 -38.87 18.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.52 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.68 -104.33 2.9 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.037 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -138.32 -66.58 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.704 0.288 . . . . 0.0 110.395 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.7 m -88.76 -3.78 58.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.344 0.592 . . . . 0.0 110.297 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.95 31.08 7.9 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.41 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -92.81 -26.81 17.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.765 0.317 . . . . 0.0 110.358 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.514 ' SD ' ' HD3' ' A' ' 115' ' ' LYS . 16.3 tpt -69.63 -36.55 76.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.375 0.607 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.416 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 4.6 tp -70.36 -32.93 52.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.913 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.471 ' HZ1' ' HB3' ' A' ' 114' ' ' LYS . 9.4 mtpm? -73.53 -28.31 61.82 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.508 0.67 . . . . 0.0 109.421 173.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.514 ' HD3' ' SD ' ' A' ' 112' ' ' MET . 21.0 tttp -68.77 -31.87 71.21 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.65 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.5 mm -62.28 -36.87 76.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.679 0.752 . . . . 0.0 109.055 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.599 HE21 HG12 ' A' ' 124' ' ' ILE . 66.2 mt-30 -72.56 -22.19 61.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.557 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 115' ' ' LYS . 92.1 m-20 -79.52 -30.57 41.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.945 0.403 . . . . 0.0 110.803 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.36 -55.86 4.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.587 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -101.02 -28.97 12.43 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.922 -176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 117' ' ' GLN . . . 88.23 74.29 1.28 Allowed Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.681 -175.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 150' ' ' ALA . 18.6 m -134.23 166.95 27.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.683 0.278 . . . . 0.0 110.927 -175.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.794 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 23.5 ttt180 -122.27 138.81 54.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.599 HG12 HE21 ' A' ' 117' ' ' GLN . 50.8 mm -112.81 136.3 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -169.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.761 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 3.9 tp-100 -132.43 138.45 47.65 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.365 174.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -111.68 113.88 26.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.54 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -128.55 152.78 47.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.929 -173.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.461 ' HB3' ' H ' ' A' ' 129' ' ' ASP . 13.1 mm100 67.73 -146.71 0.14 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.723 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' H ' ' HB3' ' A' ' 128' ' ' GLN . 2.4 m-20 -45.27 106.02 0.07 Allowed 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 124.214 0.946 . . . . 0.0 112.0 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -103.58 11.07 36.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.156 -174.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 151.43 -14.21 0.82 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.132 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.9 p -60.64 -57.22 13.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.013 0.435 . . . . 0.0 109.852 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.85 175.19 55.12 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 171.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.94 -33.71 19.23 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.546 2.164 . . . . 0.0 112.178 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 98' ' ' PRO . 3.0 mp0 -111.48 153.98 25.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.899 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 129' ' ' ASP . 22.7 mtpp -109.96 113.23 25.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.367 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.54 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 17.5 mm -68.86 105.71 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.113 0.482 . . . . 0.0 111.123 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.878 ' HB1' HG21 ' A' ' 95' ' ' VAL . . . -94.77 141.4 28.67 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.368 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.761 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -96.65 113.61 25.19 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.182 176.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.665 HD12 ' HB1' ' A' ' 150' ' ' ALA . 48.0 mt -93.22 119.6 41.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.634 173.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.794 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 38.0 ttm -105.89 137.77 43.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.445 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.48 179.34 26.17 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.318 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.36 149.17 23.69 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.927 2.418 . . . . 0.0 111.824 175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.52 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 76.8 Cg_exo -51.34 -27.69 24.58 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.684 2.923 . . . . 0.0 113.684 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 12.5 t70 -76.97 -46.42 24.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.06 0.457 . . . . 0.0 109.84 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.45 -47.3 86.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.912 -177.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.545 ' HA ' ' CG2' ' A' ' 140' ' ' ILE . 17.7 p -57.58 -56.5 21.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.777 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -68.45 -23.46 64.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.814 0.34 . . . . 0.0 111.463 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.46 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 4.6 t60 -70.41 -30.37 67.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.134 0.492 . . . . 0.0 109.673 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 140' ' ' ILE . . . -79.09 -41.66 28.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.926 -177.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.22 -32.02 69.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.04 0.448 . . . . 0.0 110.857 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -76.98 -19.48 57.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.381 -177.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 149' ' ' HIS . 63.3 mt -81.08 -43.06 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.309 0.576 . . . . 0.0 109.575 174.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.3 mt -63.42 -46.94 93.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.572 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -60.14 -35.63 75.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.384 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.42 -40.45 86.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.14 0.495 . . . . 0.0 110.125 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.39 -41.0 81.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.625 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 51.2 mt -67.1 -30.0 69.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.151 0.501 . . . . 0.0 110.579 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 30.0 tt0 -83.16 -28.74 29.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.208 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.0 p -80.22 -22.89 41.32 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' A' ' 101' ' ' SER . 3.5 pp -87.74 20.82 2.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 159' ' ' GLN . 52.6 mtp180 -46.17 130.4 10.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.538 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.4 p -92.54 166.99 12.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.278 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.675 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.554 -179.192 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.861 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 57' ' ' PRO . 16.2 m -83.49 73.05 10.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.189 0.519 . . . . 0.0 109.896 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 17.9 m -101.06 134.58 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.34 0.591 . . . . 0.0 111.196 -177.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -125.63 155.39 40.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.904 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 46.8 mt-10 -113.45 117.27 31.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.328 0.585 . . . . 0.0 112.104 -173.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -105.68 142.4 18.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.754 175.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.523 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 48.0 tpp -91.94 125.51 36.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.681 0.277 . . . . 0.0 110.899 -176.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.924 HD13 ' HB2' ' A' ' 51' ' ' LEU . 3.5 mp -96.84 106.02 27.6 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.644 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.773 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 23.9 Cg_exo -67.37 148.37 79.46 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.936 2.424 . . . . 0.0 111.531 175.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.59 134.39 54.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.486 ' O ' ' HG2' ' A' ' 76' ' ' GLN . . . 102.99 -36.25 4.44 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -170.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.897 ' HG3' HD11 ' A' ' 15' ' ' LEU . 12.6 mptt -82.42 8.46 11.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.961 0.41 . . . . 0.0 110.363 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -59.02 -39.84 83.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.914 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.459 ' O ' ' HA2' ' A' ' 18' ' ' GLY . . . -69.15 -15.34 69.68 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.265 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.897 HD11 ' HG3' ' A' ' 12' ' ' LYS . 16.2 mt -90.67 -40.93 11.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.917 -0.142 . . . . 0.0 111.235 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.68 HG23 HG13 ' A' ' 8' ' ' ILE . 61.8 t -92.84 -51.16 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.658 HG13 ' H ' ' A' ' 19' ' ' LYS . 17.3 pt -91.51 -28.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.075 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . 89.84 15.81 57.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.185 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.658 ' H ' HG13 ' A' ' 17' ' ' ILE . 66.6 mmtt 67.36 -58.28 0.42 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.417 0.687 . . . . 0.0 111.704 -177.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.19 -5.9 75.68 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.501 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.94 4.36 54.37 Favored Glycine 0 C--O 1.229 -0.213 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.757 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.728 ' HA ' ' CD ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -73.39 -28.77 62.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -175.148 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 15' ' ' LEU . 91.5 m -71.53 -41.27 69.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.252 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' A' ' 35' ' ' MET . 6.9 tp -65.56 -27.45 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.151 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.728 ' CD ' ' HA ' ' A' ' 22' ' ' GLU . 11.9 mtpp -57.79 -49.5 76.42 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -72.84 -35.99 67.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.102 -175.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 98.1 mt -66.01 -27.69 68.31 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 121.837 -0.539 . . . . 0.0 110.382 176.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.741 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.6 mt-30 -84.88 -52.88 5.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.421 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -84.28 -56.38 3.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -174.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.47 HH22 ' HB3' ' A' ' 82' ' ' ARG . 3.5 ttp180 -56.27 -42.28 77.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.864 0.364 . . . . 0.0 110.461 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -87.65 -29.83 20.88 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.368 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.47 10.37 70.76 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.26 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.6 m -117.31 152.04 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.743 0.306 . . . . 0.0 110.3 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -96.56 110.98 23.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 46.4 mtt -94.81 125.79 39.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' A' ' 52' ' ' ARG . 5.0 tp -117.6 114.5 45.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.886 0.85 . . . . 0.0 109.941 -177.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.691 HD23 ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -132.82 142.94 49.23 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.676 -175.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.416 HD12 ' HG2' ' A' ' 50' ' ' PRO . 2.0 mp -61.62 112.84 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.17 0.51 . . . . 0.0 110.882 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.403 ' OE1' HD13 ' A' ' 17' ' ' ILE . 22.2 mm-40 -125.26 -53.51 1.61 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.067 176.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.29 72.17 9.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.541 0.686 . . . . 0.0 109.588 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.13 106.02 0.24 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.563 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.9 t -79.2 65.22 4.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.588 0.708 . . . . 0.0 111.103 -173.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -131.41 -52.25 1.01 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.187 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.632 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.7 m-20 -113.32 47.09 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.358 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 p -78.37 -48.55 15.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.991 0.424 . . . . 0.0 110.825 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -93.23 -11.8 31.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.587 0.708 . . . . 0.0 109.417 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.632 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 50.1 t -88.92 162.65 2.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.815 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.85 154.12 26.9 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.463 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 39.4 mttp -127.28 144.31 50.25 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.874 -170.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HG2' HD12 ' A' ' 38' ' ' ILE . 83.3 Cg_endo -92.08 122.11 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.81 2.34 . . . . 0.0 112.886 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.924 ' HB2' HD13 ' A' ' 8' ' ' ILE . 8.4 tt -101.56 126.23 48.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.7 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.546 ' HB2' HG21 ' A' ' 36' ' ' ILE . 3.3 mpt_? -107.92 121.1 44.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.691 0.282 . . . . 0.0 110.287 174.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 61.6 mt -89.47 117.3 32.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.174 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.4 mt -103.84 120.31 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.97 -171.05 43.93 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.336 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.553 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 18.9 m-20 -71.63 146.77 91.57 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 122.459 0.303 . . . . 0.0 110.504 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.598 ' HA ' HG22 ' A' ' 2' ' ' THR . 99.8 Cg_exo -44.33 -51.24 7.07 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.463 2.775 . . . . 0.0 113.7 -175.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -60.58 -49.61 76.85 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.756 0.312 . . . . 0.0 111.223 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 1.015 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 5.3 ptpp? -72.73 -23.55 60.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.926 -175.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 2' ' ' THR . 71.4 t -71.22 -43.04 74.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -58.17 9.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.78 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.72 -21.62 66.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.598 -174.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -85.36 -39.17 17.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.463 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 68' ' ' MET . 37.9 t -56.59 -50.56 71.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.606 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.54 -33.54 75.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.083 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.804 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 18.2 ptt? -79.57 -36.21 38.58 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.738 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 63' ' ' ALA . 69.9 t -56.27 -44.57 79.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 57.1 mtp -66.63 -32.57 73.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.566 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 35.2 t70 -85.24 -28.71 25.2 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -88.82 -21.69 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.098 -1.001 . . . . 0.0 110.438 173.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.489 HD13 ' CG2' ' A' ' 16' ' ' VAL . 5.8 tt -82.08 -26.29 33.78 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.354 178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.439 ' NH2' ' HA ' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -61.05 -13.95 20.3 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.213 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.611 ' HG3' ' H ' ' A' ' 75' ' ' ASP . 9.0 tp10 -55.47 135.28 50.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.217 0.532 . . . . 0.0 111.684 -175.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -75.72 -19.1 59.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.587 0.708 . . . . 0.0 109.578 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.611 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 10.8 m-20 -106.39 -174.8 2.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.632 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 11' ' ' GLY . 48.2 mt-30 -94.91 41.03 1.09 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.85 45.4 1.17 Allowed Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.705 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.603 ' H ' HD23 ' A' ' 15' ' ' LEU . . . -67.33 178.63 17.26 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 172.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.401 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 86.5 m-85 -68.32 -31.57 71.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.283 0.541 . . . . 0.0 111.581 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 23' ' ' THR . . . 101.45 -2.64 53.74 Favored Glycine 0 CA--C 1.508 -0.348 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 82' ' ' ARG . 1.6 p30 -179.17 -63.54 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.804 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 6.8 ttt85 173.41 -29.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.241 165.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.507 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 4.1 t30 52.33 65.77 1.41 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.937 0.399 . . . . 0.0 110.373 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 1.022 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 30.5 tt0 176.28 -47.54 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.754 0.787 . . . . 0.0 109.844 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.79 ' HA ' ' NE2' ' A' ' 139' ' ' HIS . 36.4 p90 -173.78 157.98 3.17 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.43 175.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -143.03 95.42 0.18 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 1.015 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 67.8 m 70.75 -52.64 0.67 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.678 ' HD3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -67.6 -82.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.078 0.466 . . . . 0.0 111.738 -175.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.678 HD12 ' HD3' ' A' ' 88' ' ' ARG . 41.3 mm -54.34 -88.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -168.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.73 78.42 1.33 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -169.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.24 94.2 2.1 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.232 -0.508 . . . . 0.0 112.063 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.712 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 148.94 -144.06 11.69 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.022 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 49.9 pt -152.43 158.13 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 117.476 0.638 . . . . 0.0 110.057 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.507 ' OD2' ' HA ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -105.27 140.71 38.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.981 0.42 . . . . 0.0 110.53 175.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 2.8 t -137.45 116.72 10.17 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.659 -176.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.61 107.75 2.25 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.013 1.809 . . . . 0.0 111.629 169.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 102' ' ' VAL . 40.9 t -99.17 126.14 39.05 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.945 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.679 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 74.1 Cg_exo -43.69 130.68 7.47 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.662 2.908 . . . . 0.0 113.13 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.552 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 33.1 ptt180 -60.24 -24.22 64.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.025 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -92.81 20.34 6.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.729 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 105' ' ' VAL . 14.6 t -145.79 -31.46 0.38 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.126 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.413 ' HA ' HG13 ' A' ' 97' ' ' VAL . 7.3 p -49.38 -37.66 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.24 -28.95 63.06 Favored Glycine 0 C--O 1.235 0.178 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.925 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.7 t -75.11 -35.07 33.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.027 0.441 . . . . 0.0 109.873 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 101' ' ' SER . 66.9 t -59.59 -40.05 81.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.905 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.765 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.3 mm -72.95 -37.71 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.389 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.93 34.57 21.17 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 65.66 -76.73 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.514 0.725 . . . . 0.0 111.399 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.2 p -93.73 9.62 36.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.868 0.366 . . . . 0.0 111.662 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.34 8.12 60.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.892 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -65.26 -32.2 73.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 110.913 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 15.4 tpt -89.93 -37.85 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.817 -176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.765 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.2 tp -64.98 -27.97 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.084 0.469 . . . . 0.0 110.382 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -72.58 -21.86 61.08 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.182 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -71.57 -33.84 69.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.732 0.301 . . . . 0.0 110.543 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.545 HG22 HD12 ' A' ' 153' ' ' ILE . 32.3 mt -67.92 -40.38 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 0.0 109.469 176.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -70.02 -28.21 65.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.437 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -79.52 -37.52 36.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.9 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -79.57 -55.16 5.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.578 -176.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.96 -15.01 26.75 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.55 32.5 57.5 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.881 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 146' ' ' ARG . 14.9 m -102.98 159.15 4.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.216 0.531 . . . . 0.0 112.103 -173.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.895 ' HB2' ' HB2' ' A' ' 141' ' ' MET . 65.3 mtm180 -101.26 144.09 30.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.223 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.513 HG23 HD13 ' A' ' 113' ' ' ILE . 51.2 mm -116.79 121.54 67.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.567 ' HB2' ' SD ' ' A' ' 141' ' ' MET . 5.9 tp-100 -123.94 111.14 15.69 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.597 ' CE1' HD12 ' A' ' 106' ' ' ILE . 27.4 m-85 -87.53 133.26 33.8 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.561 0.696 . . . . 0.0 110.104 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.718 ' HD3' ' HD1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -157.03 -166.25 2.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.381 -171.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -47.96 125.81 9.58 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.426 0.454 . . . . 0.0 111.813 -177.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' HB2' ' HA ' ' A' ' 136' ' ' LYS . 7.6 p-10 -104.15 -164.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.824 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -62.45 -38.03 88.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.39 . . . . 0.0 110.287 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.53 -59.79 1.85 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.567 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.5 t -96.64 -23.65 16.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.096 0.474 . . . . 0.0 110.133 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.07 148.84 43.41 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.552 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 14.2 Cg_exo -69.47 -19.68 37.19 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.829 2.352 . . . . 0.0 112.452 -176.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.679 ' OE2' ' HA ' ' A' ' 98' ' ' PRO . 1.3 mp0 -94.73 154.17 17.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.972 0.415 . . . . 0.0 111.248 -174.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -119.79 124.73 46.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.328 0.585 . . . . 0.0 111.359 -178.039 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.602 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 44.8 mm -63.3 115.8 2.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.295 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.75 132.45 38.12 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 164.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.79 ' NE2' ' HA ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -108.34 115.24 29.74 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.676 -177.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.697 HD11 ' HB1' ' A' ' 150' ' ' ALA . 82.7 mt -83.85 137.58 20.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.522 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.895 ' HB2' ' HB2' ' A' ' 123' ' ' ARG . 31.2 mtp -120.42 129.26 53.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.066 -176.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.75 -167.03 28.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.635 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.745 ' HB2' ' HD3' ' A' ' 146' ' ' ARG . 32.8 Cg_exo -61.0 147.28 96.19 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.085 2.524 . . . . 0.0 112.195 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.702 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 52.0 Cg_exo -57.04 -18.65 29.46 Favored 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 123.955 3.104 . . . . 0.0 113.817 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.94 -30.17 26.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.326 0.584 . . . . 0.0 110.178 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.745 ' HD3' ' HB2' ' A' ' 143' ' ' PRO . 8.4 mpt_? -84.13 -44.12 14.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.408 -174.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.702 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 10.6 p -53.85 -55.1 29.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.011 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.414 ' OE2' HG23 ' A' ' 93' ' ' ILE . 38.5 mm-40 -62.65 -37.87 88.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.48 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.409 ' O ' HG13 ' A' ' 153' ' ' ILE . 15.7 t60 -65.49 -26.76 68.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.223 0.535 . . . . 0.0 110.316 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.697 ' HB1' HD11 ' A' ' 140' ' ' ILE . . . -79.98 -40.26 28.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.005 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 93' ' ' ILE . . . -65.94 -24.92 66.92 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.366 0.603 . . . . 0.0 110.149 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -18.94 59.56 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.538 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.545 HD12 HG22 ' A' ' 116' ' ' ILE . 63.1 mt -81.76 -45.06 20.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.316 172.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.466 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.9 mt -62.21 -40.77 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.006 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -58.84 -37.33 76.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.71 -34.16 77.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 34.1 mt -68.87 -33.87 74.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.824 -178.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.529 HD22 ' HD2' ' A' ' 98' ' ' PRO . 18.4 mt -67.08 -28.68 68.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.357 0.599 . . . . 0.0 110.127 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -85.45 -28.56 24.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.58 0.705 . . . . 0.0 110.416 172.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 157' ' ' LEU . 22.4 t -75.48 -20.38 58.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.997 -173.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 pp -59.57 -9.9 2.99 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -68.2 -17.57 64.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.345 0.593 . . . . 0.0 110.02 174.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.1 t -140.41 -166.11 2.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.63 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.319 -178.911 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.4 ' O ' HG21 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -112.05 67.42 0.65 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.944 0.402 . . . . 0.0 111.143 -178.659 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 27.7 m -123.5 130.39 74.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.159 175.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -118.47 142.72 47.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.625 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 45.3 mt-10 -108.01 116.74 32.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.361 0.6 . . . . 0.0 111.775 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 6' ' ' ILE . 3.9 mp -106.82 142.82 18.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 87.6 mmm -92.88 116.09 28.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.937 0.399 . . . . 0.0 110.704 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.497 HG12 HG11 ' A' ' 16' ' ' VAL . 1.8 mp -91.36 113.77 59.55 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.586 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 75.1 Cg_exo -55.77 152.15 36.51 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.425 2.75 . . . . 0.0 112.775 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.616 ' HA ' ' NZ ' ' A' ' 49' ' ' LYS . . . -59.62 129.93 44.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 172.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.58 -39.21 2.94 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.81 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.728 ' HG3' HD21 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -65.38 -19.68 66.05 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.805 0.335 . . . . 0.0 111.249 -177.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.643 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -58.38 -24.04 58.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.863 0.363 . . . . 0.0 110.374 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.55 ' CA ' ' HD3' ' A' ' 19' ' ' LYS . . . -61.29 -41.15 99.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.246 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.728 HD21 ' HG3' ' A' ' 12' ' ' LYS . 0.5 OUTLIER -90.42 -23.84 20.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.811 0.305 . . . . 0.0 110.992 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.617 HG21 HD11 ' A' ' 71' ' ' LEU . 77.1 t -82.63 -52.05 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.692 HD11 ' HG3' ' A' ' 39' ' ' GLN . 19.2 pt -91.53 -20.09 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 121.526 -0.734 . . . . 0.0 110.155 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.602 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.19 17.09 32.97 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -175.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.55 ' HD3' ' CA ' ' A' ' 14' ' ' GLY . 13.6 tptp 55.66 31.81 18.08 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.421 0.688 . . . . 0.0 110.428 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.77 -40.17 0.3 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.551 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.593 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 158.1 -8.84 0.2 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.157 -1.02 . . . . 0.0 114.07 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 44.4 tt0 -58.64 -43.37 89.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.504 0.652 . . . . 0.0 112.377 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.602 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 55.2 m -78.3 -36.73 46.19 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.195 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 35' ' ' MET . 5.6 tp -64.6 -20.1 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.937 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 27.6 mtpp -58.36 -59.45 5.33 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.42 0.629 . . . . 0.0 109.503 170.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -67.22 -35.23 79.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.91 -174.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 87.7 mt -65.1 -32.91 74.85 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 122.037 -0.415 . . . . 0.0 110.835 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.719 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 47.9 mt-30 -85.5 -46.61 10.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.062 0.458 . . . . 0.0 111.41 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -88.16 -35.36 17.45 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.503 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 5.5 ttm180 -82.87 -43.42 16.6 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.746 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.803 ' HB2' ' HE1' ' A' ' 66' ' ' MET . . . -83.18 -22.29 33.26 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.982 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.69 68.16 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.097 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 34.2 m -128.15 150.69 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 110.846 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -90.72 109.99 21.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 1.073 ' HB3' HD12 ' A' ' 51' ' ' LEU . 48.4 mtt -100.29 123.31 44.36 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 tt -121.02 113.87 41.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.799 0.809 . . . . 0.0 110.768 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.628 HD23 HD11 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -134.86 143.57 47.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.948 -177.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.527 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 3.7 mp -73.34 101.18 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.307 0.575 . . . . 0.0 111.351 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.692 ' HG3' HD11 ' A' ' 17' ' ' ILE . 4.9 mm-40 -131.36 15.68 5.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.44 170.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.03 -30.74 62.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.825 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.527 ' HA2' ' CG2' ' A' ' 45' ' ' THR . . . 113.56 8.28 19.04 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.036 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 m -61.77 -49.9 74.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.678 0.275 . . . . 0.0 111.688 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -164.44 -42.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.851 0.358 . . . . 0.0 111.091 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.624 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 13.3 m120 -78.98 51.49 1.14 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.926 0.393 . . . . 0.0 111.266 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.527 ' CG2' ' HA2' ' A' ' 41' ' ' GLY . 14.3 p -86.09 -61.77 1.67 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.178 0.513 . . . . 0.0 110.867 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -92.33 -6.82 49.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.455 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.624 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 48.9 t -93.38 156.27 3.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.944 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.4 149.4 38.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.619 ' HE3' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -111.21 124.15 33.45 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.816 -174.397 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.12 112.89 2.34 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.452 2.101 . . . . 0.0 111.825 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 1.073 HD12 ' HB3' ' A' ' 35' ' ' MET . 21.2 tp -92.98 121.1 33.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.775 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 2.7 mpt_? -102.05 114.14 28.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.853 0.358 . . . . 0.0 110.657 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 70.0 mt -89.42 110.63 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.229 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.4 mt -106.13 122.08 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.376 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.87 -171.43 44.51 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.956 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.518 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . 3.2 m-20 -61.58 148.75 85.96 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 122.282 0.233 . . . . 0.0 110.536 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.65 -55.61 3.82 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.119 2.546 . . . . 0.0 114.188 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -66.73 -26.91 67.23 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.926 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.846 ' HG2' ' HB2' ' A' ' 87' ' ' SER . 93.2 mttt -66.67 -53.02 38.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.187 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 2' ' ' THR . 46.4 t -59.89 -32.51 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.589 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.22 -54.91 30.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.823 HE21 ' HA ' ' A' ' 62' ' ' GLN . 0.0 OUTLIER -69.88 -34.1 73.12 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.051 -178.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.552 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -69.88 -47.5 62.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.431 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.2 t -55.95 -38.36 70.23 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.19 0.519 . . . . 0.0 109.862 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -64.53 -52.82 55.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.695 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.803 ' HE1' ' HB2' ' A' ' 31' ' ' ALA . 8.4 ptt? -65.69 -36.07 82.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.472 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.484 HG21 HD13 ' A' ' 53' ' ' ILE . 53.5 t -57.06 -48.38 81.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.245 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 69.4 mtm -69.78 -25.35 63.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.184 0.516 . . . . 0.0 110.214 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.48 -37.82 42.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.926 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' HB ' ' H ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -90.22 -30.77 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.86 176.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.617 HD11 HG21 ' A' ' 16' ' ' VAL . 5.2 tt -70.93 -26.45 63.2 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -63.9 0.95 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.176 0.298 . . . . 0.0 110.404 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.995 ' HG2' ' H ' ' A' ' 74' ' ' ARG . 23.6 tt0 42.31 -159.83 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 169.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.995 ' H ' ' HG2' ' A' ' 73' ' ' GLU . 20.9 mmt180 -145.54 -47.06 0.22 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.807 0.843 . . . . 0.0 108.751 167.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -173.66 102.23 0.11 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.011 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 61.66 69.49 0.64 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.459 0.647 . . . . 0.0 111.399 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.41 -5.52 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.372 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.22 150.78 48.88 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.669 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.53 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 74.5 m-85 -76.99 3.53 12.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -170.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.53 ' O ' HG23 ' A' ' 23' ' ' THR . . . 73.14 4.13 62.62 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.723 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.443 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.5 OUTLIER 175.89 -62.91 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.883 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.745 ' HB3' ' CZ ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER 154.13 -35.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 O-C-N 125.1 1.5 . . . . 0.0 109.101 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 55.81 73.51 0.43 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.371 0.419 . . . . 0.0 110.399 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.924 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 70.4 tt0 -175.71 -51.13 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.665 -173.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.705 ' HA ' HD11 ' A' ' 89' ' ' ILE . 4.5 p90 -151.04 -75.89 0.14 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.654 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 101.15 -43.38 1.74 Allowed Glycine 0 C--O 1.229 -0.198 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.846 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 32.5 p -171.06 -57.16 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -69.98 -177.23 1.28 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.379 167.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.705 HD11 ' HA ' ' A' ' 85' ' ' TYR . 59.8 mt 70.57 -74.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.09 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.12 47.21 49.92 Favored Glycine 0 C--N 1.336 0.552 0 O-C-N 123.727 0.642 . . . . 0.0 112.501 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.25 99.36 0.4 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -176.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.813 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 135.79 -138.51 9.98 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -174.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.924 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.8 pt -145.53 159.59 12.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 171.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.572 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . 1.9 p30 -99.22 132.58 44.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 31.3 t -126.65 106.2 23.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -171.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 135' ' ' GLU . 42.8 Cg_endo -68.79 121.44 8.33 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.234 1.956 . . . . 0.0 111.389 171.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.64 HG11 HD21 ' A' ' 158' ' ' LEU . 51.3 t -117.71 124.9 28.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.653 0.263 . . . . 0.0 111.216 177.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 86.1 Cg_exo -44.62 130.51 9.54 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.753 2.968 . . . . 0.0 113.475 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 134' ' ' PRO . 35.2 mtp180 -51.63 -37.92 52.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.151 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.476 ' CE1' ' HB3' ' A' ' 98' ' ' PRO . 0.7 OUTLIER -92.26 6.43 46.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.655 -174.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 98' ' ' PRO . 9.8 m -130.03 -25.52 2.5 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.607 -173.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.4 p -53.15 -26.26 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.742 0.306 . . . . 0.0 111.592 172.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.3 -44.96 89.41 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.947 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 101' ' ' SER . 7.6 p -77.38 -25.23 15.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.208 0.528 . . . . 0.0 110.587 -178.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.1 t -69.68 -33.14 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.85 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.546 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 49.6 mm -87.12 -65.06 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.352 176.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.82 52.19 3.39 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.696 -173.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 108' ' ' ARG . 45.2 mtp180 54.77 -89.84 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.71 0.804 . . . . 0.0 112.375 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -72.75 -8.82 57.25 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.594 0.711 . . . . 0.0 110.348 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.26 45.72 2.52 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.587 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.37 -43.88 80.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.8 0.3 . . . . 0.0 110.942 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.454 ' O ' HG13 ' A' ' 116' ' ' ILE . 15.3 tpt -83.59 -38.55 21.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.848 0.356 . . . . 0.0 110.641 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.637 HD12 HG23 ' A' ' 124' ' ' ILE . 8.9 tp -63.91 -31.08 51.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.5 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -82.73 -20.12 36.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.657 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.545 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -71.23 -37.44 72.01 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 112' ' ' MET . 23.1 mt -64.64 -37.27 79.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.201 0.524 . . . . 0.0 109.603 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 86.6 mt-30 -66.6 -27.36 67.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.724 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -85.65 -46.26 10.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.039 0.447 . . . . 0.0 111.045 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -79.33 -55.36 5.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.778 -173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.14 -26.96 39.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.058 0.456 . . . . 0.0 110.293 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.96 19.98 62.02 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.138 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.76 144.88 9.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 111.879 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.774 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 7.7 tpp180 -91.34 143.41 26.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.637 HG23 HD12 ' A' ' 113' ' ' ILE . 34.3 mm -129.01 142.21 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -170.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 1.012 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 3.8 pt20 -149.54 167.8 25.29 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 167.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.496 ' CE1' HD11 ' A' ' 106' ' ' ILE . 31.7 m-85 -121.95 133.55 54.83 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -152.66 128.16 10.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.352 -171.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 58.31 -166.64 0.15 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.052 0.453 . . . . 0.0 111.216 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.405 ' HA ' ' H ' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -145.33 -175.09 4.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.363 176.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.477 ' OD2' ' HB ' ' A' ' 132' ' ' THR . 51.2 p-10 -70.42 -11.49 60.95 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.73 7.55 87.3 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.328 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.477 ' HB ' ' OD2' ' A' ' 130' ' ' ASP . 34.6 m -113.34 -41.78 3.61 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 137.67 -58.82 0.63 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.75 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.55 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 15.0 Cg_exo -69.52 -17.18 38.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.795 2.33 . . . . 0.0 114.734 -170.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 51.1 mt-10 -127.18 141.35 51.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -114.02 130.62 56.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.478 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.572 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 23.5 mm -74.62 131.54 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -105.88 141.47 37.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.358 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 1.012 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -89.27 110.15 20.96 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.187 175.17 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.707 HD11 ' HB3' ' A' ' 150' ' ' ALA . 68.5 mt -94.26 135.84 27.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.463 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.774 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 41.6 ttm -122.92 124.55 43.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.056 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.59 -170.66 34.11 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.91 149.02 91.54 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.713 2.276 . . . . 0.0 111.986 174.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.4 -50.71 6.53 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 123.314 2.676 . . . . 0.0 113.665 -177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.66 -47.53 79.6 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.13 0.49 . . . . 0.0 110.224 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -60.0 -41.93 93.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.631 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.813 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 66.7 m -56.26 -60.53 3.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.224 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.631 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 38.2 mt-10 -66.82 -33.17 75.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.287 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -26.88 68.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.707 ' HB3' HD11 ' A' ' 140' ' ' ILE . . . -78.13 -37.19 46.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.826 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.27 67.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.409 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.631 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -76.56 -31.48 57.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.287 -178.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.44 -44.58 83.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.197 0.522 . . . . 0.0 109.644 174.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.669 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 70.4 mt -63.03 -53.38 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.741 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.576 HD21 HD12 ' A' ' 158' ' ' LEU . 12.0 m120 -55.47 -38.29 68.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.476 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -59.87 -44.1 94.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 110.756 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.12 -39.48 89.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.594 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 68.4 mt -61.25 -52.03 66.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.941 -178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 155' ' ' ASN . 10.5 mm100 -67.39 -21.75 65.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.072 0.463 . . . . 0.0 111.028 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 61.6 m -73.3 -22.46 60.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.835 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.5 mt -103.91 -49.65 3.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.252 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 68.56 -63.13 0.36 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.026 0.829 . . . . 0.0 109.313 -172.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.4 m -86.46 -90.25 0.11 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.51 175.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.368 -179.505 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.1 m -104.85 140.67 37.78 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.5 m -132.1 133.4 60.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.105 0.478 . . . . 0.0 111.179 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 5.4 mm-40 -108.09 145.08 34.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.909 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.728 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 42.1 mt-10 -112.05 104.28 12.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.329 0.585 . . . . 0.0 111.343 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 6' ' ' ILE . 4.0 mp -105.65 141.97 19.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.01 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.518 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 45.5 ttm -100.56 114.58 28.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.911 0.386 . . . . 0.0 110.646 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.459 ' HA ' HD11 ' A' ' 71' ' ' LEU . 1.8 mp -83.22 110.07 21.46 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.043 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.833 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 31.3 Cg_exo -62.26 137.25 64.65 Favored 'Trans proline' 0 CA--C 1.519 -0.259 0 C-N-CA 122.81 2.34 . . . . 0.0 111.273 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.59 114.88 3.22 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.56 -34.78 3.66 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -169.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.833 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -89.29 3.78 50.97 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 172.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' HB3' HD13 ' A' ' 17' ' ' ILE . . . -60.73 -41.19 94.85 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.545 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.82 -14.29 50.94 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.702 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.652 ' O ' HG21 ' A' ' 23' ' ' THR . 22.6 mt -89.56 -57.04 3.01 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.539 0.169 . . . . 0.0 111.187 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.423 HG21 HD12 ' A' ' 71' ' ' LEU . 61.8 t -79.58 -54.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.545 HD13 ' HB3' ' A' ' 13' ' ' ALA . 12.7 pt -92.47 -10.7 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.699 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.471 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 69.64 31.47 70.65 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 19' ' ' LYS . 44.1 tptt 73.27 -58.08 0.61 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.097 0.959 . . . . 0.0 111.356 -178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.2 24.48 5.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.874 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 24' ' ' ILE . . . 116.06 -13.21 16.86 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.684 174.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.486 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 35.8 mm-40 -56.95 -46.67 81.94 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.652 HG21 ' O ' ' A' ' 15' ' ' LEU . 55.4 m -80.33 -34.24 36.82 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.265 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.498 HD12 HD21 ' A' ' 37' ' ' LEU . 5.2 tp -62.28 -24.96 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.486 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 83.6 mttt -57.25 -58.89 6.25 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.102 170.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.46 ' CB ' ' HB3' ' A' ' 81' ' ' ASP . 42.7 mt-30 -67.57 -20.25 65.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.206 -174.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.828 HD21 ' HE3' ' A' ' 66' ' ' MET . 85.3 mt -79.74 -30.85 40.97 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.22 173.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.441 ' HG3' ' HE1' ' A' ' 35' ' ' MET . 79.8 mt-30 -84.31 -32.26 24.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.569 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.62 -63.38 1.33 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.606 0.241 . . . . 0.0 111.285 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.48 ' HB3' HH22 ' A' ' 82' ' ' ARG . 10.6 ttm180 -66.66 -31.45 72.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.162 -172.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -96.38 -27.17 15.05 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.37 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' HA3' ' NE2' ' A' ' 128' ' ' GLN . . . 78.56 2.89 85.98 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.774 -0.726 . . . . 0.0 113.286 175.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.67 HG22 ' SD ' ' A' ' 35' ' ' MET . 27.6 m -101.08 161.91 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -103.99 109.49 21.28 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.326 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.67 ' SD ' HG22 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -92.12 121.09 33.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 52' ' ' ARG . 6.2 tp -113.56 102.34 13.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.964 0.888 . . . . 0.0 109.219 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.749 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -132.31 142.21 49.26 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.819 -176.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.619 HG21 ' H ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -60.77 122.24 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.403 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.2 -37.23 0.57 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.299 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.85 -48.11 55.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.121 0.486 . . . . 0.0 110.398 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.63 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 137.14 34.48 0.2 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.335 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -78.99 -22.32 45.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.037 0.446 . . . . 0.0 110.829 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.519 ' HB3' HG12 ' A' ' 38' ' ' ILE . 54.1 tp60 -136.72 -80.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.781 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.619 ' H ' HG21 ' A' ' 38' ' ' ILE . 96.7 m-20 -107.56 87.31 2.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.168 0.509 . . . . 0.0 110.757 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.63 ' HB ' ' HA2' ' A' ' 41' ' ' GLY . 1.8 t -81.51 -42.67 19.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.262 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -94.17 -35.45 12.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.746 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.72 160.33 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.386 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.604 ' OD1' ' HA ' ' A' ' 9' ' ' PRO . 61.7 m-20 -49.53 139.93 11.52 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.391 0.432 . . . . 0.0 111.05 177.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 65.2 mttt -113.06 128.52 25.52 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.163 -165.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -84.8 140.29 7.96 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.798 2.332 . . . . 0.0 113.376 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.749 ' HA ' ' HB3' ' A' ' 37' ' ' LEU . 9.0 tt -117.92 139.81 50.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.361 -174.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.545 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.3 mpt_? -123.35 123.42 40.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.453 0.168 . . . . 0.0 110.589 170.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.4 mt -93.82 116.77 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.7 mt -103.67 120.34 53.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.653 0.263 . . . . 0.0 111.281 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.09 -170.76 43.51 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.372 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.516 ' HB3' ' HE2' ' A' ' 59' ' ' LYS . 9.9 t70 -60.57 138.81 92.78 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.847 -0.677 . . . . 0.0 110.675 172.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.42 -28.83 9.06 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.967 3.111 . . . . 0.0 114.676 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -73.17 -52.05 15.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.949 0.404 . . . . 0.0 110.225 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.749 ' HB3' ' HZ1' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -68.83 -30.14 68.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.468 -177.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.6 -32.87 51.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.448 175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.447 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 0.8 OUTLIER -70.23 -52.45 23.1 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -65.01 -23.2 67.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.358 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.665 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -86.6 -43.97 12.25 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.949 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 68' ' ' MET . 30.4 p -61.9 -30.98 71.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.692 0.282 . . . . 0.0 111.447 -174.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.415 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 6.0 pt-20 -83.43 -30.51 27.24 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.794 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.828 ' HE3' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -79.3 -34.34 42.5 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.326 -176.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.08 -27.45 42.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.924 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 44.8 mtm -82.95 -35.95 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 0.0 109.607 171.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.531 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 36.0 t70 -62.97 -43.76 97.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.782 -175.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.851 HG23 ' HA ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -87.05 -21.5 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.37 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 8' ' ' ILE . 3.5 tt -84.29 -24.69 29.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.64 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -35.55 76.39 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.146 -0.222 . . . . 0.0 110.537 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 1.1 pt-20 37.83 -145.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.199 0.937 . . . . 0.0 112.867 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.436 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 8.1 ptm180 173.26 -12.67 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.264 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -154.87 35.62 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.531 -173.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? 58.54 76.13 0.36 Allowed 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.614 0.721 . . . . 0.0 109.404 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.66 116.78 0.72 Allowed Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.257 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . -99.37 -75.32 1.18 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.264 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -144.53 -58.38 0.37 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.768 0.794 . . . . 0.0 109.028 176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.42 -91.3 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.46 ' HB3' ' CB ' ' A' ' 26' ' ' GLN . 5.7 p-10 -90.52 -44.75 9.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 164.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.851 ' HA ' HG23 ' A' ' 70' ' ' ILE . 0.0 OUTLIER 170.37 -51.46 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.689 -172.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.493 ' HA ' ' HB2' ' A' ' 94' ' ' ASP . 18.8 m120 57.45 53.41 7.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 171.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 0.7 OUTLIER -174.36 2.99 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 177.559 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.823 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -161.66 -71.53 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.987 -1.071 . . . . 0.0 110.959 174.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.484 ' CA ' ' HA ' ' A' ' 31' ' ' ALA . . . 53.67 65.67 3.27 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.581 -174.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.511 ' C ' ' HD2' ' A' ' 88' ' ' ARG . 17.0 t 74.31 -21.62 0.27 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.692 0.797 . . . . 0.0 112.086 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.569 ' HG3' ' HB2' ' A' ' 127' ' ' LYS . 2.6 mmm180 -119.05 -166.32 1.24 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -172.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.823 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 55.6 mt 70.59 -83.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 167.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.573 ' HA2' ' HD2' ' A' ' 85' ' ' TYR . . . 62.87 54.97 29.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.126 -173.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 128.96 58.71 0.11 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.513 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 89' ' ' ILE . . . 164.59 163.28 17.34 Favored Glycine 0 C--O 1.207 -1.572 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.0 pt -90.31 154.26 3.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 119.14 1.47 . . . . 0.0 112.39 -169.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 83' ' ' ASN . 36.2 m-20 -90.38 117.48 29.13 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.836 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.65 HG23 HD13 ' A' ' 140' ' ' ILE . 1.3 t -116.69 95.1 45.48 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.874 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.17 108.53 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.52 2.146 . . . . 0.0 111.782 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.619 HG13 ' HA ' ' A' ' 102' ' ' VAL . 86.0 t -94.77 118.75 66.74 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.443 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.619 ' HD2' HD23 ' A' ' 158' ' ' LEU . 47.0 Cg_exo -38.11 123.6 0.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.014 2.476 . . . . 0.0 111.478 171.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -34.46 -58.55 0.48 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -168.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -71.92 -23.71 61.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 t -78.63 -15.1 58.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.594 0.235 . . . . 0.0 111.143 -172.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.619 ' HA ' HG13 ' A' ' 97' ' ' VAL . 58.1 t -54.82 -37.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.154 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.51 -36.03 82.87 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.701 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.625 HG23 HD11 ' A' ' 161' ' ' LEU . 61.4 t -73.18 -37.83 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.353 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.33 -34.28 69.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.346 0.593 . . . . 0.0 110.36 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.708 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 39.7 mm -76.45 -43.57 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.29 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.56 34.87 8.21 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.477 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 65.65 -75.28 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.357 0.663 . . . . 0.0 111.673 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 m -87.49 2.79 49.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 114' ' ' LYS . . . 92.52 14.08 56.06 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.877 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -65.89 -40.86 91.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.751 0.31 . . . . 0.0 111.297 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 55.7 tpp -78.23 -36.34 47.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.708 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.0 tp -68.18 -29.66 45.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.816 0.341 . . . . 0.0 110.157 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 110' ' ' GLY . 42.2 mmtm -70.16 -34.73 73.37 Favored 'General case' 0 CA--C 1.523 -0.086 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 173.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 112' ' ' MET . 25.5 mmmt -61.61 -38.7 88.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.981 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.12 -43.04 95.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.26 0.552 . . . . 0.0 109.552 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 60.5 mt-30 -69.04 -26.81 65.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.733 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -86.22 -45.54 11.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.073 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.17 -36.42 47.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.986 -173.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 146' ' ' ARG . . . -103.98 -20.35 13.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.96 37.96 31.81 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.886 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.409 HG12 HG22 ' A' ' 140' ' ' ILE . 33.1 m -112.79 154.23 14.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.959 0.409 . . . . 0.0 111.944 -173.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.547 ' HD3' ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -108.25 135.18 50.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.607 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.547 ' N ' ' HD3' ' A' ' 123' ' ' ARG . 45.3 mm -99.58 143.66 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.087 0.47 . . . . 0.0 111.957 -170.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 5.5 tt0 -147.79 104.95 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.682 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -74.29 111.42 9.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.061 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.569 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -125.22 156.32 38.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.181 -173.715 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . 0.519 ' NE2' ' HA3' ' A' ' 32' ' ' GLY . 12.0 mm100 69.08 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.848 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 24.3 m-20 -90.48 104.82 17.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.112 0.482 . . . . 0.0 111.285 -171.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.409 ' O ' ' HE2' ' A' ' 136' ' ' LYS . 16.4 t70 -132.6 -49.16 0.9 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.514 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -97.82 19.78 53.23 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.3 t -161.08 158.37 27.6 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.92 160.39 36.35 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.856 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.27 -14.85 10.45 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.575 2.183 . . . . 0.0 111.682 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -131.24 152.79 50.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.913 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.513 ' HD2' HG22 ' A' ' 102' ' ' VAL . 82.8 mttt -110.7 113.36 25.91 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.496 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 1.7 mm -72.55 112.57 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.194 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 95' ' ' VAL . . . -96.29 135.8 37.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.802 173.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.779 ' CE1' HG22 ' A' ' 89' ' ' ILE . 1.5 t60 -86.87 109.04 19.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.903 174.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 150' ' ' ALA . 41.0 mt -91.19 123.25 43.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 170.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.451 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 13.9 ttp -112.53 131.41 55.61 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -171.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.32 -178.11 27.98 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.68 147.13 96.04 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.859 1.706 . . . . 0.0 110.764 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -41.16 -44.27 5.32 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.475 2.783 . . . . 0.0 112.834 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.31 -40.96 62.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.789 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 9.3 mtm180 -84.53 -38.89 19.48 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.509 ' HA ' ' CG2' ' A' ' 140' ' ' ILE . 61.2 m -58.59 -61.32 2.69 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 111.002 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.67 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 6.2 mm-40 -58.02 -40.85 81.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.182 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -57.58 -31.96 66.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.903 0.382 . . . . 0.0 111.282 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.687 ' HB3' HD11 ' A' ' 140' ' ' ILE . . . -78.46 -36.79 44.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.972 0.415 . . . . 0.0 110.915 -176.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.17 -24.1 66.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.798 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.67 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 11.3 mpt_? -78.59 -28.04 45.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.755 0.312 . . . . 0.0 110.424 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.3 mt -70.15 -47.93 64.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.233 0.539 . . . . 0.0 109.551 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.505 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.0 mt -63.18 -42.99 98.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.705 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -57.84 -39.21 77.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.982 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.55 -32.58 74.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.772 0.32 . . . . 0.0 110.302 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 44.0 mt -67.64 -47.95 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.969 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.619 HD23 ' HD2' ' A' ' 98' ' ' PRO . 13.3 mt -59.69 -40.56 88.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.896 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -68.02 -31.18 70.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.452 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 64.1 m -79.29 -27.03 42.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.266 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.625 HD11 HG23 ' A' ' 104' ' ' VAL . 82.6 mt -86.17 -34.49 20.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.483 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.4 mtm-85 65.67 95.53 0.06 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.555 0.693 . . . . 0.0 111.614 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.7 m -97.05 68.85 2.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.356 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.58 178.402 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 57' ' ' PRO . 1.6 m -81.45 85.33 6.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.958 0.408 . . . . 0.0 110.25 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 12.0 m -124.12 128.79 74.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.09 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -114.15 133.95 55.23 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.543 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.578 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 43.5 mt-10 -103.04 126.12 50.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.223 0.535 . . . . 0.0 111.869 -175.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.421 ' N ' HD11 ' A' ' 6' ' ' ILE . 4.2 mp -117.8 144.52 25.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 174.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.4 mtp -93.1 112.44 24.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.158 0.504 . . . . 0.0 110.777 -176.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.521 HG12 HG13 ' A' ' 16' ' ' VAL . 1.7 mp -95.21 114.93 64.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.706 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.558 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 41.8 Cg_exo -61.72 152.42 74.23 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.449 2.766 . . . . 0.0 112.815 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.73 131.51 45.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.61 -42.01 2.13 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -169.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 9' ' ' PRO . 13.1 tptt -68.7 -32.48 72.31 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.703 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -52.39 -31.75 35.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.315 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.617 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -59.0 -42.09 96.73 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.431 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.906 HD22 ' HA ' ' A' ' 76' ' ' GLN . 3.8 pp -89.67 -17.95 27.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.756 0.278 . . . . 0.0 111.663 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.521 HG13 HG12 ' A' ' 8' ' ' ILE . 82.9 t -83.5 -48.69 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.703 HG12 ' O ' ' A' ' 13' ' ' ALA . 13.3 pt -90.52 -24.79 5.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.516 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 100.91 11.58 39.66 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.669 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.617 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 5.4 tptm 52.33 44.2 30.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.324 0.583 . . . . 0.0 110.353 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.83 -24.4 0.55 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.474 -173.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.99 -11.53 7.34 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.331 175.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -59.32 -34.32 72.19 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -174.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 15' ' ' LEU . 28.3 m -84.23 -41.57 16.8 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.316 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 35' ' ' MET . 8.3 tp -66.44 -32.4 57.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -47.91 -48.14 31.83 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.58 170.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 49.4 mt-30 -73.8 -42.07 61.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.657 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.533 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 81.6 mt -60.65 -28.1 68.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.179 0.514 . . . . 0.0 110.709 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 87.6 mt-30 -85.58 -53.75 4.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.567 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -82.23 -49.75 9.75 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -172.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.507 ' HD3' ' OD2' ' A' ' 81' ' ' ASP . 21.3 ttt180 -67.61 -51.75 46.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 110.01 -176.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.634 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -70.31 -29.05 65.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.934 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.07 3.23 87.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.832 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.1 m -103.44 -179.34 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.039 0.447 . . . . 0.0 110.376 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -121.5 114.25 20.97 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.67 ' HB2' HD11 ' A' ' 24' ' ' ILE . 51.6 mtt -100.66 121.1 41.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.457 HG21 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tp -114.02 110.99 34.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.915 0.864 . . . . 0.0 110.213 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.822 HD11 HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -133.22 144.42 49.78 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.319 -174.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.6 mm -60.76 100.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.134 0.492 . . . . 0.0 110.615 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.528 ' HG2' HG22 ' A' ' 17' ' ' ILE . 42.4 mt-30 -105.4 -42.73 5.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.526 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.74 -19.65 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.511 -177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.04 49.46 3.53 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.199 174.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 m -59.83 -71.37 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.832 0.349 . . . . 0.0 110.847 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -117.85 -26.0 6.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.146 0.498 . . . . 0.0 110.832 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -107.56 75.35 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.985 0.422 . . . . 0.0 110.823 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 p -83.29 -63.22 1.4 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.927 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -94.96 -4.47 46.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.289 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.24 158.21 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.004 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.46 144.77 16.13 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.49 0.494 . . . . 0.0 110.872 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -117.46 127.98 26.31 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.796 -171.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.88 116.76 3.49 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.248 1.966 . . . . 0.0 112.141 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.822 HD12 HD11 ' A' ' 37' ' ' LEU . 8.4 tt -98.48 119.89 37.95 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.483 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.578 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.4 mpt_? -100.11 116.27 31.75 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 176.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.503 ' CG2' HG23 ' A' ' 60' ' ' VAL . 27.7 mt -89.43 118.37 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.444 HG12 ' CG1' ' A' ' 3' ' ' VAL . 27.5 mt -104.67 121.32 56.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 177.49 -177.92 48.32 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.483 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.578 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 13.8 t70 -62.04 139.98 95.9 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.602 ' HA ' HG22 ' A' ' 2' ' ' THR . 69.7 Cg_exo -38.7 -45.86 2.51 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.912 3.075 . . . . 0.0 115.157 -175.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -74.43 -33.51 62.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.251 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.982 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 19.0 ptpt -79.2 -41.68 27.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -175.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.503 HG23 ' CG2' ' A' ' 53' ' ' ILE . 8.0 p -67.36 -24.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.503 0.668 . . . . 0.0 109.935 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -66.88 -57.89 6.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.24 178.066 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -61.45 -33.16 73.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -69.51 -45.73 68.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.745 177.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.437 ' HA ' HG21 ' A' ' 67' ' ' VAL . 42.8 t -58.97 -35.63 73.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.52 0.676 . . . . 0.0 109.632 177.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.25 -37.08 84.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.616 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.822 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 15.5 ptt? -84.95 -33.47 22.65 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.975 -176.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 35.1 m -62.37 -28.96 45.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.299 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.6 mtm -81.6 -21.03 38.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 110.32 174.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -83.2 -46.26 12.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.894 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.697 HG23 ' HD1' ' A' ' 79' ' ' PHE . 2.6 pp -83.22 -26.7 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.333 . . . . 0.0 111.743 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 6.0 tt -75.72 -18.35 59.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.876 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -53.39 -42.1 66.61 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.505 ' HG2' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER 56.07 137.73 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 170.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.415 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 72.7 mtp180 -112.43 -13.45 13.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 161.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.505 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 36.1 t70 -163.18 135.06 5.1 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.544 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.906 ' HA ' HD22 ' A' ' 15' ' ' LEU . 78.4 mt-30 -43.81 106.65 0.07 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.289 1.042 . . . . 0.0 112.188 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.469 ' N ' ' HB3' ' A' ' 15' ' ' LEU . . . 150.82 -34.38 0.95 Allowed Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.103 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.95 -111.23 3.61 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.697 ' HD1' HG23 ' A' ' 70' ' ' ILE . 97.3 m-85 -127.78 -13.77 5.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.74 0.305 . . . . 0.0 110.609 174.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.561 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 81.23 91.92 0.52 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -174.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.561 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 5.7 t70 71.22 -75.04 0.08 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -170.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.822 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 24.9 ttt180 173.17 -35.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 O-C-N 124.18 0.925 . . . . 0.0 110.332 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 69.19 13.54 8.62 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.65 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.792 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 84.9 tt0 -123.96 -34.43 2.99 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.608 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 25.6 p90 171.27 127.31 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.139 175.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.747 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -82.99 -66.69 1.51 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.946 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.982 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 45.2 m -144.98 22.56 1.57 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.776 0.798 . . . . 0.0 109.125 176.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 1.8 mpt_? -133.84 -164.16 1.46 Allowed 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.043 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.608 ' HB ' ' HB3' ' A' ' 85' ' ' TYR . 23.9 mt 64.71 -81.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.45 50.71 57.86 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 132.96 85.02 0.26 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.286 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 153.94 -143.76 10.48 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.792 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.9 pt -144.97 160.55 13.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 117.302 0.551 . . . . 0.0 110.844 175.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.464 ' OD1' HD13 ' A' ' 89' ' ' ILE . 5.0 m-20 -107.0 119.68 40.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.949 173.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.803 HG21 ' HB1' ' A' ' 138' ' ' ALA . 6.2 m -113.35 104.88 55.56 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.169 0.509 . . . . 0.0 112.172 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.518 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 51.8 Cg_endo -72.34 108.6 2.54 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.816 2.344 . . . . 0.0 111.634 173.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.634 HG13 HD22 ' A' ' 158' ' ' LEU . 46.9 t -102.35 124.92 37.87 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.071 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.588 ' HD2' HD23 ' A' ' 158' ' ' LEU . 78.7 Cg_exo -44.54 133.65 9.8 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.636 2.89 . . . . 0.0 112.783 173.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -58.59 -30.6 67.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.651 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -89.88 1.36 56.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.424 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.474 ' O ' HG21 ' A' ' 105' ' ' VAL . 25.1 m -119.56 -27.97 5.41 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.54 ' HA ' HG11 ' A' ' 97' ' ' VAL . 11.2 p -52.33 -34.43 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.38 -37.76 94.19 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.85 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.9 -37.14 53.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 0.0 110.36 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 101' ' ' SER . 48.0 t -65.35 -38.67 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.326 0.584 . . . . 0.0 110.669 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.793 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 13.7 mt -81.03 -26.33 10.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.238 0.542 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.4 48.44 5.94 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 59.02 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.83 0.852 . . . . 0.0 112.244 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.9 m -75.08 -24.49 58.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 111.065 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.402 ' HA2' ' CG2' ' A' ' 106' ' ' ILE . . . 130.41 50.7 0.11 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.725 177.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.546 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 40.4 mt-10 -93.42 -58.98 2.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.882 0.373 . . . . 0.0 110.302 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.504 ' SD ' HD11 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -68.37 -31.54 70.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.163 -173.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.793 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.0 tp -65.46 -22.88 31.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.253 0.549 . . . . 0.0 110.675 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -82.32 -26.06 33.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.046 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 111' ' ' GLU . 2.7 mptp? -65.24 -38.13 89.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.504 HD11 ' SD ' ' A' ' 112' ' ' MET . 28.9 mm -59.12 -43.12 88.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.491 175.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.452 HE21 HG12 ' A' ' 124' ' ' ILE . 59.7 mt-30 -67.04 -33.61 75.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.744 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -79.26 -42.32 26.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.613 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.64 -40.62 33.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.464 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.17 18.47 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.93 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.19 46.35 8.25 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.464 HG12 HG22 ' A' ' 140' ' ' ILE . 1.9 t -118.02 143.75 27.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.109 -0.546 . . . . 0.0 111.678 -169.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.475 ' HD3' ' SD ' ' A' ' 141' ' ' MET . 79.4 mtp180 -103.53 148.68 25.67 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.452 HG12 HE21 ' A' ' 117' ' ' GLN . 46.2 mm -114.63 135.03 55.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.189 0.519 . . . . 0.0 111.937 -171.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.571 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 24.1 tt0 -137.32 105.67 5.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.219 176.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 33.6 m-85 -80.76 106.53 12.84 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 121.942 -0.474 . . . . 0.0 109.949 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.827 ' HE2' ' O ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.47 127.28 48.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.235 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 63.81 -170.3 0.19 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.384 0.612 . . . . 0.0 111.589 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -138.57 -168.3 2.37 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -68.81 -27.5 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 132.73 -20.94 4.28 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.453 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.882 HG22 ' HD2' ' A' ' 134' ' ' PRO . 6.2 t -136.62 -27.21 1.05 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.87 -47.74 0.68 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.368 -1.396 . . . . 0.0 115.465 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.882 ' HD2' HG22 ' A' ' 132' ' ' THR . 51.0 Cg_exo -37.76 -47.76 2.02 Favored 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 123.777 2.984 . . . . 0.0 115.091 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 130' ' ' ASP . 20.1 mt-10 -132.74 146.35 51.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.358 0.599 . . . . 0.0 111.525 -177.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -119.47 115.94 25.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.747 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.572 HG21 ' NZ ' ' A' ' 127' ' ' LYS . 18.0 mm -72.84 108.32 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.569 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.803 ' HB1' HG21 ' A' ' 95' ' ' VAL . . . -96.79 141.4 30.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.671 175.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.593 ' CG ' HG12 ' A' ' 89' ' ' ILE . 3.2 t-160 -91.52 117.52 29.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.879 0.371 . . . . 0.0 110.414 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.684 HD12 ' HB1' ' A' ' 150' ' ' ALA . 37.9 mt -97.17 118.24 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.248 171.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.475 ' SD ' ' HD3' ' A' ' 123' ' ' ARG . 46.3 ttm -102.13 121.61 42.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 -174.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 164.33 170.26 29.02 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.16 150.83 82.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.585 2.19 . . . . 0.0 111.6 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.691 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 87.2 Cg_exo -42.3 -40.02 6.65 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.931 3.087 . . . . 0.0 114.999 -172.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.3 -32.07 64.4 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.998 -0.439 . . . . 0.0 110.855 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -85.0 -35.17 22.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.778 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.691 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 27.7 p -62.99 -51.08 68.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.594 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 28.3 mt-10 -66.38 -29.01 69.09 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.935 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -55.49 -36.08 66.26 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.116 0.484 . . . . 0.0 110.136 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.684 ' HB1' HD12 ' A' ' 140' ' ' ILE . . . -79.14 -35.04 42.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.922 -174.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' A' ' 93' ' ' ILE . . . -67.15 -24.93 65.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.594 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 2.9 mpt_? -77.84 -18.5 56.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.981 0.42 . . . . 0.0 110.314 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.5 mt -82.41 -44.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 66.7 mt -65.94 -52.51 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.347 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -60.74 -30.21 69.85 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.251 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.63 -39.48 93.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.996 0.427 . . . . 0.0 110.013 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.424 HD11 ' HE1' ' A' ' 112' ' ' MET . 82.7 mt -67.07 -44.06 81.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.776 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.634 HD22 HG13 ' A' ' 97' ' ' VAL . 71.3 mt -63.1 -33.8 76.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.776 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -73.34 -37.66 66.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.447 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.8 t -71.04 -38.57 72.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.685 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 163' ' ' SER . 74.1 mt -80.36 -78.36 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 56.29 -77.45 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.093 0.871 . . . . 0.0 113.099 174.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 161' ' ' LEU . 38.5 t 169.96 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -173.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.818 178.571 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.437 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.683 HG21 ' HA ' ' A' ' 57' ' ' PRO . 36.5 m -137.09 94.91 3.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.051 0.453 . . . . 0.0 109.986 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 17.5 m -132.28 141.4 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.699 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -123.52 141.72 51.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.732 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 45.6 mt-10 -112.23 121.38 44.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.363 0.601 . . . . 0.0 111.703 -175.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.625 HG13 HG22 ' A' ' 67' ' ' VAL . 44.7 mm -110.52 150.08 13.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.665 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.481 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 50.4 tpp -101.37 117.03 34.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.881 0.372 . . . . 0.0 110.848 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.743 HG12 HG12 ' A' ' 16' ' ' VAL . 3.0 mp -99.37 104.39 26.56 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.185 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 7' ' ' MET . 21.2 Cg_exo -67.52 159.45 52.44 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 123.08 2.52 . . . . 0.0 111.82 177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.51 141.56 57.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.14 -51.42 1.89 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -172.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.78 -25.01 64.49 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.004 0.431 . . . . 0.0 110.411 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.738 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -52.11 -37.47 54.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.67 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.546 ' HA3' ' OE1' ' A' ' 76' ' ' GLN . . . -63.03 -38.46 96.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.984 -178.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 1.051 HD23 ' HA ' ' A' ' 76' ' ' GLN . 2.9 pp -89.93 -15.82 31.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.98 0.39 . . . . 0.0 111.656 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.743 HG12 HG12 ' A' ' 8' ' ' ILE . 70.8 t -90.2 -49.94 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.738 HG12 ' O ' ' A' ' 13' ' ' ALA . 17.6 pt -87.51 -23.42 6.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.321 -0.551 . . . . 0.0 109.895 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.713 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 89.92 17.95 52.33 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.719 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 29.7 mmtp 65.05 -63.36 0.19 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.667 0.787 . . . . 0.0 111.658 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.75 19.35 47.56 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.257 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 92.82 8.04 62.33 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.025 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.604 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 28.6 tt0 -63.01 -48.34 79.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.687 0.28 . . . . 0.0 111.594 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.713 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 78.9 m -67.23 -39.45 86.23 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.204 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.626 HD11 HD11 ' A' ' 27' ' ' LEU . 1.3 tp -64.6 -22.1 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.67 0.272 . . . . 0.0 110.899 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.604 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 49.8 mttm -56.79 -57.86 10.62 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.619 0.723 . . . . 0.0 109.981 173.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -69.31 -26.98 65.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.963 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.907 HD21 ' HE3' ' A' ' 66' ' ' MET . 36.6 mt -75.03 -30.14 61.0 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.045 -0.409 . . . . 0.0 111.019 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.695 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.2 mt-30 -84.83 -42.45 15.1 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.032 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -88.07 -62.1 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.634 HH21 ' HA3' ' A' ' 86' ' ' GLY . 2.2 ttp180 -58.47 -43.75 89.02 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.933 0.397 . . . . 0.0 110.891 -176.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.658 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -75.45 -22.39 57.36 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.356 0.598 . . . . 0.0 111.178 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.99 78.4 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.778 -0.647 . . . . 0.0 112.672 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 28.6 m -121.75 151.0 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.843 0.354 . . . . 0.0 110.455 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -89.19 109.49 20.36 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 1.041 ' HB3' HD11 ' A' ' 51' ' ' LEU . 59.4 mtt -98.2 114.43 26.67 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.671 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.9 tp -110.44 112.25 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 122.006 0.908 . . . . 0.0 109.677 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -132.29 143.38 49.85 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.95 -175.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 78.7 mt -54.37 107.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 124.01 0.819 . . . . 0.0 111.892 -173.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -126.37 -14.55 5.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.837 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.28 158.61 20.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.676 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.29 69.11 0.88 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.966 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.4 t -89.38 -62.89 1.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -175.6 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.393 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -86.75 62.5 7.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.114 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 p -83.29 -61.13 1.93 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.81 0.338 . . . . 0.0 111.347 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -93.39 -17.08 23.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.283 0.563 . . . . 0.0 109.819 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 11.9 t -79.15 166.17 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.886 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.4 p30 -47.84 140.91 6.13 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.159 0.504 . . . . 0.0 111.282 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 16.6 mtmm -130.1 137.46 30.92 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.087 -170.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.53 133.21 5.22 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.597 2.198 . . . . 0.0 112.4 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 1.041 HD11 ' HB3' ' A' ' 35' ' ' MET . 22.4 tp -108.05 120.18 41.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.813 -177.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.671 ' HB2' HG23 ' A' ' 36' ' ' ILE . 5.1 mpt_? -96.27 115.57 27.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.37 174.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.3 mt -91.47 110.1 22.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.786 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.442 HG12 ' CG1' ' A' ' 3' ' ' VAL . 35.3 mt -108.06 121.04 60.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.452 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.512 ' HA3' HG13 ' A' ' 33' ' ' VAL . . . 172.86 -170.2 43.33 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.986 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 1.003 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . 2.1 m-20 -51.03 146.75 10.11 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.647 0.263 . . . . 0.0 110.514 175.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.683 ' HA ' HG21 ' A' ' 2' ' ' THR . 51.3 Cg_exo -54.72 -52.62 7.66 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 121.909 1.739 . . . . 0.0 112.773 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -61.03 -30.65 70.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.638 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 1.003 ' HG3' ' HB2' ' A' ' 56' ' ' ASP . 46.1 mttp -64.77 -47.97 76.22 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.294 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.31 -39.0 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.165 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.19 -51.88 67.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.564 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.877 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -68.7 -35.43 77.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 -178.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -72.31 -42.48 65.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.89 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 47.3 t -57.35 -36.76 71.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.358 0.599 . . . . 0.0 109.568 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -67.49 -45.63 75.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.21 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.907 ' HE3' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -73.94 -37.7 64.48 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.837 -175.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.625 HG22 HG13 ' A' ' 6' ' ' ILE . 35.9 m -62.49 -35.18 68.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.678 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.72 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 66.2 mtt -71.24 -21.22 62.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.737 0.303 . . . . 0.0 110.632 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.597 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 8.9 t70 -85.59 -41.51 15.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.967 0.413 . . . . 0.0 111.04 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.839 HG23 ' HD1' ' A' ' 79' ' ' PHE . 2.1 pp -86.85 -23.99 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.922 0.392 . . . . 0.0 111.856 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.612 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 3.6 tt -86.47 -20.06 28.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.551 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.72 ' HB3' ' O ' ' A' ' 68' ' ' MET . 5.3 ptm180 -61.55 -11.36 10.81 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.85 0.357 . . . . 0.0 111.076 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 1.029 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 16.0 tp10 -50.98 138.79 18.65 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.401 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -66.7 -30.08 70.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.827 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.448 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 29.1 t70 -135.23 -89.32 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.716 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 1.051 ' HA ' HD23 ' A' ' 15' ' ' LEU . 9.3 tt0 -153.66 61.45 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.544 0.688 . . . . 0.0 110.296 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 1.029 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . -137.64 30.49 2.58 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.8 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.75 158.27 40.73 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.839 ' HD1' HG23 ' A' ' 70' ' ' ILE . 4.5 m-85 -60.59 -45.51 93.7 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.82 -75.49 0.42 Allowed Glycine 0 CA--C 1.496 -1.099 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 169.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.525 ' HA ' HD23 ' A' ' 27' ' ' LEU . 19.2 p-10 -92.33 -15.61 27.12 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.418 -0.891 . . . . 0.0 110.473 174.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.44 ' CB ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER 84.58 64.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.635 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.556 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 28.8 t-20 -49.54 102.93 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.709 176.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 1.07 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.7 tt0 162.65 -41.97 0.0 OUTLIER 'General case' 0 C--O 1.232 0.157 0 O-C-N 124.572 1.17 . . . . 0.0 108.32 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 53.2 p90 -175.03 151.27 1.3 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.449 -177.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.61 80.04 0.18 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.877 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 40.1 m 72.38 -20.41 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.107 0.479 . . . . 0.0 111.001 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.566 ' HD3' ' H ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -103.96 154.03 20.13 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.733 171.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.686 HG23 ' CE1' ' A' ' 139' ' ' HIS . 33.3 mm 62.58 -88.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.119 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.03 46.45 1.73 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.661 -172.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.464 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 151.71 164.82 12.48 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.739 -0.545 . . . . 0.0 111.739 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.742 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 86.13 -122.02 5.91 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.081 -0.581 . . . . 0.0 111.724 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 1.07 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 28.7 pt -155.43 178.5 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 122.921 0.489 . . . . 0.0 109.852 171.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.476 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -120.22 137.04 54.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.694 170.364 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 29.2 t -124.12 98.06 39.55 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.073 -175.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.485 ' HA ' HD12 ' A' ' 137' ' ' ILE . 38.2 Cg_endo -69.98 107.75 1.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.671 1.581 . . . . 0.0 110.92 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.653 HG21 HG22 ' A' ' 105' ' ' VAL . 14.8 p -116.02 126.75 27.35 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.014 0.435 . . . . 0.0 110.574 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.528 ' HA ' ' HG2' ' A' ' 135' ' ' GLU . 73.6 Cg_exo -46.96 136.17 17.54 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.499 2.799 . . . . 0.0 112.546 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -54.77 -29.13 53.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.343 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -92.29 10.55 29.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.895 0.379 . . . . 0.0 111.354 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.478 ' HB3' HD23 ' A' ' 161' ' ' LEU . 46.1 m -128.64 -15.19 4.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.761 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 106' ' ' ILE . 7.6 p -64.51 -35.28 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.267 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.73 -28.56 73.5 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.184 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.29 -37.97 39.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.653 HG22 HG21 ' A' ' 97' ' ' VAL . 62.1 t -59.78 -41.09 84.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.919 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.76 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 46.0 mm -67.39 -46.3 83.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.245 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.06 33.26 9.02 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.611 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 108' ' ' ARG . 27.9 mtp180 64.9 -78.28 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.264 0.626 . . . . 0.0 111.914 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.428 ' HB2' ' HG3' ' A' ' 111' ' ' GLU . 18.0 m -81.81 11.32 5.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.878 0.37 . . . . 0.0 110.815 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.51 22.12 76.0 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.919 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 109' ' ' SER . 41.0 mt-10 -71.46 -50.47 31.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.895 0.378 . . . . 0.0 110.916 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.536 ' O ' HG12 ' A' ' 116' ' ' ILE . 13.6 tpt -68.49 -39.11 81.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.081 -173.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.76 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.3 tp -65.96 -32.37 57.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.608 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -81.41 -30.58 33.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.203 0.525 . . . . 0.0 109.731 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -66.15 -38.74 88.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.945 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 112' ' ' MET . 45.6 mm -62.15 -39.04 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.354 0.597 . . . . 0.0 109.651 174.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 77.6 mt-30 -65.8 -32.22 73.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.833 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -79.8 -42.4 24.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.567 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -79.46 -43.58 22.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.65 -18.94 20.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.929 0.395 . . . . 0.0 111.671 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.53 47.42 8.03 Favored Glycine 0 C--O 1.228 -0.223 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.886 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.438 ' HB ' HG23 ' A' ' 140' ' ' ILE . 27.1 m -122.17 179.58 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 111.653 -173.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.735 ' HB3' ' HG2' ' A' ' 141' ' ' MET . 43.1 ttt180 -145.68 145.78 31.04 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.548 HG13 HD11 ' A' ' 113' ' ' ILE . 44.9 mm -107.68 138.46 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -168.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.758 HE21 ' HA ' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -138.48 94.92 2.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.866 175.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 138' ' ' ALA . 44.2 m-85 -73.72 105.97 5.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.687 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -102.04 -166.74 1.32 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.076 -173.451 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.44 48.65 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -169.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -135.97 66.32 1.5 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -105.3 -48.16 3.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.952 -174.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.97 1.9 27.14 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.605 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.4 t -100.0 40.6 1.23 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.587 0.708 . . . . 0.0 110.775 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.88 165.84 28.83 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.925 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.41 -11.18 17.4 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.844 2.363 . . . . 0.0 111.231 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 98' ' ' PRO . 45.7 mt-10 -129.36 151.03 50.45 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.872 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.501 ' O ' HG13 ' A' ' 97' ' ' VAL . 66.9 mttm -109.38 113.82 26.97 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -175.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 14.9 mm -67.13 109.86 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.864 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.481 ' HB2' ' CE1' ' A' ' 126' ' ' PHE . . . -97.79 135.14 39.98 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 170.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.686 ' CE1' HG23 ' A' ' 89' ' ' ILE . 13.2 t60 -86.69 123.43 31.85 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.979 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.568 HD11 ' HB3' ' A' ' 150' ' ' ALA . 32.3 mt -103.24 126.15 57.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.275 171.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.735 ' HG2' ' HB3' ' A' ' 123' ' ' ARG . 16.8 ptp -107.23 165.49 11.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.958 0.409 . . . . 0.0 110.665 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.76 172.96 13.26 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.475 ' HD2' ' HD3' ' A' ' 146' ' ' ARG . 38.1 Cg_exo -58.89 143.5 99.36 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.415 2.076 . . . . 0.0 111.765 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.66 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 72.5 Cg_exo -41.59 -43.97 6.24 Favored 'Trans proline' 0 N--CA 1.476 0.466 0 C-N-CA 124.006 3.137 . . . . 0.0 114.497 -173.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 11.4 t70 -57.59 -42.93 84.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.612 0.244 . . . . 0.0 111.417 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.475 ' HD3' ' HD2' ' A' ' 143' ' ' PRO . 18.3 mtp180 -79.75 -39.15 31.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.52 -172.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.66 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 12.2 p -63.11 -50.65 69.64 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.652 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 5.7 mm-40 -62.21 -38.88 90.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.664 0.269 . . . . 0.0 110.718 176.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 18.6 t60 -57.66 -32.31 67.18 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.953 0.406 . . . . 0.0 111.076 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 140' ' ' ILE . . . -77.91 -34.02 51.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.778 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.505 ' HB2' HH11 ' A' ' 152' ' ' ARG . . . -67.47 -25.26 65.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.396 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.652 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 10.9 mpt_? -77.83 -32.73 52.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.845 0.355 . . . . 0.0 110.264 -177.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.444 ' O ' HD12 ' A' ' 157' ' ' LEU . 63.4 mt -65.4 -46.36 90.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.813 176.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.626 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 68.3 mt -62.41 -37.48 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.294 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.85 -31.3 69.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.462 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 159' ' ' GLN . 15.6 t70 -79.08 -37.48 38.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.14 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 153' ' ' ILE . 7.8 mp -53.49 -42.29 67.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 25.5 mt -62.22 -36.65 82.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.424 -176.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 156' ' ' ASP . 21.3 pt20 -84.21 -25.47 29.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.666 0.27 . . . . 0.0 111.31 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.3 m -79.64 -26.78 41.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -175.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.478 HD23 ' HB3' ' A' ' 101' ' ' SER . 3.5 pp -81.36 19.94 0.92 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -173.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -73.98 -26.5 60.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.262 0.554 . . . . 0.0 109.967 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.9 t -159.29 110.93 2.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.471 0 C-N-CA 120.111 -1.043 . . . . 0.0 113.279 -174.823 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 15.0 m -133.54 115.18 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.502 0.668 . . . . 0.0 111.525 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -115.28 141.33 48.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.487 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 39.5 mt-10 -109.77 136.04 49.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.555 0.693 . . . . 0.0 112.504 -174.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.0 148.22 29.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.07 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 68.3 mtp -101.49 129.18 47.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.151 0.5 . . . . 0.0 111.56 -174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 51' ' ' LEU . 3.9 mp -105.54 107.29 58.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.301 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.494 ' HD2' ' HG3' ' A' ' 12' ' ' LYS . 8.1 Cg_exo -74.64 152.23 42.43 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.211 2.607 . . . . 0.0 111.429 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.61 129.43 40.53 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.47 -15.4 24.77 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HD2' ' O ' ' A' ' 71' ' ' LEU . 71.0 mmtt -112.66 9.27 19.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.045 0.45 . . . . 0.0 110.132 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.417 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -62.92 -41.67 99.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.95 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.6 -15.72 66.72 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.175 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.862 HD11 ' HB2' ' A' ' 73' ' ' GLU . 24.7 mt -87.32 -58.61 2.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 120.81 0.338 . . . . 0.0 110.719 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.673 HG11 HG12 ' A' ' 8' ' ' ILE . 85.3 t -81.68 -48.83 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 13' ' ' ALA . 39.8 pt -91.52 -26.78 4.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.917 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.35 33.92 13.18 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.457 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm 57.65 29.66 17.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.977 0.511 . . . . 0.0 112.093 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.1 -33.47 0.61 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 119.951 -1.119 . . . . 0.0 113.304 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 157.07 -6.33 0.19 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 119.908 -1.139 . . . . 0.0 113.792 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.74 -46.57 67.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.964 0.382 . . . . 0.0 111.549 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 81' ' ' ASP . 86.0 m -73.36 -42.9 61.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.23 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.731 HD11 ' HB2' ' A' ' 35' ' ' MET . 5.8 tp -62.35 -26.1 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.75 -174.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 89.3 mttt -53.54 -56.89 13.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.945 0.879 . . . . 0.0 109.96 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.731 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 96.7 mt-30 -73.96 -27.69 61.12 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.607 -174.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.579 HD12 HD12 ' A' ' 24' ' ' ILE . 91.8 mt -66.59 -27.64 67.88 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.236 0.541 . . . . 0.0 109.853 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.679 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 97.2 mt-30 -85.41 -46.42 10.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.019 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -79.82 -62.44 1.68 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.504 ' HG2' HH22 ' A' ' 82' ' ' ARG . 3.0 ttm180 -62.34 -38.37 89.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.395 -173.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -87.51 -26.46 23.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.825 0.345 . . . . 0.0 111.634 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.4 70.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.76 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.5 m -127.41 156.06 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -94.25 109.37 21.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.822 ' HB3' HD21 ' A' ' 51' ' ' LEU . 48.8 mtt -100.24 114.04 27.18 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.172 0.51 . . . . 0.0 109.64 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.4 tt -111.72 113.8 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.982 0.896 . . . . 0.0 109.932 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.742 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 1.1 pt? -132.6 141.19 48.56 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.197 -175.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.692 HD13 ' HG2' ' A' ' 50' ' ' PRO . 2.1 mp -59.43 102.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.421 0.629 . . . . 0.0 111.012 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 19.46 17.73 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.6 123.37 25.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.405 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.767 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . -79.59 -0.97 85.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.225 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.6 m -90.09 -26.35 20.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.086 0.443 . . . . 0.0 110.865 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -115.79 -81.53 0.61 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.282 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.565 ' HB2' ' CG2' ' A' ' 38' ' ' ILE . 15.0 m120 -96.76 67.31 2.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.94 0.4 . . . . 0.0 110.994 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.767 ' HB ' ' HA2' ' A' ' 41' ' ' GLY . 1.9 t -83.44 -56.49 3.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.315 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -94.3 -21.8 18.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.124 0.488 . . . . 0.0 110.856 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.11 158.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.755 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.2 148.0 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.442 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -122.86 133.86 24.71 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.018 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.692 ' HG2' HD13 ' A' ' 38' ' ' ILE . 94.7 Cg_endo -86.98 119.91 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.421 2.081 . . . . 0.0 112.649 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.0 tt -88.06 111.11 21.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.675 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 2.6 mtp85 -96.73 100.12 11.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.722 0.296 . . . . 0.0 110.544 177.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 59.9 mt -80.83 112.61 19.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.23 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.4 mt -104.43 121.24 55.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.34 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.63 -171.01 44.21 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.23 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -69.05 153.1 96.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.5 -54.98 4.36 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.217 2.612 . . . . 0.0 114.227 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -65.68 -26.87 67.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 110.811 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.633 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 87.6 mttt -69.67 -51.06 38.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.112 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.91 -29.0 46.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.321 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.36 -56.18 16.14 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.516 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -65.04 -37.2 86.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.657 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -67.33 -46.67 72.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.356 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.9 t -55.68 -36.64 67.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.074 0.464 . . . . 0.0 110.447 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -63.95 -50.72 67.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.148 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 8.2 ptt? -68.69 -38.96 80.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.951 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 63' ' ' ALA . 61.6 t -57.53 -41.83 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.567 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.0 mtp -68.33 -25.71 65.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.306 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.671 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 11.8 t70 -84.54 -54.46 4.73 Favored 'General case' 0 C--O 1.219 -0.5 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.692 -176.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -71.51 -21.04 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.997 -174.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.624 HD12 HG21 ' A' ' 16' ' ' VAL . 5.1 tt -76.34 -16.82 59.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.069 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.736 ' HD2' ' HG2' ' A' ' 74' ' ' ARG . 10.9 ptp180 -56.7 -36.6 69.83 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.862 ' HB2' HD11 ' A' ' 15' ' ' LEU . 1.3 tm-20 65.85 98.98 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.853 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.736 ' HG2' ' HD2' ' A' ' 72' ' ' ARG . 43.2 mtt180 -96.36 -27.8 14.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.378 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -151.65 29.1 0.61 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.129 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.762 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 2.4 pm0 37.86 35.67 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.004 0.921 . . . . 0.0 112.827 -169.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.47 -44.26 0.79 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 65.03 25.57 70.93 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.698 -0.287 . . . . 0.0 112.876 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 67.8 -50.93 0.52 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.622 0.769 . . . . 0.0 111.889 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 111.34 99.15 2.48 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -174.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 0.7 OUTLIER 72.59 -66.38 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.02 0.482 . . . . 0.0 109.91 -169.261 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.634 ' HB3' ' NH1' ' A' ' 82' ' ' ARG . 0.8 OUTLIER 170.17 -42.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.328 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 57.95 78.11 0.26 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.213 0.53 . . . . 0.0 110.765 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 1.056 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.6 tt0 -174.91 -68.27 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.288 -175.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.629 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 1.1 p90 -141.32 -69.22 0.38 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 120.689 -1.257 . . . . 0.0 112.367 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.428 ' H ' ' HD1' ' A' ' 85' ' ' TYR . . . 68.45 75.39 0.52 Allowed Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.288 -174.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.633 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 9.6 m 74.86 -38.74 0.39 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.541 0.736 . . . . 0.0 112.71 176.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.702 ' HG2' ' HD2' ' A' ' 127' ' ' LYS . 3.9 mpt_? -66.21 -88.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.629 ' O ' ' HB3' ' A' ' 85' ' ' TYR . 10.5 mm -111.65 88.82 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.1 -174.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.39 91.01 0.08 OUTLIER Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.496 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.57 93.79 0.29 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.85 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 112.41 165.13 16.98 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 -174.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.056 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 45.6 pt -94.15 155.71 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 117.125 0.463 . . . . 0.0 111.967 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.496 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 2.1 p30 -96.35 147.16 24.1 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.656 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 40.6 t -136.51 99.72 10.52 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 95' ' ' VAL . 38.6 Cg_endo -71.07 106.7 1.95 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.113 1.875 . . . . 0.0 111.412 170.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.586 HG23 HD21 ' A' ' 158' ' ' LEU . 13.4 p -109.65 131.32 21.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.58 144.51 51.93 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.447 2.765 . . . . 0.0 112.747 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -64.49 -22.13 66.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.772 -172.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -86.35 -4.48 59.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 110.516 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 105' ' ' VAL . 16.4 m -114.85 -29.61 6.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.1 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.21 -39.96 70.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.12 -27.12 74.11 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.071 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.95 -33.62 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.08 0.467 . . . . 0.0 109.745 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 101' ' ' SER . 94.3 t -60.19 -39.8 81.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.171 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.411 HD11 ' CZ ' ' A' ' 126' ' ' PHE . 33.6 mm -72.2 -59.05 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.467 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.4 -137.72 14.26 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -98.42 -57.34 2.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.222 0.511 . . . . 0.0 110.014 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 m -105.65 -24.27 12.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.612 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 136.81 20.54 0.59 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.469 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 1.8 mp0 -49.75 -43.68 48.12 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.1 0.476 . . . . 0.0 110.991 -176.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.678 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.2 tpt -76.37 -52.7 9.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.584 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 124' ' ' ILE . 20.1 tt -69.92 -26.26 29.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.743 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.23 -29.28 63.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.552 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.678 ' HG2' ' O ' ' A' ' 112' ' ' MET . 16.5 ptpt -80.04 -22.59 42.2 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.265 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.36 -45.68 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -69.26 -25.29 64.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.625 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -79.39 -39.46 32.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.046 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -78.98 -54.08 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.404 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.446 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -88.23 -15.29 36.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.06 57.46 6.95 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.129 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.9 m -131.62 174.21 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.872 0.368 . . . . 0.0 111.314 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.803 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 86.6 mtt180 -125.04 151.41 45.65 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.669 HG21 HD11 ' A' ' 113' ' ' ILE . 47.8 mm -112.23 136.35 48.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.079 0.466 . . . . 0.0 111.155 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.664 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 3.9 tp-100 -130.72 110.99 11.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.309 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 52.1 m-85 -80.97 102.89 10.43 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.113 171.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.941 ' HE2' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -99.2 164.67 12.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.847 -178.283 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.44 ' CD ' HH21 ' A' ' 88' ' ' ARG . 4.9 pt20 . . . . . 0 C--O 1.236 0.382 0 O-C-N 124.146 0.904 . . . . 0.0 110.52 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 CA--C 1.532 0.407 0 N-CA-C 114.393 0.882 . . . . 0.0 114.393 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.17 148.87 21.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.619 . . . . 0.0 111.757 -172.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 97' ' ' VAL . 60.3 mttm -127.46 123.21 35.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.894 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.941 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 6.4 mm -74.13 107.67 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.35 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.656 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -99.4 104.71 16.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.664 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 60.7 t-80 -73.32 133.73 43.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.0 0.428 . . . . 0.0 111.485 -172.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.687 HD13 ' HB3' ' A' ' 150' ' ' ALA . 95.9 mt -101.2 111.83 32.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.887 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.803 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 37.6 ttm -97.19 137.36 36.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.936 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.82 -161.21 29.45 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.011 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -71.39 139.12 34.15 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.982 2.455 . . . . 0.0 111.344 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.94 -47.21 10.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.037 3.158 . . . . 0.0 113.964 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.53 -39.6 91.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 111.155 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.446 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 57.7 mtt180 -76.16 -28.29 57.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.178 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.85 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 73.1 m -56.92 -59.74 4.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.202 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.698 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 31.3 mt-10 -61.58 -39.82 92.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.464 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -54.79 -31.41 58.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.393 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.687 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.34 -34.74 48.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.974 0.416 . . . . 0.0 110.635 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 93' ' ' ILE . . . -71.73 -21.39 61.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.286 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.698 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 8.2 mpt_? -76.74 -30.42 56.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.595 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 58.1 mt -70.13 -51.29 40.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.591 175.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.547 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 67.1 mt -59.04 -44.83 92.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.091 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.28 -32.2 72.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.386 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.86 -35.51 67.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 47.3 mt -62.0 -38.2 87.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.001 176.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.586 HD21 HG23 ' A' ' 97' ' ' VAL . 22.2 mt . . . . . 0 C--N 1.333 -0.15 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.691 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.441 ' HB ' HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 111.405 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.572 HG22 HG12 ' A' ' 54' ' ' ILE . 38.0 t -125.03 113.62 36.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.5 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -107.32 146.98 30.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.449 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.595 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 42.5 mt-10 -109.03 120.49 42.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.136 0.493 . . . . 0.0 111.507 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.8 mm -108.55 127.17 65.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.038 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 ttm -79.64 119.85 23.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.137 0.494 . . . . 0.0 111.525 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.457 HG12 HG11 ' A' ' 16' ' ' VAL . 1.6 mp -100.48 119.01 59.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.171 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.657 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 50.4 Cg_exo -61.74 148.41 93.13 Favored 'Trans proline' 0 N--CA 1.476 0.451 0 C-N-CA 123.761 2.974 . . . . 0.0 112.609 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.99 135.45 52.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.7 -45.8 1.69 Allowed Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -170.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.836 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -71.41 -34.01 69.96 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.01 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.25 -41.27 60.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.106 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.845 ' HA3' ' HE3' ' A' ' 19' ' ' LYS . . . -61.19 -32.25 79.88 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.957 -0.565 . . . . 0.0 113.221 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.4 pp -91.59 -22.2 20.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.001 0.401 . . . . 0.0 111.401 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.457 HG11 HG12 ' A' ' 8' ' ' ILE . 70.6 t -81.32 -46.56 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.656 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 13' ' ' ALA . 25.0 pt -91.6 -27.29 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.193 0.52 . . . . 0.0 110.383 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.7 132.6 6.43 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.845 ' HE3' ' HA3' ' A' ' 14' ' ' GLY . 30.9 mmtp -63.96 -17.81 63.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.122 0.461 . . . . 0.0 110.693 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.45 13.83 8.26 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.87 -1.09 74.07 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.977 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -53.9 -52.85 59.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 15' ' ' LEU . 19.2 m -62.32 -36.45 82.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.822 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.734 HD12 HD12 ' A' ' 27' ' ' LEU . 2.6 tp -66.7 -33.28 62.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.897 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -57.24 -41.7 80.06 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.433 0.635 . . . . 0.0 110.375 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 30' ' ' ARG . 50.1 mt-30 -71.86 -26.37 62.33 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.229 -176.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.734 HD12 HD12 ' A' ' 24' ' ' ILE . 74.2 mt -81.14 -34.36 32.53 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.08 0.467 . . . . 0.0 110.857 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.85 HE22 ' HB2' ' A' ' 35' ' ' MET . 18.6 mm-40 -84.83 -59.12 2.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.271 0.558 . . . . 0.0 110.843 -176.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.89 -46.17 10.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.722 -172.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.976 HH12 ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -65.84 -52.6 49.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 111.09 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -71.5 -28.95 64.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.642 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.72 17.36 54.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.054 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.5 m -118.39 171.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' HD2' ' OE1' ' A' ' 28' ' ' GLN . 52.7 tptt -114.53 109.47 18.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.832 0.825 . . . . 0.0 109.723 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.85 ' HB2' HE22 ' A' ' 28' ' ' GLN . 48.3 mtt -94.68 112.64 24.38 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.452 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.654 HG23 ' HB2' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -111.01 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.905 0.859 . . . . 0.0 109.219 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.718 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 1.8 pt? -133.46 142.5 48.31 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.041 -173.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.524 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 3.2 mp -66.28 105.13 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.563 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.501 ' HG2' HG21 ' A' ' 17' ' ' ILE . 49.1 mt-30 -85.67 -57.84 2.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.925 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -174.43 118.59 0.22 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.86 -49.86 0.36 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.997 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.3 p -72.16 -75.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.904 0.352 . . . . 0.0 111.616 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -157.55 -35.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.189 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -79.62 67.32 5.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.443 0.639 . . . . 0.0 110.207 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 p -83.34 -57.76 3.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.918 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.19 -14.3 27.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.442 0.639 . . . . 0.0 110.239 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.04 158.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.7 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.89 150.36 16.71 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.394 0.434 . . . . 0.0 110.49 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 64.8 mttt -127.33 123.56 23.33 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.24 -167.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.19 124.44 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.81 2.34 . . . . 0.0 112.891 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.718 ' HA ' ' HB3' ' A' ' 37' ' ' LEU . 7.2 tt -98.98 118.6 36.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.697 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.654 ' HB2' HG23 ' A' ' 36' ' ' ILE . 3.9 mpt_? -97.52 119.4 36.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.644 0.259 . . . . 0.0 110.53 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 56.4 mt -92.46 110.16 22.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.021 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.572 HG12 HG22 ' A' ' 3' ' ' VAL . 27.5 mt -104.55 120.84 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.53 -171.08 44.09 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.028 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.479 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 9.5 t70 -60.73 135.49 92.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 O-C-N 123.786 0.345 . . . . 0.0 110.782 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -43.48 -46.73 9.73 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.174 2.582 . . . . 0.0 114.262 -174.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.48 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 87.3 t80 -64.81 -40.39 95.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.296 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 52.0 mttp -67.52 -42.26 83.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.281 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.441 HG21 ' HB ' ' A' ' 2' ' ' THR . 98.9 t -60.16 -33.49 53.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.674 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -68.71 -50.1 53.54 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.638 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 70.5 mm-40 -65.37 -39.68 92.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.223 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.514 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -63.56 -43.45 97.02 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.773 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.2 m -56.93 -44.36 82.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.761 0.315 . . . . 0.0 110.356 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.99 -42.16 99.76 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.905 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.643 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 5.6 ptt? -77.51 -34.22 54.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.406 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 54.1 t -61.62 -38.69 80.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 110.243 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.8 mtt -69.98 -21.84 63.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.542 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.614 ' HB2' HH21 ' A' ' 82' ' ' ARG . 31.9 t70 -84.84 -59.25 2.4 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.789 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -68.44 -20.04 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.069 -174.013 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.836 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 6.5 tt -76.51 -10.26 59.26 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.309 175.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -65.58 -17.37 64.53 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.917 0.389 . . . . 0.0 110.351 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' HB3' HD22 ' A' ' 15' ' ' LEU . 10.5 tp10 -56.83 128.43 36.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.522 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -96.7 -20.18 18.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.013 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -122.46 36.63 4.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.648 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 65.08 105.43 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.247 173.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.69 -104.23 0.22 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.753 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 91.26 33.43 8.11 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.541 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 21.0 m-85 67.89 -56.68 0.47 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.215 0.606 . . . . 0.0 111.871 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 115.28 105.79 2.56 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -172.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 2.5 t70 73.39 -61.34 0.5 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.673 0.389 . . . . 0.0 110.354 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.823 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 8.6 ttm180 169.72 -21.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.564 1.165 . . . . 0.0 108.712 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.6 ' HA ' ' OD1' ' A' ' 94' ' ' ASP . 11.4 t-20 66.1 31.89 8.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.611 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 1.077 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 34.4 tt0 -141.07 -40.05 0.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.157 -173.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 20.0 p90 -159.98 -44.07 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.976 ' HA3' HH12 ' A' ' 30' ' ' ARG . . . 65.12 72.74 0.67 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.572 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.774 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 49.7 m 67.67 -37.89 0.34 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 175.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.467 ' HD2' HD13 ' A' ' 89' ' ' ILE . 2.8 tmt_? -68.53 -81.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.981 HD11 ' HG2' ' A' ' 125' ' ' GLN . 31.5 mm -65.97 -80.35 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -168.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.4 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 109.96 73.47 0.75 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -170.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.581 ' H ' ' HD2' ' A' ' 85' ' ' TYR . . . 118.75 161.12 11.66 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.812 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 89.34 -146.66 19.11 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.144 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.077 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 43.4 pt -149.24 162.02 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 172.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.6 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 2.3 p-10 -107.4 140.51 40.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.815 HG23 ' HB3' ' A' ' 138' ' ' ALA . 17.2 m -132.91 95.24 19.4 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.466 0.65 . . . . 0.0 111.472 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 95' ' ' VAL . 12.3 Cg_endo -58.47 108.68 0.42 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.191 2.594 . . . . 0.0 111.899 173.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.731 HG13 HD21 ' A' ' 158' ' ' LEU . 89.8 t -98.2 118.64 63.32 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.447 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.576 ' HD2' HD22 ' A' ' 158' ' ' LEU . 59.9 Cg_exo -41.35 132.57 3.38 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.518 2.812 . . . . 0.0 112.217 172.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -61.19 -26.47 67.74 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.019 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -92.21 6.73 45.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.4 m -122.63 -29.14 4.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.553 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.422 ' HA ' HG11 ' A' ' 97' ' ' VAL . 14.1 p -51.55 -30.75 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.08 -44.7 96.14 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.098 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.08 -35.0 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.865 0.364 . . . . 0.0 110.448 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.93 -42.54 95.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.979 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.677 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 48.2 mm -75.49 -45.35 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.892 0.377 . . . . 0.0 110.612 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.12 -147.64 16.86 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.654 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.407 ' HG3' ' N ' ' A' ' 109' ' ' SER . 14.9 ptm180 -108.68 -44.52 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.056 0.455 . . . . 0.0 110.274 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.536 ' HB2' ' HG3' ' A' ' 111' ' ' GLU . 46.2 m -106.6 10.35 31.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.197 0.522 . . . . 0.0 109.748 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.03 28.05 59.23 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.325 -176.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -92.48 -20.35 21.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.362 0.125 . . . . 0.0 111.203 -178.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.435 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 16.7 tpt -74.41 -43.22 57.28 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.677 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 6.2 tp -63.84 -28.24 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.222 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.718 ' HA ' ' HG2' ' A' ' 117' ' ' GLN . 98.8 mttt -78.68 -19.12 53.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.63 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 63.6 mttm -64.76 -31.82 73.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.8 mm -67.78 -38.61 80.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.245 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.718 ' HG2' ' HA ' ' A' ' 114' ' ' LYS . 2.7 mm100 -72.39 -27.23 62.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.04 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.18 -38.63 35.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.399 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -81.29 -54.99 5.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.357 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.0 -5.06 51.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -172.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.88 29.23 67.23 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.727 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.7 m -95.82 177.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.168 0.508 . . . . 0.0 111.549 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -129.41 133.87 47.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.062 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.545 HG12 HE22 ' A' ' 117' ' ' GLN . 47.7 mm -99.72 127.23 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.336 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.981 ' HG2' HD11 ' A' ' 89' ' ' ILE . 5.3 tp-100 -122.64 97.13 5.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.513 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -74.94 106.39 6.43 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.598 ' HE3' ' O ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -125.62 132.3 52.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.157 -177.451 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 170.238 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.463 -0.283 0 CA-C-O 120.941 0.309 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 5.3 mp0 -114.24 161.95 17.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.962 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -110.46 110.93 21.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 34.1 mm -68.24 102.18 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.181 0.515 . . . . 0.0 111.287 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.815 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -80.82 141.05 35.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.738 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 57.7 t-80 -106.33 115.02 29.49 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.877 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 154' ' ' ILE . 83.7 mt -80.14 110.75 16.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 27.7 ttp -109.06 123.69 49.56 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.018 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.72 -161.12 34.9 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.43 ' HG2' ' CZ ' ' A' ' 146' ' ' ARG . 18.2 Cg_exo -67.58 141.14 54.23 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.689 2.259 . . . . 0.0 111.531 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -44.31 -51.11 7.2 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.799 2.999 . . . . 0.0 114.343 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.58 -38.31 86.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.411 0.624 . . . . 0.0 110.559 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.43 ' CZ ' ' HG2' ' A' ' 143' ' ' PRO . 12.1 ttm180 -72.49 -30.44 64.53 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.253 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.812 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 77.5 m -56.35 -57.97 10.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.913 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 6.4 mm-40 -64.28 -27.75 69.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.679 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -65.92 -29.78 70.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.176 0.512 . . . . 0.0 110.373 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.662 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.2 -34.97 49.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.261 0.553 . . . . 0.0 109.903 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -17.03 64.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.408 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -76.19 -42.1 47.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 0.0 110.193 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.85 -42.28 82.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.952 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.775 HD12 HD11 ' A' ' 140' ' ' ILE . 73.4 mt -67.57 -34.96 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.472 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -62.46 -48.81 77.99 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.8 -44.58 70.29 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.094 176.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.11 -52.95 62.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.415 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.731 HD21 HG13 ' A' ' 97' ' ' VAL . 86.1 mt . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.372 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 47.5 t -126.95 112.72 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.676 171.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -113.41 144.91 42.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.056 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.582 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 41.2 mt-10 -109.52 111.77 23.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.243 0.544 . . . . 0.0 111.654 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.3 mp -105.2 139.07 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.401 ' HB3' ' OD2' ' A' ' 48' ' ' ASP . 54.2 mtp -95.71 123.73 39.41 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.265 0.555 . . . . 0.0 110.645 -174.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.758 HG12 HG11 ' A' ' 16' ' ' VAL . 1.6 mp -96.98 114.8 65.24 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.725 -175.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.84 147.94 92.06 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.771 2.981 . . . . 0.0 113.007 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.36 132.37 47.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 168.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.53 -44.16 1.59 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -170.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -72.05 -26.32 62.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.008 0.432 . . . . 0.0 110.003 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.6 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.31 -32.55 25.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.472 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.445 ' O ' ' HA2' ' A' ' 18' ' ' GLY . . . -60.98 -38.53 95.65 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.566 -0.825 . . . . 0.0 112.903 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.777 HD21 ' HB2' ' A' ' 73' ' ' GLU . 3.5 pp -91.01 -27.23 18.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.405 0.602 . . . . 0.0 111.419 176.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.758 HG11 HG12 ' A' ' 8' ' ' ILE . 75.8 t -70.04 -58.93 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.645 HG13 ' H ' ' A' ' 19' ' ' LYS . 37.9 pt -91.77 -22.64 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.67 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . 84.42 19.41 60.43 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.645 ' H ' HG13 ' A' ' 17' ' ' ILE . 32.9 mmtp 65.6 -68.76 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.671 0.788 . . . . 0.0 111.314 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.55 5.9 79.47 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.69 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.78 10.09 58.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.769 177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 27.7 tt0 -66.25 -39.15 89.29 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.809 -0.23 . . . . 0.0 111.513 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.539 HG21 ' O ' ' A' ' 15' ' ' LEU . 20.5 m -77.25 -33.88 55.95 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.317 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.511 HD13 ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -67.06 -29.99 48.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.901 178.184 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.554 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 10.7 ttmm -49.68 -55.23 14.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.66 0.743 . . . . 0.0 109.098 168.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.405 ' HB3' ' CB ' ' A' ' 81' ' ' ASP . 41.4 mt-30 -70.32 -39.3 74.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.493 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 32.1 mt -66.61 -25.61 66.69 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.945 -0.472 . . . . 0.0 111.488 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 43.8 mt-30 -85.73 -41.17 15.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.732 0.301 . . . . 0.0 111.352 173.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 25' ' ' LYS . 12.4 mm-40 -86.66 -55.25 3.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -175.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.695 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 6.9 ttm180 -67.1 -50.59 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.198 0.523 . . . . 0.0 110.865 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' A' ' 87' ' ' SER . . . -70.13 -9.99 57.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.415 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.54 23.0 60.01 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.999 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.685 HG21 HG23 ' A' ' 53' ' ' ILE . 34.2 m -132.2 155.57 41.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -89.98 109.1 20.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.588 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 58.4 mtt -96.71 116.03 28.43 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.432 HD13 ' C ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -109.58 107.12 22.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 122.322 1.058 . . . . 0.0 108.79 178.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.997 HD13 HD12 ' A' ' 51' ' ' LEU . 1.3 pt? -133.47 144.85 49.71 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.013 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.87 HG23 ' HB2' ' A' ' 42' ' ' SER . 2.5 mp -56.95 122.08 5.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 123.507 0.504 . . . . 0.0 110.145 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -129.91 -159.58 0.97 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.64 99.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.536 0.684 . . . . 0.0 110.346 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.84 -39.24 0.5 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.87 ' HB2' HG23 ' A' ' 38' ' ' ILE . 16.8 m -88.31 171.92 9.81 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -89.84 -13.74 35.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.884 0.373 . . . . 0.0 111.486 -171.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.827 ' HB2' HG21 ' A' ' 38' ' ' ILE . 94.8 m-20 -87.68 34.9 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -176.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -64.97 -46.13 82.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -85.26 -14.44 46.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.594 0.711 . . . . 0.0 109.76 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.52 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 35.5 t -79.66 156.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.462 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 7' ' ' MET . 11.2 t70 -66.81 131.13 45.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 173.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.675 ' HD2' ' O ' ' A' ' 38' ' ' ILE . 26.8 mtmm -121.68 125.97 26.59 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -165.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.525 ' HD2' HD13 ' A' ' 38' ' ' ILE . 88.3 Cg_endo -80.57 130.67 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.581 2.187 . . . . 0.0 112.313 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.997 HD12 HD13 ' A' ' 37' ' ' LEU . 6.8 tt -108.37 128.59 54.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.695 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.1 mpt_? -97.62 118.94 35.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.481 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.685 HG23 HG21 ' A' ' 33' ' ' VAL . 59.9 mt -88.08 109.51 19.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.476 HG12 HG22 ' A' ' 3' ' ' VAL . 29.4 mt -110.39 119.12 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.86 -170.61 43.54 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.834 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.457 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 7.5 t70 -64.72 137.79 97.25 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 122.781 0.432 . . . . 0.0 110.914 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -40.3 -49.13 3.97 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.601 2.867 . . . . 0.0 113.964 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -63.46 -45.42 90.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.765 0.317 . . . . 0.0 110.724 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 46.2 mttm -62.95 -43.74 97.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.848 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 53' ' ' ILE . 90.9 t -63.52 -29.25 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.633 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 5.9 tm0? -80.5 -46.28 16.1 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -173.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -66.99 -32.57 73.89 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.46 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.744 ' HA ' ' SD ' ' A' ' 66' ' ' MET . . . -70.42 -45.02 66.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 61' ' ' GLN . 26.5 p -63.02 -27.23 69.27 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.311 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.05 -47.54 28.43 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.202 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.744 ' SD ' ' HA ' ' A' ' 63' ' ' ALA . 6.6 ptm -69.13 -38.58 78.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.439 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 26.9 m -63.4 -31.79 54.18 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-N 117.961 0.346 . . . . 0.0 111.326 -178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.7 mtt -81.18 -20.75 40.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.402 0.62 . . . . 0.0 109.959 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 21.1 t70 -83.16 -52.62 6.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.214 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.858 HG22 ' HB2' ' A' ' 79' ' ' PHE . 2.7 pp -72.51 -21.43 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 111.363 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 70' ' ' ILE . 6.1 tt -85.9 -4.18 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 12.3 ptm180 -51.87 -42.02 62.33 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.923 ' HG3' ' HA ' ' A' ' 76' ' ' GLN . 26.0 tt0 60.93 101.53 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.449 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.2 ttm105 -101.64 -36.92 8.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.037 170.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -119.81 8.32 11.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.128 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.923 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . 44.6 tt0 68.57 12.29 8.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.789 0.804 . . . . 0.0 110.915 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.06 -19.56 6.74 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 64.15 -102.64 0.61 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.858 ' HB2' HG22 ' A' ' 70' ' ' ILE . 87.8 m-85 -135.83 -29.23 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.231 0.515 . . . . 0.0 110.624 173.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.42 79.91 1.47 Allowed Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.695 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER 71.18 -60.52 0.51 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 124.499 0.764 . . . . 0.0 110.353 -172.225 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 4.8 ttm-85 142.65 91.74 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 126.204 1.802 . . . . 0.0 108.117 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -67.92 52.04 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.038 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.953 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 33.4 mt-10 -152.13 -45.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.747 -176.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 88' ' ' ARG . 33.1 p90 -177.44 144.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 111.306 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.522 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -128.51 -94.34 0.79 Allowed Glycine 0 C--O 1.221 -0.659 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 174.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.659 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 19.6 p -87.52 13.27 10.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.17 0.509 . . . . 0.0 110.2 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.667 ' CG ' ' HD3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -143.23 174.63 10.55 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.329 -170.795 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.579 HG12 ' ND1' ' A' ' 139' ' ' HIS . 8.9 mt 59.46 -80.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.768 173.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.73 41.07 89.73 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 141' ' ' MET . . . 151.38 66.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.736 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 168.22 -142.79 7.69 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.953 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 38.9 pt -142.7 143.83 25.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 117.277 0.538 . . . . 0.0 111.262 176.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.442 ' OD2' HG21 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -89.95 126.77 35.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.541 177.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 70.2 t -116.38 95.22 44.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.52 ' CA ' HD13 ' A' ' 137' ' ' ILE . 38.1 Cg_endo -71.28 106.51 1.94 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 121.4 1.4 . . . . 0.0 111.276 169.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 136' ' ' LYS . 10.7 p -104.47 129.39 25.12 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 121.229 0.538 . . . . 0.0 110.169 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.655 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 52.9 Cg_exo -52.79 128.83 30.04 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.221 2.614 . . . . 0.0 112.624 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.508 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 0.6 OUTLIER -57.43 -25.57 59.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.904 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -92.09 16.36 11.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.605 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.542 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 2.7 p -155.97 12.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 p -77.01 -20.57 14.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.464 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.13 -33.59 86.31 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.92 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 112' ' ' MET . 7.3 p -74.99 -24.02 17.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.063 0.459 . . . . 0.0 110.412 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 97' ' ' VAL . 30.9 t -72.88 -37.62 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.064 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 46.7 mm -84.26 -38.99 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.425 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.29 -133.56 11.65 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -102.4 -74.03 0.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.915 0.388 . . . . 0.0 110.443 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.534 ' HB2' ' OE1' ' A' ' 111' ' ' GLU . 30.5 m -89.38 -4.73 57.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.894 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.494 ' O ' HG22 ' A' ' 113' ' ' ILE . . . 114.01 6.74 20.35 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.06 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' HB2' ' A' ' 109' ' ' SER . 1.1 mp0 -65.16 -24.02 67.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 104' ' ' VAL . 15.8 tpt -76.49 -40.61 49.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.402 . . . . 0.0 110.907 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.636 HD11 HG21 ' A' ' 124' ' ' ILE . 6.6 tp -70.02 -32.34 51.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 88.7 mttt -71.29 -29.32 64.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.429 0.633 . . . . 0.0 109.642 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.512 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 7.0 ttmt -66.28 -36.85 84.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.746 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.5 mt -65.1 -39.72 86.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.148 0.499 . . . . 0.0 109.709 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.415 ' NE2' ' HA ' ' A' ' 114' ' ' LYS . 14.4 mt-30 -63.93 -24.84 67.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.428 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -87.01 -50.54 6.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.235 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.02 -40.06 32.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.153 -172.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.58 -16.69 20.91 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.266 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.7 42.11 62.81 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.4 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.9 150.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.09 0.471 . . . . 0.0 111.628 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -96.74 122.35 39.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.56 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.636 HG21 HD11 ' A' ' 113' ' ' ILE . 50.0 mm -109.44 141.85 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.942 0.401 . . . . 0.0 111.998 -170.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.756 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 1.9 pt20 -158.89 144.13 16.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -96.82 107.5 19.99 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.744 -0.597 . . . . 0.0 109.741 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.667 ' HD3' ' CG ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -112.55 134.0 54.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.458 -171.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 . . . . . 0 N--CA 1.467 0.406 0 O-C-N 123.962 0.789 . . . . 0.0 112.892 174.636 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.508 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 20.5 Cg_endo . . . . . 0 CA--C 1.529 0.271 0 N-CA-C 112.508 0.157 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.655 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 0.4 OUTLIER -86.13 155.6 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.833 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.617 ' O ' HG12 ' A' ' 97' ' ' VAL . 74.0 mttt -110.96 113.56 26.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.199 -175.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 4.9 mm -79.19 115.1 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.186 0.517 . . . . 0.0 111.711 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . . . -87.31 142.34 27.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.666 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.756 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 3.9 t60 -86.95 107.69 18.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.12 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.557 HD13 ' HB3' ' A' ' 150' ' ' ALA . 23.1 mt -105.42 121.99 58.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 172.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 91' ' ' GLY . 43.7 ttp -129.82 139.71 51.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 -176.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.5 -155.01 25.92 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.3 139.25 37.93 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.475 2.117 . . . . 0.0 111.174 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.29 -47.93 8.53 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 123.691 2.927 . . . . 0.0 113.229 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.28 -48.2 82.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.484 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -66.86 -29.97 70.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.837 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.736 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 66.9 m -59.31 -62.43 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.72 -42.79 89.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.882 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.508 ' O ' HG13 ' A' ' 153' ' ' ILE . 11.9 t-160 -58.49 -24.75 61.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.235 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.557 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -81.06 -52.36 7.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.27 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.05 -26.14 68.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -79.66 -19.04 50.01 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.798 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 149' ' ' HIS . 78.4 mt -72.06 -42.53 67.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 167.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.686 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 71.1 mt -61.07 -49.95 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.358 176.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -53.12 -40.22 64.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.529 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.25 -43.73 95.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.883 0.373 . . . . 0.0 110.564 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.03 -39.81 94.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.406 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 33.3 mt . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.564 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.429 ' HB ' HG21 ' A' ' 60' ' ' VAL . 9.9 m . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 78.8 t -127.91 125.95 65.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.077 0.465 . . . . 0.0 111.186 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -122.43 145.16 48.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.837 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 67.3 mt-10 -111.84 126.7 55.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.48 0.657 . . . . 0.0 112.222 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -119.74 126.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 173.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 ttm -82.34 125.08 30.6 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.019 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.642 HG12 HG11 ' A' ' 16' ' ' VAL . 1.6 mp -101.05 119.37 58.23 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.617 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.642 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 51.2 Cg_exo -60.27 154.5 52.04 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.582 2.854 . . . . 0.0 113.047 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 129.76 39.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.63 -38.6 3.04 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -170.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.66 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -70.6 -30.76 67.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.601 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -54.67 -35.08 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.618 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.51 -32.57 73.52 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.157 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.755 ' HB3' ' HA ' ' A' ' 76' ' ' GLN . 0.8 OUTLIER -91.48 -25.91 19.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 117.069 0.435 . . . . 0.0 111.433 177.005 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.642 HG11 HG12 ' A' ' 8' ' ' ILE . 85.5 t -77.32 -48.84 23.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.704 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.706 HG13 ' H ' ' A' ' 19' ' ' LYS . 36.8 pt -91.93 -15.42 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.199 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.528 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 90.51 5.47 69.3 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.706 ' H ' HG13 ' A' ' 17' ' ' ILE . 13.6 tptm 65.27 -64.4 0.18 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.31 1.044 . . . . 0.0 110.645 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.09 -6.76 88.77 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 108.11 3.14 33.8 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.663 174.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.72 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 34.9 tt0 -62.41 -45.37 93.44 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.434 0.617 . . . . 0.0 111.981 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.528 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 25.7 m -71.27 -37.81 71.89 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.566 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.714 HD12 HD12 ' A' ' 27' ' ' LEU . 4.9 tp -64.76 -25.55 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.802 0.334 . . . . 0.0 110.381 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.72 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 76.0 mttt -58.77 -46.95 86.32 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.63 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -68.33 -39.07 82.06 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.917 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.714 HD12 HD12 ' A' ' 24' ' ' ILE . 39.1 mt -66.63 -26.89 67.29 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.135 -0.353 . . . . 0.0 110.922 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.736 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 29.2 mt-30 -85.52 -52.1 6.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -86.58 -55.29 3.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.54 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.635 HH22 ' HA ' ' A' ' 83' ' ' ASN . 2.7 mtp180 -62.61 -47.88 81.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.169 0.509 . . . . 0.0 111.269 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -78.16 -2.81 39.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.695 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.12 22.02 41.27 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.765 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.736 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.3 m -133.74 153.66 37.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -93.55 109.24 20.86 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.956 ' HB3' HD21 ' A' ' 51' ' ' LEU . 46.9 mtt -93.47 113.89 26.14 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.413 HD13 ' C ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -109.96 107.96 24.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 122.46 1.124 . . . . 0.0 109.464 -177.505 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.705 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.1 pt? -133.36 142.81 48.59 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.014 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.9 mm -64.5 98.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.115 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.44 ' HG2' HG21 ' A' ' 17' ' ' ILE . 78.1 mt-30 -82.03 -59.8 2.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -122.12 -176.94 3.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.636 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.632 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . 105.6 157.37 22.49 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -82.24 28.97 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -105.41 -96.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -100.28 58.5 0.98 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 1.6 t -61.95 -61.19 2.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.508 -174.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.521 ' H ' HG23 ' A' ' 45' ' ' THR . 66.1 t30 -96.03 -22.43 17.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.834 -0.541 . . . . 0.0 111.316 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 m -83.85 -168.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -169.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.14 147.97 23.33 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.347 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -135.14 133.98 21.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.887 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.07 111.13 1.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.691 2.261 . . . . 0.0 111.578 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.956 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.0 tm? -88.46 111.76 22.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.239 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 35' ' ' MET . 5.3 mpt_? -98.69 111.02 23.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.923 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.2 mt -85.95 110.42 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.595 HG12 HG22 ' A' ' 3' ' ' VAL . 21.1 mt -110.18 119.93 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.202 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.522 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.72 -170.44 43.36 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.032 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.945 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 7.3 m-20 -61.56 141.9 94.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 122.487 0.315 . . . . 0.0 110.646 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 54.1 Cg_exo -50.53 -51.69 10.54 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.403 2.736 . . . . 0.0 114.174 -169.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -57.02 -44.55 82.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.065 0.459 . . . . 0.0 110.44 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.945 ' HE2' ' HB2' ' A' ' 56' ' ' ASP . 42.1 mtmt -68.58 -40.57 80.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.759 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 2' ' ' THR . 88.3 t -61.93 -35.65 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.463 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -66.03 -54.25 28.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -65.43 -27.48 68.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.546 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -79.7 -36.53 37.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 68' ' ' MET . 38.1 t -56.82 -42.4 79.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.075 0.464 . . . . 0.0 110.005 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.47 -26.69 38.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.448 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.656 ' HA ' ' HE ' ' A' ' 82' ' ' ARG . 9.9 ptp -66.37 -48.02 71.49 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.462 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.635 ' N ' ' HG3' ' A' ' 66' ' ' MET . 91.9 t -59.83 -47.61 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.815 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 64' ' ' CYS . 19.9 ptp -70.57 -20.59 62.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.924 0.392 . . . . 0.0 111.12 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 25.3 t70 -85.98 -44.2 12.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -81.82 -21.37 10.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.901 -0.719 . . . . 0.0 111.053 -177.471 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.717 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.2 pp -77.02 -2.71 35.36 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.229 174.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 8.4 ptp180 -63.88 -19.95 65.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.278 0.561 . . . . 0.0 109.531 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.593 ' HG2' ' N ' ' A' ' 77' ' ' GLY . 9.5 tp10 -52.47 144.17 13.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.338 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -87.63 -60.1 2.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.013 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -113.61 55.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.7 -173.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.755 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 62.2 tt0 69.39 114.09 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.739 0.78 . . . . 0.0 112.545 173.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.593 ' N ' ' HG2' ' A' ' 73' ' ' GLU . . . 157.3 -96.35 0.15 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.476 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.7 -99.2 1.48 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.588 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -141.29 -41.42 0.38 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.868 0.366 . . . . 0.0 110.053 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 91.25 91.62 1.35 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -171.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 3.4 t70 70.57 -69.89 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -165.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.656 ' HE ' ' HA ' ' A' ' 66' ' ' MET . 20.8 ttm-85 171.62 -40.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.763 0.825 . . . . 0.0 109.129 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.635 ' HA ' HH22 ' A' ' 30' ' ' ARG . 4.7 t30 61.87 59.13 1.79 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.629 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 1.06 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 44.9 tt0 -173.95 -38.5 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.275 -173.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.434 ' CB ' ' H ' ' A' ' 90' ' ' GLY . 5.6 p90 -168.4 90.16 0.27 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.626 166.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.603 ' HA2' ' HE1' ' A' ' 66' ' ' MET . . . -83.87 96.94 2.01 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 170.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.617 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 61.3 p 66.84 -53.69 0.45 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.112 1.365 . . . . 0.0 111.896 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 6.0 mmt180 -97.42 -167.2 1.5 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.019 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.661 HG23 ' ND1' ' A' ' 139' ' ' HIS . 71.0 mt 75.52 -66.44 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 124.083 0.864 . . . . 0.0 111.085 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.434 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 50.42 61.03 6.23 Favored Glycine 0 N--CA 1.451 -0.352 0 O-C-N 123.691 0.619 . . . . 0.0 112.497 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.34 88.89 1.02 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.878 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 154.36 -128.06 2.27 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.06 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 31.1 pt -148.37 154.39 10.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -89.03 128.05 35.71 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 53.5 t -119.1 96.72 50.3 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.872 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.512 ' CA ' HD13 ' A' ' 137' ' ' ILE . 60.1 Cg_endo -77.38 107.54 2.42 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.786 1.657 . . . . 0.0 110.941 174.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 102' ' ' VAL . 21.7 t -100.64 124.43 42.4 Favored Pre-proline 0 C--N 1.319 -0.74 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.205 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.1 129.53 22.01 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.589 2.193 . . . . 0.0 110.742 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -57.57 -28.51 63.64 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -172.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -80.67 -7.26 59.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.752 0.311 . . . . 0.0 110.877 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 m -113.31 -27.27 8.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.71 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.404 ' HA ' HG11 ' A' ' 97' ' ' VAL . 12.1 p -57.44 -30.08 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 111.596 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.49 -34.72 89.95 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.091 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.8 t -74.14 -29.42 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.024 0.44 . . . . 0.0 110.273 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -34.99 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.149 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.9 mm -84.13 -47.89 17.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.2 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.39 -116.42 5.51 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.549 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -128.7 -54.31 1.23 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.141 0.496 . . . . 0.0 110.009 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 m -105.1 20.55 18.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.297 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.1 18.15 76.26 Favored Glycine 0 C--O 1.224 -0.475 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.46 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.484 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 6.0 tp10 -68.49 -37.06 79.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.993 0.425 . . . . 0.0 111.092 -174.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.6 tpt -69.68 -43.39 72.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.693 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.44 HD11 ' CB ' ' A' ' 124' ' ' ILE . 19.8 tt -67.31 -27.03 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.155 0.502 . . . . 0.0 111.032 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 50.4 mtpt -65.12 -32.03 73.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.421 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -72.3 -32.33 66.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 113' ' ' ILE . 10.8 mm -63.98 -50.59 76.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -62.84 -29.72 70.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.287 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -79.84 -38.7 32.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.601 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -79.5 -38.91 33.31 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.786 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.456 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -96.65 -11.25 25.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 111.49 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.4 23.35 75.8 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.592 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.03 173.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.337 . . . . 0.0 111.425 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 31.6 mtp180 -136.24 141.04 43.91 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 173.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.44 ' CB ' HD11 ' A' ' 113' ' ' ILE . 36.5 mm -110.26 138.67 37.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.524 0.678 . . . . 0.0 112.561 -171.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 138.17 44.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.148 171.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -84.86 105.28 15.52 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.72 ' HE2' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -94.82 -166.13 1.42 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.298 -169.042 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.429 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 27.7 tp60 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.618 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 N--CA 1.454 -0.82 0 N-CA-C 113.185 0.417 . . . . 0.0 113.185 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -143.8 165.84 26.57 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.356 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -123.08 118.21 27.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.728 0.299 . . . . 0.0 110.353 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.72 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 18.8 mm -70.14 124.22 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 111.966 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -102.39 140.66 36.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.298 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.661 ' ND1' HG23 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -83.54 112.09 19.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.602 178.162 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.765 HD13 ' HB3' ' A' ' 150' ' ' ALA . 24.7 mt -91.81 123.76 44.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.66 169.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.492 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 44.5 ttm -102.71 136.75 41.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.75 -169.98 24.16 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.126 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 14.5 Cg_exo -70.29 139.1 37.61 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.109 2.539 . . . . 0.0 111.166 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 143' ' ' PRO . 87.0 Cg_exo -48.6 -32.92 22.52 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.24 3.293 . . . . 0.0 114.456 -174.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.1 -43.1 68.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.001 0.429 . . . . 0.0 110.781 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 49.8 mtt180 -72.36 -26.34 61.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.062 0.458 . . . . 0.0 110.03 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.612 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 92.7 m -55.91 -58.04 9.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.801 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.85 -30.02 71.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.911 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.428 ' O ' HG13 ' A' ' 153' ' ' ILE . 4.2 t60 -57.86 -35.73 71.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.311 0.577 . . . . 0.0 110.214 176.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.765 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.6 -38.35 40.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.905 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.82 -25.16 67.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.58 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -79.15 -25.0 42.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.237 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.44 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 42.1 mt -73.35 -37.74 52.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 57.3 mt -71.77 -33.33 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.176 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -63.68 -40.52 97.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.746 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.29 -30.45 71.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.703 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 26.9 mt -66.08 -32.15 73.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.981 0.42 . . . . 0.0 110.096 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.879 176.686 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 89.1 t -133.91 131.34 56.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.458 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -134.52 149.2 50.65 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 46.4 mt-10 -106.49 135.76 47.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.23 0.538 . . . . 0.0 111.741 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.0 mp -119.22 148.15 22.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -92.33 114.25 26.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.707 0.289 . . . . 0.0 111.369 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.571 ' CD1' ' HB2' ' A' ' 51' ' ' LEU . 2.3 mp -100.14 108.01 50.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.101 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 12' ' ' LYS . 7.3 Cg_exo -75.92 155.0 38.65 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.939 2.426 . . . . 0.0 111.474 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.17 128.97 38.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.04 -34.56 5.36 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -169.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HA ' ' HG ' ' A' ' 15' ' ' LEU . 10.0 mptt -94.53 -4.39 48.09 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.129 0.49 . . . . 0.0 110.747 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.689 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -61.61 -43.06 99.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.548 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.25 -11.15 55.08 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.831 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.609 ' CD1' ' HB3' ' A' ' 73' ' ' GLU . 34.1 mt -84.84 -47.8 9.99 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.485 HG21 ' CG1' ' A' ' 8' ' ' ILE . 65.1 t -78.06 -44.58 27.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.989 -176.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.847 HG13 ' H ' ' A' ' 19' ' ' LYS . 23.3 pt -90.77 -15.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 121.54 -0.725 . . . . 0.0 110.468 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.45 -1.19 89.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.783 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.847 ' H ' HG13 ' A' ' 17' ' ' ILE . 14.3 tptm 72.9 -44.04 0.58 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.015 0.926 . . . . 0.0 110.702 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.95 -11.04 55.72 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.914 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.81 -9.03 29.84 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.447 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 10.5 mp0 -54.09 -49.29 69.41 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.954 0.502 . . . . 0.0 112.33 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 15' ' ' LEU . 26.4 m -70.11 -43.42 71.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 24' ' ' ILE . 6.0 tp -61.99 -25.9 38.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.331 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 42.6 mttm -62.68 -42.59 99.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.496 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.503 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 49.2 mt-30 -83.55 -29.16 28.07 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.003 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.578 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 82.7 mt -65.89 -24.8 66.93 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.541 -0.725 . . . . 0.0 109.683 171.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.768 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.2 mt-30 -86.1 -55.42 3.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.618 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -80.76 -45.4 17.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.574 ' NH2' ' HA ' ' A' ' 83' ' ' ASN . 11.4 mtp180 -76.06 -42.08 48.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.631 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -82.87 -9.07 59.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.122 0.486 . . . . 0.0 110.425 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.04 20.95 71.32 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.456 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.768 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 31.4 m -134.7 163.1 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -100.24 110.28 22.52 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 1.0 ' HB3' HD11 ' A' ' 51' ' ' LEU . 51.4 mtt -93.59 114.52 26.88 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' C ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -110.85 108.02 24.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 122.399 1.095 . . . . 0.0 109.302 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.66 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.3 pt? -133.68 142.64 48.11 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.262 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 38' ' ' ILE . 3.5 mp -64.31 101.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.208 0.528 . . . . 0.0 111.107 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -99.29 -58.47 1.93 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -95.42 159.81 14.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.429 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.58 117.03 3.36 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.072 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 t -74.28 78.73 1.83 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.313 0.578 . . . . 0.0 110.775 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -142.65 -54.46 0.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.783 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 14.5 m120 -118.58 39.79 3.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.659 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 p -70.71 -61.5 1.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.832 0.349 . . . . 0.0 111.232 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -91.29 -4.08 56.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.498 0.666 . . . . 0.0 109.968 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.588 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 39.3 t -90.72 160.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.328 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 47' ' ' VAL . 3.8 p-10 -58.3 145.65 37.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.165 0.507 . . . . 0.0 109.706 171.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 128.21 26.04 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.704 -169.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.42 113.29 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.793 2.329 . . . . 0.0 112.13 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.0 HD11 ' HB3' ' A' ' 35' ' ' MET . 48.7 tp -85.58 105.34 16.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.226 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -89.52 101.6 14.28 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.33 174.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.4 mt -83.63 109.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 3' ' ' VAL . 14.5 mt -107.95 119.47 57.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.152 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.525 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.77 -169.97 42.98 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.265 -1.445 . . . . 0.0 113.697 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HB3' ' HD2' ' A' ' 59' ' ' LYS . 13.1 t70 -55.02 136.05 67.18 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 114.642 -0.779 . . . . 0.0 110.642 174.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 33.0 Cg_exo -57.34 -34.32 97.7 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.496 2.797 . . . . 0.0 113.813 -173.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.461 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 68.4 t80 -72.37 -35.64 68.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.556 0.693 . . . . 0.0 109.419 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' HD2' ' HB3' ' A' ' 56' ' ' ASP . 53.3 mttp -76.84 -41.62 43.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.768 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG22 HG22 ' A' ' 53' ' ' ILE . 95.1 t -59.72 -36.61 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.11 176.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -56.55 17.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.45 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 72.9 mm-40 -67.05 -34.52 77.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.067 -176.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -69.98 -44.77 68.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.21 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.9 t -56.74 -35.05 68.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.498 0.666 . . . . 0.0 109.584 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' HG2' ' NH2' ' A' ' 82' ' ' ARG . 33.9 tt0 -72.61 -33.83 66.95 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.013 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.769 ' HA ' ' HE ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -74.98 -37.52 61.87 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.347 177.088 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.616 ' N ' ' HG3' ' A' ' 66' ' ' MET . 85.0 t -56.34 -52.35 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.277 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.3 mtp -62.57 -21.01 65.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.892 0.377 . . . . 0.0 111.077 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 30.6 t70 -79.37 -56.18 4.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.614 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.908 HG21 ' H ' ' A' ' 82' ' ' ARG . 2.1 pp -81.7 -21.38 10.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 71' ' ' LEU . 6.4 tt -84.8 -10.64 57.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.333 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 4.4 ptp180 -66.15 -11.44 49.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.078 0.466 . . . . 0.0 110.342 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.609 ' HB3' ' CD1' ' A' ' 15' ' ' LEU . 10.0 tp10 -50.64 142.22 11.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.13 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 74' ' ' ARG . 11.4 mmt180 -80.77 -49.39 11.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.469 -175.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -171.98 20.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.828 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -109.6 -86.46 0.53 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.079 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -151.56 -24.56 0.05 OUTLIER Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.774 -1.203 . . . . 0.0 114.543 -173.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.37 -127.23 8.78 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.826 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.445 ' HD2' HG22 ' A' ' 70' ' ' ILE . 70.3 m-85 -133.1 -60.28 0.86 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.962 0.411 . . . . 0.0 110.121 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.52 76.78 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 26' ' ' GLN . 3.9 m-20 54.6 44.38 28.77 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.119 0.962 . . . . 0.0 109.184 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.908 ' H ' HG21 ' A' ' 70' ' ' ILE . 30.8 ttm-85 69.06 -45.52 0.55 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.624 -1.625 . . . . 0.0 112.353 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.574 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 6.2 t30 61.21 63.64 1.2 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.616 0.722 . . . . 0.0 109.233 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 1.045 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 37.0 tt0 -177.17 -41.72 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.428 -170.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.0 p90 175.08 151.36 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.643 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.34 -12.96 1.75 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.88 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 6.3 p -172.88 -57.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.809 0.814 . . . . 0.0 108.815 -174.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.47 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -73.5 -178.44 3.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.473 170.225 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.805 HG22 ' H ' ' A' ' 91' ' ' GLY . 68.1 mt 74.13 -82.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 167.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.03 41.49 94.49 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.649 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.805 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 153.45 91.15 0.08 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.681 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.684 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 158.63 -132.96 3.25 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 175.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.045 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 27.7 pt -147.19 165.94 6.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 169.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.554 ' HB3' ' CG2' ' A' ' 137' ' ' ILE . 19.8 m-20 -111.36 132.18 54.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.86 HG23 ' HB3' ' A' ' 138' ' ' ALA . 2.6 m -120.86 95.28 48.97 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 120.965 0.412 . . . . 0.0 111.015 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.77 108.73 1.95 Allowed 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 122.99 2.46 . . . . 0.0 110.946 173.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.648 HG21 HG21 ' A' ' 105' ' ' VAL . 14.0 p -116.64 127.58 26.63 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.861 0.363 . . . . 0.0 111.123 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.427 ' N ' ' HG2' ' A' ' 135' ' ' GLU . 6.9 Cg_endo -50.42 131.56 32.52 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.385 2.723 . . . . 0.0 112.406 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' HG12 ' A' ' 102' ' ' VAL . 15.7 ptt180 -64.22 -25.45 68.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.51 -171.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.84 -4.77 57.28 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.373 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.0 m -123.82 -10.14 7.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.758 0.313 . . . . 0.0 111.548 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 99' ' ' ARG . 12.5 p -63.83 -28.07 44.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 110.387 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.66 -30.03 71.31 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.957 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.0 t -76.53 -36.44 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.41 . . . . 0.0 110.079 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.648 HG21 HG21 ' A' ' 97' ' ' VAL . 54.2 t -69.7 -37.45 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.446 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.736 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 45.7 mm -76.55 -46.92 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.177 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.28 170.23 25.91 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -70.94 -53.15 16.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.103 0.478 . . . . 0.0 110.188 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -87.88 -6.93 57.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.182 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.69 29.06 27.66 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.687 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 78.7 mm-40 -88.99 -25.73 21.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.659 0.266 . . . . 0.0 110.743 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.529 ' SD ' ' HD2' ' A' ' 115' ' ' LYS . 17.4 tpt -68.79 -40.61 79.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.902 0.382 . . . . 0.0 110.328 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.736 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.6 tp -65.79 -27.33 41.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.297 0.57 . . . . 0.0 109.912 177.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 55.5 mtpt -76.41 -30.33 57.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.522 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.529 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 99.2 mttt -62.77 -35.87 81.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.191 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.2 mm -60.88 -45.45 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.491 0.662 . . . . 0.0 109.295 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.34 -34.6 76.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.6 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -79.49 -42.17 25.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.729 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.58 -54.26 6.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.34 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -85.44 -14.37 46.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.859 0.361 . . . . 0.0 111.466 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.51 32.6 57.46 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.168 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -106.27 171.81 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.191 0.519 . . . . 0.0 111.532 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 27.2 mtm180 -122.13 140.49 52.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.354 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 113' ' ' ILE . 50.8 mm -103.45 141.57 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 111.653 -172.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 24.5 tt0 -144.08 106.92 4.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.794 177.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -82.82 148.54 27.7 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.623 ' HD2' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -151.07 93.43 1.92 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -168.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 124.539 1.136 . . . . 0.0 112.313 178.897 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.316 0.465 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.427 ' HG2' ' N ' ' A' ' 98' ' ' PRO . 25.6 mt-10 -128.06 147.34 50.52 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.801 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -109.38 118.13 35.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.614 -168.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.623 ' O ' ' HD2' ' A' ' 127' ' ' LYS . 5.5 mm -78.7 99.5 3.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.55 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.86 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -91.95 141.94 28.09 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.878 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.528 ' CE1' HG23 ' A' ' 89' ' ' ILE . 6.7 t-160 -95.55 123.49 39.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.006 0.431 . . . . 0.0 110.504 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.612 ' HB ' ' CG1' ' A' ' 93' ' ' ILE . 37.0 mt -97.33 114.85 35.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.284 170.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.489 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 52.7 ttm -101.77 134.59 44.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.179 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.55 -165.24 31.39 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.459 ' HD2' ' HD2' ' A' ' 146' ' ' ARG . 20.5 Cg_exo -66.41 148.32 83.95 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.67 2.246 . . . . 0.0 111.658 176.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.39 -53.98 3.88 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.541 2.828 . . . . 0.0 113.645 -176.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.24 -44.77 96.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.084 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.459 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 53.8 mtt180 -64.84 -39.12 93.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.99 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.446 ' HA ' ' CG2' ' A' ' 140' ' ' ILE . 75.7 m -58.06 -59.21 5.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.003 0.43 . . . . 0.0 110.654 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.645 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 35.0 mm-40 -61.83 -34.73 76.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.836 -176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -67.95 -29.06 68.02 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.798 0.333 . . . . 0.0 110.73 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.552 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -77.72 -34.23 52.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.086 0.47 . . . . 0.0 110.3 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -60.87 -31.38 70.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.749 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.645 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 7.3 mpt_? -77.7 -19.94 54.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.723 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.6 mt -73.22 -40.98 58.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 84.5 mt -68.96 -45.27 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.236 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -56.73 -32.39 65.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.789 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.39 -41.7 90.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.188 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.89 -44.58 92.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.223 0.535 . . . . 0.0 110.485 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.513 HD21 HG23 ' A' ' 97' ' ' VAL . 17.2 mt . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.152 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 57' ' ' PRO . 10.7 m . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.099 0.476 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 44.5 t -132.16 113.02 20.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.609 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -108.64 142.25 39.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.964 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.592 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 48.7 mt-10 -104.27 129.58 52.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -115.9 141.42 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 96.6 mmm -90.69 104.84 17.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.973 0.416 . . . . 0.0 110.965 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.56 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -91.85 118.86 68.49 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.764 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.458 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 43.4 Cg_exo -63.21 140.3 76.92 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.655 2.904 . . . . 0.0 112.809 176.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.94 123.61 21.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 170.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.08 -36.97 3.75 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -168.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 74' ' ' ARG . 11.6 mptt -74.11 -19.48 60.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -47.53 -41.02 20.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.164 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 19' ' ' LYS . . . -60.24 -36.9 92.04 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.622 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' A' ' 73' ' ' GLU . 3.9 pp -91.42 -23.88 19.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.883 0.341 . . . . 0.0 111.518 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.56 HG11 HG12 ' A' ' 8' ' ' ILE . 86.7 t -82.24 -55.04 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.594 HG13 ' H ' ' A' ' 19' ' ' LYS . 40.6 pt -91.79 -14.99 8.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.367 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.738 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 92.18 6.56 64.72 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.858 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER 64.98 -68.35 0.11 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.874 0.869 . . . . 0.0 110.204 -176.271 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.83 -1.09 90.13 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.237 -0.506 . . . . 0.0 111.918 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.59 -5.92 29.71 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.409 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.664 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 57.4 mm-40 -50.87 -51.95 46.42 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.738 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 27.6 m -71.87 -39.31 69.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -174.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 27' ' ' LEU . 2.6 tp -66.17 -27.64 41.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.08 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.338 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.664 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 22.0 mttm -56.29 -59.2 5.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.453 0.644 . . . . 0.0 109.561 172.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.609 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 93.8 mt-30 -63.51 -37.53 87.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.559 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.609 HD12 HD12 ' A' ' 24' ' ' ILE . 95.7 mt -63.2 -33.64 75.93 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.921 -0.487 . . . . 0.0 110.815 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.752 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 46.7 mt-30 -85.11 -44.77 12.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.905 0.384 . . . . 0.0 111.512 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.61 -51.47 5.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -65.78 -52.41 51.13 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.063 0.459 . . . . 0.0 109.975 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.57 -28.62 63.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.74 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.35 3.55 86.85 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.116 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.2 m -101.2 149.29 6.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -87.66 110.7 20.6 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.778 ' HE1' HD11 ' A' ' 51' ' ' LEU . 32.0 mmm -92.14 111.87 23.6 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.667 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tp -112.22 104.97 17.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.816 0.817 . . . . 0.0 109.379 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.721 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.2 pt? -132.76 127.25 34.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.561 -175.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.561 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.2 mp -68.78 99.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HA ' ' HD2' ' A' ' 49' ' ' LYS . 7.2 tp-100 -123.76 -34.06 3.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.049 0.452 . . . . 0.0 110.29 -174.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -127.85 42.54 3.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.545 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.17 -156.76 8.4 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.127 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -90.52 -164.42 1.17 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.164 0.186 . . . . 0.0 111.214 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 71.62 -79.47 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.229 0.612 . . . . 0.0 111.008 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.544 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 5.7 m-20 -116.74 94.65 4.69 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 p -85.53 -61.87 1.66 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.021 0.438 . . . . 0.0 111.615 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -94.33 -8.7 38.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.926 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.556 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 17.3 t -85.89 164.81 2.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.908 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.403 ' N ' HG12 ' A' ' 47' ' ' VAL . 4.1 m-20 -54.48 142.59 26.86 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.997 0.427 . . . . 0.0 110.29 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 46.1 mtmt -131.6 131.18 22.67 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.75 -167.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.58 131.86 9.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.858 2.372 . . . . 0.0 113.382 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.778 HD11 ' HE1' ' A' ' 35' ' ' MET . 0.4 OUTLIER -111.73 124.59 52.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.494 178.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.667 ' HB2' HG23 ' A' ' 36' ' ' ILE . 4.7 mpt_? -101.11 119.69 39.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.017 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.543 HG12 ' SD ' ' A' ' 35' ' ' MET . 57.9 mt -91.19 115.28 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 173.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.1 mt -104.74 120.72 55.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.381 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.45 -170.92 43.94 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.495 -0.859 . . . . 0.0 113.149 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.721 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 13.8 t70 -72.12 143.5 86.21 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.529 ' HA ' HG21 ' A' ' 2' ' ' THR . 74.6 Cg_exo -40.49 -50.32 3.8 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.756 2.971 . . . . 0.0 114.983 -175.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -62.12 -38.94 90.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 111.221 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.917 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 19.4 ptmt -79.64 -35.42 39.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -175.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.17 -31.42 52.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.215 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -68.77 -55.84 9.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.806 0.336 . . . . 0.0 110.356 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 85.3 mm-40 -59.55 -35.86 75.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.643 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.53 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -73.13 -43.61 61.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.614 ' O ' ' HG3' ' A' ' 68' ' ' MET . 36.0 t -59.11 -42.54 90.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.004 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.87 -32.54 67.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.599 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.948 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 14.7 ptt? -78.69 -38.67 38.64 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.91 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.516 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 33.7 m -61.8 -22.11 27.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 120.649 0.261 . . . . 0.0 110.602 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 48.7 mtt -81.71 -39.94 23.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.069 0.462 . . . . 0.0 110.167 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.73 -26.58 29.61 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -171.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -87.13 -20.93 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 120.865 -1.147 . . . . 0.0 109.714 173.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.491 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 5.2 tt -75.86 -18.04 59.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.045 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -60.5 -14.24 18.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.213 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.65 ' HB3' HD22 ' A' ' 15' ' ' LEU . 8.2 tp10 -47.01 -41.49 16.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.423 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.795 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 45.1 ttp180 74.62 -67.53 0.25 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.501 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.46 62.05 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -171.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.412 HE22 ' HA3' ' A' ' 14' ' ' GLY . 6.8 tp-100 67.38 127.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.787 0.68 . . . . 0.0 112.63 170.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' A' ' 15' ' ' LEU . . . 137.84 -103.83 0.43 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.683 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.534 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 73.6 24.8 73.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.368 174.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 68.4 -54.57 0.53 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.514 0.726 . . . . 0.0 111.962 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 110.91 102.45 2.68 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -173.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.703 ' H ' HG23 ' A' ' 23' ' ' THR . 2.7 t70 71.38 -69.37 0.19 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -169.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.948 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 50.9 ttt85 162.13 -33.54 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.846 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.35 32.93 14.31 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.33 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.902 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 23.5 tt0 -130.73 -57.97 1.04 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.869 -174.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 9.9 p90 -146.79 -26.32 0.41 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.202 -0.936 . . . . 0.0 113.149 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.584 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 65.63 -89.16 0.11 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.816 -176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.917 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 29.3 m -147.83 22.27 1.12 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.271 0.558 . . . . 0.0 109.606 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -96.41 -86.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.188 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.739 HD11 ' HG2' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -94.44 -164.08 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.251 175.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.597 ' H ' HG22 ' A' ' 89' ' ' ILE . . . -141.92 2.43 1.88 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.711 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.82 125.17 3.34 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.852 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 103.5 163.34 25.32 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.902 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 46.3 pt -97.85 157.11 3.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.017 0.437 . . . . 0.0 111.732 -174.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.11 117.47 33.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.619 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 25.0 t -107.56 105.73 56.7 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -172.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.443 ' HA ' HD13 ' A' ' 137' ' ' ILE . 48.6 Cg_endo -72.48 108.02 2.43 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.826 1.684 . . . . 0.0 110.897 169.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.654 HG23 HD21 ' A' ' 158' ' ' LEU . 11.0 p -124.91 131.14 24.06 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.122 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 87.2 Cg_exo -45.52 134.01 12.83 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.389 2.726 . . . . 0.0 113.437 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 102' ' ' VAL . 10.3 ptm180 -55.85 -33.22 64.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.854 -174.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -86.04 -15.18 42.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.103 0.477 . . . . 0.0 110.416 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 16.0 m -95.28 -28.45 14.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.85 -176.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 106' ' ' ILE . 13.6 p -63.49 -28.21 44.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.399 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.84 -28.06 72.92 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.811 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.06 -30.49 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.189 0.519 . . . . 0.0 109.765 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.6 t -68.82 -34.37 64.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.225 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 102' ' ' VAL . 37.0 mm -80.45 -50.25 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.166 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.59 -117.8 5.47 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -126.8 -53.97 1.42 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.1 m -102.18 -15.77 16.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.036 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.51 14.53 6.86 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.85 -24.61 67.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.873 0.368 . . . . 0.0 110.987 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.621 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.0 tpt -86.15 -42.82 13.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.882 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.627 HD11 HG13 ' A' ' 124' ' ' ILE . 15.5 tt -74.01 -35.85 43.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.572 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -69.71 -23.87 63.49 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.495 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 112' ' ' MET . 16.9 ptpt -75.35 -21.96 57.96 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.364 175.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 mm -65.41 -40.94 89.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.636 ' HG3' ' O ' ' A' ' 122' ' ' VAL . 1.8 mp0 -63.78 -31.28 72.41 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.268 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.09 -53.43 7.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.541 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -79.4 -51.26 9.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.113 -172.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.08 -22.42 31.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.866 0.365 . . . . 0.0 111.425 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.01 41.42 40.37 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.088 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.636 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 27.4 m -121.08 160.23 22.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 111.72 -173.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.795 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 83.3 mtp180 -111.11 151.12 28.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.633 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.627 HG13 HD11 ' A' ' 113' ' ' ILE . 48.9 mm -114.4 130.99 67.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.082 0.468 . . . . 0.0 111.333 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.739 ' HG2' HD11 ' A' ' 89' ' ' ILE . 5.4 tp-100 -128.2 110.44 12.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.545 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -82.45 107.12 14.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.128 0.49 . . . . 0.0 110.014 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.507 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.15 -174.67 3.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.07 -174.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.4 ' O ' ' HE3' ' A' ' 127' ' ' LYS . 14.8 mm100 . . . . . 0 N--CA 1.467 0.424 0 O-C-N 123.442 0.464 . . . . 0.0 111.101 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.556 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 88.1 Cg_exo . . . . . 0 CA--C 1.528 0.211 0 N-CA-C 113.501 0.539 . . . . 0.0 113.501 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 98' ' ' PRO . 36.1 mt-10 -120.7 137.64 54.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.794 0.33 . . . . 0.0 111.101 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -110.97 133.11 53.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.128 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 6.8 mm -78.17 105.64 7.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.192 0.52 . . . . 0.0 111.45 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.619 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -100.78 109.11 21.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 170.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 28.3 t60 -73.64 132.42 42.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.955 0.407 . . . . 0.0 111.119 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.616 HD13 ' HB3' ' A' ' 150' ' ' ALA . 80.5 mt -104.13 107.16 21.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.501 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.795 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 41.1 ttm -93.42 143.4 26.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.076 -174.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.44 -165.45 26.74 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 146' ' ' ARG . 32.2 Cg_exo -60.51 136.8 69.81 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.648 2.232 . . . . 0.0 110.523 172.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.9 -32.19 55.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.034 3.156 . . . . 0.0 113.236 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.09 -51.92 58.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.293 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.595 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 98.1 mtt180 -60.4 -40.73 92.01 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.479 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.852 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 73.2 m -52.33 -59.35 4.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.316 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.16 -39.61 93.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.871 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -56.6 -29.83 62.56 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.3 0.572 . . . . 0.0 110.558 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.616 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.97 -36.08 36.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.848 -175.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.75 -19.66 65.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.589 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -77.83 -36.66 49.85 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.9 mt -66.87 -40.49 85.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.833 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.601 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 54.3 mt -66.46 -41.74 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.456 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -60.31 -39.87 88.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.176 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -55.92 -41.01 73.94 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.103 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.542 HD11 ' HE2' ' A' ' 112' ' ' MET . 96.5 mt -62.31 -47.57 83.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.266 175.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.654 HD21 HG23 ' A' ' 97' ' ' VAL . 24.8 mt . . . . . 0 N--CA 1.465 0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.798 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 30.0 m -131.37 137.13 56.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.165 0.507 . . . . 0.0 111.417 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -130.35 150.65 51.49 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 73.8 mt-10 -106.19 123.86 48.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 111.57 -173.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -112.33 140.21 33.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.4 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 44.8 tpp -89.15 113.41 24.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.722 0.296 . . . . 0.0 110.909 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.754 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -98.61 111.14 59.48 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.065 0.459 . . . . 0.0 110.526 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.588 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 51.5 Cg_exo -60.22 139.6 87.9 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.307 2.672 . . . . 0.0 112.713 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.3 125.78 25.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 169.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.16 -46.25 1.2 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -167.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.867 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.7 -32.7 64.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.71 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.661 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.21 -31.89 21.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.55 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.431 ' HA2' ' HE3' ' A' ' 19' ' ' LYS . . . -56.16 -44.99 88.75 Favored Glycine 0 C--O 1.223 -0.593 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.49 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 73' ' ' GLU . 3.3 pp -90.09 -18.13 26.45 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.69 -0.3 . . . . 0.0 111.651 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.754 HG11 HG12 ' A' ' 8' ' ' ILE . 91.6 t -82.73 -49.01 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.781 0.324 . . . . 0.0 111.682 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.661 HG12 ' O ' ' A' ' 13' ' ' ALA . 10.1 pt -91.36 -21.67 6.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.944 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.794 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 96.16 13.12 50.21 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.597 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HE3' ' HA2' ' A' ' 14' ' ' GLY . 3.4 tppp? 67.36 -57.7 0.43 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.961 0.904 . . . . 0.0 110.922 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.53 2.58 46.11 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 109.39 13.23 17.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.088 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.731 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 33.7 tt0 -68.32 -43.59 77.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.841 0.353 . . . . 0.0 111.736 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.794 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 59.3 m -71.06 -40.34 71.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.502 -177.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 35' ' ' MET . 7.3 tp -64.08 -21.53 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.83 0.348 . . . . 0.0 110.529 -176.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.731 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 47.9 mttm -59.0 -48.31 82.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.288 0.566 . . . . 0.0 110.136 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -79.33 -29.83 42.49 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.505 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.42 -27.25 66.03 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 121.844 -0.535 . . . . 0.0 110.449 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.4 mt-30 -84.27 -45.52 12.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.337 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.82 -39.23 15.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.514 ' HD3' ' OD2' ' A' ' 94' ' ' ASP . 4.0 ttm180 -75.29 -46.48 33.23 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.217 -176.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.56 -27.0 34.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.28 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.01 21.7 60.66 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.677 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.3 m -121.97 147.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.91 0.386 . . . . 0.0 111.195 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -90.54 110.38 21.52 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.771 ' HB2' HD11 ' A' ' 24' ' ' ILE . 60.3 mtt -95.09 124.0 38.9 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.3 tp -110.93 100.81 11.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 122.156 0.979 . . . . 0.0 110.451 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 51' ' ' LEU . 1.4 pt? -134.93 142.87 46.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.889 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.2 mp -65.83 99.94 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 111.188 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -101.56 -29.04 12.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.004 176.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.19 175.03 7.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.524 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.12 48.13 3.28 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.363 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.0 t -90.21 -157.81 0.5 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -55.82 -61.37 2.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.578 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.6 m-20 -85.58 48.63 1.62 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.99 0.424 . . . . 0.0 111.218 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -76.95 -47.94 19.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -93.51 -17.01 23.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.419 0.628 . . . . 0.0 110.068 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.578 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 23.1 t -79.4 151.35 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.377 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.588 ' OD2' ' HA ' ' A' ' 9' ' ' PRO . 6.6 m-20 -58.97 145.14 42.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -114.63 125.72 28.78 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-O 121.029 0.442 . . . . 0.0 111.989 -162.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.8 125.5 3.23 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.825 2.35 . . . . 0.0 111.15 174.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 37' ' ' LEU . 7.3 tt -106.51 120.67 42.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.93 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 36' ' ' ILE . 5.1 mpt_? -102.93 120.74 41.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 71.8 mt -91.1 115.47 30.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.108 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.467 HG12 ' CG1' ' A' ' 3' ' ' VAL . 24.7 mt -104.16 121.39 55.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.98 -170.83 43.76 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.37 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.827 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 1.9 m-20 -57.42 149.08 51.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 123.171 0.589 . . . . 0.0 110.472 175.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.13 -50.28 10.19 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.842 2.361 . . . . 0.0 113.332 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.44 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 50.4 p90 -67.89 -42.53 81.04 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.827 ' HG2' ' HB2' ' A' ' 56' ' ' ASP . 16.8 ptpt -72.12 -29.91 64.54 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.969 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.87 -34.57 70.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.447 . . . . 0.0 110.051 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.565 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 59.2 tp60 -77.03 -45.91 25.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.522 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 79.3 mm-40 -63.0 -27.18 69.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.079 0.466 . . . . 0.0 110.131 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.628 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -84.6 -41.81 16.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.784 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.603 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.8 p -61.1 -34.45 74.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.594 0.235 . . . . 0.0 111.595 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.77 -30.64 32.25 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.745 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.73 ' SD ' ' HD3' ' A' ' 82' ' ' ARG . 17.4 ptt? -76.02 -34.97 59.7 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.446 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 27.2 m -68.8 -22.68 26.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.636 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.603 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 49.3 mtt -82.21 -24.5 34.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.664 0.745 . . . . 0.0 109.394 172.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.463 ' CG ' HH21 ' A' ' 72' ' ' ARG . 10.0 t70 -84.58 -53.3 5.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.594 -171.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.012 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.6 pp -76.17 -20.77 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.412 0.625 . . . . 0.0 111.455 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.867 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 2.0 tt -76.06 -9.25 58.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.072 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 15.0 ptp180 -52.39 -53.5 44.15 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.604 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER 53.97 144.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 176.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.604 ' HD2' ' O ' ' A' ' 73' ' ' GLU . 13.0 mmm180 -121.14 -30.31 4.36 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.723 -0.611 . . . . 0.0 110.247 172.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -147.19 41.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.643 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.475 ' H ' ' CG ' ' A' ' 73' ' ' GLU . 49.6 mt-30 62.77 30.73 16.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.373 0.606 . . . . 0.0 110.068 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.68 82.7 0.35 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.199 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.36 175.94 44.69 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.646 ' CD1' HG22 ' A' ' 70' ' ' ILE . 92.8 m-85 -81.45 4.29 21.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.097 0.949 . . . . 0.0 112.348 -173.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 23' ' ' THR . . . 78.03 -3.94 59.72 Favored Glycine 0 N--CA 1.461 0.35 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.638 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -177.49 -61.57 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -178.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 1.012 ' HA ' HG21 ' A' ' 70' ' ' ILE . 2.9 ttp-105 162.47 -34.59 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 124.616 1.197 . . . . 0.0 109.45 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.745 ' HA ' ' OD1' ' A' ' 94' ' ' ASP . 2.2 t-20 57.98 58.99 3.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.931 0.872 . . . . 0.0 110.173 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 1.065 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 0.8 OUTLIER -171.95 -136.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.878 -178.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.573 ' HB3' ' H ' ' A' ' 90' ' ' GLY . 1.3 p90 -59.19 -74.42 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.694 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 85.02 -38.57 2.97 Favored Glycine 0 C--O 1.226 -0.379 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 59' ' ' LYS . 13.0 t -170.92 -37.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.907 -0.647 . . . . 0.0 109.352 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.45 ' HG3' ' CB ' ' A' ' 127' ' ' LYS . 6.5 mmt180 -94.64 149.12 21.56 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.381 -176.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.754 HD12 ' HB2' ' A' ' 141' ' ' MET . 39.8 mm 75.48 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 124.083 0.864 . . . . 0.0 111.377 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.573 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 72.11 43.6 47.53 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.46 -174.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.16 73.7 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 84' ' ' GLU . . . 147.8 159.37 8.37 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -171.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.065 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 9.7 pt -91.14 165.86 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -167.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.745 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 0.6 OUTLIER -99.8 148.17 24.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.865 176.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 38.7 t -135.0 96.18 14.63 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -174.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.48 107.2 1.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.549 1.5 . . . . 0.0 110.504 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.746 HG23 HD21 ' A' ' 158' ' ' LEU . 14.9 p -117.37 128.95 25.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.584 0.231 . . . . 0.0 110.683 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.451 ' HB2' ' OG ' ' A' ' 101' ' ' SER . 64.1 Cg_exo -39.25 132.84 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.997 3.131 . . . . 0.0 113.443 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -56.99 -30.13 63.86 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.476 -171.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -90.1 -12.17 39.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.839 0.352 . . . . 0.0 111.497 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 14.8 m -96.57 -17.16 20.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.758 -173.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 106' ' ' ILE . 7.4 p -59.49 -34.7 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.13 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.38 -31.01 79.43 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.447 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.63 -37.05 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 109.952 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 97' ' ' VAL . 52.9 t -63.27 -39.87 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.294 176.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.715 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.6 mm -72.41 -42.68 64.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.309 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.98 35.94 7.44 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.788 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 63.25 -78.06 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.03 0.532 . . . . 0.0 111.857 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -69.71 -15.28 63.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.768 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.462 ' HA2' HG22 ' A' ' 106' ' ' ILE . . . 90.99 17.26 52.1 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.839 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -7.9 51.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.865 0.364 . . . . 0.0 110.968 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 14.8 tpt -90.24 -41.43 11.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.966 0.412 . . . . 0.0 109.918 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.715 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 8.9 tp -64.31 -22.43 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.207 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 99.3 mttt -81.74 -21.79 37.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.029 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -67.74 -40.24 84.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.008 0.432 . . . . 0.0 109.901 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.536 HG23 HD12 ' A' ' 153' ' ' ILE . 22.1 mt -60.85 -43.65 96.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.78 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -73.71 -18.9 60.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.165 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -87.96 -45.39 10.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.824 0.345 . . . . 0.0 110.882 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -78.49 -46.67 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 146' ' ' ARG . . . -87.16 -17.46 32.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.842 0.354 . . . . 0.0 111.258 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.65 23.96 77.3 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.697 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.4 m -95.47 177.8 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.912 0.387 . . . . 0.0 111.273 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.698 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 98.5 mtt180 -129.24 131.93 47.13 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.606 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.676 HG21 HD11 ' A' ' 113' ' ' ILE . 47.0 mm -98.6 118.69 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.974 0.416 . . . . 0.0 111.02 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.69 ' HB3' HD11 ' A' ' 89' ' ' ILE . 50.6 tp60 -116.23 109.94 18.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.838 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -82.58 140.7 33.1 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HD2' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -146.61 -172.36 3.95 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.067 -171.474 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 . . . . . 0 C--O 1.236 0.38 0 CA-C-O 120.859 0.361 . . . . 0.0 110.404 175.165 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo . . . . . 0 N--CA 1.461 -0.44 0 CA-C-O 120.844 0.268 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -125.83 155.82 40.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.038 0.447 . . . . 0.0 111.301 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.432 ' O ' HG12 ' A' ' 97' ' ' VAL . 23.8 mtpp -110.42 123.91 50.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.222 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.527 ' O ' ' HD2' ' A' ' 127' ' ' LYS . 15.2 mm -72.91 102.31 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.007 0.432 . . . . 0.0 112.005 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -92.72 140.96 28.99 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 169.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.508 ' HB3' ' CG1' ' A' ' 89' ' ' ILE . 2.2 m80 -106.33 138.24 42.87 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.197 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.845 HD13 ' HB3' ' A' ' 150' ' ' ALA . 87.8 mt -107.4 107.25 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.325 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.754 ' HB2' HD12 ' A' ' 89' ' ' ILE . 47.4 ttm -85.83 124.43 32.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.824 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.92 -177.82 34.49 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.131 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.64 147.74 86.45 Favored 'Trans proline' 0 C--O 1.224 -0.177 0 C-N-CA 122.913 2.409 . . . . 0.0 111.389 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.712 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 87.5 Cg_exo -45.16 -46.66 13.34 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.286 2.657 . . . . 0.0 114.132 -174.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -60.53 -34.55 74.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.764 0.316 . . . . 0.0 110.889 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 120' ' ' ALA . 7.0 mtm180 -86.79 -34.48 19.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.188 -176.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.712 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 25.7 p -61.42 -47.14 87.13 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -69.6 -35.64 75.48 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.597 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -54.56 -32.92 59.3 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.149 0.5 . . . . 0.0 110.942 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.845 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.86 -28.77 44.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.089 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.77 -23.65 63.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.955 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -78.08 -25.02 47.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.322 . . . . 0.0 110.412 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.536 HD12 HG23 ' A' ' 116' ' ' ILE . 62.1 mt -73.87 -42.84 53.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.242 0.544 . . . . 0.0 109.868 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.3 mt -68.81 -39.39 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.469 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -58.86 -36.75 75.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.486 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.21 -42.03 93.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.173 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.44 -35.23 80.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.49 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.746 HD21 HG23 ' A' ' 97' ' ' VAL . 35.5 mt . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.219 0.533 . . . . 0.0 110.323 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.955 0.407 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 38.5 t -130.35 112.52 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.439 173.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -110.87 146.93 35.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.613 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 38.4 mt-10 -110.91 116.9 32.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.219 0.533 . . . . 0.0 112.033 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.2 mm -110.16 132.28 58.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 173.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.0 ttm -90.41 119.4 30.66 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.516 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.841 HG12 HG11 ' A' ' 16' ' ' VAL . 1.8 mp -92.95 115.63 65.24 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.252 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HA ' ' OD1' ' A' ' 48' ' ' ASP . 59.6 Cg_exo -57.12 142.14 94.32 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.598 2.865 . . . . 0.0 112.404 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.38 121.37 13.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.6 -54.2 0.6 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -167.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.508 ' HE2' ' OE2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -64.69 -29.77 70.77 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 172.221 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.702 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -50.33 -33.82 21.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.03 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.777 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -59.56 -41.47 97.27 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.731 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.798 HD22 ' HA ' ' A' ' 76' ' ' GLN . 0.5 OUTLIER -89.39 -31.07 17.93 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.957 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.841 HG11 HG12 ' A' ' 8' ' ' ILE . 78.4 t -67.29 -47.91 79.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.765 HG13 ' H ' ' A' ' 19' ' ' LYS . 21.6 pt -91.03 -21.68 6.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.281 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 98.4 -2.5 59.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.859 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.777 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 6.1 tptm 69.78 -50.59 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 111.047 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.57 4.96 69.92 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 172.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.7 3.62 64.25 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.801 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 46.7 mt-10 -65.05 -34.31 78.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.545 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 26.7 m -85.37 -40.93 15.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.92 -175.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.491 HD12 HD12 ' A' ' 27' ' ' LEU . 3.3 tp -67.19 -26.39 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 63.7 tttt -52.73 -50.99 62.32 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.83 169.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 78.7 mt-30 -74.43 -36.5 63.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.363 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.637 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 88.0 mt -66.13 -28.23 68.64 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.173 -0.329 . . . . 0.0 111.135 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 98.4 mt-30 -85.6 -43.64 13.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.793 0.33 . . . . 0.0 111.503 176.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.59 -52.0 6.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.532 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 29.6 ttm180 -70.35 -53.35 17.03 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.765 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -65.68 -26.2 67.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.349 0.595 . . . . 0.0 110.711 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.93 0.38 75.29 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.998 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 35.3 m -103.88 151.38 6.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -92.51 110.3 21.72 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 1.025 ' HB3' HD21 ' A' ' 51' ' ' LEU . 56.8 mtt -97.24 115.38 27.5 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.361 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.93 104.42 17.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 122.334 1.064 . . . . 0.0 109.664 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.717 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.2 pt? -134.26 142.5 47.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.859 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.0 mp -69.29 100.11 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -80.76 -67.12 0.8 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -130.54 101.65 5.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.972 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 45' ' ' THR . . . -155.86 149.51 20.57 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 p -69.76 71.87 0.36 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.12 0.485 . . . . 0.0 111.58 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -169.85 -56.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.411 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.528 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 90.1 m-20 -126.9 60.55 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.898 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 41' ' ' GLY . 2.2 p -83.86 -59.87 2.29 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.637 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.13 -14.92 39.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.354 0.597 . . . . 0.0 109.727 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 47.2 t -79.77 146.06 8.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.833 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.504 ' OD1' ' HA ' ' A' ' 9' ' ' PRO . 42.7 m-20 -58.81 149.91 25.33 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.565 0.541 . . . . 0.0 109.615 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -115.97 122.18 32.82 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.936 -166.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.43 121.34 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.47 2.113 . . . . 0.0 111.537 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.025 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.1 tm? -106.19 125.17 50.66 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.299 -174.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.613 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 1.7 mpt_? -103.42 121.25 42.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.378 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 62.9 mt -89.81 109.09 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.9 mt -105.94 119.7 55.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.992 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.525 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.18 -171.14 44.04 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.432 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.05 146.72 97.41 Favored Pre-proline 0 C--N 1.327 -0.397 0 O-C-N 123.67 0.276 . . . . 0.0 110.522 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.12 -51.89 8.68 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.367 2.711 . . . . 0.0 114.186 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -58.2 -44.19 87.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.233 0.54 . . . . 0.0 110.457 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 86.5 mttt -62.82 -46.72 86.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.486 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.13 -34.21 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.52 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -69.63 -50.04 48.1 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.616 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 20.8 mm-40 -65.88 -33.5 75.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.341 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.56 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -69.7 -47.78 61.96 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.079 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 83.3 m -56.27 -37.82 70.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.171 0.51 . . . . 0.0 110.304 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -70.08 -41.92 73.45 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.888 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.936 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 10.5 ptt? -78.31 -35.69 47.44 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.425 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.533 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 26.9 m -59.44 -47.02 92.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.492 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.1 mtm -65.16 -24.29 67.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 110.479 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 35.2 t70 -83.32 -41.97 17.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.514 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -86.99 -32.65 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.442 -179.235 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.622 ' HA ' HD11 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -82.66 -11.66 58.19 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.348 -175.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -62.75 -40.67 97.96 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 175.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.508 ' OE2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 37.21 -156.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.622 1.201 . . . . 0.0 113.431 175.495 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -165.12 -19.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.492 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -163.2 63.93 0.18 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.894 169.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.798 ' HA ' HD22 ' A' ' 15' ' ' LEU . 65.2 tt0 70.94 -18.81 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.59 0.756 . . . . 0.0 112.619 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.09 86.03 0.58 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.327 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.695 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -121.25 35.29 3.68 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.468 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 65.97 -60.78 0.29 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.626 0.77 . . . . 0.0 112.258 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 106.62 107.53 3.22 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -172.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 1.9 t70 70.64 -72.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -168.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.936 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 47.5 ttt-85 165.03 -27.79 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.825 1.25 . . . . 0.0 108.532 172.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 67.04 26.19 9.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.282 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 1.039 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 13.9 tt0 -130.52 -66.79 0.75 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.188 0.518 . . . . 0.0 110.191 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.498 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 13.3 p90 -144.84 86.9 1.81 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.771 0.796 . . . . 0.0 110.348 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -74.18 71.45 1.47 Allowed Glycine 0 C--N 1.315 -0.617 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.748 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.616 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 47.4 m 66.23 2.41 2.35 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.598 ' HD2' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -85.17 -86.11 0.14 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.212 0.529 . . . . 0.0 110.448 174.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.908 HD11 ' HG2' ' A' ' 125' ' ' GLN . 1.7 mt -88.75 -167.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.805 ' H ' HG22 ' A' ' 89' ' ' ILE . . . -144.57 39.62 1.21 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HE1' ' A' ' 139' ' ' HIS . . . -177.42 124.41 0.94 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.654 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 96.9 165.41 32.84 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.039 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 43.3 pt -94.06 156.22 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 117.292 0.546 . . . . 0.0 112.412 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.496 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 2.2 m-20 -95.88 114.14 25.84 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 175.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.619 HG21 HD12 ' A' ' 140' ' ' ILE . 44.1 t -111.65 104.81 56.45 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HA ' HD13 ' A' ' 137' ' ' ILE . 46.1 Cg_endo -71.32 115.26 4.21 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.349 2.033 . . . . 0.0 112.341 171.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.674 HG23 HD21 ' A' ' 158' ' ' LEU . 10.5 p -117.43 126.22 27.55 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.398 0.618 . . . . 0.0 110.277 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 24.3 Cg_exo -61.79 143.06 95.7 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.306 2.671 . . . . 0.0 112.501 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -59.2 -33.96 71.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.273 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -85.27 20.94 1.83 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -149.55 -24.52 0.28 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.415 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 106' ' ' ILE . 10.6 p -60.57 -26.55 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 120.694 0.283 . . . . 0.0 110.696 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.84 -35.89 84.65 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.255 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.79 -35.18 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 110.055 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 97' ' ' VAL . 41.5 t -63.25 -38.66 82.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.569 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.798 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 44.7 mm -73.87 -40.87 53.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.197 0.522 . . . . 0.0 110.07 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.46 -149.52 19.36 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -75.73 -83.27 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 m -95.92 21.74 8.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.214 0.53 . . . . 0.0 110.645 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.666 ' O ' ' HD3' ' A' ' 114' ' ' LYS . . . 91.79 47.67 3.36 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -170.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -94.26 -54.14 3.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.846 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.2 tpt -67.67 -34.29 76.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.882 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.798 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 7.9 tp -67.13 -31.96 55.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.546 -177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.688 ' HD2' HG23 ' A' ' 113' ' ' ILE . 5.7 mptp? -79.51 -23.47 42.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.124 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.422 ' HB3' ' HE3' ' A' ' 115' ' ' LYS . 22.9 mmmt -66.07 -37.27 85.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.8 mm -60.34 -42.87 92.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.519 0.675 . . . . 0.0 109.281 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -67.58 -33.13 74.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.916 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -79.29 -46.58 17.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.514 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -42.23 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.928 -172.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.54 -13.51 29.66 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.286 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.62 23.26 75.69 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.651 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.8 m -99.94 175.28 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.131 0.491 . . . . 0.0 111.432 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 71.1 mtm180 -129.0 141.36 51.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.039 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 113' ' ' ILE . 49.5 mm -102.38 130.0 52.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.024 0.44 . . . . 0.0 110.8 -175.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.908 ' HG2' HD11 ' A' ' 89' ' ' ILE . 6.1 tp-100 -126.62 96.86 4.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.868 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -75.55 112.78 12.25 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 169.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.781 ' NZ ' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -134.57 163.98 28.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.768 -168.186 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 171.477 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 36.6 Cg_endo . . . . . 0 C--O 1.234 0.284 0 N-CA-C 114.242 0.824 . . . . 0.0 114.242 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -133.61 148.52 51.57 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.391 0.615 . . . . 0.0 112.089 -168.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 97' ' ' VAL . 30.7 mttm -123.44 117.28 24.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.937 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.781 ' HB ' ' NZ ' ' A' ' 127' ' ' LYS . 12.2 mm -71.93 102.22 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.123 0.487 . . . . 0.0 110.676 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.538 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -87.37 98.26 11.26 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 63.9 t-80 -72.1 127.72 33.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.056 0.455 . . . . 0.0 110.634 -172.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 95' ' ' VAL . 93.9 mt -98.65 107.66 20.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.174 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.511 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 38.6 ttm -92.95 137.72 32.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.876 -176.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.26 -160.92 28.61 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.703 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.83 140.6 35.6 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.739 2.293 . . . . 0.0 111.507 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -41.54 -49.64 5.07 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.891 3.061 . . . . 0.0 114.249 -174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -59.42 -52.1 67.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.335 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -61.61 -35.51 78.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.35 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.654 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 72.9 m -56.96 -59.46 5.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.856 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -66.92 -33.73 76.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.971 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.439 ' O ' HG13 ' A' ' 153' ' ' ILE . 12.3 t-80 -60.02 -33.17 71.65 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.211 0.529 . . . . 0.0 110.018 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.559 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.09 -45.93 22.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.906 -176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.57 -20.74 66.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.06 0.457 . . . . 0.0 110.244 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -28.2 52.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.089 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 149' ' ' HIS . 71.6 mt -77.62 -44.93 29.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.132 0.492 . . . . 0.0 109.829 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.488 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 73.2 mt -65.49 -41.15 90.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.01 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -57.04 -42.6 80.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.346 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.95 -36.87 80.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.92 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.15 -42.18 99.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 109.989 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.674 HD21 HG23 ' A' ' 97' ' ' VAL . 17.6 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.99 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 18.6 m -123.47 120.6 60.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.327 0.584 . . . . 0.0 111.098 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 4' ' ' GLN . 11.7 mm-40 -106.32 139.13 41.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.844 174.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.805 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 61.9 mt-10 -110.99 116.11 30.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.28 0.562 . . . . 0.0 111.54 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.9 mp -105.79 140.13 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.425 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 86.7 mmm -87.02 106.31 17.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.996 0.426 . . . . 0.0 110.901 -176.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.477 ' CG1' HG21 ' A' ' 16' ' ' VAL . 1.8 mp -90.62 109.49 34.69 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.985 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 12' ' ' LYS . 13.3 Cg_exo -72.85 165.75 31.9 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 123.322 2.681 . . . . 0.0 111.695 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.97 148.78 34.07 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.59 ' O ' ' HB3' ' A' ' 76' ' ' GLN . . . 84.65 -58.1 5.0 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.145 -172.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.656 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 7.5 mptt -60.98 -31.0 70.6 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.644 0.259 . . . . 0.0 111.268 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.7 -38.03 53.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.59 ' HA2' ' HG2' ' A' ' 19' ' ' LYS . . . -63.26 -37.51 94.99 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.946 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 3.8 pp -80.97 -24.28 38.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.98 0.39 . . . . 0.0 110.133 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG21 ' CG1' ' A' ' 8' ' ' ILE . 96.2 t -79.77 -52.34 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.311 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.757 HG13 ' H ' ' A' ' 19' ' ' LYS . 27.8 pt -77.64 -27.45 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.287 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.487 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 95.49 8.19 58.67 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.35 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.757 ' H ' HG13 ' A' ' 17' ' ' ILE . 54.3 mmtt 42.47 58.22 3.15 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.678 0.752 . . . . 0.0 110.955 -176.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.17 -27.52 1.56 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.398 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.69 -8.02 10.18 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.127 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.716 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 32.8 tt0 -49.96 -59.21 4.09 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -176.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.487 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 23.5 m -67.27 -38.19 84.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 35' ' ' MET . 3.4 tp -65.25 -27.19 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.197 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.716 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 35.0 mttm -57.97 -54.46 46.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.19 0.519 . . . . 0.0 109.797 171.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 25.6 mt-30 -68.88 -34.28 75.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.475 -176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.69 HD13 ' HE2' ' A' ' 35' ' ' MET . 32.6 mt -70.69 -25.7 63.09 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.343 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.762 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 27.0 mt-30 -85.75 -44.07 12.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.691 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -86.11 -54.01 4.73 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.654 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 28.0 ttm180 -71.44 -42.18 68.55 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.972 0.415 . . . . 0.0 110.44 -175.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.666 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -83.32 -9.18 59.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.824 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.12 23.49 66.14 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.886 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 20.6 m -129.02 152.11 36.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.982 0.391 . . . . 0.0 110.426 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 49.9 tptt -87.74 110.19 20.27 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.69 ' HE2' HD13 ' A' ' 27' ' ' LEU . 27.9 mmm -92.7 116.39 28.97 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.7 tp -110.08 111.66 37.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.978 0.894 . . . . 0.0 110.214 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.549 HD13 HD23 ' A' ' 51' ' ' LEU . 3.1 mm? -99.29 135.68 40.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.759 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.484 HG21 ' HD2' ' A' ' 50' ' ' PRO . 13.0 tt -86.79 99.87 8.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.839 0.828 . . . . 0.0 109.755 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.49 32.88 0.13 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.761 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.15 -29.27 16.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.444 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.66 -177.82 16.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.26 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 m -79.37 69.85 5.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.329 0.585 . . . . 0.0 110.737 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -134.52 -63.32 0.72 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.036 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 13.1 m120 -124.78 28.2 6.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.532 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -82.1 -36.17 27.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.132 0.491 . . . . 0.0 109.768 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -93.72 -11.99 30.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.533 0.682 . . . . 0.0 109.676 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 38.0 t -104.19 164.75 3.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.201 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 47' ' ' VAL . 4.1 p30 -55.88 151.33 11.7 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.028 170.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 40.2 mttp -130.86 125.59 21.37 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.735 -168.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.484 ' HD2' HG21 ' A' ' 38' ' ' ILE . 66.3 Cg_endo -74.27 103.89 1.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.144 1.896 . . . . 0.0 110.831 172.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.805 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -84.7 127.46 34.11 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.975 -175.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.583 ' N ' HD22 ' A' ' 51' ' ' LEU . 3.5 mpt_? -102.42 113.39 26.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.004 0.43 . . . . 0.0 110.728 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 59.1 mt -83.84 112.41 21.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.512 172.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 34' ' ' LYS . 52.0 mt -104.22 120.28 54.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.17 -170.58 43.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.681 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.613 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 9.5 m-20 -68.12 152.57 96.37 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 122.688 0.395 . . . . 0.0 111.139 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.8 -54.71 3.92 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.256 2.637 . . . . 0.0 114.394 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -62.22 -48.46 79.87 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.707 0.289 . . . . 0.0 111.594 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.613 ' HD2' ' H ' ' A' ' 56' ' ' ASP . 16.8 ptpt -68.57 -34.11 75.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.771 -175.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 56' ' ' ASP . 76.7 t -65.3 -30.06 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 0.0 110.189 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -80.23 -48.55 12.92 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 85.7 mm-40 -63.35 -39.92 95.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.433 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.674 ' HA ' ' CG ' ' A' ' 66' ' ' MET . . . -70.02 -41.22 74.59 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.842 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.1 t -55.53 -43.5 75.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.47 0.652 . . . . 0.0 109.631 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -65.16 -48.56 73.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.232 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.674 ' CG ' ' HA ' ' A' ' 63' ' ' ALA . 2.0 ppp? -67.01 -42.56 84.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.472 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.645 HG12 HD23 ' A' ' 71' ' ' LEU . 75.3 t -58.47 -49.97 80.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 122.971 0.17 . . . . 0.0 110.924 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.414 ' HE3' HG13 ' A' ' 6' ' ' ILE . 64.4 mtt -58.64 -29.86 66.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.165 0.507 . . . . 0.0 110.425 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 8.7 t70 -85.54 -35.63 20.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.044 -173.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.731 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.7 pp -86.87 -21.57 7.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.985 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.645 HD23 HG12 ' A' ' 67' ' ' VAL . 3.0 pp -86.35 2.2 48.3 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.341 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 7.4 ptp180 -64.07 -14.24 53.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.989 0.423 . . . . 0.0 109.86 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.506 ' HG2' ' C ' ' A' ' 77' ' ' GLY . 8.0 tp10 -51.57 146.75 7.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.452 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -64.01 -36.58 84.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.552 -174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -168.1 112.77 0.65 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.375 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.63 ' HA ' HD23 ' A' ' 15' ' ' LEU . 22.4 pt20 37.64 63.48 0.76 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.347 1.059 . . . . 0.0 113.84 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.506 ' C ' ' HG2' ' A' ' 73' ' ' GLU . . . -152.73 29.15 0.84 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.165 176.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.69 171.25 34.49 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.282 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.731 ' HD1' HG22 ' A' ' 70' ' ' ILE . 80.0 m-85 -65.81 -20.42 66.24 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 84.31 98.68 0.63 Allowed Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.654 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 4.0 t70 71.57 -82.94 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -168.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.651 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 44.4 ttt85 169.36 -36.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.197 0.599 . . . . 0.0 109.616 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 62.38 36.34 14.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.515 0.674 . . . . 0.0 110.218 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 1.002 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.6 tt0 -142.35 -49.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.455 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 13.1 p90 -177.04 135.47 0.2 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.96 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -115.27 -72.49 0.53 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.704 174.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.628 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 18.5 t -108.08 -4.83 17.38 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.16 0.505 . . . . 0.0 110.429 176.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.589 ' HG2' ' HB2' ' A' ' 127' ' ' LYS . 1.4 mpt_? -129.81 172.52 11.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.662 -172.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.609 HG12 ' HB2' ' A' ' 139' ' ' HIS . 35.7 mt 73.21 -78.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 123.813 0.695 . . . . 0.0 112.243 171.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.27 44.54 96.42 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.231 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.409 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 151.28 78.05 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.162 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.713 ' HA3' ' O ' ' A' ' 140' ' ' ILE . . . 158.56 -129.28 2.24 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.002 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 29.4 pt -149.99 160.79 4.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 117.081 0.44 . . . . 0.0 109.847 173.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.5 125.73 45.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.342 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 39.9 t -126.2 101.88 27.96 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.65 107.36 2.45 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.021 1.814 . . . . 0.0 112.057 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.512 HG23 HG12 ' A' ' 95' ' ' VAL . 37.8 t -98.89 128.51 32.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.006 0.432 . . . . 0.0 111.449 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.555 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 5.5 Cg_endo -47.4 129.26 16.02 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.852 3.034 . . . . 0.0 112.215 174.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.727 ' HD3' ' HB2' ' A' ' 134' ' ' PRO . 23.1 ptt180 -57.49 -32.06 66.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.372 -174.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -87.92 11.34 16.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.734 0.302 . . . . 0.0 111.196 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 m -127.89 -30.14 2.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.383 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.39 -33.13 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.36 66.31 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.533 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.69 -37.1 12.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.08 0.467 . . . . 0.0 110.08 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.97 -41.79 93.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.713 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.652 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 34.1 mm -77.1 -45.69 29.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.518 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.64 -124.79 8.36 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.553 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -112.36 -70.39 0.81 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.028 0.442 . . . . 0.0 110.1 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.7 m -99.04 20.4 13.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.56 37.2 35.89 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.794 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -93.88 -33.4 13.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.643 0.258 . . . . 0.0 110.466 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 17.1 tpt -68.43 -41.84 79.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.403 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.1 tp -63.65 -21.69 29.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.614 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -80.61 -19.22 45.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -68.2 -28.97 67.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.167 0.508 . . . . 0.0 110.166 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.647 HD12 HD12 ' A' ' 113' ' ' ILE . 27.1 mt -71.67 -33.64 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.682 0.754 . . . . 0.0 109.172 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -72.18 -23.93 61.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.292 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -79.86 -40.93 27.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.564 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.4 -56.27 4.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.469 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -86.94 -23.73 25.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 111.597 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.16 26.65 43.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.703 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 141' ' ' MET . 29.8 m -95.2 164.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.669 0.271 . . . . 0.0 111.225 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.435 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 13.8 mmt180 -118.33 139.1 51.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 139' ' ' HIS . 48.5 mm -114.64 141.88 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.666 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 18.9 tp60 -155.23 106.06 2.56 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.248 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 106' ' ' ILE . 18.2 m-85 -73.39 105.0 4.58 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.888 176.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.589 ' HB2' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -107.25 96.25 6.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.119 -174.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 C--O 1.236 0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.759 179.637 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.727 ' HB2' ' HD3' ' A' ' 99' ' ' ARG . 5.8 Cg_exo . . . . . 0 CA--C 1.528 0.177 0 CA-C-O 121.153 0.397 . . . . 0.0 112.414 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.555 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 1.4 mp0 -83.92 147.59 27.41 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.273 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -108.91 120.9 43.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.555 -174.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 7.0 mm -73.55 123.61 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.016 0.436 . . . . 0.0 111.294 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . . . -99.0 126.77 44.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.608 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.666 ' HB3' ' O ' ' A' ' 125' ' ' GLN . 1.5 t60 -73.87 126.85 31.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.713 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 82.9 mt -113.98 142.74 25.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.78 172.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 51.0 ttm -132.09 131.35 42.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.552 0.215 . . . . 0.0 110.562 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.8 -167.97 30.52 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.82 142.63 76.87 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.537 2.158 . . . . 0.0 111.477 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.91 -46.69 18.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.215 2.61 . . . . 0.0 113.529 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.46 -36.87 79.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.083 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.513 ' HA ' ' HB3' ' A' ' 149' ' ' HIS . 53.1 mtt180 -80.1 -26.43 39.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.86 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.59 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 69.9 m -60.65 -56.1 25.35 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.68 -31.42 72.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.599 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.537 ' O ' HG13 ' A' ' 153' ' ' ILE . 11.9 t60 -59.75 -33.38 71.6 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.145 0.497 . . . . 0.0 110.258 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.713 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.37 -42.39 30.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.388 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 93' ' ' ILE . . . -63.53 -28.42 69.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.08 0.466 . . . . 0.0 110.275 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -25.71 52.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.297 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 149' ' ' HIS . 75.3 mt -74.64 -47.6 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.676 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.1 mt -61.36 -46.18 97.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.822 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -54.45 -44.06 72.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.356 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.39 -36.13 83.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.405 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 73.5 mt -63.54 -45.55 90.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.085 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 20.7 mt . . . . . 0 N--CA 1.462 0.17 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.27 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 5.0 m . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 4.2 p -140.79 140.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.519 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -125.69 140.66 52.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.258 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 13.0 mp0 -102.39 119.99 39.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.168 0.508 . . . . 0.0 111.623 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.695 HG13 HG21 ' A' ' 67' ' ' VAL . 39.1 mm -113.08 146.62 17.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.027 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.455 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 42.3 mtp -105.38 116.46 31.99 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.482 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.697 HG12 HG11 ' A' ' 16' ' ' VAL . 2.1 mp -97.39 109.14 48.72 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.883 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.823 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 50.8 Cg_exo -61.4 152.78 70.53 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.364 2.709 . . . . 0.0 112.558 175.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.67 144.39 57.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.17 -45.54 2.64 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -171.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.823 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -69.19 -15.65 63.44 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 110.274 174.245 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.555 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -54.23 -38.64 65.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.511 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 18' ' ' GLY . . . -65.89 -31.17 78.81 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.925 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.697 ' CD1' ' HA ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -91.92 -29.48 16.65 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.446 -0.443 . . . . 0.0 112.157 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.697 HG11 HG12 ' A' ' 8' ' ' ILE . 89.2 t -83.78 -56.66 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 13' ' ' ALA . 32.0 pt -93.05 -21.12 6.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.864 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . 103.77 -61.74 0.43 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 23.1 tptp 169.31 -35.91 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 170.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.92 -0.36 7.08 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.224 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.648 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 133.11 0.54 4.21 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.189 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HB2' ' HA3' ' A' ' 18' ' ' GLY . 36.3 mp0 -51.08 -54.7 22.5 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.072 0.549 . . . . 0.0 112.08 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.565 HG21 ' O ' ' A' ' 15' ' ' LEU . 87.3 m -81.67 -26.12 34.97 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.508 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.733 HD12 HD12 ' A' ' 27' ' ' LEU . 2.7 tp -67.75 -22.9 28.76 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.156 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.648 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 7.8 mtpm? -56.03 -54.76 41.07 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.555 169.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 45.0 mt-30 -60.6 -44.12 96.65 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.659 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.733 HD12 HD12 ' A' ' 24' ' ' ILE . 50.7 mt -64.38 -28.59 69.8 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.264 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.738 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 47.1 mt-30 -86.88 -49.09 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 111.664 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.41 -54.24 4.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.707 -171.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 94' ' ' ASP . 10.5 ttt180 -63.8 -51.82 63.06 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.793 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -70.9 -26.79 63.38 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.754 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.79 16.83 80.43 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.876 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.9 m -120.11 160.7 20.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -98.11 110.44 23.02 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.677 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 1.048 ' HB3' HD11 ' A' ' 51' ' ' LEU . 43.5 mtt -101.43 125.75 48.11 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.614 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tt -122.53 115.09 44.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.856 0.836 . . . . 0.0 110.733 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.693 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -134.69 145.18 48.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.332 -175.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.798 HG23 ' HB2' ' A' ' 42' ' ' SER . 33.5 mm -59.9 99.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.469 0.652 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -155.45 23.47 0.41 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.972 175.181 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -111.34 -63.78 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.269 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.43 20.67 0.27 Allowed Glycine 0 CA--C 1.517 0.206 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.736 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.798 ' HB2' HG23 ' A' ' 38' ' ' ILE . 54.6 m -90.95 -166.22 1.53 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.279 0.539 . . . . 0.0 110.781 177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.28 -27.25 24.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -174.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.541 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.4 m-20 -79.58 56.58 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.028 0.442 . . . . 0.0 110.698 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.9 p -83.1 -50.98 7.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.425 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -90.55 -21.47 21.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.525 0.678 . . . . 0.0 109.683 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 23.0 t -79.15 158.82 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.267 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -60.32 153.53 22.41 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.184 0.516 . . . . 0.0 110.525 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -123.88 135.05 25.83 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.766 -163.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.22 104.0 0.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.891 2.394 . . . . 0.0 111.843 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.048 HD11 ' HB3' ' A' ' 35' ' ' MET . 29.5 tp -87.6 129.44 35.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.027 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.614 ' HB2' HG23 ' A' ' 36' ' ' ILE . 7.7 mpt_? -106.73 117.61 34.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.407 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.1 mt -92.79 109.34 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.851 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.9 mt -106.11 121.54 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.72 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 177.82 -171.21 43.75 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.668 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.733 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 11.4 m-20 -64.78 156.28 79.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 122.412 0.285 . . . . 0.0 110.882 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -48.03 -54.85 4.64 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.148 2.565 . . . . 0.0 113.851 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -63.57 -31.54 72.73 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.946 0.403 . . . . 0.0 110.287 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 56' ' ' ASP . 89.7 mttt -66.84 -52.39 44.26 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.566 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.31 -28.76 45.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.299 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -79.85 -41.65 25.89 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.438 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -72.52 -25.21 61.31 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.831 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.712 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -83.42 -40.43 19.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.61 -33.29 72.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.574 0.702 . . . . 0.0 109.246 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.27 -47.22 62.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.681 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.712 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 2.3 ppp? -66.91 -42.13 85.93 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.58 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.695 HG21 HG13 ' A' ' 6' ' ' ILE . 27.0 m -59.63 -42.84 89.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.927 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.3 mtt -68.75 -24.76 64.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.734 ' HA ' ' HE ' ' A' ' 72' ' ' ARG . 52.3 m-20 -81.67 -40.91 22.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.818 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.868 HG22 ' HD2' ' A' ' 79' ' ' PHE . 2.8 pp -88.07 -31.58 5.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.697 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 1.6 tt -75.71 -15.26 60.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.849 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.734 ' HE ' ' HA ' ' A' ' 69' ' ' ASP . 16.4 ptp180 -60.94 -53.6 55.23 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' HG2' ' CD2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER 40.35 -169.73 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 174.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -162.09 -30.25 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.0 -1.455 . . . . 0.0 109.214 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -129.16 32.66 4.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.556 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 39.4 mt-30 64.42 16.74 10.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.062 0.458 . . . . 0.0 111.351 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -114.11 86.44 0.42 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 80' ' ' GLY . . . -98.82 40.61 2.41 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.183 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.868 ' HD2' HG22 ' A' ' 70' ' ' ILE . 24.7 m-85 69.28 -32.11 0.22 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.918 0.887 . . . . 0.0 112.818 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 93.83 95.95 1.55 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 4.1 t70 72.31 -67.15 0.27 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -170.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.794 ' HA ' HG21 ' A' ' 70' ' ' ILE . 48.0 ttt-85 178.03 -1.93 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.214 169.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 47.5 t30 67.85 -58.65 0.44 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.213 0.605 . . . . 0.0 111.64 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.867 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 36.1 mt-10 -72.92 -23.19 60.67 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -174.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.609 ' CB ' ' HB ' ' A' ' 89' ' ' ILE . 44.7 p90 172.12 140.17 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 122.912 0.485 . . . . 0.0 111.136 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.793 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -112.25 97.33 0.9 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 168.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.495 ' HB2' ' HB1' ' A' ' 31' ' ' ALA . 21.8 t 71.62 -38.15 0.41 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.447 ' HG3' HH11 ' A' ' 88' ' ' ARG . 0.2 OUTLIER -89.73 -167.87 1.98 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.456 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.751 HG13 ' CG ' ' A' ' 139' ' ' HIS . 1.5 mp 67.19 -75.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 123.671 0.607 . . . . 0.0 112.3 171.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.428 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 80.23 -31.91 2.32 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.459 -0.401 . . . . 0.0 112.781 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.414 ' N ' HG22 ' A' ' 89' ' ' ILE . . . -148.42 118.61 0.99 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.01 -146.18 17.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.867 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 44.4 pt -140.98 160.61 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.904 0.352 . . . . 0.0 110.258 174.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 85' ' ' TYR . 32.8 m-20 -108.04 117.88 35.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.03 174.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.799 HG23 ' HB3' ' A' ' 138' ' ' ALA . 20.7 m -117.03 106.03 48.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -176.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 32.4 Cg_endo -66.29 107.83 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.455 2.103 . . . . 0.0 111.311 172.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.412 ' HA ' ' HD2' ' A' ' 98' ' ' PRO . 10.7 p -102.85 127.96 28.89 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.936 0.398 . . . . 0.0 110.85 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.658 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 7.3 Cg_endo -52.73 129.3 31.92 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.185 2.59 . . . . 0.0 112.677 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.603 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -44.77 -40.9 6.46 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 113.988 -1.46 . . . . 0.0 113.268 -176.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.499 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 16.6 p80 -82.45 -4.87 58.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.732 -173.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.526 ' O ' HG12 ' A' ' 104' ' ' VAL . 22.6 t -124.49 8.18 8.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.327 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.45 -26.39 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.155 0.503 . . . . 0.0 110.224 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.63 -39.58 67.26 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.906 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 101' ' ' SER . 6.0 p -64.35 -24.71 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.083 0.468 . . . . 0.0 110.458 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 101' ' ' SER . 48.9 t -74.23 -45.47 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.46 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.19 -36.4 37.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.428 0.633 . . . . 0.0 110.578 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.07 -72.68 2.55 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -171.2 -71.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.8 m -95.66 20.63 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.442 0.639 . . . . 0.0 110.088 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.42 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 84.96 2.37 88.44 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.876 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -57.4 -24.8 57.67 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 15.1 tpt -89.54 -51.51 5.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.69 0.281 . . . . 0.0 110.852 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.885 HD11 HG13 ' A' ' 124' ' ' ILE . 19.5 tt -67.68 -31.54 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.735 -174.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.557 ' HA ' ' HG2' ' A' ' 117' ' ' GLN . 98.0 mttt -68.65 -19.16 64.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.673 0.273 . . . . 0.0 111.201 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -74.65 -31.06 61.83 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.107 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.0 mm -63.37 -38.4 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.557 ' HG2' ' HA ' ' A' ' 114' ' ' LYS . 5.4 mm-40 -64.1 -32.21 73.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.629 -1.168 . . . . 0.0 110.704 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -87.16 -41.9 13.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.458 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.15 -48.09 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -89.13 -16.22 31.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.152 0.501 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 53.79 6.31 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.122 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 141' ' ' MET . 29.1 m -133.46 170.81 19.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -172.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.669 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 85.9 mtt180 -132.36 153.27 50.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.885 HG13 HD11 ' A' ' 113' ' ' ILE . 49.6 mm -114.71 140.44 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -172.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.984 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 52.0 tp60 -143.95 101.19 3.7 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.521 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -73.14 116.35 13.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.997 0.427 . . . . 0.0 110.574 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.672 ' O ' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -139.03 129.42 25.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.689 -177.303 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 172.118 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.448 ' HG2' ' HD2' ' A' ' 99' ' ' ARG . 10.3 Cg_endo . . . . . 0 N--CA 1.453 -0.866 0 CA-C-O 120.875 0.281 . . . . 0.0 112.143 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.658 ' OE2' ' HA ' ' A' ' 98' ' ' PRO . 0.8 OUTLIER -81.52 152.27 27.38 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.256 0.551 . . . . 0.0 111.026 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.405 ' O ' HG12 ' A' ' 97' ' ' VAL . 59.0 mttm -110.53 114.8 28.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.582 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.672 ' HB ' ' O ' ' A' ' 127' ' ' LYS . 12.5 mm -70.32 105.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.306 0.574 . . . . 0.0 110.357 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.799 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -94.3 126.95 39.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.984 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 7.3 t-160 -77.8 117.37 19.11 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.099 173.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.609 ' HB ' ' CG1' ' A' ' 93' ' ' ILE . 48.7 mt -97.98 106.57 18.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.669 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 52.9 ttm -85.73 126.63 34.12 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.219 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.15 157.81 8.5 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.496 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.98 149.78 19.92 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.699 2.266 . . . . 0.0 111.741 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.837 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 50.7 Cg_exo -39.12 -44.42 2.64 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 124.037 3.158 . . . . 0.0 114.457 -175.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.32 -40.77 87.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.079 0.466 . . . . 0.0 111.484 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -78.62 -50.61 11.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.512 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.837 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 18.8 p -61.33 -52.36 64.99 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.667 -175.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.56 -30.47 71.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.735 0.302 . . . . 0.0 111.685 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -70.83 -25.08 62.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.231 0.539 . . . . 0.0 110.461 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.28 -42.91 24.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.964 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.89 -30.23 68.87 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -19.95 54.44 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.915 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.5 mt -80.18 -45.13 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.6 mt -64.11 -45.01 97.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.342 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -56.06 -37.35 69.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.305 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.85 -43.61 90.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 110.305 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 70.3 mt -63.14 -40.33 97.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.425 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 7.7 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.039 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 57' ' ' PRO . 37.1 m . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.869 0.366 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 70.5 t -122.52 116.63 49.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.044 0.449 . . . . 0.0 111.027 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -107.77 163.03 13.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 49.0 mt-10 -127.82 120.09 27.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.079 0.466 . . . . 0.0 111.768 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.7 mp -111.36 140.52 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.535 -0.757 . . . . 0.0 108.969 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.498 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 39.0 ttm -90.12 122.44 33.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.811 0.339 . . . . 0.0 110.808 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.589 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.7 mp -95.88 110.78 53.4 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.751 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.784 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 32.6 Cg_exo -65.82 146.66 83.95 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.463 2.775 . . . . 0.0 111.909 172.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.42 130.72 44.84 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.63 -40.31 2.59 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.784 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 1.3 mptm? -84.36 -30.68 25.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.952 173.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.604 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -49.54 -45.45 47.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.855 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -58.0 -39.59 92.12 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.467 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 76' ' ' GLN . 3.5 pp -84.87 -36.39 21.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.069 0.434 . . . . 0.0 110.918 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.658 HG21 HD12 ' A' ' 71' ' ' LEU . 59.9 t -65.94 -42.79 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.682 0.277 . . . . 0.0 111.727 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.895 HG13 ' H ' ' A' ' 19' ' ' LYS . 13.9 pt -92.25 -27.13 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.033 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.587 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 99.88 0.17 56.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.643 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.895 ' H ' HG13 ' A' ' 17' ' ' ILE . 7.2 tptm 74.28 -35.66 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.139 0.975 . . . . 0.0 111.423 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.99 2.55 17.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.945 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.78 -2.76 38.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.608 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 6.8 mp0 -55.52 -44.94 77.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.587 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 88.5 m -74.16 -46.95 39.1 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.496 -177.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 35' ' ' MET . 7.6 tp -62.83 -26.58 41.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 1.3 tmtm? -55.41 -44.83 76.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.212 173.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.414 ' HG3' ' HD2' ' A' ' 25' ' ' LYS . 96.4 mt-30 -85.36 -20.55 29.75 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.707 -177.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.703 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 33.8 mt -79.38 -24.25 42.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.44 0.638 . . . . 0.0 109.494 176.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.5 mt-30 -86.03 -38.88 17.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.892 174.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -86.73 -63.06 1.37 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.431 ' HD3' ' CG ' ' A' ' 94' ' ' ASP . 13.7 ttm180 -65.96 -34.21 77.59 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 110.778 -174.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -87.63 -9.74 53.38 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.024 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.01 22.7 55.84 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.484 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.6 m -126.95 148.99 31.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -89.75 109.01 20.03 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.922 ' HB3' HD11 ' A' ' 51' ' ' LEU . 7.4 mtm -98.29 117.26 32.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.1 tp -111.29 104.7 17.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.928 0.87 . . . . 0.0 110.5 -173.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -133.98 142.28 47.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.915 -178.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.699 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 3.9 mp -68.31 100.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.159 0.504 . . . . 0.0 110.604 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 12.2 mt-30 -96.58 -56.05 2.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -121.54 95.9 4.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.089 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.44 158.56 24.95 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.829 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.7 t -88.82 85.35 6.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.972 0.415 . . . . 0.0 110.453 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -164.46 -79.07 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.021 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 3.2 m-20 -118.52 66.2 0.77 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.51 -56.3 3.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.717 -174.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -93.73 -6.01 47.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.208 1.004 . . . . 0.0 108.519 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 56.5 t -86.42 158.74 3.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.952 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -60.32 148.79 35.66 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 110.323 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.699 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 52.0 mttt -128.62 134.73 26.6 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.024 -166.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.7 121.64 3.34 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.665 2.244 . . . . 0.0 112.125 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.922 HD11 ' HB3' ' A' ' 35' ' ' MET . 53.3 tp -98.03 111.68 23.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.794 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.9 mpt_? -98.22 116.22 29.98 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.506 175.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 49.8 mt -92.14 111.19 23.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.553 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.9 mt -106.6 120.26 57.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.767 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.428 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 173.15 -171.51 44.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.42 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.648 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 3.7 m-20 -65.14 141.69 98.35 Favored Pre-proline 0 C--N 1.33 -0.239 0 C-N-CA 122.149 0.18 . . . . 0.0 111.332 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.496 ' HA ' HG21 ' A' ' 2' ' ' THR . 96.7 Cg_exo -43.39 -54.2 3.73 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.873 3.049 . . . . 0.0 114.234 -174.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -61.13 -41.82 97.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.666 0.27 . . . . 0.0 111.579 -174.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.991 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 18.3 ptpt -77.44 -27.16 52.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.381 -173.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 56' ' ' ASP . 91.4 t -64.56 -32.06 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.986 175.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -73.04 -52.81 12.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -61.98 -37.84 86.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.554 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.562 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -72.25 -39.15 68.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.725 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.413 ' HA ' HG22 ' A' ' 67' ' ' VAL . 42.5 t -57.73 -35.29 70.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.268 0.556 . . . . 0.0 110.076 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.63 -40.93 76.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.774 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.562 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -78.11 -34.95 49.8 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.494 -176.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 33.1 m -67.92 -26.3 34.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 120.811 0.338 . . . . 0.0 110.614 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 66.3 mtt -81.4 -21.36 39.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.011 0.434 . . . . 0.0 109.897 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.85 -55.31 4.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.944 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.658 ' HB ' ' H ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -70.01 -19.71 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.397 0.617 . . . . 0.0 110.48 -177.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.658 HD12 HG21 ' A' ' 16' ' ' VAL . 3.1 tt -85.77 -16.33 39.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.19 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 68' ' ' MET . 8.2 ptm180 -69.83 -8.29 47.16 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.902 -0.136 . . . . 0.0 111.306 -174.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 10.3 tp10 -59.21 -94.87 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 O-C-N 123.586 0.554 . . . . 0.0 111.99 -172.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 37.8 ttp180 159.59 -59.74 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -86.97 147.15 25.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.272 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.664 ' HA ' HD23 ' A' ' 15' ' ' LEU . 29.7 tt0 -54.12 99.87 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.162 0.506 . . . . 0.0 110.834 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.39 -78.6 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.308 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 59.48 -117.26 10.57 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.658 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 90.7 m-85 -127.73 -55.32 1.31 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.496 ' O ' HG13 ' A' ' 70' ' ' ILE . . . 135.98 -79.97 0.31 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 82' ' ' ARG . 6.2 p-10 -103.25 2.78 34.74 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.828 0.823 . . . . 0.0 109.237 170.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 20.4 ttt180 86.86 -31.21 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.587 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.4 t30 51.5 71.99 0.41 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 18.0 tt0 -176.36 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.003 -171.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.854 ' HA ' HD12 ' A' ' 89' ' ' ILE . 34.8 p90 -171.88 -37.63 0.02 OUTLIER 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 175.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.57 -91.69 0.58 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.818 -175.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.991 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 46.1 p -117.16 -11.68 10.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.588 0.708 . . . . 0.0 111.01 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.712 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 46.9 mtt180 -113.65 -163.98 0.9 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.571 -169.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.854 HD12 ' HA ' ' A' ' 85' ' ' TYR . 75.6 mt 60.66 -84.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.678 0.611 . . . . 0.0 112.274 168.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.17 45.4 81.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.857 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.492 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 150.82 90.62 0.08 OUTLIER Glycine 0 CA--C 1.518 0.261 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.46 -149.64 18.71 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 23.7 pt -136.77 167.14 24.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 117.605 0.703 . . . . 0.0 111.107 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . 2.1 p30 -105.43 141.8 36.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.373 173.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.851 HG23 ' HB3' ' A' ' 138' ' ' ALA . 6.2 m -136.92 102.86 9.14 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.076 0.465 . . . . 0.0 111.451 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HB3' HD13 ' A' ' 137' ' ' ILE . 36.1 Cg_endo -67.2 107.86 1.44 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.893 2.395 . . . . 0.0 111.739 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 105' ' ' VAL . 7.6 p -105.79 131.2 21.95 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.247 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.428 ' HD2' HD22 ' A' ' 158' ' ' LEU . 84.6 Cg_exo -45.28 125.91 7.66 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.673 2.915 . . . . 0.0 113.104 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -61.46 -21.03 63.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.947 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -92.04 8.11 39.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.704 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 105' ' ' VAL . 41.7 m -141.88 0.44 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 106' ' ' ILE . 10.1 p -66.84 -33.37 62.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.393 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.18 -29.9 76.49 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.894 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.08 -40.22 58.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 109.988 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 97' ' ' VAL . 40.4 t -64.22 -41.6 92.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.303 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.738 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.1 mm -67.07 -49.28 74.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.487 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.38 69.16 1.42 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.126 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 57.43 -88.85 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.522 0.729 . . . . 0.0 112.309 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.0 t -97.69 18.81 14.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.987 0.422 . . . . 0.0 110.971 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.66 22.92 41.16 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.057 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -72.91 -43.91 61.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.047 0.451 . . . . 0.0 110.839 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.4 ' SD ' ' HD2' ' A' ' 115' ' ' LYS . 16.6 tpt -74.05 -40.29 62.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.632 -177.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.738 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.5 tp -66.47 -32.67 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.815 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -80.85 -22.63 39.72 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.991 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.4 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -66.76 -37.25 84.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.151 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.9 mt -63.28 -40.97 91.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 75.1 mt-30 -63.05 -32.85 74.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.29 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -84.6 -40.1 17.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.987 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.78 -42.04 28.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.361 -172.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.66 2.41 47.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.513 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.98 32.49 82.31 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.464 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.91 171.6 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.008 0.432 . . . . 0.0 111.263 -175.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.844 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 3.2 mmp_? -124.1 152.28 42.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.6 mm -117.08 133.47 63.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.087 0.47 . . . . 0.0 111.65 -175.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 23.8 tp60 -139.37 99.63 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.368 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -74.9 140.6 43.91 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 121.932 -0.48 . . . . 0.0 109.792 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.616 ' HD3' HH11 ' A' ' 88' ' ' ARG . 0.7 OUTLIER -153.11 138.2 17.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.146 -175.169 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.412 ' HB2' ' NH1' ' A' ' 88' ' ' ARG . 86.2 mm-40 . . . . . 0 N--CA 1.467 0.416 0 O-C-N 123.438 0.461 . . . . 0.0 111.254 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 N--CA 1.464 -0.257 0 CA-C-O 120.883 0.285 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 98' ' ' PRO . 5.3 mp0 -121.86 159.93 25.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.043 0.449 . . . . 0.0 111.019 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -121.77 117.53 26.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.542 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.537 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 30.1 mm -71.42 102.45 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.244 0.545 . . . . 0.0 111.968 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.851 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -90.5 142.48 27.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.558 176.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.588 ' NE2' HG23 ' A' ' 89' ' ' ILE . 6.0 t-160 -91.23 115.66 28.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.658 HD13 ' HB3' ' A' ' 150' ' ' ALA . 47.3 mt -94.15 113.98 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.25 172.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.844 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 43.8 ttm -98.95 132.84 43.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.575 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.17 -175.14 31.74 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.925 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.93 145.91 75.9 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.681 2.254 . . . . 0.0 111.592 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.685 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 96.8 Cg_exo -44.68 -48.63 10.23 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.523 2.816 . . . . 0.0 113.869 -173.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.9 -38.69 79.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.936 0.398 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.56 -37.33 21.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.874 -174.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 29.4 p -57.74 -47.83 81.34 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -69.22 -32.95 72.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.683 0.277 . . . . 0.0 110.655 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -64.69 -27.78 69.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.658 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -77.19 -29.77 54.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.9 0.381 . . . . 0.0 110.704 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.69 -25.32 66.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.839 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -78.29 -20.32 51.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.469 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.5 mt -79.77 -39.89 20.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.28 0.562 . . . . 0.0 109.56 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.568 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 53.2 mt -71.17 -51.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.824 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -58.07 -32.21 67.82 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.995 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.24 -32.29 72.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.245 0.545 . . . . 0.0 110.462 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.8 -44.44 23.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.814 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 57.6 mt . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.117 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 14.0 m . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.853 0.358 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 22.4 m -124.85 145.77 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.27 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 73.1 mm-40 -130.42 150.78 51.49 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.55 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 43.6 mt-10 -111.21 121.93 46.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.908 0.385 . . . . 0.0 111.505 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.4 mp -106.06 140.58 23.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.404 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -87.37 110.09 20.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.444 -177.612 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.69 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -98.36 111.48 59.9 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.151 0.5 . . . . 0.0 111.084 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 7' ' ' MET . 37.1 Cg_exo -62.55 151.87 80.83 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.707 2.938 . . . . 0.0 112.789 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.36 133.45 46.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.4 -49.9 1.02 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -167.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 13.9 mptt -69.08 -32.71 72.35 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 170.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -50.99 -35.09 31.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.415 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.415 ' CA ' ' HG2' ' A' ' 19' ' ' LYS . . . -64.3 -38.05 95.34 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.489 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.3 pp -89.06 -21.17 23.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.711 0.255 . . . . 0.0 111.18 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.69 HG11 HG12 ' A' ' 8' ' ' ILE . 96.6 t -82.58 -41.35 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.828 HG21 ' HG3' ' A' ' 39' ' ' GLN . 11.2 pt -92.25 -22.68 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 121.52 -0.738 . . . . 0.0 110.912 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.676 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 92.69 16.55 48.37 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.377 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.415 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 66.0 mmtt 48.64 50.82 16.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.911 0.484 . . . . 0.0 111.297 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.91 -28.49 1.57 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.096 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.25 -13.94 2.78 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.006 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.812 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 1.2 mm-40 -43.7 -55.28 4.49 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.676 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 73.8 m -75.11 -35.11 61.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.49 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.78 HD11 HD21 ' A' ' 37' ' ' LEU . 1.7 tp -68.35 -26.78 34.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.613 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.812 ' HD3' ' HA ' ' A' ' 22' ' ' GLU . 14.3 mtpp -55.04 -51.89 64.88 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.483 0.659 . . . . 0.0 109.998 174.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.442 ' HB2' ' CG ' ' A' ' 81' ' ' ASP . 23.1 mt-30 -81.63 -31.72 32.27 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.887 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.634 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 83.8 mt -66.83 -23.43 66.04 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.742 -0.599 . . . . 0.0 110.479 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 24.1 mt-30 -84.81 -46.46 11.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.13 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.44 -56.69 3.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -175.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HA ' ' OE1' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -57.87 -41.97 83.58 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.144 0.497 . . . . 0.0 110.223 -178.27 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -86.79 -6.46 58.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.533 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.23 23.22 52.46 Favored Glycine 0 CA--C 1.517 0.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 113.52 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.0 m -132.21 153.88 39.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.893 0.377 . . . . 0.0 110.449 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -90.93 109.52 20.75 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.634 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 47.8 mtt -95.37 113.51 25.19 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 tp -110.96 106.87 21.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 122.027 0.918 . . . . 0.0 110.152 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.844 HD22 ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -132.99 142.12 48.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.254 -177.707 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.778 HG21 ' HB2' ' A' ' 43' ' ' GLN . 71.8 mt -86.14 101.6 10.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.726 0.298 . . . . 0.0 111.09 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.828 ' HG3' HG21 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -134.69 -26.51 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.291 177.018 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -88.16 -34.13 17.95 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.4 146.78 34.88 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.75 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -79.71 38.8 0.39 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.778 ' HB2' HG21 ' A' ' 38' ' ' ILE . 48.8 mt-30 -106.38 -49.6 3.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.111 0.482 . . . . 0.0 110.345 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -131.45 30.96 4.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.488 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -70.58 -40.28 73.37 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.022 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -93.84 -26.17 17.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.094 0.473 . . . . 0.0 110.288 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 48' ' ' ASP . 40.0 t -79.3 169.57 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.629 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' N ' HG12 ' A' ' 47' ' ' VAL . 3.4 p30 -60.28 151.95 26.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.985 0.421 . . . . 0.0 110.415 172.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 11.6 mptt -108.64 130.87 22.22 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.024 -171.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -88.88 103.95 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.685 2.257 . . . . 0.0 111.4 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.844 ' HG ' HD22 ' A' ' 37' ' ' LEU . 5.7 tt -87.92 109.7 19.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.868 -174.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.55 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.3 mpt_? -97.23 115.43 27.6 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.697 0.284 . . . . 0.0 110.51 175.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 72.7 mt -87.71 115.67 28.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.054 175.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.431 HG12 ' CG1' ' A' ' 3' ' ' VAL . 32.5 mt -104.13 120.74 54.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 172.22 -170.78 43.76 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.62 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.437 ' HB3' ' HD2' ' A' ' 59' ' ' LYS . 5.5 t70 -65.79 140.42 97.29 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.229 174.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -43.39 -49.45 7.52 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.252 2.635 . . . . 0.0 114.308 -176.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.38 -36.55 84.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.409 0.623 . . . . 0.0 110.204 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.577 ' HG2' ' HB2' ' A' ' 87' ' ' SER . 45.8 mttp -68.95 -44.0 73.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.9 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -59.3 -34.41 53.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.047 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.518 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 0.3 OUTLIER -72.15 -52.2 17.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.545 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -59.93 -32.35 70.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.251 0.548 . . . . 0.0 110.477 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.73 -44.54 14.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.057 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.649 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.9 p -59.5 -33.9 71.92 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 111.272 -175.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.28 -32.78 61.13 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.239 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.593 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 14.2 ptt? -84.4 -32.82 23.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.344 -175.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.655 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 34.9 m -61.0 -31.79 50.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.425 175.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.649 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 36.6 mtm -81.26 -35.36 31.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 175.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.593 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 30.8 t70 -64.66 -40.66 95.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.205 -175.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 66' ' ' MET . 0.2 OUTLIER -87.79 -22.21 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.009 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.655 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -83.93 -24.41 30.72 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.298 -178.186 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.4 1.17 3.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 9.8 tp10 -58.07 150.5 20.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.799 173.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 74' ' ' ARG . 44.3 ttt-85 -79.49 59.43 2.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.312 0.577 . . . . 0.0 110.187 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 64.38 75.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.439 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -156.98 -71.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.931 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.474 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . -172.93 -36.53 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.768 -177.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.01 -97.99 2.22 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.988 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.51 -35.31 1.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.872 0.368 . . . . 0.0 111.039 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.55 67.61 0.64 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.442 ' CG ' ' HB2' ' A' ' 26' ' ' GLN . 5.8 m-20 61.97 30.7 18.09 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 122.026 0.917 . . . . 0.0 109.998 -174.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.534 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 35.5 ttt85 73.99 -40.23 0.45 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.035 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 t30 66.79 11.56 8.33 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.383 0.611 . . . . 0.0 110.601 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.721 ' HG3' ' O ' ' A' ' 92' ' ' GLY . 42.7 tt0 -115.83 -39.49 3.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.033 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.636 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 4.7 p90 -176.13 -157.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.697 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.675 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -176.2 -28.58 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.577 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 20.4 p -165.41 -48.63 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.593 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -73.66 173.36 9.88 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.034 169.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.8 ' HA ' ' CE1' ' A' ' 139' ' ' HIS . 65.5 mt 74.49 -77.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 O-C-N 123.538 0.524 . . . . 0.0 111.539 178.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.71 40.94 49.55 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.367 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.67 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 144.93 98.79 0.25 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.747 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 135.9 -138.79 10.19 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 29.6 pt -143.67 158.35 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 117.109 0.454 . . . . 0.0 110.493 173.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.585 ' OD2' HG21 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -93.4 117.84 30.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.021 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.953 HG21 HD12 ' A' ' 140' ' ' ILE . 75.2 t -116.8 95.29 46.19 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.719 -168.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.479 ' HA ' HD13 ' A' ' 137' ' ' ILE . 50.8 Cg_endo -72.22 113.51 3.72 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.037 1.825 . . . . 0.0 111.893 172.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.609 HG21 HG21 ' A' ' 105' ' ' VAL . 10.4 p -116.84 133.84 23.03 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -48.43 128.98 18.75 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.202 2.602 . . . . 0.0 112.226 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.872 ' HG2' ' HG3' ' A' ' 136' ' ' LYS . 14.7 mtp180 -63.5 -44.1 95.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.414 -171.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.02 6.44 3.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.871 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 104' ' ' VAL . 4.4 m -132.51 1.92 3.77 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.834 0.35 . . . . 0.0 110.761 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 99' ' ' ARG . 10.9 p -75.42 -19.7 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 110.671 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.77 -40.67 95.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.842 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 101' ' ' SER . 8.5 p -73.15 -29.03 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.337 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.609 HG21 HG21 ' A' ' 97' ' ' VAL . 64.6 t -66.94 -41.75 87.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.775 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.76 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 40.7 mm -72.51 -38.11 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.935 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.5 38.65 5.24 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.039 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.7 ttp-105 66.33 -75.36 0.05 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.215 0.606 . . . . 0.0 111.821 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.3 p -99.99 12.5 36.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.091 0.472 . . . . 0.0 110.694 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.72 40.49 7.18 Favored Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.203 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -91.91 -32.07 15.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.116 0.484 . . . . 0.0 110.412 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.552 ' O ' HG12 ' A' ' 116' ' ' ILE . 5.9 tpt -89.64 -41.56 11.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.521 -171.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.76 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 6.2 tp -59.81 -25.99 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.33 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' A' ' 114' ' ' LYS . 10.1 mmpt? -73.32 -45.33 55.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.924 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.95 -22.44 60.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.917 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 112' ' ' MET . 37.0 mm -59.42 -44.29 92.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.641 HE21 ' HB ' ' A' ' 124' ' ' ILE . 65.0 mt-30 -68.01 -25.5 65.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.26 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -79.7 -46.75 16.52 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.025 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -78.44 -52.68 8.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.317 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.558 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -81.07 -19.34 43.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.367 -176.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.35 26.35 63.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.629 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.3 m -95.84 161.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.377 0.608 . . . . 0.0 112.109 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.808 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 6.7 mpt_? -108.68 135.15 50.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.716 HG21 HD11 ' A' ' 113' ' ' ILE . 43.2 mm -116.29 129.83 72.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 1.047 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -143.51 169.56 17.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.186 168.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -117.29 104.28 10.99 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.898 ' HD2' ' HG3' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -94.83 -12.91 26.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -165.25 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.898 ' HG3' ' HD2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 123.675 0.79 . . . . 0.0 109.055 173.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 87.6 Cg_endo . . . . . 0 N--CA 1.462 -0.326 0 CA-C-O 120.963 0.318 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -130.89 156.43 45.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.932 0.396 . . . . 0.0 111.028 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.872 ' HG3' ' HG2' ' A' ' 99' ' ' ARG . 48.9 mttm -110.03 118.51 36.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.485 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 10.6 mm -77.34 120.53 28.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.041 0.448 . . . . 0.0 112.207 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.69 36.18 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.47 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 1.047 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 12.7 t-160 -85.15 104.71 15.28 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.953 HD12 HG21 ' A' ' 95' ' ' VAL . 60.5 mt -88.35 118.27 33.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.221 170.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.808 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 41.4 ttm -109.49 127.39 54.39 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 158.56 -160.59 31.12 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.478 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 16.3 Cg_exo -68.73 139.99 45.52 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.786 2.324 . . . . 0.0 110.855 174.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 143' ' ' PRO . 75.8 Cg_exo -50.56 -32.54 35.58 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.138 3.225 . . . . 0.0 114.139 -172.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.82 -44.61 66.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.789 0.328 . . . . 0.0 110.556 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.558 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 55.7 mtt-85 -70.76 -27.72 64.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.291 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.747 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 71.2 m -57.41 -56.05 26.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.27 175.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.08 -31.81 68.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.36 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 146' ' ' ARG . 30.9 t60 -55.95 -33.1 64.43 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.265 0.555 . . . . 0.0 110.313 173.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.702 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.24 -45.01 24.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.506 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.19 -24.56 67.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.403 0.621 . . . . 0.0 110.304 176.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -76.58 -26.27 54.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.106 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.575 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 68.5 mt -78.21 -40.89 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 73.6 mt -59.55 -43.17 90.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.064 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.06 -39.34 74.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.011 0.434 . . . . 0.0 110.666 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -69.91 -33.09 71.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.303 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 70.3 mt -66.61 -40.41 88.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.087 0.47 . . . . 0.0 110.335 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 56.3 mt . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.854 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.431 HG21 ' HA ' ' A' ' 57' ' ' PRO . 24.0 m . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 121.302 0.572 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 12.1 p -125.65 121.98 61.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.858 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -109.99 150.74 28.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.759 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 39.1 mt-10 -116.06 123.36 47.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.439 0.638 . . . . 0.0 111.959 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -114.11 144.46 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.992 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.406 ' SD ' ' HB2' ' A' ' 48' ' ' ASP . 33.3 tpp -87.91 124.11 33.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.963 0.411 . . . . 0.0 111.514 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.7 mp -104.24 109.05 61.94 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.86 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.586 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 52.7 Cg_exo -61.29 147.25 96.08 Favored 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 123.596 2.864 . . . . 0.0 112.962 175.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.7 124.92 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.65 -39.14 2.99 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -169.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -79.71 -31.75 41.23 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.104 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.673 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -53.67 -34.34 58.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.881 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.03 -39.12 91.53 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.581 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.1 pp -89.7 -22.84 22.03 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.553 -0.381 . . . . 0.0 111.075 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.557 HG21 HD12 ' A' ' 71' ' ' LEU . 96.6 t -78.52 -46.83 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.729 HG13 ' H ' ' A' ' 19' ' ' LYS . 22.0 pt -91.2 -21.14 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.086 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.479 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.78 -0.73 59.44 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.759 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.729 ' H ' HG13 ' A' ' 17' ' ' ILE . 15.6 tptp 70.0 -52.33 0.63 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.975 0.91 . . . . 0.0 110.557 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.72 8.68 73.99 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.16 5.4 76.54 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.194 -0.526 . . . . 0.0 113.082 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.918 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 10.2 pt-20 -73.31 -27.57 61.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.487 HG23 ' C ' ' A' ' 80' ' ' GLY . 90.3 m -77.43 -43.67 31.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.899 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.555 ' HA ' HD12 ' A' ' 27' ' ' LEU . 6.2 tp -62.81 -24.21 35.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 CA-C-O 120.834 0.349 . . . . 0.0 110.525 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.918 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 77.9 mttt -60.85 -50.66 72.55 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.141 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.463 ' CB ' ' HB2' ' A' ' 81' ' ' ASP . 39.2 mt-30 -71.54 -31.75 67.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.107 -177.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 24' ' ' ILE . 47.7 mt -68.44 -27.58 66.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 110.611 176.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.1 mt-30 -84.65 -47.55 10.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.295 0.569 . . . . 0.0 110.565 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -84.02 -53.37 5.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.206 -171.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.679 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 26.3 ttm180 -65.6 -44.47 86.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -80.66 -7.19 59.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.316 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.77 9.34 38.74 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.763 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.2 m -109.15 172.16 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.95 0.375 . . . . 0.0 110.362 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -113.43 109.98 19.56 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.867 ' HB3' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -95.19 112.82 24.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.275 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.499 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.1 tp -111.11 100.67 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 122.392 1.091 . . . . 0.0 110.667 -177.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.896 ' HG ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -134.38 143.91 47.9 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.634 178.129 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.0 mp -62.51 100.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.886 0.374 . . . . 0.0 110.237 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -87.36 -77.21 0.34 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -104.85 86.68 2.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.224 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . -144.28 163.12 27.85 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.021 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 m -62.54 -28.74 70.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -82.16 -78.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.39 . . . . 0.0 111.77 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.625 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 76.2 m-20 -110.34 56.25 0.63 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.874 -171.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 9.3 t -80.19 -45.43 18.08 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -94.01 -26.52 16.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.824 0.821 . . . . 0.0 109.026 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.625 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 57.3 t -78.89 159.86 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.009 -175.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 47' ' ' VAL . 3.3 p-10 -55.94 151.33 11.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -126.71 129.83 23.98 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.509 -166.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.06 112.99 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.846 2.364 . . . . 0.0 112.108 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.896 HD22 ' HG ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -81.37 110.52 16.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.973 -176.569 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.573 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.6 mpt_? -98.77 107.46 19.91 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.42 174.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.3 mt -91.43 113.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.053 176.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.0 mt -103.77 123.12 57.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.806 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.4 -171.45 44.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.267 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 9.7 t70 -71.34 139.14 84.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.431 ' HA ' HG21 ' A' ' 2' ' ' THR . 30.3 Cg_exo -34.82 -47.06 0.62 Allowed 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 124.07 3.18 . . . . 0.0 114.99 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -61.81 -40.64 95.95 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.821 0.344 . . . . 0.0 111.281 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 56' ' ' ASP . 19.7 ptpt -82.14 -31.04 30.76 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.95 -175.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.98 -30.68 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.546 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -52.21 14.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.442 ' HB3' ' CD2' ' A' ' 85' ' ' TYR . 14.8 mm-40 -65.59 -23.68 66.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.708 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -81.21 -51.32 8.55 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.997 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.501 ' SG ' HD12 ' A' ' 53' ' ' ILE . 94.5 m -54.11 -40.81 67.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.272 0.558 . . . . 0.0 109.978 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -58.54 -53.28 60.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.822 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.668 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 6.6 ptt? -64.43 -40.81 96.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.89 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 63' ' ' ALA . 86.9 t -56.53 -47.64 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.531 0.205 . . . . 0.0 110.812 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.1 mtt -69.87 -26.9 64.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.956 0.408 . . . . 0.0 110.89 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.544 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -85.36 -27.91 25.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.78 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.7 pp -90.14 -32.64 5.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 O-C-N 121.71 -0.619 . . . . 0.0 111.788 175.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.588 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 4.2 tt -71.98 -12.5 61.27 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.604 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -67.36 -10.42 50.91 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.256 -0.278 . . . . 0.0 111.22 177.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.927 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 9.2 tp10 -56.57 131.13 47.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.136 0.494 . . . . 0.0 110.297 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 31.0 ptt180 -66.67 -44.57 81.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.888 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 29.1 t0 172.88 92.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.869 0.73 . . . . 0.0 109.54 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -176.19 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.926 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.927 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . 160.78 131.25 1.2 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.169 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -87.89 58.55 4.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.154 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.608 ' HD2' HG22 ' A' ' 70' ' ' ILE . 78.5 m-85 57.72 8.84 0.73 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.212 0.605 . . . . 0.0 112.416 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.487 ' C ' HG23 ' A' ' 23' ' ' THR . . . 70.06 7.34 59.41 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.581 -0.342 . . . . 0.0 113.087 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.679 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.2 OUTLIER 170.71 -62.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.107 0.479 . . . . 0.0 109.781 -172.356 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.78 ' HA ' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER 163.71 -45.02 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.446 -173.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 57.63 72.37 0.52 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.388 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 1.04 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 24.8 tt0 -171.34 -68.56 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.749 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.34 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.691 ' H ' ' HD2' ' A' ' 82' ' ' ARG . 0.9 OUTLIER -136.18 -95.7 0.24 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.527 -0.733 . . . . 0.0 111.926 178.011 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.571 ' H ' ' HD2' ' A' ' 85' ' ' TYR . . . 84.96 92.03 0.79 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 38.0 t 65.49 6.34 3.7 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.709 0.404 . . . . 0.0 110.893 -175.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.755 ' HG3' ' HD2' ' A' ' 127' ' ' LYS . 3.0 mmp_? -132.66 171.61 13.62 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.102 -173.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.98 HD11 ' HG2' ' A' ' 125' ' ' GLN . 24.3 mm 28.95 -83.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 125.725 1.891 . . . . 0.0 115.144 169.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.53 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 86.49 36.18 9.85 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -172.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.18 98.23 0.11 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.802 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 112.0 161.66 16.22 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -174.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.04 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 40.0 pt -93.98 158.77 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -172.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CG ' HG21 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -102.55 108.07 19.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.015 179.481 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 27.5 t -101.11 105.12 37.07 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.43 ' CA ' HD13 ' A' ' 137' ' ' ILE . 56.9 Cg_endo -75.06 108.12 2.64 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.047 1.832 . . . . 0.0 111.885 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.685 HG13 HD21 ' A' ' 158' ' ' LEU . 47.2 t -101.65 127.76 30.58 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.997 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.626 ' HD2' HD22 ' A' ' 158' ' ' LEU . 74.3 Cg_exo -41.59 132.97 3.72 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.803 3.002 . . . . 0.0 112.734 171.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' A' ' 134' ' ' PRO . 32.6 ptt180 -51.34 -34.92 35.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.562 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -92.5 4.69 53.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.352 -177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.6 m -122.44 -18.55 6.68 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.586 ' HA ' HG11 ' A' ' 97' ' ' VAL . 14.2 p -59.1 -34.1 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.623 0.249 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.53 -30.0 75.74 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.798 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.78 -33.79 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.055 0.455 . . . . 0.0 109.868 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.53 -36.09 76.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.01 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.752 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 37.7 mm -75.23 -46.04 39.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.266 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.45 -127.19 7.49 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 108' ' ' ARG . 4.2 mmp_? -100.39 -65.38 0.97 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.7 m -105.64 -20.96 13.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.514 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.17 50.18 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.127 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -93.86 -57.78 2.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.703 0.287 . . . . 0.0 110.472 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.573 ' HA ' ' HD3' ' A' ' 115' ' ' LYS . 14.2 tpt -59.82 -36.43 76.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.367 -174.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.752 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.6 tp -65.78 -32.39 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -86.43 -19.76 29.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.308 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.573 ' HD3' ' HA ' ' A' ' 112' ' ' MET . 26.5 mtpp -66.79 -35.68 80.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.297 174.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 112' ' ' MET . 30.1 mm -62.89 -38.51 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.198 0.523 . . . . 0.0 109.629 175.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -64.69 -34.01 77.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.675 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -82.36 -38.64 23.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.277 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.9 -55.8 4.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.002 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.85 -25.38 22.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.558 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.97 32.9 19.77 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.981 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 m -114.69 164.1 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.094 0.473 . . . . 0.0 111.449 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -109.87 163.17 13.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.641 HG21 HD11 ' A' ' 113' ' ' ILE . 45.3 mm -123.76 124.36 69.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.048 0.452 . . . . 0.0 111.492 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.98 ' HG2' HD11 ' A' ' 89' ' ' ILE . 50.5 tp60 -115.18 112.96 23.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.034 177.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.433 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 35.7 m-85 -87.64 106.04 17.76 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.365 0.602 . . . . 0.0 109.566 173.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.755 ' HD2' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -107.46 -159.28 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.753 -178.179 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.431 ' H ' ' HB2' ' A' ' 127' ' ' LYS . 50.9 tp60 . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 121.298 0.57 . . . . 0.0 112.099 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.547 ' HB2' ' HD3' ' A' ' 99' ' ' ARG . 92.4 Cg_endo . . . . . 0 N--CA 1.461 -0.39 0 CA-C-O 120.941 0.309 . . . . 0.0 112.771 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.557 ' OE1' ' HA ' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -75.37 149.24 38.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 111.131 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -124.93 123.16 39.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.996 -175.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.696 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 40.0 mm -65.43 111.25 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.954 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -90.84 91.07 8.2 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 164.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 28.0 t60 -71.18 115.86 10.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.228 0.537 . . . . 0.0 111.08 -169.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.771 HD11 HD12 ' A' ' 154' ' ' ILE . 96.4 mt -79.74 107.79 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.222 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.493 ' HB2' ' HD2' ' A' ' 139' ' ' HIS . 21.9 ttp -103.96 128.12 51.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.13 -172.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.26 -156.4 27.21 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.41 137.79 44.22 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.669 2.246 . . . . 0.0 111.705 177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -45.56 -55.07 3.81 Favored 'Trans proline' 0 N--CA 1.474 0.378 0 C-N-CA 123.543 2.828 . . . . 0.0 113.978 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -64.52 -32.86 74.68 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.798 0.333 . . . . 0.0 111.03 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -72.5 -36.06 68.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.802 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 74.5 m -60.72 -54.5 44.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.44 174.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.584 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 4.7 mm-40 -54.97 -42.04 71.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.739 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -59.65 -31.61 69.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.401 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.67 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.22 -35.15 42.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.365 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -70.71 -18.71 62.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.644 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 9.8 mpt_? -77.57 -17.3 58.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.977 0.418 . . . . 0.0 109.975 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.93 -50.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.913 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.771 HD12 HD11 ' A' ' 140' ' ' ILE . 38.7 mt -71.64 -57.18 8.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.734 -173.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.409 ' HA ' HD12 ' A' ' 158' ' ' LEU . 3.9 m-20 -59.07 -28.65 66.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.881 0.372 . . . . 0.0 110.813 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.93 -47.32 80.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.428 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 4.4 pp -76.59 -20.91 56.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.326 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.685 HD21 HG13 ' A' ' 97' ' ' VAL . 33.6 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.198 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 57' ' ' PRO . 6.6 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 29.3 m -130.98 124.56 56.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 0.0 110.8 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -105.42 153.75 21.26 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.608 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 51.9 mt-10 -123.86 109.06 13.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.457 0.646 . . . . 0.0 111.677 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -105.59 139.02 28.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.7 tpp -91.01 122.35 33.6 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.716 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.696 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -95.53 113.76 62.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.749 -177.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -61.78 153.87 64.72 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.628 2.886 . . . . 0.0 112.459 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.74 144.66 55.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 171.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.42 -53.15 3.46 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -170.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -63.36 -35.11 79.29 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.372 172.656 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.675 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -49.12 -34.37 13.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.839 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -60.06 -44.34 97.37 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.615 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 75' ' ' ASP . 4.1 pp -85.48 -23.95 27.58 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.081 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.696 HG11 HG12 ' A' ' 8' ' ' ILE . 97.7 t -73.69 -42.9 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.681 HG13 ' H ' ' A' ' 19' ' ' LYS . 21.2 pt -91.56 -25.24 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 121.679 -0.638 . . . . 0.0 111.083 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.612 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 100.49 3.77 55.17 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.904 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.681 ' H ' HG13 ' A' ' 17' ' ' ILE . 7.6 tptm 53.82 48.13 22.05 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.542 0.687 . . . . 0.0 110.462 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.57 -1.48 0.52 Allowed Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.945 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.34 26.46 13.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.605 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -84.11 -60.12 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.988 0.423 . . . . 0.0 110.555 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.612 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 54.4 m -61.33 -44.52 97.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.359 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -31.4 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.032 0.444 . . . . 0.0 110.19 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -39.01 93.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.264 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 30' ' ' ARG . 76.4 mt-30 -77.85 -39.53 43.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.269 0.557 . . . . 0.0 109.61 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.625 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 74.8 mt -64.0 -23.85 67.49 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.81 0.338 . . . . 0.0 110.61 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.692 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.9 mt-30 -85.89 -58.37 2.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.808 0.337 . . . . 0.0 111.751 174.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -82.59 -42.26 18.51 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -172.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.57 ' HG3' HG13 ' A' ' 137' ' ' ILE . 1.9 mtp180 -73.7 -38.72 64.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.83 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -84.39 -12.22 54.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.209 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.75 75.09 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.992 175.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 23.3 m -128.15 153.15 37.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.844 0.354 . . . . 0.0 110.675 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -90.13 110.14 21.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . 1.014 ' HB3' HD21 ' A' ' 51' ' ' LEU . 48.9 mtt -96.25 124.58 40.31 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.446 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 6.1 tp -119.09 111.12 32.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.776 0.798 . . . . 0.0 110.217 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.724 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -134.15 144.35 48.48 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.829 -174.451 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.492 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 43.8 mm -68.19 104.48 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.05 0.452 . . . . 0.0 111.207 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 1.3 pp0? -146.71 20.85 1.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.64 0.733 . . . . 0.0 109.868 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.27 23.15 0.29 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.702 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . 82.33 -55.59 4.96 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.223 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.4 t -90.53 -157.9 0.51 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 62.04 -132.27 0.59 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.304 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.477 ' H ' HG21 ' A' ' 38' ' ' ILE . 93.8 m-20 -80.88 69.51 7.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.487 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 4.0 t -79.58 -44.96 20.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.904 0.383 . . . . 0.0 110.801 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -93.27 -3.54 53.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.161 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.11 159.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.913 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.02 156.22 36.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 18.2 mttm -131.06 128.35 22.24 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.301 -161.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.53 125.35 8.25 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.435 2.09 . . . . 0.0 112.021 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.014 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.5 tm? -105.88 120.42 41.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.603 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.608 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.7 mpt_? -102.98 121.61 42.9 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.395 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.9 mt -90.5 109.92 21.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.465 HG12 HG12 ' A' ' 3' ' ' VAL . 36.8 mt -104.92 119.33 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.524 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.45 -170.74 43.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.921 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -67.24 142.03 96.55 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HA ' HG21 ' A' ' 2' ' ' THR . 87.4 Cg_exo -46.29 -47.68 14.6 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.129 2.553 . . . . 0.0 113.931 -172.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.483 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 46.1 t80 -59.23 -40.71 86.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.151 0.5 . . . . 0.0 110.647 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -67.99 -45.49 73.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.093 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.6 t -58.33 -34.08 49.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.558 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -73.99 -40.51 62.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.737 0.303 . . . . 0.0 111.377 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.646 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 72.9 mm-40 -72.99 -29.02 62.73 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.139 0.495 . . . . 0.0 110.268 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -85.65 -36.59 20.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.8 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.7 p -55.56 -43.4 75.83 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.96 0.41 . . . . 0.0 111.146 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.53 -38.85 81.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.593 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.803 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 4.9 ptt? -71.49 -34.27 70.0 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.598 -176.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 63' ' ' ALA . 89.4 t -56.99 -36.17 49.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 174.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 36.2 mtm -82.0 -28.34 32.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.449 0.642 . . . . 0.0 110.19 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 36.5 t70 -75.87 -41.29 52.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.311 -171.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.909 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.8 pp -89.63 -26.3 5.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 8' ' ' ILE . 5.8 tt -69.6 -24.27 63.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.673 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -19.94 59.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.591 -177.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 12.5 tp10 -51.19 -90.31 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.561 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 61.9 ttt180 168.08 -82.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.1 p-10 -168.52 12.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.828 172.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -86.46 -76.26 0.36 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.501 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -140.43 83.65 0.23 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.792 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.561 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -91.83 24.07 22.85 Favored Glycine 0 C--O 1.226 -0.388 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 175.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.725 ' HD2' HG22 ' A' ' 70' ' ' ILE . 54.6 m-85 69.05 -23.86 0.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.394 1.078 . . . . 0.0 113.56 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.496 ' C ' HG23 ' A' ' 23' ' ' THR . . . 84.14 15.4 69.61 Favored Glycine 0 C--N 1.328 0.129 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.399 177.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.423 ' HA ' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER 173.89 -65.69 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -174.567 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.909 ' HA ' HG21 ' A' ' 70' ' ' ILE . 32.3 ttt180 166.88 -18.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.906 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 79' ' ' PHE . 0.3 OUTLIER 67.66 42.7 1.98 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.025 176.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 28.9 tt0 -160.64 -52.56 0.05 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.472 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 46.0 p90 -176.71 171.7 2.22 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 110.075 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.682 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -132.95 -11.13 1.88 Allowed Glycine 0 CA--C 1.523 0.57 0 O-C-N 123.726 0.641 . . . . 0.0 112.28 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.646 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 18.0 p 178.28 -55.97 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.62 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 1.4 mpt_? -70.08 179.1 2.46 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.752 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.666 HG23 ' CD2' ' A' ' 139' ' ' HIS . 54.2 mt 78.36 -74.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.64 0.587 . . . . 0.0 111.136 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 46.91 46.73 19.65 Favored Glycine 0 C--N 1.337 0.609 0 O-C-N 123.41 0.444 . . . . 0.0 112.582 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 142.85 99.88 0.34 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.673 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 113.69 166.11 16.03 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -174.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 2.8 pp -93.66 -178.43 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.223 0.535 . . . . 0.0 112.253 -173.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.565 ' OD2' ' HD3' ' A' ' 96' ' ' PRO . 1.7 p-10 -109.74 147.01 33.96 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.142 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.895 HG23 ' HB3' ' A' ' 138' ' ' ALA . 3.5 m -137.56 97.14 10.48 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 121.229 0.537 . . . . 0.0 111.666 173.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HD3' ' OD2' ' A' ' 94' ' ' ASP . 37.2 Cg_endo -67.04 108.55 1.53 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.155 2.57 . . . . 0.0 111.692 173.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 102' ' ' VAL . 99.0 t -103.52 120.1 52.78 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.818 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -46.32 128.02 11.77 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.768 2.312 . . . . 0.0 110.872 170.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.71 -31.5 37.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -173.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -82.12 -9.76 59.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.968 0.413 . . . . 0.0 110.809 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -107.06 -19.1 13.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.514 ' HA ' HG11 ' A' ' 97' ' ' VAL . 94.6 t -48.31 -45.39 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.491 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.87 -22.13 61.9 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.986 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.7 t -86.51 -38.78 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.89 0.376 . . . . 0.0 110.075 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.6 t -66.61 -38.77 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 121.345 0.593 . . . . 0.0 109.904 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.762 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 38.9 mm -70.54 -43.36 77.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.562 174.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.92 66.92 1.39 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.726 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 108' ' ' ARG . 4.0 mpt_? 57.81 -94.81 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.061 0.544 . . . . 0.0 112.055 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.1 m -77.21 -13.29 59.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.399 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' A' ' 106' ' ' ILE . . . 109.11 22.38 6.9 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.992 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 12.8 pt-20 -85.45 -10.81 55.63 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.737 -0.272 . . . . 0.0 111.689 -176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.9 tpt -89.94 -40.8 12.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 0.0 110.421 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.762 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 11.0 tp -62.19 -25.32 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.449 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 45.6 mtpt -85.93 -22.05 27.61 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.605 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 61.1 mttp -68.51 -32.95 73.28 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.533 HG23 HD12 ' A' ' 153' ' ' ILE . 29.8 mt -63.65 -37.02 78.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.505 0.669 . . . . 0.0 109.43 174.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -73.04 -26.33 61.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.858 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -87.56 -41.24 13.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.024 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.1 -51.33 10.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.185 -174.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.584 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -92.77 -11.05 34.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.084 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.42 31.65 68.37 Favored Glycine 0 C--O 1.229 -0.196 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.484 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.65 -177.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.036 0.446 . . . . 0.0 111.909 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.631 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 55.1 ttt180 -132.57 143.2 49.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.177 176.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.565 HG21 HD11 ' A' ' 113' ' ' ILE . 47.0 mm -110.86 142.84 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.041 0.448 . . . . 0.0 112.164 -171.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 2.2 tt0 -148.34 114.38 5.8 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.281 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.401 ' CE1' HD11 ' A' ' 106' ' ' ILE . 36.6 m-85 -79.45 111.21 15.48 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.803 -0.56 . . . . 0.0 109.635 175.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -121.34 112.91 19.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.369 -174.447 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 121.224 0.535 . . . . 0.0 110.984 178.793 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.476 0.483 0 N-CA-C 115.249 1.211 . . . . 0.0 115.249 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -94.46 134.66 36.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.581 0.705 . . . . 0.0 112.358 -169.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -110.88 120.8 43.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.804 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.57 HG13 ' HG3' ' A' ' 30' ' ' ARG . 9.1 mm -72.34 116.37 14.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.808 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.895 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -105.09 143.12 33.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.199 0.523 . . . . 0.0 111.417 174.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.666 ' CD2' HG23 ' A' ' 89' ' ' ILE . 10.4 t-160 -86.38 125.58 33.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.902 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.675 HD12 HD11 ' A' ' 93' ' ' ILE . 30.6 mt -106.91 107.8 23.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.805 170.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.631 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 37.0 ttm -95.59 129.69 42.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.151 -175.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.64 -167.79 36.56 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.633 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.12 143.44 78.15 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.489 2.126 . . . . 0.0 110.811 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.32 -48.17 8.41 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 124.023 3.148 . . . . 0.0 113.758 -173.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -61.79 -47.81 83.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.32 0.581 . . . . 0.0 110.945 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 49.7 mtt180 -69.51 -22.38 63.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.307 -176.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.673 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 77.8 m -59.22 -52.31 66.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.249 0.547 . . . . 0.0 110.003 174.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -74.39 -31.71 62.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.731 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 146' ' ' ARG . 9.4 t60 -62.49 -29.91 70.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.243 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.556 ' HB3' HG21 ' A' ' 140' ' ' ILE . . . -80.17 -38.85 30.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.506 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.3 -23.82 66.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.302 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 149' ' ' HIS . 13.5 ptt180 -76.62 -25.14 53.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -174.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.568 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 62.5 mt -68.82 -41.46 82.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.529 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.8 -40.74 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.057 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -57.8 -45.79 85.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.458 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -57.84 -37.31 73.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.926 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 77.4 mt -65.36 -50.77 64.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.545 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 mt . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 121.217 0.532 . . . . 0.0 110.192 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.762 HG22 HG12 ' A' ' 54' ' ' ILE . 20.6 t -142.8 112.65 2.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.688 166.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 88.3 mm-40 -123.85 159.59 29.27 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 176.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 48.7 mt-10 -116.88 129.15 55.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.17 0.51 . . . . 0.0 111.35 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.799 HD11 ' HA ' ' A' ' 64' ' ' CYS . 74.5 mt -111.43 145.97 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.54 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.21 110.29 20.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.835 0.35 . . . . 0.0 111.427 -175.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.9 mp -106.42 106.39 57.33 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.276 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.82 163.95 37.3 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.793 2.329 . . . . 0.0 111.342 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.85 145.3 56.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.47 -56.57 2.0 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -172.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -68.93 -27.91 66.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.827 0.346 . . . . 0.0 110.481 175.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.614 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -53.52 -35.37 60.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.133 174.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.705 ' HA3' ' HE3' ' A' ' 19' ' ' LYS . . . -63.37 -47.69 85.36 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.846 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 73' ' ' GLU . 2.7 pp -78.68 -19.16 53.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.2 0.5 . . . . 0.0 111.407 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.403 ' N ' HD12 ' A' ' 15' ' ' LEU . 74.8 t -78.41 -40.24 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.764 0.316 . . . . 0.0 111.151 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 13' ' ' ALA . 30.9 pt -88.86 -29.48 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.075 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.521 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.9 16.8 32.18 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.705 ' HE3' ' HA3' ' A' ' 14' ' ' GLY . 33.4 mmtp 55.44 47.07 21.93 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.006 0.522 . . . . 0.0 110.867 -175.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.11 -35.83 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.35 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 152.87 -12.43 0.62 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.295 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.526 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 20.1 mm-40 -45.26 -49.81 12.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.521 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 26.1 m -81.29 -34.89 31.69 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.435 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 21' ' ' GLY . 7.3 tp -64.91 -26.92 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.012 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 84.4 mttt -55.19 -53.6 54.0 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.913 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.488 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 70.5 mt-30 -66.14 -45.08 82.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.592 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.618 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 95.7 mt -59.87 -29.13 68.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.897 0.38 . . . . 0.0 111.124 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.712 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 27.5 mt-30 -85.89 -49.81 7.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.147 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.63 -51.78 5.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.656 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 15.2 ttm180 -65.14 -42.83 93.44 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -80.89 -29.66 35.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.557 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.73 0.92 85.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.351 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 34.6 m -112.87 151.45 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -91.39 109.66 20.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.607 ' HB3' HD21 ' A' ' 51' ' ' LEU . 41.6 mtt -95.61 114.05 25.77 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.625 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.5 tp -113.12 109.63 29.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.99 0.9 . . . . 0.0 109.532 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.86 HD13 HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -124.11 136.86 54.52 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.45 -174.537 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.697 HG22 ' HD2' ' A' ' 50' ' ' PRO . 10.8 tp -76.15 100.8 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 122.012 0.91 . . . . 0.0 110.014 -174.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 41' ' ' GLY . 21.6 tm0? -132.09 135.1 46.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.084 -173.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 t70 72.52 -23.81 0.2 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.82 0.848 . . . . 0.0 111.874 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 39' ' ' GLN . . . -68.24 155.81 53.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.203 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -74.28 76.17 1.84 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.066 0.46 . . . . 0.0 111.415 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -160.98 -62.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.158 176.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -131.68 53.71 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 110.439 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -83.08 -41.53 18.5 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.714 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -91.61 -4.2 55.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.386 0.612 . . . . 0.0 109.875 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 48' ' ' ASP . 40.3 t -108.45 165.03 5.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.519 -173.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.453 ' N ' HG12 ' A' ' 47' ' ' VAL . 5.0 p-10 -58.14 150.58 20.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.123 0.487 . . . . 0.0 110.289 171.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -126.99 127.43 24.37 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.101 -169.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.697 ' HD2' HG22 ' A' ' 38' ' ' ILE . 83.3 Cg_endo -81.18 108.18 1.98 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.74 2.294 . . . . 0.0 112.09 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.86 HD12 HD13 ' A' ' 37' ' ' LEU . 9.6 tt -84.17 117.55 23.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.841 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 36' ' ' ILE . 1.5 mpt_? -91.42 112.22 24.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.107 0.254 . . . . 0.0 110.964 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.751 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 62.5 mt -89.12 113.02 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.057 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.762 HG12 HG22 ' A' ' 3' ' ' VAL . 30.3 mt -104.55 118.17 51.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.493 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 176.52 -170.9 43.83 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.393 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.468 ' O ' HG23 ' A' ' 60' ' ' VAL . 9.3 m-20 -65.11 147.38 98.58 Favored Pre-proline 0 N--CA 1.462 0.156 0 C-N-CA 122.46 0.304 . . . . 0.0 110.507 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.89 -52.41 8.94 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.112 2.542 . . . . 0.0 114.613 -173.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.437 ' HE2' ' HG2' ' A' ' 88' ' ' ARG . 17.5 p90 -63.17 -27.07 69.12 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.949 0.404 . . . . 0.0 110.571 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 91.7 mttt -72.46 -50.52 25.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.555 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 56' ' ' ASP . 22.0 t -59.93 -34.95 57.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.03 -176.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -66.3 -51.19 59.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 77.3 mm-40 -64.83 -37.71 88.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 110.38 -177.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.596 ' HB2' ' OG ' ' A' ' 87' ' ' SER . . . -69.19 -40.38 78.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.751 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.799 ' HA ' HD11 ' A' ' 6' ' ' ILE . 54.0 t -52.41 -43.4 64.77 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.209 0.528 . . . . 0.0 110.208 177.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 37.9 tt0 -71.1 -46.14 62.32 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.587 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.587 ' SD ' ' HA ' ' A' ' 63' ' ' ALA . 3.8 ptt? -65.35 -39.69 92.69 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.494 -171.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.774 ' HB ' HD13 ' A' ' 6' ' ' ILE . 90.4 t -62.32 -50.19 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.367 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.542 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 56.4 mtp -63.32 -30.29 71.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.05 0.452 . . . . 0.0 110.586 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -73.37 -40.24 64.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.898 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.855 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.9 pp -86.67 -24.29 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.684 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.751 HD23 HG12 ' A' ' 67' ' ' VAL . 3.6 pp -83.09 -0.38 48.83 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.37 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 11.9 ptm180 -50.92 -42.8 59.74 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.746 ' HB2' HD21 ' A' ' 15' ' ' LEU . 27.1 tt0 60.07 110.84 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 124.373 1.046 . . . . 0.0 113.107 174.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -107.67 -39.17 5.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -140.66 50.58 1.66 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 59.49 68.2 0.82 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.18 0.514 . . . . 0.0 111.571 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.32 -40.62 0.24 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.652 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 76.48 -96.7 1.15 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.182 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.596 ' HD2' ' HA ' ' A' ' 70' ' ' ILE . 97.2 m-85 -144.47 -29.95 0.47 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.851 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.72 100.48 0.64 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 27.1 t70 68.79 -72.75 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -169.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.855 ' HA ' HG21 ' A' ' 70' ' ' ILE . 26.6 ttt180 178.26 -29.36 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.483 169.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t30 66.96 16.04 10.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.195 0.998 . . . . 0.0 109.479 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.962 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 74.6 mt-10 -129.12 -31.29 2.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.787 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.729 ' CB ' ' HB ' ' A' ' 89' ' ' ILE . 30.0 p90 176.98 152.68 0.2 Allowed 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.385 172.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.559 ' C ' ' HA ' ' A' ' 31' ' ' ALA . . . -117.53 106.31 1.38 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.404 168.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.804 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 43.4 m 51.51 35.64 14.94 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.7 ' HB3' HD12 ' A' ' 89' ' ' ILE . 11.8 mtt180 -166.12 -162.36 0.54 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.729 ' HB ' ' CB ' ' A' ' 85' ' ' TYR . 2.8 mp 63.97 -77.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 124.039 0.837 . . . . 0.0 111.806 173.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 57.51 48.06 83.76 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.65 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 144.91 81.27 0.05 OUTLIER Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.292 -0.48 . . . . 0.0 111.92 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 141.37 -150.16 21.65 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.962 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 47.9 pt -136.56 167.34 24.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 116.9 0.35 . . . . 0.0 111.219 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.656 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 3.5 p30 -108.59 139.22 43.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 171.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.881 HG23 ' HB3' ' A' ' 138' ' ' ALA . 11.8 m -133.35 95.48 18.19 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 121.107 0.48 . . . . 0.0 111.277 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 19.9 Cg_endo -62.54 108.31 0.7 Allowed 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.692 2.261 . . . . 0.0 111.071 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.463 ' HA ' ' HD2' ' A' ' 98' ' ' PRO . 12.8 p -110.27 125.02 31.85 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.955 0.407 . . . . 0.0 111.102 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 97' ' ' VAL . 5.5 Cg_endo -48.64 124.06 10.4 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.221 2.614 . . . . 0.0 111.774 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -63.64 -20.94 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.706 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -83.7 -0.87 52.61 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.785 0.326 . . . . 0.0 110.775 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.9 m -129.63 -2.43 4.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.653 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.95 -24.78 24.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 110.592 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.96 -28.88 66.82 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.394 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.1 t -77.14 -37.61 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.083 0.468 . . . . 0.0 110.388 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.1 t -71.02 -37.31 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.609 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.6 mm -80.19 -38.87 18.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.52 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.68 -104.33 2.9 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.037 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -138.32 -66.58 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.704 0.288 . . . . 0.0 110.395 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.7 m -88.76 -3.78 58.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.344 0.592 . . . . 0.0 110.297 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.95 31.08 7.9 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.41 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -92.81 -26.81 17.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.765 0.317 . . . . 0.0 110.358 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.518 ' SD ' ' HD3' ' A' ' 115' ' ' LYS . 16.3 tpt -69.63 -36.55 76.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.375 0.607 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.427 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 4.6 tp -70.36 -32.93 52.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.913 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -73.53 -28.31 61.82 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.508 0.67 . . . . 0.0 109.421 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.518 ' HD3' ' SD ' ' A' ' 112' ' ' MET . 21.0 tttp -68.77 -31.87 71.21 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.65 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.5 mm -62.28 -36.87 76.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.679 0.752 . . . . 0.0 109.055 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 13.8 mt-30 -72.56 -22.19 61.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.557 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -79.52 -30.57 41.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.945 0.403 . . . . 0.0 110.803 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.36 -55.86 4.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.587 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -101.02 -28.97 12.43 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.922 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 117' ' ' GLN . . . 88.23 74.29 1.28 Allowed Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.681 -175.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 150' ' ' ALA . 18.6 m -134.23 166.95 27.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.683 0.278 . . . . 0.0 110.927 -175.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.816 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 23.5 ttt180 -122.27 138.81 54.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.8 mm -112.81 136.3 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -169.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.754 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 3.9 tp-100 -132.43 138.45 47.65 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.365 174.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -111.68 113.88 26.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.558 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -128.55 152.78 47.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.929 -173.127 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 . . . . . 0 C--O 1.235 0.316 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.723 177.32 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 C--O 1.234 0.293 0 CA-C-O 121.033 0.347 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 98' ' ' PRO . 3.0 mp0 -111.48 153.98 25.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.899 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.4 ' O ' HG12 ' A' ' 97' ' ' VAL . 22.7 mtpp -109.96 113.23 25.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.367 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.558 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 17.5 mm -68.86 105.71 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.113 0.482 . . . . 0.0 111.123 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.881 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -94.77 141.4 28.67 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.368 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -96.65 113.61 25.19 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.182 176.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.639 HD13 ' HB3' ' A' ' 150' ' ' ALA . 48.0 mt -93.22 119.6 41.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.634 173.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.816 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 38.0 ttm -105.89 137.77 43.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.445 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.48 179.34 26.17 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.318 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 74.1 Cg_exo -52.36 149.17 23.69 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.927 2.418 . . . . 0.0 111.824 175.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.6 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 76.8 Cg_exo -51.34 -27.69 24.58 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.684 2.923 . . . . 0.0 113.684 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 12.5 t70 -76.97 -46.42 24.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.06 0.457 . . . . 0.0 109.84 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -60.45 -47.3 86.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.912 -177.072 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 17.7 p -57.58 -56.5 21.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.777 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -68.45 -23.46 64.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.814 0.34 . . . . 0.0 111.463 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.477 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 4.6 t60 -70.41 -30.37 67.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.134 0.492 . . . . 0.0 109.673 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.639 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.09 -41.66 28.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.926 -177.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.22 -32.02 69.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.04 0.448 . . . . 0.0 110.857 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -76.98 -19.48 57.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.381 -177.299 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 149' ' ' HIS . 63.3 mt -81.08 -43.06 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.309 0.576 . . . . 0.0 109.575 174.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.3 mt -63.42 -46.94 93.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.572 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -60.14 -35.63 75.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.384 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.42 -40.45 86.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.14 0.495 . . . . 0.0 110.125 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.39 -41.0 81.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.625 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 51.2 mt . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 121.151 0.501 . . . . 0.0 110.579 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 57' ' ' PRO . 16.2 m . . . . . 0 C--O 1.223 -0.295 0 CA-C-O 121.189 0.519 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 17.9 m -101.06 134.58 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.34 0.591 . . . . 0.0 111.196 -177.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -125.63 155.39 40.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.904 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 46.8 mt-10 -113.45 117.27 31.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.328 0.585 . . . . 0.0 112.104 -173.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -105.68 142.4 18.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.754 175.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.527 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 48.0 tpp -91.94 125.51 36.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.681 0.277 . . . . 0.0 110.899 -176.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 51' ' ' LEU . 3.5 mp -96.84 106.02 27.6 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.644 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.801 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 23.9 Cg_exo -67.37 148.37 79.46 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.936 2.424 . . . . 0.0 111.531 175.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.59 134.39 54.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 76' ' ' GLN . . . 102.99 -36.25 4.44 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -170.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.944 ' HG3' HD12 ' A' ' 15' ' ' LEU . 12.6 mptt -82.42 8.46 11.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.961 0.41 . . . . 0.0 110.363 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -59.02 -39.84 83.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.914 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 18' ' ' GLY . . . -69.15 -15.34 69.68 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.265 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.944 HD12 ' HG3' ' A' ' 12' ' ' LYS . 16.2 mt -90.67 -40.93 11.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.917 -0.142 . . . . 0.0 111.235 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.711 HG21 HG13 ' A' ' 8' ' ' ILE . 61.8 t -92.84 -51.16 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.701 HG13 ' H ' ' A' ' 19' ' ' LYS . 17.3 pt -91.51 -28.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.075 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . 89.84 15.81 57.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.185 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.701 ' H ' HG13 ' A' ' 17' ' ' ILE . 66.6 mmtt 67.36 -58.28 0.42 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.417 0.687 . . . . 0.0 111.704 -177.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.19 -5.9 75.68 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.501 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.94 4.36 54.37 Favored Glycine 0 C--O 1.229 -0.213 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.757 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.747 ' HA ' ' CD ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -73.39 -28.77 62.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -175.148 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.615 HG21 ' O ' ' A' ' 15' ' ' LEU . 91.5 m -71.53 -41.27 69.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.252 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 35' ' ' MET . 6.9 tp -65.56 -27.45 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.151 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.747 ' CD ' ' HA ' ' A' ' 22' ' ' GLU . 11.9 mtpp -57.79 -49.5 76.42 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -72.84 -35.99 67.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.102 -175.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.485 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 98.1 mt -66.01 -27.69 68.31 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 121.837 -0.539 . . . . 0.0 110.382 176.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.752 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.6 mt-30 -84.88 -52.88 5.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.421 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -84.28 -56.38 3.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -174.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HE ' ' HB3' ' A' ' 30' ' ' ARG . 3.5 ttp180 -56.27 -42.28 77.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.864 0.364 . . . . 0.0 110.461 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -87.65 -29.83 20.88 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.368 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.47 10.37 70.76 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.26 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.6 m -117.31 152.04 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.743 0.306 . . . . 0.0 110.3 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -96.56 110.98 23.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 46.4 mtt -94.81 125.79 39.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.0 tp -117.6 114.5 45.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.886 0.85 . . . . 0.0 109.941 -177.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.656 HD22 ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -132.82 142.94 49.23 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.676 -175.442 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.43 HD13 ' HG2' ' A' ' 50' ' ' PRO . 2.0 mp -61.62 112.84 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.17 0.51 . . . . 0.0 110.882 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.427 ' OE1' HD13 ' A' ' 17' ' ' ILE . 22.2 mm-40 -125.26 -53.51 1.61 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.067 176.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.29 72.17 9.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.541 0.686 . . . . 0.0 109.588 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.13 106.02 0.24 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.563 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.9 t -79.2 65.22 4.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.588 0.708 . . . . 0.0 111.103 -173.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -131.41 -52.25 1.01 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.187 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.634 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.7 m-20 -113.32 47.09 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.358 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 p -78.37 -48.55 15.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.991 0.424 . . . . 0.0 110.825 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -93.23 -11.8 31.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.587 0.708 . . . . 0.0 109.417 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 50.1 t -88.92 162.65 2.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.815 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' N ' HG12 ' A' ' 47' ' ' VAL . 4.2 m-20 -61.85 154.12 26.9 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 39.4 mttp -127.28 144.31 50.25 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.874 -170.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HG2' HD13 ' A' ' 38' ' ' ILE . 83.3 Cg_endo -92.08 122.11 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.81 2.34 . . . . 0.0 112.886 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.941 ' HB2' HD11 ' A' ' 8' ' ' ILE . 8.4 tt -101.56 126.23 48.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.7 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 36' ' ' ILE . 3.3 mpt_? -107.92 121.1 44.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.691 0.282 . . . . 0.0 110.287 174.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 61.6 mt -89.47 117.3 32.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.174 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.4 mt -103.84 120.31 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.97 -171.05 43.93 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.336 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 18.9 m-20 -71.63 146.77 91.57 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 122.459 0.303 . . . . 0.0 110.504 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.582 ' HA ' HG21 ' A' ' 2' ' ' THR . 99.8 Cg_exo -44.33 -51.24 7.07 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.463 2.775 . . . . 0.0 113.7 -175.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -60.58 -49.61 76.85 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.756 0.312 . . . . 0.0 111.223 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.025 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 5.3 ptpp? -72.73 -23.55 60.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.926 -175.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 2' ' ' THR . 71.4 t -71.22 -43.04 74.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -58.17 9.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.78 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.72 -21.62 66.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.598 -174.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -85.36 -39.17 17.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.463 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 68' ' ' MET . 37.9 t -56.59 -50.56 71.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.606 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.54 -33.54 75.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.083 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.843 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 18.2 ptt? -79.57 -36.21 38.58 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.738 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 63' ' ' ALA . 69.9 t -56.27 -44.57 79.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 57.1 mtp -66.63 -32.57 73.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.566 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.456 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 35.2 t70 -85.24 -28.71 25.2 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -88.82 -21.69 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.098 -1.001 . . . . 0.0 110.438 173.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.499 HD12 ' CG2' ' A' ' 16' ' ' VAL . 5.8 tt -82.08 -26.29 33.78 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.354 178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -61.05 -13.95 20.3 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.213 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.67 ' HG3' ' H ' ' A' ' 75' ' ' ASP . 9.0 tp10 -55.47 135.28 50.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.217 0.532 . . . . 0.0 111.684 -175.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -75.72 -19.1 59.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.587 0.708 . . . . 0.0 109.578 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.67 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 10.8 m-20 -106.39 -174.8 2.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.632 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 11' ' ' GLY . 48.2 mt-30 -94.91 41.03 1.09 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.85 45.4 1.17 Allowed Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.705 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.707 ' H ' HD22 ' A' ' 15' ' ' LEU . . . -67.33 178.63 17.26 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 172.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.479 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 86.5 m-85 -68.32 -31.57 71.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.283 0.541 . . . . 0.0 111.581 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 23' ' ' THR . . . 101.45 -2.64 53.74 Favored Glycine 0 CA--C 1.508 -0.348 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 82' ' ' ARG . 1.6 p30 -179.17 -63.54 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.843 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 6.8 ttt85 173.41 -29.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.241 165.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.506 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 4.1 t30 52.33 65.77 1.41 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.937 0.399 . . . . 0.0 110.373 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 1.041 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 30.5 tt0 176.28 -47.54 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.754 0.787 . . . . 0.0 109.844 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.796 ' HA ' ' NE2' ' A' ' 139' ' ' HIS . 36.4 p90 -173.78 157.98 3.17 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.43 175.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -143.03 95.42 0.18 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . 1.025 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 67.8 m 70.75 -52.64 0.67 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.691 ' HD3' HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -67.6 -82.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.078 0.466 . . . . 0.0 111.738 -175.658 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.691 HD13 ' HD3' ' A' ' 88' ' ' ARG . 41.3 mm -54.34 -88.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -168.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.42 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 89.73 78.42 1.33 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -169.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.24 94.2 2.1 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.232 -0.508 . . . . 0.0 112.063 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.725 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 148.94 -144.06 11.69 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.041 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 49.9 pt -152.43 158.13 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 117.476 0.638 . . . . 0.0 110.057 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -105.27 140.71 38.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.981 0.42 . . . . 0.0 110.53 175.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 2.8 t -137.45 116.72 10.17 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.659 -176.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.61 107.75 2.25 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.013 1.809 . . . . 0.0 111.629 169.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG13 HD21 ' A' ' 158' ' ' LEU . 40.9 t -99.17 126.14 39.05 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.945 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.691 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 74.1 Cg_exo -43.69 130.68 7.47 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.662 2.908 . . . . 0.0 113.13 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 33.1 ptt180 -60.24 -24.22 64.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.025 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 98' ' ' PRO . 12.6 p80 -92.81 20.34 6.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.729 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 105' ' ' VAL . 14.6 t -145.79 -31.46 0.38 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.126 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -49.38 -37.66 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.24 -28.95 63.06 Favored Glycine 0 C--O 1.235 0.178 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.925 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.7 t -75.11 -35.07 33.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.027 0.441 . . . . 0.0 109.873 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 101' ' ' SER . 66.9 t -59.59 -40.05 81.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.905 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.785 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.3 mm -72.95 -37.71 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.389 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.93 34.57 21.17 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 65.66 -76.73 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.514 0.725 . . . . 0.0 111.399 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.2 p -93.73 9.62 36.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.868 0.366 . . . . 0.0 111.662 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.411 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 94.34 8.12 60.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.892 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -65.26 -32.2 73.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 110.913 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.405 ' SD ' ' HD3' ' A' ' 115' ' ' LYS . 15.4 tpt -89.93 -37.85 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.817 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.785 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.2 tp -64.98 -27.97 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.084 0.469 . . . . 0.0 110.382 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -72.58 -21.86 61.08 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.182 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.405 ' HD3' ' SD ' ' A' ' 112' ' ' MET . 27.6 mtpp -71.57 -33.84 69.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.732 0.301 . . . . 0.0 110.543 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.576 HG23 HD12 ' A' ' 153' ' ' ILE . 32.3 mt -67.92 -40.38 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 0.0 109.469 176.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -70.02 -28.21 65.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.437 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -79.52 -37.52 36.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.9 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -79.57 -55.16 5.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.578 -176.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.96 -15.01 26.75 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.55 32.5 57.5 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.881 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.546 ' CG1' ' HB3' ' A' ' 146' ' ' ARG . 14.9 m -102.98 159.15 4.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.216 0.531 . . . . 0.0 112.103 -173.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.921 ' HB2' ' HB2' ' A' ' 141' ' ' MET . 65.3 mtm180 -101.26 144.09 30.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.223 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 113' ' ' ILE . 51.2 mm -116.79 121.54 67.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.584 ' HB2' ' SD ' ' A' ' 141' ' ' MET . 5.9 tp-100 -123.94 111.14 15.69 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.604 ' CE1' HD11 ' A' ' 106' ' ' ILE . 27.4 m-85 -87.53 133.26 33.8 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.561 0.696 . . . . 0.0 110.104 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' HD3' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -157.03 -166.25 2.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.381 -171.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 . . . . . 0 N--CA 1.469 0.491 0 O-C-N 123.426 0.454 . . . . 0.0 111.813 -177.348 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 14.2 Cg_exo . . . . . 0 N--CA 1.464 -0.234 0 CA-C-O 120.893 0.289 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.691 ' OE2' ' HA ' ' A' ' 98' ' ' PRO . 1.3 mp0 -94.73 154.17 17.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.972 0.415 . . . . 0.0 111.248 -174.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.79 124.73 46.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.328 0.585 . . . . 0.0 111.359 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 44.8 mm -63.3 115.8 2.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.295 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.75 132.45 38.12 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 164.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.796 ' NE2' ' HA ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -108.34 115.24 29.74 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.676 -177.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.718 HG21 ' HA ' ' A' ' 147' ' ' CYS . 82.7 mt -83.85 137.58 20.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.522 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.921 ' HB2' ' HB2' ' A' ' 123' ' ' ARG . 31.2 mtp -120.42 129.26 53.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.066 -176.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.75 -167.03 28.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.635 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.763 ' HB2' ' HD3' ' A' ' 146' ' ' ARG . 32.8 Cg_exo -61.0 147.28 96.19 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.085 2.524 . . . . 0.0 112.195 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.773 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 52.0 Cg_exo -57.04 -18.65 29.46 Favored 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 123.955 3.104 . . . . 0.0 113.817 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.94 -30.17 26.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.326 0.584 . . . . 0.0 110.178 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.763 ' HD3' ' HB2' ' A' ' 143' ' ' PRO . 8.4 mpt_? -84.13 -44.12 14.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.408 -174.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.773 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 10.6 p -53.85 -55.1 29.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.011 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.431 ' OE2' HG21 ' A' ' 93' ' ' ILE . 38.5 mm-40 -62.65 -37.87 88.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.48 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.412 ' O ' HG13 ' A' ' 153' ' ' ILE . 15.7 t60 -65.49 -26.76 68.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.223 0.535 . . . . 0.0 110.316 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.708 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.98 -40.26 28.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.005 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.633 ' HB2' HD11 ' A' ' 93' ' ' ILE . . . -65.94 -24.92 66.92 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.366 0.603 . . . . 0.0 110.149 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -18.94 59.56 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.538 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.576 HD12 HG23 ' A' ' 116' ' ' ILE . 63.1 mt -81.76 -45.06 20.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.316 172.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.475 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.9 mt -62.21 -40.77 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.006 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -58.84 -37.33 76.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.71 -34.16 77.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 34.1 mt -68.87 -33.87 74.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.824 -178.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.511 HD22 ' HD2' ' A' ' 98' ' ' PRO . 18.4 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.357 0.599 . . . . 0.0 110.127 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 60' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.642 0 CA-C-O 120.944 0.402 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 27.7 m -123.5 130.39 74.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.159 175.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -118.47 142.72 47.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.625 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 45.3 mt-10 -108.01 116.74 32.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.361 0.6 . . . . 0.0 111.775 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 6' ' ' ILE . 3.9 mp -106.82 142.82 18.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.402 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 87.6 mmm -92.88 116.09 28.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.937 0.399 . . . . 0.0 110.704 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.499 HG12 HG11 ' A' ' 16' ' ' VAL . 1.8 mp -91.36 113.77 59.55 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.586 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 75.1 Cg_exo -55.77 152.15 36.51 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.425 2.75 . . . . 0.0 112.775 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.622 ' HA ' ' NZ ' ' A' ' 49' ' ' LYS . . . -59.62 129.93 44.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 172.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.58 -39.21 2.94 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.81 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.724 ' HG3' HD21 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -65.38 -19.68 66.05 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.805 0.335 . . . . 0.0 111.249 -177.753 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.665 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -58.38 -24.04 58.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.863 0.363 . . . . 0.0 110.374 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' CA ' ' HD3' ' A' ' 19' ' ' LYS . . . -61.29 -41.15 99.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.246 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.724 HD21 ' HG3' ' A' ' 12' ' ' LYS . 0.5 OUTLIER -90.42 -23.84 20.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.811 0.305 . . . . 0.0 110.992 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.6 HG21 HD12 ' A' ' 71' ' ' LEU . 77.1 t -82.63 -52.05 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.679 HD13 ' HG3' ' A' ' 39' ' ' GLN . 19.2 pt -91.53 -20.09 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 121.526 -0.734 . . . . 0.0 110.155 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.62 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.19 17.09 32.97 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -175.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HD3' ' CA ' ' A' ' 14' ' ' GLY . 13.6 tptp 55.66 31.81 18.08 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.421 0.688 . . . . 0.0 110.428 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.77 -40.17 0.3 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.551 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.594 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 158.1 -8.84 0.2 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.157 -1.02 . . . . 0.0 114.07 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.473 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 44.4 tt0 -58.64 -43.37 89.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.504 0.652 . . . . 0.0 112.377 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.62 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 55.2 m -78.3 -36.73 46.19 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.195 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 35' ' ' MET . 5.6 tp -64.6 -20.1 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.937 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 27.6 mtpp -58.36 -59.45 5.33 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.42 0.629 . . . . 0.0 109.503 170.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 48.6 mt-30 -67.22 -35.23 79.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.91 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 87.7 mt -65.1 -32.91 74.85 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 122.037 -0.415 . . . . 0.0 110.835 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.724 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 47.9 mt-30 -85.5 -46.61 10.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.062 0.458 . . . . 0.0 111.41 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -88.16 -35.36 17.45 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.519 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 5.5 ttm180 -82.87 -43.42 16.6 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.746 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -83.18 -22.29 33.26 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.982 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.69 68.16 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.097 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 34.2 m -128.15 150.69 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 110.846 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -90.72 109.99 21.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . 1.056 ' HB3' HD11 ' A' ' 51' ' ' LEU . 48.4 mtt -100.29 123.31 44.36 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 tt -121.02 113.87 41.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.799 0.809 . . . . 0.0 110.768 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.691 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -134.86 143.57 47.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.948 -177.152 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 3.7 mp -73.34 101.18 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.307 0.575 . . . . 0.0 111.351 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.679 ' HG3' HD13 ' A' ' 17' ' ' ILE . 5.2 mm100 -131.36 15.68 5.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.44 170.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.03 -30.74 62.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.825 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' A' ' 45' ' ' THR . . . 113.56 8.28 19.04 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.036 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 m -61.77 -49.9 74.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.678 0.275 . . . . 0.0 111.688 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -164.44 -42.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.851 0.358 . . . . 0.0 111.091 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.636 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 13.3 m120 -78.98 51.49 1.14 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.926 0.393 . . . . 0.0 111.266 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.536 ' CG2' ' HA2' ' A' ' 41' ' ' GLY . 14.3 p -86.09 -61.77 1.67 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.178 0.513 . . . . 0.0 110.867 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -92.33 -6.82 49.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.455 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 48.9 t -93.38 156.27 3.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.944 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.4 149.4 38.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.63 ' HE3' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -111.21 124.15 33.45 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.816 -174.397 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.12 112.89 2.34 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.452 2.101 . . . . 0.0 111.825 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.056 HD11 ' HB3' ' A' ' 35' ' ' MET . 21.2 tp -92.98 121.1 33.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.775 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.529 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 2.7 mpt_? -102.05 114.14 28.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.853 0.358 . . . . 0.0 110.657 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 70.0 mt -89.42 110.63 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.229 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.4 mt -106.13 122.08 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.376 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.402 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 173.87 -171.43 44.51 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.956 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . 3.2 m-20 -61.58 148.75 85.96 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 122.282 0.233 . . . . 0.0 110.536 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.65 -55.61 3.82 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.119 2.546 . . . . 0.0 114.188 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -66.73 -26.91 67.23 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.926 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.869 ' HG2' ' HB2' ' A' ' 87' ' ' SER . 93.2 mttt -66.67 -53.02 38.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.187 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 2' ' ' THR . 46.4 t -59.89 -32.51 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.589 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.22 -54.91 30.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.441 ' HB3' ' CD2' ' A' ' 85' ' ' TYR . 18.0 mm-40 -69.88 -34.1 73.12 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.051 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -69.88 -47.5 62.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.431 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.2 t -55.95 -38.36 70.23 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.19 0.519 . . . . 0.0 109.862 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -64.53 -52.82 55.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.695 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.655 ' SD ' ' HA2' ' A' ' 86' ' ' GLY . 8.4 ptt? -65.69 -36.07 82.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.472 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 53' ' ' ILE . 53.5 t -57.06 -48.38 81.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.245 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 69.4 mtm -69.78 -25.35 63.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.184 0.516 . . . . 0.0 110.214 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.48 -37.82 42.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.926 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.566 ' HB ' ' H ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -90.22 -30.77 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.86 176.601 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.6 HD12 HG21 ' A' ' 16' ' ' VAL . 5.2 tt -70.93 -26.45 63.2 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -63.9 0.95 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.176 0.298 . . . . 0.0 110.404 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.961 ' HG2' ' H ' ' A' ' 74' ' ' ARG . 23.6 tt0 42.31 -159.83 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 169.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.961 ' H ' ' HG2' ' A' ' 73' ' ' GLU . 20.9 mmt180 -145.54 -47.06 0.22 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.807 0.843 . . . . 0.0 108.751 167.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -173.66 102.23 0.11 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.011 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 61.66 69.49 0.64 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.459 0.647 . . . . 0.0 111.399 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.41 -5.52 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.372 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.22 150.78 48.88 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.669 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.566 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 74.5 m-85 -76.99 3.53 12.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -170.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 23' ' ' THR . . . 73.14 4.13 62.62 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.723 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.5 OUTLIER 175.89 -62.91 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.736 ' CZ ' ' HB3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER 154.13 -35.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 O-C-N 125.1 1.5 . . . . 0.0 109.101 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 55.81 73.51 0.43 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.371 0.419 . . . . 0.0 110.399 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.934 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 70.4 tt0 -175.71 -51.13 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.665 -173.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.741 ' HA ' HD12 ' A' ' 89' ' ' ILE . 4.5 p90 -151.04 -75.89 0.14 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.655 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 101.15 -43.38 1.74 Allowed Glycine 0 C--O 1.229 -0.198 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.869 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 32.5 p -171.06 -57.16 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -69.98 -177.23 1.28 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.379 167.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 85' ' ' TYR . 59.8 mt 70.57 -74.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.09 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.417 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 51.12 47.21 49.92 Favored Glycine 0 C--N 1.336 0.552 0 O-C-N 123.727 0.642 . . . . 0.0 112.501 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.25 99.36 0.4 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -176.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.816 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 135.79 -138.51 9.98 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -174.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.934 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.8 pt -145.53 159.59 12.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 171.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.593 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . 1.9 p30 -99.22 132.58 44.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 31.3 t -126.65 106.2 23.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -171.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.419 ' HB2' ' HB3' ' A' ' 135' ' ' GLU . 42.8 Cg_endo -68.79 121.44 8.33 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.234 1.956 . . . . 0.0 111.389 171.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.633 HG13 HD21 ' A' ' 158' ' ' LEU . 51.3 t -117.71 124.9 28.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.653 0.263 . . . . 0.0 111.216 177.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 86.1 Cg_exo -44.62 130.51 9.54 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.753 2.968 . . . . 0.0 113.475 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 134' ' ' PRO . 35.2 mtp180 -51.63 -37.92 52.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.151 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.495 ' CE1' ' HB3' ' A' ' 98' ' ' PRO . 0.7 OUTLIER -92.26 6.43 46.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.655 -174.745 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 98' ' ' PRO . 9.8 m -130.03 -25.52 2.5 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.607 -173.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.4 p -53.15 -26.26 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.742 0.306 . . . . 0.0 111.592 172.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.3 -44.96 89.41 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.947 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 101' ' ' SER . 7.6 p -77.38 -25.23 15.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.208 0.528 . . . . 0.0 110.587 -178.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.1 t -69.68 -33.14 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.85 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.568 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 49.6 mm -87.12 -65.06 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.352 176.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.82 52.19 3.39 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.696 -173.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 108' ' ' ARG . 45.2 mtp180 54.77 -89.84 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.71 0.804 . . . . 0.0 112.375 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -72.75 -8.82 57.25 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.594 0.711 . . . . 0.0 110.348 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.26 45.72 2.52 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.587 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.37 -43.88 80.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.8 0.3 . . . . 0.0 110.942 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.466 ' O ' HG13 ' A' ' 116' ' ' ILE . 15.3 tpt -83.59 -38.55 21.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.848 0.356 . . . . 0.0 110.641 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 124' ' ' ILE . 8.9 tp -63.91 -31.08 51.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.5 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -82.73 -20.12 36.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.657 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -71.23 -37.44 72.01 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.467 HD12 HD12 ' A' ' 113' ' ' ILE . 23.1 mt -64.64 -37.27 79.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.201 0.524 . . . . 0.0 109.603 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 86.6 mt-30 -66.6 -27.36 67.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.724 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -85.65 -46.26 10.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.039 0.447 . . . . 0.0 111.045 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -79.33 -55.36 5.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.778 -173.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.14 -26.96 39.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.058 0.456 . . . . 0.0 110.293 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.96 19.98 62.02 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.138 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.76 144.88 9.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 111.879 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.786 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 7.7 tpp180 -91.34 143.41 26.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.723 HG21 HD11 ' A' ' 113' ' ' ILE . 34.3 mm -129.01 142.21 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -170.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 1.031 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 3.8 pt20 -149.54 167.8 25.29 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 167.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 106' ' ' ILE . 31.7 m-85 -121.95 133.55 54.83 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.535 ' O ' ' HB ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -152.66 128.16 10.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.352 -171.403 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.052 0.453 . . . . 0.0 111.216 179.664 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 15.0 Cg_exo . . . . . 0 CA--C 1.528 0.19 0 N-CA-C 114.734 1.013 . . . . 0.0 114.734 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 51.1 mt-10 -127.18 141.35 51.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -114.02 130.62 56.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.478 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 23.5 mm -74.62 131.54 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -105.88 141.47 37.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.358 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 1.031 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -89.27 110.15 20.96 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.187 175.17 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.753 HD13 ' HB3' ' A' ' 150' ' ' ALA . 68.5 mt -94.26 135.84 27.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.463 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.786 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 41.6 ttm -122.92 124.55 43.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.056 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.59 -170.66 34.11 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.91 149.02 91.54 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.713 2.276 . . . . 0.0 111.986 174.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.4 -50.71 6.53 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 123.314 2.676 . . . . 0.0 113.665 -177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.66 -47.53 79.6 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.13 0.49 . . . . 0.0 110.224 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -60.0 -41.93 93.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.631 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.816 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 66.7 m -56.26 -60.53 3.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.224 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.638 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 38.2 mt-10 -66.82 -33.17 75.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.287 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -26.88 68.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.753 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.13 -37.19 46.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.826 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.27 67.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.409 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -76.56 -31.48 57.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.287 -178.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.44 -44.58 83.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.197 0.522 . . . . 0.0 109.644 174.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.68 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 70.4 mt -63.03 -53.38 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.741 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.64 HD22 HD12 ' A' ' 158' ' ' LEU . 12.0 m120 -55.47 -38.29 68.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.476 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -59.87 -44.1 94.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 110.756 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.12 -39.48 89.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.594 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 68.4 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.941 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.407 ' O ' HG21 ' A' ' 60' ' ' VAL . 91.1 m . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.5 m -132.1 133.4 60.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.105 0.478 . . . . 0.0 111.179 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 5.4 mm-40 -108.09 145.08 34.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.909 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.74 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 42.1 mt-10 -112.05 104.28 12.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.329 0.585 . . . . 0.0 111.343 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.0 mp -105.65 141.97 19.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.01 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.518 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 45.5 ttm -100.56 114.58 28.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.911 0.386 . . . . 0.0 110.646 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.474 ' HA ' HD11 ' A' ' 71' ' ' LEU . 1.8 mp -83.22 110.07 21.46 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.043 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.854 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 31.3 Cg_exo -62.26 137.25 64.65 Favored 'Trans proline' 0 CA--C 1.519 -0.259 0 C-N-CA 122.81 2.34 . . . . 0.0 111.273 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.59 114.88 3.22 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.56 -34.78 3.66 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -169.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.854 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -89.29 3.78 50.97 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 172.565 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.506 ' HB1' HD11 ' A' ' 17' ' ' ILE . . . -60.73 -41.19 94.85 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.545 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.82 -14.29 50.94 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.702 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.655 ' O ' HG21 ' A' ' 23' ' ' THR . 22.6 mt -89.56 -57.04 3.01 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.539 0.169 . . . . 0.0 111.187 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.452 ' CG2' HD12 ' A' ' 71' ' ' LEU . 61.8 t -79.58 -54.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.506 HD11 ' HB1' ' A' ' 13' ' ' ALA . 12.7 pt -92.47 -10.7 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.699 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 69.64 31.47 70.65 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 tptt 73.27 -58.08 0.61 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.097 0.959 . . . . 0.0 111.356 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.2 24.48 5.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.874 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 24' ' ' ILE . . . 116.06 -13.21 16.86 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.684 174.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 35.8 mm-40 -56.95 -46.67 81.94 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.655 HG21 ' O ' ' A' ' 15' ' ' LEU . 55.4 m -80.33 -34.24 36.82 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.265 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.495 HD11 HD21 ' A' ' 37' ' ' LEU . 5.2 tp -62.28 -24.96 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 83.6 mttt -57.25 -58.89 6.25 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.102 170.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HB3' ' A' ' 81' ' ' ASP . 42.7 mt-30 -67.57 -20.25 65.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.206 -174.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 85.3 mt -79.74 -30.85 40.97 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.22 173.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 79.8 mt-30 -84.31 -32.26 24.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.569 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.62 -63.38 1.33 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.606 0.241 . . . . 0.0 111.285 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.509 ' HB3' HH22 ' A' ' 82' ' ' ARG . 10.6 ttm180 -66.66 -31.45 72.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.162 -172.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -96.38 -27.17 15.05 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.37 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' HA3' ' NE2' ' A' ' 128' ' ' GLN . . . 78.56 2.89 85.98 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.774 -0.726 . . . . 0.0 113.286 175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.683 HG23 ' SD ' ' A' ' 35' ' ' MET . 27.6 m -101.08 161.91 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -103.99 109.49 21.28 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.326 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.683 ' SD ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -92.12 121.09 33.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.155 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.2 tp -113.56 102.34 13.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.964 0.888 . . . . 0.0 109.219 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.751 HD13 HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -132.31 142.21 49.26 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.819 -176.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.681 HG21 ' H ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -60.77 122.24 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.403 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.2 -37.23 0.57 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.299 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.85 -48.11 55.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.121 0.486 . . . . 0.0 110.398 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.665 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 137.14 34.48 0.2 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.335 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -78.99 -22.32 45.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.037 0.446 . . . . 0.0 110.829 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.54 ' HB3' HG12 ' A' ' 38' ' ' ILE . 54.1 tp60 -136.72 -80.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.781 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.681 ' H ' HG21 ' A' ' 38' ' ' ILE . 96.7 m-20 -107.56 87.31 2.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.168 0.509 . . . . 0.0 110.757 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.665 ' HB ' ' HA2' ' A' ' 41' ' ' GLY . 1.8 t -81.51 -42.67 19.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.262 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -94.17 -35.45 12.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.746 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.72 160.33 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.386 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.637 ' OD1' ' HA ' ' A' ' 9' ' ' PRO . 61.7 m-20 -49.53 139.93 11.52 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.391 0.432 . . . . 0.0 111.05 177.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 65.2 mttt -113.06 128.52 25.52 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.163 -165.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -84.8 140.29 7.96 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.798 2.332 . . . . 0.0 113.376 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.751 HD12 HD13 ' A' ' 37' ' ' LEU . 9.0 tt -117.92 139.81 50.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.361 -174.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.3 mpt_? -123.35 123.42 40.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.453 0.168 . . . . 0.0 110.589 170.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.613 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.4 mt -93.82 116.77 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.7 mt -103.67 120.34 53.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.653 0.263 . . . . 0.0 111.281 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.09 -170.76 43.51 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.372 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.541 ' HB3' ' HE2' ' A' ' 59' ' ' LYS . 9.9 t70 -60.57 138.81 92.78 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.847 -0.677 . . . . 0.0 110.675 172.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.42 -28.83 9.06 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.967 3.111 . . . . 0.0 114.676 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -73.17 -52.05 15.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.949 0.404 . . . . 0.0 110.225 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HE2' ' HB3' ' A' ' 56' ' ' ASP . 0.3 OUTLIER -68.83 -30.14 68.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.468 -177.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 2' ' ' THR . 88.6 t -70.6 -32.87 51.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.448 175.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.443 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 0.8 OUTLIER -70.23 -52.45 23.1 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.064 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -65.01 -23.2 67.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.358 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.674 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -86.6 -43.97 12.25 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.949 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 68' ' ' MET . 30.4 p -61.9 -30.98 71.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.692 0.282 . . . . 0.0 111.447 -174.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -83.43 -30.51 27.24 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.794 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.82 ' HB2' ' HG3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -79.3 -34.34 42.5 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.326 -176.459 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.08 -27.45 42.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.924 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 44.8 mtm -82.95 -35.95 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 0.0 109.607 171.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 36.0 t70 -62.97 -43.76 97.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.782 -175.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.879 HG21 ' HA ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -87.05 -21.5 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.37 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 8' ' ' ILE . 3.5 tt -84.29 -24.69 29.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.64 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.406 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -60.6 -35.55 76.39 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.146 -0.222 . . . . 0.0 110.537 -177.557 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 1.1 pt-20 37.83 -145.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.199 0.937 . . . . 0.0 112.867 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 8.1 ptm180 173.26 -12.67 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.264 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -154.87 35.62 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.531 -173.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? 58.54 76.13 0.36 Allowed 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.614 0.721 . . . . 0.0 109.404 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.66 116.78 0.72 Allowed Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.257 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . -99.37 -75.32 1.18 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.264 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -144.53 -58.38 0.37 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.768 0.794 . . . . 0.0 109.028 176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.42 -91.3 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB3' ' CB ' ' A' ' 26' ' ' GLN . 5.7 p-10 -90.52 -44.75 9.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 164.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.879 ' HA ' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER 170.37 -51.46 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.689 -172.256 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.536 ' HA ' ' HB2' ' A' ' 94' ' ' ASP . 18.8 m120 57.45 53.41 7.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 171.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.712 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 0.7 OUTLIER -174.36 2.99 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 177.559 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.816 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -161.66 -71.53 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.987 -1.071 . . . . 0.0 110.959 174.74 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.524 ' H ' ' CD ' ' A' ' 82' ' ' ARG . . . 53.67 65.67 3.27 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.581 -174.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.511 ' C ' ' HD2' ' A' ' 88' ' ' ARG . 17.0 t 74.31 -21.62 0.27 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.692 0.797 . . . . 0.0 112.086 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.586 ' HG3' ' HB2' ' A' ' 127' ' ' LYS . 2.6 mmm180 -119.05 -166.32 1.24 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -172.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.816 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 55.6 mt 70.59 -83.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 167.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.575 ' HA2' ' HD2' ' A' ' 85' ' ' TYR . . . 62.87 54.97 29.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.126 -173.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 128.96 58.71 0.11 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.513 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.551 ' O ' HG21 ' A' ' 89' ' ' ILE . . . 164.59 163.28 17.34 Favored Glycine 0 C--O 1.207 -1.572 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.712 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.0 pt -90.31 154.26 3.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 119.14 1.47 . . . . 0.0 112.39 -169.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 83' ' ' ASN . 36.2 m-20 -90.38 117.48 29.13 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.836 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.685 HG21 HD12 ' A' ' 140' ' ' ILE . 1.3 t -116.69 95.1 45.48 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.874 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.17 108.53 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.52 2.146 . . . . 0.0 111.782 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.589 HG13 HD21 ' A' ' 158' ' ' LEU . 86.0 t -94.77 118.75 66.74 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.443 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.641 ' HD2' HD22 ' A' ' 158' ' ' LEU . 47.0 Cg_exo -38.11 123.6 0.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.014 2.476 . . . . 0.0 111.478 171.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -34.46 -58.55 0.48 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -168.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -71.92 -23.71 61.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 t -78.63 -15.1 58.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.594 0.235 . . . . 0.0 111.143 -172.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.556 ' HA ' HG11 ' A' ' 97' ' ' VAL . 58.1 t -54.82 -37.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.154 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.51 -36.03 82.87 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.701 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.18 -37.83 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.353 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.33 -34.28 69.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.346 0.593 . . . . 0.0 110.36 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.73 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 39.7 mm -76.45 -43.57 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.29 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.56 34.87 8.21 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.477 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 65.65 -75.28 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.357 0.663 . . . . 0.0 111.673 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 m -87.49 2.79 49.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.496 ' O ' ' HG2' ' A' ' 114' ' ' LYS . . . 92.52 14.08 56.06 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.877 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -65.89 -40.86 91.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.751 0.31 . . . . 0.0 111.297 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 55.7 tpp -78.23 -36.34 47.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.73 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.0 tp -68.18 -29.66 45.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.816 0.341 . . . . 0.0 110.157 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 110' ' ' GLY . 42.2 mmtm -70.16 -34.73 73.37 Favored 'General case' 0 CA--C 1.523 -0.086 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 173.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 112' ' ' MET . 25.5 mmmt -61.61 -38.7 88.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.981 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.12 -43.04 95.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.26 0.552 . . . . 0.0 109.552 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 60.5 mt-30 -69.04 -26.81 65.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.733 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -86.22 -45.54 11.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.073 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.17 -36.42 47.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.986 -173.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 146' ' ' ARG . . . -103.98 -20.35 13.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.96 37.96 31.81 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.886 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.406 HG11 HG23 ' A' ' 140' ' ' ILE . 33.1 m -112.79 154.23 14.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.959 0.409 . . . . 0.0 111.944 -173.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.553 ' HD3' ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -108.25 135.18 50.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.607 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.553 ' N ' ' HD3' ' A' ' 123' ' ' ARG . 45.3 mm -99.58 143.66 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.087 0.47 . . . . 0.0 111.957 -170.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 5.5 tt0 -147.79 104.95 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.682 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -74.29 111.42 9.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.061 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -125.22 156.32 38.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.181 -173.715 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.529 ' NE2' ' HA3' ' A' ' 32' ' ' GLY . 12.0 mm100 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.848 175.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.46 -0.494 0 CA-C-O 121.237 0.432 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -131.24 152.79 50.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.913 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HD2' HG21 ' A' ' 102' ' ' VAL . 82.8 mttt -110.7 113.36 25.91 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.513 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 1.7 mm -72.55 112.57 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.194 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -96.29 135.8 37.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.802 173.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.777 ' CE1' HG23 ' A' ' 89' ' ' ILE . 1.5 t60 -86.87 109.04 19.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.903 174.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' A' ' 150' ' ' ALA . 41.0 mt -91.19 123.25 43.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 170.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.449 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 13.9 ttp -112.53 131.41 55.61 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -171.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.32 -178.11 27.98 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.68 147.13 96.04 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.859 1.706 . . . . 0.0 110.764 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -41.16 -44.27 5.32 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.475 2.783 . . . . 0.0 112.834 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.31 -40.96 62.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.789 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 9.3 mtm180 -84.53 -38.89 19.48 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 140' ' ' ILE . 61.2 m -58.59 -61.32 2.69 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 111.002 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.686 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 6.2 mm-40 -58.02 -40.85 81.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.182 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -57.58 -31.96 66.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.903 0.382 . . . . 0.0 111.282 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.697 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.46 -36.79 44.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.972 0.415 . . . . 0.0 110.915 -176.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.408 ' HB3' HH11 ' A' ' 152' ' ' ARG . . . -66.17 -24.1 66.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.798 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.686 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 11.3 mpt_? -78.59 -28.04 45.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.755 0.312 . . . . 0.0 110.424 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.3 mt -70.15 -47.93 64.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.233 0.539 . . . . 0.0 109.551 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.517 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.0 mt -63.18 -42.99 98.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.705 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -57.84 -39.21 77.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.982 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.55 -32.58 74.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.772 0.32 . . . . 0.0 110.302 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 44.0 mt -67.64 -47.95 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.969 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.641 HD22 ' HD2' ' A' ' 98' ' ' PRO . 13.3 mt . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.896 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 57' ' ' PRO . 1.6 m . . . . . 0 N--CA 1.451 -0.409 0 CA-C-O 120.958 0.408 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 12.0 m -124.12 128.79 74.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.09 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -114.15 133.95 55.23 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.543 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 43.5 mt-10 -103.04 126.12 50.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.223 0.535 . . . . 0.0 111.869 -175.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -117.8 144.52 25.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 174.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.4 mtp -93.1 112.44 24.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.158 0.504 . . . . 0.0 110.777 -176.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.549 HG13 HG21 ' A' ' 16' ' ' VAL . 1.7 mp -95.21 114.93 64.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.706 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.54 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 41.8 Cg_exo -61.72 152.42 74.23 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.449 2.766 . . . . 0.0 112.815 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.73 131.51 45.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.61 -42.01 2.13 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -169.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 9' ' ' PRO . 13.1 tptt -68.7 -32.48 72.31 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.711 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -52.39 -31.75 35.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.315 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.661 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -59.0 -42.09 96.73 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.431 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.952 HD23 ' HA ' ' A' ' 76' ' ' GLN . 3.8 pp -89.67 -17.95 27.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.756 0.278 . . . . 0.0 111.663 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.549 HG21 HG13 ' A' ' 8' ' ' ILE . 82.9 t -83.5 -48.69 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.711 HG12 ' O ' ' A' ' 13' ' ' ALA . 13.3 pt -90.52 -24.79 5.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.516 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.515 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 100.91 11.58 39.66 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.669 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.661 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 5.4 tptm 52.33 44.2 30.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.324 0.583 . . . . 0.0 110.353 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.83 -24.4 0.55 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.474 -173.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.99 -11.53 7.34 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.331 175.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -59.32 -34.32 72.19 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -174.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.515 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 28.3 m -84.23 -41.57 16.8 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.316 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 35' ' ' MET . 8.3 tp -66.44 -32.4 57.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -47.91 -48.14 31.83 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.58 170.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.599 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 49.2 mt-30 -73.8 -42.07 61.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.657 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.544 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 81.6 mt -60.65 -28.1 68.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.179 0.514 . . . . 0.0 110.709 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 87.6 mt-30 -85.58 -53.75 4.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.567 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -82.23 -49.75 9.75 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -172.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.525 ' HD3' ' OD2' ' A' ' 81' ' ' ASP . 21.3 ttt180 -67.61 -51.75 46.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 110.01 -176.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.625 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -70.31 -29.05 65.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.934 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.07 3.23 87.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.832 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.1 m -103.44 -179.34 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.039 0.447 . . . . 0.0 110.376 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -121.5 114.25 20.97 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.676 ' HB2' HD11 ' A' ' 24' ' ' ILE . 51.6 mtt -100.66 121.1 41.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tp -114.02 110.99 34.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.915 0.864 . . . . 0.0 110.213 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.818 HD13 HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -133.22 144.42 49.78 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.319 -174.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.6 mm -60.76 100.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.134 0.492 . . . . 0.0 110.615 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.547 ' HG2' HG21 ' A' ' 17' ' ' ILE . 42.4 mt-30 -105.4 -42.73 5.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.526 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.74 -19.65 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.511 -177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.04 49.46 3.53 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.199 174.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 m -59.83 -71.37 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.832 0.349 . . . . 0.0 110.847 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -117.85 -26.0 6.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.146 0.498 . . . . 0.0 110.832 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -107.56 75.35 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.985 0.422 . . . . 0.0 110.823 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 p -83.29 -63.22 1.4 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.927 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -94.96 -4.47 46.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.289 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.24 158.21 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.004 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.46 144.77 16.13 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.49 0.494 . . . . 0.0 110.872 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -117.46 127.98 26.31 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.796 -171.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.88 116.76 3.49 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.248 1.966 . . . . 0.0 112.141 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.818 HD12 HD13 ' A' ' 37' ' ' LEU . 8.4 tt -98.48 119.89 37.95 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.483 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.602 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.4 mpt_? -100.11 116.27 31.75 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 176.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CG2' HG23 ' A' ' 60' ' ' VAL . 27.7 mt -89.43 118.37 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 3' ' ' VAL . 27.5 mt -104.67 121.32 56.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 177.49 -177.92 48.32 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.483 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.612 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 13.8 t70 -62.04 139.98 95.9 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.565 ' HA ' HG21 ' A' ' 2' ' ' THR . 69.7 Cg_exo -38.7 -45.86 2.51 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.912 3.075 . . . . 0.0 115.157 -175.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -74.43 -33.51 62.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.251 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 1.007 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 19.0 ptpt -79.2 -41.68 27.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -175.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.512 HG23 ' CG2' ' A' ' 53' ' ' ILE . 8.0 p -67.36 -24.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.503 0.668 . . . . 0.0 109.935 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -66.88 -57.89 6.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.24 178.066 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -61.45 -33.16 73.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -69.51 -45.73 68.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.745 177.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.455 ' HA ' HG22 ' A' ' 67' ' ' VAL . 42.8 t -58.97 -35.63 73.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.52 0.676 . . . . 0.0 109.632 177.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.25 -37.08 84.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.616 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.867 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 15.5 ptt? -84.95 -33.47 22.65 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.975 -176.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 35.1 m -62.37 -28.96 45.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.299 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.6 mtm -81.6 -21.03 38.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 110.32 174.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -83.2 -46.26 12.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.894 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.702 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.6 pp -83.22 -26.7 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.333 . . . . 0.0 111.743 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 6.0 tt -75.72 -18.35 59.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.876 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 5.8 ptm180 -53.39 -42.1 66.61 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.529 ' HG2' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER 56.07 137.73 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 170.411 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 72.7 mtp180 -112.43 -13.45 13.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 161.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.529 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 36.1 t70 -163.18 135.06 5.1 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.544 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.952 ' HA ' HD23 ' A' ' 15' ' ' LEU . 78.4 mt-30 -43.81 106.65 0.07 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.289 1.042 . . . . 0.0 112.188 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.483 ' N ' ' HB3' ' A' ' 15' ' ' LEU . . . 150.82 -34.38 0.95 Allowed Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.103 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.95 -111.23 3.61 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.702 ' HD1' HG22 ' A' ' 70' ' ' ILE . 97.3 m-85 -127.78 -13.77 5.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.74 0.305 . . . . 0.0 110.609 174.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 81.23 91.92 0.52 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -174.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.599 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 5.7 t70 71.22 -75.04 0.08 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -170.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.867 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 24.9 ttt180 173.17 -35.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 O-C-N 124.18 0.925 . . . . 0.0 110.332 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 69.19 13.54 8.62 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.65 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.808 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 84.9 tt0 -123.96 -34.43 2.99 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.631 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 25.6 p90 171.27 127.31 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.139 175.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.753 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -82.99 -66.69 1.51 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.946 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . 1.007 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 45.2 m -144.98 22.56 1.57 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.776 0.798 . . . . 0.0 109.125 176.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 1.8 mpt_? -133.84 -164.16 1.46 Allowed 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.043 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' A' ' 85' ' ' TYR . 23.9 mt 64.71 -81.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.45 50.71 57.86 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 132.96 85.02 0.26 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.286 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 153.94 -143.76 10.48 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.808 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.9 pt -144.97 160.55 13.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 117.302 0.551 . . . . 0.0 110.844 175.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.491 ' HB3' ' HE ' ' A' ' 30' ' ' ARG . 5.0 m-20 -107.0 119.68 40.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.949 173.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.828 HG23 ' HB3' ' A' ' 138' ' ' ALA . 6.2 m -113.35 104.88 55.56 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.169 0.509 . . . . 0.0 112.172 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 51.8 Cg_endo -72.34 108.6 2.54 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.816 2.344 . . . . 0.0 111.634 173.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.678 HG13 HD21 ' A' ' 158' ' ' LEU . 46.9 t -102.35 124.92 37.87 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.071 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.552 ' HD2' HD22 ' A' ' 158' ' ' LEU . 78.7 Cg_exo -44.54 133.65 9.8 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.636 2.89 . . . . 0.0 112.783 173.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -58.59 -30.6 67.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.651 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -89.88 1.36 56.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.424 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 105' ' ' VAL . 25.1 m -119.56 -27.97 5.41 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.505 ' HA ' HG11 ' A' ' 97' ' ' VAL . 11.2 p -52.33 -34.43 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.38 -37.76 94.19 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.85 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.9 -37.14 53.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 0.0 110.36 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 101' ' ' SER . 48.0 t -65.35 -38.67 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.326 0.584 . . . . 0.0 110.669 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.814 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 13.7 mt -81.03 -26.33 10.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.238 0.542 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.4 48.44 5.94 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 59.02 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.83 0.852 . . . . 0.0 112.244 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.9 m -75.08 -24.49 58.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 111.065 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.413 ' HA2' ' CG2' ' A' ' 106' ' ' ILE . . . 130.41 50.7 0.11 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.725 177.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.563 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 40.4 mt-10 -93.42 -58.98 2.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.882 0.373 . . . . 0.0 110.302 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -68.37 -31.54 70.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.163 -173.573 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.814 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.0 tp -65.46 -22.88 31.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.253 0.549 . . . . 0.0 110.675 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -82.32 -26.06 33.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.046 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.563 ' HD3' ' O ' ' A' ' 111' ' ' GLU . 2.7 mptp? -65.24 -38.13 89.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.455 HD11 ' SD ' ' A' ' 112' ' ' MET . 28.9 mm -59.12 -43.12 88.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.491 175.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 17.0 mt-30 -67.04 -33.61 75.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.744 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -79.26 -42.32 26.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.613 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.64 -40.62 33.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.464 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.17 18.47 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.93 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.19 46.35 8.25 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.438 HG21 HG23 ' A' ' 140' ' ' ILE . 1.9 t -118.02 143.75 27.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.109 -0.546 . . . . 0.0 111.678 -169.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.475 ' HD3' ' SD ' ' A' ' 141' ' ' MET . 79.4 mtp180 -103.53 148.68 25.67 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.2 mm -114.63 135.03 55.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.189 0.519 . . . . 0.0 111.937 -171.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.586 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 24.1 tt0 -137.32 105.67 5.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.219 176.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.493 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 33.6 m-85 -80.76 106.53 12.84 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 121.942 -0.474 . . . . 0.0 109.949 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.832 ' O ' ' HE2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.47 127.28 48.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.235 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 . . . . . 0 N--CA 1.466 0.353 0 CA-C-O 121.384 0.612 . . . . 0.0 111.589 175.567 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.476 0.445 0 N-CA-C 115.091 1.15 . . . . 0.0 115.091 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -132.74 146.35 51.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.358 0.599 . . . . 0.0 111.525 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -119.47 115.94 25.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.747 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.546 HG22 ' NZ ' ' A' ' 127' ' ' LYS . 18.0 mm -72.84 108.32 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.569 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.828 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -96.79 141.4 30.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.671 175.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.6 ' NE2' HG23 ' A' ' 89' ' ' ILE . 3.2 t-160 -91.52 117.52 29.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.879 0.371 . . . . 0.0 110.414 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.655 HD13 ' HB3' ' A' ' 150' ' ' ALA . 37.9 mt -97.17 118.24 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.248 171.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.475 ' SD ' ' HD3' ' A' ' 123' ' ' ARG . 46.3 ttm -102.13 121.61 42.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 -174.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 164.33 170.26 29.02 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.16 150.83 82.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.585 2.19 . . . . 0.0 111.6 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.775 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 87.2 Cg_exo -42.3 -40.02 6.65 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.931 3.087 . . . . 0.0 114.999 -172.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.3 -32.07 64.4 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.998 -0.439 . . . . 0.0 110.855 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 149' ' ' HIS . 92.7 mtt-85 -85.0 -35.17 22.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.778 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.775 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 27.7 p -62.99 -51.08 68.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.609 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 28.3 mt-10 -66.38 -29.01 69.09 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.935 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 4.4 t60 -55.49 -36.08 66.26 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.116 0.484 . . . . 0.0 110.136 175.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.655 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.14 -35.04 42.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.922 -174.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.473 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -67.15 -24.93 65.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.609 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 2.9 mpt_? -77.84 -18.5 56.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.981 0.42 . . . . 0.0 110.314 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.5 mt -82.41 -44.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 66.7 mt -65.94 -52.51 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.347 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -60.74 -30.21 69.85 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.251 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.63 -39.48 93.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.996 0.427 . . . . 0.0 110.013 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.424 HD11 ' CE ' ' A' ' 112' ' ' MET . 82.7 mt -67.07 -44.06 81.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.776 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.678 HD21 HG13 ' A' ' 97' ' ' VAL . 71.3 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.776 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.656 HG21 ' HA ' ' A' ' 57' ' ' PRO . 36.5 m . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 17.5 m -132.28 141.4 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.699 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -123.52 141.72 51.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.742 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 45.6 mt-10 -112.23 121.38 44.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.363 0.601 . . . . 0.0 111.703 -175.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.66 HG13 HG21 ' A' ' 67' ' ' VAL . 44.7 mm -110.52 150.08 13.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.665 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.489 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 50.4 tpp -101.37 117.03 34.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.881 0.372 . . . . 0.0 110.848 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.779 HG12 HG11 ' A' ' 16' ' ' VAL . 3.0 mp -99.37 104.39 26.56 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.185 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 7' ' ' MET . 21.2 Cg_exo -67.52 159.45 52.44 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 123.08 2.52 . . . . 0.0 111.82 177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.51 141.56 57.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.14 -51.42 1.89 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -172.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.78 -25.01 64.49 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.004 0.431 . . . . 0.0 110.411 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.748 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -52.11 -37.47 54.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.67 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA3' ' OE1' ' A' ' 76' ' ' GLN . . . -63.03 -38.46 96.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.984 -178.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.077 HD23 ' HA ' ' A' ' 76' ' ' GLN . 2.9 pp -89.93 -15.82 31.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.98 0.39 . . . . 0.0 111.656 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.779 HG11 HG12 ' A' ' 8' ' ' ILE . 70.8 t -90.2 -49.94 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.748 HG12 ' O ' ' A' ' 13' ' ' ALA . 17.6 pt -87.51 -23.42 6.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.321 -0.551 . . . . 0.0 109.895 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.761 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 89.92 17.95 52.33 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.719 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.452 ' H ' HG13 ' A' ' 17' ' ' ILE . 29.7 mmtp 65.05 -63.36 0.19 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.667 0.787 . . . . 0.0 111.658 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.75 19.35 47.56 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.257 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 92.82 8.04 62.33 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.025 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.605 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 28.6 tt0 -63.01 -48.34 79.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.687 0.28 . . . . 0.0 111.594 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.761 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 78.9 m -67.23 -39.45 86.23 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.204 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.667 HD12 HD12 ' A' ' 27' ' ' LEU . 1.3 tp -64.6 -22.1 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.67 0.272 . . . . 0.0 110.899 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.605 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 49.8 mttm -56.79 -57.86 10.62 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.619 0.723 . . . . 0.0 109.981 173.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -69.31 -26.98 65.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.963 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.667 HD12 HD12 ' A' ' 24' ' ' ILE . 36.6 mt -75.03 -30.14 61.0 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.045 -0.409 . . . . 0.0 111.019 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.706 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.2 mt-30 -84.83 -42.45 15.1 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.032 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -88.07 -62.1 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.66 HH21 ' HA3' ' A' ' 86' ' ' GLY . 2.2 ttp180 -58.47 -43.75 89.02 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.933 0.397 . . . . 0.0 110.891 -176.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -75.45 -22.39 57.36 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.356 0.598 . . . . 0.0 111.178 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.99 78.4 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.778 -0.647 . . . . 0.0 112.672 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 28.6 m -121.75 151.0 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.843 0.354 . . . . 0.0 110.455 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -89.19 109.49 20.36 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 1.044 ' HB3' HD11 ' A' ' 51' ' ' LEU . 59.4 mtt -98.2 114.43 26.67 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.707 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.9 tp -110.44 112.25 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 122.006 0.908 . . . . 0.0 109.677 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.638 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -132.29 143.38 49.85 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.95 -175.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 78.7 mt -54.37 107.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 124.01 0.819 . . . . 0.0 111.892 -173.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -126.37 -14.55 5.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.837 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.28 158.61 20.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.676 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.29 69.11 0.88 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.966 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.4 t -89.38 -62.89 1.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -175.6 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.393 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -86.75 62.5 7.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.114 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 p -83.29 -61.13 1.93 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.81 0.338 . . . . 0.0 111.347 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -93.39 -17.08 23.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.283 0.563 . . . . 0.0 109.819 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 11.9 t -79.15 166.17 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.886 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.4 p30 -47.84 140.91 6.13 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.159 0.504 . . . . 0.0 111.282 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 16.6 mtmm -130.1 137.46 30.92 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.087 -170.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.53 133.21 5.22 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.597 2.198 . . . . 0.0 112.4 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.044 HD11 ' HB3' ' A' ' 35' ' ' MET . 22.4 tp -108.05 120.18 41.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.813 -177.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.707 ' HB2' HG23 ' A' ' 36' ' ' ILE . 5.1 mpt_? -96.27 115.57 27.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.37 174.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.3 mt -91.47 110.1 22.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.786 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 3' ' ' VAL . 35.3 mt -108.06 121.04 60.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.452 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.544 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.86 -170.2 43.33 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.986 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.985 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . 2.1 m-20 -51.03 146.75 10.11 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.647 0.263 . . . . 0.0 110.514 175.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.656 ' HA ' HG21 ' A' ' 2' ' ' THR . 51.3 Cg_exo -54.72 -52.62 7.66 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 121.909 1.739 . . . . 0.0 112.773 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -61.03 -30.65 70.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.638 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.985 ' HG3' ' HB2' ' A' ' 56' ' ' ASP . 46.1 mttp -64.77 -47.97 76.22 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.294 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.31 -39.0 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.165 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.19 -51.88 67.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.564 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.89 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 17.8 mm-40 -68.7 -35.43 77.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 -178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -72.31 -42.48 65.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.89 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 47.3 t -57.35 -36.76 71.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.358 0.599 . . . . 0.0 109.568 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -67.49 -45.63 75.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.21 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.633 ' O ' HG13 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -73.94 -37.7 64.48 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.837 -175.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.66 HG21 HG13 ' A' ' 6' ' ' ILE . 35.9 m -62.49 -35.18 68.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.678 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.726 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 66.2 mtt -71.24 -21.22 62.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.737 0.303 . . . . 0.0 110.632 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 8.9 t70 -85.59 -41.51 15.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.967 0.413 . . . . 0.0 111.04 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.812 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.1 pp -86.85 -23.99 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.922 0.392 . . . . 0.0 111.856 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.622 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 3.6 tt -86.47 -20.06 28.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.551 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.726 ' HB3' ' O ' ' A' ' 68' ' ' MET . 5.3 ptm180 -61.55 -11.36 10.81 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.85 0.357 . . . . 0.0 111.076 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 1.05 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 16.0 tp10 -50.98 138.79 18.65 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.401 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -66.7 -30.08 70.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.827 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 29.1 t70 -135.23 -89.32 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.716 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 1.077 ' HA ' HD23 ' A' ' 15' ' ' LEU . 9.3 tt0 -153.66 61.45 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.544 0.688 . . . . 0.0 110.296 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 1.05 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . -137.64 30.49 2.58 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.8 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.75 158.27 40.73 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.812 ' HD1' HG22 ' A' ' 70' ' ' ILE . 4.5 m-85 -60.59 -45.51 93.7 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.82 -75.49 0.42 Allowed Glycine 0 CA--C 1.496 -1.099 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 169.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.526 ' HA ' HD21 ' A' ' 27' ' ' LEU . 19.2 p-10 -92.33 -15.61 27.12 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.418 -0.891 . . . . 0.0 110.473 174.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.446 ' CB ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER 84.58 64.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.635 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 28.8 t-20 -49.54 102.93 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.709 176.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 1.065 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.7 tt0 162.65 -41.97 0.0 OUTLIER 'General case' 0 C--O 1.232 0.157 0 O-C-N 124.572 1.17 . . . . 0.0 108.32 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 53.2 p90 -175.03 151.27 1.3 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.449 -177.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.61 80.04 0.18 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.89 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 40.1 m 72.38 -20.41 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.107 0.479 . . . . 0.0 111.001 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.663 ' HD3' ' H ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -103.96 154.03 20.13 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.733 171.207 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.694 HG21 ' CE1' ' A' ' 139' ' ' HIS . 33.3 mm 62.58 -88.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.119 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.03 46.45 1.73 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.661 -172.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 151.71 164.82 12.48 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.739 -0.545 . . . . 0.0 111.739 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.748 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 86.13 -122.02 5.91 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.081 -0.581 . . . . 0.0 111.724 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 1.065 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 28.7 pt -155.43 178.5 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 122.921 0.489 . . . . 0.0 109.852 171.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -120.22 137.04 54.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.694 170.364 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 29.2 t -124.12 98.06 39.55 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.073 -175.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.441 ' CA ' HD13 ' A' ' 137' ' ' ILE . 38.2 Cg_endo -69.98 107.75 1.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.671 1.581 . . . . 0.0 110.92 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.672 HG21 HG21 ' A' ' 105' ' ' VAL . 14.8 p -116.02 126.75 27.35 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.014 0.435 . . . . 0.0 110.574 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.496 ' HA ' ' HG2' ' A' ' 135' ' ' GLU . 73.6 Cg_exo -46.96 136.17 17.54 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.499 2.799 . . . . 0.0 112.546 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -54.77 -29.13 53.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.343 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -92.29 10.55 29.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.895 0.379 . . . . 0.0 111.354 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 105' ' ' VAL . 46.1 m -128.64 -15.19 4.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.761 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 106' ' ' ILE . 7.6 p -64.51 -35.28 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.267 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.73 -28.56 73.5 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.184 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.29 -37.97 39.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.672 HG21 HG21 ' A' ' 97' ' ' VAL . 62.1 t -59.78 -41.09 84.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.919 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.784 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 46.0 mm -67.39 -46.3 83.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.245 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.06 33.26 9.02 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.611 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' A' ' 108' ' ' ARG . 27.9 mtp180 64.9 -78.28 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.264 0.626 . . . . 0.0 111.914 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.457 ' HB2' ' HG3' ' A' ' 111' ' ' GLU . 18.0 m -81.81 11.32 5.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.878 0.37 . . . . 0.0 110.815 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.407 ' O ' ' HG2' ' A' ' 114' ' ' LYS . . . 75.51 22.12 76.0 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.919 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 109' ' ' SER . 41.0 mt-10 -71.46 -50.47 31.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.895 0.378 . . . . 0.0 110.916 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.544 ' O ' HG12 ' A' ' 116' ' ' ILE . 13.6 tpt -68.49 -39.11 81.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.081 -173.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.784 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.3 tp -65.96 -32.37 57.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.608 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 110' ' ' GLY . 74.6 mmtt -81.41 -30.58 33.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.203 0.525 . . . . 0.0 109.731 176.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -66.15 -38.74 88.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.945 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 112' ' ' MET . 45.6 mm -62.15 -39.04 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.354 0.597 . . . . 0.0 109.651 174.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 77.6 mt-30 -65.8 -32.22 73.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.833 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -79.8 -42.4 24.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.567 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -79.46 -43.58 22.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.65 -18.94 20.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.929 0.395 . . . . 0.0 111.671 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.53 47.42 8.03 Favored Glycine 0 C--O 1.228 -0.223 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.886 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.459 ' HB ' HG23 ' A' ' 140' ' ' ILE . 27.1 m -122.17 179.58 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 111.653 -173.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.748 ' HB3' ' HG2' ' A' ' 141' ' ' MET . 43.1 ttt180 -145.68 145.78 31.04 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.558 HG13 HD11 ' A' ' 113' ' ' ILE . 44.9 mm -107.68 138.46 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -168.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.673 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 7.0 tp60 -138.48 94.92 2.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.866 175.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 138' ' ' ALA . 44.2 m-85 -73.72 105.97 5.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.776 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -102.04 -166.74 1.32 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.076 -173.451 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . 0.408 ' OE1' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -169.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--O 1.237 0.45 0 CA-C-O 121.519 0.55 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 98' ' ' PRO . 45.7 mt-10 -129.36 151.03 50.45 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.872 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.494 ' O ' HG12 ' A' ' 97' ' ' VAL . 66.9 mttm -109.38 113.82 26.97 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -175.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 14.9 mm -67.13 109.86 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.864 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 126' ' ' PHE . . . -97.79 135.14 39.98 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 170.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.694 ' CE1' HG21 ' A' ' 89' ' ' ILE . 13.2 t60 -86.69 123.43 31.85 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.979 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.551 HD13 ' HB3' ' A' ' 150' ' ' ALA . 32.3 mt -103.24 126.15 57.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.275 171.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.748 ' HG2' ' HB3' ' A' ' 123' ' ' ARG . 16.8 ptp -107.23 165.49 11.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.958 0.409 . . . . 0.0 110.665 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.76 172.96 13.26 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.503 ' HD2' ' HD3' ' A' ' 146' ' ' ARG . 38.1 Cg_exo -58.89 143.5 99.36 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.415 2.076 . . . . 0.0 111.765 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.747 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 72.5 Cg_exo -41.59 -43.97 6.24 Favored 'Trans proline' 0 N--CA 1.476 0.466 0 C-N-CA 124.006 3.137 . . . . 0.0 114.497 -173.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 11.4 t70 -57.59 -42.93 84.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.612 0.244 . . . . 0.0 111.417 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.503 ' HD3' ' HD2' ' A' ' 143' ' ' PRO . 18.3 mtp180 -79.75 -39.15 31.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.52 -172.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.747 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 12.2 p -63.11 -50.65 69.64 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.666 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 5.7 mm-40 -62.21 -38.88 90.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.664 0.269 . . . . 0.0 110.718 176.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 18.6 t60 -57.66 -32.31 67.18 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.953 0.406 . . . . 0.0 111.076 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.551 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -77.91 -34.02 51.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.778 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.512 ' HB3' HH11 ' A' ' 152' ' ' ARG . . . -67.47 -25.26 65.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.396 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.666 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 10.9 mpt_? -77.83 -32.73 52.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.845 0.355 . . . . 0.0 110.264 -177.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.44 ' O ' HD13 ' A' ' 157' ' ' LEU . 63.4 mt -65.4 -46.36 90.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.813 176.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.633 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 68.3 mt -62.41 -37.48 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.294 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.85 -31.3 69.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.462 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.08 -37.48 38.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.14 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 153' ' ' ILE . 7.8 mp -53.49 -42.29 67.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 25.5 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.424 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.807 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m -79.51 125.08 29.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.886 0.343 . . . . 0.0 110.201 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 15.0 m -133.54 115.18 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.502 0.668 . . . . 0.0 111.525 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -115.28 141.33 48.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.487 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 39.5 mt-10 -109.77 136.04 49.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.555 0.693 . . . . 0.0 112.504 -174.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.0 148.22 29.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.07 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 68.3 mtp -101.49 129.18 47.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.151 0.5 . . . . 0.0 111.56 -174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 51' ' ' LEU . 3.9 mp -105.54 107.29 58.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.301 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.494 ' HD2' ' HG3' ' A' ' 12' ' ' LYS . 8.1 Cg_exo -74.64 152.23 42.43 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.211 2.607 . . . . 0.0 111.429 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.61 129.43 40.53 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.47 -15.4 24.77 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HD2' ' O ' ' A' ' 71' ' ' LEU . 71.0 mmtt -112.66 9.27 19.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.045 0.45 . . . . 0.0 110.132 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.417 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -62.92 -41.67 99.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.95 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.6 -15.72 66.72 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.175 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.862 HD11 ' HB2' ' A' ' 73' ' ' GLU . 24.7 mt -87.32 -58.61 2.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 120.81 0.338 . . . . 0.0 110.719 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.673 HG11 HG12 ' A' ' 8' ' ' ILE . 85.3 t -81.68 -48.83 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 13' ' ' ALA . 39.8 pt -91.52 -26.78 4.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.917 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.35 33.92 13.18 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.457 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm 57.65 29.66 17.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.977 0.511 . . . . 0.0 112.093 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.1 -33.47 0.61 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 119.951 -1.119 . . . . 0.0 113.304 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 157.07 -6.33 0.19 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 119.908 -1.139 . . . . 0.0 113.792 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.74 -46.57 67.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.964 0.382 . . . . 0.0 111.549 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 81' ' ' ASP . 86.0 m -73.36 -42.9 61.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.23 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.731 HD11 ' HB2' ' A' ' 35' ' ' MET . 5.8 tp -62.35 -26.1 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.75 -174.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 89.3 mttt -53.54 -56.89 13.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.945 0.879 . . . . 0.0 109.96 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.731 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 96.7 mt-30 -73.96 -27.69 61.12 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.607 -174.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.579 HD12 HD12 ' A' ' 24' ' ' ILE . 91.8 mt -66.59 -27.64 67.88 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.236 0.541 . . . . 0.0 109.853 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.679 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 97.2 mt-30 -85.41 -46.42 10.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.019 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -79.82 -62.44 1.68 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.504 ' HG2' HH22 ' A' ' 82' ' ' ARG . 3.0 ttm180 -62.34 -38.37 89.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.395 -173.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -87.51 -26.46 23.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.825 0.345 . . . . 0.0 111.634 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.4 70.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.76 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.5 m -127.41 156.06 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -94.25 109.37 21.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.822 ' HB3' HD21 ' A' ' 51' ' ' LEU . 48.8 mtt -100.24 114.04 27.18 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.172 0.51 . . . . 0.0 109.64 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.4 tt -111.72 113.8 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.982 0.896 . . . . 0.0 109.932 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.742 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 1.1 pt? -132.6 141.19 48.56 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.197 -175.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.692 HD13 ' HG2' ' A' ' 50' ' ' PRO . 2.1 mp -59.43 102.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.421 0.629 . . . . 0.0 111.012 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 19.46 17.73 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.6 123.37 25.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.405 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.767 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . -79.59 -0.97 85.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.225 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.6 m -90.09 -26.35 20.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.086 0.443 . . . . 0.0 110.865 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -115.79 -81.53 0.61 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.282 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.565 ' HB2' ' CG2' ' A' ' 38' ' ' ILE . 15.0 m120 -96.76 67.31 2.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.94 0.4 . . . . 0.0 110.994 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.767 ' HB ' ' HA2' ' A' ' 41' ' ' GLY . 1.9 t -83.44 -56.49 3.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.315 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -94.3 -21.8 18.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.124 0.488 . . . . 0.0 110.856 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.11 158.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.755 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.2 148.0 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.442 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -122.86 133.86 24.71 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.018 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.692 ' HG2' HD13 ' A' ' 38' ' ' ILE . 94.7 Cg_endo -86.98 119.91 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.421 2.081 . . . . 0.0 112.649 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.0 tt -88.06 111.11 21.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.675 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 2.6 mtp85 -96.73 100.12 11.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.722 0.296 . . . . 0.0 110.544 177.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 59.9 mt -80.83 112.61 19.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.23 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.4 mt -104.43 121.24 55.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.34 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.63 -171.01 44.21 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.23 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -69.05 153.1 96.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.5 -54.98 4.36 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.217 2.612 . . . . 0.0 114.227 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -65.68 -26.87 67.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 110.811 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.633 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 87.6 mttt -69.67 -51.06 38.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.112 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.91 -29.0 46.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.321 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.36 -56.18 16.14 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.516 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -65.04 -37.2 86.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.657 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -67.33 -46.67 72.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.356 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.9 t -55.68 -36.64 67.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.074 0.464 . . . . 0.0 110.447 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -63.95 -50.72 67.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.148 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 8.2 ptt? -68.69 -38.96 80.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.951 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 63' ' ' ALA . 61.6 t -57.53 -41.83 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.567 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.0 mtp -68.33 -25.71 65.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.306 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.671 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 11.8 t70 -84.54 -54.46 4.73 Favored 'General case' 0 C--O 1.219 -0.5 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.692 -176.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -71.51 -21.04 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.997 -174.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.624 HD12 HG21 ' A' ' 16' ' ' VAL . 5.1 tt -76.34 -16.82 59.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.069 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.736 ' HD2' ' HG2' ' A' ' 74' ' ' ARG . 10.9 ptp180 -56.7 -36.6 69.83 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.862 ' HB2' HD11 ' A' ' 15' ' ' LEU . 1.3 tm-20 65.85 98.98 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.853 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.736 ' HG2' ' HD2' ' A' ' 72' ' ' ARG . 43.2 mtt180 -96.36 -27.8 14.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.378 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -151.65 29.1 0.61 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.129 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.762 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 2.4 pm0 37.86 35.67 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.004 0.921 . . . . 0.0 112.827 -169.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.47 -44.26 0.79 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 65.03 25.57 70.93 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.698 -0.287 . . . . 0.0 112.876 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 67.8 -50.93 0.52 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.622 0.769 . . . . 0.0 111.889 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 111.34 99.15 2.48 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -174.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 0.7 OUTLIER 72.59 -66.38 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.02 0.482 . . . . 0.0 109.91 -169.261 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.634 ' HB3' ' NH1' ' A' ' 82' ' ' ARG . 0.8 OUTLIER 170.17 -42.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.328 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 57.95 78.11 0.26 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.213 0.53 . . . . 0.0 110.765 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 1.056 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.6 tt0 -174.91 -68.27 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.288 -175.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.629 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 1.1 p90 -141.32 -69.22 0.38 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 120.689 -1.257 . . . . 0.0 112.367 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.428 ' H ' ' HD1' ' A' ' 85' ' ' TYR . . . 68.45 75.39 0.52 Allowed Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.288 -174.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.633 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 9.6 m 74.86 -38.74 0.39 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.541 0.736 . . . . 0.0 112.71 176.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.702 ' HG2' ' HD2' ' A' ' 127' ' ' LYS . 3.9 mpt_? -66.21 -88.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.629 ' O ' ' HB3' ' A' ' 85' ' ' TYR . 10.5 mm -111.65 88.82 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.1 -174.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.39 91.01 0.08 OUTLIER Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.496 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.57 93.79 0.29 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.85 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 112.41 165.13 16.98 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 -174.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.056 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 45.6 pt -94.15 155.71 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 117.125 0.463 . . . . 0.0 111.967 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.496 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 2.1 p30 -96.35 147.16 24.1 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.656 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 40.6 t -136.51 99.72 10.52 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 95' ' ' VAL . 38.6 Cg_endo -71.07 106.7 1.95 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.113 1.875 . . . . 0.0 111.412 170.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.586 HG23 HD21 ' A' ' 158' ' ' LEU . 13.4 p -109.65 131.32 21.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.58 144.51 51.93 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.447 2.765 . . . . 0.0 112.747 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -64.49 -22.13 66.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.772 -172.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -86.35 -4.48 59.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 110.516 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 105' ' ' VAL . 16.4 m -114.85 -29.61 6.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.1 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.21 -39.96 70.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.12 -27.12 74.11 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.071 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.534 HG11 HD21 ' A' ' 161' ' ' LEU . 62.1 t -77.95 -33.62 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.08 0.467 . . . . 0.0 109.745 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 101' ' ' SER . 94.3 t -60.19 -39.8 81.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.171 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.411 HD11 ' CZ ' ' A' ' 126' ' ' PHE . 33.6 mm -72.2 -59.05 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.467 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.4 -137.72 14.26 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -98.42 -57.34 2.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.222 0.511 . . . . 0.0 110.014 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 m -105.65 -24.27 12.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.612 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 136.81 20.54 0.59 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.469 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 1.8 mp0 -49.75 -43.68 48.12 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.1 0.476 . . . . 0.0 110.991 -176.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.678 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.2 tpt -76.37 -52.7 9.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.584 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 124' ' ' ILE . 20.1 tt -69.92 -26.26 29.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.743 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.23 -29.28 63.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.552 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.678 ' HG2' ' O ' ' A' ' 112' ' ' MET . 16.5 ptpt -80.04 -22.59 42.2 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.265 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.36 -45.68 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -69.26 -25.29 64.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.625 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -79.39 -39.46 32.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.046 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -78.98 -54.08 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.404 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.446 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -88.23 -15.29 36.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.06 57.46 6.95 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.129 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.9 m -131.62 174.21 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.872 0.368 . . . . 0.0 111.314 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.803 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 86.6 mtt180 -125.04 151.41 45.65 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.669 HG21 HD11 ' A' ' 113' ' ' ILE . 47.8 mm -112.23 136.35 48.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.079 0.466 . . . . 0.0 111.155 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.664 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 3.9 tp-100 -130.72 110.99 11.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.309 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 52.1 m-85 -80.97 102.89 10.43 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.113 171.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.941 ' HE2' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -99.2 164.67 12.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.847 -178.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.44 ' CD ' HH21 ' A' ' 88' ' ' ARG . 4.9 pt20 -46.32 100.26 0.02 OUTLIER 'General case' 0 C--O 1.236 0.382 0 O-C-N 124.146 0.904 . . . . 0.0 110.52 173.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -64.35 149.06 49.02 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.754 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.81 116.45 2.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.189 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.87 75.43 0.74 Allowed Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.861 0.726 . . . . 0.0 113.555 -167.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.415 ' C ' ' HD2' ' A' ' 134' ' ' PRO . 20.2 p -124.63 -32.32 3.12 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.685 0.279 . . . . 0.0 110.765 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 123.33 -69.44 0.45 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.405 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.415 ' HD2' ' C ' ' A' ' 132' ' ' THR . 12.2 Cg_endo -55.22 -65.22 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.394 2.73 . . . . 0.0 114.393 -174.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.17 148.87 21.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.619 . . . . 0.0 111.757 -172.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 97' ' ' VAL . 60.3 mttm -127.46 123.21 35.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.894 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.941 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 6.4 mm -74.13 107.67 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.35 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.656 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -99.4 104.71 16.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.664 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 60.7 t-80 -73.32 133.73 43.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.0 0.428 . . . . 0.0 111.485 -172.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.687 HD13 ' HB3' ' A' ' 150' ' ' ALA . 95.9 mt -101.2 111.83 32.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.887 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.803 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 37.6 ttm -97.19 137.36 36.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.936 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.82 -161.21 29.45 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.011 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -71.39 139.12 34.15 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.982 2.455 . . . . 0.0 111.344 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.94 -47.21 10.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.037 3.158 . . . . 0.0 113.964 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.53 -39.6 91.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 111.155 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.446 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 57.7 mtt180 -76.16 -28.29 57.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.178 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.85 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 73.1 m -56.92 -59.74 4.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.202 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.698 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 31.3 mt-10 -61.58 -39.82 92.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.464 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -54.79 -31.41 58.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.393 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.687 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.34 -34.74 48.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.974 0.416 . . . . 0.0 110.635 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 93' ' ' ILE . . . -71.73 -21.39 61.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.286 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.698 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 8.2 mpt_? -76.74 -30.42 56.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.595 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 58.1 mt -70.13 -51.29 40.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.591 175.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.547 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 67.1 mt -59.04 -44.83 92.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.091 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.28 -32.2 72.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.386 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.86 -35.51 67.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 47.3 mt -62.0 -38.2 87.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.001 176.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.586 HD21 HG23 ' A' ' 97' ' ' VAL . 22.2 mt -61.08 -41.28 96.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.691 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -72.25 -32.13 66.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.949 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 34.7 t -64.84 -40.93 95.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.027 0.441 . . . . 0.0 109.906 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.534 HD21 HG11 ' A' ' 104' ' ' VAL . 93.3 mt -74.19 -22.52 59.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.972 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -73.4 -22.1 60.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.429 173.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.3 m -93.05 93.93 8.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.859 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.443 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.504 -177.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.441 ' HB ' HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -79.4 95.99 5.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.971 0.415 . . . . 0.0 111.405 179.284 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.572 HG22 HG12 ' A' ' 54' ' ' ILE . 38.0 t -125.03 113.62 36.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.5 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -107.32 146.98 30.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.449 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.595 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 42.5 mt-10 -109.03 120.49 42.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.136 0.493 . . . . 0.0 111.507 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.8 mm -108.55 127.17 65.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.038 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 ttm -79.64 119.85 23.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.137 0.494 . . . . 0.0 111.525 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.457 HG12 HG11 ' A' ' 16' ' ' VAL . 1.6 mp -100.48 119.01 59.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.171 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.657 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 50.4 Cg_exo -61.74 148.41 93.13 Favored 'Trans proline' 0 N--CA 1.476 0.451 0 C-N-CA 123.761 2.974 . . . . 0.0 112.609 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.99 135.45 52.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.7 -45.8 1.69 Allowed Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -170.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.836 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -71.41 -34.01 69.96 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.01 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.25 -41.27 60.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.106 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.845 ' HA3' ' HE3' ' A' ' 19' ' ' LYS . . . -61.19 -32.25 79.88 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.957 -0.565 . . . . 0.0 113.221 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.4 pp -91.59 -22.2 20.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.001 0.401 . . . . 0.0 111.401 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.457 HG11 HG12 ' A' ' 8' ' ' ILE . 70.6 t -81.32 -46.56 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.656 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 13' ' ' ALA . 25.0 pt -91.6 -27.29 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.193 0.52 . . . . 0.0 110.383 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.7 132.6 6.43 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.845 ' HE3' ' HA3' ' A' ' 14' ' ' GLY . 30.9 mmtp -63.96 -17.81 63.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.122 0.461 . . . . 0.0 110.693 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.45 13.83 8.26 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.87 -1.09 74.07 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.977 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -53.9 -52.85 59.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 15' ' ' LEU . 19.2 m -62.32 -36.45 82.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.822 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.734 HD12 HD12 ' A' ' 27' ' ' LEU . 2.6 tp -66.7 -33.28 62.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.897 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -57.24 -41.7 80.06 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.433 0.635 . . . . 0.0 110.375 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 30' ' ' ARG . 50.1 mt-30 -71.86 -26.37 62.33 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.229 -176.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.734 HD12 HD12 ' A' ' 24' ' ' ILE . 74.2 mt -81.14 -34.36 32.53 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.08 0.467 . . . . 0.0 110.857 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.85 HE22 ' HB2' ' A' ' 35' ' ' MET . 18.6 mm-40 -84.83 -59.12 2.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.271 0.558 . . . . 0.0 110.843 -176.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.89 -46.17 10.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.722 -172.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.976 HH12 ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -65.84 -52.6 49.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 111.09 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -71.5 -28.95 64.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.642 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.72 17.36 54.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.054 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.5 m -118.39 171.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' HD2' ' OE1' ' A' ' 28' ' ' GLN . 52.7 tptt -114.53 109.47 18.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.832 0.825 . . . . 0.0 109.723 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.85 ' HB2' HE22 ' A' ' 28' ' ' GLN . 48.3 mtt -94.68 112.64 24.38 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.452 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.654 HG23 ' HB2' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -111.01 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.905 0.859 . . . . 0.0 109.219 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.718 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 1.8 pt? -133.46 142.5 48.31 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.041 -173.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.524 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 3.2 mp -66.28 105.13 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.563 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.501 ' HG2' HG21 ' A' ' 17' ' ' ILE . 49.1 mt-30 -85.67 -57.84 2.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.925 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -174.43 118.59 0.22 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.86 -49.86 0.36 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.997 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.3 p -72.16 -75.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.904 0.352 . . . . 0.0 111.616 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -157.55 -35.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.189 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -79.62 67.32 5.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.443 0.639 . . . . 0.0 110.207 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 p -83.34 -57.76 3.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.918 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.19 -14.3 27.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.442 0.639 . . . . 0.0 110.239 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.04 158.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.7 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.89 150.36 16.71 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.394 0.434 . . . . 0.0 110.49 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 64.8 mttt -127.33 123.56 23.33 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.24 -167.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.19 124.44 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.81 2.34 . . . . 0.0 112.891 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.718 ' HA ' ' HB3' ' A' ' 37' ' ' LEU . 7.2 tt -98.98 118.6 36.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.697 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.654 ' HB2' HG23 ' A' ' 36' ' ' ILE . 3.9 mpt_? -97.52 119.4 36.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.644 0.259 . . . . 0.0 110.53 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 56.4 mt -92.46 110.16 22.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.021 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.572 HG12 HG22 ' A' ' 3' ' ' VAL . 27.5 mt -104.55 120.84 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.53 -171.08 44.09 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.028 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.479 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 9.5 t70 -60.73 135.49 92.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 O-C-N 123.786 0.345 . . . . 0.0 110.782 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -43.48 -46.73 9.73 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.174 2.582 . . . . 0.0 114.262 -174.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.48 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 87.3 t80 -64.81 -40.39 95.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.296 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 52.0 mttp -67.52 -42.26 83.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.281 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.441 HG21 ' HB ' ' A' ' 2' ' ' THR . 98.9 t -60.16 -33.49 53.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.674 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -68.71 -50.1 53.54 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.638 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 70.5 mm-40 -65.37 -39.68 92.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.223 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.514 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -63.56 -43.45 97.02 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.773 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.2 m -56.93 -44.36 82.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.761 0.315 . . . . 0.0 110.356 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.99 -42.16 99.76 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.905 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.643 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 5.6 ptt? -77.51 -34.22 54.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.406 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 54.1 t -61.62 -38.69 80.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 110.243 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.8 mtt -69.98 -21.84 63.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.542 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.614 ' HB2' HH21 ' A' ' 82' ' ' ARG . 31.9 t70 -84.84 -59.25 2.4 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.789 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -68.44 -20.04 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.069 -174.013 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.836 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 6.5 tt -76.51 -10.26 59.26 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.309 175.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -65.58 -17.37 64.53 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.917 0.389 . . . . 0.0 110.351 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.497 ' HB3' HD22 ' A' ' 15' ' ' LEU . 10.5 tp10 -56.83 128.43 36.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.522 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -96.7 -20.18 18.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.013 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -122.46 36.63 4.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.648 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 65.08 105.43 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.247 173.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.69 -104.23 0.22 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.753 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 91.26 33.43 8.11 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.541 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 21.0 m-85 67.89 -56.68 0.47 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.215 0.606 . . . . 0.0 111.871 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 115.28 105.79 2.56 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -172.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 2.5 t70 73.39 -61.34 0.5 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.673 0.389 . . . . 0.0 110.354 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.823 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 8.6 ttm180 169.72 -21.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.564 1.165 . . . . 0.0 108.712 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.6 ' HA ' ' OD1' ' A' ' 94' ' ' ASP . 11.4 t-20 66.1 31.89 8.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.611 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 1.077 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 34.4 tt0 -141.07 -40.05 0.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.157 -173.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 20.0 p90 -159.98 -44.07 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.976 ' HA3' HH12 ' A' ' 30' ' ' ARG . . . 65.12 72.74 0.67 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.572 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.774 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 49.7 m 67.67 -37.89 0.34 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 175.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.467 ' HD2' HD13 ' A' ' 89' ' ' ILE . 2.8 tmt_? -68.53 -81.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.981 HD11 ' HG2' ' A' ' 125' ' ' GLN . 31.5 mm -65.97 -80.35 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -168.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.4 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 109.96 73.47 0.75 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -170.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.581 ' H ' ' HD2' ' A' ' 85' ' ' TYR . . . 118.75 161.12 11.66 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.812 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 89.34 -146.66 19.11 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.144 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.077 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 43.4 pt -149.24 162.02 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 172.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.6 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 2.3 p-10 -107.4 140.51 40.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.815 HG23 ' HB3' ' A' ' 138' ' ' ALA . 17.2 m -132.91 95.24 19.4 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.466 0.65 . . . . 0.0 111.472 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 95' ' ' VAL . 12.3 Cg_endo -58.47 108.68 0.42 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.191 2.594 . . . . 0.0 111.899 173.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.731 HG13 HD21 ' A' ' 158' ' ' LEU . 89.8 t -98.2 118.64 63.32 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.447 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.576 ' HD2' HD22 ' A' ' 158' ' ' LEU . 59.9 Cg_exo -41.35 132.57 3.38 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.518 2.812 . . . . 0.0 112.217 172.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -61.19 -26.47 67.74 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.019 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -92.21 6.73 45.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.639 ' HB3' HD21 ' A' ' 161' ' ' LEU . 22.4 m -122.63 -29.14 4.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.553 -176.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.422 ' HA ' HG11 ' A' ' 97' ' ' VAL . 14.1 p -51.55 -30.75 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.08 -44.7 96.14 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.098 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.08 -35.0 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.865 0.364 . . . . 0.0 110.448 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.93 -42.54 95.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.979 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.677 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 48.2 mm -75.49 -45.35 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.892 0.377 . . . . 0.0 110.612 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.12 -147.64 16.86 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.654 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.407 ' HG3' ' N ' ' A' ' 109' ' ' SER . 14.9 ptm180 -108.68 -44.52 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.056 0.455 . . . . 0.0 110.274 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.536 ' HB2' ' HG3' ' A' ' 111' ' ' GLU . 46.2 m -106.6 10.35 31.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.197 0.522 . . . . 0.0 109.748 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.03 28.05 59.23 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.325 -176.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -92.48 -20.35 21.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.362 0.125 . . . . 0.0 111.203 -178.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.435 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 16.7 tpt -74.41 -43.22 57.28 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.677 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 6.2 tp -63.84 -28.24 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.222 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.718 ' HA ' ' HG2' ' A' ' 117' ' ' GLN . 98.8 mttt -78.68 -19.12 53.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.63 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 63.6 mttm -64.76 -31.82 73.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.8 mm -67.78 -38.61 80.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.245 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.718 ' HG2' ' HA ' ' A' ' 114' ' ' LYS . 2.7 mm100 -72.39 -27.23 62.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.04 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.18 -38.63 35.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.399 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -81.29 -54.99 5.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.357 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.0 -5.06 51.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -172.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.88 29.23 67.23 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.727 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.7 m -95.82 177.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.168 0.508 . . . . 0.0 111.549 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -129.41 133.87 47.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.062 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.545 HG12 HE22 ' A' ' 117' ' ' GLN . 47.7 mm -99.72 127.23 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.336 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.981 ' HG2' HD11 ' A' ' 89' ' ' ILE . 5.3 tp-100 -122.64 97.13 5.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.513 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -74.94 106.39 6.43 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.598 ' HE3' ' O ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -125.62 132.3 52.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.157 -177.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 54.66 -171.83 0.05 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 67.54 -34.9 0.25 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.302 1.041 . . . . 0.0 113.263 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -58.18 119.59 7.14 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.452 0.301 . . . . 0.0 110.599 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.87 -37.81 3.31 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.446 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.3 t -91.79 -13.43 31.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.931 0.396 . . . . 0.0 110.546 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.89 173.64 19.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.06 -27.11 4.76 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.113 2.542 . . . . 0.0 112.368 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 5.3 mp0 -114.24 161.95 17.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.962 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -110.46 110.93 21.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 34.1 mm -68.24 102.18 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.181 0.515 . . . . 0.0 111.287 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.815 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -80.82 141.05 35.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.738 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 57.7 t-80 -106.33 115.02 29.49 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.877 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 154' ' ' ILE . 83.7 mt -80.14 110.75 16.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 27.7 ttp -109.06 123.69 49.56 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.018 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.72 -161.12 34.9 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.43 ' HG2' ' CZ ' ' A' ' 146' ' ' ARG . 18.2 Cg_exo -67.58 141.14 54.23 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.689 2.259 . . . . 0.0 111.531 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -44.31 -51.11 7.2 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.799 2.999 . . . . 0.0 114.343 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.58 -38.31 86.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.411 0.624 . . . . 0.0 110.559 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.43 ' CZ ' ' HG2' ' A' ' 143' ' ' PRO . 12.1 ttm180 -72.49 -30.44 64.53 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.253 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.812 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 77.5 m -56.35 -57.97 10.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.913 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 6.4 mm-40 -64.28 -27.75 69.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.679 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -65.92 -29.78 70.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.176 0.512 . . . . 0.0 110.373 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.662 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.2 -34.97 49.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.261 0.553 . . . . 0.0 109.903 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -17.03 64.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.408 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -76.19 -42.1 47.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 0.0 110.193 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.85 -42.28 82.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.952 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.775 HD12 HD11 ' A' ' 140' ' ' ILE . 73.4 mt -67.57 -34.96 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.472 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.589 ' O ' ' HG2' ' A' ' 159' ' ' GLN . 21.2 t-20 -62.46 -48.81 77.99 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.8 -44.58 70.29 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.094 176.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.11 -52.95 62.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.415 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.731 HD21 HG13 ' A' ' 97' ' ' VAL . 86.1 mt -62.45 -29.5 70.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.372 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 155' ' ' ASN . 26.6 mm-40 -81.55 -42.94 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.963 0.411 . . . . 0.0 111.131 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.7 p -67.51 -43.39 80.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.912 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.639 HD21 ' HB3' ' A' ' 101' ' ' SER . 4.5 pp -70.48 -17.58 62.97 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -175.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 159' ' ' GLN . 3.4 ptm180 -100.44 12.25 37.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.05 0.452 . . . . 0.0 110.699 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.9 m -153.59 -167.97 2.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.286 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.673 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.64 93.48 7.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 47.5 t -126.95 112.72 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.676 171.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -113.41 144.91 42.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.056 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.582 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 41.2 mt-10 -109.52 111.77 23.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.243 0.544 . . . . 0.0 111.654 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.3 mp -105.2 139.07 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.401 ' HB3' ' OD2' ' A' ' 48' ' ' ASP . 54.2 mtp -95.71 123.73 39.41 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.265 0.555 . . . . 0.0 110.645 -174.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.758 HG12 HG11 ' A' ' 16' ' ' VAL . 1.6 mp -96.98 114.8 65.24 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.725 -175.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.84 147.94 92.06 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.771 2.981 . . . . 0.0 113.007 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.36 132.37 47.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 168.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.53 -44.16 1.59 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -170.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -72.05 -26.32 62.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.008 0.432 . . . . 0.0 110.003 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.6 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.31 -32.55 25.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.472 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.445 ' O ' ' HA2' ' A' ' 18' ' ' GLY . . . -60.98 -38.53 95.65 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.566 -0.825 . . . . 0.0 112.903 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.777 HD21 ' HB2' ' A' ' 73' ' ' GLU . 3.5 pp -91.01 -27.23 18.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.405 0.602 . . . . 0.0 111.419 176.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.758 HG11 HG12 ' A' ' 8' ' ' ILE . 75.8 t -70.04 -58.93 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.645 HG13 ' H ' ' A' ' 19' ' ' LYS . 37.9 pt -91.77 -22.64 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.67 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . 84.42 19.41 60.43 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.645 ' H ' HG13 ' A' ' 17' ' ' ILE . 32.9 mmtp 65.6 -68.76 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.671 0.788 . . . . 0.0 111.314 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.55 5.9 79.47 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.69 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.78 10.09 58.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.769 177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 27.7 tt0 -66.25 -39.15 89.29 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.809 -0.23 . . . . 0.0 111.513 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.539 HG21 ' O ' ' A' ' 15' ' ' LEU . 20.5 m -77.25 -33.88 55.95 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.317 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.511 HD13 ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -67.06 -29.99 48.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.901 178.184 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.554 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 10.7 ttmm -49.68 -55.23 14.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.66 0.743 . . . . 0.0 109.098 168.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.405 ' HB3' ' CB ' ' A' ' 81' ' ' ASP . 41.4 mt-30 -70.32 -39.3 74.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.493 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 32.1 mt -66.61 -25.61 66.69 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.945 -0.472 . . . . 0.0 111.488 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 43.8 mt-30 -85.73 -41.17 15.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.732 0.301 . . . . 0.0 111.352 173.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 25' ' ' LYS . 12.4 mm-40 -86.66 -55.25 3.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -175.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.695 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 6.9 ttm180 -67.1 -50.59 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.198 0.523 . . . . 0.0 110.865 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' A' ' 87' ' ' SER . . . -70.13 -9.99 57.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.415 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.54 23.0 60.01 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.999 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.685 HG21 HG23 ' A' ' 53' ' ' ILE . 34.2 m -132.2 155.57 41.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -89.98 109.1 20.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.588 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 58.4 mtt -96.71 116.03 28.43 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.432 HD13 ' C ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -109.58 107.12 22.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 122.322 1.058 . . . . 0.0 108.79 178.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.997 HD13 HD12 ' A' ' 51' ' ' LEU . 1.3 pt? -133.47 144.85 49.71 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.013 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.87 HG23 ' HB2' ' A' ' 42' ' ' SER . 2.5 mp -56.95 122.08 5.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 123.507 0.504 . . . . 0.0 110.145 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -129.91 -159.58 0.97 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.64 99.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.536 0.684 . . . . 0.0 110.346 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.84 -39.24 0.5 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.87 ' HB2' HG23 ' A' ' 38' ' ' ILE . 16.8 m -88.31 171.92 9.81 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -89.84 -13.74 35.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.884 0.373 . . . . 0.0 111.486 -171.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.827 ' HB2' HG21 ' A' ' 38' ' ' ILE . 94.8 m-20 -87.68 34.9 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -176.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -64.97 -46.13 82.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -85.26 -14.44 46.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.594 0.711 . . . . 0.0 109.76 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.52 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 35.5 t -79.66 156.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.462 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 7' ' ' MET . 11.2 t70 -66.81 131.13 45.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 173.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.675 ' HD2' ' O ' ' A' ' 38' ' ' ILE . 26.8 mtmm -121.68 125.97 26.59 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -165.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.525 ' HD2' HD13 ' A' ' 38' ' ' ILE . 88.3 Cg_endo -80.57 130.67 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.581 2.187 . . . . 0.0 112.313 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.997 HD12 HD13 ' A' ' 37' ' ' LEU . 6.8 tt -108.37 128.59 54.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.695 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.1 mpt_? -97.62 118.94 35.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.481 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.685 HG23 HG21 ' A' ' 33' ' ' VAL . 59.9 mt -88.08 109.51 19.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.476 HG12 HG22 ' A' ' 3' ' ' VAL . 29.4 mt -110.39 119.12 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.86 -170.61 43.54 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.834 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.457 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 7.5 t70 -64.72 137.79 97.25 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 122.781 0.432 . . . . 0.0 110.914 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -40.3 -49.13 3.97 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.601 2.867 . . . . 0.0 113.964 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -63.46 -45.42 90.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.765 0.317 . . . . 0.0 110.724 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 46.2 mttm -62.95 -43.74 97.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.848 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 53' ' ' ILE . 90.9 t -63.52 -29.25 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.633 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 5.9 tm0? -80.5 -46.28 16.1 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -173.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -66.99 -32.57 73.89 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.46 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.744 ' HA ' ' SD ' ' A' ' 66' ' ' MET . . . -70.42 -45.02 66.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 61' ' ' GLN . 26.5 p -63.02 -27.23 69.27 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.311 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.05 -47.54 28.43 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.202 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.744 ' SD ' ' HA ' ' A' ' 63' ' ' ALA . 6.6 ptm -69.13 -38.58 78.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.439 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 26.9 m -63.4 -31.79 54.18 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-N 117.961 0.346 . . . . 0.0 111.326 -178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.7 mtt -81.18 -20.75 40.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.402 0.62 . . . . 0.0 109.959 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 21.1 t70 -83.16 -52.62 6.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.214 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.858 HG22 ' HB2' ' A' ' 79' ' ' PHE . 2.7 pp -72.51 -21.43 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 111.363 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 70' ' ' ILE . 6.1 tt -85.9 -4.18 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 12.3 ptm180 -51.87 -42.02 62.33 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.923 ' HG3' ' HA ' ' A' ' 76' ' ' GLN . 26.0 tt0 60.93 101.53 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.449 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.2 ttm105 -101.64 -36.92 8.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.037 170.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -119.81 8.32 11.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.128 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.923 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . 44.6 tt0 68.57 12.29 8.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.789 0.804 . . . . 0.0 110.915 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.06 -19.56 6.74 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 64.15 -102.64 0.61 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.858 ' HB2' HG22 ' A' ' 70' ' ' ILE . 87.8 m-85 -135.83 -29.23 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.231 0.515 . . . . 0.0 110.624 173.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.42 79.91 1.47 Allowed Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.695 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER 71.18 -60.52 0.51 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 124.499 0.764 . . . . 0.0 110.353 -172.225 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 4.8 ttm-85 142.65 91.74 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 126.204 1.802 . . . . 0.0 108.117 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -67.92 52.04 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.038 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.953 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 33.4 mt-10 -152.13 -45.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.747 -176.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 88' ' ' ARG . 33.1 p90 -177.44 144.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 111.306 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.522 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -128.51 -94.34 0.79 Allowed Glycine 0 C--O 1.221 -0.659 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 174.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.659 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 19.6 p -87.52 13.27 10.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.17 0.509 . . . . 0.0 110.2 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.667 ' CG ' ' HD3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -143.23 174.63 10.55 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.329 -170.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.579 HG12 ' ND1' ' A' ' 139' ' ' HIS . 8.9 mt 59.46 -80.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.768 173.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.73 41.07 89.73 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 141' ' ' MET . . . 151.38 66.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.736 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 168.22 -142.79 7.69 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.953 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 38.9 pt -142.7 143.83 25.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 117.277 0.538 . . . . 0.0 111.262 176.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.442 ' OD2' HG21 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -89.95 126.77 35.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.541 177.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 70.2 t -116.38 95.22 44.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.52 ' CA ' HD13 ' A' ' 137' ' ' ILE . 38.1 Cg_endo -71.28 106.51 1.94 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 121.4 1.4 . . . . 0.0 111.276 169.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 136' ' ' LYS . 10.7 p -104.47 129.39 25.12 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 121.229 0.538 . . . . 0.0 110.169 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.655 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 52.9 Cg_exo -52.79 128.83 30.04 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.221 2.614 . . . . 0.0 112.624 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.508 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 0.6 OUTLIER -57.43 -25.57 59.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.904 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -92.09 16.36 11.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.605 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.542 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 2.7 p -155.97 12.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 p -77.01 -20.57 14.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.464 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.13 -33.59 86.31 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.92 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.8 ' HB ' HD11 ' A' ' 161' ' ' LEU . 7.3 p -74.99 -24.02 17.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.063 0.459 . . . . 0.0 110.412 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 97' ' ' VAL . 30.9 t -72.88 -37.62 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.064 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 46.7 mm -84.26 -38.99 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.425 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.29 -133.56 11.65 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -102.4 -74.03 0.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.915 0.388 . . . . 0.0 110.443 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.534 ' HB2' ' OE1' ' A' ' 111' ' ' GLU . 30.5 m -89.38 -4.73 57.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.894 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.494 ' O ' HG22 ' A' ' 113' ' ' ILE . . . 114.01 6.74 20.35 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.06 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' HB2' ' A' ' 109' ' ' SER . 1.1 mp0 -65.16 -24.02 67.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 104' ' ' VAL . 15.8 tpt -76.49 -40.61 49.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.402 . . . . 0.0 110.907 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.636 HD11 HG21 ' A' ' 124' ' ' ILE . 6.6 tp -70.02 -32.34 51.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 88.7 mttt -71.29 -29.32 64.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.429 0.633 . . . . 0.0 109.642 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.512 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 7.0 ttmt -66.28 -36.85 84.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.746 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.5 mt -65.1 -39.72 86.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.148 0.499 . . . . 0.0 109.709 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.415 ' NE2' ' HA ' ' A' ' 114' ' ' LYS . 14.4 mt-30 -63.93 -24.84 67.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.428 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -87.01 -50.54 6.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.235 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.02 -40.06 32.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.153 -172.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.58 -16.69 20.91 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.266 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.7 42.11 62.81 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.4 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.9 150.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.09 0.471 . . . . 0.0 111.628 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -96.74 122.35 39.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.56 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.636 HG21 HD11 ' A' ' 113' ' ' ILE . 50.0 mm -109.44 141.85 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.942 0.401 . . . . 0.0 111.998 -170.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.756 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 1.9 pt20 -158.89 144.13 16.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -96.82 107.5 19.99 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.744 -0.597 . . . . 0.0 109.741 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.667 ' HD3' ' CG ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -112.55 134.0 54.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.458 -171.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 61.55 -78.83 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.962 0.789 . . . . 0.0 112.892 174.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HA ' ' OG1' ' A' ' 132' ' ' THR . 10.4 m-20 -76.59 72.01 3.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.32 0.581 . . . . 0.0 112.04 -171.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -142.06 98.6 3.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.07 -7.45 81.6 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.988 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 129' ' ' ASP . 33.8 p -90.65 -38.01 13.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.171 0.51 . . . . 0.0 110.52 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.77 -178.11 15.21 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.532 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.508 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 20.5 Cg_endo -64.31 -61.96 0.1 Allowed 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.424 2.083 . . . . 0.0 112.508 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.655 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 0.4 OUTLIER -86.13 155.6 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.833 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.617 ' O ' HG12 ' A' ' 97' ' ' VAL . 74.0 mttt -110.96 113.56 26.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.199 -175.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 4.9 mm -79.19 115.1 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.186 0.517 . . . . 0.0 111.711 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . . . -87.31 142.34 27.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.666 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.756 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 3.9 t60 -86.95 107.69 18.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.12 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.557 HD13 ' HB3' ' A' ' 150' ' ' ALA . 23.1 mt -105.42 121.99 58.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 172.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 91' ' ' GLY . 43.7 ttp -129.82 139.71 51.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 -176.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.5 -155.01 25.92 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.3 139.25 37.93 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.475 2.117 . . . . 0.0 111.174 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.29 -47.93 8.53 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 123.691 2.927 . . . . 0.0 113.229 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.28 -48.2 82.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.484 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -66.86 -29.97 70.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.837 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.736 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 66.9 m -59.31 -62.43 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.72 -42.79 89.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.882 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.508 ' O ' HG13 ' A' ' 153' ' ' ILE . 11.9 t-160 -58.49 -24.75 61.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.235 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.557 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -81.06 -52.36 7.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.27 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.05 -26.14 68.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -79.66 -19.04 50.01 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.798 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 149' ' ' HIS . 78.4 mt -72.06 -42.53 67.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 167.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.686 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 71.1 mt -61.07 -49.95 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.358 176.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -53.12 -40.22 64.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.529 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.25 -43.73 95.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.883 0.373 . . . . 0.0 110.564 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.03 -39.81 94.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.406 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 33.3 mt -65.48 -36.57 84.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.564 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -79.36 -15.99 57.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.416 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 33.6 t -79.38 -36.43 39.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.131 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.8 HD11 ' HB ' ' A' ' 104' ' ' VAL . 38.5 mt -88.07 -41.36 13.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.852 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 68.93 -73.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.078 0.862 . . . . 0.0 110.451 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.7 t -136.87 126.23 24.93 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.677 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.622 179.101 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.429 ' HB ' HG21 ' A' ' 60' ' ' VAL . 9.9 m -85.81 119.97 26.71 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 78.8 t -127.91 125.95 65.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.077 0.465 . . . . 0.0 111.186 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -122.43 145.16 48.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.837 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 67.3 mt-10 -111.84 126.7 55.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.48 0.657 . . . . 0.0 112.222 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -119.74 126.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 173.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 ttm -82.34 125.08 30.6 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.019 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.642 HG12 HG11 ' A' ' 16' ' ' VAL . 1.6 mp -101.05 119.37 58.23 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.617 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.642 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 51.2 Cg_exo -60.27 154.5 52.04 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.582 2.854 . . . . 0.0 113.047 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 129.76 39.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.63 -38.6 3.04 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -170.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.66 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -70.6 -30.76 67.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.601 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -54.67 -35.08 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.618 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.51 -32.57 73.52 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.157 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.755 ' HB3' ' HA ' ' A' ' 76' ' ' GLN . 0.8 OUTLIER -91.48 -25.91 19.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 117.069 0.435 . . . . 0.0 111.433 177.005 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.642 HG11 HG12 ' A' ' 8' ' ' ILE . 85.5 t -77.32 -48.84 23.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.704 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.706 HG13 ' H ' ' A' ' 19' ' ' LYS . 36.8 pt -91.93 -15.42 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.199 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.528 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 90.51 5.47 69.3 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.706 ' H ' HG13 ' A' ' 17' ' ' ILE . 13.6 tptm 65.27 -64.4 0.18 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.31 1.044 . . . . 0.0 110.645 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.09 -6.76 88.77 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 108.11 3.14 33.8 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.663 174.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.72 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 34.9 tt0 -62.41 -45.37 93.44 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.434 0.617 . . . . 0.0 111.981 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.528 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 25.7 m -71.27 -37.81 71.89 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.566 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.714 HD12 HD12 ' A' ' 27' ' ' LEU . 4.9 tp -64.76 -25.55 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.802 0.334 . . . . 0.0 110.381 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.72 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 76.0 mttt -58.77 -46.95 86.32 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.63 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -68.33 -39.07 82.06 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.917 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.714 HD12 HD12 ' A' ' 24' ' ' ILE . 39.1 mt -66.63 -26.89 67.29 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.135 -0.353 . . . . 0.0 110.922 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.736 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 29.2 mt-30 -85.52 -52.1 6.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -86.58 -55.29 3.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.54 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.635 HH22 ' HA ' ' A' ' 83' ' ' ASN . 2.7 mtp180 -62.61 -47.88 81.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.169 0.509 . . . . 0.0 111.269 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -78.16 -2.81 39.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.695 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.12 22.02 41.27 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.765 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.736 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.3 m -133.74 153.66 37.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -93.55 109.24 20.86 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.956 ' HB3' HD21 ' A' ' 51' ' ' LEU . 46.9 mtt -93.47 113.89 26.14 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.413 HD13 ' C ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -109.96 107.96 24.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 122.46 1.124 . . . . 0.0 109.464 -177.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.705 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.1 pt? -133.36 142.81 48.59 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.014 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.9 mm -64.5 98.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.115 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.44 ' HG2' HG21 ' A' ' 17' ' ' ILE . 78.1 mt-30 -82.03 -59.8 2.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -122.12 -176.94 3.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.636 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.632 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . 105.6 157.37 22.49 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -82.24 28.97 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -105.41 -96.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -100.28 58.5 0.98 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 1.6 t -61.95 -61.19 2.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.508 -174.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.521 ' H ' HG23 ' A' ' 45' ' ' THR . 66.1 t30 -96.03 -22.43 17.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.834 -0.541 . . . . 0.0 111.316 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 m -83.85 -168.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -169.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.14 147.97 23.33 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.347 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -135.14 133.98 21.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.887 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.07 111.13 1.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.691 2.261 . . . . 0.0 111.578 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.956 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.0 tm? -88.46 111.76 22.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.239 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 35' ' ' MET . 5.3 mpt_? -98.69 111.02 23.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.923 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.2 mt -85.95 110.42 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.595 HG12 HG22 ' A' ' 3' ' ' VAL . 21.1 mt -110.18 119.93 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.202 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.522 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.72 -170.44 43.36 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.032 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.945 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 7.3 m-20 -61.56 141.9 94.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 122.487 0.315 . . . . 0.0 110.646 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 54.1 Cg_exo -50.53 -51.69 10.54 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.403 2.736 . . . . 0.0 114.174 -169.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -57.02 -44.55 82.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.065 0.459 . . . . 0.0 110.44 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.945 ' HE2' ' HB2' ' A' ' 56' ' ' ASP . 42.1 mtmt -68.58 -40.57 80.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.759 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 2' ' ' THR . 88.3 t -61.93 -35.65 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.463 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -66.03 -54.25 28.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -65.43 -27.48 68.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.546 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -79.7 -36.53 37.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 68' ' ' MET . 38.1 t -56.82 -42.4 79.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.075 0.464 . . . . 0.0 110.005 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.47 -26.69 38.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.448 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.656 ' HA ' ' HE ' ' A' ' 82' ' ' ARG . 9.9 ptp -66.37 -48.02 71.49 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.462 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.635 ' N ' ' HG3' ' A' ' 66' ' ' MET . 91.9 t -59.83 -47.61 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.815 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 64' ' ' CYS . 19.9 ptp -70.57 -20.59 62.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.924 0.392 . . . . 0.0 111.12 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 25.3 t70 -85.98 -44.2 12.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -81.82 -21.37 10.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.901 -0.719 . . . . 0.0 111.053 -177.471 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.717 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.2 pp -77.02 -2.71 35.36 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.229 174.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 8.4 ptp180 -63.88 -19.95 65.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.278 0.561 . . . . 0.0 109.531 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.593 ' HG2' ' N ' ' A' ' 77' ' ' GLY . 9.5 tp10 -52.47 144.17 13.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.338 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -87.63 -60.1 2.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.013 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -113.61 55.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.7 -173.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.755 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 62.2 tt0 69.39 114.09 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.739 0.78 . . . . 0.0 112.545 173.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.593 ' N ' ' HG2' ' A' ' 73' ' ' GLU . . . 157.3 -96.35 0.15 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.476 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.7 -99.2 1.48 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.588 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -141.29 -41.42 0.38 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.868 0.366 . . . . 0.0 110.053 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 91.25 91.62 1.35 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -171.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 3.4 t70 70.57 -69.89 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -165.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.656 ' HE ' ' HA ' ' A' ' 66' ' ' MET . 20.8 ttm-85 171.62 -40.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.763 0.825 . . . . 0.0 109.129 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.635 ' HA ' HH22 ' A' ' 30' ' ' ARG . 4.7 t30 61.87 59.13 1.79 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.629 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 1.06 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 44.9 tt0 -173.95 -38.5 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.275 -173.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.434 ' CB ' ' H ' ' A' ' 90' ' ' GLY . 5.6 p90 -168.4 90.16 0.27 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.626 166.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.603 ' HA2' ' HE1' ' A' ' 66' ' ' MET . . . -83.87 96.94 2.01 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 170.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.617 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 61.3 p 66.84 -53.69 0.45 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.112 1.365 . . . . 0.0 111.896 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 6.0 mmt180 -97.42 -167.2 1.5 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.019 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.661 HG23 ' ND1' ' A' ' 139' ' ' HIS . 71.0 mt 75.52 -66.44 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 124.083 0.864 . . . . 0.0 111.085 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.434 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 50.42 61.03 6.23 Favored Glycine 0 N--CA 1.451 -0.352 0 O-C-N 123.691 0.619 . . . . 0.0 112.497 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.34 88.89 1.02 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.878 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 154.36 -128.06 2.27 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.06 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 31.1 pt -148.37 154.39 10.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -89.03 128.05 35.71 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 53.5 t -119.1 96.72 50.3 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.872 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.512 ' CA ' HD13 ' A' ' 137' ' ' ILE . 60.1 Cg_endo -77.38 107.54 2.42 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.786 1.657 . . . . 0.0 110.941 174.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 102' ' ' VAL . 21.7 t -100.64 124.43 42.4 Favored Pre-proline 0 C--N 1.319 -0.74 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.205 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.1 129.53 22.01 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.589 2.193 . . . . 0.0 110.742 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -57.57 -28.51 63.64 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -172.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -80.67 -7.26 59.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.752 0.311 . . . . 0.0 110.877 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 m -113.31 -27.27 8.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.71 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.404 ' HA ' HG11 ' A' ' 97' ' ' VAL . 12.1 p -57.44 -30.08 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 111.596 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.49 -34.72 89.95 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.091 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.586 HG21 HD21 ' A' ' 161' ' ' LEU . 43.8 t -74.14 -29.42 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.024 0.44 . . . . 0.0 110.273 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -34.99 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.149 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.9 mm -84.13 -47.89 17.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.2 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.39 -116.42 5.51 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.549 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -128.7 -54.31 1.23 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.141 0.496 . . . . 0.0 110.009 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 m -105.1 20.55 18.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.297 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.1 18.15 76.26 Favored Glycine 0 C--O 1.224 -0.475 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.46 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.484 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 6.0 tp10 -68.49 -37.06 79.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.993 0.425 . . . . 0.0 111.092 -174.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.6 tpt -69.68 -43.39 72.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.693 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.44 HD11 ' CB ' ' A' ' 124' ' ' ILE . 19.8 tt -67.31 -27.03 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.155 0.502 . . . . 0.0 111.032 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 50.4 mtpt -65.12 -32.03 73.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.421 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -72.3 -32.33 66.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 113' ' ' ILE . 10.8 mm -63.98 -50.59 76.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -62.84 -29.72 70.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.287 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -79.84 -38.7 32.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.601 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -79.5 -38.91 33.31 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.786 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.456 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -96.65 -11.25 25.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 111.49 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.4 23.35 75.8 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.592 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.03 173.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.337 . . . . 0.0 111.425 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 31.6 mtp180 -136.24 141.04 43.91 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 173.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.44 ' CB ' HD11 ' A' ' 113' ' ' ILE . 36.5 mm -110.26 138.67 37.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.524 0.678 . . . . 0.0 112.561 -171.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 138.17 44.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.148 171.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -84.86 105.28 15.52 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.72 ' HE2' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -94.82 -166.13 1.42 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.298 -169.042 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.429 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 27.7 tp60 -69.17 75.55 0.34 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.618 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.497 ' OD2' ' HA ' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -163.79 81.35 0.43 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.377 172.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.51 53.8 2.92 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.743 0.783 . . . . 0.0 109.377 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.61 81.1 1.0 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.198 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.6 p -82.67 1.04 40.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.31 0.576 . . . . 0.0 110.662 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.48 -64.33 0.93 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.608 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -87.56 -84.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.677 2.251 . . . . 0.0 113.185 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -143.8 165.84 26.57 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.356 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -123.08 118.21 27.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.728 0.299 . . . . 0.0 110.353 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.72 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 18.8 mm -70.14 124.22 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 111.966 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -102.39 140.66 36.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.298 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.661 ' ND1' HG23 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -83.54 112.09 19.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.602 178.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.765 HD13 ' HB3' ' A' ' 150' ' ' ALA . 24.7 mt -91.81 123.76 44.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.66 169.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.492 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 44.5 ttm -102.71 136.75 41.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.75 -169.98 24.16 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.126 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 14.5 Cg_exo -70.29 139.1 37.61 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.109 2.539 . . . . 0.0 111.166 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 143' ' ' PRO . 87.0 Cg_exo -48.6 -32.92 22.52 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.24 3.293 . . . . 0.0 114.456 -174.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.1 -43.1 68.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.001 0.429 . . . . 0.0 110.781 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 49.8 mtt180 -72.36 -26.34 61.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.062 0.458 . . . . 0.0 110.03 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.612 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 92.7 m -55.91 -58.04 9.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.801 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.85 -30.02 71.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.911 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.428 ' O ' HG13 ' A' ' 153' ' ' ILE . 4.2 t60 -57.86 -35.73 71.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.311 0.577 . . . . 0.0 110.214 176.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.765 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.6 -38.35 40.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.905 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.82 -25.16 67.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.58 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -79.15 -25.0 42.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.237 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.44 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 42.1 mt -73.35 -37.74 52.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 57.3 mt -71.77 -33.33 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.176 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -63.68 -40.52 97.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.746 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.29 -30.45 71.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.703 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 26.9 mt -66.08 -32.15 73.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.981 0.42 . . . . 0.0 110.096 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.44 -35.69 81.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.879 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -73.15 -36.97 66.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.921 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.6 p -71.34 -21.06 62.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.588 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.586 HD21 HG21 ' A' ' 104' ' ' VAL . 70.1 mt -77.01 17.85 0.41 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -87.91 -5.06 58.75 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.8 t -122.44 144.34 49.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.956 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.731 -177.239 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.6 m -79.27 135.29 36.72 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 89.1 t -133.91 131.34 56.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.458 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -134.52 149.2 50.65 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 46.4 mt-10 -106.49 135.76 47.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.23 0.538 . . . . 0.0 111.741 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.0 mp -119.22 148.15 22.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -92.33 114.25 26.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.707 0.289 . . . . 0.0 111.369 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.571 ' CD1' ' HB2' ' A' ' 51' ' ' LEU . 2.3 mp -100.14 108.01 50.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.101 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 12' ' ' LYS . 7.3 Cg_exo -75.92 155.0 38.65 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.939 2.426 . . . . 0.0 111.474 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.17 128.97 38.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.04 -34.56 5.36 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -169.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HA ' ' HG ' ' A' ' 15' ' ' LEU . 10.0 mptt -94.53 -4.39 48.09 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.129 0.49 . . . . 0.0 110.747 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.689 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -61.61 -43.06 99.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.548 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.25 -11.15 55.08 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.831 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.609 ' CD1' ' HB3' ' A' ' 73' ' ' GLU . 34.1 mt -84.84 -47.8 9.99 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.485 HG21 ' CG1' ' A' ' 8' ' ' ILE . 65.1 t -78.06 -44.58 27.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.989 -176.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.847 HG13 ' H ' ' A' ' 19' ' ' LYS . 23.3 pt -90.77 -15.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 121.54 -0.725 . . . . 0.0 110.468 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.45 -1.19 89.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.783 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.847 ' H ' HG13 ' A' ' 17' ' ' ILE . 14.3 tptm 72.9 -44.04 0.58 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.015 0.926 . . . . 0.0 110.702 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.95 -11.04 55.72 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.914 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.81 -9.03 29.84 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.447 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 10.5 mp0 -54.09 -49.29 69.41 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.954 0.502 . . . . 0.0 112.33 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 15' ' ' LEU . 26.4 m -70.11 -43.42 71.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 24' ' ' ILE . 6.0 tp -61.99 -25.9 38.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.331 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 42.6 mttm -62.68 -42.59 99.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.496 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.503 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 49.2 mt-30 -83.55 -29.16 28.07 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.003 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.578 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 82.7 mt -65.89 -24.8 66.93 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.541 -0.725 . . . . 0.0 109.683 171.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.768 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.2 mt-30 -86.1 -55.42 3.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.618 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -80.76 -45.4 17.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.574 ' NH2' ' HA ' ' A' ' 83' ' ' ASN . 11.4 mtp180 -76.06 -42.08 48.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.631 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -82.87 -9.07 59.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.122 0.486 . . . . 0.0 110.425 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.04 20.95 71.32 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.456 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.768 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 31.4 m -134.7 163.1 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -100.24 110.28 22.52 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 1.0 ' HB3' HD11 ' A' ' 51' ' ' LEU . 51.4 mtt -93.59 114.52 26.88 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' C ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -110.85 108.02 24.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 122.399 1.095 . . . . 0.0 109.302 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.66 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.3 pt? -133.68 142.64 48.11 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.262 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 38' ' ' ILE . 3.5 mp -64.31 101.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.208 0.528 . . . . 0.0 111.107 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -99.29 -58.47 1.93 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -95.42 159.81 14.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.429 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.58 117.03 3.36 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.072 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 t -74.28 78.73 1.83 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.313 0.578 . . . . 0.0 110.775 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -142.65 -54.46 0.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.783 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 14.5 m120 -118.58 39.79 3.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.659 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 p -70.71 -61.5 1.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.832 0.349 . . . . 0.0 111.232 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -91.29 -4.08 56.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.498 0.666 . . . . 0.0 109.968 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.588 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 39.3 t -90.72 160.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.328 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 47' ' ' VAL . 3.8 p-10 -58.3 145.65 37.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.165 0.507 . . . . 0.0 109.706 171.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 128.21 26.04 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.704 -169.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.42 113.29 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.793 2.329 . . . . 0.0 112.13 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.0 HD11 ' HB3' ' A' ' 35' ' ' MET . 48.7 tp -85.58 105.34 16.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.226 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -89.52 101.6 14.28 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.33 174.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.4 mt -83.63 109.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 3' ' ' VAL . 14.5 mt -107.95 119.47 57.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.152 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.525 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.77 -169.97 42.98 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.265 -1.445 . . . . 0.0 113.697 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HB3' ' HD2' ' A' ' 59' ' ' LYS . 13.1 t70 -55.02 136.05 67.18 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 114.642 -0.779 . . . . 0.0 110.642 174.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 33.0 Cg_exo -57.34 -34.32 97.7 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.496 2.797 . . . . 0.0 113.813 -173.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.461 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 68.4 t80 -72.37 -35.64 68.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.556 0.693 . . . . 0.0 109.419 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' HD2' ' HB3' ' A' ' 56' ' ' ASP . 53.3 mttp -76.84 -41.62 43.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.768 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG22 HG22 ' A' ' 53' ' ' ILE . 95.1 t -59.72 -36.61 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.11 176.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -56.55 17.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.45 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 72.9 mm-40 -67.05 -34.52 77.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.067 -176.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -69.98 -44.77 68.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.21 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.9 t -56.74 -35.05 68.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.498 0.666 . . . . 0.0 109.584 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' HG2' ' NH2' ' A' ' 82' ' ' ARG . 33.9 tt0 -72.61 -33.83 66.95 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.013 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.769 ' HA ' ' HE ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -74.98 -37.52 61.87 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.347 177.088 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.616 ' N ' ' HG3' ' A' ' 66' ' ' MET . 85.0 t -56.34 -52.35 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.277 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.3 mtp -62.57 -21.01 65.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.892 0.377 . . . . 0.0 111.077 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 30.6 t70 -79.37 -56.18 4.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.614 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.908 HG21 ' H ' ' A' ' 82' ' ' ARG . 2.1 pp -81.7 -21.38 10.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 71' ' ' LEU . 6.4 tt -84.8 -10.64 57.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.333 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 4.4 ptp180 -66.15 -11.44 49.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.078 0.466 . . . . 0.0 110.342 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.609 ' HB3' ' CD1' ' A' ' 15' ' ' LEU . 10.0 tp10 -50.64 142.22 11.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.13 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 74' ' ' ARG . 11.4 mmt180 -80.77 -49.39 11.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.469 -175.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -171.98 20.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.828 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -109.6 -86.46 0.53 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.079 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -151.56 -24.56 0.05 OUTLIER Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.774 -1.203 . . . . 0.0 114.543 -173.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.37 -127.23 8.78 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.826 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' HD2' HG22 ' A' ' 70' ' ' ILE . 70.3 m-85 -133.1 -60.28 0.86 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.962 0.411 . . . . 0.0 110.121 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.52 76.78 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 26' ' ' GLN . 3.9 m-20 54.6 44.38 28.77 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.119 0.962 . . . . 0.0 109.184 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.908 ' H ' HG21 ' A' ' 70' ' ' ILE . 30.8 ttm-85 69.06 -45.52 0.55 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.624 -1.625 . . . . 0.0 112.353 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.574 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 6.2 t30 61.21 63.64 1.2 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.616 0.722 . . . . 0.0 109.233 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 1.045 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 37.0 tt0 -177.17 -41.72 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.428 -170.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.0 p90 175.08 151.36 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.643 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.34 -12.96 1.75 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.88 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 6.3 p -172.88 -57.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.809 0.814 . . . . 0.0 108.815 -174.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.47 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -73.5 -178.44 3.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.473 170.225 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.805 HG22 ' H ' ' A' ' 91' ' ' GLY . 68.1 mt 74.13 -82.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 167.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.03 41.49 94.49 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.649 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.805 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 153.45 91.15 0.08 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.681 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.684 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 158.63 -132.96 3.25 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 175.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.045 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 27.7 pt -147.19 165.94 6.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 169.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.554 ' HB3' ' CG2' ' A' ' 137' ' ' ILE . 19.8 m-20 -111.36 132.18 54.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.86 HG23 ' HB3' ' A' ' 138' ' ' ALA . 2.6 m -120.86 95.28 48.97 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 120.965 0.412 . . . . 0.0 111.015 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.77 108.73 1.95 Allowed 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 122.99 2.46 . . . . 0.0 110.946 173.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.648 HG21 HG21 ' A' ' 105' ' ' VAL . 14.0 p -116.64 127.58 26.63 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.861 0.363 . . . . 0.0 111.123 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.427 ' N ' ' HG2' ' A' ' 135' ' ' GLU . 6.9 Cg_endo -50.42 131.56 32.52 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.385 2.723 . . . . 0.0 112.406 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' HG12 ' A' ' 102' ' ' VAL . 15.7 ptt180 -64.22 -25.45 68.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.51 -171.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.84 -4.77 57.28 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.373 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.0 m -123.82 -10.14 7.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.758 0.313 . . . . 0.0 111.548 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 99' ' ' ARG . 12.5 p -63.83 -28.07 44.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 110.387 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.66 -30.03 71.31 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.957 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.0 t -76.53 -36.44 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.41 . . . . 0.0 110.079 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.648 HG21 HG21 ' A' ' 97' ' ' VAL . 54.2 t -69.7 -37.45 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.446 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.736 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 45.7 mm -76.55 -46.92 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.177 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.28 170.23 25.91 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -70.94 -53.15 16.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.103 0.478 . . . . 0.0 110.188 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -87.88 -6.93 57.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.182 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.69 29.06 27.66 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.687 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 78.7 mm-40 -88.99 -25.73 21.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.659 0.266 . . . . 0.0 110.743 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.529 ' SD ' ' HD2' ' A' ' 115' ' ' LYS . 17.4 tpt -68.79 -40.61 79.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.902 0.382 . . . . 0.0 110.328 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.736 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.6 tp -65.79 -27.33 41.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.297 0.57 . . . . 0.0 109.912 177.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 55.5 mtpt -76.41 -30.33 57.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.522 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.529 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 99.2 mttt -62.77 -35.87 81.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.191 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.2 mm -60.88 -45.45 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.491 0.662 . . . . 0.0 109.295 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.34 -34.6 76.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.6 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -79.49 -42.17 25.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.729 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.58 -54.26 6.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.34 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -85.44 -14.37 46.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.859 0.361 . . . . 0.0 111.466 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.51 32.6 57.46 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.168 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -106.27 171.81 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.191 0.519 . . . . 0.0 111.532 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 27.2 mtm180 -122.13 140.49 52.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.354 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 113' ' ' ILE . 50.8 mm -103.45 141.57 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 111.653 -172.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 24.5 tt0 -144.08 106.92 4.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.794 177.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -82.82 148.54 27.7 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.623 ' HD2' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -151.07 93.43 1.92 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -168.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 45.26 40.73 5.42 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.539 1.136 . . . . 0.0 112.313 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.647 ' HB2' ' HA ' ' A' ' 136' ' ' LYS . 2.4 p30 -106.04 -6.06 19.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.607 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.632 ' HA ' ' HE3' ' A' ' 136' ' ' LYS . 29.9 t70 -78.8 92.82 4.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.048 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.36 -15.78 62.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.879 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.6 p -67.71 -32.23 72.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.785 0.326 . . . . 0.0 111.397 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -140.62 -176.73 15.45 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.307 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.62 -27.17 18.86 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.05 2.5 . . . . 0.0 111.736 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.427 ' HG2' ' N ' ' A' ' 98' ' ' PRO . 25.6 mt-10 -128.06 147.34 50.52 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.801 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.647 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 36.6 mtpt -109.38 118.13 35.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.614 -168.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.623 ' O ' ' HD2' ' A' ' 127' ' ' LYS . 5.5 mm -78.7 99.5 3.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.55 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.86 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -91.95 141.94 28.09 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.878 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.528 ' CE1' HG23 ' A' ' 89' ' ' ILE . 6.7 t-160 -95.55 123.49 39.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.006 0.431 . . . . 0.0 110.504 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.612 ' HB ' ' CG1' ' A' ' 93' ' ' ILE . 37.0 mt -97.33 114.85 35.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.284 170.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.489 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 52.7 ttm -101.77 134.59 44.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.179 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.55 -165.24 31.39 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.459 ' HD2' ' HD2' ' A' ' 146' ' ' ARG . 20.5 Cg_exo -66.41 148.32 83.95 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.67 2.246 . . . . 0.0 111.658 176.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.39 -53.98 3.88 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.541 2.828 . . . . 0.0 113.645 -176.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.24 -44.77 96.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.084 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.459 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 53.8 mtt180 -64.84 -39.12 93.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.99 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.446 ' HA ' ' CG2' ' A' ' 140' ' ' ILE . 75.7 m -58.06 -59.21 5.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.003 0.43 . . . . 0.0 110.654 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.645 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 35.0 mm-40 -61.83 -34.73 76.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.836 -176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -67.95 -29.06 68.02 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.798 0.333 . . . . 0.0 110.73 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.552 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -77.72 -34.23 52.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.086 0.47 . . . . 0.0 110.3 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -60.87 -31.38 70.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.749 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.645 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 7.3 mpt_? -77.7 -19.94 54.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.723 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.6 mt -73.22 -40.98 58.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 84.5 mt -68.96 -45.27 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.236 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -56.73 -32.39 65.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.789 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.39 -41.7 90.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.188 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.89 -44.58 92.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.223 0.535 . . . . 0.0 110.485 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.513 HD21 HG23 ' A' ' 97' ' ' VAL . 17.2 mt -69.27 -33.07 72.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.152 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -64.98 -29.62 70.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.939 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.5 t -66.31 -26.07 67.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.981 0.42 . . . . 0.0 110.322 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.6 mt -89.28 5.38 45.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.678 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -121.12 109.44 15.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.693 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.4 m -82.34 24.72 0.66 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.968 0.413 . . . . 0.0 111.859 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.978 -179.003 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 57' ' ' PRO . 10.7 m -81.48 105.78 12.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.099 0.476 . . . . 0.0 111.325 -173.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 44.5 t -132.16 113.02 20.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.609 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -108.64 142.25 39.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.964 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.592 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 48.7 mt-10 -104.27 129.58 52.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -115.9 141.42 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 96.6 mmm -90.69 104.84 17.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.973 0.416 . . . . 0.0 110.965 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.56 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -91.85 118.86 68.49 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.764 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.458 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 43.4 Cg_exo -63.21 140.3 76.92 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.655 2.904 . . . . 0.0 112.809 176.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.94 123.61 21.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 170.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.08 -36.97 3.75 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -168.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 74' ' ' ARG . 11.6 mptt -74.11 -19.48 60.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -47.53 -41.02 20.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.164 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 19' ' ' LYS . . . -60.24 -36.9 92.04 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.622 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' A' ' 73' ' ' GLU . 3.9 pp -91.42 -23.88 19.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.883 0.341 . . . . 0.0 111.518 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.56 HG11 HG12 ' A' ' 8' ' ' ILE . 86.7 t -82.24 -55.04 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.594 HG13 ' H ' ' A' ' 19' ' ' LYS . 40.6 pt -91.79 -14.99 8.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.367 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.738 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 92.18 6.56 64.72 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.858 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER 64.98 -68.35 0.11 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.874 0.869 . . . . 0.0 110.204 -176.271 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.83 -1.09 90.13 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.237 -0.506 . . . . 0.0 111.918 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.59 -5.92 29.71 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.409 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.664 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 57.4 mm-40 -50.87 -51.95 46.42 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.738 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 27.6 m -71.87 -39.31 69.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -174.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 27' ' ' LEU . 2.6 tp -66.17 -27.64 41.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.08 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.338 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.664 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 22.0 mttm -56.29 -59.2 5.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.453 0.644 . . . . 0.0 109.561 172.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.609 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 93.8 mt-30 -63.51 -37.53 87.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.559 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.609 HD12 HD12 ' A' ' 24' ' ' ILE . 95.7 mt -63.2 -33.64 75.93 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.921 -0.487 . . . . 0.0 110.815 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.752 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 46.7 mt-30 -85.11 -44.77 12.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.905 0.384 . . . . 0.0 111.512 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.61 -51.47 5.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -65.78 -52.41 51.13 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.063 0.459 . . . . 0.0 109.975 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.57 -28.62 63.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.74 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.35 3.55 86.85 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.116 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.2 m -101.2 149.29 6.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -87.66 110.7 20.6 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.778 ' HE1' HD11 ' A' ' 51' ' ' LEU . 32.0 mmm -92.14 111.87 23.6 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.667 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tp -112.22 104.97 17.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.816 0.817 . . . . 0.0 109.379 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.721 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.2 pt? -132.76 127.25 34.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.561 -175.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.561 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.2 mp -68.78 99.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HA ' ' HD2' ' A' ' 49' ' ' LYS . 7.2 tp-100 -123.76 -34.06 3.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.049 0.452 . . . . 0.0 110.29 -174.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -127.85 42.54 3.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.545 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.17 -156.76 8.4 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.127 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -90.52 -164.42 1.17 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.164 0.186 . . . . 0.0 111.214 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 71.62 -79.47 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.229 0.612 . . . . 0.0 111.008 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.544 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 5.7 m-20 -116.74 94.65 4.69 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 p -85.53 -61.87 1.66 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.021 0.438 . . . . 0.0 111.615 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -94.33 -8.7 38.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.926 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.556 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 17.3 t -85.89 164.81 2.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.908 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.403 ' N ' HG12 ' A' ' 47' ' ' VAL . 4.1 m-20 -54.48 142.59 26.86 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.997 0.427 . . . . 0.0 110.29 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 46.1 mtmt -131.6 131.18 22.67 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.75 -167.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.58 131.86 9.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.858 2.372 . . . . 0.0 113.382 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.778 HD11 ' HE1' ' A' ' 35' ' ' MET . 0.4 OUTLIER -111.73 124.59 52.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.494 178.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.667 ' HB2' HG23 ' A' ' 36' ' ' ILE . 4.7 mpt_? -101.11 119.69 39.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.017 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.543 HG12 ' SD ' ' A' ' 35' ' ' MET . 57.9 mt -91.19 115.28 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 173.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.1 mt -104.74 120.72 55.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.381 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.45 -170.92 43.94 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.495 -0.859 . . . . 0.0 113.149 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.721 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 13.8 t70 -72.12 143.5 86.21 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.529 ' HA ' HG21 ' A' ' 2' ' ' THR . 74.6 Cg_exo -40.49 -50.32 3.8 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.756 2.971 . . . . 0.0 114.983 -175.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -62.12 -38.94 90.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 111.221 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.917 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 19.4 ptmt -79.64 -35.42 39.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -175.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.17 -31.42 52.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.215 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -68.77 -55.84 9.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.806 0.336 . . . . 0.0 110.356 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 85.3 mm-40 -59.55 -35.86 75.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.643 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.53 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -73.13 -43.61 61.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.614 ' O ' ' HG3' ' A' ' 68' ' ' MET . 36.0 t -59.11 -42.54 90.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.004 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.87 -32.54 67.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.599 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.948 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 14.7 ptt? -78.69 -38.67 38.64 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.91 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.516 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 33.7 m -61.8 -22.11 27.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 120.649 0.261 . . . . 0.0 110.602 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 48.7 mtt -81.71 -39.94 23.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.069 0.462 . . . . 0.0 110.167 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.73 -26.58 29.61 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -171.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -87.13 -20.93 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 120.865 -1.147 . . . . 0.0 109.714 173.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.491 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 5.2 tt -75.86 -18.04 59.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.045 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -60.5 -14.24 18.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.213 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.65 ' HB3' HD22 ' A' ' 15' ' ' LEU . 8.2 tp10 -47.01 -41.49 16.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.423 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.795 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 45.1 ttp180 74.62 -67.53 0.25 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.501 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.46 62.05 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -171.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.412 HE22 ' HA3' ' A' ' 14' ' ' GLY . 6.8 tp-100 67.38 127.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.787 0.68 . . . . 0.0 112.63 170.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' A' ' 15' ' ' LEU . . . 137.84 -103.83 0.43 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.683 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.534 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 73.6 24.8 73.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.368 174.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 68.4 -54.57 0.53 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.514 0.726 . . . . 0.0 111.962 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 110.91 102.45 2.68 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -173.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.703 ' H ' HG23 ' A' ' 23' ' ' THR . 2.7 t70 71.38 -69.37 0.19 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -169.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.948 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 50.9 ttt85 162.13 -33.54 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.846 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.35 32.93 14.31 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.33 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.902 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 23.5 tt0 -130.73 -57.97 1.04 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.869 -174.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 9.9 p90 -146.79 -26.32 0.41 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.202 -0.936 . . . . 0.0 113.149 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.584 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 65.63 -89.16 0.11 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.816 -176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.917 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 29.3 m -147.83 22.27 1.12 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.271 0.558 . . . . 0.0 109.606 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -96.41 -86.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.188 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.739 HD11 ' HG2' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -94.44 -164.08 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.251 175.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.597 ' H ' HG22 ' A' ' 89' ' ' ILE . . . -141.92 2.43 1.88 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.711 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.82 125.17 3.34 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.852 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 103.5 163.34 25.32 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.902 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 46.3 pt -97.85 157.11 3.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.017 0.437 . . . . 0.0 111.732 -174.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.11 117.47 33.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.619 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 25.0 t -107.56 105.73 56.7 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -172.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.443 ' HA ' HD13 ' A' ' 137' ' ' ILE . 48.6 Cg_endo -72.48 108.02 2.43 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.826 1.684 . . . . 0.0 110.897 169.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.654 HG23 HD21 ' A' ' 158' ' ' LEU . 11.0 p -124.91 131.14 24.06 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.122 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 87.2 Cg_exo -45.52 134.01 12.83 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.389 2.726 . . . . 0.0 113.437 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 102' ' ' VAL . 10.3 ptm180 -55.85 -33.22 64.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.854 -174.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -86.04 -15.18 42.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.103 0.477 . . . . 0.0 110.416 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 16.0 m -95.28 -28.45 14.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.85 -176.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 106' ' ' ILE . 13.6 p -63.49 -28.21 44.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.399 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.84 -28.06 72.92 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.811 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.06 -30.49 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.189 0.519 . . . . 0.0 109.765 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.6 t -68.82 -34.37 64.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.225 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 102' ' ' VAL . 37.0 mm -80.45 -50.25 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.166 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.59 -117.8 5.47 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -126.8 -53.97 1.42 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.1 m -102.18 -15.77 16.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.036 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.51 14.53 6.86 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.85 -24.61 67.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.873 0.368 . . . . 0.0 110.987 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.621 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.0 tpt -86.15 -42.82 13.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.882 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.627 HD11 HG13 ' A' ' 124' ' ' ILE . 15.5 tt -74.01 -35.85 43.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.572 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -69.71 -23.87 63.49 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.495 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 112' ' ' MET . 16.9 ptpt -75.35 -21.96 57.96 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.364 175.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 mm -65.41 -40.94 89.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.636 ' HG3' ' O ' ' A' ' 122' ' ' VAL . 1.8 mp0 -63.78 -31.28 72.41 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.268 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.09 -53.43 7.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.541 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -79.4 -51.26 9.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.113 -172.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.08 -22.42 31.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.866 0.365 . . . . 0.0 111.425 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.01 41.42 40.37 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.088 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.636 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 27.4 m -121.08 160.23 22.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 111.72 -173.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.795 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 83.3 mtp180 -111.11 151.12 28.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.633 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.627 HG13 HD11 ' A' ' 113' ' ' ILE . 48.9 mm -114.4 130.99 67.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.082 0.468 . . . . 0.0 111.333 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.739 ' HG2' HD11 ' A' ' 89' ' ' ILE . 5.4 tp-100 -128.2 110.44 12.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.545 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -82.45 107.12 14.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.128 0.49 . . . . 0.0 110.014 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.507 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.15 -174.67 3.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.07 -174.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.4 ' O ' ' HE3' ' A' ' 127' ' ' LYS . 14.8 mm100 -49.94 131.37 22.67 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.442 0.464 . . . . 0.0 111.101 177.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.487 ' HA ' HG12 ' A' ' 137' ' ' ILE . 24.2 m-20 -87.7 -173.31 4.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.796 -176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -73.55 -8.52 56.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.007 0.432 . . . . 0.0 111.071 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.39 1.36 83.83 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.855 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.7 p -80.55 -66.72 0.85 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.923 0.392 . . . . 0.0 110.954 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . 134.18 -58.05 0.69 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.579 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.556 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 88.1 Cg_exo -49.15 -39.19 41.88 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.082 2.521 . . . . 0.0 113.501 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 98' ' ' PRO . 36.1 mt-10 -120.7 137.64 54.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.794 0.33 . . . . 0.0 111.101 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -110.97 133.11 53.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.128 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 6.8 mm -78.17 105.64 7.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.192 0.52 . . . . 0.0 111.45 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.619 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -100.78 109.11 21.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 170.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 28.3 t60 -73.64 132.42 42.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.955 0.407 . . . . 0.0 111.119 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.616 HD13 ' HB3' ' A' ' 150' ' ' ALA . 80.5 mt -104.13 107.16 21.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.501 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.795 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 41.1 ttm -93.42 143.4 26.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.076 -174.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.44 -165.45 26.74 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 146' ' ' ARG . 32.2 Cg_exo -60.51 136.8 69.81 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.648 2.232 . . . . 0.0 110.523 172.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.9 -32.19 55.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.034 3.156 . . . . 0.0 113.236 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.09 -51.92 58.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.293 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.595 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 98.1 mtt180 -60.4 -40.73 92.01 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.479 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.852 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 73.2 m -52.33 -59.35 4.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.316 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.16 -39.61 93.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.871 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -56.6 -29.83 62.56 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.3 0.572 . . . . 0.0 110.558 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.616 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.97 -36.08 36.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.848 -175.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.75 -19.66 65.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.589 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -77.83 -36.66 49.85 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.9 mt -66.87 -40.49 85.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.833 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.601 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 54.3 mt -66.46 -41.74 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.456 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.559 ' O ' ' HG2' ' A' ' 159' ' ' GLN . 7.6 m-80 -60.31 -39.87 88.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.176 176.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -55.92 -41.01 73.94 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.103 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.542 HD11 ' HE2' ' A' ' 112' ' ' MET . 96.5 mt -62.31 -47.57 83.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.266 175.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.654 HD21 HG23 ' A' ' 97' ' ' VAL . 24.8 mt -61.02 -23.83 65.71 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.798 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 155' ' ' ASN . 13.1 mm100 -83.36 -48.6 10.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.161 0.505 . . . . 0.0 110.556 175.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.1 m -67.48 -33.55 75.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.306 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 157' ' ' LEU . 4.4 pp -78.02 -6.07 53.35 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.145 -0.347 . . . . 0.0 111.897 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -68.28 -37.16 80.39 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.9 p -87.56 -51.63 5.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.456 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.868 176.444 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.571 -0.611 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 t -94.53 152.42 18.57 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 30.0 m -131.37 137.13 56.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.165 0.507 . . . . 0.0 111.417 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -130.35 150.65 51.49 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 73.8 mt-10 -106.19 123.86 48.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 111.57 -173.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -112.33 140.21 33.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.4 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 44.8 tpp -89.15 113.41 24.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.722 0.296 . . . . 0.0 110.909 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.754 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -98.61 111.14 59.48 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.065 0.459 . . . . 0.0 110.526 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.588 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 51.5 Cg_exo -60.22 139.6 87.9 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.307 2.672 . . . . 0.0 112.713 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.3 125.78 25.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 169.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.16 -46.25 1.2 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -167.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.867 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.7 -32.7 64.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.661 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.21 -31.89 21.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.55 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.431 ' HA2' ' HE3' ' A' ' 19' ' ' LYS . . . -56.16 -44.99 88.75 Favored Glycine 0 C--O 1.223 -0.593 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.49 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 73' ' ' GLU . 3.3 pp -90.09 -18.13 26.45 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.69 -0.3 . . . . 0.0 111.651 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.754 HG11 HG12 ' A' ' 8' ' ' ILE . 91.6 t -82.73 -49.01 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.781 0.324 . . . . 0.0 111.682 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.661 HG12 ' O ' ' A' ' 13' ' ' ALA . 10.1 pt -91.36 -21.67 6.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.944 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.794 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 96.16 13.12 50.21 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.597 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HE3' ' HA2' ' A' ' 14' ' ' GLY . 3.4 tppp? 67.36 -57.7 0.43 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.961 0.904 . . . . 0.0 110.922 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.53 2.58 46.11 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 109.39 13.23 17.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.088 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.731 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 33.7 tt0 -68.32 -43.59 77.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.841 0.353 . . . . 0.0 111.736 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.794 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 59.3 m -71.06 -40.34 71.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.502 -177.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 35' ' ' MET . 7.3 tp -64.08 -21.53 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.83 0.348 . . . . 0.0 110.529 -176.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.731 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 47.9 mttm -59.0 -48.31 82.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.288 0.566 . . . . 0.0 110.136 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -79.33 -29.83 42.49 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.505 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.42 -27.25 66.03 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 121.844 -0.535 . . . . 0.0 110.449 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.4 mt-30 -84.27 -45.52 12.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.337 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' HB3' ' HA ' ' A' ' 130' ' ' ASP . 20.9 mt-10 -87.82 -39.23 15.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.514 ' HD3' ' OD2' ' A' ' 94' ' ' ASP . 4.0 ttm180 -75.29 -46.48 33.23 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.217 -176.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.56 -27.0 34.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.28 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.01 21.7 60.66 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.677 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.3 m -121.97 147.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.91 0.386 . . . . 0.0 111.195 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -90.54 110.38 21.52 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.771 ' HB2' HD11 ' A' ' 24' ' ' ILE . 60.3 mtt -95.09 124.0 38.9 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.3 tp -110.93 100.81 11.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 122.156 0.979 . . . . 0.0 110.451 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 51' ' ' LEU . 1.4 pt? -134.93 142.87 46.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.889 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.2 mp -65.83 99.94 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 111.188 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -101.56 -29.04 12.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.004 176.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.19 175.03 7.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.524 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.12 48.13 3.28 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.363 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.0 t -90.21 -157.81 0.5 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -55.82 -61.37 2.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.578 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.6 m-20 -85.58 48.63 1.62 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.99 0.424 . . . . 0.0 111.218 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -76.95 -47.94 19.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -93.51 -17.01 23.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.419 0.628 . . . . 0.0 110.068 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.578 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 23.1 t -79.4 151.35 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.377 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.588 ' OD2' ' HA ' ' A' ' 9' ' ' PRO . 6.6 m-20 -58.97 145.14 42.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -114.63 125.72 28.78 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-O 121.029 0.442 . . . . 0.0 111.989 -162.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.8 125.5 3.23 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.825 2.35 . . . . 0.0 111.15 174.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 37' ' ' LEU . 7.3 tt -106.51 120.67 42.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.93 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 36' ' ' ILE . 5.1 mpt_? -102.93 120.74 41.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 71.8 mt -91.1 115.47 30.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.108 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.467 HG12 ' CG1' ' A' ' 3' ' ' VAL . 24.7 mt -104.16 121.39 55.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.98 -170.83 43.76 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.37 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.827 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 1.9 m-20 -57.42 149.08 51.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 123.171 0.589 . . . . 0.0 110.472 175.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.13 -50.28 10.19 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.842 2.361 . . . . 0.0 113.332 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.44 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 50.4 p90 -67.89 -42.53 81.04 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.827 ' HG2' ' HB2' ' A' ' 56' ' ' ASP . 16.8 ptpt -72.12 -29.91 64.54 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.969 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.87 -34.57 70.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.447 . . . . 0.0 110.051 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.565 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 59.2 tp60 -77.03 -45.91 25.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.522 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 79.3 mm-40 -63.0 -27.18 69.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.079 0.466 . . . . 0.0 110.131 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.628 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -84.6 -41.81 16.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.784 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.603 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.8 p -61.1 -34.45 74.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.594 0.235 . . . . 0.0 111.595 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.77 -30.64 32.25 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.745 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.73 ' SD ' ' HD3' ' A' ' 82' ' ' ARG . 17.4 ptt? -76.02 -34.97 59.7 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.446 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 27.2 m -68.8 -22.68 26.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.636 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.603 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 49.3 mtt -82.21 -24.5 34.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.664 0.745 . . . . 0.0 109.394 172.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.463 ' CG ' HH21 ' A' ' 72' ' ' ARG . 10.0 t70 -84.58 -53.3 5.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.594 -171.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.012 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.6 pp -76.17 -20.77 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.412 0.625 . . . . 0.0 111.455 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.867 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 2.0 tt -76.06 -9.25 58.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.072 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 15.0 ptp180 -52.39 -53.5 44.15 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.604 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER 53.97 144.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 176.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.604 ' HD2' ' O ' ' A' ' 73' ' ' GLU . 13.0 mmm180 -121.14 -30.31 4.36 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.723 -0.611 . . . . 0.0 110.247 172.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -147.19 41.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.643 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.475 ' H ' ' CG ' ' A' ' 73' ' ' GLU . 49.6 mt-30 62.77 30.73 16.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.373 0.606 . . . . 0.0 110.068 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.68 82.7 0.35 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.199 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.36 175.94 44.69 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.646 ' CD1' HG22 ' A' ' 70' ' ' ILE . 92.8 m-85 -81.45 4.29 21.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.097 0.949 . . . . 0.0 112.348 -173.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 23' ' ' THR . . . 78.03 -3.94 59.72 Favored Glycine 0 N--CA 1.461 0.35 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.638 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -177.49 -61.57 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -178.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 1.012 ' HA ' HG21 ' A' ' 70' ' ' ILE . 2.9 ttp-105 162.47 -34.59 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 124.616 1.197 . . . . 0.0 109.45 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.745 ' HA ' ' OD1' ' A' ' 94' ' ' ASP . 2.2 t-20 57.98 58.99 3.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.931 0.872 . . . . 0.0 110.173 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 1.065 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 0.8 OUTLIER -171.95 -136.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.878 -178.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.573 ' HB3' ' H ' ' A' ' 90' ' ' GLY . 1.3 p90 -59.19 -74.42 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.694 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 85.02 -38.57 2.97 Favored Glycine 0 C--O 1.226 -0.379 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 59' ' ' LYS . 13.0 t -170.92 -37.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.907 -0.647 . . . . 0.0 109.352 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.45 ' HG3' ' CB ' ' A' ' 127' ' ' LYS . 6.5 mmt180 -94.64 149.12 21.56 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.381 -176.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.754 HD12 ' HB2' ' A' ' 141' ' ' MET . 39.8 mm 75.48 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 124.083 0.864 . . . . 0.0 111.377 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.573 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 72.11 43.6 47.53 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.46 -174.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.16 73.7 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 84' ' ' GLU . . . 147.8 159.37 8.37 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -171.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.065 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 9.7 pt -91.14 165.86 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -167.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.745 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 0.6 OUTLIER -99.8 148.17 24.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.865 176.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 38.7 t -135.0 96.18 14.63 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -174.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.48 107.2 1.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.549 1.5 . . . . 0.0 110.504 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.746 HG23 HD21 ' A' ' 158' ' ' LEU . 14.9 p -117.37 128.95 25.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.584 0.231 . . . . 0.0 110.683 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.451 ' HB2' ' OG ' ' A' ' 101' ' ' SER . 64.1 Cg_exo -39.25 132.84 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.997 3.131 . . . . 0.0 113.443 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -56.99 -30.13 63.86 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.476 -171.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -90.1 -12.17 39.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.839 0.352 . . . . 0.0 111.497 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 14.8 m -96.57 -17.16 20.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.758 -173.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 106' ' ' ILE . 7.4 p -59.49 -34.7 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.13 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.38 -31.01 79.43 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.447 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.63 -37.05 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 109.952 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 97' ' ' VAL . 52.9 t -63.27 -39.87 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.294 176.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.715 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.6 mm -72.41 -42.68 64.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.309 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.98 35.94 7.44 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.788 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 63.25 -78.06 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.03 0.532 . . . . 0.0 111.857 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -69.71 -15.28 63.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.768 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.462 ' HA2' HG22 ' A' ' 106' ' ' ILE . . . 90.99 17.26 52.1 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.839 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -7.9 51.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.865 0.364 . . . . 0.0 110.968 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 14.8 tpt -90.24 -41.43 11.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.966 0.412 . . . . 0.0 109.918 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.715 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 8.9 tp -64.31 -22.43 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.207 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 99.3 mttt -81.74 -21.79 37.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.029 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -67.74 -40.24 84.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.008 0.432 . . . . 0.0 109.901 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.536 HG23 HD12 ' A' ' 153' ' ' ILE . 22.1 mt -60.85 -43.65 96.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.78 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -73.71 -18.9 60.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.165 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -87.96 -45.39 10.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.824 0.345 . . . . 0.0 110.882 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -78.49 -46.67 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 146' ' ' ARG . . . -87.16 -17.46 32.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.842 0.354 . . . . 0.0 111.258 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.65 23.96 77.3 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.697 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.4 m -95.47 177.8 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.912 0.387 . . . . 0.0 111.273 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.698 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 98.5 mtt180 -129.24 131.93 47.13 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.606 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.676 HG21 HD11 ' A' ' 113' ' ' ILE . 47.0 mm -98.6 118.69 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.974 0.416 . . . . 0.0 111.02 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.69 ' HB3' HD11 ' A' ' 89' ' ' ILE . 50.6 tp60 -116.23 109.94 18.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.838 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -82.58 140.7 33.1 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HD2' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -146.61 -172.36 3.95 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.067 -171.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -52.23 121.3 6.61 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.859 0.361 . . . . 0.0 110.404 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.01 170.97 14.94 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 29' ' ' GLU . 5.0 p-10 -75.31 -45.07 41.95 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.278 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.8 -21.02 10.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.49 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 89.2 m -76.63 -38.54 54.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.158 0.504 . . . . 0.0 110.301 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.24 173.77 37.87 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -86.39 17.82 1.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.857 2.371 . . . . 0.0 112.661 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -125.83 155.82 40.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.038 0.447 . . . . 0.0 111.301 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.432 ' O ' HG12 ' A' ' 97' ' ' VAL . 23.8 mtpp -110.42 123.91 50.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.222 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.527 ' O ' ' HD2' ' A' ' 127' ' ' LYS . 15.2 mm -72.91 102.31 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.007 0.432 . . . . 0.0 112.005 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -92.72 140.96 28.99 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 169.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.508 ' HB3' ' CG1' ' A' ' 89' ' ' ILE . 2.2 m80 -106.33 138.24 42.87 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.197 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.845 HD13 ' HB3' ' A' ' 150' ' ' ALA . 87.8 mt -107.4 107.25 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.325 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.754 ' HB2' HD12 ' A' ' 89' ' ' ILE . 47.4 ttm -85.83 124.43 32.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.824 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.92 -177.82 34.49 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.131 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.64 147.74 86.45 Favored 'Trans proline' 0 C--O 1.224 -0.177 0 C-N-CA 122.913 2.409 . . . . 0.0 111.389 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.712 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 87.5 Cg_exo -45.16 -46.66 13.34 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.286 2.657 . . . . 0.0 114.132 -174.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -60.53 -34.55 74.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.764 0.316 . . . . 0.0 110.889 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 120' ' ' ALA . 7.0 mtm180 -86.79 -34.48 19.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.188 -176.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.712 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 25.7 p -61.42 -47.14 87.13 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -69.6 -35.64 75.48 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.597 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -54.56 -32.92 59.3 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.149 0.5 . . . . 0.0 110.942 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.845 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.86 -28.77 44.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.089 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.77 -23.65 63.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.955 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -78.08 -25.02 47.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.322 . . . . 0.0 110.412 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.536 HD12 HG23 ' A' ' 116' ' ' ILE . 62.1 mt -73.87 -42.84 53.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.242 0.544 . . . . 0.0 109.868 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.3 mt -68.81 -39.39 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.469 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -58.86 -36.75 75.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.486 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.21 -42.03 93.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.173 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.44 -35.23 80.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.49 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.746 HD21 HG23 ' A' ' 97' ' ' VAL . 35.5 mt -62.52 -28.95 70.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.219 0.533 . . . . 0.0 110.323 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -85.21 -47.19 10.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.705 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.2 t -66.08 -22.62 66.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.477 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.62 -15.0 57.02 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -59.82 -34.92 73.7 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.285 0.564 . . . . 0.0 109.874 173.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.4 p -101.99 54.52 0.8 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.747 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.322 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.36 107.27 12.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.955 0.407 . . . . 0.0 111.589 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 38.5 t -130.35 112.52 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.439 173.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -110.87 146.93 35.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.613 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 38.4 mt-10 -110.91 116.9 32.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.219 0.533 . . . . 0.0 112.033 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.2 mm -110.16 132.28 58.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 173.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.0 ttm -90.41 119.4 30.66 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.516 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.841 HG12 HG11 ' A' ' 16' ' ' VAL . 1.8 mp -92.95 115.63 65.24 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.252 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HA ' ' OD1' ' A' ' 48' ' ' ASP . 59.6 Cg_exo -57.12 142.14 94.32 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.598 2.865 . . . . 0.0 112.404 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.38 121.37 13.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.6 -54.2 0.6 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -167.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.508 ' HE2' ' OE2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -64.69 -29.77 70.77 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 172.221 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.702 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -50.33 -33.82 21.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.03 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.777 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -59.56 -41.47 97.27 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.731 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.798 HD22 ' HA ' ' A' ' 76' ' ' GLN . 0.5 OUTLIER -89.39 -31.07 17.93 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.957 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.841 HG11 HG12 ' A' ' 8' ' ' ILE . 78.4 t -67.29 -47.91 79.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.765 HG13 ' H ' ' A' ' 19' ' ' LYS . 21.6 pt -91.03 -21.68 6.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.281 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 98.4 -2.5 59.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.859 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.777 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 6.1 tptm 69.78 -50.59 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 111.047 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.57 4.96 69.92 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 172.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.7 3.62 64.25 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.801 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 46.7 mt-10 -65.05 -34.31 78.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.545 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 26.7 m -85.37 -40.93 15.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.92 -175.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.491 HD12 HD12 ' A' ' 27' ' ' LEU . 3.3 tp -67.19 -26.39 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 63.7 tttt -52.73 -50.99 62.32 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.83 169.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 78.7 mt-30 -74.43 -36.5 63.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.363 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.637 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 88.0 mt -66.13 -28.23 68.64 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.173 -0.329 . . . . 0.0 111.135 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 98.4 mt-30 -85.6 -43.64 13.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.793 0.33 . . . . 0.0 111.503 176.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.59 -52.0 6.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.532 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 29.6 ttm180 -70.35 -53.35 17.03 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.765 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -65.68 -26.2 67.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.349 0.595 . . . . 0.0 110.711 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.93 0.38 75.29 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.998 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 35.3 m -103.88 151.38 6.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -92.51 110.3 21.72 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 1.025 ' HB3' HD21 ' A' ' 51' ' ' LEU . 56.8 mtt -97.24 115.38 27.5 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.361 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.93 104.42 17.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 122.334 1.064 . . . . 0.0 109.664 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.717 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.2 pt? -134.26 142.5 47.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.859 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.0 mp -69.29 100.11 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -80.76 -67.12 0.8 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -130.54 101.65 5.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.972 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 45' ' ' THR . . . -155.86 149.51 20.57 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 p -69.76 71.87 0.36 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.12 0.485 . . . . 0.0 111.58 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -169.85 -56.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.411 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.528 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 90.1 m-20 -126.9 60.55 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.898 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 41' ' ' GLY . 2.2 p -83.86 -59.87 2.29 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.637 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.13 -14.92 39.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.354 0.597 . . . . 0.0 109.727 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 47.2 t -79.77 146.06 8.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.833 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.504 ' OD1' ' HA ' ' A' ' 9' ' ' PRO . 42.7 m-20 -58.81 149.91 25.33 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.565 0.541 . . . . 0.0 109.615 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -115.97 122.18 32.82 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.936 -166.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.43 121.34 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.47 2.113 . . . . 0.0 111.537 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.025 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.1 tm? -106.19 125.17 50.66 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.299 -174.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.613 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 1.7 mpt_? -103.42 121.25 42.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.378 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 62.9 mt -89.81 109.09 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.9 mt -105.94 119.7 55.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.992 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.525 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.18 -171.14 44.04 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.432 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.05 146.72 97.41 Favored Pre-proline 0 C--N 1.327 -0.397 0 O-C-N 123.67 0.276 . . . . 0.0 110.522 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.12 -51.89 8.68 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.367 2.711 . . . . 0.0 114.186 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -58.2 -44.19 87.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.233 0.54 . . . . 0.0 110.457 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 86.5 mttt -62.82 -46.72 86.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.486 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.13 -34.21 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.52 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -69.63 -50.04 48.1 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.616 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 20.8 mm-40 -65.88 -33.5 75.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.341 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.56 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -69.7 -47.78 61.96 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.079 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 83.3 m -56.27 -37.82 70.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.171 0.51 . . . . 0.0 110.304 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -70.08 -41.92 73.45 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.888 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.936 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 10.5 ptt? -78.31 -35.69 47.44 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.425 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.533 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 26.9 m -59.44 -47.02 92.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.492 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.1 mtm -65.16 -24.29 67.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 110.479 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 35.2 t70 -83.32 -41.97 17.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.514 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -86.99 -32.65 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.442 -179.235 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.622 ' HA ' HD11 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -82.66 -11.66 58.19 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.348 -175.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -62.75 -40.67 97.96 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 175.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.508 ' OE2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 37.21 -156.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.622 1.201 . . . . 0.0 113.431 175.495 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -165.12 -19.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.492 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -163.2 63.93 0.18 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.894 169.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.798 ' HA ' HD22 ' A' ' 15' ' ' LEU . 65.2 tt0 70.94 -18.81 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.59 0.756 . . . . 0.0 112.619 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.09 86.03 0.58 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.327 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.695 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -121.25 35.29 3.68 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.468 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 65.97 -60.78 0.29 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.626 0.77 . . . . 0.0 112.258 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 106.62 107.53 3.22 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -172.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 1.9 t70 70.64 -72.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -168.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.936 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 47.5 ttt-85 165.03 -27.79 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.825 1.25 . . . . 0.0 108.532 172.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 67.04 26.19 9.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.282 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 1.039 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 13.9 tt0 -130.52 -66.79 0.75 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.188 0.518 . . . . 0.0 110.191 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.498 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 13.3 p90 -144.84 86.9 1.81 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.771 0.796 . . . . 0.0 110.348 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -74.18 71.45 1.47 Allowed Glycine 0 C--N 1.315 -0.617 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.748 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.616 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 47.4 m 66.23 2.41 2.35 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.598 ' HD2' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -85.17 -86.11 0.14 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.212 0.529 . . . . 0.0 110.448 174.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.908 HD11 ' HG2' ' A' ' 125' ' ' GLN . 1.7 mt -88.75 -167.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.805 ' H ' HG22 ' A' ' 89' ' ' ILE . . . -144.57 39.62 1.21 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HE1' ' A' ' 139' ' ' HIS . . . -177.42 124.41 0.94 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.654 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 96.9 165.41 32.84 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.039 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 43.3 pt -94.06 156.22 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 117.292 0.546 . . . . 0.0 112.412 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.496 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 2.2 m-20 -95.88 114.14 25.84 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 175.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.619 HG21 HD12 ' A' ' 140' ' ' ILE . 44.1 t -111.65 104.81 56.45 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HA ' HD13 ' A' ' 137' ' ' ILE . 46.1 Cg_endo -71.32 115.26 4.21 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.349 2.033 . . . . 0.0 112.341 171.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.674 HG23 HD21 ' A' ' 158' ' ' LEU . 10.5 p -117.43 126.22 27.55 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.398 0.618 . . . . 0.0 110.277 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 24.3 Cg_exo -61.79 143.06 95.7 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.306 2.671 . . . . 0.0 112.501 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -59.2 -33.96 71.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.273 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -85.27 20.94 1.83 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -149.55 -24.52 0.28 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.415 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 106' ' ' ILE . 10.6 p -60.57 -26.55 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 120.694 0.283 . . . . 0.0 110.696 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.84 -35.89 84.65 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.255 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.79 -35.18 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 110.055 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 97' ' ' VAL . 41.5 t -63.25 -38.66 82.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.569 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.798 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 44.7 mm -73.87 -40.87 53.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.197 0.522 . . . . 0.0 110.07 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.46 -149.52 19.36 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -75.73 -83.27 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 m -95.92 21.74 8.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.214 0.53 . . . . 0.0 110.645 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.666 ' O ' ' HD3' ' A' ' 114' ' ' LYS . . . 91.79 47.67 3.36 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -170.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -94.26 -54.14 3.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.846 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.2 tpt -67.67 -34.29 76.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.882 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.798 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 7.9 tp -67.13 -31.96 55.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.546 -177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.688 ' HD2' HG23 ' A' ' 113' ' ' ILE . 5.7 mptp? -79.51 -23.47 42.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.124 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.422 ' HB3' ' HE3' ' A' ' 115' ' ' LYS . 22.9 mmmt -66.07 -37.27 85.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.8 mm -60.34 -42.87 92.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.519 0.675 . . . . 0.0 109.281 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -67.58 -33.13 74.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.916 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -79.29 -46.58 17.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.514 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -42.23 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.928 -172.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.54 -13.51 29.66 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.286 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.62 23.26 75.69 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.651 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.8 m -99.94 175.28 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.131 0.491 . . . . 0.0 111.432 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 71.1 mtm180 -129.0 141.36 51.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.039 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 113' ' ' ILE . 49.5 mm -102.38 130.0 52.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.024 0.44 . . . . 0.0 110.8 -175.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.908 ' HG2' HD11 ' A' ' 89' ' ' ILE . 6.1 tp-100 -126.62 96.86 4.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.868 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -75.55 112.78 12.25 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 169.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.781 ' NZ ' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -134.57 163.98 28.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.768 -168.186 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 40.76 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.497 ' OD2' HG12 ' A' ' 137' ' ' ILE . 0.6 OUTLIER -58.87 123.54 16.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.399 0.618 . . . . 0.0 111.562 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -123.14 -68.65 0.87 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.804 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.49 44.56 1.48 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.2 p -67.62 -13.83 62.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.328 -0.436 . . . . 0.0 111.714 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 119.56 -103.19 0.95 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.679 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 36.6 Cg_endo -65.75 -43.69 9.38 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.052 2.501 . . . . 0.0 114.242 -173.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -133.61 148.52 51.57 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.391 0.615 . . . . 0.0 112.089 -168.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 97' ' ' VAL . 30.7 mttm -123.44 117.28 24.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.937 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.781 ' HB ' ' NZ ' ' A' ' 127' ' ' LYS . 12.2 mm -71.93 102.22 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.123 0.487 . . . . 0.0 110.676 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.538 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -87.37 98.26 11.26 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 63.9 t-80 -72.1 127.72 33.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.056 0.455 . . . . 0.0 110.634 -172.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 95' ' ' VAL . 93.9 mt -98.65 107.66 20.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.174 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.511 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 38.6 ttm -92.95 137.72 32.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.876 -176.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.26 -160.92 28.61 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.703 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.83 140.6 35.6 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.739 2.293 . . . . 0.0 111.507 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -41.54 -49.64 5.07 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.891 3.061 . . . . 0.0 114.249 -174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -59.42 -52.1 67.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.335 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -61.61 -35.51 78.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.35 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.654 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 72.9 m -56.96 -59.46 5.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.856 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -66.92 -33.73 76.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.971 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.439 ' O ' HG13 ' A' ' 153' ' ' ILE . 12.3 t-80 -60.02 -33.17 71.65 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.211 0.529 . . . . 0.0 110.018 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.559 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.09 -45.93 22.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.906 -176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.57 -20.74 66.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.06 0.457 . . . . 0.0 110.244 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -28.2 52.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.089 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 149' ' ' HIS . 71.6 mt -77.62 -44.93 29.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.132 0.492 . . . . 0.0 109.829 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.488 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 73.2 mt -65.49 -41.15 90.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.01 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -57.04 -42.6 80.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.346 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.95 -36.87 80.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.92 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.15 -42.18 99.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 109.989 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.674 HD21 HG23 ' A' ' 97' ' ' VAL . 17.6 mt -66.55 -42.59 86.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.99 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -67.56 -34.81 77.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.888 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.2 t -65.83 -31.67 72.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.963 0.411 . . . . 0.0 110.377 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.16 19.26 4.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.564 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -91.76 44.44 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.98 0.419 . . . . 0.0 110.052 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.8 t -86.22 71.34 10.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.27 0.557 . . . . 0.0 109.718 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.4 -176.304 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 m -79.57 111.51 15.92 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 18.6 m -123.47 120.6 60.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.327 0.584 . . . . 0.0 111.098 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 4' ' ' GLN . 11.7 mm-40 -106.32 139.13 41.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.844 174.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.805 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 61.9 mt-10 -110.99 116.11 30.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.28 0.562 . . . . 0.0 111.54 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.9 mp -105.79 140.13 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.425 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 86.7 mmm -87.02 106.31 17.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.996 0.426 . . . . 0.0 110.901 -176.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.477 ' CG1' HG21 ' A' ' 16' ' ' VAL . 1.8 mp -90.62 109.49 34.69 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.985 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 12' ' ' LYS . 13.3 Cg_exo -72.85 165.75 31.9 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 123.322 2.681 . . . . 0.0 111.695 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.97 148.78 34.07 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.59 ' O ' ' HB3' ' A' ' 76' ' ' GLN . . . 84.65 -58.1 5.0 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.145 -172.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.656 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 7.5 mptt -60.98 -31.0 70.6 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.644 0.259 . . . . 0.0 111.268 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.7 -38.03 53.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.59 ' HA2' ' HG2' ' A' ' 19' ' ' LYS . . . -63.26 -37.51 94.99 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.946 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 3.8 pp -80.97 -24.28 38.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.98 0.39 . . . . 0.0 110.133 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG21 ' CG1' ' A' ' 8' ' ' ILE . 96.2 t -79.77 -52.34 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.311 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.757 HG13 ' H ' ' A' ' 19' ' ' LYS . 27.8 pt -77.64 -27.45 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.287 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 95.49 8.19 58.67 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.35 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.757 ' H ' HG13 ' A' ' 17' ' ' ILE . 54.3 mmtt 42.47 58.22 3.15 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.678 0.752 . . . . 0.0 110.955 -176.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.17 -27.52 1.56 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.398 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.69 -8.02 10.18 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.127 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.716 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 32.8 tt0 -49.96 -59.21 4.09 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -176.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.487 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 23.5 m -67.27 -38.19 84.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 35' ' ' MET . 3.4 tp -65.25 -27.19 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.197 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.716 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 35.0 mttm -57.97 -54.46 46.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.19 0.519 . . . . 0.0 109.797 171.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 25.6 mt-30 -68.88 -34.28 75.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.475 -176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.69 HD13 ' HE2' ' A' ' 35' ' ' MET . 32.6 mt -70.69 -25.7 63.09 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.343 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.762 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 27.0 mt-30 -85.75 -44.07 12.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.691 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -86.11 -54.01 4.73 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.654 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 28.0 ttm180 -71.44 -42.18 68.55 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.972 0.415 . . . . 0.0 110.44 -175.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.666 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -83.32 -9.18 59.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.824 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.12 23.49 66.14 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.886 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 20.6 m -129.02 152.11 36.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.982 0.391 . . . . 0.0 110.426 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 49.9 tptt -87.74 110.19 20.27 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.69 ' HE2' HD13 ' A' ' 27' ' ' LEU . 27.9 mmm -92.7 116.39 28.97 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.7 tp -110.08 111.66 37.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.978 0.894 . . . . 0.0 110.214 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.549 HD13 HD23 ' A' ' 51' ' ' LEU . 3.1 mm? -99.29 135.68 40.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.759 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.484 HG21 ' HD2' ' A' ' 50' ' ' PRO . 13.0 tt -86.79 99.87 8.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.839 0.828 . . . . 0.0 109.755 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.49 32.88 0.13 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.761 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.15 -29.27 16.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.444 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.66 -177.82 16.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.26 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 m -79.37 69.85 5.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.329 0.585 . . . . 0.0 110.737 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -134.52 -63.32 0.72 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.036 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 13.1 m120 -124.78 28.2 6.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.532 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -82.1 -36.17 27.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.132 0.491 . . . . 0.0 109.768 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -93.72 -11.99 30.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.533 0.682 . . . . 0.0 109.676 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 38.0 t -104.19 164.75 3.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.201 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 47' ' ' VAL . 4.1 p30 -55.88 151.33 11.7 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.028 170.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 40.2 mttp -130.86 125.59 21.37 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.735 -168.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.484 ' HD2' HG21 ' A' ' 38' ' ' ILE . 66.3 Cg_endo -74.27 103.89 1.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.144 1.896 . . . . 0.0 110.831 172.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.805 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -84.7 127.46 34.11 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.975 -175.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.583 ' N ' HD22 ' A' ' 51' ' ' LEU . 3.5 mpt_? -102.42 113.39 26.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.004 0.43 . . . . 0.0 110.728 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 59.1 mt -83.84 112.41 21.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.512 172.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 34' ' ' LYS . 52.0 mt -104.22 120.28 54.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.17 -170.58 43.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.681 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.613 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 9.5 m-20 -68.12 152.57 96.37 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 122.688 0.395 . . . . 0.0 111.139 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.8 -54.71 3.92 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.256 2.637 . . . . 0.0 114.394 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -62.22 -48.46 79.87 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.707 0.289 . . . . 0.0 111.594 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.613 ' HD2' ' H ' ' A' ' 56' ' ' ASP . 16.8 ptpt -68.57 -34.11 75.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.771 -175.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 56' ' ' ASP . 76.7 t -65.3 -30.06 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 0.0 110.189 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -80.23 -48.55 12.92 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 85.7 mm-40 -63.35 -39.92 95.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.433 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.674 ' HA ' ' CG ' ' A' ' 66' ' ' MET . . . -70.02 -41.22 74.59 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.842 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.1 t -55.53 -43.5 75.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.47 0.652 . . . . 0.0 109.631 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -65.16 -48.56 73.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.232 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.674 ' CG ' ' HA ' ' A' ' 63' ' ' ALA . 2.0 ppp? -67.01 -42.56 84.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.472 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.645 HG12 HD23 ' A' ' 71' ' ' LEU . 75.3 t -58.47 -49.97 80.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 122.971 0.17 . . . . 0.0 110.924 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.414 ' HE3' HG13 ' A' ' 6' ' ' ILE . 64.4 mtt -58.64 -29.86 66.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.165 0.507 . . . . 0.0 110.425 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 8.7 t70 -85.54 -35.63 20.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.044 -173.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.731 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.7 pp -86.87 -21.57 7.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.985 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.645 HD23 HG12 ' A' ' 67' ' ' VAL . 3.0 pp -86.35 2.2 48.3 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.341 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 7.4 ptp180 -64.07 -14.24 53.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.989 0.423 . . . . 0.0 109.86 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.506 ' HG2' ' C ' ' A' ' 77' ' ' GLY . 8.0 tp10 -51.57 146.75 7.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.452 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -64.01 -36.58 84.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.552 -174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -168.1 112.77 0.65 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.375 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.63 ' HA ' HD23 ' A' ' 15' ' ' LEU . 22.4 pt20 37.64 63.48 0.76 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.347 1.059 . . . . 0.0 113.84 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.506 ' C ' ' HG2' ' A' ' 73' ' ' GLU . . . -152.73 29.15 0.84 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.165 176.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.69 171.25 34.49 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.282 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.731 ' HD1' HG22 ' A' ' 70' ' ' ILE . 80.0 m-85 -65.81 -20.42 66.24 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 84.31 98.68 0.63 Allowed Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.654 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 4.0 t70 71.57 -82.94 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -168.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.651 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 44.4 ttt85 169.36 -36.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.197 0.599 . . . . 0.0 109.616 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 62.38 36.34 14.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.515 0.674 . . . . 0.0 110.218 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 1.002 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.6 tt0 -142.35 -49.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.455 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 13.1 p90 -177.04 135.47 0.2 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.96 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -115.27 -72.49 0.53 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.704 174.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.628 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 18.5 t -108.08 -4.83 17.38 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.16 0.505 . . . . 0.0 110.429 176.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.589 ' HG2' ' HB2' ' A' ' 127' ' ' LYS . 1.4 mpt_? -129.81 172.52 11.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.662 -172.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.609 HG12 ' HB2' ' A' ' 139' ' ' HIS . 35.7 mt 73.21 -78.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 123.813 0.695 . . . . 0.0 112.243 171.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.27 44.54 96.42 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.231 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.409 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 151.28 78.05 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.162 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.713 ' HA3' ' O ' ' A' ' 140' ' ' ILE . . . 158.56 -129.28 2.24 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.002 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 29.4 pt -149.99 160.79 4.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 117.081 0.44 . . . . 0.0 109.847 173.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.5 125.73 45.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.342 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 39.9 t -126.2 101.88 27.96 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.65 107.36 2.45 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.021 1.814 . . . . 0.0 112.057 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.512 HG23 HG12 ' A' ' 95' ' ' VAL . 37.8 t -98.89 128.51 32.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.006 0.432 . . . . 0.0 111.449 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.555 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 5.5 Cg_endo -47.4 129.26 16.02 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.852 3.034 . . . . 0.0 112.215 174.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.727 ' HD3' ' HB2' ' A' ' 134' ' ' PRO . 23.1 ptt180 -57.49 -32.06 66.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.372 -174.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -87.92 11.34 16.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.734 0.302 . . . . 0.0 111.196 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.656 ' HB3' HD21 ' A' ' 161' ' ' LEU . 9.3 m -127.89 -30.14 2.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.383 -176.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.39 -33.13 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.36 66.31 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.533 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.69 -37.1 12.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.08 0.467 . . . . 0.0 110.08 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.97 -41.79 93.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.713 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.652 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 34.1 mm -77.1 -45.69 29.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.518 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.64 -124.79 8.36 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.553 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -112.36 -70.39 0.81 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.028 0.442 . . . . 0.0 110.1 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.7 m -99.04 20.4 13.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.56 37.2 35.89 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.794 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -93.88 -33.4 13.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.643 0.258 . . . . 0.0 110.466 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 17.1 tpt -68.43 -41.84 79.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.403 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.1 tp -63.65 -21.69 29.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.614 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -80.61 -19.22 45.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -68.2 -28.97 67.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.167 0.508 . . . . 0.0 110.166 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.647 HD12 HD12 ' A' ' 113' ' ' ILE . 27.1 mt -71.67 -33.64 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.682 0.754 . . . . 0.0 109.172 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -72.18 -23.93 61.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.292 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -79.86 -40.93 27.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.564 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.4 -56.27 4.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.469 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -86.94 -23.73 25.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 111.597 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.16 26.65 43.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.703 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 141' ' ' MET . 29.8 m -95.2 164.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.669 0.271 . . . . 0.0 111.225 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.435 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 13.8 mmt180 -118.33 139.1 51.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 139' ' ' HIS . 48.5 mm -114.64 141.88 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.666 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 18.9 tp60 -155.23 106.06 2.56 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.248 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 106' ' ' ILE . 18.2 m-85 -73.39 105.0 4.58 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.888 176.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.589 ' HB2' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -107.25 96.25 6.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.119 -174.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 65.83 -168.63 0.21 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.759 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 136' ' ' LYS . 1.0 OUTLIER -111.26 -179.6 3.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.369 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.447 ' HA ' HD11 ' A' ' 137' ' ' ILE . 13.5 t70 -67.32 -40.6 85.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.307 0.575 . . . . 0.0 110.46 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.27 -44.69 1.75 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -174.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.6 m -66.1 -36.06 82.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.358 0.599 . . . . 0.0 110.281 175.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -146.15 178.86 23.57 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.727 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.727 ' HB2' ' HD3' ' A' ' 99' ' ' ARG . 5.8 Cg_exo -79.61 19.93 0.92 Allowed 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 123.551 2.834 . . . . 0.0 112.414 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.555 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 1.4 mp0 -83.92 147.59 27.41 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.273 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 129' ' ' ASP . 81.7 mttt -108.91 120.9 43.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.555 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 7.0 mm -73.55 123.61 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.016 0.436 . . . . 0.0 111.294 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . . . -99.0 126.77 44.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.608 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.666 ' HB3' ' O ' ' A' ' 125' ' ' GLN . 1.5 t60 -73.87 126.85 31.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.713 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 82.9 mt -113.98 142.74 25.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.78 172.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 51.0 ttm -132.09 131.35 42.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.552 0.215 . . . . 0.0 110.562 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.8 -167.97 30.52 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.82 142.63 76.87 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.537 2.158 . . . . 0.0 111.477 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.91 -46.69 18.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.215 2.61 . . . . 0.0 113.529 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.46 -36.87 79.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.083 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.513 ' HA ' ' HB3' ' A' ' 149' ' ' HIS . 53.1 mtt180 -80.1 -26.43 39.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.86 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.59 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 69.9 m -60.65 -56.1 25.35 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.68 -31.42 72.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.599 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.537 ' O ' HG13 ' A' ' 153' ' ' ILE . 11.9 t60 -59.75 -33.38 71.6 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.145 0.497 . . . . 0.0 110.258 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.713 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.37 -42.39 30.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.388 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 93' ' ' ILE . . . -63.53 -28.42 69.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.08 0.466 . . . . 0.0 110.275 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -25.71 52.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.297 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 149' ' ' HIS . 75.3 mt -74.64 -47.6 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.676 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.1 mt -61.36 -46.18 97.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.822 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -54.45 -44.06 72.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.356 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.39 -36.13 83.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.405 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 73.5 mt -63.54 -45.55 90.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.085 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 20.7 mt -62.57 -30.02 71.01 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -79.63 -33.72 41.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.881 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.3 t -79.06 -29.06 43.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.271 -172.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 101' ' ' SER . 3.2 pp -81.01 19.8 0.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -172.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -78.55 47.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.796 0.331 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.8 m -122.99 -7.23 8.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.756 0.313 . . . . 0.0 110.636 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.785 -177.437 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 5.0 m -111.83 110.6 21.03 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 4.2 p -140.79 140.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.519 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -125.69 140.66 52.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.258 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 13.0 mp0 -102.39 119.99 39.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.168 0.508 . . . . 0.0 111.623 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.695 HG13 HG21 ' A' ' 67' ' ' VAL . 39.1 mm -113.08 146.62 17.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.027 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.455 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 42.3 mtp -105.38 116.46 31.99 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.482 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.697 HG12 HG11 ' A' ' 16' ' ' VAL . 2.1 mp -97.39 109.14 48.72 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.883 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.823 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 50.8 Cg_exo -61.4 152.78 70.53 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.364 2.709 . . . . 0.0 112.558 175.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.67 144.39 57.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.17 -45.54 2.64 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -171.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.823 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -69.19 -15.65 63.44 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 110.274 174.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.555 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -54.23 -38.64 65.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.511 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 18' ' ' GLY . . . -65.89 -31.17 78.81 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.925 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.697 ' CD1' ' HA ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -91.92 -29.48 16.65 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.446 -0.443 . . . . 0.0 112.157 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.697 HG11 HG12 ' A' ' 8' ' ' ILE . 89.2 t -83.78 -56.66 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 13' ' ' ALA . 32.0 pt -93.05 -21.12 6.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.864 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . 103.77 -61.74 0.43 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 23.1 tptp 169.31 -35.91 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 170.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.92 -0.36 7.08 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.224 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.648 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 133.11 0.54 4.21 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.189 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HB2' ' HA3' ' A' ' 18' ' ' GLY . 36.3 mp0 -51.08 -54.7 22.5 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.072 0.549 . . . . 0.0 112.08 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.565 HG21 ' O ' ' A' ' 15' ' ' LEU . 87.3 m -81.67 -26.12 34.97 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.508 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.733 HD12 HD12 ' A' ' 27' ' ' LEU . 2.7 tp -67.75 -22.9 28.76 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.156 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.648 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 7.8 mtpm? -56.03 -54.76 41.07 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.555 169.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 45.0 mt-30 -60.6 -44.12 96.65 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.659 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.733 HD12 HD12 ' A' ' 24' ' ' ILE . 50.7 mt -64.38 -28.59 69.8 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.264 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.738 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 47.1 mt-30 -86.88 -49.09 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 111.664 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.41 -54.24 4.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.707 -171.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 94' ' ' ASP . 10.5 ttt180 -63.8 -51.82 63.06 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.793 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -70.9 -26.79 63.38 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.754 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.79 16.83 80.43 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.876 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.9 m -120.11 160.7 20.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -98.11 110.44 23.02 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.677 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 1.048 ' HB3' HD11 ' A' ' 51' ' ' LEU . 43.5 mtt -101.43 125.75 48.11 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.614 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tt -122.53 115.09 44.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.856 0.836 . . . . 0.0 110.733 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.693 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -134.69 145.18 48.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.332 -175.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.798 HG23 ' HB2' ' A' ' 42' ' ' SER . 33.5 mm -59.9 99.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.469 0.652 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -155.45 23.47 0.41 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.972 175.181 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -111.34 -63.78 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.269 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.43 20.67 0.27 Allowed Glycine 0 CA--C 1.517 0.206 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.736 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.798 ' HB2' HG23 ' A' ' 38' ' ' ILE . 54.6 m -90.95 -166.22 1.53 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.279 0.539 . . . . 0.0 110.781 177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.28 -27.25 24.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -174.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.541 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.4 m-20 -79.58 56.58 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.028 0.442 . . . . 0.0 110.698 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.9 p -83.1 -50.98 7.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.425 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -90.55 -21.47 21.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.525 0.678 . . . . 0.0 109.683 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 23.0 t -79.15 158.82 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.267 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -60.32 153.53 22.41 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.184 0.516 . . . . 0.0 110.525 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -123.88 135.05 25.83 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.766 -163.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.22 104.0 0.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.891 2.394 . . . . 0.0 111.843 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.048 HD11 ' HB3' ' A' ' 35' ' ' MET . 29.5 tp -87.6 129.44 35.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.027 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.614 ' HB2' HG23 ' A' ' 36' ' ' ILE . 7.7 mpt_? -106.73 117.61 34.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.407 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.1 mt -92.79 109.34 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.851 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.9 mt -106.11 121.54 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.72 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 177.82 -171.21 43.75 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.668 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.733 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 11.4 m-20 -64.78 156.28 79.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 122.412 0.285 . . . . 0.0 110.882 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -48.03 -54.85 4.64 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.148 2.565 . . . . 0.0 113.851 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -63.57 -31.54 72.73 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.946 0.403 . . . . 0.0 110.287 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 56' ' ' ASP . 89.7 mttt -66.84 -52.39 44.26 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.566 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.31 -28.76 45.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.299 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -79.85 -41.65 25.89 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.438 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -72.52 -25.21 61.31 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.831 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.712 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -83.42 -40.43 19.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.61 -33.29 72.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.574 0.702 . . . . 0.0 109.246 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.27 -47.22 62.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.681 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.712 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 2.3 ppp? -66.91 -42.13 85.93 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.58 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.695 HG21 HG13 ' A' ' 6' ' ' ILE . 27.0 m -59.63 -42.84 89.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.927 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.3 mtt -68.75 -24.76 64.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.734 ' HA ' ' HE ' ' A' ' 72' ' ' ARG . 52.3 m-20 -81.67 -40.91 22.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.818 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.868 HG22 ' HD2' ' A' ' 79' ' ' PHE . 2.8 pp -88.07 -31.58 5.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.697 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 1.6 tt -75.71 -15.26 60.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.849 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.734 ' HE ' ' HA ' ' A' ' 69' ' ' ASP . 16.4 ptp180 -60.94 -53.6 55.23 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' HG2' ' CD2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER 40.35 -169.73 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 174.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -162.09 -30.25 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.0 -1.455 . . . . 0.0 109.214 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -129.16 32.66 4.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.556 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 39.4 mt-30 64.42 16.74 10.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.062 0.458 . . . . 0.0 111.351 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -114.11 86.44 0.42 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 80' ' ' GLY . . . -98.82 40.61 2.41 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.183 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.868 ' HD2' HG22 ' A' ' 70' ' ' ILE . 24.7 m-85 69.28 -32.11 0.22 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.918 0.887 . . . . 0.0 112.818 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 93.83 95.95 1.55 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 4.1 t70 72.31 -67.15 0.27 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -170.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.794 ' HA ' HG21 ' A' ' 70' ' ' ILE . 48.0 ttt-85 178.03 -1.93 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.214 169.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 47.5 t30 67.85 -58.65 0.44 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.213 0.605 . . . . 0.0 111.64 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.867 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 36.1 mt-10 -72.92 -23.19 60.67 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -174.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.609 ' CB ' ' HB ' ' A' ' 89' ' ' ILE . 44.7 p90 172.12 140.17 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 122.912 0.485 . . . . 0.0 111.136 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.793 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -112.25 97.33 0.9 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 168.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.495 ' HB2' ' HB1' ' A' ' 31' ' ' ALA . 21.8 t 71.62 -38.15 0.41 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.447 ' HG3' HH11 ' A' ' 88' ' ' ARG . 0.2 OUTLIER -89.73 -167.87 1.98 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.751 HG13 ' CG ' ' A' ' 139' ' ' HIS . 1.5 mp 67.19 -75.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 123.671 0.607 . . . . 0.0 112.3 171.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.428 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 80.23 -31.91 2.32 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.459 -0.401 . . . . 0.0 112.781 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.414 ' N ' HG22 ' A' ' 89' ' ' ILE . . . -148.42 118.61 0.99 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.01 -146.18 17.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.867 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 44.4 pt -140.98 160.61 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.904 0.352 . . . . 0.0 110.258 174.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 85' ' ' TYR . 32.8 m-20 -108.04 117.88 35.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.03 174.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.799 HG23 ' HB3' ' A' ' 138' ' ' ALA . 20.7 m -117.03 106.03 48.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -176.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 32.4 Cg_endo -66.29 107.83 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.455 2.103 . . . . 0.0 111.311 172.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.412 ' HA ' ' HD2' ' A' ' 98' ' ' PRO . 10.7 p -102.85 127.96 28.89 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.936 0.398 . . . . 0.0 110.85 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.658 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 7.3 Cg_endo -52.73 129.3 31.92 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.185 2.59 . . . . 0.0 112.677 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.603 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -44.77 -40.9 6.46 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 113.988 -1.46 . . . . 0.0 113.268 -176.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.499 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 16.6 p80 -82.45 -4.87 58.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.732 -173.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.526 ' O ' HG12 ' A' ' 104' ' ' VAL . 22.6 t -124.49 8.18 8.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.327 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.45 -26.39 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.155 0.503 . . . . 0.0 110.224 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.63 -39.58 67.26 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.906 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 101' ' ' SER . 6.0 p -64.35 -24.71 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.083 0.468 . . . . 0.0 110.458 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 101' ' ' SER . 48.9 t -74.23 -45.47 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.46 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.19 -36.4 37.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.428 0.633 . . . . 0.0 110.578 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.07 -72.68 2.55 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -171.2 -71.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.8 m -95.66 20.63 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.442 0.639 . . . . 0.0 110.088 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.42 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 84.96 2.37 88.44 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.876 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -57.4 -24.8 57.67 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 15.1 tpt -89.54 -51.51 5.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.69 0.281 . . . . 0.0 110.852 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.885 HD11 HG13 ' A' ' 124' ' ' ILE . 19.5 tt -67.68 -31.54 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.735 -174.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.557 ' HA ' ' HG2' ' A' ' 117' ' ' GLN . 98.0 mttt -68.65 -19.16 64.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.673 0.273 . . . . 0.0 111.201 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -74.65 -31.06 61.83 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.107 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.0 mm -63.37 -38.4 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.557 ' HG2' ' HA ' ' A' ' 114' ' ' LYS . 5.4 mm-40 -64.1 -32.21 73.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.629 -1.168 . . . . 0.0 110.704 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -87.16 -41.9 13.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.458 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.15 -48.09 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -89.13 -16.22 31.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.152 0.501 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 53.79 6.31 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.122 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 141' ' ' MET . 29.1 m -133.46 170.81 19.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -172.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.669 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 85.9 mtt180 -132.36 153.27 50.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.885 HG13 HD11 ' A' ' 113' ' ' ILE . 49.6 mm -114.71 140.44 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -172.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.984 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 52.0 tp60 -143.95 101.19 3.7 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.521 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -73.14 116.35 13.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.997 0.427 . . . . 0.0 110.574 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.672 ' O ' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -139.03 129.42 25.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.689 -177.303 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 61.53 -171.23 0.15 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 172.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.17 168.63 21.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.141 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.23 -11.54 54.65 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -171.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.44 -46.07 3.36 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.862 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.8 t -83.89 -1.36 54.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.362 0.601 . . . . 0.0 109.846 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -156.21 177.92 32.99 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.384 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.448 ' HG2' ' HD2' ' A' ' 99' ' ' ARG . 10.3 Cg_endo -93.43 30.27 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.711 2.94 . . . . 0.0 112.143 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.658 ' OE2' ' HA ' ' A' ' 98' ' ' PRO . 0.8 OUTLIER -81.52 152.27 27.38 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.256 0.551 . . . . 0.0 111.026 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' O ' HG12 ' A' ' 97' ' ' VAL . 59.0 mttm -110.53 114.8 28.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.582 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.672 ' HB ' ' O ' ' A' ' 127' ' ' LYS . 12.5 mm -70.32 105.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.306 0.574 . . . . 0.0 110.357 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.799 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -94.3 126.95 39.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.984 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 7.3 t-160 -77.8 117.37 19.11 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.099 173.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.609 ' HB ' ' CG1' ' A' ' 93' ' ' ILE . 48.7 mt -97.98 106.57 18.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.669 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 52.9 ttm -85.73 126.63 34.12 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.219 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.15 157.81 8.5 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.496 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.98 149.78 19.92 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.699 2.266 . . . . 0.0 111.741 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.837 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 50.7 Cg_exo -39.12 -44.42 2.64 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 124.037 3.158 . . . . 0.0 114.457 -175.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.32 -40.77 87.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.079 0.466 . . . . 0.0 111.484 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -78.62 -50.61 11.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.512 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.837 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 18.8 p -61.33 -52.36 64.99 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.667 -175.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.56 -30.47 71.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.735 0.302 . . . . 0.0 111.685 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -70.83 -25.08 62.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.231 0.539 . . . . 0.0 110.461 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.28 -42.91 24.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.964 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.89 -30.23 68.87 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -19.95 54.44 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.915 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.5 mt -80.18 -45.13 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.6 mt -64.11 -45.01 97.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.342 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -56.06 -37.35 69.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.305 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.85 -43.61 90.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 110.305 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 70.3 mt -63.14 -40.33 97.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.425 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 7.7 mt -62.5 -40.83 97.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.039 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.44 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . 91.7 mt-30 -68.37 -28.9 67.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.855 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.7 t -73.72 -33.16 64.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.376 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.1 mt -92.15 19.62 6.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.391 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 159' ' ' GLN . 39.8 mmt180 -79.76 68.64 5.9 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.4 p -69.72 93.72 0.75 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.33 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.348 -175.209 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.868 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 57' ' ' PRO . 37.1 m -152.67 96.21 2.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.869 0.366 . . . . 0.0 110.155 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 70.5 t -122.52 116.63 49.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.044 0.449 . . . . 0.0 111.027 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -107.77 163.03 13.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 49.0 mt-10 -127.82 120.09 27.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.079 0.466 . . . . 0.0 111.768 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.7 mp -111.36 140.52 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.535 -0.757 . . . . 0.0 108.969 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.498 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 39.0 ttm -90.12 122.44 33.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.811 0.339 . . . . 0.0 110.808 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.589 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.7 mp -95.88 110.78 53.4 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.751 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.784 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 32.6 Cg_exo -65.82 146.66 83.95 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.463 2.775 . . . . 0.0 111.909 172.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.42 130.72 44.84 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.63 -40.31 2.59 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.784 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 1.3 mptm? -84.36 -30.68 25.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.952 173.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.604 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -49.54 -45.45 47.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.855 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -58.0 -39.59 92.12 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.467 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 76' ' ' GLN . 3.5 pp -84.87 -36.39 21.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.069 0.434 . . . . 0.0 110.918 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.658 HG21 HD12 ' A' ' 71' ' ' LEU . 59.9 t -65.94 -42.79 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.682 0.277 . . . . 0.0 111.727 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.895 HG13 ' H ' ' A' ' 19' ' ' LYS . 13.9 pt -92.25 -27.13 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.033 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.587 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 99.88 0.17 56.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.643 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.895 ' H ' HG13 ' A' ' 17' ' ' ILE . 7.2 tptm 74.28 -35.66 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.139 0.975 . . . . 0.0 111.423 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.99 2.55 17.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.945 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.78 -2.76 38.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.608 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 6.8 mp0 -55.52 -44.94 77.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.587 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 88.5 m -74.16 -46.95 39.1 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.496 -177.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 35' ' ' MET . 7.6 tp -62.83 -26.58 41.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 1.3 tmtm? -55.41 -44.83 76.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.212 173.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.414 ' HG3' ' HD2' ' A' ' 25' ' ' LYS . 96.4 mt-30 -85.36 -20.55 29.75 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.707 -177.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.703 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 33.8 mt -79.38 -24.25 42.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.44 0.638 . . . . 0.0 109.494 176.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.5 mt-30 -86.03 -38.88 17.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.892 174.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -86.73 -63.06 1.37 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.431 ' HD3' ' CG ' ' A' ' 94' ' ' ASP . 13.7 ttm180 -65.96 -34.21 77.59 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 110.778 -174.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -87.63 -9.74 53.38 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.024 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.01 22.7 55.84 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.484 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.6 m -126.95 148.99 31.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -89.75 109.01 20.03 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.922 ' HB3' HD11 ' A' ' 51' ' ' LEU . 7.4 mtm -98.29 117.26 32.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.1 tp -111.29 104.7 17.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.928 0.87 . . . . 0.0 110.5 -173.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -133.98 142.28 47.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.915 -178.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.699 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 3.9 mp -68.31 100.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.159 0.504 . . . . 0.0 110.604 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 12.2 mt-30 -96.58 -56.05 2.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -121.54 95.9 4.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.089 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.44 158.56 24.95 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.829 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.7 t -88.82 85.35 6.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.972 0.415 . . . . 0.0 110.453 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -164.46 -79.07 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.021 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 3.2 m-20 -118.52 66.2 0.77 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.51 -56.3 3.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.717 -174.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -93.73 -6.01 47.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.208 1.004 . . . . 0.0 108.519 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 56.5 t -86.42 158.74 3.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.952 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -60.32 148.79 35.66 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 110.323 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.699 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 52.0 mttt -128.62 134.73 26.6 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.024 -166.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.7 121.64 3.34 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.665 2.244 . . . . 0.0 112.125 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.922 HD11 ' HB3' ' A' ' 35' ' ' MET . 53.3 tp -98.03 111.68 23.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.794 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.9 mpt_? -98.22 116.22 29.98 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.506 175.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 49.8 mt -92.14 111.19 23.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.553 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.9 mt -106.6 120.26 57.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.767 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.428 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 173.15 -171.51 44.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.42 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.648 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 3.7 m-20 -65.14 141.69 98.35 Favored Pre-proline 0 C--N 1.33 -0.239 0 C-N-CA 122.149 0.18 . . . . 0.0 111.332 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.496 ' HA ' HG21 ' A' ' 2' ' ' THR . 96.7 Cg_exo -43.39 -54.2 3.73 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.873 3.049 . . . . 0.0 114.234 -174.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -61.13 -41.82 97.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.666 0.27 . . . . 0.0 111.579 -174.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.991 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 18.3 ptpt -77.44 -27.16 52.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.381 -173.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 56' ' ' ASP . 91.4 t -64.56 -32.06 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.986 175.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -73.04 -52.81 12.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -61.98 -37.84 86.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.554 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.562 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -72.25 -39.15 68.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.725 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.413 ' HA ' HG22 ' A' ' 67' ' ' VAL . 42.5 t -57.73 -35.29 70.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.268 0.556 . . . . 0.0 110.076 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.63 -40.93 76.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.774 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.562 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -78.11 -34.95 49.8 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.494 -176.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 33.1 m -67.92 -26.3 34.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 120.811 0.338 . . . . 0.0 110.614 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 66.3 mtt -81.4 -21.36 39.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.011 0.434 . . . . 0.0 109.897 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.85 -55.31 4.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.944 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.658 ' HB ' ' H ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -70.01 -19.71 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.397 0.617 . . . . 0.0 110.48 -177.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.658 HD12 HG21 ' A' ' 16' ' ' VAL . 3.1 tt -85.77 -16.33 39.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.19 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 68' ' ' MET . 8.2 ptm180 -69.83 -8.29 47.16 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.902 -0.136 . . . . 0.0 111.306 -174.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 10.3 tp10 -59.21 -94.87 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 O-C-N 123.586 0.554 . . . . 0.0 111.99 -172.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 37.8 ttp180 159.59 -59.74 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -86.97 147.15 25.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.272 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.664 ' HA ' HD23 ' A' ' 15' ' ' LEU . 29.7 tt0 -54.12 99.87 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.162 0.506 . . . . 0.0 110.834 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.39 -78.6 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.308 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 59.48 -117.26 10.57 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.658 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 90.7 m-85 -127.73 -55.32 1.31 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.496 ' O ' HG13 ' A' ' 70' ' ' ILE . . . 135.98 -79.97 0.31 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 82' ' ' ARG . 6.2 p-10 -103.25 2.78 34.74 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.828 0.823 . . . . 0.0 109.237 170.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 20.4 ttt180 86.86 -31.21 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.587 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.4 t30 51.5 71.99 0.41 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 18.0 tt0 -176.36 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.003 -171.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.854 ' HA ' HD12 ' A' ' 89' ' ' ILE . 34.8 p90 -171.88 -37.63 0.02 OUTLIER 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 175.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.57 -91.69 0.58 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.818 -175.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.991 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 46.1 p -117.16 -11.68 10.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.588 0.708 . . . . 0.0 111.01 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.712 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 46.9 mtt180 -113.65 -163.98 0.9 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.571 -169.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.854 HD12 ' HA ' ' A' ' 85' ' ' TYR . 75.6 mt 60.66 -84.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.678 0.611 . . . . 0.0 112.274 168.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.17 45.4 81.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.857 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.492 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 150.82 90.62 0.08 OUTLIER Glycine 0 CA--C 1.518 0.261 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.46 -149.64 18.71 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 23.7 pt -136.77 167.14 24.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 117.605 0.703 . . . . 0.0 111.107 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . 2.1 p30 -105.43 141.8 36.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.373 173.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.851 HG23 ' HB3' ' A' ' 138' ' ' ALA . 6.2 m -136.92 102.86 9.14 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.076 0.465 . . . . 0.0 111.451 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HB3' HD13 ' A' ' 137' ' ' ILE . 36.1 Cg_endo -67.2 107.86 1.44 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.893 2.395 . . . . 0.0 111.739 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 105' ' ' VAL . 7.6 p -105.79 131.2 21.95 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.247 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.467 ' HG3' ' NH2' ' A' ' 162' ' ' ARG . 84.6 Cg_exo -45.28 125.91 7.66 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.673 2.915 . . . . 0.0 113.104 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -61.46 -21.03 63.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.947 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -92.04 8.11 39.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.704 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 105' ' ' VAL . 41.7 m -141.88 0.44 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 106' ' ' ILE . 10.1 p -66.84 -33.37 62.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.393 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.18 -29.9 76.49 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.894 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.08 -40.22 58.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 109.988 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 97' ' ' VAL . 40.4 t -64.22 -41.6 92.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.303 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.738 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.1 mm -67.07 -49.28 74.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.487 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.38 69.16 1.42 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.126 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 57.43 -88.85 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.522 0.729 . . . . 0.0 112.309 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.0 t -97.69 18.81 14.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.987 0.422 . . . . 0.0 110.971 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.66 22.92 41.16 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.057 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -72.91 -43.91 61.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.047 0.451 . . . . 0.0 110.839 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.4 ' SD ' ' HD2' ' A' ' 115' ' ' LYS . 16.6 tpt -74.05 -40.29 62.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.632 -177.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.738 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.5 tp -66.47 -32.67 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.815 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -80.85 -22.63 39.72 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.991 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.4 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -66.76 -37.25 84.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.151 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.9 mt -63.28 -40.97 91.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 75.1 mt-30 -63.05 -32.85 74.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.29 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -84.6 -40.1 17.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.987 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.78 -42.04 28.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.361 -172.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.66 2.41 47.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.513 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.98 32.49 82.31 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.464 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.91 171.6 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.008 0.432 . . . . 0.0 111.263 -175.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.844 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 3.2 mmp_? -124.1 152.28 42.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.6 mm -117.08 133.47 63.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.087 0.47 . . . . 0.0 111.65 -175.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 23.8 tp60 -139.37 99.63 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.368 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -74.9 140.6 43.91 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 121.932 -0.48 . . . . 0.0 109.792 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.616 ' HD3' HH11 ' A' ' 88' ' ' ARG . 0.7 OUTLIER -153.11 138.2 17.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.146 -175.169 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.412 ' HB2' ' NH1' ' A' ' 88' ' ' ARG . 86.2 mm-40 51.48 -164.65 0.06 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.438 0.461 . . . . 0.0 111.254 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 46.28 39.63 6.52 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.024 0.827 . . . . 0.0 111.777 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -102.0 80.54 2.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.812 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.09 -14.9 44.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.051 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.8 p -64.06 -66.62 0.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.133 0.492 . . . . 0.0 111.125 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -99.24 -174.03 31.41 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.494 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.69 -21.61 14.45 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.858 2.372 . . . . 0.0 112.204 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 98' ' ' PRO . 5.3 mp0 -121.86 159.93 25.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.043 0.449 . . . . 0.0 111.019 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -121.77 117.53 26.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.542 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.537 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 30.1 mm -71.42 102.45 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.244 0.545 . . . . 0.0 111.968 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.851 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -90.5 142.48 27.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.558 176.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.588 ' NE2' HG23 ' A' ' 89' ' ' ILE . 6.0 t-160 -91.23 115.66 28.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.658 HD13 ' HB3' ' A' ' 150' ' ' ALA . 47.3 mt -94.15 113.98 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.25 172.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.844 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 43.8 ttm -98.95 132.84 43.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.575 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.17 -175.14 31.74 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.925 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.93 145.91 75.9 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.681 2.254 . . . . 0.0 111.592 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.685 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 96.8 Cg_exo -44.68 -48.63 10.23 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.523 2.816 . . . . 0.0 113.869 -173.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.9 -38.69 79.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.936 0.398 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.56 -37.33 21.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.874 -174.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 29.4 p -57.74 -47.83 81.34 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -69.22 -32.95 72.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.683 0.277 . . . . 0.0 110.655 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -64.69 -27.78 69.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.658 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -77.19 -29.77 54.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.9 0.381 . . . . 0.0 110.704 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.69 -25.32 66.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.839 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -78.29 -20.32 51.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.469 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.5 mt -79.77 -39.89 20.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.28 0.562 . . . . 0.0 109.56 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.568 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 53.2 mt -71.17 -51.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.824 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -58.07 -32.21 67.82 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.995 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.24 -32.29 72.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.245 0.545 . . . . 0.0 110.462 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.8 -44.44 23.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.814 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.827 ' HA ' HD21 ' A' ' 161' ' ' LEU . 57.6 mt -64.12 -26.61 68.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.117 -174.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -74.22 -15.28 61.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.831 0.348 . . . . 0.0 110.732 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.572 ' HB3' HD13 ' A' ' 161' ' ' LEU . 20.5 t -79.68 -60.3 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.464 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.827 HD21 ' HA ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -73.98 21.51 0.09 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.14 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.467 ' NH2' ' HG3' ' A' ' 98' ' ' PRO . 35.1 mmt180 -97.63 40.66 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 169.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.3 m -67.23 132.87 48.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.806 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.316 178.21 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 14.0 m -92.86 89.38 6.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.853 0.358 . . . . 0.0 110.148 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 22.4 m -124.85 145.77 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.27 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 73.1 mm-40 -130.42 150.78 51.49 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.55 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 43.6 mt-10 -111.21 121.93 46.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.908 0.385 . . . . 0.0 111.505 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.4 mp -106.06 140.58 23.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.404 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -87.37 110.09 20.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.444 -177.612 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.69 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -98.36 111.48 59.9 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.151 0.5 . . . . 0.0 111.084 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 7' ' ' MET . 37.1 Cg_exo -62.55 151.87 80.83 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.707 2.938 . . . . 0.0 112.789 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.36 133.45 46.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.4 -49.9 1.02 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -167.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 13.9 mptt -69.08 -32.71 72.35 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 170.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -50.99 -35.09 31.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.415 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.415 ' CA ' ' HG2' ' A' ' 19' ' ' LYS . . . -64.3 -38.05 95.34 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.489 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.3 pp -89.06 -21.17 23.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.711 0.255 . . . . 0.0 111.18 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.69 HG11 HG12 ' A' ' 8' ' ' ILE . 96.6 t -82.58 -41.35 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.828 HG21 ' HG3' ' A' ' 39' ' ' GLN . 11.2 pt -92.25 -22.68 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 121.52 -0.738 . . . . 0.0 110.912 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.676 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 92.69 16.55 48.37 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.377 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.415 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 66.0 mmtt 48.64 50.82 16.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.911 0.484 . . . . 0.0 111.297 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.91 -28.49 1.57 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.096 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.25 -13.94 2.78 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.006 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.812 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 1.2 mm-40 -43.7 -55.28 4.49 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.676 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 73.8 m -75.11 -35.11 61.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.49 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.78 HD11 HD21 ' A' ' 37' ' ' LEU . 1.7 tp -68.35 -26.78 34.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.613 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.812 ' HD3' ' HA ' ' A' ' 22' ' ' GLU . 14.3 mtpp -55.04 -51.89 64.88 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.483 0.659 . . . . 0.0 109.998 174.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.442 ' HB2' ' CG ' ' A' ' 81' ' ' ASP . 23.1 mt-30 -81.63 -31.72 32.27 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.887 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.634 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 83.8 mt -66.83 -23.43 66.04 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.742 -0.599 . . . . 0.0 110.479 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 24.1 mt-30 -84.81 -46.46 11.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.13 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.737 ' HB3' ' O ' ' A' ' 130' ' ' ASP . 15.2 mm-40 -86.44 -56.69 3.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -175.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HA ' ' OE1' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -57.87 -41.97 83.58 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.144 0.497 . . . . 0.0 110.223 -178.27 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -86.79 -6.46 58.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.533 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.23 23.22 52.46 Favored Glycine 0 CA--C 1.517 0.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 113.52 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.0 m -132.21 153.88 39.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.893 0.377 . . . . 0.0 110.449 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -90.93 109.52 20.75 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.634 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 47.8 mtt -95.37 113.51 25.19 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 tp -110.96 106.87 21.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 122.027 0.918 . . . . 0.0 110.152 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.844 HD22 ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -132.99 142.12 48.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.254 -177.707 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.778 HG21 ' HB2' ' A' ' 43' ' ' GLN . 71.8 mt -86.14 101.6 10.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.726 0.298 . . . . 0.0 111.09 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.828 ' HG3' HG21 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -134.69 -26.51 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.291 177.018 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -88.16 -34.13 17.95 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.4 146.78 34.88 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.75 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -79.71 38.8 0.39 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.778 ' HB2' HG21 ' A' ' 38' ' ' ILE . 48.8 mt-30 -106.38 -49.6 3.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.111 0.482 . . . . 0.0 110.345 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -131.45 30.96 4.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.488 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -70.58 -40.28 73.37 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.022 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -93.84 -26.17 17.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.094 0.473 . . . . 0.0 110.288 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 48' ' ' ASP . 40.0 t -79.3 169.57 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.629 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' N ' HG12 ' A' ' 47' ' ' VAL . 3.4 p30 -60.28 151.95 26.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.985 0.421 . . . . 0.0 110.415 172.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 11.6 mptt -108.64 130.87 22.22 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.024 -171.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -88.88 103.95 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.685 2.257 . . . . 0.0 111.4 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.844 ' HG ' HD22 ' A' ' 37' ' ' LEU . 5.7 tt -87.92 109.7 19.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.868 -174.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.55 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.3 mpt_? -97.23 115.43 27.6 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.697 0.284 . . . . 0.0 110.51 175.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 72.7 mt -87.71 115.67 28.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.054 175.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.431 HG12 ' CG1' ' A' ' 3' ' ' VAL . 32.5 mt -104.13 120.74 54.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 172.22 -170.78 43.76 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.62 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.437 ' HB3' ' HD2' ' A' ' 59' ' ' LYS . 5.5 t70 -65.79 140.42 97.29 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.229 174.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -43.39 -49.45 7.52 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.252 2.635 . . . . 0.0 114.308 -176.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.38 -36.55 84.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.409 0.623 . . . . 0.0 110.204 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.577 ' HG2' ' HB2' ' A' ' 87' ' ' SER . 45.8 mttp -68.95 -44.0 73.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.9 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -59.3 -34.41 53.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.047 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.518 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 0.3 OUTLIER -72.15 -52.2 17.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.545 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -59.93 -32.35 70.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.251 0.548 . . . . 0.0 110.477 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.73 -44.54 14.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.057 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.649 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.9 p -59.5 -33.9 71.92 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 111.272 -175.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.28 -32.78 61.13 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.239 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.593 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 14.2 ptt? -84.4 -32.82 23.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.344 -175.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.655 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 34.9 m -61.0 -31.79 50.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.425 175.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.649 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 36.6 mtm -81.26 -35.36 31.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 175.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.593 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 30.8 t70 -64.66 -40.66 95.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.205 -175.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 66' ' ' MET . 0.2 OUTLIER -87.79 -22.21 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.009 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.655 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -83.93 -24.41 30.72 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.298 -178.186 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.4 1.17 3.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 9.8 tp10 -58.07 150.5 20.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.799 173.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 74' ' ' ARG . 44.3 ttt-85 -79.49 59.43 2.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.312 0.577 . . . . 0.0 110.187 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 64.38 75.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.439 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -156.98 -71.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.931 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.474 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . -172.93 -36.53 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.768 -177.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.01 -97.99 2.22 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.988 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.51 -35.31 1.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.872 0.368 . . . . 0.0 111.039 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.55 67.61 0.64 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.442 ' CG ' ' HB2' ' A' ' 26' ' ' GLN . 5.8 m-20 61.97 30.7 18.09 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 122.026 0.917 . . . . 0.0 109.998 -174.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.534 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 35.5 ttt85 73.99 -40.23 0.45 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.035 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 t30 66.79 11.56 8.33 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.383 0.611 . . . . 0.0 110.601 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.721 ' HG3' ' O ' ' A' ' 92' ' ' GLY . 42.7 tt0 -115.83 -39.49 3.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.033 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.636 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 4.7 p90 -176.13 -157.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.697 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.675 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -176.2 -28.58 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.577 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 20.4 p -165.41 -48.63 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.593 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -73.66 173.36 9.88 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.034 169.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.8 ' HA ' ' CE1' ' A' ' 139' ' ' HIS . 65.5 mt 74.49 -77.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 O-C-N 123.538 0.524 . . . . 0.0 111.539 178.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.71 40.94 49.55 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.367 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.67 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 144.93 98.79 0.25 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.747 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 135.9 -138.79 10.19 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 29.6 pt -143.67 158.35 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 117.109 0.454 . . . . 0.0 110.493 173.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.585 ' OD2' HG21 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -93.4 117.84 30.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.021 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.953 HG21 HD12 ' A' ' 140' ' ' ILE . 75.2 t -116.8 95.29 46.19 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.719 -168.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.479 ' HA ' HD13 ' A' ' 137' ' ' ILE . 50.8 Cg_endo -72.22 113.51 3.72 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.037 1.825 . . . . 0.0 111.893 172.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.609 HG21 HG21 ' A' ' 105' ' ' VAL . 10.4 p -116.84 133.84 23.03 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -48.43 128.98 18.75 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.202 2.602 . . . . 0.0 112.226 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.872 ' HG2' ' HG3' ' A' ' 136' ' ' LYS . 14.7 mtp180 -63.5 -44.1 95.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.414 -171.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.02 6.44 3.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.871 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 104' ' ' VAL . 4.4 m -132.51 1.92 3.77 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.834 0.35 . . . . 0.0 110.761 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 99' ' ' ARG . 10.9 p -75.42 -19.7 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 110.671 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.77 -40.67 95.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.842 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 101' ' ' SER . 8.5 p -73.15 -29.03 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.337 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.609 HG21 HG21 ' A' ' 97' ' ' VAL . 64.6 t -66.94 -41.75 87.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.775 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.76 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 40.7 mm -72.51 -38.11 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.935 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.5 38.65 5.24 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.039 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.7 ttp-105 66.33 -75.36 0.05 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.215 0.606 . . . . 0.0 111.821 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.3 p -99.99 12.5 36.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.091 0.472 . . . . 0.0 110.694 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.72 40.49 7.18 Favored Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.203 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -91.91 -32.07 15.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.116 0.484 . . . . 0.0 110.412 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.552 ' O ' HG12 ' A' ' 116' ' ' ILE . 5.9 tpt -89.64 -41.56 11.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.521 -171.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.76 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 6.2 tp -59.81 -25.99 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.33 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' A' ' 114' ' ' LYS . 10.1 mmpt? -73.32 -45.33 55.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.924 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.95 -22.44 60.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.917 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 112' ' ' MET . 37.0 mm -59.42 -44.29 92.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.641 HE21 ' HB ' ' A' ' 124' ' ' ILE . 65.0 mt-30 -68.01 -25.5 65.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.26 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -79.7 -46.75 16.52 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.025 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -78.44 -52.68 8.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.317 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.558 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -81.07 -19.34 43.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.367 -176.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.35 26.35 63.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.629 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.3 m -95.84 161.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.377 0.608 . . . . 0.0 112.109 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.808 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 6.7 mpt_? -108.68 135.15 50.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.716 HG21 HD11 ' A' ' 113' ' ' ILE . 43.2 mm -116.29 129.83 72.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 1.047 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -143.51 169.56 17.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.186 168.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -117.29 104.28 10.99 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.898 ' HD2' ' HG3' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -94.83 -12.91 26.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -165.25 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.898 ' HG3' ' HD2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER 166.73 140.45 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.675 0.79 . . . . 0.0 109.055 173.244 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.573 ' OD2' ' HG2' ' A' ' 136' ' ' LYS . 1.3 m-20 -90.59 46.29 1.32 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.987 0.179 . . . . 0.0 111.059 -174.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.737 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 30.8 t70 56.57 -90.98 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -167.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 139.79 -22.66 2.81 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.499 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.5 p -113.22 -36.4 5.04 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.802 0.334 . . . . 0.0 110.334 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -87.31 159.24 30.8 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.393 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 87.6 Cg_endo -87.73 36.53 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.321 2.68 . . . . 0.0 112.656 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -130.89 156.43 45.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.932 0.396 . . . . 0.0 111.028 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.872 ' HG3' ' HG2' ' A' ' 99' ' ' ARG . 48.9 mttm -110.03 118.51 36.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.485 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 10.6 mm -77.34 120.53 28.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.041 0.448 . . . . 0.0 112.207 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.69 36.18 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.47 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 1.047 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 12.7 t-160 -85.15 104.71 15.28 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.953 HD12 HG21 ' A' ' 95' ' ' VAL . 60.5 mt -88.35 118.27 33.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.221 170.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.808 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 41.4 ttm -109.49 127.39 54.39 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 158.56 -160.59 31.12 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.478 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 16.3 Cg_exo -68.73 139.99 45.52 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.786 2.324 . . . . 0.0 110.855 174.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 143' ' ' PRO . 75.8 Cg_exo -50.56 -32.54 35.58 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.138 3.225 . . . . 0.0 114.139 -172.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.82 -44.61 66.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.789 0.328 . . . . 0.0 110.556 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.558 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 55.7 mtt-85 -70.76 -27.72 64.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.291 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.747 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 71.2 m -57.41 -56.05 26.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.27 175.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.08 -31.81 68.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.36 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 146' ' ' ARG . 30.9 t60 -55.95 -33.1 64.43 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.265 0.555 . . . . 0.0 110.313 173.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.702 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.24 -45.01 24.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.506 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.19 -24.56 67.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.403 0.621 . . . . 0.0 110.304 176.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -76.58 -26.27 54.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.106 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.575 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 68.5 mt -78.21 -40.89 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 73.6 mt -59.55 -43.17 90.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.064 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -57.06 -39.34 74.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.011 0.434 . . . . 0.0 110.666 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -69.91 -33.09 71.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.303 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 70.3 mt -66.61 -40.41 88.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.087 0.47 . . . . 0.0 110.335 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 56.3 mt -66.56 -28.73 68.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.854 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -83.36 -16.12 47.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.673 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 44.4 m -73.25 -20.6 60.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.557 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.43 0.46 1.04 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.845 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -68.92 -50.81 46.13 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.6 m -162.81 117.27 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.514 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.474 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.318 -179.65 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 112.071 -0.412 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.431 HG21 ' HA ' ' A' ' 57' ' ' PRO . 24.0 m -82.05 92.88 6.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.302 0.572 . . . . 0.0 110.945 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 12.1 p -125.65 121.98 61.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.858 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -109.99 150.74 28.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.759 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 39.1 mt-10 -116.06 123.36 47.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.439 0.638 . . . . 0.0 111.959 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -114.11 144.46 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.992 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.406 ' SD ' ' HB2' ' A' ' 48' ' ' ASP . 33.3 tpp -87.91 124.11 33.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.963 0.411 . . . . 0.0 111.514 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.7 mp -104.24 109.05 61.94 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.86 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.586 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 52.7 Cg_exo -61.29 147.25 96.08 Favored 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 123.596 2.864 . . . . 0.0 112.962 175.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.7 124.92 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.65 -39.14 2.99 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -169.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -79.71 -31.75 41.23 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.104 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.673 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -53.67 -34.34 58.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.881 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.03 -39.12 91.53 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.581 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.1 pp -89.7 -22.84 22.03 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.553 -0.381 . . . . 0.0 111.075 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.557 HG21 HD12 ' A' ' 71' ' ' LEU . 96.6 t -78.52 -46.83 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.729 HG13 ' H ' ' A' ' 19' ' ' LYS . 22.0 pt -91.2 -21.14 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.086 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.479 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.78 -0.73 59.44 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.759 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.729 ' H ' HG13 ' A' ' 17' ' ' ILE . 15.6 tptp 70.0 -52.33 0.63 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.975 0.91 . . . . 0.0 110.557 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.72 8.68 73.99 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.16 5.4 76.54 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.194 -0.526 . . . . 0.0 113.082 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.918 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 10.2 pt-20 -73.31 -27.57 61.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.487 HG23 ' C ' ' A' ' 80' ' ' GLY . 90.3 m -77.43 -43.67 31.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.899 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.555 ' HA ' HD12 ' A' ' 27' ' ' LEU . 6.2 tp -62.81 -24.21 35.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 CA-C-O 120.834 0.349 . . . . 0.0 110.525 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.918 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 77.9 mttt -60.85 -50.66 72.55 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.141 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.463 ' CB ' ' HB2' ' A' ' 81' ' ' ASP . 39.2 mt-30 -71.54 -31.75 67.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.107 -177.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 24' ' ' ILE . 47.7 mt -68.44 -27.58 66.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 110.611 176.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.1 mt-30 -84.65 -47.55 10.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.295 0.569 . . . . 0.0 110.565 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.951 ' HB3' ' HA3' ' A' ' 131' ' ' GLY . 21.4 mm-40 -84.02 -53.37 5.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.206 -171.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.679 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 26.3 ttm180 -65.6 -44.47 86.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -80.66 -7.19 59.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.316 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.77 9.34 38.74 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.763 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.2 m -109.15 172.16 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.95 0.375 . . . . 0.0 110.362 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -113.43 109.98 19.56 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.867 ' HB3' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -95.19 112.82 24.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.275 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.499 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.1 tp -111.11 100.67 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 122.392 1.091 . . . . 0.0 110.667 -177.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.896 ' HG ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -134.38 143.91 47.9 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.634 178.129 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.0 mp -62.51 100.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.886 0.374 . . . . 0.0 110.237 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -87.36 -77.21 0.34 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -104.85 86.68 2.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.224 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . -144.28 163.12 27.85 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.021 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 m -62.54 -28.74 70.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -82.16 -78.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.39 . . . . 0.0 111.77 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.625 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 76.2 m-20 -110.34 56.25 0.63 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.874 -171.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 9.3 t -80.19 -45.43 18.08 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -94.01 -26.52 16.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.824 0.821 . . . . 0.0 109.026 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.625 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 57.3 t -78.89 159.86 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.009 -175.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 47' ' ' VAL . 3.3 p-10 -55.94 151.33 11.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -126.71 129.83 23.98 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.509 -166.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.06 112.99 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.846 2.364 . . . . 0.0 112.108 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.896 HD22 ' HG ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -81.37 110.52 16.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.973 -176.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.573 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.6 mpt_? -98.77 107.46 19.91 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.42 174.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.3 mt -91.43 113.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.053 176.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.0 mt -103.77 123.12 57.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.806 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.4 -171.45 44.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.267 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 9.7 t70 -71.34 139.14 84.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.431 ' HA ' HG21 ' A' ' 2' ' ' THR . 30.3 Cg_exo -34.82 -47.06 0.62 Allowed 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 124.07 3.18 . . . . 0.0 114.99 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -61.81 -40.64 95.95 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.821 0.344 . . . . 0.0 111.281 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 56' ' ' ASP . 19.7 ptpt -82.14 -31.04 30.76 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.95 -175.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.98 -30.68 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.546 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -52.21 14.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.442 ' HB3' ' CD2' ' A' ' 85' ' ' TYR . 14.8 mm-40 -65.59 -23.68 66.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.708 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -81.21 -51.32 8.55 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.997 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.501 ' SG ' HD12 ' A' ' 53' ' ' ILE . 94.5 m -54.11 -40.81 67.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.272 0.558 . . . . 0.0 109.978 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -58.54 -53.28 60.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.822 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.668 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 6.6 ptt? -64.43 -40.81 96.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.89 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 63' ' ' ALA . 86.9 t -56.53 -47.64 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.531 0.205 . . . . 0.0 110.812 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.1 mtt -69.87 -26.9 64.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.956 0.408 . . . . 0.0 110.89 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.544 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -85.36 -27.91 25.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.78 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.7 pp -90.14 -32.64 5.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 O-C-N 121.71 -0.619 . . . . 0.0 111.788 175.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.588 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 4.2 tt -71.98 -12.5 61.27 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.604 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -67.36 -10.42 50.91 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.256 -0.278 . . . . 0.0 111.22 177.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.927 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 9.2 tp10 -56.57 131.13 47.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.136 0.494 . . . . 0.0 110.297 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 31.0 ptt180 -66.67 -44.57 81.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.888 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 29.1 t0 172.88 92.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.869 0.73 . . . . 0.0 109.54 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -176.19 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.926 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.927 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . 160.78 131.25 1.2 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.169 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -87.89 58.55 4.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.154 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.608 ' HD2' HG22 ' A' ' 70' ' ' ILE . 78.5 m-85 57.72 8.84 0.73 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.212 0.605 . . . . 0.0 112.416 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.487 ' C ' HG23 ' A' ' 23' ' ' THR . . . 70.06 7.34 59.41 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.581 -0.342 . . . . 0.0 113.087 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.679 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.2 OUTLIER 170.71 -62.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.107 0.479 . . . . 0.0 109.781 -172.356 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.78 ' HA ' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER 163.71 -45.02 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.446 -173.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 57.63 72.37 0.52 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.388 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 1.04 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 24.8 tt0 -171.34 -68.56 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.749 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.34 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.691 ' H ' ' HD2' ' A' ' 82' ' ' ARG . 0.9 OUTLIER -136.18 -95.7 0.24 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.527 -0.733 . . . . 0.0 111.926 178.011 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.571 ' H ' ' HD2' ' A' ' 85' ' ' TYR . . . 84.96 92.03 0.79 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 38.0 t 65.49 6.34 3.7 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.709 0.404 . . . . 0.0 110.893 -175.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.755 ' HG3' ' HD2' ' A' ' 127' ' ' LYS . 3.0 mmp_? -132.66 171.61 13.62 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.102 -173.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.98 HD11 ' HG2' ' A' ' 125' ' ' GLN . 24.3 mm 28.95 -83.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 125.725 1.891 . . . . 0.0 115.144 169.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.53 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 86.49 36.18 9.85 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -172.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.18 98.23 0.11 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.802 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 112.0 161.66 16.22 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -174.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.04 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 40.0 pt -93.98 158.77 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -172.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CG ' HG21 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -102.55 108.07 19.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.015 179.481 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 27.5 t -101.11 105.12 37.07 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' CA ' HD13 ' A' ' 137' ' ' ILE . 56.9 Cg_endo -75.06 108.12 2.64 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.047 1.832 . . . . 0.0 111.885 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.685 HG13 HD21 ' A' ' 158' ' ' LEU . 47.2 t -101.65 127.76 30.58 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.997 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.626 ' HD2' HD22 ' A' ' 158' ' ' LEU . 74.3 Cg_exo -41.59 132.97 3.72 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.803 3.002 . . . . 0.0 112.734 171.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' A' ' 134' ' ' PRO . 32.6 ptt180 -51.34 -34.92 35.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.562 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -92.5 4.69 53.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.352 -177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.6 m -122.44 -18.55 6.68 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.586 ' HA ' HG11 ' A' ' 97' ' ' VAL . 14.2 p -59.1 -34.1 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.623 0.249 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.53 -30.0 75.74 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.798 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.78 -33.79 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.055 0.455 . . . . 0.0 109.868 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.53 -36.09 76.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.01 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.752 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 37.7 mm -75.23 -46.04 39.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.266 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.45 -127.19 7.49 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 108' ' ' ARG . 4.2 mmp_? -100.39 -65.38 0.97 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.7 m -105.64 -20.96 13.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.514 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.17 50.18 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.127 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -93.86 -57.78 2.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.703 0.287 . . . . 0.0 110.472 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.573 ' HA ' ' HD3' ' A' ' 115' ' ' LYS . 14.2 tpt -59.82 -36.43 76.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.367 -174.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.752 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.6 tp -65.78 -32.39 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -86.43 -19.76 29.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.308 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.573 ' HD3' ' HA ' ' A' ' 112' ' ' MET . 26.5 mtpp -66.79 -35.68 80.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.297 174.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 112' ' ' MET . 30.1 mm -62.89 -38.51 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.198 0.523 . . . . 0.0 109.629 175.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -64.69 -34.01 77.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.675 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -82.36 -38.64 23.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.277 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.9 -55.8 4.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.002 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.85 -25.38 22.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.558 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.97 32.9 19.77 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.981 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 m -114.69 164.1 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.094 0.473 . . . . 0.0 111.449 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -109.87 163.17 13.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.641 HG21 HD11 ' A' ' 113' ' ' ILE . 45.3 mm -123.76 124.36 69.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.048 0.452 . . . . 0.0 111.492 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.98 ' HG2' HD11 ' A' ' 89' ' ' ILE . 50.5 tp60 -115.18 112.96 23.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.034 177.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.433 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 35.7 m-85 -87.64 106.04 17.76 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.365 0.602 . . . . 0.0 109.566 173.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.755 ' HD2' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -107.46 -159.28 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.753 -178.179 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.431 ' H ' ' HB2' ' A' ' 127' ' ' LYS . 50.9 tp60 -71.65 63.66 0.43 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.298 0.57 . . . . 0.0 112.099 -176.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.512 ' OD2' ' HG2' ' A' ' 136' ' ' LYS . 0.9 OUTLIER 48.84 -163.82 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 170.035 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.567 ' OD2' HG22 ' A' ' 132' ' ' THR . 16.3 t70 -88.05 -65.53 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.368 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.951 ' HA3' ' HB3' ' A' ' 29' ' ' GLU . . . 132.3 -48.12 0.98 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.775 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.567 HG22 ' OD2' ' A' ' 130' ' ' ASP . 13.9 t -72.57 -12.23 60.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.413 0.607 . . . . 0.0 111.11 -173.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -163.92 -156.15 8.64 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.779 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.547 ' HB2' ' HD3' ' A' ' 99' ' ' ARG . 92.4 Cg_endo -81.33 9.49 3.84 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.802 2.335 . . . . 0.0 112.771 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.557 ' OE1' ' HA ' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -75.37 149.24 38.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 111.131 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.512 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 60.1 mttm -124.93 123.16 39.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.996 -175.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.696 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 40.0 mm -65.43 111.25 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.954 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -90.84 91.07 8.2 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 164.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 28.0 t60 -71.18 115.86 10.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.228 0.537 . . . . 0.0 111.08 -169.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.771 HD11 HD12 ' A' ' 154' ' ' ILE . 96.4 mt -79.74 107.79 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.222 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.493 ' HB2' ' HD2' ' A' ' 139' ' ' HIS . 21.9 ttp -103.96 128.12 51.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.13 -172.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.26 -156.4 27.21 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.41 137.79 44.22 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.669 2.246 . . . . 0.0 111.705 177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -45.56 -55.07 3.81 Favored 'Trans proline' 0 N--CA 1.474 0.378 0 C-N-CA 123.543 2.828 . . . . 0.0 113.978 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -64.52 -32.86 74.68 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.798 0.333 . . . . 0.0 111.03 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -72.5 -36.06 68.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.802 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 74.5 m -60.72 -54.5 44.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.44 174.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.584 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 4.7 mm-40 -54.97 -42.04 71.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.739 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -59.65 -31.61 69.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.401 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.67 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.22 -35.15 42.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.365 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -70.71 -18.71 62.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.644 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 9.8 mpt_? -77.57 -17.3 58.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.977 0.418 . . . . 0.0 109.975 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.93 -50.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.913 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.771 HD12 HD11 ' A' ' 140' ' ' ILE . 38.7 mt -71.64 -57.18 8.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.734 -173.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.552 ' O ' ' HG2' ' A' ' 159' ' ' GLN . 3.9 m-20 -59.07 -28.65 66.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.881 0.372 . . . . 0.0 110.813 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.93 -47.32 80.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.428 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 4.4 pp -76.59 -20.91 56.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.326 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.685 HD21 HG13 ' A' ' 97' ' ' VAL . 33.6 mt -67.91 -33.64 75.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.198 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 155' ' ' ASN . 61.9 mm-40 -67.66 -30.49 70.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 109.67 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 157' ' ' LEU . 49.8 m -64.12 -23.08 67.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.596 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.5 mt -111.1 2.77 18.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.934 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -111.24 59.38 0.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.095 0.474 . . . . 0.0 110.783 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.1 m -83.96 -10.49 57.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.341 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.0 176.49 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 57' ' ' PRO . 6.6 m -129.31 104.35 7.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 29.3 m -130.98 124.56 56.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 0.0 110.8 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -105.42 153.75 21.26 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.608 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 51.9 mt-10 -123.86 109.06 13.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.457 0.646 . . . . 0.0 111.677 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -105.59 139.02 28.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.7 tpp -91.01 122.35 33.6 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.716 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.696 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -95.53 113.76 62.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.749 -177.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -61.78 153.87 64.72 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.628 2.886 . . . . 0.0 112.459 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.74 144.66 55.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 171.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.42 -53.15 3.46 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -170.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -63.36 -35.11 79.29 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.372 172.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.675 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -49.12 -34.37 13.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.839 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -60.06 -44.34 97.37 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.615 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 75' ' ' ASP . 4.1 pp -85.48 -23.95 27.58 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.081 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.696 HG11 HG12 ' A' ' 8' ' ' ILE . 97.7 t -73.69 -42.9 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.681 HG13 ' H ' ' A' ' 19' ' ' LYS . 21.2 pt -91.56 -25.24 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 121.679 -0.638 . . . . 0.0 111.083 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.612 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 100.49 3.77 55.17 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.904 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.681 ' H ' HG13 ' A' ' 17' ' ' ILE . 7.6 tptm 53.82 48.13 22.05 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.542 0.687 . . . . 0.0 110.462 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.57 -1.48 0.52 Allowed Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.945 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.34 26.46 13.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.605 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -84.11 -60.12 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.988 0.423 . . . . 0.0 110.555 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.612 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 54.4 m -61.33 -44.52 97.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.359 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -31.4 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.032 0.444 . . . . 0.0 110.19 -177.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HG2' ' HA3' ' A' ' 131' ' ' GLY . 0.1 OUTLIER -64.25 -39.01 93.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.264 177.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 30' ' ' ARG . 76.4 mt-30 -77.85 -39.53 43.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.269 0.557 . . . . 0.0 109.61 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.625 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 74.8 mt -64.0 -23.85 67.49 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.81 0.338 . . . . 0.0 110.61 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.692 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.9 mt-30 -85.89 -58.37 2.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.808 0.337 . . . . 0.0 111.751 174.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -82.59 -42.26 18.51 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -172.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.57 ' HG3' HG13 ' A' ' 137' ' ' ILE . 1.9 mtp180 -73.7 -38.72 64.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.83 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -84.39 -12.22 54.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.209 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.75 75.09 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.992 175.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 23.3 m -128.15 153.15 37.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.844 0.354 . . . . 0.0 110.675 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -90.13 110.14 21.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 1.014 ' HB3' HD21 ' A' ' 51' ' ' LEU . 48.9 mtt -96.25 124.58 40.31 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.446 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 6.1 tp -119.09 111.12 32.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.776 0.798 . . . . 0.0 110.217 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.724 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -134.15 144.35 48.48 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.829 -174.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.492 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 43.8 mm -68.19 104.48 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.05 0.452 . . . . 0.0 111.207 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 1.3 pp0? -146.71 20.85 1.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.64 0.733 . . . . 0.0 109.868 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.27 23.15 0.29 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.702 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . 82.33 -55.59 4.96 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.223 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.4 t -90.53 -157.9 0.51 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 62.04 -132.27 0.59 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.304 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.477 ' H ' HG21 ' A' ' 38' ' ' ILE . 93.8 m-20 -80.88 69.51 7.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.487 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 4.0 t -79.58 -44.96 20.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.904 0.383 . . . . 0.0 110.801 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -93.27 -3.54 53.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.161 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.11 159.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.913 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.02 156.22 36.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 18.2 mttm -131.06 128.35 22.24 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.301 -161.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.53 125.35 8.25 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.435 2.09 . . . . 0.0 112.021 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.014 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.5 tm? -105.88 120.42 41.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.603 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.608 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.7 mpt_? -102.98 121.61 42.9 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.395 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.9 mt -90.5 109.92 21.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.465 HG12 HG12 ' A' ' 3' ' ' VAL . 36.8 mt -104.92 119.33 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.524 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.45 -170.74 43.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.921 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -67.24 142.03 96.55 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HA ' HG21 ' A' ' 2' ' ' THR . 87.4 Cg_exo -46.29 -47.68 14.6 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.129 2.553 . . . . 0.0 113.931 -172.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.483 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 46.1 t80 -59.23 -40.71 86.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.151 0.5 . . . . 0.0 110.647 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -67.99 -45.49 73.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.093 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.6 t -58.33 -34.08 49.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.558 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -73.99 -40.51 62.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.737 0.303 . . . . 0.0 111.377 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.646 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 72.9 mm-40 -72.99 -29.02 62.73 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.139 0.495 . . . . 0.0 110.268 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -85.65 -36.59 20.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.8 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.7 p -55.56 -43.4 75.83 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.96 0.41 . . . . 0.0 111.146 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.53 -38.85 81.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.593 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.803 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 4.9 ptt? -71.49 -34.27 70.0 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.598 -176.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 63' ' ' ALA . 89.4 t -56.99 -36.17 49.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 174.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 36.2 mtm -82.0 -28.34 32.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.449 0.642 . . . . 0.0 110.19 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 36.5 t70 -75.87 -41.29 52.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.311 -171.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.909 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.8 pp -89.63 -26.3 5.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 8' ' ' ILE . 5.8 tt -69.6 -24.27 63.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.673 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -19.94 59.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.591 -177.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 12.5 tp10 -51.19 -90.31 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.561 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 61.9 ttt180 168.08 -82.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.1 p-10 -168.52 12.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.828 172.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -86.46 -76.26 0.36 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.501 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -140.43 83.65 0.23 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.792 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.561 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -91.83 24.07 22.85 Favored Glycine 0 C--O 1.226 -0.388 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 175.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.725 ' HD2' HG22 ' A' ' 70' ' ' ILE . 54.6 m-85 69.05 -23.86 0.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.394 1.078 . . . . 0.0 113.56 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.496 ' C ' HG23 ' A' ' 23' ' ' THR . . . 84.14 15.4 69.61 Favored Glycine 0 C--N 1.328 0.129 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.399 177.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.423 ' HA ' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER 173.89 -65.69 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -174.567 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.909 ' HA ' HG21 ' A' ' 70' ' ' ILE . 32.3 ttt180 166.88 -18.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.906 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 79' ' ' PHE . 0.3 OUTLIER 67.66 42.7 1.98 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.025 176.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 28.9 tt0 -160.64 -52.56 0.05 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.472 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 46.0 p90 -176.71 171.7 2.22 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 110.075 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.682 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -132.95 -11.13 1.88 Allowed Glycine 0 CA--C 1.523 0.57 0 O-C-N 123.726 0.641 . . . . 0.0 112.28 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.646 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 18.0 p 178.28 -55.97 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.62 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 1.4 mpt_? -70.08 179.1 2.46 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.752 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.666 HG23 ' CD2' ' A' ' 139' ' ' HIS . 54.2 mt 78.36 -74.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.64 0.587 . . . . 0.0 111.136 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 46.91 46.73 19.65 Favored Glycine 0 C--N 1.337 0.609 0 O-C-N 123.41 0.444 . . . . 0.0 112.582 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 142.85 99.88 0.34 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.673 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 113.69 166.11 16.03 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -174.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 2.8 pp -93.66 -178.43 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.223 0.535 . . . . 0.0 112.253 -173.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.565 ' OD2' ' HD3' ' A' ' 96' ' ' PRO . 1.7 p-10 -109.74 147.01 33.96 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.142 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.895 HG23 ' HB3' ' A' ' 138' ' ' ALA . 3.5 m -137.56 97.14 10.48 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 121.229 0.537 . . . . 0.0 111.666 173.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HD3' ' OD2' ' A' ' 94' ' ' ASP . 37.2 Cg_endo -67.04 108.55 1.53 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.155 2.57 . . . . 0.0 111.692 173.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 102' ' ' VAL . 99.0 t -103.52 120.1 52.78 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.818 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -46.32 128.02 11.77 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.768 2.312 . . . . 0.0 110.872 170.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.71 -31.5 37.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -173.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -82.12 -9.76 59.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.968 0.413 . . . . 0.0 110.809 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -107.06 -19.1 13.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.514 ' HA ' HG11 ' A' ' 97' ' ' VAL . 94.6 t -48.31 -45.39 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.491 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.87 -22.13 61.9 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.986 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.7 t -86.51 -38.78 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.89 0.376 . . . . 0.0 110.075 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.6 t -66.61 -38.77 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 121.345 0.593 . . . . 0.0 109.904 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.762 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 38.9 mm -70.54 -43.36 77.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.562 174.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.92 66.92 1.39 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.726 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 108' ' ' ARG . 4.0 mpt_? 57.81 -94.81 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.061 0.544 . . . . 0.0 112.055 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.1 m -77.21 -13.29 59.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.399 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' A' ' 106' ' ' ILE . . . 109.11 22.38 6.9 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.992 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 12.8 pt-20 -85.45 -10.81 55.63 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.737 -0.272 . . . . 0.0 111.689 -176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.9 tpt -89.94 -40.8 12.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 0.0 110.421 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.762 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 11.0 tp -62.19 -25.32 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.449 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 45.6 mtpt -85.93 -22.05 27.61 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.605 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 61.1 mttp -68.51 -32.95 73.28 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.533 HG23 HD12 ' A' ' 153' ' ' ILE . 29.8 mt -63.65 -37.02 78.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.505 0.669 . . . . 0.0 109.43 174.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -73.04 -26.33 61.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.858 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -87.56 -41.24 13.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.024 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.1 -51.33 10.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.185 -174.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.584 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -92.77 -11.05 34.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.084 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.42 31.65 68.37 Favored Glycine 0 C--O 1.229 -0.196 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.484 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.65 -177.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.036 0.446 . . . . 0.0 111.909 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.631 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 55.1 ttt180 -132.57 143.2 49.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.177 176.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.565 HG21 HD11 ' A' ' 113' ' ' ILE . 47.0 mm -110.86 142.84 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.041 0.448 . . . . 0.0 112.164 -171.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 2.2 tt0 -148.34 114.38 5.8 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.281 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.401 ' CE1' HD11 ' A' ' 106' ' ' ILE . 36.6 m-85 -79.45 111.21 15.48 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.803 -0.56 . . . . 0.0 109.635 175.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -121.34 112.91 19.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.369 -174.447 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 59.69 -167.46 0.17 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.224 0.535 . . . . 0.0 110.984 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.582 ' OD1' ' HG2' ' A' ' 136' ' ' LYS . 5.7 m-20 -135.93 171.68 14.11 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.525 ' HB2' HD11 ' A' ' 137' ' ' ILE . 15.5 t70 -84.72 139.6 31.88 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.415 ' HA3' ' HG2' ' A' ' 25' ' ' LYS . . . -63.08 -10.46 33.7 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 114.268 -171.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.635 HG23 ' HD2' ' A' ' 134' ' ' PRO . 14.5 t -77.44 -26.28 51.41 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.566 0.683 . . . . 0.0 110.358 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 118.67 -70.61 0.32 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.714 -0.755 . . . . 0.0 114.267 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.635 ' HD2' HG23 ' A' ' 132' ' ' THR . 9.3 Cg_endo -51.67 -50.1 15.08 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.708 2.939 . . . . 0.0 115.249 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -94.46 134.66 36.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.581 0.705 . . . . 0.0 112.358 -169.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HG2' ' OD1' ' A' ' 129' ' ' ASP . 48.3 mttm -110.88 120.8 43.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.804 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.57 HG13 ' HG3' ' A' ' 30' ' ' ARG . 9.1 mm -72.34 116.37 14.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.808 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.895 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -105.09 143.12 33.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.199 0.523 . . . . 0.0 111.417 174.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.666 ' CD2' HG23 ' A' ' 89' ' ' ILE . 10.4 t-160 -86.38 125.58 33.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.902 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.675 HD12 HD11 ' A' ' 93' ' ' ILE . 30.6 mt -106.91 107.8 23.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.805 170.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.631 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 37.0 ttm -95.59 129.69 42.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.151 -175.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.64 -167.79 36.56 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.633 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.12 143.44 78.15 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.489 2.126 . . . . 0.0 110.811 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.32 -48.17 8.41 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 124.023 3.148 . . . . 0.0 113.758 -173.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -61.79 -47.81 83.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.32 0.581 . . . . 0.0 110.945 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 49.7 mtt180 -69.51 -22.38 63.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.307 -176.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.673 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 77.8 m -59.22 -52.31 66.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.249 0.547 . . . . 0.0 110.003 174.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -74.39 -31.71 62.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.731 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 146' ' ' ARG . 9.4 t60 -62.49 -29.91 70.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.243 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.556 ' HB3' HG21 ' A' ' 140' ' ' ILE . . . -80.17 -38.85 30.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.506 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.3 -23.82 66.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.302 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 149' ' ' HIS . 13.5 ptt180 -76.62 -25.14 53.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -174.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.568 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 62.5 mt -68.82 -41.46 82.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.529 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.8 -40.74 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.057 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -57.8 -45.79 85.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.458 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -57.84 -37.31 73.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.926 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 77.4 mt -65.36 -50.77 64.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.545 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 mt -63.91 -37.13 86.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.217 0.532 . . . . 0.0 110.192 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -69.86 -34.1 73.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.799 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.2 t -69.12 -22.64 63.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.985 0.421 . . . . 0.0 110.492 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 81.9 mt -84.05 -4.33 58.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.248 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -76.2 135.6 39.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.6 t -73.92 103.17 4.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.101 0.477 . . . . 0.0 109.833 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.244 -174.846 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 0.9 OUTLIER -161.32 -42.01 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.384 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.762 HG22 HG12 ' A' ' 54' ' ' ILE . 20.6 t -142.8 112.65 2.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.688 166.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 16.6 mm100 -123.85 159.59 29.27 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 176.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 48.7 mt-10 -116.88 129.15 55.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.17 0.51 . . . . 0.0 111.35 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.799 HD11 ' HA ' ' A' ' 64' ' ' CYS . 74.5 mt -111.43 145.97 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.54 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.21 110.29 20.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.835 0.35 . . . . 0.0 111.427 -175.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.9 mp -106.42 106.39 57.33 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.276 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.82 163.95 37.3 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.793 2.329 . . . . 0.0 111.342 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.85 145.3 56.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.47 -56.57 2.0 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -172.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -68.93 -27.91 66.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.827 0.346 . . . . 0.0 110.481 175.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.614 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -53.52 -35.37 60.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.133 174.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.705 ' HA3' ' HE3' ' A' ' 19' ' ' LYS . . . -63.37 -47.69 85.36 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.846 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 73' ' ' GLU . 2.7 pp -78.68 -19.16 53.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.2 0.5 . . . . 0.0 111.407 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.403 ' N ' HD12 ' A' ' 15' ' ' LEU . 74.8 t -78.41 -40.24 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.764 0.316 . . . . 0.0 111.151 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 13' ' ' ALA . 30.9 pt -88.86 -29.48 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.075 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.521 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.9 16.8 32.18 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.705 ' HE3' ' HA3' ' A' ' 14' ' ' GLY . 33.4 mmtp 55.44 47.07 21.93 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.006 0.522 . . . . 0.0 110.867 -175.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.11 -35.83 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.35 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 152.87 -12.43 0.62 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.295 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.526 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 20.1 mm-40 -45.26 -49.81 12.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.521 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 26.1 m -81.29 -34.89 31.69 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.435 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 21' ' ' GLY . 7.3 tp -64.91 -26.92 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.012 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 84.4 mttt -55.19 -53.6 54.0 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.913 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.488 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 70.5 mt-30 -66.14 -45.08 82.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.592 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.618 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 95.7 mt -59.87 -29.13 68.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.897 0.38 . . . . 0.0 111.124 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.712 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 27.5 mt-30 -85.89 -49.81 7.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.147 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.63 -51.78 5.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.656 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 15.2 ttm180 -65.14 -42.83 93.44 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -80.89 -29.66 35.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.557 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.73 0.92 85.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.351 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 34.6 m -112.87 151.45 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -91.39 109.66 20.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.607 ' HB3' HD21 ' A' ' 51' ' ' LEU . 41.6 mtt -95.61 114.05 25.77 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.625 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.5 tp -113.12 109.63 29.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.99 0.9 . . . . 0.0 109.532 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.86 HD13 HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -124.11 136.86 54.52 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.45 -174.537 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.697 HG22 ' HD2' ' A' ' 50' ' ' PRO . 10.8 tp -76.15 100.8 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 122.012 0.91 . . . . 0.0 110.014 -174.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 41' ' ' GLY . 21.6 tm0? -132.09 135.1 46.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.084 -173.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 t70 72.52 -23.81 0.2 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.82 0.848 . . . . 0.0 111.874 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 39' ' ' GLN . . . -68.24 155.81 53.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.203 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -74.28 76.17 1.84 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.066 0.46 . . . . 0.0 111.415 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -160.98 -62.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.158 176.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -131.68 53.71 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 110.439 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -83.08 -41.53 18.5 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.714 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -91.61 -4.2 55.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.386 0.612 . . . . 0.0 109.875 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 48' ' ' ASP . 40.3 t -108.45 165.03 5.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.519 -173.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.453 ' N ' HG12 ' A' ' 47' ' ' VAL . 5.0 p-10 -58.14 150.58 20.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.123 0.487 . . . . 0.0 110.289 171.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -126.99 127.43 24.37 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.101 -169.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.697 ' HD2' HG22 ' A' ' 38' ' ' ILE . 83.3 Cg_endo -81.18 108.18 1.98 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.74 2.294 . . . . 0.0 112.09 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.86 HD12 HD13 ' A' ' 37' ' ' LEU . 9.6 tt -84.17 117.55 23.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.841 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 36' ' ' ILE . 1.5 mpt_? -91.42 112.22 24.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.107 0.254 . . . . 0.0 110.964 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.751 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 62.5 mt -89.12 113.02 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.057 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.762 HG12 HG22 ' A' ' 3' ' ' VAL . 30.3 mt -104.55 118.17 51.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.493 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 176.52 -170.9 43.83 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.393 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.468 ' O ' HG23 ' A' ' 60' ' ' VAL . 9.3 m-20 -65.11 147.38 98.58 Favored Pre-proline 0 N--CA 1.462 0.156 0 C-N-CA 122.46 0.304 . . . . 0.0 110.507 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 1' ' ' GLY . 83.2 Cg_exo -49.89 -52.41 8.94 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.112 2.542 . . . . 0.0 114.613 -173.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.437 ' HE2' ' HG2' ' A' ' 88' ' ' ARG . 17.5 p90 -63.17 -27.07 69.12 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.949 0.404 . . . . 0.0 110.571 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 91.7 mttt -72.46 -50.52 25.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.555 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 56' ' ' ASP . 22.0 t -59.93 -34.95 57.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.03 -176.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -66.3 -51.19 59.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 77.3 mm-40 -64.83 -37.71 88.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 110.38 -177.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.596 ' HB2' ' OG ' ' A' ' 87' ' ' SER . . . -69.19 -40.38 78.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.751 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.799 ' HA ' HD11 ' A' ' 6' ' ' ILE . 54.0 t -52.41 -43.4 64.77 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.209 0.528 . . . . 0.0 110.208 177.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 37.9 tt0 -71.1 -46.14 62.32 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.587 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.587 ' SD ' ' HA ' ' A' ' 63' ' ' ALA . 3.8 ptt? -65.35 -39.69 92.69 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.494 -171.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.774 ' HB ' HD13 ' A' ' 6' ' ' ILE . 90.4 t -62.32 -50.19 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.367 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.542 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 56.4 mtp -63.32 -30.29 71.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.05 0.452 . . . . 0.0 110.586 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -73.37 -40.24 64.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.898 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.855 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.9 pp -86.67 -24.29 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.684 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.751 HD23 HG12 ' A' ' 67' ' ' VAL . 3.6 pp -83.09 -0.38 48.83 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.37 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 11.9 ptm180 -50.92 -42.8 59.74 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.746 ' HB2' HD21 ' A' ' 15' ' ' LEU . 27.1 tt0 60.07 110.84 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 124.373 1.046 . . . . 0.0 113.107 174.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -107.67 -39.17 5.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -140.66 50.58 1.66 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 59.49 68.2 0.82 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.18 0.514 . . . . 0.0 111.571 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.32 -40.62 0.24 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.652 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 76.48 -96.7 1.15 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.182 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.596 ' HD2' ' HA ' ' A' ' 70' ' ' ILE . 97.2 m-85 -144.47 -29.95 0.47 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.851 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.72 100.48 0.64 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 27.1 t70 68.79 -72.75 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -169.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.855 ' HA ' HG21 ' A' ' 70' ' ' ILE . 26.6 ttt180 178.26 -29.36 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.483 169.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t30 66.96 16.04 10.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.195 0.998 . . . . 0.0 109.479 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.962 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 74.6 mt-10 -129.12 -31.29 2.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.787 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.729 ' CB ' ' HB ' ' A' ' 89' ' ' ILE . 30.0 p90 176.98 152.68 0.2 Allowed 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.385 172.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.559 ' C ' ' HA ' ' A' ' 31' ' ' ALA . . . -117.53 106.31 1.38 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.404 168.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.804 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 43.4 m 51.51 35.64 14.94 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.7 ' HB3' HD12 ' A' ' 89' ' ' ILE . 11.8 mtt180 -166.12 -162.36 0.54 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.729 ' HB ' ' CB ' ' A' ' 85' ' ' TYR . 2.8 mp 63.97 -77.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 124.039 0.837 . . . . 0.0 111.806 173.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 57.51 48.06 83.76 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.65 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 144.91 81.27 0.05 OUTLIER Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.292 -0.48 . . . . 0.0 111.92 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 141.37 -150.16 21.65 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.962 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 47.9 pt -136.56 167.34 24.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 116.9 0.35 . . . . 0.0 111.219 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.656 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 3.5 p30 -108.59 139.22 43.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 171.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.881 HG23 ' HB3' ' A' ' 138' ' ' ALA . 11.8 m -133.35 95.48 18.19 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 121.107 0.48 . . . . 0.0 111.277 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 19.9 Cg_endo -62.54 108.31 0.7 Allowed 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.692 2.261 . . . . 0.0 111.071 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.463 ' HA ' ' HD2' ' A' ' 98' ' ' PRO . 12.8 p -110.27 125.02 31.85 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.955 0.407 . . . . 0.0 111.102 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 97' ' ' VAL . 5.5 Cg_endo -48.64 124.06 10.4 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.221 2.614 . . . . 0.0 111.774 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -63.64 -20.94 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.706 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -83.7 -0.87 52.61 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.785 0.326 . . . . 0.0 110.775 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.667 ' HB3' HD21 ' A' ' 161' ' ' LEU . 18.9 m -129.63 -2.43 4.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.653 -175.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.95 -24.78 24.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 110.592 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.96 -28.88 66.82 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.394 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.1 t -77.14 -37.61 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.083 0.468 . . . . 0.0 110.388 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.1 t -71.02 -37.31 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.609 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.6 mm -80.19 -38.87 18.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.52 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.68 -104.33 2.9 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.037 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -138.32 -66.58 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.704 0.288 . . . . 0.0 110.395 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.7 m -88.76 -3.78 58.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.344 0.592 . . . . 0.0 110.297 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.95 31.08 7.9 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.41 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -92.81 -26.81 17.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.765 0.317 . . . . 0.0 110.358 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.518 ' SD ' ' HD3' ' A' ' 115' ' ' LYS . 16.3 tpt -69.63 -36.55 76.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.375 0.607 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.427 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 4.6 tp -70.36 -32.93 52.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.913 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -73.53 -28.31 61.82 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.508 0.67 . . . . 0.0 109.421 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.518 ' HD3' ' SD ' ' A' ' 112' ' ' MET . 21.0 tttp -68.77 -31.87 71.21 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.65 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.5 mm -62.28 -36.87 76.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.679 0.752 . . . . 0.0 109.055 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 13.8 mt-30 -72.56 -22.19 61.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.557 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -79.52 -30.57 41.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.945 0.403 . . . . 0.0 110.803 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.36 -55.86 4.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.587 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -101.02 -28.97 12.43 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.922 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 117' ' ' GLN . . . 88.23 74.29 1.28 Allowed Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.681 -175.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 150' ' ' ALA . 18.6 m -134.23 166.95 27.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.683 0.278 . . . . 0.0 110.927 -175.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.816 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 23.5 ttt180 -122.27 138.81 54.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.8 mm -112.81 136.3 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -169.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.754 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 3.9 tp-100 -132.43 138.45 47.65 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.365 174.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -111.68 113.88 26.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.558 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -128.55 152.78 47.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.929 -173.127 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.478 ' HB3' ' H ' ' A' ' 129' ' ' ASP . 13.1 mm100 67.73 -146.71 0.14 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.723 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' A' ' 128' ' ' GLN . 2.4 m-20 -45.27 106.02 0.07 Allowed 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 124.214 0.946 . . . . 0.0 112.0 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -103.58 11.07 36.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.156 -174.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 151.43 -14.21 0.82 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.132 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.9 p -60.64 -57.22 13.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.013 0.435 . . . . 0.0 109.852 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.85 175.19 55.12 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 171.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.94 -33.71 19.23 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.546 2.164 . . . . 0.0 112.178 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 98' ' ' PRO . 3.0 mp0 -111.48 153.98 25.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.899 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 129' ' ' ASP . 22.7 mtpp -109.96 113.23 25.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.367 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.558 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 17.5 mm -68.86 105.71 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.113 0.482 . . . . 0.0 111.123 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.881 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -94.77 141.4 28.67 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.368 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -96.65 113.61 25.19 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.182 176.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.639 HD13 ' HB3' ' A' ' 150' ' ' ALA . 48.0 mt -93.22 119.6 41.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.634 173.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.816 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 38.0 ttm -105.89 137.77 43.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.445 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.48 179.34 26.17 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.318 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 74.1 Cg_exo -52.36 149.17 23.69 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.927 2.418 . . . . 0.0 111.824 175.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.6 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 76.8 Cg_exo -51.34 -27.69 24.58 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.684 2.923 . . . . 0.0 113.684 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 12.5 t70 -76.97 -46.42 24.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.06 0.457 . . . . 0.0 109.84 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -60.45 -47.3 86.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.912 -177.072 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 17.7 p -57.58 -56.5 21.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.777 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -68.45 -23.46 64.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.814 0.34 . . . . 0.0 111.463 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.477 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 4.6 t60 -70.41 -30.37 67.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.134 0.492 . . . . 0.0 109.673 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.639 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.09 -41.66 28.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.926 -177.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.22 -32.02 69.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.04 0.448 . . . . 0.0 110.857 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -76.98 -19.48 57.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.381 -177.299 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 149' ' ' HIS . 63.3 mt -81.08 -43.06 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.309 0.576 . . . . 0.0 109.575 174.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.3 mt -63.42 -46.94 93.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.572 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -60.14 -35.63 75.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.384 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.42 -40.45 86.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.14 0.495 . . . . 0.0 110.125 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.39 -41.0 81.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.625 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 51.2 mt -67.1 -30.0 69.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.151 0.501 . . . . 0.0 110.579 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 30.0 tt0 -83.16 -28.74 29.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.208 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.0 p -80.22 -22.89 41.32 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.667 HD21 ' HB3' ' A' ' 101' ' ' SER . 3.5 pp -87.74 20.82 2.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 159' ' ' GLN . 52.6 mtp180 -46.17 130.4 10.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.538 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.4 p -92.54 166.99 12.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.278 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.675 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.554 -179.192 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.861 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 57' ' ' PRO . 16.2 m -83.49 73.05 10.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.189 0.519 . . . . 0.0 109.896 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 17.9 m -101.06 134.58 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.34 0.591 . . . . 0.0 111.196 -177.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -125.63 155.39 40.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.904 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 46.8 mt-10 -113.45 117.27 31.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.328 0.585 . . . . 0.0 112.104 -173.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -105.68 142.4 18.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.754 175.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.527 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 48.0 tpp -91.94 125.51 36.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.681 0.277 . . . . 0.0 110.899 -176.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 51' ' ' LEU . 3.5 mp -96.84 106.02 27.6 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.644 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.801 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 23.9 Cg_exo -67.37 148.37 79.46 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.936 2.424 . . . . 0.0 111.531 175.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.59 134.39 54.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 76' ' ' GLN . . . 102.99 -36.25 4.44 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -170.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.944 ' HG3' HD12 ' A' ' 15' ' ' LEU . 12.6 mptt -82.42 8.46 11.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.961 0.41 . . . . 0.0 110.363 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -59.02 -39.84 83.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.914 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 18' ' ' GLY . . . -69.15 -15.34 69.68 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.265 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.944 HD12 ' HG3' ' A' ' 12' ' ' LYS . 16.2 mt -90.67 -40.93 11.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.917 -0.142 . . . . 0.0 111.235 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.711 HG21 HG13 ' A' ' 8' ' ' ILE . 61.8 t -92.84 -51.16 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.701 HG13 ' H ' ' A' ' 19' ' ' LYS . 17.3 pt -91.51 -28.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.075 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . 89.84 15.81 57.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.185 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.701 ' H ' HG13 ' A' ' 17' ' ' ILE . 66.6 mmtt 67.36 -58.28 0.42 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.417 0.687 . . . . 0.0 111.704 -177.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.19 -5.9 75.68 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.501 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.94 4.36 54.37 Favored Glycine 0 C--O 1.229 -0.213 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.757 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.747 ' HA ' ' CD ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -73.39 -28.77 62.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -175.148 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.615 HG21 ' O ' ' A' ' 15' ' ' LEU . 91.5 m -71.53 -41.27 69.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.252 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 35' ' ' MET . 6.9 tp -65.56 -27.45 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.151 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.747 ' CD ' ' HA ' ' A' ' 22' ' ' GLU . 11.9 mtpp -57.79 -49.5 76.42 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -72.84 -35.99 67.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.102 -175.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.485 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 98.1 mt -66.01 -27.69 68.31 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 121.837 -0.539 . . . . 0.0 110.382 176.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.752 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.6 mt-30 -84.88 -52.88 5.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.421 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -84.28 -56.38 3.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -174.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HE ' ' HB3' ' A' ' 30' ' ' ARG . 3.5 ttp180 -56.27 -42.28 77.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.864 0.364 . . . . 0.0 110.461 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -87.65 -29.83 20.88 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.368 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.47 10.37 70.76 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.26 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.6 m -117.31 152.04 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.743 0.306 . . . . 0.0 110.3 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -96.56 110.98 23.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 46.4 mtt -94.81 125.79 39.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.0 tp -117.6 114.5 45.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.886 0.85 . . . . 0.0 109.941 -177.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.656 HD22 ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -132.82 142.94 49.23 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.676 -175.442 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.43 HD13 ' HG2' ' A' ' 50' ' ' PRO . 2.0 mp -61.62 112.84 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.17 0.51 . . . . 0.0 110.882 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.427 ' OE1' HD13 ' A' ' 17' ' ' ILE . 22.2 mm-40 -125.26 -53.51 1.61 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.067 176.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.29 72.17 9.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.541 0.686 . . . . 0.0 109.588 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.13 106.02 0.24 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.563 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.9 t -79.2 65.22 4.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.588 0.708 . . . . 0.0 111.103 -173.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -131.41 -52.25 1.01 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.187 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.634 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.7 m-20 -113.32 47.09 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.358 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 p -78.37 -48.55 15.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.991 0.424 . . . . 0.0 110.825 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -93.23 -11.8 31.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.587 0.708 . . . . 0.0 109.417 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 50.1 t -88.92 162.65 2.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.815 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' N ' HG12 ' A' ' 47' ' ' VAL . 4.2 m-20 -61.85 154.12 26.9 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 39.4 mttp -127.28 144.31 50.25 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.874 -170.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HG2' HD13 ' A' ' 38' ' ' ILE . 83.3 Cg_endo -92.08 122.11 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.81 2.34 . . . . 0.0 112.886 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.941 ' HB2' HD11 ' A' ' 8' ' ' ILE . 8.4 tt -101.56 126.23 48.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.7 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 36' ' ' ILE . 3.3 mpt_? -107.92 121.1 44.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.691 0.282 . . . . 0.0 110.287 174.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 61.6 mt -89.47 117.3 32.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.174 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.4 mt -103.84 120.31 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.97 -171.05 43.93 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.336 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 18.9 m-20 -71.63 146.77 91.57 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 122.459 0.303 . . . . 0.0 110.504 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.582 ' HA ' HG21 ' A' ' 2' ' ' THR . 99.8 Cg_exo -44.33 -51.24 7.07 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.463 2.775 . . . . 0.0 113.7 -175.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -60.58 -49.61 76.85 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.756 0.312 . . . . 0.0 111.223 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.025 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 5.3 ptpp? -72.73 -23.55 60.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.926 -175.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 2' ' ' THR . 71.4 t -71.22 -43.04 74.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -58.17 9.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.78 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.72 -21.62 66.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.598 -174.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -85.36 -39.17 17.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.463 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 68' ' ' MET . 37.9 t -56.59 -50.56 71.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.606 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.54 -33.54 75.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.083 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.843 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 18.2 ptt? -79.57 -36.21 38.58 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.738 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 63' ' ' ALA . 69.9 t -56.27 -44.57 79.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 57.1 mtp -66.63 -32.57 73.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.566 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.456 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 35.2 t70 -85.24 -28.71 25.2 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -88.82 -21.69 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.098 -1.001 . . . . 0.0 110.438 173.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.499 HD12 ' CG2' ' A' ' 16' ' ' VAL . 5.8 tt -82.08 -26.29 33.78 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.354 178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -61.05 -13.95 20.3 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.213 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.67 ' HG3' ' H ' ' A' ' 75' ' ' ASP . 9.0 tp10 -55.47 135.28 50.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.217 0.532 . . . . 0.0 111.684 -175.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -75.72 -19.1 59.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.587 0.708 . . . . 0.0 109.578 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.67 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 10.8 m-20 -106.39 -174.8 2.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.632 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 11' ' ' GLY . 48.2 mt-30 -94.91 41.03 1.09 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.85 45.4 1.17 Allowed Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.705 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.707 ' H ' HD22 ' A' ' 15' ' ' LEU . . . -67.33 178.63 17.26 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 172.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.479 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 86.5 m-85 -68.32 -31.57 71.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.283 0.541 . . . . 0.0 111.581 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 23' ' ' THR . . . 101.45 -2.64 53.74 Favored Glycine 0 CA--C 1.508 -0.348 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 82' ' ' ARG . 1.6 p30 -179.17 -63.54 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.843 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 6.8 ttt85 173.41 -29.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.241 165.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.506 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 4.1 t30 52.33 65.77 1.41 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.937 0.399 . . . . 0.0 110.373 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 1.041 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 30.5 tt0 176.28 -47.54 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.754 0.787 . . . . 0.0 109.844 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.796 ' HA ' ' NE2' ' A' ' 139' ' ' HIS . 36.4 p90 -173.78 157.98 3.17 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.43 175.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -143.03 95.42 0.18 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . 1.025 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 67.8 m 70.75 -52.64 0.67 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.691 ' HD3' HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -67.6 -82.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.078 0.466 . . . . 0.0 111.738 -175.658 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.691 HD13 ' HD3' ' A' ' 88' ' ' ARG . 41.3 mm -54.34 -88.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -168.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 89.73 78.42 1.33 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -169.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.24 94.2 2.1 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.232 -0.508 . . . . 0.0 112.063 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.725 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 148.94 -144.06 11.69 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.041 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 49.9 pt -152.43 158.13 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 117.476 0.638 . . . . 0.0 110.057 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -105.27 140.71 38.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.981 0.42 . . . . 0.0 110.53 175.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 2.8 t -137.45 116.72 10.17 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.659 -176.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.61 107.75 2.25 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.013 1.809 . . . . 0.0 111.629 169.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.409 HG13 HD21 ' A' ' 158' ' ' LEU . 40.9 t -99.17 126.14 39.05 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.945 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.691 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 74.1 Cg_exo -43.69 130.68 7.47 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.662 2.908 . . . . 0.0 113.13 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 33.1 ptt180 -60.24 -24.22 64.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.025 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 98' ' ' PRO . 12.6 p80 -92.81 20.34 6.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.729 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 105' ' ' VAL . 14.6 t -145.79 -31.46 0.38 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.126 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -49.38 -37.66 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.24 -28.95 63.06 Favored Glycine 0 C--O 1.235 0.178 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.925 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.7 t -75.11 -35.07 33.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.027 0.441 . . . . 0.0 109.873 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 101' ' ' SER . 66.9 t -59.59 -40.05 81.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.905 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.785 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.3 mm -72.95 -37.71 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.389 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.93 34.57 21.17 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 65.66 -76.73 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.514 0.725 . . . . 0.0 111.399 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.2 p -93.73 9.62 36.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.868 0.366 . . . . 0.0 111.662 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.411 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 94.34 8.12 60.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.892 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -65.26 -32.2 73.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 110.913 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.405 ' SD ' ' HD3' ' A' ' 115' ' ' LYS . 15.4 tpt -89.93 -37.85 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.817 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.785 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.2 tp -64.98 -27.97 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.084 0.469 . . . . 0.0 110.382 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -72.58 -21.86 61.08 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.182 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.405 ' HD3' ' SD ' ' A' ' 112' ' ' MET . 27.6 mtpp -71.57 -33.84 69.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.732 0.301 . . . . 0.0 110.543 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.576 HG23 HD12 ' A' ' 153' ' ' ILE . 32.3 mt -67.92 -40.38 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 0.0 109.469 176.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -70.02 -28.21 65.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.437 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -79.52 -37.52 36.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.9 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -79.57 -55.16 5.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.578 -176.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.96 -15.01 26.75 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.55 32.5 57.5 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.881 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.546 ' CG1' ' HB3' ' A' ' 146' ' ' ARG . 14.9 m -102.98 159.15 4.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.216 0.531 . . . . 0.0 112.103 -173.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.921 ' HB2' ' HB2' ' A' ' 141' ' ' MET . 65.3 mtm180 -101.26 144.09 30.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.223 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 113' ' ' ILE . 51.2 mm -116.79 121.54 67.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.584 ' HB2' ' SD ' ' A' ' 141' ' ' MET . 5.9 tp-100 -123.94 111.14 15.69 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.604 ' CE1' HD11 ' A' ' 106' ' ' ILE . 27.4 m-85 -87.53 133.26 33.8 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.561 0.696 . . . . 0.0 110.104 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' HD3' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -157.03 -166.25 2.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.381 -171.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -47.96 125.81 9.58 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.426 0.454 . . . . 0.0 111.813 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 136' ' ' LYS . 7.6 p-10 -104.15 -164.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.824 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -62.45 -38.03 88.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.39 . . . . 0.0 110.287 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.53 -59.79 1.85 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.567 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.5 t -96.64 -23.65 16.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.096 0.474 . . . . 0.0 110.133 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.07 148.84 43.41 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 14.2 Cg_exo -69.47 -19.68 37.19 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.829 2.352 . . . . 0.0 112.452 -176.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.691 ' OE2' ' HA ' ' A' ' 98' ' ' PRO . 1.3 mp0 -94.73 154.17 17.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.972 0.415 . . . . 0.0 111.248 -174.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -119.79 124.73 46.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.328 0.585 . . . . 0.0 111.359 -178.039 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 44.8 mm -63.3 115.8 2.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.295 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.75 132.45 38.12 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 164.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.796 ' NE2' ' HA ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -108.34 115.24 29.74 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.676 -177.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.718 HG21 ' HA ' ' A' ' 147' ' ' CYS . 82.7 mt -83.85 137.58 20.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.522 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.921 ' HB2' ' HB2' ' A' ' 123' ' ' ARG . 31.2 mtp -120.42 129.26 53.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.066 -176.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.75 -167.03 28.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.635 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.763 ' HB2' ' HD3' ' A' ' 146' ' ' ARG . 32.8 Cg_exo -61.0 147.28 96.19 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.085 2.524 . . . . 0.0 112.195 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.773 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 52.0 Cg_exo -57.04 -18.65 29.46 Favored 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 123.955 3.104 . . . . 0.0 113.817 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.94 -30.17 26.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.326 0.584 . . . . 0.0 110.178 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.763 ' HD3' ' HB2' ' A' ' 143' ' ' PRO . 8.4 mpt_? -84.13 -44.12 14.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.408 -174.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.773 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 10.6 p -53.85 -55.1 29.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.011 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.431 ' OE2' HG21 ' A' ' 93' ' ' ILE . 38.5 mm-40 -62.65 -37.87 88.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.48 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.412 ' O ' HG13 ' A' ' 153' ' ' ILE . 15.7 t60 -65.49 -26.76 68.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.223 0.535 . . . . 0.0 110.316 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.708 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.98 -40.26 28.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.005 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.633 ' HB2' HD11 ' A' ' 93' ' ' ILE . . . -65.94 -24.92 66.92 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.366 0.603 . . . . 0.0 110.149 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -18.94 59.56 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.538 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.576 HD12 HG23 ' A' ' 116' ' ' ILE . 63.1 mt -81.76 -45.06 20.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.316 172.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.475 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.9 mt -62.21 -40.77 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.006 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -58.84 -37.33 76.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.71 -34.16 77.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 34.1 mt -68.87 -33.87 74.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.824 -178.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.511 HD22 ' HD2' ' A' ' 98' ' ' PRO . 18.4 mt -67.08 -28.68 68.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.357 0.599 . . . . 0.0 110.127 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -85.45 -28.56 24.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.58 0.705 . . . . 0.0 110.416 172.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 157' ' ' LEU . 22.4 t -75.48 -20.38 58.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.997 -173.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 pp -59.57 -9.9 2.99 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -68.2 -17.57 64.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.345 0.593 . . . . 0.0 110.02 174.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.1 t -140.41 -166.11 2.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.63 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.319 -178.911 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -112.05 67.42 0.65 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.944 0.402 . . . . 0.0 111.143 -178.659 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 27.7 m -123.5 130.39 74.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.159 175.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -118.47 142.72 47.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.625 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 45.3 mt-10 -108.01 116.74 32.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.361 0.6 . . . . 0.0 111.775 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 6' ' ' ILE . 3.9 mp -106.82 142.82 18.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.402 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 87.6 mmm -92.88 116.09 28.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.937 0.399 . . . . 0.0 110.704 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.499 HG12 HG11 ' A' ' 16' ' ' VAL . 1.8 mp -91.36 113.77 59.55 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.586 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 75.1 Cg_exo -55.77 152.15 36.51 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.425 2.75 . . . . 0.0 112.775 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.622 ' HA ' ' NZ ' ' A' ' 49' ' ' LYS . . . -59.62 129.93 44.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 172.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.58 -39.21 2.94 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.81 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.724 ' HG3' HD21 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -65.38 -19.68 66.05 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.805 0.335 . . . . 0.0 111.249 -177.753 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.665 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -58.38 -24.04 58.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.863 0.363 . . . . 0.0 110.374 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' CA ' ' HD3' ' A' ' 19' ' ' LYS . . . -61.29 -41.15 99.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.246 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.724 HD21 ' HG3' ' A' ' 12' ' ' LYS . 0.5 OUTLIER -90.42 -23.84 20.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.811 0.305 . . . . 0.0 110.992 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.6 HG21 HD12 ' A' ' 71' ' ' LEU . 77.1 t -82.63 -52.05 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.679 HD13 ' HG3' ' A' ' 39' ' ' GLN . 19.2 pt -91.53 -20.09 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 121.526 -0.734 . . . . 0.0 110.155 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.62 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.19 17.09 32.97 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -175.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HD3' ' CA ' ' A' ' 14' ' ' GLY . 13.6 tptp 55.66 31.81 18.08 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.421 0.688 . . . . 0.0 110.428 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.77 -40.17 0.3 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.551 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.594 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 158.1 -8.84 0.2 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.157 -1.02 . . . . 0.0 114.07 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.473 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 44.4 tt0 -58.64 -43.37 89.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.504 0.652 . . . . 0.0 112.377 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.62 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 55.2 m -78.3 -36.73 46.19 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.195 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 35' ' ' MET . 5.6 tp -64.6 -20.1 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.937 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 27.6 mtpp -58.36 -59.45 5.33 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.42 0.629 . . . . 0.0 109.503 170.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 48.6 mt-30 -67.22 -35.23 79.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.91 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 87.7 mt -65.1 -32.91 74.85 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 122.037 -0.415 . . . . 0.0 110.835 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.724 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 47.9 mt-30 -85.5 -46.61 10.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.062 0.458 . . . . 0.0 111.41 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -88.16 -35.36 17.45 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.519 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 5.5 ttm180 -82.87 -43.42 16.6 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.746 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -83.18 -22.29 33.26 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.982 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.69 68.16 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.097 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 34.2 m -128.15 150.69 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 110.846 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -90.72 109.99 21.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 1.056 ' HB3' HD11 ' A' ' 51' ' ' LEU . 48.4 mtt -100.29 123.31 44.36 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 tt -121.02 113.87 41.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.799 0.809 . . . . 0.0 110.768 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.691 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -134.86 143.57 47.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.948 -177.152 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 3.7 mp -73.34 101.18 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.307 0.575 . . . . 0.0 111.351 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.679 ' HG3' HD13 ' A' ' 17' ' ' ILE . 5.2 mm100 -131.36 15.68 5.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.44 170.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.03 -30.74 62.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.825 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' A' ' 45' ' ' THR . . . 113.56 8.28 19.04 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.036 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 m -61.77 -49.9 74.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.678 0.275 . . . . 0.0 111.688 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -164.44 -42.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.851 0.358 . . . . 0.0 111.091 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.636 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 13.3 m120 -78.98 51.49 1.14 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.926 0.393 . . . . 0.0 111.266 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.536 ' CG2' ' HA2' ' A' ' 41' ' ' GLY . 14.3 p -86.09 -61.77 1.67 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.178 0.513 . . . . 0.0 110.867 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -92.33 -6.82 49.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.455 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 48.9 t -93.38 156.27 3.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.944 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.4 149.4 38.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.63 ' HE3' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -111.21 124.15 33.45 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.816 -174.397 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.12 112.89 2.34 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.452 2.101 . . . . 0.0 111.825 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.056 HD11 ' HB3' ' A' ' 35' ' ' MET . 21.2 tp -92.98 121.1 33.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.775 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.529 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 2.7 mpt_? -102.05 114.14 28.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.853 0.358 . . . . 0.0 110.657 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 70.0 mt -89.42 110.63 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.229 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.4 mt -106.13 122.08 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.376 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.402 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 173.87 -171.43 44.51 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.956 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . 3.2 m-20 -61.58 148.75 85.96 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 122.282 0.233 . . . . 0.0 110.536 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.65 -55.61 3.82 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.119 2.546 . . . . 0.0 114.188 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -66.73 -26.91 67.23 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.926 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.869 ' HG2' ' HB2' ' A' ' 87' ' ' SER . 93.2 mttt -66.67 -53.02 38.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.187 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 2' ' ' THR . 46.4 t -59.89 -32.51 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.589 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.22 -54.91 30.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.441 ' HB3' ' CD2' ' A' ' 85' ' ' TYR . 18.0 mm-40 -69.88 -34.1 73.12 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.051 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -69.88 -47.5 62.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.431 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.2 t -55.95 -38.36 70.23 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.19 0.519 . . . . 0.0 109.862 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -64.53 -52.82 55.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.695 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.655 ' SD ' ' HA2' ' A' ' 86' ' ' GLY . 8.4 ptt? -65.69 -36.07 82.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.472 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 53' ' ' ILE . 53.5 t -57.06 -48.38 81.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.245 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 69.4 mtm -69.78 -25.35 63.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.184 0.516 . . . . 0.0 110.214 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.48 -37.82 42.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.926 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.566 ' HB ' ' H ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -90.22 -30.77 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.86 176.601 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.6 HD12 HG21 ' A' ' 16' ' ' VAL . 5.2 tt -70.93 -26.45 63.2 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -63.9 0.95 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.176 0.298 . . . . 0.0 110.404 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.961 ' HG2' ' H ' ' A' ' 74' ' ' ARG . 23.6 tt0 42.31 -159.83 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 169.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.961 ' H ' ' HG2' ' A' ' 73' ' ' GLU . 20.9 mmt180 -145.54 -47.06 0.22 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.807 0.843 . . . . 0.0 108.751 167.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -173.66 102.23 0.11 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.011 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 61.66 69.49 0.64 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.459 0.647 . . . . 0.0 111.399 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.41 -5.52 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.372 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.22 150.78 48.88 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.669 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.566 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 74.5 m-85 -76.99 3.53 12.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -170.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 23' ' ' THR . . . 73.14 4.13 62.62 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.723 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.5 OUTLIER 175.89 -62.91 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.736 ' CZ ' ' HB3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER 154.13 -35.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 O-C-N 125.1 1.5 . . . . 0.0 109.101 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 55.81 73.51 0.43 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.371 0.419 . . . . 0.0 110.399 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.934 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 70.4 tt0 -175.71 -51.13 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.665 -173.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.741 ' HA ' HD12 ' A' ' 89' ' ' ILE . 4.5 p90 -151.04 -75.89 0.14 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.655 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 101.15 -43.38 1.74 Allowed Glycine 0 C--O 1.229 -0.198 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.869 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 32.5 p -171.06 -57.16 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -69.98 -177.23 1.28 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.379 167.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 85' ' ' TYR . 59.8 mt 70.57 -74.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.09 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.417 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 51.12 47.21 49.92 Favored Glycine 0 C--N 1.336 0.552 0 O-C-N 123.727 0.642 . . . . 0.0 112.501 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.25 99.36 0.4 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -176.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.816 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 135.79 -138.51 9.98 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -174.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.934 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.8 pt -145.53 159.59 12.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 171.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.593 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . 1.9 p30 -99.22 132.58 44.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 31.3 t -126.65 106.2 23.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -171.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.419 ' HB2' ' HB3' ' A' ' 135' ' ' GLU . 42.8 Cg_endo -68.79 121.44 8.33 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.234 1.956 . . . . 0.0 111.389 171.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.633 HG13 HD21 ' A' ' 158' ' ' LEU . 51.3 t -117.71 124.9 28.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.653 0.263 . . . . 0.0 111.216 177.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 86.1 Cg_exo -44.62 130.51 9.54 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.753 2.968 . . . . 0.0 113.475 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 134' ' ' PRO . 35.2 mtp180 -51.63 -37.92 52.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.151 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.495 ' CE1' ' HB3' ' A' ' 98' ' ' PRO . 0.7 OUTLIER -92.26 6.43 46.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.655 -174.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 98' ' ' PRO . 9.8 m -130.03 -25.52 2.5 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.607 -173.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.4 p -53.15 -26.26 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.742 0.306 . . . . 0.0 111.592 172.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.3 -44.96 89.41 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.947 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 101' ' ' SER . 7.6 p -77.38 -25.23 15.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.208 0.528 . . . . 0.0 110.587 -178.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.1 t -69.68 -33.14 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.85 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.568 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 49.6 mm -87.12 -65.06 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.352 176.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.82 52.19 3.39 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.696 -173.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 108' ' ' ARG . 45.2 mtp180 54.77 -89.84 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.71 0.804 . . . . 0.0 112.375 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -72.75 -8.82 57.25 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.594 0.711 . . . . 0.0 110.348 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.26 45.72 2.52 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.587 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.37 -43.88 80.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.8 0.3 . . . . 0.0 110.942 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.466 ' O ' HG13 ' A' ' 116' ' ' ILE . 15.3 tpt -83.59 -38.55 21.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.848 0.356 . . . . 0.0 110.641 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 124' ' ' ILE . 8.9 tp -63.91 -31.08 51.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.5 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -82.73 -20.12 36.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.657 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -71.23 -37.44 72.01 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.467 HD12 HD12 ' A' ' 113' ' ' ILE . 23.1 mt -64.64 -37.27 79.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.201 0.524 . . . . 0.0 109.603 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 86.6 mt-30 -66.6 -27.36 67.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.724 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -85.65 -46.26 10.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.039 0.447 . . . . 0.0 111.045 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -79.33 -55.36 5.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.778 -173.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.14 -26.96 39.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.058 0.456 . . . . 0.0 110.293 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.96 19.98 62.02 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.138 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.76 144.88 9.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 111.879 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.786 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 7.7 tpp180 -91.34 143.41 26.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.723 HG21 HD11 ' A' ' 113' ' ' ILE . 34.3 mm -129.01 142.21 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -170.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 1.031 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 3.8 pt20 -149.54 167.8 25.29 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 167.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 106' ' ' ILE . 31.7 m-85 -121.95 133.55 54.83 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.535 ' O ' ' HB ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -152.66 128.16 10.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.352 -171.403 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 58.31 -166.64 0.15 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.052 0.453 . . . . 0.0 111.216 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.417 ' HA ' ' H ' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -145.33 -175.09 4.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.363 176.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.48 ' OD2' ' HB ' ' A' ' 132' ' ' THR . 51.2 p-10 -70.42 -11.49 60.95 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.73 7.55 87.3 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.328 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.48 ' HB ' ' OD2' ' A' ' 130' ' ' ASP . 34.6 m -113.34 -41.78 3.61 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 137.67 -58.82 0.63 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.75 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 15.0 Cg_exo -69.52 -17.18 38.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.795 2.33 . . . . 0.0 114.734 -170.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 51.1 mt-10 -127.18 141.35 51.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -114.02 130.62 56.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.478 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 23.5 mm -74.62 131.54 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -105.88 141.47 37.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.358 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 1.031 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -89.27 110.15 20.96 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.187 175.17 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.753 HD13 ' HB3' ' A' ' 150' ' ' ALA . 68.5 mt -94.26 135.84 27.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.463 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.786 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 41.6 ttm -122.92 124.55 43.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.056 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.59 -170.66 34.11 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.91 149.02 91.54 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.713 2.276 . . . . 0.0 111.986 174.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.4 -50.71 6.53 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 123.314 2.676 . . . . 0.0 113.665 -177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.66 -47.53 79.6 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.13 0.49 . . . . 0.0 110.224 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -60.0 -41.93 93.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.631 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.816 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 66.7 m -56.26 -60.53 3.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.224 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.638 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 38.2 mt-10 -66.82 -33.17 75.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.287 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -26.88 68.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.753 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.13 -37.19 46.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.826 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.27 67.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.409 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -76.56 -31.48 57.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.287 -178.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.44 -44.58 83.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.197 0.522 . . . . 0.0 109.644 174.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.68 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 70.4 mt -63.03 -53.38 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.741 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.64 HD22 HD12 ' A' ' 158' ' ' LEU . 12.0 m120 -55.47 -38.29 68.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.476 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -59.87 -44.1 94.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 110.756 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.12 -39.48 89.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.594 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 68.4 mt -61.25 -52.03 66.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.941 -178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 155' ' ' ASN . 10.5 mm100 -67.39 -21.75 65.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.072 0.463 . . . . 0.0 111.028 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 61.6 m -73.3 -22.46 60.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.835 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.5 mt -103.91 -49.65 3.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.252 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 68.56 -63.13 0.36 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.026 0.829 . . . . 0.0 109.313 -172.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.4 m -86.46 -90.25 0.11 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.51 175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.368 -179.505 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.407 ' O ' HG21 ' A' ' 60' ' ' VAL . 91.1 m -104.85 140.67 37.78 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.5 m -132.1 133.4 60.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.105 0.478 . . . . 0.0 111.179 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 5.4 mm-40 -108.09 145.08 34.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.909 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.74 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 42.1 mt-10 -112.05 104.28 12.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.329 0.585 . . . . 0.0 111.343 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.0 mp -105.65 141.97 19.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.01 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.518 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 45.5 ttm -100.56 114.58 28.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.911 0.386 . . . . 0.0 110.646 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.474 ' HA ' HD11 ' A' ' 71' ' ' LEU . 1.8 mp -83.22 110.07 21.46 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.043 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.854 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 31.3 Cg_exo -62.26 137.25 64.65 Favored 'Trans proline' 0 CA--C 1.519 -0.259 0 C-N-CA 122.81 2.34 . . . . 0.0 111.273 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.59 114.88 3.22 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.56 -34.78 3.66 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -169.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.854 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -89.29 3.78 50.97 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 172.565 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.506 ' HB1' HD11 ' A' ' 17' ' ' ILE . . . -60.73 -41.19 94.85 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.545 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.82 -14.29 50.94 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.702 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.655 ' O ' HG21 ' A' ' 23' ' ' THR . 22.6 mt -89.56 -57.04 3.01 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.539 0.169 . . . . 0.0 111.187 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.452 ' CG2' HD12 ' A' ' 71' ' ' LEU . 61.8 t -79.58 -54.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.506 HD11 ' HB1' ' A' ' 13' ' ' ALA . 12.7 pt -92.47 -10.7 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.699 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 69.64 31.47 70.65 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 tptt 73.27 -58.08 0.61 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.097 0.959 . . . . 0.0 111.356 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.2 24.48 5.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.874 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 24' ' ' ILE . . . 116.06 -13.21 16.86 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.684 174.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 35.8 mm-40 -56.95 -46.67 81.94 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.655 HG21 ' O ' ' A' ' 15' ' ' LEU . 55.4 m -80.33 -34.24 36.82 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.265 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.495 HD11 HD21 ' A' ' 37' ' ' LEU . 5.2 tp -62.28 -24.96 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 83.6 mttt -57.25 -58.89 6.25 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.102 170.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HB3' ' A' ' 81' ' ' ASP . 42.7 mt-30 -67.57 -20.25 65.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.206 -174.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 85.3 mt -79.74 -30.85 40.97 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.22 173.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 79.8 mt-30 -84.31 -32.26 24.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.569 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.62 -63.38 1.33 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.606 0.241 . . . . 0.0 111.285 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.509 ' HB3' HH22 ' A' ' 82' ' ' ARG . 10.6 ttm180 -66.66 -31.45 72.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.162 -172.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -96.38 -27.17 15.05 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.37 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' HA3' ' NE2' ' A' ' 128' ' ' GLN . . . 78.56 2.89 85.98 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.774 -0.726 . . . . 0.0 113.286 175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.683 HG23 ' SD ' ' A' ' 35' ' ' MET . 27.6 m -101.08 161.91 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -103.99 109.49 21.28 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.326 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.683 ' SD ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -92.12 121.09 33.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.155 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.2 tp -113.56 102.34 13.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.964 0.888 . . . . 0.0 109.219 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.751 HD13 HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -132.31 142.21 49.26 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.819 -176.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.681 HG21 ' H ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -60.77 122.24 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.403 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.2 -37.23 0.57 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.299 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.85 -48.11 55.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.121 0.486 . . . . 0.0 110.398 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.665 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 137.14 34.48 0.2 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.335 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -78.99 -22.32 45.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.037 0.446 . . . . 0.0 110.829 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.54 ' HB3' HG12 ' A' ' 38' ' ' ILE . 54.1 tp60 -136.72 -80.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.781 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.681 ' H ' HG21 ' A' ' 38' ' ' ILE . 96.7 m-20 -107.56 87.31 2.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.168 0.509 . . . . 0.0 110.757 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.665 ' HB ' ' HA2' ' A' ' 41' ' ' GLY . 1.8 t -81.51 -42.67 19.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.262 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -94.17 -35.45 12.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.746 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.72 160.33 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.386 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.637 ' OD1' ' HA ' ' A' ' 9' ' ' PRO . 61.7 m-20 -49.53 139.93 11.52 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.391 0.432 . . . . 0.0 111.05 177.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 65.2 mttt -113.06 128.52 25.52 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.163 -165.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -84.8 140.29 7.96 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.798 2.332 . . . . 0.0 113.376 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.751 HD12 HD13 ' A' ' 37' ' ' LEU . 9.0 tt -117.92 139.81 50.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.361 -174.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.3 mpt_? -123.35 123.42 40.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.453 0.168 . . . . 0.0 110.589 170.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.613 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.4 mt -93.82 116.77 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.7 mt -103.67 120.34 53.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.653 0.263 . . . . 0.0 111.281 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.09 -170.76 43.51 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.372 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.541 ' HB3' ' HE2' ' A' ' 59' ' ' LYS . 9.9 t70 -60.57 138.81 92.78 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.847 -0.677 . . . . 0.0 110.675 172.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.42 -28.83 9.06 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.967 3.111 . . . . 0.0 114.676 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -73.17 -52.05 15.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.949 0.404 . . . . 0.0 110.225 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HE2' ' HB3' ' A' ' 56' ' ' ASP . 0.3 OUTLIER -68.83 -30.14 68.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.468 -177.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 2' ' ' THR . 88.6 t -70.6 -32.87 51.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.448 175.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.443 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 0.8 OUTLIER -70.23 -52.45 23.1 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.064 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -65.01 -23.2 67.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.358 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.674 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -86.6 -43.97 12.25 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.949 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 68' ' ' MET . 30.4 p -61.9 -30.98 71.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.692 0.282 . . . . 0.0 111.447 -174.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -83.43 -30.51 27.24 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.794 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.82 ' HB2' ' HG3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -79.3 -34.34 42.5 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.326 -176.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.08 -27.45 42.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.924 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 44.8 mtm -82.95 -35.95 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 0.0 109.607 171.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 36.0 t70 -62.97 -43.76 97.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.782 -175.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.879 HG21 ' HA ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -87.05 -21.5 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.37 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 8' ' ' ILE . 3.5 tt -84.29 -24.69 29.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.64 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.406 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -60.6 -35.55 76.39 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.146 -0.222 . . . . 0.0 110.537 -177.557 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 1.1 pt-20 37.83 -145.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.199 0.937 . . . . 0.0 112.867 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 8.1 ptm180 173.26 -12.67 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.264 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -154.87 35.62 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.531 -173.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? 58.54 76.13 0.36 Allowed 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.614 0.721 . . . . 0.0 109.404 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.66 116.78 0.72 Allowed Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.257 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . -99.37 -75.32 1.18 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.264 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -144.53 -58.38 0.37 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.768 0.794 . . . . 0.0 109.028 176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.42 -91.3 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB3' ' CB ' ' A' ' 26' ' ' GLN . 5.7 p-10 -90.52 -44.75 9.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 164.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.879 ' HA ' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER 170.37 -51.46 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.689 -172.256 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.536 ' HA ' ' HB2' ' A' ' 94' ' ' ASP . 18.8 m120 57.45 53.41 7.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 171.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.712 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 0.7 OUTLIER -174.36 2.99 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 177.559 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.816 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -161.66 -71.53 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.987 -1.071 . . . . 0.0 110.959 174.74 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.524 ' H ' ' CD ' ' A' ' 82' ' ' ARG . . . 53.67 65.67 3.27 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.581 -174.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.511 ' C ' ' HD2' ' A' ' 88' ' ' ARG . 17.0 t 74.31 -21.62 0.27 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.692 0.797 . . . . 0.0 112.086 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.586 ' HG3' ' HB2' ' A' ' 127' ' ' LYS . 2.6 mmm180 -119.05 -166.32 1.24 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -172.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.816 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 55.6 mt 70.59 -83.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 167.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.575 ' HA2' ' HD2' ' A' ' 85' ' ' TYR . . . 62.87 54.97 29.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.126 -173.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 128.96 58.71 0.11 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.513 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.551 ' O ' HG21 ' A' ' 89' ' ' ILE . . . 164.59 163.28 17.34 Favored Glycine 0 C--O 1.207 -1.572 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.712 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.0 pt -90.31 154.26 3.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 119.14 1.47 . . . . 0.0 112.39 -169.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 83' ' ' ASN . 36.2 m-20 -90.38 117.48 29.13 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.836 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.685 HG21 HD12 ' A' ' 140' ' ' ILE . 1.3 t -116.69 95.1 45.48 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.874 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.17 108.53 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.52 2.146 . . . . 0.0 111.782 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.589 HG13 HD21 ' A' ' 158' ' ' LEU . 86.0 t -94.77 118.75 66.74 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.443 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.641 ' HD2' HD22 ' A' ' 158' ' ' LEU . 47.0 Cg_exo -38.11 123.6 0.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.014 2.476 . . . . 0.0 111.478 171.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -34.46 -58.55 0.48 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -168.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -71.92 -23.71 61.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 t -78.63 -15.1 58.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.594 0.235 . . . . 0.0 111.143 -172.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.556 ' HA ' HG11 ' A' ' 97' ' ' VAL . 58.1 t -54.82 -37.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.154 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.51 -36.03 82.87 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.701 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 161' ' ' LEU . 61.4 t -73.18 -37.83 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.353 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.33 -34.28 69.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.346 0.593 . . . . 0.0 110.36 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.73 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 39.7 mm -76.45 -43.57 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.29 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.56 34.87 8.21 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.477 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 65.65 -75.28 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.357 0.663 . . . . 0.0 111.673 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 m -87.49 2.79 49.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.496 ' O ' ' HG2' ' A' ' 114' ' ' LYS . . . 92.52 14.08 56.06 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.877 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -65.89 -40.86 91.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.751 0.31 . . . . 0.0 111.297 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 55.7 tpp -78.23 -36.34 47.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.73 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.0 tp -68.18 -29.66 45.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.816 0.341 . . . . 0.0 110.157 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 110' ' ' GLY . 42.2 mmtm -70.16 -34.73 73.37 Favored 'General case' 0 CA--C 1.523 -0.086 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 173.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 112' ' ' MET . 25.5 mmmt -61.61 -38.7 88.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.981 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.12 -43.04 95.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.26 0.552 . . . . 0.0 109.552 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 60.5 mt-30 -69.04 -26.81 65.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.733 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -86.22 -45.54 11.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.073 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.17 -36.42 47.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.986 -173.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 146' ' ' ARG . . . -103.98 -20.35 13.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.96 37.96 31.81 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.886 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.406 HG11 HG23 ' A' ' 140' ' ' ILE . 33.1 m -112.79 154.23 14.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.959 0.409 . . . . 0.0 111.944 -173.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.553 ' HD3' ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -108.25 135.18 50.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.607 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.553 ' N ' ' HD3' ' A' ' 123' ' ' ARG . 45.3 mm -99.58 143.66 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.087 0.47 . . . . 0.0 111.957 -170.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 5.5 tt0 -147.79 104.95 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.682 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -74.29 111.42 9.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.061 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -125.22 156.32 38.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.181 -173.715 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.529 ' NE2' ' HA3' ' A' ' 32' ' ' GLY . 12.0 mm100 69.08 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.848 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 24.3 m-20 -90.48 104.82 17.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.112 0.482 . . . . 0.0 111.285 -171.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.403 ' O ' ' HE2' ' A' ' 136' ' ' LYS . 16.4 t70 -132.6 -49.16 0.9 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.514 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -97.82 19.78 53.23 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.3 t -161.08 158.37 27.6 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.92 160.39 36.35 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.856 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.27 -14.85 10.45 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.575 2.183 . . . . 0.0 111.682 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -131.24 152.79 50.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.913 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HD2' HG21 ' A' ' 102' ' ' VAL . 82.8 mttt -110.7 113.36 25.91 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.513 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 1.7 mm -72.55 112.57 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.194 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -96.29 135.8 37.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.802 173.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.777 ' CE1' HG23 ' A' ' 89' ' ' ILE . 1.5 t60 -86.87 109.04 19.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.903 174.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' A' ' 150' ' ' ALA . 41.0 mt -91.19 123.25 43.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 170.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.449 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 13.9 ttp -112.53 131.41 55.61 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -171.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.32 -178.11 27.98 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.68 147.13 96.04 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.859 1.706 . . . . 0.0 110.764 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -41.16 -44.27 5.32 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.475 2.783 . . . . 0.0 112.834 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.31 -40.96 62.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.789 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 9.3 mtm180 -84.53 -38.89 19.48 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 140' ' ' ILE . 61.2 m -58.59 -61.32 2.69 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 111.002 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.686 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 6.2 mm-40 -58.02 -40.85 81.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.182 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -57.58 -31.96 66.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.903 0.382 . . . . 0.0 111.282 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.697 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.46 -36.79 44.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.972 0.415 . . . . 0.0 110.915 -176.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.408 ' HB3' HH11 ' A' ' 152' ' ' ARG . . . -66.17 -24.1 66.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.798 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.686 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 11.3 mpt_? -78.59 -28.04 45.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.755 0.312 . . . . 0.0 110.424 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.3 mt -70.15 -47.93 64.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.233 0.539 . . . . 0.0 109.551 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.517 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.0 mt -63.18 -42.99 98.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.705 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -57.84 -39.21 77.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.982 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.55 -32.58 74.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.772 0.32 . . . . 0.0 110.302 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 44.0 mt -67.64 -47.95 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.969 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.641 HD22 ' HD2' ' A' ' 98' ' ' PRO . 13.3 mt -59.69 -40.56 88.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.896 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -68.02 -31.18 70.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.452 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 64.1 m -79.29 -27.03 42.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.266 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.646 HD11 HG21 ' A' ' 104' ' ' VAL . 82.6 mt -86.17 -34.49 20.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.483 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.4 mtm-85 65.67 95.53 0.06 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.555 0.693 . . . . 0.0 111.614 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.7 m -97.05 68.85 2.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.356 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.58 178.402 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 57' ' ' PRO . 1.6 m -81.45 85.33 6.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.958 0.408 . . . . 0.0 110.25 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 12.0 m -124.12 128.79 74.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.09 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -114.15 133.95 55.23 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.543 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 43.5 mt-10 -103.04 126.12 50.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.223 0.535 . . . . 0.0 111.869 -175.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -117.8 144.52 25.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 174.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.4 mtp -93.1 112.44 24.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.158 0.504 . . . . 0.0 110.777 -176.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.549 HG13 HG21 ' A' ' 16' ' ' VAL . 1.7 mp -95.21 114.93 64.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.706 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.54 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 41.8 Cg_exo -61.72 152.42 74.23 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.449 2.766 . . . . 0.0 112.815 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.73 131.51 45.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.61 -42.01 2.13 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -169.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 9' ' ' PRO . 13.1 tptt -68.7 -32.48 72.31 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.711 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -52.39 -31.75 35.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.315 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.661 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -59.0 -42.09 96.73 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.431 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.952 HD23 ' HA ' ' A' ' 76' ' ' GLN . 3.8 pp -89.67 -17.95 27.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.756 0.278 . . . . 0.0 111.663 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.549 HG21 HG13 ' A' ' 8' ' ' ILE . 82.9 t -83.5 -48.69 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.711 HG12 ' O ' ' A' ' 13' ' ' ALA . 13.3 pt -90.52 -24.79 5.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.516 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.515 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 100.91 11.58 39.66 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.669 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.661 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 5.4 tptm 52.33 44.2 30.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.324 0.583 . . . . 0.0 110.353 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.83 -24.4 0.55 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.474 -173.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.99 -11.53 7.34 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.331 175.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -59.32 -34.32 72.19 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -174.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.515 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 28.3 m -84.23 -41.57 16.8 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.316 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 35' ' ' MET . 8.3 tp -66.44 -32.4 57.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -47.91 -48.14 31.83 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.58 170.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.599 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 49.2 mt-30 -73.8 -42.07 61.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.657 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.544 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 81.6 mt -60.65 -28.1 68.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.179 0.514 . . . . 0.0 110.709 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 87.6 mt-30 -85.58 -53.75 4.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.567 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -82.23 -49.75 9.75 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -172.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.525 ' HD3' ' OD2' ' A' ' 81' ' ' ASP . 21.3 ttt180 -67.61 -51.75 46.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 110.01 -176.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.625 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -70.31 -29.05 65.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.934 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.07 3.23 87.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.832 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.1 m -103.44 -179.34 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.039 0.447 . . . . 0.0 110.376 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -121.5 114.25 20.97 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.676 ' HB2' HD11 ' A' ' 24' ' ' ILE . 51.6 mtt -100.66 121.1 41.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tp -114.02 110.99 34.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.915 0.864 . . . . 0.0 110.213 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.818 HD13 HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -133.22 144.42 49.78 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.319 -174.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.6 mm -60.76 100.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.134 0.492 . . . . 0.0 110.615 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.547 ' HG2' HG21 ' A' ' 17' ' ' ILE . 42.4 mt-30 -105.4 -42.73 5.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.526 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.74 -19.65 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.511 -177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.04 49.46 3.53 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.199 174.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 m -59.83 -71.37 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.832 0.349 . . . . 0.0 110.847 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -117.85 -26.0 6.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.146 0.498 . . . . 0.0 110.832 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -107.56 75.35 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.985 0.422 . . . . 0.0 110.823 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 p -83.29 -63.22 1.4 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.927 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -94.96 -4.47 46.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.289 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.24 158.21 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.004 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.46 144.77 16.13 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.49 0.494 . . . . 0.0 110.872 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -117.46 127.98 26.31 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.796 -171.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.88 116.76 3.49 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.248 1.966 . . . . 0.0 112.141 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.818 HD12 HD13 ' A' ' 37' ' ' LEU . 8.4 tt -98.48 119.89 37.95 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.483 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.602 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.4 mpt_? -100.11 116.27 31.75 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 176.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CG2' HG23 ' A' ' 60' ' ' VAL . 27.7 mt -89.43 118.37 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 3' ' ' VAL . 27.5 mt -104.67 121.32 56.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 177.49 -177.92 48.32 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.483 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.612 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 13.8 t70 -62.04 139.98 95.9 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.565 ' HA ' HG21 ' A' ' 2' ' ' THR . 69.7 Cg_exo -38.7 -45.86 2.51 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.912 3.075 . . . . 0.0 115.157 -175.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -74.43 -33.51 62.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.251 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 1.007 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 19.0 ptpt -79.2 -41.68 27.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -175.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.512 HG23 ' CG2' ' A' ' 53' ' ' ILE . 8.0 p -67.36 -24.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.503 0.668 . . . . 0.0 109.935 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -66.88 -57.89 6.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.24 178.066 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -61.45 -33.16 73.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -69.51 -45.73 68.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.745 177.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.455 ' HA ' HG22 ' A' ' 67' ' ' VAL . 42.8 t -58.97 -35.63 73.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.52 0.676 . . . . 0.0 109.632 177.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.25 -37.08 84.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.616 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.867 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 15.5 ptt? -84.95 -33.47 22.65 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.975 -176.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 35.1 m -62.37 -28.96 45.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.299 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.6 mtm -81.6 -21.03 38.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 110.32 174.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -83.2 -46.26 12.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.894 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.702 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.6 pp -83.22 -26.7 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.333 . . . . 0.0 111.743 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 6.0 tt -75.72 -18.35 59.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.876 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 5.8 ptm180 -53.39 -42.1 66.61 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' HG2' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER 56.07 137.73 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 170.411 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 72.7 mtp180 -112.43 -13.45 13.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 161.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.529 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 36.1 t70 -163.18 135.06 5.1 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.544 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.952 ' HA ' HD23 ' A' ' 15' ' ' LEU . 78.4 mt-30 -43.81 106.65 0.07 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.289 1.042 . . . . 0.0 112.188 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.483 ' N ' ' HB3' ' A' ' 15' ' ' LEU . . . 150.82 -34.38 0.95 Allowed Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.103 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.95 -111.23 3.61 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.702 ' HD1' HG22 ' A' ' 70' ' ' ILE . 97.3 m-85 -127.78 -13.77 5.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.74 0.305 . . . . 0.0 110.609 174.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 81.23 91.92 0.52 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -174.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.599 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 5.7 t70 71.22 -75.04 0.08 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -170.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.867 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 24.9 ttt180 173.17 -35.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 O-C-N 124.18 0.925 . . . . 0.0 110.332 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 69.19 13.54 8.62 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.65 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.808 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 84.9 tt0 -123.96 -34.43 2.99 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.631 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 25.6 p90 171.27 127.31 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.139 175.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.753 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -82.99 -66.69 1.51 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.946 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . 1.007 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 45.2 m -144.98 22.56 1.57 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.776 0.798 . . . . 0.0 109.125 176.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 1.8 mpt_? -133.84 -164.16 1.46 Allowed 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.043 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' A' ' 85' ' ' TYR . 23.9 mt 64.71 -81.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.45 50.71 57.86 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 132.96 85.02 0.26 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.286 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 153.94 -143.76 10.48 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.808 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.9 pt -144.97 160.55 13.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 117.302 0.551 . . . . 0.0 110.844 175.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.491 ' HB3' ' HE ' ' A' ' 30' ' ' ARG . 5.0 m-20 -107.0 119.68 40.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.949 173.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.828 HG23 ' HB3' ' A' ' 138' ' ' ALA . 6.2 m -113.35 104.88 55.56 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.169 0.509 . . . . 0.0 112.172 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 51.8 Cg_endo -72.34 108.6 2.54 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.816 2.344 . . . . 0.0 111.634 173.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.678 HG13 HD21 ' A' ' 158' ' ' LEU . 46.9 t -102.35 124.92 37.87 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.071 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.552 ' HD2' HD22 ' A' ' 158' ' ' LEU . 78.7 Cg_exo -44.54 133.65 9.8 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.636 2.89 . . . . 0.0 112.783 173.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -58.59 -30.6 67.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.651 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -89.88 1.36 56.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.424 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 105' ' ' VAL . 25.1 m -119.56 -27.97 5.41 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.505 ' HA ' HG11 ' A' ' 97' ' ' VAL . 11.2 p -52.33 -34.43 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.38 -37.76 94.19 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.85 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.9 -37.14 53.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 0.0 110.36 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 101' ' ' SER . 48.0 t -65.35 -38.67 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.326 0.584 . . . . 0.0 110.669 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.814 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 13.7 mt -81.03 -26.33 10.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.238 0.542 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.4 48.44 5.94 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 59.02 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.83 0.852 . . . . 0.0 112.244 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.9 m -75.08 -24.49 58.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 111.065 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.413 ' HA2' ' CG2' ' A' ' 106' ' ' ILE . . . 130.41 50.7 0.11 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.725 177.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.563 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 40.4 mt-10 -93.42 -58.98 2.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.882 0.373 . . . . 0.0 110.302 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -68.37 -31.54 70.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.163 -173.573 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.814 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.0 tp -65.46 -22.88 31.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.253 0.549 . . . . 0.0 110.675 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -82.32 -26.06 33.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.046 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.563 ' HD3' ' O ' ' A' ' 111' ' ' GLU . 2.7 mptp? -65.24 -38.13 89.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.455 HD11 ' SD ' ' A' ' 112' ' ' MET . 28.9 mm -59.12 -43.12 88.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.491 175.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 17.0 mt-30 -67.04 -33.61 75.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.744 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -79.26 -42.32 26.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.613 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.64 -40.62 33.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.464 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.17 18.47 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.93 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.19 46.35 8.25 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.438 HG21 HG23 ' A' ' 140' ' ' ILE . 1.9 t -118.02 143.75 27.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.109 -0.546 . . . . 0.0 111.678 -169.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.475 ' HD3' ' SD ' ' A' ' 141' ' ' MET . 79.4 mtp180 -103.53 148.68 25.67 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.2 mm -114.63 135.03 55.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.189 0.519 . . . . 0.0 111.937 -171.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.586 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 24.1 tt0 -137.32 105.67 5.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.219 176.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.493 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 33.6 m-85 -80.76 106.53 12.84 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 121.942 -0.474 . . . . 0.0 109.949 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.832 ' O ' ' HE2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.47 127.28 48.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.235 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 63.81 -170.3 0.19 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.384 0.612 . . . . 0.0 111.589 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -138.57 -168.3 2.37 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -68.81 -27.5 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 132.73 -20.94 4.28 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.453 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.907 HG23 ' HD2' ' A' ' 134' ' ' PRO . 6.2 t -136.62 -27.21 1.05 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.87 -47.74 0.68 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.368 -1.396 . . . . 0.0 115.465 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.907 ' HD2' HG23 ' A' ' 132' ' ' THR . 51.0 Cg_exo -37.76 -47.76 2.02 Favored 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 123.777 2.984 . . . . 0.0 115.091 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 130' ' ' ASP . 20.1 mt-10 -132.74 146.35 51.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.358 0.599 . . . . 0.0 111.525 -177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -119.47 115.94 25.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.747 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.546 HG22 ' NZ ' ' A' ' 127' ' ' LYS . 18.0 mm -72.84 108.32 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.569 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.828 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -96.79 141.4 30.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.671 175.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.6 ' NE2' HG23 ' A' ' 89' ' ' ILE . 3.2 t-160 -91.52 117.52 29.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.879 0.371 . . . . 0.0 110.414 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.655 HD13 ' HB3' ' A' ' 150' ' ' ALA . 37.9 mt -97.17 118.24 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.248 171.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.475 ' SD ' ' HD3' ' A' ' 123' ' ' ARG . 46.3 ttm -102.13 121.61 42.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 -174.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 164.33 170.26 29.02 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.16 150.83 82.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.585 2.19 . . . . 0.0 111.6 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.775 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 87.2 Cg_exo -42.3 -40.02 6.65 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.931 3.087 . . . . 0.0 114.999 -172.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.3 -32.07 64.4 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.998 -0.439 . . . . 0.0 110.855 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 149' ' ' HIS . 92.7 mtt-85 -85.0 -35.17 22.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.778 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.775 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 27.7 p -62.99 -51.08 68.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.609 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 28.3 mt-10 -66.38 -29.01 69.09 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.935 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 4.4 t60 -55.49 -36.08 66.26 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.116 0.484 . . . . 0.0 110.136 175.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.655 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.14 -35.04 42.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.922 -174.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.473 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -67.15 -24.93 65.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.609 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 2.9 mpt_? -77.84 -18.5 56.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.981 0.42 . . . . 0.0 110.314 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.5 mt -82.41 -44.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 66.7 mt -65.94 -52.51 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.347 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -60.74 -30.21 69.85 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.251 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.63 -39.48 93.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.996 0.427 . . . . 0.0 110.013 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.424 HD11 ' CE ' ' A' ' 112' ' ' MET . 82.7 mt -67.07 -44.06 81.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.776 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.678 HD21 HG13 ' A' ' 97' ' ' VAL . 71.3 mt -63.1 -33.8 76.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.776 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -73.34 -37.66 66.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.447 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.8 t -71.04 -38.57 72.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.685 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 163' ' ' SER . 74.1 mt -80.36 -78.36 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 56.29 -77.45 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.093 0.871 . . . . 0.0 113.099 174.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 161' ' ' LEU . 38.5 t 169.96 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -173.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.818 178.571 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.437 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.656 HG21 ' HA ' ' A' ' 57' ' ' PRO . 36.5 m -137.09 94.91 3.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.051 0.453 . . . . 0.0 109.986 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 17.5 m -132.28 141.4 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.699 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -123.52 141.72 51.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.742 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 45.6 mt-10 -112.23 121.38 44.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.363 0.601 . . . . 0.0 111.703 -175.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.66 HG13 HG21 ' A' ' 67' ' ' VAL . 44.7 mm -110.52 150.08 13.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.665 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.489 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 50.4 tpp -101.37 117.03 34.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.881 0.372 . . . . 0.0 110.848 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.779 HG12 HG11 ' A' ' 16' ' ' VAL . 3.0 mp -99.37 104.39 26.56 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.185 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 7' ' ' MET . 21.2 Cg_exo -67.52 159.45 52.44 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 123.08 2.52 . . . . 0.0 111.82 177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.51 141.56 57.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.14 -51.42 1.89 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -172.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.78 -25.01 64.49 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.004 0.431 . . . . 0.0 110.411 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.748 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -52.11 -37.47 54.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.67 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA3' ' OE1' ' A' ' 76' ' ' GLN . . . -63.03 -38.46 96.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.984 -178.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.077 HD23 ' HA ' ' A' ' 76' ' ' GLN . 2.9 pp -89.93 -15.82 31.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.98 0.39 . . . . 0.0 111.656 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.779 HG11 HG12 ' A' ' 8' ' ' ILE . 70.8 t -90.2 -49.94 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.748 HG12 ' O ' ' A' ' 13' ' ' ALA . 17.6 pt -87.51 -23.42 6.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.321 -0.551 . . . . 0.0 109.895 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.761 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 89.92 17.95 52.33 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.719 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.452 ' H ' HG13 ' A' ' 17' ' ' ILE . 29.7 mmtp 65.05 -63.36 0.19 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.667 0.787 . . . . 0.0 111.658 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.75 19.35 47.56 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.257 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 92.82 8.04 62.33 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.025 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.605 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 28.6 tt0 -63.01 -48.34 79.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.687 0.28 . . . . 0.0 111.594 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.761 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 78.9 m -67.23 -39.45 86.23 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.204 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.667 HD12 HD12 ' A' ' 27' ' ' LEU . 1.3 tp -64.6 -22.1 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.67 0.272 . . . . 0.0 110.899 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.605 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 49.8 mttm -56.79 -57.86 10.62 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.619 0.723 . . . . 0.0 109.981 173.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -69.31 -26.98 65.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.963 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.667 HD12 HD12 ' A' ' 24' ' ' ILE . 36.6 mt -75.03 -30.14 61.0 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.045 -0.409 . . . . 0.0 111.019 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.706 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.2 mt-30 -84.83 -42.45 15.1 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.032 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -88.07 -62.1 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.66 HH21 ' HA3' ' A' ' 86' ' ' GLY . 2.2 ttp180 -58.47 -43.75 89.02 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.933 0.397 . . . . 0.0 110.891 -176.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -75.45 -22.39 57.36 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.356 0.598 . . . . 0.0 111.178 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.99 78.4 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.778 -0.647 . . . . 0.0 112.672 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 28.6 m -121.75 151.0 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.843 0.354 . . . . 0.0 110.455 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -89.19 109.49 20.36 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 1.044 ' HB3' HD11 ' A' ' 51' ' ' LEU . 59.4 mtt -98.2 114.43 26.67 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.707 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.9 tp -110.44 112.25 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 122.006 0.908 . . . . 0.0 109.677 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.638 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -132.29 143.38 49.85 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.95 -175.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 78.7 mt -54.37 107.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 124.01 0.819 . . . . 0.0 111.892 -173.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -126.37 -14.55 5.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.837 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.28 158.61 20.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.676 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.29 69.11 0.88 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.966 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.4 t -89.38 -62.89 1.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -175.6 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.393 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -86.75 62.5 7.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.114 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 p -83.29 -61.13 1.93 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.81 0.338 . . . . 0.0 111.347 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -93.39 -17.08 23.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.283 0.563 . . . . 0.0 109.819 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 11.9 t -79.15 166.17 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.886 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.4 p30 -47.84 140.91 6.13 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.159 0.504 . . . . 0.0 111.282 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 16.6 mtmm -130.1 137.46 30.92 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.087 -170.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.53 133.21 5.22 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.597 2.198 . . . . 0.0 112.4 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.044 HD11 ' HB3' ' A' ' 35' ' ' MET . 22.4 tp -108.05 120.18 41.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.813 -177.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.707 ' HB2' HG23 ' A' ' 36' ' ' ILE . 5.1 mpt_? -96.27 115.57 27.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.37 174.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.3 mt -91.47 110.1 22.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.786 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 3' ' ' VAL . 35.3 mt -108.06 121.04 60.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.452 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.544 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.86 -170.2 43.33 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.986 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.985 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . 2.1 m-20 -51.03 146.75 10.11 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.647 0.263 . . . . 0.0 110.514 175.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.656 ' HA ' HG21 ' A' ' 2' ' ' THR . 51.3 Cg_exo -54.72 -52.62 7.66 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 121.909 1.739 . . . . 0.0 112.773 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -61.03 -30.65 70.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.638 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.985 ' HG3' ' HB2' ' A' ' 56' ' ' ASP . 46.1 mttp -64.77 -47.97 76.22 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.294 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.31 -39.0 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.165 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.19 -51.88 67.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.564 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.89 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 17.8 mm-40 -68.7 -35.43 77.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 -178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -72.31 -42.48 65.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.89 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 47.3 t -57.35 -36.76 71.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.358 0.599 . . . . 0.0 109.568 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -67.49 -45.63 75.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.21 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.633 ' O ' HG13 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -73.94 -37.7 64.48 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.837 -175.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.66 HG21 HG13 ' A' ' 6' ' ' ILE . 35.9 m -62.49 -35.18 68.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.678 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.726 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 66.2 mtt -71.24 -21.22 62.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.737 0.303 . . . . 0.0 110.632 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 8.9 t70 -85.59 -41.51 15.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.967 0.413 . . . . 0.0 111.04 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.812 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.1 pp -86.85 -23.99 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.922 0.392 . . . . 0.0 111.856 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.622 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 3.6 tt -86.47 -20.06 28.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.551 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.726 ' HB3' ' O ' ' A' ' 68' ' ' MET . 5.3 ptm180 -61.55 -11.36 10.81 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.85 0.357 . . . . 0.0 111.076 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 1.05 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 16.0 tp10 -50.98 138.79 18.65 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.401 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -66.7 -30.08 70.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.827 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 29.1 t70 -135.23 -89.32 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.716 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 1.077 ' HA ' HD23 ' A' ' 15' ' ' LEU . 9.3 tt0 -153.66 61.45 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.544 0.688 . . . . 0.0 110.296 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 1.05 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . -137.64 30.49 2.58 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.8 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.75 158.27 40.73 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.812 ' HD1' HG22 ' A' ' 70' ' ' ILE . 4.5 m-85 -60.59 -45.51 93.7 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.82 -75.49 0.42 Allowed Glycine 0 CA--C 1.496 -1.099 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 169.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.526 ' HA ' HD21 ' A' ' 27' ' ' LEU . 19.2 p-10 -92.33 -15.61 27.12 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.418 -0.891 . . . . 0.0 110.473 174.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.446 ' CB ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER 84.58 64.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.635 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 28.8 t-20 -49.54 102.93 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.709 176.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 1.065 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.7 tt0 162.65 -41.97 0.0 OUTLIER 'General case' 0 C--O 1.232 0.157 0 O-C-N 124.572 1.17 . . . . 0.0 108.32 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 53.2 p90 -175.03 151.27 1.3 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.449 -177.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.61 80.04 0.18 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.89 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 40.1 m 72.38 -20.41 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.107 0.479 . . . . 0.0 111.001 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.663 ' HD3' ' H ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -103.96 154.03 20.13 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.733 171.207 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.694 HG21 ' CE1' ' A' ' 139' ' ' HIS . 33.3 mm 62.58 -88.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.119 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.03 46.45 1.73 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.661 -172.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 151.71 164.82 12.48 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.739 -0.545 . . . . 0.0 111.739 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.748 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 86.13 -122.02 5.91 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.081 -0.581 . . . . 0.0 111.724 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.065 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 28.7 pt -155.43 178.5 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 122.921 0.489 . . . . 0.0 109.852 171.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -120.22 137.04 54.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.694 170.364 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 29.2 t -124.12 98.06 39.55 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.073 -175.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.441 ' CA ' HD13 ' A' ' 137' ' ' ILE . 38.2 Cg_endo -69.98 107.75 1.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.671 1.581 . . . . 0.0 110.92 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.672 HG21 HG21 ' A' ' 105' ' ' VAL . 14.8 p -116.02 126.75 27.35 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.014 0.435 . . . . 0.0 110.574 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.496 ' HA ' ' HG2' ' A' ' 135' ' ' GLU . 73.6 Cg_exo -46.96 136.17 17.54 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.499 2.799 . . . . 0.0 112.546 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -54.77 -29.13 53.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.343 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -92.29 10.55 29.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.895 0.379 . . . . 0.0 111.354 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.465 ' HB3' HD21 ' A' ' 161' ' ' LEU . 46.1 m -128.64 -15.19 4.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.761 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 106' ' ' ILE . 7.6 p -64.51 -35.28 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.267 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.73 -28.56 73.5 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.184 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.29 -37.97 39.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.672 HG21 HG21 ' A' ' 97' ' ' VAL . 62.1 t -59.78 -41.09 84.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.919 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.784 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 46.0 mm -67.39 -46.3 83.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.245 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.06 33.26 9.02 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.611 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' A' ' 108' ' ' ARG . 27.9 mtp180 64.9 -78.28 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.264 0.626 . . . . 0.0 111.914 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.457 ' HB2' ' HG3' ' A' ' 111' ' ' GLU . 18.0 m -81.81 11.32 5.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.878 0.37 . . . . 0.0 110.815 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.407 ' O ' ' HG2' ' A' ' 114' ' ' LYS . . . 75.51 22.12 76.0 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.919 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 109' ' ' SER . 41.0 mt-10 -71.46 -50.47 31.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.895 0.378 . . . . 0.0 110.916 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.544 ' O ' HG12 ' A' ' 116' ' ' ILE . 13.6 tpt -68.49 -39.11 81.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.081 -173.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.784 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.3 tp -65.96 -32.37 57.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.608 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 110' ' ' GLY . 74.6 mmtt -81.41 -30.58 33.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.203 0.525 . . . . 0.0 109.731 176.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -66.15 -38.74 88.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.945 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 112' ' ' MET . 45.6 mm -62.15 -39.04 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.354 0.597 . . . . 0.0 109.651 174.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 77.6 mt-30 -65.8 -32.22 73.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.833 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -79.8 -42.4 24.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.567 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -79.46 -43.58 22.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.65 -18.94 20.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.929 0.395 . . . . 0.0 111.671 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.53 47.42 8.03 Favored Glycine 0 C--O 1.228 -0.223 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.886 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.459 ' HB ' HG23 ' A' ' 140' ' ' ILE . 27.1 m -122.17 179.58 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 111.653 -173.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.748 ' HB3' ' HG2' ' A' ' 141' ' ' MET . 43.1 ttt180 -145.68 145.78 31.04 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.558 HG13 HD11 ' A' ' 113' ' ' ILE . 44.9 mm -107.68 138.46 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -168.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.673 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 7.0 tp60 -138.48 94.92 2.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.866 175.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 138' ' ' ALA . 44.2 m-85 -73.72 105.97 5.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.776 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -102.04 -166.74 1.32 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.076 -173.451 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . 0.408 ' OE1' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -70.44 48.65 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -169.69 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -135.97 66.32 1.5 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -105.3 -48.16 3.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.952 -174.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.97 1.9 27.14 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.605 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.4 t -100.0 40.6 1.23 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.587 0.708 . . . . 0.0 110.775 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.88 165.84 28.83 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.925 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.41 -11.18 17.4 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.844 2.363 . . . . 0.0 111.231 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 98' ' ' PRO . 45.7 mt-10 -129.36 151.03 50.45 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.872 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.494 ' O ' HG12 ' A' ' 97' ' ' VAL . 66.9 mttm -109.38 113.82 26.97 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -175.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 14.9 mm -67.13 109.86 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.864 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 126' ' ' PHE . . . -97.79 135.14 39.98 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 170.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.694 ' CE1' HG21 ' A' ' 89' ' ' ILE . 13.2 t60 -86.69 123.43 31.85 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.979 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.551 HD13 ' HB3' ' A' ' 150' ' ' ALA . 32.3 mt -103.24 126.15 57.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.275 171.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.748 ' HG2' ' HB3' ' A' ' 123' ' ' ARG . 16.8 ptp -107.23 165.49 11.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.958 0.409 . . . . 0.0 110.665 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.76 172.96 13.26 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.503 ' HD2' ' HD3' ' A' ' 146' ' ' ARG . 38.1 Cg_exo -58.89 143.5 99.36 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.415 2.076 . . . . 0.0 111.765 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.747 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 72.5 Cg_exo -41.59 -43.97 6.24 Favored 'Trans proline' 0 N--CA 1.476 0.466 0 C-N-CA 124.006 3.137 . . . . 0.0 114.497 -173.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 11.4 t70 -57.59 -42.93 84.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.612 0.244 . . . . 0.0 111.417 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.503 ' HD3' ' HD2' ' A' ' 143' ' ' PRO . 18.3 mtp180 -79.75 -39.15 31.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.52 -172.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.747 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 12.2 p -63.11 -50.65 69.64 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.666 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 5.7 mm-40 -62.21 -38.88 90.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.664 0.269 . . . . 0.0 110.718 176.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 18.6 t60 -57.66 -32.31 67.18 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.953 0.406 . . . . 0.0 111.076 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.551 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -77.91 -34.02 51.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.778 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.512 ' HB3' HH11 ' A' ' 152' ' ' ARG . . . -67.47 -25.26 65.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.396 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.666 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 10.9 mpt_? -77.83 -32.73 52.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.845 0.355 . . . . 0.0 110.264 -177.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.44 ' O ' HD13 ' A' ' 157' ' ' LEU . 63.4 mt -65.4 -46.36 90.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.813 176.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.633 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 68.3 mt -62.41 -37.48 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.294 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.85 -31.3 69.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.462 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 159' ' ' GLN . 15.6 t70 -79.08 -37.48 38.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.14 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 153' ' ' ILE . 7.8 mp -53.49 -42.29 67.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 25.5 mt -62.22 -36.65 82.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.424 -176.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 156' ' ' ASP . 21.3 pt20 -84.21 -25.47 29.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.666 0.27 . . . . 0.0 111.31 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.3 m -79.64 -26.78 41.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -175.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.465 HD21 ' HB3' ' A' ' 101' ' ' SER . 3.5 pp -81.36 19.94 0.92 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -173.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 159' ' ' GLN . 38.4 mmt180 -73.98 -26.5 60.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.262 0.554 . . . . 0.0 109.967 177.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.9 t -159.29 110.93 2.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.471 0 C-N-CA 120.111 -1.043 . . . . 0.0 113.279 -174.823 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 15.0 m -133.54 115.18 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.502 0.668 . . . . 0.0 111.525 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -115.28 141.33 48.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.487 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 39.5 mt-10 -109.77 136.04 49.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.555 0.693 . . . . 0.0 112.504 -174.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.0 148.22 29.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.07 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 68.3 mtp -101.49 129.18 47.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.151 0.5 . . . . 0.0 111.56 -174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 51' ' ' LEU . 3.9 mp -105.54 107.29 58.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.301 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.494 ' HD2' ' HG3' ' A' ' 12' ' ' LYS . 8.1 Cg_exo -74.64 152.23 42.43 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.211 2.607 . . . . 0.0 111.429 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.61 129.43 40.53 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.47 -15.4 24.77 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HD2' ' O ' ' A' ' 71' ' ' LEU . 71.0 mmtt -112.66 9.27 19.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.045 0.45 . . . . 0.0 110.132 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.417 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -62.92 -41.67 99.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.95 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.6 -15.72 66.72 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.175 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.862 HD11 ' HB2' ' A' ' 73' ' ' GLU . 24.7 mt -87.32 -58.61 2.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 120.81 0.338 . . . . 0.0 110.719 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.673 HG11 HG12 ' A' ' 8' ' ' ILE . 85.3 t -81.68 -48.83 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 13' ' ' ALA . 39.8 pt -91.52 -26.78 4.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.917 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.35 33.92 13.18 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.457 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm 57.65 29.66 17.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.977 0.511 . . . . 0.0 112.093 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.1 -33.47 0.61 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 119.951 -1.119 . . . . 0.0 113.304 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 157.07 -6.33 0.19 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 119.908 -1.139 . . . . 0.0 113.792 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.74 -46.57 67.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.964 0.382 . . . . 0.0 111.549 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 81' ' ' ASP . 86.0 m -73.36 -42.9 61.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.23 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.731 HD11 ' HB2' ' A' ' 35' ' ' MET . 5.8 tp -62.35 -26.1 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.75 -174.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 89.3 mttt -53.54 -56.89 13.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.945 0.879 . . . . 0.0 109.96 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.731 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 22.8 mt-30 -73.96 -27.69 61.12 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.607 -174.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.579 HD12 HD12 ' A' ' 24' ' ' ILE . 91.8 mt -66.59 -27.64 67.88 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.236 0.541 . . . . 0.0 109.853 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.679 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.4 mt-30 -85.41 -46.42 10.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.019 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -79.82 -62.44 1.68 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.504 ' HG2' HH22 ' A' ' 82' ' ' ARG . 3.0 ttm180 -62.34 -38.37 89.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.395 -173.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -87.51 -26.46 23.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.825 0.345 . . . . 0.0 111.634 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.4 70.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.76 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.5 m -127.41 156.06 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -94.25 109.37 21.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.822 ' HB3' HD21 ' A' ' 51' ' ' LEU . 48.8 mtt -100.24 114.04 27.18 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.172 0.51 . . . . 0.0 109.64 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.4 tt -111.72 113.8 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.982 0.896 . . . . 0.0 109.932 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.742 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 1.1 pt? -132.6 141.19 48.56 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.197 -175.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.692 HD13 ' HG2' ' A' ' 50' ' ' PRO . 2.1 mp -59.43 102.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.421 0.629 . . . . 0.0 111.012 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 19.46 17.73 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.6 123.37 25.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.405 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.767 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . -79.59 -0.97 85.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.225 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.6 m -90.09 -26.35 20.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.086 0.443 . . . . 0.0 110.865 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -115.79 -81.53 0.61 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.282 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.565 ' HB2' ' CG2' ' A' ' 38' ' ' ILE . 15.0 m120 -96.76 67.31 2.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.94 0.4 . . . . 0.0 110.994 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.767 ' HB ' ' HA2' ' A' ' 41' ' ' GLY . 1.9 t -83.44 -56.49 3.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.315 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -94.3 -21.8 18.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.124 0.488 . . . . 0.0 110.856 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.11 158.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.755 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.2 148.0 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.442 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -122.86 133.86 24.71 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.018 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.692 ' HG2' HD13 ' A' ' 38' ' ' ILE . 94.7 Cg_endo -86.98 119.91 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.421 2.081 . . . . 0.0 112.649 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.0 tt -88.06 111.11 21.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.675 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 2.6 mtp85 -96.73 100.12 11.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.722 0.296 . . . . 0.0 110.544 177.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 59.9 mt -80.83 112.61 19.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.23 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.4 mt -104.43 121.24 55.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.34 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.63 -171.01 44.21 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.23 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -69.05 153.1 96.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.5 -54.98 4.36 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.217 2.612 . . . . 0.0 114.227 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -65.68 -26.87 67.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 110.811 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.633 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 87.6 mttt -69.67 -51.06 38.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.112 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.91 -29.0 46.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.321 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.36 -56.18 16.14 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.516 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.924 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -65.04 -37.2 86.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.657 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -67.33 -46.67 72.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.356 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.9 t -55.68 -36.64 67.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.074 0.464 . . . . 0.0 110.447 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -63.95 -50.72 67.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.148 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 8.2 ptt? -68.69 -38.96 80.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.951 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 63' ' ' ALA . 61.6 t -57.53 -41.83 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.567 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.0 mtp -68.33 -25.71 65.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.306 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.671 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 11.8 t70 -84.54 -54.46 4.73 Favored 'General case' 0 C--O 1.219 -0.5 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.692 -176.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -71.51 -21.04 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.997 -174.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.624 HD12 HG21 ' A' ' 16' ' ' VAL . 5.1 tt -76.34 -16.82 59.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.069 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.736 ' HD2' ' HG2' ' A' ' 74' ' ' ARG . 10.9 ptp180 -56.7 -36.6 69.83 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.862 ' HB2' HD11 ' A' ' 15' ' ' LEU . 1.3 tm-20 65.85 98.98 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.853 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.736 ' HG2' ' HD2' ' A' ' 72' ' ' ARG . 43.2 mtt180 -96.36 -27.8 14.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.378 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -151.65 29.1 0.61 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.129 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.762 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 37.86 35.67 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.004 0.921 . . . . 0.0 112.827 -169.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.47 -44.26 0.79 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 65.03 25.57 70.93 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.698 -0.287 . . . . 0.0 112.876 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 67.8 -50.93 0.52 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.622 0.769 . . . . 0.0 111.889 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 111.34 99.15 2.48 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -174.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 0.7 OUTLIER 72.59 -66.38 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.02 0.482 . . . . 0.0 109.91 -169.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.634 ' HB3' ' NH1' ' A' ' 82' ' ' ARG . 0.8 OUTLIER 170.17 -42.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.328 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 57.95 78.11 0.26 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.213 0.53 . . . . 0.0 110.765 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 1.056 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.6 tt0 -174.91 -68.27 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.288 -175.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.629 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 1.1 p90 -141.32 -69.22 0.38 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 120.689 -1.257 . . . . 0.0 112.367 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.428 ' H ' ' HD1' ' A' ' 85' ' ' TYR . . . 68.45 75.39 0.52 Allowed Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.288 -174.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.633 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 9.6 m 74.86 -38.74 0.39 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.541 0.736 . . . . 0.0 112.71 176.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.702 ' HG2' ' HD2' ' A' ' 127' ' ' LYS . 3.9 mpt_? -66.21 -88.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.629 ' O ' ' HB3' ' A' ' 85' ' ' TYR . 10.5 mm -111.65 88.82 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.1 -174.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.39 91.01 0.08 OUTLIER Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.496 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.57 93.79 0.29 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.85 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 112.41 165.13 16.98 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 -174.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.056 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 45.6 pt -94.15 155.71 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 117.125 0.463 . . . . 0.0 111.967 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.496 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 2.1 p30 -96.35 147.16 24.1 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.656 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 40.6 t -136.51 99.72 10.52 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 95' ' ' VAL . 38.6 Cg_endo -71.07 106.7 1.95 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.113 1.875 . . . . 0.0 111.412 170.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.586 HG23 HD21 ' A' ' 158' ' ' LEU . 13.4 p -109.65 131.32 21.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.58 144.51 51.93 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.447 2.765 . . . . 0.0 112.747 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -64.49 -22.13 66.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.772 -172.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -86.35 -4.48 59.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 110.516 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 105' ' ' VAL . 16.4 m -114.85 -29.61 6.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.1 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.21 -39.96 70.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.12 -27.12 74.11 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.071 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.95 -33.62 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.08 0.467 . . . . 0.0 109.745 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 101' ' ' SER . 94.3 t -60.19 -39.8 81.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.171 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.411 HD11 ' CZ ' ' A' ' 126' ' ' PHE . 33.6 mm -72.2 -59.05 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.467 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.4 -137.72 14.26 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -98.42 -57.34 2.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.222 0.511 . . . . 0.0 110.014 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 m -105.65 -24.27 12.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.612 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 136.81 20.54 0.59 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.469 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 1.8 mp0 -49.75 -43.68 48.12 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.1 0.476 . . . . 0.0 110.991 -176.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.678 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.2 tpt -76.37 -52.7 9.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.584 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 124' ' ' ILE . 20.1 tt -69.92 -26.26 29.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.743 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.23 -29.28 63.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.552 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.678 ' HG2' ' O ' ' A' ' 112' ' ' MET . 16.5 ptpt -80.04 -22.59 42.2 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.265 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.36 -45.68 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -69.26 -25.29 64.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.625 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -79.39 -39.46 32.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.046 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -78.98 -54.08 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.404 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.446 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -88.23 -15.29 36.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.06 57.46 6.95 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.129 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.9 m -131.62 174.21 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.872 0.368 . . . . 0.0 111.314 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.803 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 86.6 mtt180 -125.04 151.41 45.65 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.669 HG21 HD11 ' A' ' 113' ' ' ILE . 47.8 mm -112.23 136.35 48.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.079 0.466 . . . . 0.0 111.155 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.664 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 3.9 tp-100 -130.72 110.99 11.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.309 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 52.1 m-85 -80.97 102.89 10.43 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.113 171.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.941 ' HE2' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -99.2 164.67 12.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.847 -178.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.44 ' CD ' HH21 ' A' ' 88' ' ' ARG . 4.9 pt20 . . . . . 0 C--O 1.236 0.382 0 O-C-N 124.146 0.904 . . . . 0.0 110.52 173.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 CA--C 1.532 0.407 0 N-CA-C 114.393 0.882 . . . . 0.0 114.393 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.17 148.87 21.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.619 . . . . 0.0 111.757 -172.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 97' ' ' VAL . 60.3 mttm -127.46 123.21 35.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.894 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.941 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 6.4 mm -74.13 107.67 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.35 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.656 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -99.4 104.71 16.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.664 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 60.7 t-80 -73.32 133.73 43.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.0 0.428 . . . . 0.0 111.485 -172.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.687 HD13 ' HB3' ' A' ' 150' ' ' ALA . 95.9 mt -101.2 111.83 32.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.887 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.803 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 37.6 ttm -97.19 137.36 36.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.936 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.82 -161.21 29.45 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.011 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -71.39 139.12 34.15 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.982 2.455 . . . . 0.0 111.344 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.94 -47.21 10.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.037 3.158 . . . . 0.0 113.964 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.53 -39.6 91.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 111.155 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.446 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 57.7 mtt180 -76.16 -28.29 57.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.178 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.85 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 73.1 m -56.92 -59.74 4.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.202 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.698 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 31.3 mt-10 -61.58 -39.82 92.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.464 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -54.79 -31.41 58.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.393 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.687 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.34 -34.74 48.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.974 0.416 . . . . 0.0 110.635 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 93' ' ' ILE . . . -71.73 -21.39 61.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.286 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.698 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 8.2 mpt_? -76.74 -30.42 56.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.595 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 58.1 mt -70.13 -51.29 40.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.591 175.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.547 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 67.1 mt -59.04 -44.83 92.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.091 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.28 -32.2 72.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.386 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.86 -35.51 67.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 47.3 mt -62.0 -38.2 87.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.001 176.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.586 HD21 HG23 ' A' ' 97' ' ' VAL . 22.2 mt . . . . . 0 C--N 1.333 -0.15 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.691 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.441 ' HB ' HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 111.405 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.572 HG22 HG12 ' A' ' 54' ' ' ILE . 38.0 t -125.03 113.62 36.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.5 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -107.32 146.98 30.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.449 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.595 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 42.5 mt-10 -109.03 120.49 42.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.136 0.493 . . . . 0.0 111.507 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.8 mm -108.55 127.17 65.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.038 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 ttm -79.64 119.85 23.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.137 0.494 . . . . 0.0 111.525 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.457 HG12 HG11 ' A' ' 16' ' ' VAL . 1.6 mp -100.48 119.01 59.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.171 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.657 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 50.4 Cg_exo -61.74 148.41 93.13 Favored 'Trans proline' 0 N--CA 1.476 0.451 0 C-N-CA 123.761 2.974 . . . . 0.0 112.609 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.99 135.45 52.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.7 -45.8 1.69 Allowed Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -170.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.836 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -71.41 -34.01 69.96 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.25 -41.27 60.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.106 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.845 ' HA3' ' HE3' ' A' ' 19' ' ' LYS . . . -61.19 -32.25 79.88 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.957 -0.565 . . . . 0.0 113.221 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.4 pp -91.59 -22.2 20.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.001 0.401 . . . . 0.0 111.401 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.457 HG11 HG12 ' A' ' 8' ' ' ILE . 70.6 t -81.32 -46.56 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.656 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 13' ' ' ALA . 25.0 pt -91.6 -27.29 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.193 0.52 . . . . 0.0 110.383 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.7 132.6 6.43 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.845 ' HE3' ' HA3' ' A' ' 14' ' ' GLY . 30.9 mmtp -63.96 -17.81 63.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.122 0.461 . . . . 0.0 110.693 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.45 13.83 8.26 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.87 -1.09 74.07 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.977 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -53.9 -52.85 59.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 15' ' ' LEU . 19.2 m -62.32 -36.45 82.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.822 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.734 HD12 HD12 ' A' ' 27' ' ' LEU . 2.6 tp -66.7 -33.28 62.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.897 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -57.24 -41.7 80.06 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.433 0.635 . . . . 0.0 110.375 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 30' ' ' ARG . 10.7 mt-30 -71.86 -26.37 62.33 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.229 -176.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.734 HD12 HD12 ' A' ' 24' ' ' ILE . 74.2 mt -81.14 -34.36 32.53 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.08 0.467 . . . . 0.0 110.857 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.85 HE22 ' HB2' ' A' ' 35' ' ' MET . 18.6 mm-40 -84.83 -59.12 2.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.271 0.558 . . . . 0.0 110.843 -176.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.89 -46.17 10.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.722 -172.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.976 HH12 ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -65.84 -52.6 49.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 111.09 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -71.5 -28.95 64.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.642 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.72 17.36 54.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.054 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.5 m -118.39 171.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' HD2' ' OE1' ' A' ' 28' ' ' GLN . 52.7 tptt -114.53 109.47 18.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.832 0.825 . . . . 0.0 109.723 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.85 ' HB2' HE22 ' A' ' 28' ' ' GLN . 48.3 mtt -94.68 112.64 24.38 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.452 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.654 HG23 ' HB2' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -111.01 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.905 0.859 . . . . 0.0 109.219 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.718 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 1.8 pt? -133.46 142.5 48.31 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.041 -173.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.524 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 3.2 mp -66.28 105.13 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.563 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.501 ' HG2' HG21 ' A' ' 17' ' ' ILE . 49.1 mt-30 -85.67 -57.84 2.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.925 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -174.43 118.59 0.22 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.86 -49.86 0.36 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.997 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.3 p -72.16 -75.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.904 0.352 . . . . 0.0 111.616 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -157.55 -35.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.189 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -79.62 67.32 5.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.443 0.639 . . . . 0.0 110.207 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 p -83.34 -57.76 3.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.918 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.19 -14.3 27.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.442 0.639 . . . . 0.0 110.239 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.04 158.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.7 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.89 150.36 16.71 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.394 0.434 . . . . 0.0 110.49 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 64.8 mttt -127.33 123.56 23.33 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.24 -167.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.19 124.44 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.81 2.34 . . . . 0.0 112.891 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.718 ' HA ' ' HB3' ' A' ' 37' ' ' LEU . 7.2 tt -98.98 118.6 36.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.697 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.654 ' HB2' HG23 ' A' ' 36' ' ' ILE . 3.9 mpt_? -97.52 119.4 36.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.644 0.259 . . . . 0.0 110.53 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 56.4 mt -92.46 110.16 22.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.021 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.572 HG12 HG22 ' A' ' 3' ' ' VAL . 27.5 mt -104.55 120.84 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.53 -171.08 44.09 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.028 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.479 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 9.5 t70 -60.73 135.49 92.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 O-C-N 123.786 0.345 . . . . 0.0 110.782 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -43.48 -46.73 9.73 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.174 2.582 . . . . 0.0 114.262 -174.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.48 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 87.3 t80 -64.81 -40.39 95.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.296 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 52.0 mttp -67.52 -42.26 83.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.281 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.441 HG21 ' HB ' ' A' ' 2' ' ' THR . 98.9 t -60.16 -33.49 53.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.674 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.71 -50.1 53.54 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.638 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 12.5 mm100 -65.37 -39.68 92.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.223 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.514 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -63.56 -43.45 97.02 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.773 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.2 m -56.93 -44.36 82.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.761 0.315 . . . . 0.0 110.356 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.99 -42.16 99.76 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.905 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.643 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 5.6 ptt? -77.51 -34.22 54.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.406 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 54.1 t -61.62 -38.69 80.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 110.243 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.8 mtt -69.98 -21.84 63.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.542 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.614 ' HB2' HH21 ' A' ' 82' ' ' ARG . 31.9 t70 -84.84 -59.25 2.4 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.789 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -68.44 -20.04 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.069 -174.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.836 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 6.5 tt -76.51 -10.26 59.26 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.309 175.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -65.58 -17.37 64.53 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.917 0.389 . . . . 0.0 110.351 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' HB3' HD22 ' A' ' 15' ' ' LEU . 10.5 tp10 -56.83 128.43 36.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.522 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -96.7 -20.18 18.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.013 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -122.46 36.63 4.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.648 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 65.08 105.43 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.247 173.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.69 -104.23 0.22 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.753 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 91.26 33.43 8.11 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.541 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 21.0 m-85 67.89 -56.68 0.47 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.215 0.606 . . . . 0.0 111.871 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 115.28 105.79 2.56 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -172.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 2.5 t70 73.39 -61.34 0.5 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.673 0.389 . . . . 0.0 110.354 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.823 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 8.6 ttm180 169.72 -21.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.564 1.165 . . . . 0.0 108.712 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.6 ' HA ' ' OD1' ' A' ' 94' ' ' ASP . 0.2 OUTLIER 66.1 31.89 8.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.611 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 1.077 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 34.4 tt0 -141.07 -40.05 0.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.157 -173.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 20.0 p90 -159.98 -44.07 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.976 ' HA3' HH12 ' A' ' 30' ' ' ARG . . . 65.12 72.74 0.67 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.572 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.774 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 49.7 m 67.67 -37.89 0.34 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 175.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.467 ' HD2' HD13 ' A' ' 89' ' ' ILE . 2.8 tmt_? -68.53 -81.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.981 HD11 ' HG2' ' A' ' 125' ' ' GLN . 31.5 mm -65.97 -80.35 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -168.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.4 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 109.96 73.47 0.75 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -170.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.581 ' H ' ' HD2' ' A' ' 85' ' ' TYR . . . 118.75 161.12 11.66 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.812 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 89.34 -146.66 19.11 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.144 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.077 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 43.4 pt -149.24 162.02 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 172.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.6 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 2.3 p-10 -107.4 140.51 40.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.815 HG23 ' HB3' ' A' ' 138' ' ' ALA . 17.2 m -132.91 95.24 19.4 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.466 0.65 . . . . 0.0 111.472 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 95' ' ' VAL . 12.3 Cg_endo -58.47 108.68 0.42 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.191 2.594 . . . . 0.0 111.899 173.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.731 HG13 HD21 ' A' ' 158' ' ' LEU . 89.8 t -98.2 118.64 63.32 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.447 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.576 ' HD2' HD22 ' A' ' 158' ' ' LEU . 59.9 Cg_exo -41.35 132.57 3.38 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.518 2.812 . . . . 0.0 112.217 172.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -61.19 -26.47 67.74 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.019 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -92.21 6.73 45.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.4 m -122.63 -29.14 4.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.553 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.422 ' HA ' HG11 ' A' ' 97' ' ' VAL . 14.1 p -51.55 -30.75 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.08 -44.7 96.14 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.098 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.08 -35.0 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.865 0.364 . . . . 0.0 110.448 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.93 -42.54 95.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.979 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.677 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 48.2 mm -75.49 -45.35 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.892 0.377 . . . . 0.0 110.612 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.12 -147.64 16.86 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.654 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.407 ' HG3' ' N ' ' A' ' 109' ' ' SER . 14.9 ptm180 -108.68 -44.52 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.056 0.455 . . . . 0.0 110.274 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.536 ' HB2' ' HG3' ' A' ' 111' ' ' GLU . 46.2 m -106.6 10.35 31.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.197 0.522 . . . . 0.0 109.748 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.03 28.05 59.23 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.325 -176.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -92.48 -20.35 21.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.362 0.125 . . . . 0.0 111.203 -178.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.435 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 16.7 tpt -74.41 -43.22 57.28 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.677 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 6.2 tp -63.84 -28.24 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.222 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.718 ' HA ' ' HG2' ' A' ' 117' ' ' GLN . 98.8 mttt -78.68 -19.12 53.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.63 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 63.6 mttm -64.76 -31.82 73.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.8 mm -67.78 -38.61 80.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.245 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.718 ' HG2' ' HA ' ' A' ' 114' ' ' LYS . 2.7 mm100 -72.39 -27.23 62.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.04 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.18 -38.63 35.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.399 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -81.29 -54.99 5.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.357 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.0 -5.06 51.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -172.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.88 29.23 67.23 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.727 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.7 m -95.82 177.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.168 0.508 . . . . 0.0 111.549 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -129.41 133.87 47.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.062 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.545 HG12 HE22 ' A' ' 117' ' ' GLN . 47.7 mm -99.72 127.23 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.336 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.981 ' HG2' HD11 ' A' ' 89' ' ' ILE . 5.3 tp-100 -122.64 97.13 5.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.513 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -74.94 106.39 6.43 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.598 ' HE3' ' O ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -125.62 132.3 52.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.157 -177.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 170.238 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.463 -0.283 0 CA-C-O 120.941 0.309 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 5.3 mp0 -114.24 161.95 17.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.962 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -110.46 110.93 21.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 34.1 mm -68.24 102.18 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.181 0.515 . . . . 0.0 111.287 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.815 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -80.82 141.05 35.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.738 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 57.7 t-80 -106.33 115.02 29.49 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.877 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 154' ' ' ILE . 83.7 mt -80.14 110.75 16.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 27.7 ttp -109.06 123.69 49.56 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.018 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.72 -161.12 34.9 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.43 ' HG2' ' CZ ' ' A' ' 146' ' ' ARG . 18.2 Cg_exo -67.58 141.14 54.23 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.689 2.259 . . . . 0.0 111.531 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -44.31 -51.11 7.2 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.799 2.999 . . . . 0.0 114.343 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.58 -38.31 86.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.411 0.624 . . . . 0.0 110.559 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.43 ' CZ ' ' HG2' ' A' ' 143' ' ' PRO . 12.1 ttm180 -72.49 -30.44 64.53 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.253 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.812 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 77.5 m -56.35 -57.97 10.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.913 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 6.4 mm-40 -64.28 -27.75 69.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.679 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -65.92 -29.78 70.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.176 0.512 . . . . 0.0 110.373 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.662 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.2 -34.97 49.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.261 0.553 . . . . 0.0 109.903 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -17.03 64.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.408 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -76.19 -42.1 47.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 0.0 110.193 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.85 -42.28 82.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.952 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.775 HD12 HD11 ' A' ' 140' ' ' ILE . 73.4 mt -67.57 -34.96 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.472 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -62.46 -48.81 77.99 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.8 -44.58 70.29 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.094 176.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.11 -52.95 62.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.415 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.731 HD21 HG13 ' A' ' 97' ' ' VAL . 86.1 mt . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.372 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 47.5 t -126.95 112.72 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.676 171.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -113.41 144.91 42.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.056 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.582 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 41.2 mt-10 -109.52 111.77 23.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.243 0.544 . . . . 0.0 111.654 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.3 mp -105.2 139.07 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.401 ' HB3' ' OD2' ' A' ' 48' ' ' ASP . 54.2 mtp -95.71 123.73 39.41 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.265 0.555 . . . . 0.0 110.645 -174.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.758 HG12 HG11 ' A' ' 16' ' ' VAL . 1.6 mp -96.98 114.8 65.24 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.725 -175.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.84 147.94 92.06 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.771 2.981 . . . . 0.0 113.007 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.36 132.37 47.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 168.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.53 -44.16 1.59 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -170.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -72.05 -26.32 62.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.008 0.432 . . . . 0.0 110.003 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.6 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.31 -32.55 25.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.472 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.445 ' O ' ' HA2' ' A' ' 18' ' ' GLY . . . -60.98 -38.53 95.65 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.566 -0.825 . . . . 0.0 112.903 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.777 HD21 ' HB2' ' A' ' 73' ' ' GLU . 3.5 pp -91.01 -27.23 18.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.405 0.602 . . . . 0.0 111.419 176.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.758 HG11 HG12 ' A' ' 8' ' ' ILE . 75.8 t -70.04 -58.93 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.645 HG13 ' H ' ' A' ' 19' ' ' LYS . 37.9 pt -91.77 -22.64 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.67 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . 84.42 19.41 60.43 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.645 ' H ' HG13 ' A' ' 17' ' ' ILE . 32.9 mmtp 65.6 -68.76 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.671 0.788 . . . . 0.0 111.314 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.55 5.9 79.47 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.69 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.78 10.09 58.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.769 177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 27.7 tt0 -66.25 -39.15 89.29 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.809 -0.23 . . . . 0.0 111.513 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.539 HG21 ' O ' ' A' ' 15' ' ' LEU . 20.5 m -77.25 -33.88 55.95 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.317 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.511 HD13 ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -67.06 -29.99 48.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.901 178.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.554 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 10.7 ttmm -49.68 -55.23 14.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.66 0.743 . . . . 0.0 109.098 168.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.581 HE21 ' NH1' ' A' ' 30' ' ' ARG . 35.9 mt-30 -70.32 -39.3 74.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.493 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 32.1 mt -66.61 -25.61 66.69 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.945 -0.472 . . . . 0.0 111.488 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 43.8 mt-30 -85.73 -41.17 15.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.732 0.301 . . . . 0.0 111.352 173.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 25' ' ' LYS . 12.4 mm-40 -86.66 -55.25 3.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -175.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.695 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 6.9 ttm180 -67.1 -50.59 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.198 0.523 . . . . 0.0 110.865 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' A' ' 87' ' ' SER . . . -70.13 -9.99 57.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.415 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.54 23.0 60.01 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.999 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.685 HG21 HG23 ' A' ' 53' ' ' ILE . 34.2 m -132.2 155.57 41.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -89.98 109.1 20.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.588 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 58.4 mtt -96.71 116.03 28.43 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.432 HD13 ' C ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -109.58 107.12 22.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 122.322 1.058 . . . . 0.0 108.79 178.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.997 HD13 HD12 ' A' ' 51' ' ' LEU . 1.3 pt? -133.47 144.85 49.71 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.013 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.87 HG23 ' HB2' ' A' ' 42' ' ' SER . 2.5 mp -56.95 122.08 5.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 123.507 0.504 . . . . 0.0 110.145 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -129.91 -159.58 0.97 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.64 99.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.536 0.684 . . . . 0.0 110.346 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.84 -39.24 0.5 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.87 ' HB2' HG23 ' A' ' 38' ' ' ILE . 16.8 m -88.31 171.92 9.81 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -89.84 -13.74 35.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.884 0.373 . . . . 0.0 111.486 -171.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.827 ' HB2' HG21 ' A' ' 38' ' ' ILE . 94.8 m-20 -87.68 34.9 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -176.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -64.97 -46.13 82.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -85.26 -14.44 46.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.594 0.711 . . . . 0.0 109.76 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.52 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 35.5 t -79.66 156.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.462 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 7' ' ' MET . 11.2 t70 -66.81 131.13 45.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 173.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.675 ' HD2' ' O ' ' A' ' 38' ' ' ILE . 26.8 mtmm -121.68 125.97 26.59 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -165.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.525 ' HD2' HD13 ' A' ' 38' ' ' ILE . 88.3 Cg_endo -80.57 130.67 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.581 2.187 . . . . 0.0 112.313 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.997 HD12 HD13 ' A' ' 37' ' ' LEU . 6.8 tt -108.37 128.59 54.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.695 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.1 mpt_? -97.62 118.94 35.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.481 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.685 HG23 HG21 ' A' ' 33' ' ' VAL . 59.9 mt -88.08 109.51 19.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.476 HG12 HG22 ' A' ' 3' ' ' VAL . 29.4 mt -110.39 119.12 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.86 -170.61 43.54 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.834 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.457 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 7.5 t70 -64.72 137.79 97.25 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 122.781 0.432 . . . . 0.0 110.914 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -40.3 -49.13 3.97 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.601 2.867 . . . . 0.0 113.964 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -63.46 -45.42 90.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.765 0.317 . . . . 0.0 110.724 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 46.2 mttm -62.95 -43.74 97.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.848 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 53' ' ' ILE . 90.9 t -63.52 -29.25 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.633 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -80.5 -46.28 16.1 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -173.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -66.99 -32.57 73.89 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.46 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.744 ' HA ' ' SD ' ' A' ' 66' ' ' MET . . . -70.42 -45.02 66.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 61' ' ' GLN . 26.5 p -63.02 -27.23 69.27 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.311 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.05 -47.54 28.43 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.202 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.744 ' SD ' ' HA ' ' A' ' 63' ' ' ALA . 6.6 ptm -69.13 -38.58 78.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.439 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 26.9 m -63.4 -31.79 54.18 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-N 117.961 0.346 . . . . 0.0 111.326 -178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.7 mtt -81.18 -20.75 40.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.402 0.62 . . . . 0.0 109.959 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 21.1 t70 -83.16 -52.62 6.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.214 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.858 HG22 ' HB2' ' A' ' 79' ' ' PHE . 2.7 pp -72.51 -21.43 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 111.363 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 70' ' ' ILE . 6.1 tt -85.9 -4.18 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 12.3 ptm180 -51.87 -42.02 62.33 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.923 ' HG3' ' HA ' ' A' ' 76' ' ' GLN . 26.0 tt0 60.93 101.53 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.449 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.2 ttm105 -101.64 -36.92 8.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.037 170.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -119.81 8.32 11.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.128 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.923 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . 44.6 tt0 68.57 12.29 8.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.789 0.804 . . . . 0.0 110.915 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.06 -19.56 6.74 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 64.15 -102.64 0.61 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.858 ' HB2' HG22 ' A' ' 70' ' ' ILE . 87.8 m-85 -135.83 -29.23 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.231 0.515 . . . . 0.0 110.624 173.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.42 79.91 1.47 Allowed Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.695 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER 71.18 -60.52 0.51 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 124.499 0.764 . . . . 0.0 110.353 -172.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 4.8 ttm-85 142.65 91.74 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 126.204 1.802 . . . . 0.0 108.117 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -67.92 52.04 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.038 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.953 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 33.4 mt-10 -152.13 -45.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.747 -176.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 88' ' ' ARG . 33.1 p90 -177.44 144.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 111.306 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.522 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -128.51 -94.34 0.79 Allowed Glycine 0 C--O 1.221 -0.659 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 174.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.659 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 19.6 p -87.52 13.27 10.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.17 0.509 . . . . 0.0 110.2 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.667 ' CG ' ' HD3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -143.23 174.63 10.55 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.329 -170.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.779 HG12 ' CD2' ' A' ' 139' ' ' HIS . 8.9 mt 59.46 -80.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.768 173.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.73 41.07 89.73 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 141' ' ' MET . . . 151.38 66.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.736 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 168.22 -142.79 7.69 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.953 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 38.9 pt -142.7 143.83 25.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 117.277 0.538 . . . . 0.0 111.262 176.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.442 ' OD2' HG21 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -89.95 126.77 35.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.541 177.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 70.2 t -116.38 95.22 44.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.52 ' CA ' HD13 ' A' ' 137' ' ' ILE . 38.1 Cg_endo -71.28 106.51 1.94 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 121.4 1.4 . . . . 0.0 111.276 169.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 136' ' ' LYS . 10.7 p -104.47 129.39 25.12 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 121.229 0.538 . . . . 0.0 110.169 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.655 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 52.9 Cg_exo -52.79 128.83 30.04 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.221 2.614 . . . . 0.0 112.624 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.508 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 0.6 OUTLIER -57.43 -25.57 59.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.904 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -92.09 16.36 11.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.605 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.542 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 2.7 p -155.97 12.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 p -77.01 -20.57 14.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.464 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.13 -33.59 86.31 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.92 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 112' ' ' MET . 7.3 p -74.99 -24.02 17.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.063 0.459 . . . . 0.0 110.412 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 97' ' ' VAL . 30.9 t -72.88 -37.62 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.064 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 46.7 mm -84.26 -38.99 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.425 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.29 -133.56 11.65 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -102.4 -74.03 0.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.915 0.388 . . . . 0.0 110.443 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.534 ' HB2' ' OE1' ' A' ' 111' ' ' GLU . 30.5 m -89.38 -4.73 57.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.894 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.494 ' O ' HG22 ' A' ' 113' ' ' ILE . . . 114.01 6.74 20.35 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.06 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' HB2' ' A' ' 109' ' ' SER . 1.1 mp0 -65.16 -24.02 67.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 104' ' ' VAL . 15.8 tpt -76.49 -40.61 49.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.402 . . . . 0.0 110.907 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.636 HD11 HG21 ' A' ' 124' ' ' ILE . 6.6 tp -70.02 -32.34 51.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 88.7 mttt -71.29 -29.32 64.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.429 0.633 . . . . 0.0 109.642 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.512 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 7.0 ttmt -66.28 -36.85 84.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.746 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.5 mt -65.1 -39.72 86.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.148 0.499 . . . . 0.0 109.709 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.639 HE21 ' HB ' ' A' ' 124' ' ' ILE . 79.2 mt-30 -63.93 -24.84 67.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.428 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -87.01 -50.54 6.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.235 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.02 -40.06 32.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.153 -172.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.58 -16.69 20.91 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.266 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.7 42.11 62.81 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.4 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.9 150.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.09 0.471 . . . . 0.0 111.628 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -96.74 122.35 39.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.56 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.639 ' HB ' HE21 ' A' ' 117' ' ' GLN . 50.0 mm -109.44 141.85 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.942 0.401 . . . . 0.0 111.998 -170.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.756 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 1.9 pt20 -158.89 144.13 16.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -96.82 107.5 19.99 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.744 -0.597 . . . . 0.0 109.741 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.667 ' HD3' ' CG ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -112.55 134.0 54.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.458 -171.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 . . . . . 0 N--CA 1.467 0.406 0 O-C-N 123.962 0.789 . . . . 0.0 112.892 174.636 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.508 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 20.5 Cg_endo . . . . . 0 CA--C 1.529 0.271 0 N-CA-C 112.508 0.157 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.655 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 0.4 OUTLIER -86.13 155.6 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.833 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.617 ' O ' HG12 ' A' ' 97' ' ' VAL . 74.0 mttt -110.96 113.56 26.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.199 -175.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 4.9 mm -79.19 115.1 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.186 0.517 . . . . 0.0 111.711 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . . . -87.31 142.34 27.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.666 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.779 ' CD2' HG12 ' A' ' 89' ' ' ILE . 2.9 t-80 -86.95 107.69 18.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.12 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.557 HD13 ' HB3' ' A' ' 150' ' ' ALA . 23.1 mt -105.42 121.99 58.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 172.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 91' ' ' GLY . 43.7 ttp -129.82 139.71 51.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 -176.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.5 -155.01 25.92 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.3 139.25 37.93 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.475 2.117 . . . . 0.0 111.174 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.29 -47.93 8.53 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 123.691 2.927 . . . . 0.0 113.229 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.28 -48.2 82.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.484 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -66.86 -29.97 70.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.837 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.736 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 66.9 m -59.31 -62.43 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.72 -42.79 89.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.882 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.508 ' O ' HG13 ' A' ' 153' ' ' ILE . 11.9 t-160 -58.49 -24.75 61.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.235 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.557 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -81.06 -52.36 7.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.27 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.05 -26.14 68.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -79.66 -19.04 50.01 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.798 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 149' ' ' HIS . 78.4 mt -72.06 -42.53 67.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 167.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.686 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 71.1 mt -61.07 -49.95 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.358 176.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -53.12 -40.22 64.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.529 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.25 -43.73 95.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.883 0.373 . . . . 0.0 110.564 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.03 -39.81 94.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.406 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 33.3 mt . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.564 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.429 ' HB ' HG21 ' A' ' 60' ' ' VAL . 9.9 m . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 78.8 t -127.91 125.95 65.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.077 0.465 . . . . 0.0 111.186 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -122.43 145.16 48.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.837 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 67.3 mt-10 -111.84 126.7 55.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.48 0.657 . . . . 0.0 112.222 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -119.74 126.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 173.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 ttm -82.34 125.08 30.6 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.019 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.642 HG12 HG11 ' A' ' 16' ' ' VAL . 1.6 mp -101.05 119.37 58.23 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.617 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.642 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 51.2 Cg_exo -60.27 154.5 52.04 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.582 2.854 . . . . 0.0 113.047 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 129.76 39.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.63 -38.6 3.04 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -170.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.66 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -70.6 -30.76 67.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.601 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -54.67 -35.08 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.618 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.51 -32.57 73.52 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.157 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.755 ' HB3' ' HA ' ' A' ' 76' ' ' GLN . 0.8 OUTLIER -91.48 -25.91 19.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 117.069 0.435 . . . . 0.0 111.433 177.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.642 HG11 HG12 ' A' ' 8' ' ' ILE . 85.5 t -77.32 -48.84 23.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.704 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.706 HG13 ' H ' ' A' ' 19' ' ' LYS . 36.8 pt -91.93 -15.42 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.199 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.528 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 90.51 5.47 69.3 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.706 ' H ' HG13 ' A' ' 17' ' ' ILE . 13.6 tptm 65.27 -64.4 0.18 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.31 1.044 . . . . 0.0 110.645 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.09 -6.76 88.77 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 108.11 3.14 33.8 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.663 174.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.72 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 34.9 tt0 -62.41 -45.37 93.44 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.434 0.617 . . . . 0.0 111.981 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.528 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 25.7 m -71.27 -37.81 71.89 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.566 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.714 HD12 HD12 ' A' ' 27' ' ' LEU . 4.9 tp -64.76 -25.55 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.802 0.334 . . . . 0.0 110.381 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.72 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 76.0 mttt -58.77 -46.95 86.32 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.63 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -68.33 -39.07 82.06 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.917 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.714 HD12 HD12 ' A' ' 24' ' ' ILE . 39.1 mt -66.63 -26.89 67.29 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.135 -0.353 . . . . 0.0 110.922 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.736 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 79.7 mt-30 -85.52 -52.1 6.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -86.58 -55.29 3.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.54 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.635 HH22 ' HA ' ' A' ' 83' ' ' ASN . 2.7 mtp180 -62.61 -47.88 81.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.169 0.509 . . . . 0.0 111.269 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -78.16 -2.81 39.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.695 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.12 22.02 41.27 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.765 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.736 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.3 m -133.74 153.66 37.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -93.55 109.24 20.86 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.956 ' HB3' HD21 ' A' ' 51' ' ' LEU . 46.9 mtt -93.47 113.89 26.14 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.413 HD13 ' C ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -109.96 107.96 24.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 122.46 1.124 . . . . 0.0 109.464 -177.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.705 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.1 pt? -133.36 142.81 48.59 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.014 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.9 mm -64.5 98.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.115 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.44 ' HG2' HG21 ' A' ' 17' ' ' ILE . 26.0 mt-30 -82.03 -59.8 2.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -122.12 -176.94 3.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.636 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.632 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . 105.6 157.37 22.49 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -82.24 28.97 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -105.41 -96.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -100.28 58.5 0.98 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 1.6 t -61.95 -61.19 2.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.508 -174.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.521 ' H ' HG23 ' A' ' 45' ' ' THR . 66.1 t30 -96.03 -22.43 17.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.834 -0.541 . . . . 0.0 111.316 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 m -83.85 -168.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -169.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.14 147.97 23.33 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.347 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -135.14 133.98 21.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.887 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.07 111.13 1.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.691 2.261 . . . . 0.0 111.578 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.956 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.0 tm? -88.46 111.76 22.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.239 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 35' ' ' MET . 5.3 mpt_? -98.69 111.02 23.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.923 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.2 mt -85.95 110.42 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.595 HG12 HG22 ' A' ' 3' ' ' VAL . 21.1 mt -110.18 119.93 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.202 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.522 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.72 -170.44 43.36 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.032 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.945 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 7.3 m-20 -61.56 141.9 94.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 122.487 0.315 . . . . 0.0 110.646 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 54.1 Cg_exo -50.53 -51.69 10.54 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.403 2.736 . . . . 0.0 114.174 -169.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -57.02 -44.55 82.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.065 0.459 . . . . 0.0 110.44 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.945 ' HE2' ' HB2' ' A' ' 56' ' ' ASP . 42.1 mtmt -68.58 -40.57 80.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.759 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 2' ' ' THR . 88.3 t -61.93 -35.65 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.463 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.03 -54.25 28.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -65.43 -27.48 68.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.546 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -79.7 -36.53 37.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 68' ' ' MET . 38.1 t -56.82 -42.4 79.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.075 0.464 . . . . 0.0 110.005 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.47 -26.69 38.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.448 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.656 ' HA ' ' HE ' ' A' ' 82' ' ' ARG . 9.9 ptp -66.37 -48.02 71.49 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.462 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.635 ' N ' ' HG3' ' A' ' 66' ' ' MET . 91.9 t -59.83 -47.61 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.815 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 64' ' ' CYS . 19.9 ptp -70.57 -20.59 62.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.924 0.392 . . . . 0.0 111.12 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 25.3 t70 -85.98 -44.2 12.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -81.82 -21.37 10.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.901 -0.719 . . . . 0.0 111.053 -177.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.717 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.2 pp -77.02 -2.71 35.36 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.229 174.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 8.4 ptp180 -63.88 -19.95 65.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.278 0.561 . . . . 0.0 109.531 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.593 ' HG2' ' N ' ' A' ' 77' ' ' GLY . 9.5 tp10 -52.47 144.17 13.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.338 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -87.63 -60.1 2.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.013 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -113.61 55.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.7 -173.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.755 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 62.2 tt0 69.39 114.09 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.739 0.78 . . . . 0.0 112.545 173.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.593 ' N ' ' HG2' ' A' ' 73' ' ' GLU . . . 157.3 -96.35 0.15 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.476 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.7 -99.2 1.48 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.588 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -141.29 -41.42 0.38 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.868 0.366 . . . . 0.0 110.053 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 91.25 91.62 1.35 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -171.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 3.4 t70 70.57 -69.89 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -165.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.656 ' HE ' ' HA ' ' A' ' 66' ' ' MET . 20.8 ttm-85 171.62 -40.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.763 0.825 . . . . 0.0 109.129 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.635 ' HA ' HH22 ' A' ' 30' ' ' ARG . 4.7 t30 61.87 59.13 1.79 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.629 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 1.06 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 44.9 tt0 -173.95 -38.5 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.275 -173.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.434 ' CB ' ' H ' ' A' ' 90' ' ' GLY . 5.6 p90 -168.4 90.16 0.27 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.626 166.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.603 ' HA2' ' HE1' ' A' ' 66' ' ' MET . . . -83.87 96.94 2.01 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 170.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.617 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 61.3 p 66.84 -53.69 0.45 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.112 1.365 . . . . 0.0 111.896 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 6.0 mmt180 -97.42 -167.2 1.5 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.019 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.661 HG23 ' ND1' ' A' ' 139' ' ' HIS . 71.0 mt 75.52 -66.44 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 124.083 0.864 . . . . 0.0 111.085 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.434 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 50.42 61.03 6.23 Favored Glycine 0 N--CA 1.451 -0.352 0 O-C-N 123.691 0.619 . . . . 0.0 112.497 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.34 88.89 1.02 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.878 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 154.36 -128.06 2.27 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.06 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 31.1 pt -148.37 154.39 10.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -89.03 128.05 35.71 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 53.5 t -119.1 96.72 50.3 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.872 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.512 ' CA ' HD13 ' A' ' 137' ' ' ILE . 60.1 Cg_endo -77.38 107.54 2.42 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.786 1.657 . . . . 0.0 110.941 174.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 102' ' ' VAL . 21.7 t -100.64 124.43 42.4 Favored Pre-proline 0 C--N 1.319 -0.74 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.205 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.1 129.53 22.01 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.589 2.193 . . . . 0.0 110.742 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -57.57 -28.51 63.64 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -172.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -80.67 -7.26 59.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.752 0.311 . . . . 0.0 110.877 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 m -113.31 -27.27 8.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.71 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.404 ' HA ' HG11 ' A' ' 97' ' ' VAL . 12.1 p -57.44 -30.08 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 111.596 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.49 -34.72 89.95 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.091 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.8 t -74.14 -29.42 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.024 0.44 . . . . 0.0 110.273 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -34.99 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.149 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.9 mm -84.13 -47.89 17.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.2 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.39 -116.42 5.51 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.549 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -128.7 -54.31 1.23 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.141 0.496 . . . . 0.0 110.009 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 m -105.1 20.55 18.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.297 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.1 18.15 76.26 Favored Glycine 0 C--O 1.224 -0.475 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.46 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.484 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 6.0 tp10 -68.49 -37.06 79.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.993 0.425 . . . . 0.0 111.092 -174.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.6 tpt -69.68 -43.39 72.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.693 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.44 HD11 ' CB ' ' A' ' 124' ' ' ILE . 19.8 tt -67.31 -27.03 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.155 0.502 . . . . 0.0 111.032 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 50.4 mtpt -65.12 -32.03 73.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.421 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -72.3 -32.33 66.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 113' ' ' ILE . 10.8 mm -63.98 -50.59 76.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -62.84 -29.72 70.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.287 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -79.84 -38.7 32.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.601 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -79.5 -38.91 33.31 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.786 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.456 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -96.65 -11.25 25.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 111.49 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.4 23.35 75.8 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.592 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.03 173.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.337 . . . . 0.0 111.425 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 31.6 mtp180 -136.24 141.04 43.91 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 173.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.44 ' CB ' HD11 ' A' ' 113' ' ' ILE . 36.5 mm -110.26 138.67 37.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.524 0.678 . . . . 0.0 112.561 -171.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 138.17 44.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.148 171.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -84.86 105.28 15.52 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.72 ' HE2' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -94.82 -166.13 1.42 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.298 -169.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.429 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 27.7 tp60 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.618 -175.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 N--CA 1.454 -0.82 0 N-CA-C 113.185 0.417 . . . . 0.0 113.185 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -143.8 165.84 26.57 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.356 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -123.08 118.21 27.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.728 0.299 . . . . 0.0 110.353 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.72 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 18.8 mm -70.14 124.22 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 111.966 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -102.39 140.66 36.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.298 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.661 ' ND1' HG23 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -83.54 112.09 19.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.602 178.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.765 HD13 ' HB3' ' A' ' 150' ' ' ALA . 24.7 mt -91.81 123.76 44.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.66 169.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.492 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 44.5 ttm -102.71 136.75 41.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.75 -169.98 24.16 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.126 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 14.5 Cg_exo -70.29 139.1 37.61 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.109 2.539 . . . . 0.0 111.166 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 143' ' ' PRO . 87.0 Cg_exo -48.6 -32.92 22.52 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.24 3.293 . . . . 0.0 114.456 -174.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.1 -43.1 68.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.001 0.429 . . . . 0.0 110.781 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 49.8 mtt180 -72.36 -26.34 61.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.062 0.458 . . . . 0.0 110.03 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.612 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 92.7 m -55.91 -58.04 9.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.801 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.85 -30.02 71.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.911 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.428 ' O ' HG13 ' A' ' 153' ' ' ILE . 4.2 t60 -57.86 -35.73 71.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.311 0.577 . . . . 0.0 110.214 176.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.765 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.6 -38.35 40.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.905 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.82 -25.16 67.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.58 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -79.15 -25.0 42.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.237 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.44 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 42.1 mt -73.35 -37.74 52.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 57.3 mt -71.77 -33.33 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.176 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -63.68 -40.52 97.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.746 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.29 -30.45 71.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.703 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 26.9 mt -66.08 -32.15 73.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.981 0.42 . . . . 0.0 110.096 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.879 176.686 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 89.1 t -133.91 131.34 56.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.458 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -134.52 149.2 50.65 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 46.4 mt-10 -106.49 135.76 47.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.23 0.538 . . . . 0.0 111.741 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.0 mp -119.22 148.15 22.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -92.33 114.25 26.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.707 0.289 . . . . 0.0 111.369 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.571 ' CD1' ' HB2' ' A' ' 51' ' ' LEU . 2.3 mp -100.14 108.01 50.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.101 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 12' ' ' LYS . 7.3 Cg_exo -75.92 155.0 38.65 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.939 2.426 . . . . 0.0 111.474 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.17 128.97 38.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.04 -34.56 5.36 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -169.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HA ' ' HG ' ' A' ' 15' ' ' LEU . 10.0 mptt -94.53 -4.39 48.09 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.129 0.49 . . . . 0.0 110.747 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.689 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -61.61 -43.06 99.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.548 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.25 -11.15 55.08 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.831 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.609 ' CD1' ' HB3' ' A' ' 73' ' ' GLU . 34.1 mt -84.84 -47.8 9.99 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.485 HG21 ' CG1' ' A' ' 8' ' ' ILE . 65.1 t -78.06 -44.58 27.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.989 -176.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.847 HG13 ' H ' ' A' ' 19' ' ' LYS . 23.3 pt -90.77 -15.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 121.54 -0.725 . . . . 0.0 110.468 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.45 -1.19 89.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.783 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.847 ' H ' HG13 ' A' ' 17' ' ' ILE . 14.3 tptm 72.9 -44.04 0.58 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.015 0.926 . . . . 0.0 110.702 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.95 -11.04 55.72 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.914 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.81 -9.03 29.84 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.447 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 10.5 mp0 -54.09 -49.29 69.41 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.954 0.502 . . . . 0.0 112.33 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 15' ' ' LEU . 26.4 m -70.11 -43.42 71.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 24' ' ' ILE . 6.0 tp -61.99 -25.9 38.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.331 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 42.6 mttm -62.68 -42.59 99.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.496 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.503 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 49.2 mt-30 -83.55 -29.16 28.07 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.003 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.578 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 82.7 mt -65.89 -24.8 66.93 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.541 -0.725 . . . . 0.0 109.683 171.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.768 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.2 mt-30 -86.1 -55.42 3.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.618 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -80.76 -45.4 17.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.574 ' NH2' ' HA ' ' A' ' 83' ' ' ASN . 11.4 mtp180 -76.06 -42.08 48.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.631 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -82.87 -9.07 59.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.122 0.486 . . . . 0.0 110.425 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.04 20.95 71.32 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.456 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.768 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 31.4 m -134.7 163.1 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -100.24 110.28 22.52 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 1.0 ' HB3' HD11 ' A' ' 51' ' ' LEU . 51.4 mtt -93.59 114.52 26.88 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' C ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -110.85 108.02 24.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 122.399 1.095 . . . . 0.0 109.302 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.66 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.3 pt? -133.68 142.64 48.11 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.262 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 38' ' ' ILE . 3.5 mp -64.31 101.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.208 0.528 . . . . 0.0 111.107 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -99.29 -58.47 1.93 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -95.42 159.81 14.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.429 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.58 117.03 3.36 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.072 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 t -74.28 78.73 1.83 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.313 0.578 . . . . 0.0 110.775 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -142.65 -54.46 0.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.783 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 14.5 m120 -118.58 39.79 3.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.659 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 p -70.71 -61.5 1.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.832 0.349 . . . . 0.0 111.232 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -91.29 -4.08 56.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.498 0.666 . . . . 0.0 109.968 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.588 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 39.3 t -90.72 160.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.328 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 47' ' ' VAL . 3.8 p-10 -58.3 145.65 37.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.165 0.507 . . . . 0.0 109.706 171.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 128.21 26.04 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.704 -169.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.42 113.29 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.793 2.329 . . . . 0.0 112.13 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.0 HD11 ' HB3' ' A' ' 35' ' ' MET . 48.7 tp -85.58 105.34 16.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.226 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -89.52 101.6 14.28 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.33 174.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.4 mt -83.63 109.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 3' ' ' VAL . 14.5 mt -107.95 119.47 57.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.152 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.525 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.77 -169.97 42.98 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.265 -1.445 . . . . 0.0 113.697 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HB3' ' HD2' ' A' ' 59' ' ' LYS . 13.1 t70 -55.02 136.05 67.18 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 114.642 -0.779 . . . . 0.0 110.642 174.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 33.0 Cg_exo -57.34 -34.32 97.7 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.496 2.797 . . . . 0.0 113.813 -173.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.461 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 68.4 t80 -72.37 -35.64 68.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.556 0.693 . . . . 0.0 109.419 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' HD2' ' HB3' ' A' ' 56' ' ' ASP . 53.3 mttp -76.84 -41.62 43.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.768 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG22 HG22 ' A' ' 53' ' ' ILE . 95.1 t -59.72 -36.61 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.11 176.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -56.55 17.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.45 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 12.4 mm100 -67.05 -34.52 77.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.067 -176.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -69.98 -44.77 68.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.21 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.9 t -56.74 -35.05 68.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.498 0.666 . . . . 0.0 109.584 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' HG2' ' NH2' ' A' ' 82' ' ' ARG . 33.9 tt0 -72.61 -33.83 66.95 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.013 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.769 ' HA ' ' HE ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -74.98 -37.52 61.87 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.347 177.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.616 ' N ' ' HG3' ' A' ' 66' ' ' MET . 85.0 t -56.34 -52.35 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.277 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.3 mtp -62.57 -21.01 65.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.892 0.377 . . . . 0.0 111.077 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 30.6 t70 -79.37 -56.18 4.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.614 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.908 HG21 ' H ' ' A' ' 82' ' ' ARG . 2.1 pp -81.7 -21.38 10.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 71' ' ' LEU . 6.4 tt -84.8 -10.64 57.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.333 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 4.4 ptp180 -66.15 -11.44 49.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.078 0.466 . . . . 0.0 110.342 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.609 ' HB3' ' CD1' ' A' ' 15' ' ' LEU . 10.0 tp10 -50.64 142.22 11.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.13 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 74' ' ' ARG . 11.4 mmt180 -80.77 -49.39 11.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.469 -175.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -171.98 20.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.828 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -109.6 -86.46 0.53 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.079 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -151.56 -24.56 0.05 OUTLIER Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.774 -1.203 . . . . 0.0 114.543 -173.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.37 -127.23 8.78 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.826 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.445 ' HD2' HG22 ' A' ' 70' ' ' ILE . 70.3 m-85 -133.1 -60.28 0.86 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.962 0.411 . . . . 0.0 110.121 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.52 76.78 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 26' ' ' GLN . 3.9 m-20 54.6 44.38 28.77 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.119 0.962 . . . . 0.0 109.184 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.908 ' H ' HG21 ' A' ' 70' ' ' ILE . 30.8 ttm-85 69.06 -45.52 0.55 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.624 -1.625 . . . . 0.0 112.353 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.574 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 6.2 t30 61.21 63.64 1.2 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.616 0.722 . . . . 0.0 109.233 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 1.045 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 37.0 tt0 -177.17 -41.72 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.428 -170.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.0 p90 175.08 151.36 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.643 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.34 -12.96 1.75 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.88 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 6.3 p -172.88 -57.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.809 0.814 . . . . 0.0 108.815 -174.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.47 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -73.5 -178.44 3.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.473 170.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.805 HG22 ' H ' ' A' ' 91' ' ' GLY . 68.1 mt 74.13 -82.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 167.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.03 41.49 94.49 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.649 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.805 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 153.45 91.15 0.08 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.681 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.684 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 158.63 -132.96 3.25 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 175.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.045 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 27.7 pt -147.19 165.94 6.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 169.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.554 ' HB3' ' CG2' ' A' ' 137' ' ' ILE . 19.8 m-20 -111.36 132.18 54.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.86 HG23 ' HB3' ' A' ' 138' ' ' ALA . 2.6 m -120.86 95.28 48.97 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 120.965 0.412 . . . . 0.0 111.015 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.77 108.73 1.95 Allowed 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 122.99 2.46 . . . . 0.0 110.946 173.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.648 HG21 HG21 ' A' ' 105' ' ' VAL . 14.0 p -116.64 127.58 26.63 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.861 0.363 . . . . 0.0 111.123 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.427 ' N ' ' HG2' ' A' ' 135' ' ' GLU . 6.9 Cg_endo -50.42 131.56 32.52 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.385 2.723 . . . . 0.0 112.406 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' HG12 ' A' ' 102' ' ' VAL . 15.7 ptt180 -64.22 -25.45 68.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.51 -171.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.84 -4.77 57.28 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.373 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.0 m -123.82 -10.14 7.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.758 0.313 . . . . 0.0 111.548 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 99' ' ' ARG . 12.5 p -63.83 -28.07 44.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 110.387 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.66 -30.03 71.31 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.957 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.0 t -76.53 -36.44 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.41 . . . . 0.0 110.079 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.648 HG21 HG21 ' A' ' 97' ' ' VAL . 54.2 t -69.7 -37.45 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.446 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.736 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 45.7 mm -76.55 -46.92 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.177 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.28 170.23 25.91 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -70.94 -53.15 16.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.103 0.478 . . . . 0.0 110.188 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -87.88 -6.93 57.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.182 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.69 29.06 27.66 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.687 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 78.7 mm-40 -88.99 -25.73 21.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.659 0.266 . . . . 0.0 110.743 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.529 ' SD ' ' HD2' ' A' ' 115' ' ' LYS . 17.4 tpt -68.79 -40.61 79.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.902 0.382 . . . . 0.0 110.328 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.736 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.6 tp -65.79 -27.33 41.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.297 0.57 . . . . 0.0 109.912 177.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 55.5 mtpt -76.41 -30.33 57.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.522 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.529 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 99.2 mttt -62.77 -35.87 81.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.191 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.2 mm -60.88 -45.45 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.491 0.662 . . . . 0.0 109.295 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.34 -34.6 76.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.6 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -79.49 -42.17 25.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.729 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.58 -54.26 6.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.34 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -85.44 -14.37 46.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.859 0.361 . . . . 0.0 111.466 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.51 32.6 57.46 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.168 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -106.27 171.81 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.191 0.519 . . . . 0.0 111.532 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 27.2 mtm180 -122.13 140.49 52.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.354 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 113' ' ' ILE . 50.8 mm -103.45 141.57 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 111.653 -172.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 24.5 tt0 -144.08 106.92 4.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.794 177.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -82.82 148.54 27.7 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.623 ' HD2' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -151.07 93.43 1.92 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -168.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 124.539 1.136 . . . . 0.0 112.313 178.897 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.316 0.465 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.427 ' HG2' ' N ' ' A' ' 98' ' ' PRO . 25.6 mt-10 -128.06 147.34 50.52 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.801 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -109.38 118.13 35.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.614 -168.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.623 ' O ' ' HD2' ' A' ' 127' ' ' LYS . 5.5 mm -78.7 99.5 3.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.55 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.86 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -91.95 141.94 28.09 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.878 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.528 ' CE1' HG23 ' A' ' 89' ' ' ILE . 6.7 t-160 -95.55 123.49 39.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.006 0.431 . . . . 0.0 110.504 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.612 ' HB ' ' CG1' ' A' ' 93' ' ' ILE . 37.0 mt -97.33 114.85 35.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.284 170.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.489 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 52.7 ttm -101.77 134.59 44.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.179 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.55 -165.24 31.39 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.459 ' HD2' ' HD2' ' A' ' 146' ' ' ARG . 20.5 Cg_exo -66.41 148.32 83.95 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.67 2.246 . . . . 0.0 111.658 176.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.39 -53.98 3.88 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.541 2.828 . . . . 0.0 113.645 -176.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.24 -44.77 96.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.084 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.459 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 53.8 mtt180 -64.84 -39.12 93.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.99 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.446 ' HA ' ' CG2' ' A' ' 140' ' ' ILE . 75.7 m -58.06 -59.21 5.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.003 0.43 . . . . 0.0 110.654 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.645 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 35.0 mm-40 -61.83 -34.73 76.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.836 -176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -67.95 -29.06 68.02 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.798 0.333 . . . . 0.0 110.73 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.552 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -77.72 -34.23 52.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.086 0.47 . . . . 0.0 110.3 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -60.87 -31.38 70.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.749 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.645 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 7.3 mpt_? -77.7 -19.94 54.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.723 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.6 mt -73.22 -40.98 58.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 84.5 mt -68.96 -45.27 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.236 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -56.73 -32.39 65.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.789 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.39 -41.7 90.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.188 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.89 -44.58 92.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.223 0.535 . . . . 0.0 110.485 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.513 HD21 HG23 ' A' ' 97' ' ' VAL . 17.2 mt . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.152 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 57' ' ' PRO . 10.7 m . . . . . 0 N--CA 1.45 -0.44 0 CA-C-O 121.099 0.476 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 44.5 t -132.16 113.02 20.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.609 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -108.64 142.25 39.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.964 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.592 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 48.7 mt-10 -104.27 129.58 52.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -115.9 141.42 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 96.6 mmm -90.69 104.84 17.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.973 0.416 . . . . 0.0 110.965 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.56 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -91.85 118.86 68.49 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.764 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.458 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 43.4 Cg_exo -63.21 140.3 76.92 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.655 2.904 . . . . 0.0 112.809 176.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.94 123.61 21.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 170.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.08 -36.97 3.75 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -168.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 74' ' ' ARG . 11.6 mptt -74.11 -19.48 60.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -47.53 -41.02 20.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.164 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 19' ' ' LYS . . . -60.24 -36.9 92.04 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.622 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' A' ' 73' ' ' GLU . 3.9 pp -91.42 -23.88 19.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.883 0.341 . . . . 0.0 111.518 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.56 HG11 HG12 ' A' ' 8' ' ' ILE . 86.7 t -82.24 -55.04 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.594 HG13 ' H ' ' A' ' 19' ' ' LYS . 40.6 pt -91.79 -14.99 8.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.367 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.738 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 92.18 6.56 64.72 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.858 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER 64.98 -68.35 0.11 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.874 0.869 . . . . 0.0 110.204 -176.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.83 -1.09 90.13 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.237 -0.506 . . . . 0.0 111.918 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.59 -5.92 29.71 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.409 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.664 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 57.4 mm-40 -50.87 -51.95 46.42 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.738 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 27.6 m -71.87 -39.31 69.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -174.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 27' ' ' LEU . 2.6 tp -66.17 -27.64 41.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.08 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.338 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.664 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 22.0 mttm -56.29 -59.2 5.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.453 0.644 . . . . 0.0 109.561 172.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.609 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 18.9 mt-30 -63.51 -37.53 87.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.559 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.609 HD12 HD12 ' A' ' 24' ' ' ILE . 95.7 mt -63.2 -33.64 75.93 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.921 -0.487 . . . . 0.0 110.815 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.752 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 46.7 mt-30 -85.11 -44.77 12.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.905 0.384 . . . . 0.0 111.512 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.61 -51.47 5.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -65.78 -52.41 51.13 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.063 0.459 . . . . 0.0 109.975 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.57 -28.62 63.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.74 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.35 3.55 86.85 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.116 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.2 m -101.2 149.29 6.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -87.66 110.7 20.6 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.778 ' HE1' HD11 ' A' ' 51' ' ' LEU . 32.0 mmm -92.14 111.87 23.6 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.667 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tp -112.22 104.97 17.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.816 0.817 . . . . 0.0 109.379 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.721 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.2 pt? -132.76 127.25 34.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.561 -175.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.561 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.2 mp -68.78 99.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HA ' ' HD2' ' A' ' 49' ' ' LYS . 7.2 tp-100 -123.76 -34.06 3.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.049 0.452 . . . . 0.0 110.29 -174.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -127.85 42.54 3.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.545 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.17 -156.76 8.4 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.127 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -90.52 -164.42 1.17 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.164 0.186 . . . . 0.0 111.214 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 71.62 -79.47 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.229 0.612 . . . . 0.0 111.008 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.544 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 5.7 m-20 -116.74 94.65 4.69 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 p -85.53 -61.87 1.66 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.021 0.438 . . . . 0.0 111.615 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -94.33 -8.7 38.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.926 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.556 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 17.3 t -85.89 164.81 2.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.908 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.403 ' N ' HG12 ' A' ' 47' ' ' VAL . 4.1 m-20 -54.48 142.59 26.86 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.997 0.427 . . . . 0.0 110.29 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 46.1 mtmt -131.6 131.18 22.67 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.75 -167.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.58 131.86 9.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.858 2.372 . . . . 0.0 113.382 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.778 HD11 ' HE1' ' A' ' 35' ' ' MET . 0.4 OUTLIER -111.73 124.59 52.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.494 178.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.667 ' HB2' HG23 ' A' ' 36' ' ' ILE . 4.7 mpt_? -101.11 119.69 39.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.017 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.543 HG12 ' SD ' ' A' ' 35' ' ' MET . 57.9 mt -91.19 115.28 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 173.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.1 mt -104.74 120.72 55.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.381 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.45 -170.92 43.94 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.495 -0.859 . . . . 0.0 113.149 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.721 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 13.8 t70 -72.12 143.5 86.21 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.529 ' HA ' HG21 ' A' ' 2' ' ' THR . 74.6 Cg_exo -40.49 -50.32 3.8 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.756 2.971 . . . . 0.0 114.983 -175.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -62.12 -38.94 90.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 111.221 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.917 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 19.4 ptmt -79.64 -35.42 39.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -175.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.17 -31.42 52.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.215 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -68.77 -55.84 9.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.806 0.336 . . . . 0.0 110.356 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 15.2 mm100 -59.55 -35.86 75.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.643 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.53 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -73.13 -43.61 61.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.614 ' O ' ' HG3' ' A' ' 68' ' ' MET . 36.0 t -59.11 -42.54 90.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.004 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.87 -32.54 67.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.599 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.948 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 14.7 ptt? -78.69 -38.67 38.64 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.91 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.516 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 33.7 m -61.8 -22.11 27.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 120.649 0.261 . . . . 0.0 110.602 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 48.7 mtt -81.71 -39.94 23.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.069 0.462 . . . . 0.0 110.167 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.73 -26.58 29.61 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -171.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -87.13 -20.93 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 120.865 -1.147 . . . . 0.0 109.714 173.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.491 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 5.2 tt -75.86 -18.04 59.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.045 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -60.5 -14.24 18.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.213 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.65 ' HB3' HD22 ' A' ' 15' ' ' LEU . 8.2 tp10 -47.01 -41.49 16.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.423 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.795 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 45.1 ttp180 74.62 -67.53 0.25 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.501 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.46 62.05 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -171.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.412 HE22 ' HA3' ' A' ' 14' ' ' GLY . 6.8 tp-100 67.38 127.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.787 0.68 . . . . 0.0 112.63 170.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' A' ' 15' ' ' LEU . . . 137.84 -103.83 0.43 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.683 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.534 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 73.6 24.8 73.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.368 174.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 68.4 -54.57 0.53 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.514 0.726 . . . . 0.0 111.962 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 110.91 102.45 2.68 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -173.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.703 ' H ' HG23 ' A' ' 23' ' ' THR . 2.7 t70 71.38 -69.37 0.19 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -169.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.948 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 50.9 ttt85 162.13 -33.54 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.846 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.35 32.93 14.31 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.33 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.902 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 23.5 tt0 -130.73 -57.97 1.04 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.869 -174.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 9.9 p90 -146.79 -26.32 0.41 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.202 -0.936 . . . . 0.0 113.149 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.584 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 65.63 -89.16 0.11 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.816 -176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.917 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 29.3 m -147.83 22.27 1.12 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.271 0.558 . . . . 0.0 109.606 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -96.41 -86.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.188 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.739 HD11 ' HG2' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -94.44 -164.08 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.251 175.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.597 ' H ' HG22 ' A' ' 89' ' ' ILE . . . -141.92 2.43 1.88 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.711 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.82 125.17 3.34 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.852 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 103.5 163.34 25.32 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.902 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 46.3 pt -97.85 157.11 3.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.017 0.437 . . . . 0.0 111.732 -174.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.11 117.47 33.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.619 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 25.0 t -107.56 105.73 56.7 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -172.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.443 ' HA ' HD13 ' A' ' 137' ' ' ILE . 48.6 Cg_endo -72.48 108.02 2.43 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.826 1.684 . . . . 0.0 110.897 169.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.654 HG23 HD21 ' A' ' 158' ' ' LEU . 11.0 p -124.91 131.14 24.06 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.122 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 87.2 Cg_exo -45.52 134.01 12.83 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.389 2.726 . . . . 0.0 113.437 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 102' ' ' VAL . 10.3 ptm180 -55.85 -33.22 64.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.854 -174.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -86.04 -15.18 42.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.103 0.477 . . . . 0.0 110.416 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 16.0 m -95.28 -28.45 14.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.85 -176.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 106' ' ' ILE . 13.6 p -63.49 -28.21 44.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.399 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.84 -28.06 72.92 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.811 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.06 -30.49 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.189 0.519 . . . . 0.0 109.765 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.6 t -68.82 -34.37 64.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.225 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 102' ' ' VAL . 37.0 mm -80.45 -50.25 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.166 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.59 -117.8 5.47 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -126.8 -53.97 1.42 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.1 m -102.18 -15.77 16.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.036 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.51 14.53 6.86 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.85 -24.61 67.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.873 0.368 . . . . 0.0 110.987 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.621 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.0 tpt -86.15 -42.82 13.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.882 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.627 HD11 HG13 ' A' ' 124' ' ' ILE . 15.5 tt -74.01 -35.85 43.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.572 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -69.71 -23.87 63.49 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.495 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 112' ' ' MET . 16.9 ptpt -75.35 -21.96 57.96 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.364 175.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 mm -65.41 -40.94 89.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.636 ' HG3' ' O ' ' A' ' 122' ' ' VAL . 1.8 mp0 -63.78 -31.28 72.41 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.268 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.09 -53.43 7.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.541 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -79.4 -51.26 9.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.113 -172.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.08 -22.42 31.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.866 0.365 . . . . 0.0 111.425 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.01 41.42 40.37 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.088 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.636 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 27.4 m -121.08 160.23 22.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 111.72 -173.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.795 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 83.3 mtp180 -111.11 151.12 28.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.633 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.627 HG13 HD11 ' A' ' 113' ' ' ILE . 48.9 mm -114.4 130.99 67.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.082 0.468 . . . . 0.0 111.333 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.739 ' HG2' HD11 ' A' ' 89' ' ' ILE . 5.4 tp-100 -128.2 110.44 12.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.545 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -82.45 107.12 14.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.128 0.49 . . . . 0.0 110.014 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.507 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.15 -174.67 3.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.07 -174.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.4 ' O ' ' HE3' ' A' ' 127' ' ' LYS . 14.8 mm100 . . . . . 0 N--CA 1.467 0.424 0 O-C-N 123.442 0.464 . . . . 0.0 111.101 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.556 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 88.1 Cg_exo . . . . . 0 CA--C 1.528 0.211 0 N-CA-C 113.501 0.539 . . . . 0.0 113.501 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 98' ' ' PRO . 36.1 mt-10 -120.7 137.64 54.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.794 0.33 . . . . 0.0 111.101 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -110.97 133.11 53.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.128 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 6.8 mm -78.17 105.64 7.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.192 0.52 . . . . 0.0 111.45 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.619 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -100.78 109.11 21.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 170.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 28.3 t60 -73.64 132.42 42.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.955 0.407 . . . . 0.0 111.119 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.616 HD13 ' HB3' ' A' ' 150' ' ' ALA . 80.5 mt -104.13 107.16 21.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.501 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.795 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 41.1 ttm -93.42 143.4 26.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.076 -174.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.44 -165.45 26.74 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 146' ' ' ARG . 32.2 Cg_exo -60.51 136.8 69.81 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.648 2.232 . . . . 0.0 110.523 172.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.9 -32.19 55.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.034 3.156 . . . . 0.0 113.236 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.09 -51.92 58.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.293 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.595 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 98.1 mtt180 -60.4 -40.73 92.01 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.479 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.852 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 73.2 m -52.33 -59.35 4.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.316 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.16 -39.61 93.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.871 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -56.6 -29.83 62.56 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.3 0.572 . . . . 0.0 110.558 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.616 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.97 -36.08 36.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.848 -175.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.75 -19.66 65.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.589 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -77.83 -36.66 49.85 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.9 mt -66.87 -40.49 85.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.833 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.601 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 54.3 mt -66.46 -41.74 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.456 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -60.31 -39.87 88.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.176 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -55.92 -41.01 73.94 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.103 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.542 HD11 ' HE2' ' A' ' 112' ' ' MET . 96.5 mt -62.31 -47.57 83.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.266 175.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.654 HD21 HG23 ' A' ' 97' ' ' VAL . 24.8 mt . . . . . 0 N--CA 1.465 0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.798 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 30.0 m -131.37 137.13 56.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.165 0.507 . . . . 0.0 111.417 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -130.35 150.65 51.49 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 73.8 mt-10 -106.19 123.86 48.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 111.57 -173.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -112.33 140.21 33.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.4 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 44.8 tpp -89.15 113.41 24.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.722 0.296 . . . . 0.0 110.909 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.754 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -98.61 111.14 59.48 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.065 0.459 . . . . 0.0 110.526 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.588 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 51.5 Cg_exo -60.22 139.6 87.9 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.307 2.672 . . . . 0.0 112.713 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.3 125.78 25.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 169.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.16 -46.25 1.2 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -167.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.867 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.7 -32.7 64.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.661 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.21 -31.89 21.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.55 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.431 ' HA2' ' HE3' ' A' ' 19' ' ' LYS . . . -56.16 -44.99 88.75 Favored Glycine 0 C--O 1.223 -0.593 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.49 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 73' ' ' GLU . 3.3 pp -90.09 -18.13 26.45 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.69 -0.3 . . . . 0.0 111.651 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.754 HG11 HG12 ' A' ' 8' ' ' ILE . 91.6 t -82.73 -49.01 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.781 0.324 . . . . 0.0 111.682 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.661 HG12 ' O ' ' A' ' 13' ' ' ALA . 10.1 pt -91.36 -21.67 6.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.944 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.794 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 96.16 13.12 50.21 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.597 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HE3' ' HA2' ' A' ' 14' ' ' GLY . 3.4 tppp? 67.36 -57.7 0.43 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.961 0.904 . . . . 0.0 110.922 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.53 2.58 46.11 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 109.39 13.23 17.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.088 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.731 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 33.7 tt0 -68.32 -43.59 77.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.841 0.353 . . . . 0.0 111.736 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.794 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 59.3 m -71.06 -40.34 71.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.502 -177.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 35' ' ' MET . 7.3 tp -64.08 -21.53 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.83 0.348 . . . . 0.0 110.529 -176.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.731 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 47.9 mttm -59.0 -48.31 82.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.288 0.566 . . . . 0.0 110.136 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -79.33 -29.83 42.49 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.505 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.42 -27.25 66.03 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 121.844 -0.535 . . . . 0.0 110.449 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.4 mt-30 -84.27 -45.52 12.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.337 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.82 -39.23 15.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.514 ' HD3' ' OD2' ' A' ' 94' ' ' ASP . 4.0 ttm180 -75.29 -46.48 33.23 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.217 -176.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.56 -27.0 34.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.28 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.01 21.7 60.66 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.677 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.3 m -121.97 147.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.91 0.386 . . . . 0.0 111.195 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -90.54 110.38 21.52 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.771 ' HB2' HD11 ' A' ' 24' ' ' ILE . 60.3 mtt -95.09 124.0 38.9 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.3 tp -110.93 100.81 11.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 122.156 0.979 . . . . 0.0 110.451 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 51' ' ' LEU . 1.4 pt? -134.93 142.87 46.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.889 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.2 mp -65.83 99.94 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 111.188 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -101.56 -29.04 12.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.004 176.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.19 175.03 7.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.524 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.12 48.13 3.28 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.363 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.0 t -90.21 -157.81 0.5 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -55.82 -61.37 2.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.578 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.6 m-20 -85.58 48.63 1.62 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.99 0.424 . . . . 0.0 111.218 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -76.95 -47.94 19.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -93.51 -17.01 23.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.419 0.628 . . . . 0.0 110.068 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.578 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 23.1 t -79.4 151.35 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.377 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.588 ' OD2' ' HA ' ' A' ' 9' ' ' PRO . 6.6 m-20 -58.97 145.14 42.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -114.63 125.72 28.78 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-O 121.029 0.442 . . . . 0.0 111.989 -162.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.8 125.5 3.23 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.825 2.35 . . . . 0.0 111.15 174.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 37' ' ' LEU . 7.3 tt -106.51 120.67 42.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.93 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 36' ' ' ILE . 5.1 mpt_? -102.93 120.74 41.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 71.8 mt -91.1 115.47 30.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.108 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.467 HG12 ' CG1' ' A' ' 3' ' ' VAL . 24.7 mt -104.16 121.39 55.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.98 -170.83 43.76 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.37 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.827 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 1.9 m-20 -57.42 149.08 51.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 123.171 0.589 . . . . 0.0 110.472 175.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.13 -50.28 10.19 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.842 2.361 . . . . 0.0 113.332 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.44 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 50.4 p90 -67.89 -42.53 81.04 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.827 ' HG2' ' HB2' ' A' ' 56' ' ' ASP . 16.8 ptpt -72.12 -29.91 64.54 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.969 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.87 -34.57 70.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.447 . . . . 0.0 110.051 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.565 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 59.2 tp60 -77.03 -45.91 25.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.522 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 14.4 mm100 -63.0 -27.18 69.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.079 0.466 . . . . 0.0 110.131 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.628 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -84.6 -41.81 16.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.784 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.603 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.8 p -61.1 -34.45 74.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.594 0.235 . . . . 0.0 111.595 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.77 -30.64 32.25 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.745 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.73 ' SD ' ' HD3' ' A' ' 82' ' ' ARG . 17.4 ptt? -76.02 -34.97 59.7 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.446 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 27.2 m -68.8 -22.68 26.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.636 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.603 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 49.3 mtt -82.21 -24.5 34.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.664 0.745 . . . . 0.0 109.394 172.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.463 ' CG ' HH21 ' A' ' 72' ' ' ARG . 10.0 t70 -84.58 -53.3 5.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.594 -171.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.012 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.6 pp -76.17 -20.77 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.412 0.625 . . . . 0.0 111.455 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.867 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 2.0 tt -76.06 -9.25 58.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.072 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 15.0 ptp180 -52.39 -53.5 44.15 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.604 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER 53.97 144.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 176.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.604 ' HD2' ' O ' ' A' ' 73' ' ' GLU . 13.0 mmm180 -121.14 -30.31 4.36 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.723 -0.611 . . . . 0.0 110.247 172.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -147.19 41.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.643 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.475 ' H ' ' CG ' ' A' ' 73' ' ' GLU . 49.6 mt-30 62.77 30.73 16.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.373 0.606 . . . . 0.0 110.068 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.68 82.7 0.35 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.199 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.36 175.94 44.69 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.646 ' CD1' HG22 ' A' ' 70' ' ' ILE . 92.8 m-85 -81.45 4.29 21.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.097 0.949 . . . . 0.0 112.348 -173.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 23' ' ' THR . . . 78.03 -3.94 59.72 Favored Glycine 0 N--CA 1.461 0.35 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.638 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -177.49 -61.57 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -178.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 1.012 ' HA ' HG21 ' A' ' 70' ' ' ILE . 2.9 ttp-105 162.47 -34.59 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 124.616 1.197 . . . . 0.0 109.45 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.745 ' HA ' ' OD1' ' A' ' 94' ' ' ASP . 2.2 t-20 57.98 58.99 3.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.931 0.872 . . . . 0.0 110.173 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 1.065 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 0.8 OUTLIER -171.95 -136.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.878 -178.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.573 ' HB3' ' H ' ' A' ' 90' ' ' GLY . 1.3 p90 -59.19 -74.42 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.694 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 85.02 -38.57 2.97 Favored Glycine 0 C--O 1.226 -0.379 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 59' ' ' LYS . 13.0 t -170.92 -37.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.907 -0.647 . . . . 0.0 109.352 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.45 ' HG3' ' CB ' ' A' ' 127' ' ' LYS . 6.5 mmt180 -94.64 149.12 21.56 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.381 -176.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.754 HD12 ' HB2' ' A' ' 141' ' ' MET . 39.8 mm 75.48 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 124.083 0.864 . . . . 0.0 111.377 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.573 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 72.11 43.6 47.53 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.46 -174.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.16 73.7 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 84' ' ' GLU . . . 147.8 159.37 8.37 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -171.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.065 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 9.7 pt -91.14 165.86 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -167.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.745 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 0.6 OUTLIER -99.8 148.17 24.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.865 176.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 38.7 t -135.0 96.18 14.63 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -174.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.48 107.2 1.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.549 1.5 . . . . 0.0 110.504 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.746 HG23 HD21 ' A' ' 158' ' ' LEU . 14.9 p -117.37 128.95 25.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.584 0.231 . . . . 0.0 110.683 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.451 ' HB2' ' OG ' ' A' ' 101' ' ' SER . 64.1 Cg_exo -39.25 132.84 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.997 3.131 . . . . 0.0 113.443 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -56.99 -30.13 63.86 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.476 -171.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -90.1 -12.17 39.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.839 0.352 . . . . 0.0 111.497 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 14.8 m -96.57 -17.16 20.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.758 -173.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 106' ' ' ILE . 7.4 p -59.49 -34.7 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.13 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.38 -31.01 79.43 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.447 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.63 -37.05 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 109.952 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 97' ' ' VAL . 52.9 t -63.27 -39.87 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.294 176.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.715 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.6 mm -72.41 -42.68 64.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.309 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.98 35.94 7.44 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.788 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 63.25 -78.06 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.03 0.532 . . . . 0.0 111.857 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -69.71 -15.28 63.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.768 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.462 ' HA2' HG22 ' A' ' 106' ' ' ILE . . . 90.99 17.26 52.1 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.839 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -7.9 51.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.865 0.364 . . . . 0.0 110.968 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 14.8 tpt -90.24 -41.43 11.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.966 0.412 . . . . 0.0 109.918 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.715 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 8.9 tp -64.31 -22.43 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.207 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 99.3 mttt -81.74 -21.79 37.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.029 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -67.74 -40.24 84.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.008 0.432 . . . . 0.0 109.901 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.536 HG23 HD12 ' A' ' 153' ' ' ILE . 22.1 mt -60.85 -43.65 96.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.78 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -73.71 -18.9 60.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.165 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -87.96 -45.39 10.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.824 0.345 . . . . 0.0 110.882 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -78.49 -46.67 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 146' ' ' ARG . . . -87.16 -17.46 32.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.842 0.354 . . . . 0.0 111.258 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.65 23.96 77.3 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.697 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.4 m -95.47 177.8 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.912 0.387 . . . . 0.0 111.273 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.698 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 98.5 mtt180 -129.24 131.93 47.13 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.606 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.676 HG21 HD11 ' A' ' 113' ' ' ILE . 47.0 mm -98.6 118.69 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.974 0.416 . . . . 0.0 111.02 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.69 ' HB3' HD11 ' A' ' 89' ' ' ILE . 50.6 tp60 -116.23 109.94 18.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.838 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -82.58 140.7 33.1 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HD2' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -146.61 -172.36 3.95 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.067 -171.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 . . . . . 0 C--O 1.236 0.38 0 CA-C-O 120.859 0.361 . . . . 0.0 110.404 175.165 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo . . . . . 0 N--CA 1.461 -0.44 0 CA-C-O 120.844 0.268 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -125.83 155.82 40.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.038 0.447 . . . . 0.0 111.301 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.432 ' O ' HG12 ' A' ' 97' ' ' VAL . 23.8 mtpp -110.42 123.91 50.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.222 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.527 ' O ' ' HD2' ' A' ' 127' ' ' LYS . 15.2 mm -72.91 102.31 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.007 0.432 . . . . 0.0 112.005 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -92.72 140.96 28.99 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 169.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.508 ' HB3' ' CG1' ' A' ' 89' ' ' ILE . 2.2 m80 -106.33 138.24 42.87 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.197 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.845 HD13 ' HB3' ' A' ' 150' ' ' ALA . 87.8 mt -107.4 107.25 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.325 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.754 ' HB2' HD12 ' A' ' 89' ' ' ILE . 47.4 ttm -85.83 124.43 32.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.824 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.92 -177.82 34.49 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.131 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.64 147.74 86.45 Favored 'Trans proline' 0 C--O 1.224 -0.177 0 C-N-CA 122.913 2.409 . . . . 0.0 111.389 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.712 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 87.5 Cg_exo -45.16 -46.66 13.34 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.286 2.657 . . . . 0.0 114.132 -174.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -60.53 -34.55 74.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.764 0.316 . . . . 0.0 110.889 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 120' ' ' ALA . 7.0 mtm180 -86.79 -34.48 19.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.188 -176.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.712 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 25.7 p -61.42 -47.14 87.13 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -69.6 -35.64 75.48 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.597 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -54.56 -32.92 59.3 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.149 0.5 . . . . 0.0 110.942 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.845 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.86 -28.77 44.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.089 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.77 -23.65 63.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.955 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -78.08 -25.02 47.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.322 . . . . 0.0 110.412 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.536 HD12 HG23 ' A' ' 116' ' ' ILE . 62.1 mt -73.87 -42.84 53.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.242 0.544 . . . . 0.0 109.868 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.3 mt -68.81 -39.39 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.469 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -58.86 -36.75 75.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.486 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.21 -42.03 93.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.173 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.44 -35.23 80.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.49 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.746 HD21 HG23 ' A' ' 97' ' ' VAL . 35.5 mt . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.219 0.533 . . . . 0.0 110.323 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.955 0.407 . . . . 0.0 111.589 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 38.5 t -130.35 112.52 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.439 173.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -110.87 146.93 35.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.613 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 38.4 mt-10 -110.91 116.9 32.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.219 0.533 . . . . 0.0 112.033 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.2 mm -110.16 132.28 58.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 173.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.0 ttm -90.41 119.4 30.66 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.516 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.841 HG12 HG11 ' A' ' 16' ' ' VAL . 1.8 mp -92.95 115.63 65.24 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.252 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HA ' ' OD1' ' A' ' 48' ' ' ASP . 59.6 Cg_exo -57.12 142.14 94.32 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.598 2.865 . . . . 0.0 112.404 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.38 121.37 13.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.6 -54.2 0.6 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -167.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.508 ' HE2' ' OE2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -64.69 -29.77 70.77 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 172.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.702 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -50.33 -33.82 21.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.03 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.777 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -59.56 -41.47 97.27 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.731 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.798 HD22 ' HA ' ' A' ' 76' ' ' GLN . 0.5 OUTLIER -89.39 -31.07 17.93 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.957 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.841 HG11 HG12 ' A' ' 8' ' ' ILE . 78.4 t -67.29 -47.91 79.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.765 HG13 ' H ' ' A' ' 19' ' ' LYS . 21.6 pt -91.03 -21.68 6.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.281 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 98.4 -2.5 59.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.859 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.777 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 6.1 tptm 69.78 -50.59 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 111.047 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.57 4.96 69.92 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 172.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.7 3.62 64.25 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.801 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 46.7 mt-10 -65.05 -34.31 78.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.545 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 26.7 m -85.37 -40.93 15.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.92 -175.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.516 HG21 HE22 ' A' ' 39' ' ' GLN . 3.3 tp -67.19 -26.39 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 63.7 tttt -52.73 -50.99 62.32 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.83 169.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 28.4 mt-30 -74.43 -36.5 63.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.363 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.637 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 88.0 mt -66.13 -28.23 68.64 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.173 -0.329 . . . . 0.0 111.135 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 24.3 mt-30 -85.6 -43.64 13.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.793 0.33 . . . . 0.0 111.503 176.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.59 -52.0 6.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.532 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 29.6 ttm180 -70.35 -53.35 17.03 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.765 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -65.68 -26.2 67.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.349 0.595 . . . . 0.0 110.711 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.93 0.38 75.29 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.998 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 35.3 m -103.88 151.38 6.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -92.51 110.3 21.72 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 1.025 ' HB3' HD21 ' A' ' 51' ' ' LEU . 56.8 mtt -97.24 115.38 27.5 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.361 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.93 104.42 17.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 122.334 1.064 . . . . 0.0 109.664 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.717 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.2 pt? -134.26 142.5 47.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.859 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.0 mp -69.29 100.11 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.516 HE22 HG21 ' A' ' 24' ' ' ILE . 70.2 mt-30 -80.76 -67.12 0.8 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -130.54 101.65 5.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.972 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 45' ' ' THR . . . -155.86 149.51 20.57 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 p -69.76 71.87 0.36 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.12 0.485 . . . . 0.0 111.58 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -169.85 -56.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.411 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.528 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 90.1 m-20 -126.9 60.55 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.898 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 41' ' ' GLY . 2.2 p -83.86 -59.87 2.29 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.637 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.13 -14.92 39.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.354 0.597 . . . . 0.0 109.727 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 47.2 t -79.77 146.06 8.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.833 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.504 ' OD1' ' HA ' ' A' ' 9' ' ' PRO . 42.7 m-20 -58.81 149.91 25.33 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.565 0.541 . . . . 0.0 109.615 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -115.97 122.18 32.82 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.936 -166.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.43 121.34 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.47 2.113 . . . . 0.0 111.537 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.025 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.1 tm? -106.19 125.17 50.66 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.299 -174.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.613 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 1.7 mpt_? -103.42 121.25 42.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.378 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 62.9 mt -89.81 109.09 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.9 mt -105.94 119.7 55.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.992 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.525 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.18 -171.14 44.04 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.432 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.05 146.72 97.41 Favored Pre-proline 0 C--N 1.327 -0.397 0 O-C-N 123.67 0.276 . . . . 0.0 110.522 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.12 -51.89 8.68 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.367 2.711 . . . . 0.0 114.186 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -58.2 -44.19 87.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.233 0.54 . . . . 0.0 110.457 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 86.5 mttt -62.82 -46.72 86.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.486 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.13 -34.21 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.52 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -69.63 -50.04 48.1 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.828 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -65.88 -33.5 75.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.341 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.56 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -69.7 -47.78 61.96 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.079 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 83.3 m -56.27 -37.82 70.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.171 0.51 . . . . 0.0 110.304 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -70.08 -41.92 73.45 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.888 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.936 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 10.5 ptt? -78.31 -35.69 47.44 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.425 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.533 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 26.9 m -59.44 -47.02 92.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.492 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.1 mtm -65.16 -24.29 67.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 110.479 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 35.2 t70 -83.32 -41.97 17.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.514 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -86.99 -32.65 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.442 -179.235 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.622 ' HA ' HD11 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -82.66 -11.66 58.19 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.348 -175.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -62.75 -40.67 97.96 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 175.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.508 ' OE2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 37.21 -156.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.622 1.201 . . . . 0.0 113.431 175.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -165.12 -19.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.492 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -163.2 63.93 0.18 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.894 169.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.798 ' HA ' HD22 ' A' ' 15' ' ' LEU . 65.2 tt0 70.94 -18.81 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.59 0.756 . . . . 0.0 112.619 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.09 86.03 0.58 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.327 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.695 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -121.25 35.29 3.68 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.468 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 65.97 -60.78 0.29 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.626 0.77 . . . . 0.0 112.258 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 106.62 107.53 3.22 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -172.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 1.9 t70 70.64 -72.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -168.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.936 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 47.5 ttt-85 165.03 -27.79 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.825 1.25 . . . . 0.0 108.532 172.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 67.04 26.19 9.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.282 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 1.039 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 13.9 tt0 -130.52 -66.79 0.75 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.188 0.518 . . . . 0.0 110.191 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.498 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 13.3 p90 -144.84 86.9 1.81 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.771 0.796 . . . . 0.0 110.348 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -74.18 71.45 1.47 Allowed Glycine 0 C--N 1.315 -0.617 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.748 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.616 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 47.4 m 66.23 2.41 2.35 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.598 ' HD2' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -85.17 -86.11 0.14 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.212 0.529 . . . . 0.0 110.448 174.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.908 HD11 ' HG2' ' A' ' 125' ' ' GLN . 1.7 mt -88.75 -167.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.805 ' H ' HG22 ' A' ' 89' ' ' ILE . . . -144.57 39.62 1.21 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HE1' ' A' ' 139' ' ' HIS . . . -177.42 124.41 0.94 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.654 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 96.9 165.41 32.84 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.039 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 43.3 pt -94.06 156.22 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 117.292 0.546 . . . . 0.0 112.412 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.496 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 2.2 m-20 -95.88 114.14 25.84 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 175.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.619 HG21 HD12 ' A' ' 140' ' ' ILE . 44.1 t -111.65 104.81 56.45 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HA ' HD13 ' A' ' 137' ' ' ILE . 46.1 Cg_endo -71.32 115.26 4.21 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.349 2.033 . . . . 0.0 112.341 171.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.674 HG23 HD21 ' A' ' 158' ' ' LEU . 10.5 p -117.43 126.22 27.55 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.398 0.618 . . . . 0.0 110.277 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 24.3 Cg_exo -61.79 143.06 95.7 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.306 2.671 . . . . 0.0 112.501 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -59.2 -33.96 71.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.273 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -85.27 20.94 1.83 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -149.55 -24.52 0.28 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.415 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 106' ' ' ILE . 10.6 p -60.57 -26.55 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 120.694 0.283 . . . . 0.0 110.696 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.84 -35.89 84.65 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.255 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.79 -35.18 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 110.055 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 97' ' ' VAL . 41.5 t -63.25 -38.66 82.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.569 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.798 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 44.7 mm -73.87 -40.87 53.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.197 0.522 . . . . 0.0 110.07 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.46 -149.52 19.36 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -75.73 -83.27 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 m -95.92 21.74 8.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.214 0.53 . . . . 0.0 110.645 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.666 ' O ' ' HD3' ' A' ' 114' ' ' LYS . . . 91.79 47.67 3.36 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -170.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -94.26 -54.14 3.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.846 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.2 tpt -67.67 -34.29 76.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.882 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.798 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 7.9 tp -67.13 -31.96 55.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.546 -177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.688 ' HD2' HG23 ' A' ' 113' ' ' ILE . 5.7 mptp? -79.51 -23.47 42.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.124 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.422 ' HB3' ' HE3' ' A' ' 115' ' ' LYS . 22.9 mmmt -66.07 -37.27 85.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.8 mm -60.34 -42.87 92.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.519 0.675 . . . . 0.0 109.281 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -67.58 -33.13 74.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.916 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -79.29 -46.58 17.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.514 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -42.23 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.928 -172.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.54 -13.51 29.66 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.286 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.62 23.26 75.69 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.651 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.8 m -99.94 175.28 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.131 0.491 . . . . 0.0 111.432 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 71.1 mtm180 -129.0 141.36 51.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.039 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 113' ' ' ILE . 49.5 mm -102.38 130.0 52.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.024 0.44 . . . . 0.0 110.8 -175.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.908 ' HG2' HD11 ' A' ' 89' ' ' ILE . 6.1 tp-100 -126.62 96.86 4.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.868 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -75.55 112.78 12.25 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 169.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.781 ' NZ ' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -134.57 163.98 28.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.768 -168.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 171.477 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 36.6 Cg_endo . . . . . 0 C--O 1.234 0.284 0 N-CA-C 114.242 0.824 . . . . 0.0 114.242 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -133.61 148.52 51.57 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.391 0.615 . . . . 0.0 112.089 -168.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 97' ' ' VAL . 30.7 mttm -123.44 117.28 24.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.937 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.781 ' HB ' ' NZ ' ' A' ' 127' ' ' LYS . 12.2 mm -71.93 102.22 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.123 0.487 . . . . 0.0 110.676 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.538 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -87.37 98.26 11.26 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 63.9 t-80 -72.1 127.72 33.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.056 0.455 . . . . 0.0 110.634 -172.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 95' ' ' VAL . 93.9 mt -98.65 107.66 20.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.174 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.511 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 38.6 ttm -92.95 137.72 32.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.876 -176.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.26 -160.92 28.61 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.703 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.83 140.6 35.6 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.739 2.293 . . . . 0.0 111.507 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -41.54 -49.64 5.07 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.891 3.061 . . . . 0.0 114.249 -174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -59.42 -52.1 67.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.335 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -61.61 -35.51 78.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.35 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.654 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 72.9 m -56.96 -59.46 5.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.856 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -66.92 -33.73 76.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.971 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.439 ' O ' HG13 ' A' ' 153' ' ' ILE . 4.2 t60 -60.02 -33.17 71.65 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.211 0.529 . . . . 0.0 110.018 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.559 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.09 -45.93 22.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.906 -176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.57 -20.74 66.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.06 0.457 . . . . 0.0 110.244 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -28.2 52.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.089 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 149' ' ' HIS . 71.6 mt -77.62 -44.93 29.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.132 0.492 . . . . 0.0 109.829 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.488 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 73.2 mt -65.49 -41.15 90.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.01 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -57.04 -42.6 80.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.346 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.95 -36.87 80.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.92 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.15 -42.18 99.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 109.989 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.674 HD21 HG23 ' A' ' 97' ' ' VAL . 17.6 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.99 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.448 -0.571 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 18.6 m -123.47 120.6 60.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.327 0.584 . . . . 0.0 111.098 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 4' ' ' GLN . 11.7 mm-40 -106.32 139.13 41.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.844 174.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.805 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 61.9 mt-10 -110.99 116.11 30.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.28 0.562 . . . . 0.0 111.54 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.9 mp -105.79 140.13 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.425 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 86.7 mmm -87.02 106.31 17.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.996 0.426 . . . . 0.0 110.901 -176.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.477 ' CG1' HG21 ' A' ' 16' ' ' VAL . 1.8 mp -90.62 109.49 34.69 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.985 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 12' ' ' LYS . 13.3 Cg_exo -72.85 165.75 31.9 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 123.322 2.681 . . . . 0.0 111.695 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.97 148.78 34.07 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.59 ' O ' ' HB3' ' A' ' 76' ' ' GLN . . . 84.65 -58.1 5.0 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.145 -172.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.656 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 7.5 mptt -60.98 -31.0 70.6 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.644 0.259 . . . . 0.0 111.268 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.7 -38.03 53.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.59 ' HA2' ' HG2' ' A' ' 19' ' ' LYS . . . -63.26 -37.51 94.99 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.946 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 3.8 pp -80.97 -24.28 38.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.98 0.39 . . . . 0.0 110.133 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG21 ' CG1' ' A' ' 8' ' ' ILE . 96.2 t -79.77 -52.34 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.311 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.757 HG13 ' H ' ' A' ' 19' ' ' LYS . 27.8 pt -77.64 -27.45 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.287 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.487 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 95.49 8.19 58.67 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.35 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.757 ' H ' HG13 ' A' ' 17' ' ' ILE . 54.3 mmtt 42.47 58.22 3.15 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.678 0.752 . . . . 0.0 110.955 -176.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.17 -27.52 1.56 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.398 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.69 -8.02 10.18 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.127 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.716 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 32.8 tt0 -49.96 -59.21 4.09 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -176.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.487 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 23.5 m -67.27 -38.19 84.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 35' ' ' MET . 3.4 tp -65.25 -27.19 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.197 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.716 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 35.0 mttm -57.97 -54.46 46.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.19 0.519 . . . . 0.0 109.797 171.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 25.6 mt-30 -68.88 -34.28 75.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.475 -176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.69 HD13 ' HE2' ' A' ' 35' ' ' MET . 32.6 mt -70.69 -25.7 63.09 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.343 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.762 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 27.0 mt-30 -85.75 -44.07 12.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.691 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -86.11 -54.01 4.73 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.654 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 28.0 ttm180 -71.44 -42.18 68.55 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.972 0.415 . . . . 0.0 110.44 -175.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.666 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -83.32 -9.18 59.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.824 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.12 23.49 66.14 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.886 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 20.6 m -129.02 152.11 36.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.982 0.391 . . . . 0.0 110.426 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 49.9 tptt -87.74 110.19 20.27 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.69 ' HE2' HD13 ' A' ' 27' ' ' LEU . 27.9 mmm -92.7 116.39 28.97 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.7 tp -110.08 111.66 37.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.978 0.894 . . . . 0.0 110.214 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.549 HD13 HD23 ' A' ' 51' ' ' LEU . 3.1 mm? -99.29 135.68 40.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.759 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.484 HG21 ' HD2' ' A' ' 50' ' ' PRO . 13.0 tt -86.79 99.87 8.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.839 0.828 . . . . 0.0 109.755 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.49 32.88 0.13 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.761 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.15 -29.27 16.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.444 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.66 -177.82 16.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.26 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 m -79.37 69.85 5.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.329 0.585 . . . . 0.0 110.737 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -134.52 -63.32 0.72 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.036 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 13.1 m120 -124.78 28.2 6.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.532 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -82.1 -36.17 27.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.132 0.491 . . . . 0.0 109.768 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -93.72 -11.99 30.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.533 0.682 . . . . 0.0 109.676 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 38.0 t -104.19 164.75 3.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.201 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 47' ' ' VAL . 4.1 p30 -55.88 151.33 11.7 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.028 170.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 40.2 mttp -130.86 125.59 21.37 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.735 -168.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.484 ' HD2' HG21 ' A' ' 38' ' ' ILE . 66.3 Cg_endo -74.27 103.89 1.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.144 1.896 . . . . 0.0 110.831 172.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.805 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -84.7 127.46 34.11 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.975 -175.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.583 ' N ' HD22 ' A' ' 51' ' ' LEU . 3.5 mpt_? -102.42 113.39 26.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.004 0.43 . . . . 0.0 110.728 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 59.1 mt -83.84 112.41 21.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.512 172.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 34' ' ' LYS . 52.0 mt -104.22 120.28 54.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.17 -170.58 43.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.681 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.613 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 9.5 m-20 -68.12 152.57 96.37 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 122.688 0.395 . . . . 0.0 111.139 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.8 -54.71 3.92 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.256 2.637 . . . . 0.0 114.394 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -62.22 -48.46 79.87 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.707 0.289 . . . . 0.0 111.594 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.613 ' HD2' ' H ' ' A' ' 56' ' ' ASP . 16.8 ptpt -68.57 -34.11 75.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.771 -175.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 56' ' ' ASP . 76.7 t -65.3 -30.06 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 0.0 110.189 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.23 -48.55 12.92 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 15.6 mm100 -63.35 -39.92 95.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.433 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.674 ' HA ' ' CG ' ' A' ' 66' ' ' MET . . . -70.02 -41.22 74.59 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.842 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.1 t -55.53 -43.5 75.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.47 0.652 . . . . 0.0 109.631 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -65.16 -48.56 73.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.232 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.674 ' CG ' ' HA ' ' A' ' 63' ' ' ALA . 2.0 ppp? -67.01 -42.56 84.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.472 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.645 HG12 HD23 ' A' ' 71' ' ' LEU . 75.3 t -58.47 -49.97 80.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 122.971 0.17 . . . . 0.0 110.924 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.414 ' HE3' HG13 ' A' ' 6' ' ' ILE . 64.4 mtt -58.64 -29.86 66.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.165 0.507 . . . . 0.0 110.425 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 8.7 t70 -85.54 -35.63 20.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.044 -173.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.731 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.7 pp -86.87 -21.57 7.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.985 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.645 HD23 HG12 ' A' ' 67' ' ' VAL . 3.0 pp -86.35 2.2 48.3 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.341 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 7.4 ptp180 -64.07 -14.24 53.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.989 0.423 . . . . 0.0 109.86 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.506 ' HG2' ' C ' ' A' ' 77' ' ' GLY . 8.0 tp10 -51.57 146.75 7.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.452 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -64.01 -36.58 84.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.552 -174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -168.1 112.77 0.65 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.375 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.63 ' HA ' HD23 ' A' ' 15' ' ' LEU . 22.4 pt20 37.64 63.48 0.76 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.347 1.059 . . . . 0.0 113.84 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.506 ' C ' ' HG2' ' A' ' 73' ' ' GLU . . . -152.73 29.15 0.84 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.165 176.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.69 171.25 34.49 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.282 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.731 ' HD1' HG22 ' A' ' 70' ' ' ILE . 80.0 m-85 -65.81 -20.42 66.24 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 84.31 98.68 0.63 Allowed Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.654 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 4.0 t70 71.57 -82.94 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -168.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.651 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 44.4 ttt85 169.36 -36.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.197 0.599 . . . . 0.0 109.616 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 62.38 36.34 14.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.515 0.674 . . . . 0.0 110.218 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 1.002 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.6 tt0 -142.35 -49.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.455 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 13.1 p90 -177.04 135.47 0.2 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.96 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -115.27 -72.49 0.53 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.704 174.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.628 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 18.5 t -108.08 -4.83 17.38 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.16 0.505 . . . . 0.0 110.429 176.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.589 ' HG2' ' HB2' ' A' ' 127' ' ' LYS . 1.4 mpt_? -129.81 172.52 11.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.662 -172.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.609 HG12 ' HB2' ' A' ' 139' ' ' HIS . 35.7 mt 73.21 -78.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 123.813 0.695 . . . . 0.0 112.243 171.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.27 44.54 96.42 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.231 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.409 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 151.28 78.05 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.162 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.713 ' HA3' ' O ' ' A' ' 140' ' ' ILE . . . 158.56 -129.28 2.24 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.002 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 29.4 pt -149.99 160.79 4.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 117.081 0.44 . . . . 0.0 109.847 173.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.5 125.73 45.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.342 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 39.9 t -126.2 101.88 27.96 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.65 107.36 2.45 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.021 1.814 . . . . 0.0 112.057 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.512 HG23 HG12 ' A' ' 95' ' ' VAL . 37.8 t -98.89 128.51 32.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.006 0.432 . . . . 0.0 111.449 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.555 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 5.5 Cg_endo -47.4 129.26 16.02 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.852 3.034 . . . . 0.0 112.215 174.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.727 ' HD3' ' HB2' ' A' ' 134' ' ' PRO . 23.1 ptt180 -57.49 -32.06 66.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.372 -174.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -87.92 11.34 16.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.734 0.302 . . . . 0.0 111.196 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.3 m -127.89 -30.14 2.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.383 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.39 -33.13 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.36 66.31 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.533 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.69 -37.1 12.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.08 0.467 . . . . 0.0 110.08 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.97 -41.79 93.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.713 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.652 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 34.1 mm -77.1 -45.69 29.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.518 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.64 -124.79 8.36 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.553 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -112.36 -70.39 0.81 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.028 0.442 . . . . 0.0 110.1 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.7 m -99.04 20.4 13.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.56 37.2 35.89 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.794 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -93.88 -33.4 13.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.643 0.258 . . . . 0.0 110.466 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 17.1 tpt -68.43 -41.84 79.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.403 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.1 tp -63.65 -21.69 29.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.614 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -80.61 -19.22 45.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -68.2 -28.97 67.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.167 0.508 . . . . 0.0 110.166 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.647 HD12 HD12 ' A' ' 113' ' ' ILE . 27.1 mt -71.67 -33.64 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.682 0.754 . . . . 0.0 109.172 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -72.18 -23.93 61.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.292 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -79.86 -40.93 27.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.564 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.4 -56.27 4.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.469 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -86.94 -23.73 25.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 111.597 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.16 26.65 43.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.703 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 141' ' ' MET . 29.8 m -95.2 164.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.669 0.271 . . . . 0.0 111.225 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.435 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 13.8 mmt180 -118.33 139.1 51.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 139' ' ' HIS . 48.5 mm -114.64 141.88 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.666 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 1.1 tp-100 -155.23 106.06 2.56 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.248 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 106' ' ' ILE . 18.2 m-85 -73.39 105.0 4.58 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.888 176.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.589 ' HB2' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -107.25 96.25 6.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.119 -174.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 C--O 1.236 0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.759 179.637 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.727 ' HB2' ' HD3' ' A' ' 99' ' ' ARG . 5.8 Cg_exo . . . . . 0 CA--C 1.528 0.177 0 CA-C-O 121.153 0.397 . . . . 0.0 112.414 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.555 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 1.4 mp0 -83.92 147.59 27.41 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.273 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -108.91 120.9 43.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.555 -174.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 7.0 mm -73.55 123.61 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.016 0.436 . . . . 0.0 111.294 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . . . -99.0 126.77 44.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.608 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.666 ' HB3' ' O ' ' A' ' 125' ' ' GLN . 1.5 t60 -73.87 126.85 31.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.713 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 82.9 mt -113.98 142.74 25.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.78 172.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 51.0 ttm -132.09 131.35 42.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.552 0.215 . . . . 0.0 110.562 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.8 -167.97 30.52 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.82 142.63 76.87 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.537 2.158 . . . . 0.0 111.477 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.91 -46.69 18.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.215 2.61 . . . . 0.0 113.529 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.46 -36.87 79.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.083 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.513 ' HA ' ' HB3' ' A' ' 149' ' ' HIS . 53.1 mtt180 -80.1 -26.43 39.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.86 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.59 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 69.9 m -60.65 -56.1 25.35 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.68 -31.42 72.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.599 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.537 ' O ' HG13 ' A' ' 153' ' ' ILE . 11.9 t60 -59.75 -33.38 71.6 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.145 0.497 . . . . 0.0 110.258 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.713 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.37 -42.39 30.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.388 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 93' ' ' ILE . . . -63.53 -28.42 69.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.08 0.466 . . . . 0.0 110.275 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -25.71 52.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.297 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 149' ' ' HIS . 75.3 mt -74.64 -47.6 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.676 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.1 mt -61.36 -46.18 97.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.822 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -54.45 -44.06 72.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.356 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.39 -36.13 83.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.405 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 73.5 mt -63.54 -45.55 90.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.085 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 20.7 mt . . . . . 0 N--CA 1.462 0.17 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.27 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 5.0 m . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 4.2 p -140.79 140.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.519 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -125.69 140.66 52.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.258 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 13.0 mp0 -102.39 119.99 39.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.168 0.508 . . . . 0.0 111.623 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.695 HG13 HG21 ' A' ' 67' ' ' VAL . 39.1 mm -113.08 146.62 17.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.027 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.455 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 42.3 mtp -105.38 116.46 31.99 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.482 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.697 HG12 HG11 ' A' ' 16' ' ' VAL . 2.1 mp -97.39 109.14 48.72 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.883 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.823 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 50.8 Cg_exo -61.4 152.78 70.53 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.364 2.709 . . . . 0.0 112.558 175.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.67 144.39 57.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.17 -45.54 2.64 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -171.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.823 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -69.19 -15.65 63.44 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 110.274 174.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.555 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -54.23 -38.64 65.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.511 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 18' ' ' GLY . . . -65.89 -31.17 78.81 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.925 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.697 ' CD1' ' HA ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -91.92 -29.48 16.65 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.446 -0.443 . . . . 0.0 112.157 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.697 HG11 HG12 ' A' ' 8' ' ' ILE . 89.2 t -83.78 -56.66 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 13' ' ' ALA . 32.0 pt -93.05 -21.12 6.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.864 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . 103.77 -61.74 0.43 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 23.1 tptp 169.31 -35.91 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 170.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.92 -0.36 7.08 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.224 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.648 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 133.11 0.54 4.21 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.189 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HB2' ' HA3' ' A' ' 18' ' ' GLY . 36.3 mp0 -51.08 -54.7 22.5 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.072 0.549 . . . . 0.0 112.08 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.565 HG21 ' O ' ' A' ' 15' ' ' LEU . 87.3 m -81.67 -26.12 34.97 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.508 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.733 HD12 HD12 ' A' ' 27' ' ' LEU . 2.7 tp -67.75 -22.9 28.76 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.156 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.648 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 7.8 mtpm? -56.03 -54.76 41.07 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.555 169.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 45.0 mt-30 -60.6 -44.12 96.65 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.659 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.733 HD12 HD12 ' A' ' 24' ' ' ILE . 50.7 mt -64.38 -28.59 69.8 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.264 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.738 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 47.1 mt-30 -86.88 -49.09 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 111.664 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.41 -54.24 4.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.707 -171.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 94' ' ' ASP . 10.5 ttt180 -63.8 -51.82 63.06 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.793 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -70.9 -26.79 63.38 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.754 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.79 16.83 80.43 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.876 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.9 m -120.11 160.7 20.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -98.11 110.44 23.02 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.677 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 1.048 ' HB3' HD11 ' A' ' 51' ' ' LEU . 43.5 mtt -101.43 125.75 48.11 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.614 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tt -122.53 115.09 44.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.856 0.836 . . . . 0.0 110.733 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.693 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -134.69 145.18 48.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.332 -175.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.798 HG23 ' HB2' ' A' ' 42' ' ' SER . 33.5 mm -59.9 99.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.469 0.652 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -155.45 23.47 0.41 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.972 175.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -111.34 -63.78 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.269 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.43 20.67 0.27 Allowed Glycine 0 CA--C 1.517 0.206 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.736 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.798 ' HB2' HG23 ' A' ' 38' ' ' ILE . 54.6 m -90.95 -166.22 1.53 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.279 0.539 . . . . 0.0 110.781 177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.28 -27.25 24.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -174.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.541 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.4 m-20 -79.58 56.58 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.028 0.442 . . . . 0.0 110.698 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.9 p -83.1 -50.98 7.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.425 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -90.55 -21.47 21.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.525 0.678 . . . . 0.0 109.683 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 23.0 t -79.15 158.82 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.267 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -60.32 153.53 22.41 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.184 0.516 . . . . 0.0 110.525 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -123.88 135.05 25.83 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.766 -163.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.22 104.0 0.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.891 2.394 . . . . 0.0 111.843 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.048 HD11 ' HB3' ' A' ' 35' ' ' MET . 29.5 tp -87.6 129.44 35.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.027 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.614 ' HB2' HG23 ' A' ' 36' ' ' ILE . 7.7 mpt_? -106.73 117.61 34.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.407 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.1 mt -92.79 109.34 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.851 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.9 mt -106.11 121.54 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.72 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 177.82 -171.21 43.75 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.668 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.733 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 11.4 m-20 -64.78 156.28 79.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 122.412 0.285 . . . . 0.0 110.882 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -48.03 -54.85 4.64 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.148 2.565 . . . . 0.0 113.851 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -63.57 -31.54 72.73 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.946 0.403 . . . . 0.0 110.287 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 56' ' ' ASP . 89.7 mttt -66.84 -52.39 44.26 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.566 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.31 -28.76 45.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.299 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -79.85 -41.65 25.89 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.438 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.839 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -72.52 -25.21 61.31 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.831 178.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.712 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -83.42 -40.43 19.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.61 -33.29 72.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.574 0.702 . . . . 0.0 109.246 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.27 -47.22 62.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.681 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.712 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 2.3 ppp? -66.91 -42.13 85.93 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.58 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.695 HG21 HG13 ' A' ' 6' ' ' ILE . 27.0 m -59.63 -42.84 89.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.927 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.3 mtt -68.75 -24.76 64.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.734 ' HA ' ' HE ' ' A' ' 72' ' ' ARG . 52.3 m-20 -81.67 -40.91 22.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.818 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.868 HG22 ' HD2' ' A' ' 79' ' ' PHE . 2.8 pp -88.07 -31.58 5.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.697 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 1.6 tt -75.71 -15.26 60.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.849 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.734 ' HE ' ' HA ' ' A' ' 69' ' ' ASP . 16.4 ptp180 -60.94 -53.6 55.23 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.541 ' HG2' ' CD2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER 40.35 -169.73 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 174.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -162.09 -30.25 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.0 -1.455 . . . . 0.0 109.214 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -129.16 32.66 4.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.556 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 39.4 mt-30 64.42 16.74 10.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.062 0.458 . . . . 0.0 111.351 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -114.11 86.44 0.42 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 80' ' ' GLY . . . -98.82 40.61 2.41 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.183 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.868 ' HD2' HG22 ' A' ' 70' ' ' ILE . 24.7 m-85 69.28 -32.11 0.22 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.918 0.887 . . . . 0.0 112.818 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 93.83 95.95 1.55 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 4.1 t70 72.31 -67.15 0.27 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -170.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.794 ' HA ' HG21 ' A' ' 70' ' ' ILE . 48.0 ttt-85 178.03 -1.93 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.214 169.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 47.5 t30 67.85 -58.65 0.44 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.213 0.605 . . . . 0.0 111.64 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.867 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 36.1 mt-10 -72.92 -23.19 60.67 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -174.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.609 ' CB ' ' HB ' ' A' ' 89' ' ' ILE . 44.7 p90 172.12 140.17 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 122.912 0.485 . . . . 0.0 111.136 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.793 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -112.25 97.33 0.9 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 168.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.495 ' HB2' ' HB1' ' A' ' 31' ' ' ALA . 21.8 t 71.62 -38.15 0.41 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.447 ' HG3' HH11 ' A' ' 88' ' ' ARG . 0.2 OUTLIER -89.73 -167.87 1.98 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.751 HG13 ' CG ' ' A' ' 139' ' ' HIS . 1.5 mp 67.19 -75.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 123.671 0.607 . . . . 0.0 112.3 171.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.428 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 80.23 -31.91 2.32 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.459 -0.401 . . . . 0.0 112.781 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.414 ' N ' HG22 ' A' ' 89' ' ' ILE . . . -148.42 118.61 0.99 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.01 -146.18 17.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.867 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 44.4 pt -140.98 160.61 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.904 0.352 . . . . 0.0 110.258 174.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 85' ' ' TYR . 32.8 m-20 -108.04 117.88 35.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.03 174.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.799 HG23 ' HB3' ' A' ' 138' ' ' ALA . 20.7 m -117.03 106.03 48.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -176.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 32.4 Cg_endo -66.29 107.83 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.455 2.103 . . . . 0.0 111.311 172.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.412 ' HA ' ' HD2' ' A' ' 98' ' ' PRO . 10.7 p -102.85 127.96 28.89 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.936 0.398 . . . . 0.0 110.85 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.658 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 7.3 Cg_endo -52.73 129.3 31.92 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.185 2.59 . . . . 0.0 112.677 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.603 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -44.77 -40.9 6.46 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 113.988 -1.46 . . . . 0.0 113.268 -176.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.499 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 16.6 p80 -82.45 -4.87 58.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.732 -173.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.526 ' O ' HG12 ' A' ' 104' ' ' VAL . 22.6 t -124.49 8.18 8.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.327 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.45 -26.39 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.155 0.503 . . . . 0.0 110.224 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.63 -39.58 67.26 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.906 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 101' ' ' SER . 6.0 p -64.35 -24.71 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.083 0.468 . . . . 0.0 110.458 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 101' ' ' SER . 48.9 t -74.23 -45.47 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.46 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.19 -36.4 37.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.428 0.633 . . . . 0.0 110.578 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.07 -72.68 2.55 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -171.2 -71.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.8 m -95.66 20.63 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.442 0.639 . . . . 0.0 110.088 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.42 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 84.96 2.37 88.44 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.876 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -57.4 -24.8 57.67 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 15.1 tpt -89.54 -51.51 5.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.69 0.281 . . . . 0.0 110.852 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.885 HD11 HG13 ' A' ' 124' ' ' ILE . 19.5 tt -67.68 -31.54 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.735 -174.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.557 ' HA ' ' HG2' ' A' ' 117' ' ' GLN . 98.0 mttt -68.65 -19.16 64.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.673 0.273 . . . . 0.0 111.201 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -74.65 -31.06 61.83 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.107 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.0 mm -63.37 -38.4 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.716 HE22 HG12 ' A' ' 124' ' ' ILE . 4.9 mm100 -64.1 -32.21 73.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.629 -1.168 . . . . 0.0 110.704 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -87.16 -41.9 13.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.458 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.15 -48.09 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -89.13 -16.22 31.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.152 0.501 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 53.79 6.31 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.122 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 141' ' ' MET . 29.1 m -133.46 170.81 19.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -172.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.669 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 85.9 mtt180 -132.36 153.27 50.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.885 HG13 HD11 ' A' ' 113' ' ' ILE . 49.6 mm -114.71 140.44 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -172.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.984 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 52.0 tp60 -143.95 101.19 3.7 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.521 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -73.14 116.35 13.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.997 0.427 . . . . 0.0 110.574 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.672 ' O ' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -139.03 129.42 25.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.689 -177.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 . . . . . 0 N--CA 1.466 0.354 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 172.118 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.448 ' HG2' ' HD2' ' A' ' 99' ' ' ARG . 10.3 Cg_endo . . . . . 0 N--CA 1.453 -0.866 0 CA-C-O 120.875 0.281 . . . . 0.0 112.143 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.658 ' OE2' ' HA ' ' A' ' 98' ' ' PRO . 0.8 OUTLIER -81.52 152.27 27.38 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.256 0.551 . . . . 0.0 111.026 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.405 ' O ' HG12 ' A' ' 97' ' ' VAL . 59.0 mttm -110.53 114.8 28.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.582 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.672 ' HB ' ' O ' ' A' ' 127' ' ' LYS . 12.5 mm -70.32 105.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.306 0.574 . . . . 0.0 110.357 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.799 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -94.3 126.95 39.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.984 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 7.3 t-160 -77.8 117.37 19.11 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.099 173.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.609 ' HB ' ' CG1' ' A' ' 93' ' ' ILE . 48.7 mt -97.98 106.57 18.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.669 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 52.9 ttm -85.73 126.63 34.12 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.219 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.15 157.81 8.5 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.496 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.98 149.78 19.92 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.699 2.266 . . . . 0.0 111.741 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.837 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 50.7 Cg_exo -39.12 -44.42 2.64 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 124.037 3.158 . . . . 0.0 114.457 -175.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.32 -40.77 87.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.079 0.466 . . . . 0.0 111.484 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -78.62 -50.61 11.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.512 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.837 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 18.8 p -61.33 -52.36 64.99 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.667 -175.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.56 -30.47 71.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.735 0.302 . . . . 0.0 111.685 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -70.83 -25.08 62.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.231 0.539 . . . . 0.0 110.461 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.28 -42.91 24.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.964 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.89 -30.23 68.87 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -19.95 54.44 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.915 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.5 mt -80.18 -45.13 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.6 mt -64.11 -45.01 97.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.342 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -56.06 -37.35 69.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.305 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.85 -43.61 90.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 110.305 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 70.3 mt -63.14 -40.33 97.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.425 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 7.7 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.039 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 57' ' ' PRO . 37.1 m . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 120.869 0.366 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 70.5 t -122.52 116.63 49.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.044 0.449 . . . . 0.0 111.027 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -107.77 163.03 13.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 49.0 mt-10 -127.82 120.09 27.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.079 0.466 . . . . 0.0 111.768 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.7 mp -111.36 140.52 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.535 -0.757 . . . . 0.0 108.969 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.498 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 39.0 ttm -90.12 122.44 33.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.811 0.339 . . . . 0.0 110.808 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.589 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.7 mp -95.88 110.78 53.4 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.751 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.784 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 32.6 Cg_exo -65.82 146.66 83.95 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.463 2.775 . . . . 0.0 111.909 172.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.42 130.72 44.84 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.63 -40.31 2.59 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.784 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 1.3 mptm? -84.36 -30.68 25.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.952 173.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.604 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -49.54 -45.45 47.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.855 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -58.0 -39.59 92.12 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.467 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 76' ' ' GLN . 3.5 pp -84.87 -36.39 21.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.069 0.434 . . . . 0.0 110.918 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.658 HG21 HD12 ' A' ' 71' ' ' LEU . 59.9 t -65.94 -42.79 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.682 0.277 . . . . 0.0 111.727 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.895 HG13 ' H ' ' A' ' 19' ' ' LYS . 13.9 pt -92.25 -27.13 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.033 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.587 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 99.88 0.17 56.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.643 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.895 ' H ' HG13 ' A' ' 17' ' ' ILE . 7.2 tptm 74.28 -35.66 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.139 0.975 . . . . 0.0 111.423 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.99 2.55 17.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.945 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.78 -2.76 38.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.608 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 6.8 mp0 -55.52 -44.94 77.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.587 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 88.5 m -74.16 -46.95 39.1 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.496 -177.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 35' ' ' MET . 7.6 tp -62.83 -26.58 41.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 1.3 tmtm? -55.41 -44.83 76.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.212 173.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.414 ' HG3' ' HD2' ' A' ' 25' ' ' LYS . 20.7 mt-30 -85.36 -20.55 29.75 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.707 -177.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.703 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 33.8 mt -79.38 -24.25 42.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.44 0.638 . . . . 0.0 109.494 176.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.5 mt-30 -86.03 -38.88 17.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.892 174.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -86.73 -63.06 1.37 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.431 ' HD3' ' CG ' ' A' ' 94' ' ' ASP . 13.7 ttm180 -65.96 -34.21 77.59 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 110.778 -174.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -87.63 -9.74 53.38 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.024 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.01 22.7 55.84 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.484 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.6 m -126.95 148.99 31.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -89.75 109.01 20.03 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.922 ' HB3' HD11 ' A' ' 51' ' ' LEU . 7.4 mtm -98.29 117.26 32.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.1 tp -111.29 104.7 17.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.928 0.87 . . . . 0.0 110.5 -173.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -133.98 142.28 47.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.915 -178.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.699 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 3.9 mp -68.31 100.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.159 0.504 . . . . 0.0 110.604 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 12.2 mt-30 -96.58 -56.05 2.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -121.54 95.9 4.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.089 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.44 158.56 24.95 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.829 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.7 t -88.82 85.35 6.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.972 0.415 . . . . 0.0 110.453 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -164.46 -79.07 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.021 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 3.2 m-20 -118.52 66.2 0.77 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.51 -56.3 3.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.717 -174.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -93.73 -6.01 47.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.208 1.004 . . . . 0.0 108.519 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 56.5 t -86.42 158.74 3.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.952 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -60.32 148.79 35.66 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 110.323 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.699 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 52.0 mttt -128.62 134.73 26.6 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.024 -166.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.7 121.64 3.34 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.665 2.244 . . . . 0.0 112.125 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.922 HD11 ' HB3' ' A' ' 35' ' ' MET . 53.3 tp -98.03 111.68 23.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.794 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.9 mpt_? -98.22 116.22 29.98 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.506 175.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 49.8 mt -92.14 111.19 23.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.553 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.9 mt -106.6 120.26 57.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.767 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.428 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 173.15 -171.51 44.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.42 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.648 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 3.7 m-20 -65.14 141.69 98.35 Favored Pre-proline 0 C--N 1.33 -0.239 0 C-N-CA 122.149 0.18 . . . . 0.0 111.332 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.496 ' HA ' HG21 ' A' ' 2' ' ' THR . 96.7 Cg_exo -43.39 -54.2 3.73 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.873 3.049 . . . . 0.0 114.234 -174.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -61.13 -41.82 97.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.666 0.27 . . . . 0.0 111.579 -174.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.991 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 18.3 ptpt -77.44 -27.16 52.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.381 -173.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 56' ' ' ASP . 91.4 t -64.56 -32.06 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.986 175.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -73.04 -52.81 12.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -61.98 -37.84 86.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.554 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.562 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -72.25 -39.15 68.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.725 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.413 ' HA ' HG22 ' A' ' 67' ' ' VAL . 42.5 t -57.73 -35.29 70.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.268 0.556 . . . . 0.0 110.076 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.63 -40.93 76.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.774 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.562 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -78.11 -34.95 49.8 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.494 -176.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 33.1 m -67.92 -26.3 34.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 120.811 0.338 . . . . 0.0 110.614 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 66.3 mtt -81.4 -21.36 39.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.011 0.434 . . . . 0.0 109.897 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.85 -55.31 4.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.944 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.658 ' HB ' ' H ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -70.01 -19.71 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.397 0.617 . . . . 0.0 110.48 -177.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.658 HD12 HG21 ' A' ' 16' ' ' VAL . 3.1 tt -85.77 -16.33 39.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.19 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 68' ' ' MET . 8.2 ptm180 -69.83 -8.29 47.16 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.902 -0.136 . . . . 0.0 111.306 -174.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 10.3 tp10 -59.21 -94.87 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 O-C-N 123.586 0.554 . . . . 0.0 111.99 -172.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 37.8 ttp180 159.59 -59.74 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -86.97 147.15 25.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.272 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.664 ' HA ' HD23 ' A' ' 15' ' ' LEU . 29.7 tt0 -54.12 99.87 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.162 0.506 . . . . 0.0 110.834 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.39 -78.6 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.308 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 59.48 -117.26 10.57 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.658 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 90.7 m-85 -127.73 -55.32 1.31 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.496 ' O ' HG13 ' A' ' 70' ' ' ILE . . . 135.98 -79.97 0.31 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 82' ' ' ARG . 6.2 p-10 -103.25 2.78 34.74 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.828 0.823 . . . . 0.0 109.237 170.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 20.4 ttt180 86.86 -31.21 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.587 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.4 t30 51.5 71.99 0.41 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 18.0 tt0 -176.36 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.003 -171.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.854 ' HA ' HD12 ' A' ' 89' ' ' ILE . 34.8 p90 -171.88 -37.63 0.02 OUTLIER 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 175.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.57 -91.69 0.58 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.818 -175.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.991 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 46.1 p -117.16 -11.68 10.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.588 0.708 . . . . 0.0 111.01 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.712 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 46.9 mtt180 -113.65 -163.98 0.9 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.571 -169.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.854 HD12 ' HA ' ' A' ' 85' ' ' TYR . 75.6 mt 60.66 -84.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.678 0.611 . . . . 0.0 112.274 168.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.17 45.4 81.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.857 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.492 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 150.82 90.62 0.08 OUTLIER Glycine 0 CA--C 1.518 0.261 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.46 -149.64 18.71 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 23.7 pt -136.77 167.14 24.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 117.605 0.703 . . . . 0.0 111.107 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . 2.1 p30 -105.43 141.8 36.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.373 173.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.851 HG23 ' HB3' ' A' ' 138' ' ' ALA . 6.2 m -136.92 102.86 9.14 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.076 0.465 . . . . 0.0 111.451 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HB3' HD13 ' A' ' 137' ' ' ILE . 36.1 Cg_endo -67.2 107.86 1.44 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.893 2.395 . . . . 0.0 111.739 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 105' ' ' VAL . 7.6 p -105.79 131.2 21.95 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.247 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.428 ' HD2' HD22 ' A' ' 158' ' ' LEU . 84.6 Cg_exo -45.28 125.91 7.66 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.673 2.915 . . . . 0.0 113.104 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -61.46 -21.03 63.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.947 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -92.04 8.11 39.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.704 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 105' ' ' VAL . 41.7 m -141.88 0.44 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 106' ' ' ILE . 10.1 p -66.84 -33.37 62.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.393 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.18 -29.9 76.49 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.894 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.08 -40.22 58.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 109.988 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 97' ' ' VAL . 40.4 t -64.22 -41.6 92.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.303 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.738 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.1 mm -67.07 -49.28 74.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.487 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.38 69.16 1.42 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.126 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 57.43 -88.85 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.522 0.729 . . . . 0.0 112.309 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.0 t -97.69 18.81 14.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.987 0.422 . . . . 0.0 110.971 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.66 22.92 41.16 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.057 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -72.91 -43.91 61.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.047 0.451 . . . . 0.0 110.839 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.4 ' SD ' ' HD2' ' A' ' 115' ' ' LYS . 16.6 tpt -74.05 -40.29 62.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.632 -177.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.738 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.5 tp -66.47 -32.67 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.815 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -80.85 -22.63 39.72 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.991 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.4 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -66.76 -37.25 84.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.9 mt -63.28 -40.97 91.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 75.1 mt-30 -63.05 -32.85 74.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.29 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -84.6 -40.1 17.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.987 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.78 -42.04 28.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.361 -172.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.66 2.41 47.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.513 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.98 32.49 82.31 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.464 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.91 171.6 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.008 0.432 . . . . 0.0 111.263 -175.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.844 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 3.2 mmp_? -124.1 152.28 42.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.6 mm -117.08 133.47 63.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.087 0.47 . . . . 0.0 111.65 -175.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 23.8 tp60 -139.37 99.63 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.368 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -74.9 140.6 43.91 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 121.932 -0.48 . . . . 0.0 109.792 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.616 ' HD3' HH11 ' A' ' 88' ' ' ARG . 0.7 OUTLIER -153.11 138.2 17.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.146 -175.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.412 ' HB2' ' NH1' ' A' ' 88' ' ' ARG . 14.2 mm100 . . . . . 0 N--CA 1.467 0.416 0 O-C-N 123.438 0.461 . . . . 0.0 111.254 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 N--CA 1.464 -0.257 0 CA-C-O 120.883 0.285 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 98' ' ' PRO . 5.3 mp0 -121.86 159.93 25.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.043 0.449 . . . . 0.0 111.019 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -121.77 117.53 26.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.542 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.537 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 30.1 mm -71.42 102.45 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.244 0.545 . . . . 0.0 111.968 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.851 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -90.5 142.48 27.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.558 176.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.588 ' NE2' HG23 ' A' ' 89' ' ' ILE . 6.0 t-160 -91.23 115.66 28.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.658 HD13 ' HB3' ' A' ' 150' ' ' ALA . 47.3 mt -94.15 113.98 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.25 172.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.844 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 43.8 ttm -98.95 132.84 43.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.575 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.17 -175.14 31.74 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.925 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.93 145.91 75.9 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.681 2.254 . . . . 0.0 111.592 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.685 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 96.8 Cg_exo -44.68 -48.63 10.23 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.523 2.816 . . . . 0.0 113.869 -173.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.9 -38.69 79.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.936 0.398 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.56 -37.33 21.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.874 -174.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 29.4 p -57.74 -47.83 81.34 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -69.22 -32.95 72.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.683 0.277 . . . . 0.0 110.655 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -64.69 -27.78 69.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.658 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -77.19 -29.77 54.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.9 0.381 . . . . 0.0 110.704 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.69 -25.32 66.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.839 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -78.29 -20.32 51.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.469 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.5 mt -79.77 -39.89 20.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.28 0.562 . . . . 0.0 109.56 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.568 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 53.2 mt -71.17 -51.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.824 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -58.07 -32.21 67.82 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.995 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.24 -32.29 72.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.245 0.545 . . . . 0.0 110.462 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.8 -44.44 23.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.814 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 57.6 mt . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.117 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 14.0 m . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.853 0.358 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 22.4 m -124.85 145.77 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.27 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 73.1 mm-40 -130.42 150.78 51.49 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.55 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 43.6 mt-10 -111.21 121.93 46.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.908 0.385 . . . . 0.0 111.505 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.4 mp -106.06 140.58 23.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.404 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -87.37 110.09 20.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.444 -177.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.69 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -98.36 111.48 59.9 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.151 0.5 . . . . 0.0 111.084 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 7' ' ' MET . 37.1 Cg_exo -62.55 151.87 80.83 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.707 2.938 . . . . 0.0 112.789 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.36 133.45 46.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.4 -49.9 1.02 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -167.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 13.9 mptt -69.08 -32.71 72.35 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 170.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.677 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -50.99 -35.09 31.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.415 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.415 ' CA ' ' HG2' ' A' ' 19' ' ' LYS . . . -64.3 -38.05 95.34 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.489 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.3 pp -89.06 -21.17 23.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.711 0.255 . . . . 0.0 111.18 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.69 HG11 HG12 ' A' ' 8' ' ' ILE . 96.6 t -82.58 -41.35 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.828 HG21 ' HG3' ' A' ' 39' ' ' GLN . 11.2 pt -92.25 -22.68 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 121.52 -0.738 . . . . 0.0 110.912 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.676 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 92.69 16.55 48.37 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.377 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.415 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 66.0 mmtt 48.64 50.82 16.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.911 0.484 . . . . 0.0 111.297 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.91 -28.49 1.57 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.096 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.25 -13.94 2.78 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.006 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.812 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 1.2 mm-40 -43.7 -55.28 4.49 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.676 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 73.8 m -75.11 -35.11 61.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.49 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.78 HD11 HD21 ' A' ' 37' ' ' LEU . 1.7 tp -68.35 -26.78 34.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.613 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.812 ' HD3' ' HA ' ' A' ' 22' ' ' GLU . 14.3 mtpp -55.04 -51.89 64.88 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.483 0.659 . . . . 0.0 109.998 174.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.442 ' HB2' ' CG ' ' A' ' 81' ' ' ASP . 23.1 mt-30 -81.63 -31.72 32.27 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.887 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.634 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 83.8 mt -66.83 -23.43 66.04 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.742 -0.599 . . . . 0.0 110.479 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 24.1 mt-30 -84.81 -46.46 11.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.13 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.44 -56.69 3.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -175.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HA ' ' OE1' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -57.87 -41.97 83.58 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.144 0.497 . . . . 0.0 110.223 -178.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -86.79 -6.46 58.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.533 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.23 23.22 52.46 Favored Glycine 0 CA--C 1.517 0.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 113.52 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.0 m -132.21 153.88 39.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.893 0.377 . . . . 0.0 110.449 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -90.93 109.52 20.75 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.634 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 47.8 mtt -95.37 113.51 25.19 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 tp -110.96 106.87 21.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 122.027 0.918 . . . . 0.0 110.152 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.844 HD22 ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -132.99 142.12 48.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.254 -177.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.778 HG21 ' HB2' ' A' ' 43' ' ' GLN . 71.8 mt -86.14 101.6 10.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.726 0.298 . . . . 0.0 111.09 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.828 ' HG3' HG21 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -134.69 -26.51 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.291 177.018 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -88.16 -34.13 17.95 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.4 146.78 34.88 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.75 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -79.71 38.8 0.39 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.778 ' HB2' HG21 ' A' ' 38' ' ' ILE . 48.8 mt-30 -106.38 -49.6 3.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.111 0.482 . . . . 0.0 110.345 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -131.45 30.96 4.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.488 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -70.58 -40.28 73.37 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.022 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -93.84 -26.17 17.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.094 0.473 . . . . 0.0 110.288 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 48' ' ' ASP . 40.0 t -79.3 169.57 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.629 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' N ' HG12 ' A' ' 47' ' ' VAL . 3.4 p30 -60.28 151.95 26.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.985 0.421 . . . . 0.0 110.415 172.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 11.6 mptt -108.64 130.87 22.22 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.024 -171.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -88.88 103.95 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.685 2.257 . . . . 0.0 111.4 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.844 ' HG ' HD22 ' A' ' 37' ' ' LEU . 5.7 tt -87.92 109.7 19.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.868 -174.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.55 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.3 mpt_? -97.23 115.43 27.6 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.697 0.284 . . . . 0.0 110.51 175.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 72.7 mt -87.71 115.67 28.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.054 175.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.431 HG12 ' CG1' ' A' ' 3' ' ' VAL . 32.5 mt -104.13 120.74 54.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 172.22 -170.78 43.76 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.62 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.437 ' HB3' ' HD2' ' A' ' 59' ' ' LYS . 5.5 t70 -65.79 140.42 97.29 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.229 174.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -43.39 -49.45 7.52 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.252 2.635 . . . . 0.0 114.308 -176.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.38 -36.55 84.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.409 0.623 . . . . 0.0 110.204 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.577 ' HG2' ' HB2' ' A' ' 87' ' ' SER . 45.8 mttp -68.95 -44.0 73.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.9 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -59.3 -34.41 53.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.047 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.579 HE21 ' C ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -72.15 -52.2 17.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.545 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.798 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -59.93 -32.35 70.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.251 0.548 . . . . 0.0 110.477 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.73 -44.54 14.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.057 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.649 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.9 p -59.5 -33.9 71.92 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 111.272 -175.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.28 -32.78 61.13 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.239 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.593 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 14.2 ptt? -84.4 -32.82 23.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.344 -175.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.655 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 34.9 m -61.0 -31.79 50.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.425 175.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.649 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 36.6 mtm -81.26 -35.36 31.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 175.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.593 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 30.8 t70 -64.66 -40.66 95.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.205 -175.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 66' ' ' MET . 0.2 OUTLIER -87.79 -22.21 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.009 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.655 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -83.93 -24.41 30.72 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.298 -178.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.4 1.17 3.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 9.8 tp10 -58.07 150.5 20.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.799 173.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 74' ' ' ARG . 44.3 ttt-85 -79.49 59.43 2.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.312 0.577 . . . . 0.0 110.187 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 64.38 75.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.439 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -156.98 -71.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.931 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.474 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . -172.93 -36.53 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.768 -177.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.01 -97.99 2.22 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.988 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.51 -35.31 1.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.872 0.368 . . . . 0.0 111.039 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.55 67.61 0.64 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.442 ' CG ' ' HB2' ' A' ' 26' ' ' GLN . 5.8 m-20 61.97 30.7 18.09 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 122.026 0.917 . . . . 0.0 109.998 -174.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.534 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 35.5 ttt85 73.99 -40.23 0.45 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.035 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 t30 66.79 11.56 8.33 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.383 0.611 . . . . 0.0 110.601 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.721 ' HG3' ' O ' ' A' ' 92' ' ' GLY . 42.7 tt0 -115.83 -39.49 3.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.033 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.636 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 4.7 p90 -176.13 -157.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.697 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.675 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -176.2 -28.58 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.577 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 20.4 p -165.41 -48.63 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.593 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -73.66 173.36 9.88 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.034 169.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.8 ' HA ' ' CE1' ' A' ' 139' ' ' HIS . 65.5 mt 74.49 -77.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 O-C-N 123.538 0.524 . . . . 0.0 111.539 178.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.71 40.94 49.55 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.367 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.67 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 144.93 98.79 0.25 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.747 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 135.9 -138.79 10.19 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 29.6 pt -143.67 158.35 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 117.109 0.454 . . . . 0.0 110.493 173.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.585 ' OD2' HG21 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -93.4 117.84 30.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.021 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.953 HG21 HD12 ' A' ' 140' ' ' ILE . 75.2 t -116.8 95.29 46.19 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.719 -168.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.479 ' HA ' HD13 ' A' ' 137' ' ' ILE . 50.8 Cg_endo -72.22 113.51 3.72 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.037 1.825 . . . . 0.0 111.893 172.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.609 HG21 HG21 ' A' ' 105' ' ' VAL . 10.4 p -116.84 133.84 23.03 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -48.43 128.98 18.75 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.202 2.602 . . . . 0.0 112.226 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.872 ' HG2' ' HG3' ' A' ' 136' ' ' LYS . 14.7 mtp180 -63.5 -44.1 95.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.414 -171.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.02 6.44 3.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.871 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 104' ' ' VAL . 4.4 m -132.51 1.92 3.77 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.834 0.35 . . . . 0.0 110.761 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 99' ' ' ARG . 10.9 p -75.42 -19.7 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 110.671 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.77 -40.67 95.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.842 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 101' ' ' SER . 8.5 p -73.15 -29.03 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.337 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.609 HG21 HG21 ' A' ' 97' ' ' VAL . 64.6 t -66.94 -41.75 87.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.775 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.76 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 40.7 mm -72.51 -38.11 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.935 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.5 38.65 5.24 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.039 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.7 ttp-105 66.33 -75.36 0.05 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.215 0.606 . . . . 0.0 111.821 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.3 p -99.99 12.5 36.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.091 0.472 . . . . 0.0 110.694 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.72 40.49 7.18 Favored Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.203 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -91.91 -32.07 15.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.116 0.484 . . . . 0.0 110.412 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.552 ' O ' HG12 ' A' ' 116' ' ' ILE . 5.9 tpt -89.64 -41.56 11.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.521 -171.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.76 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 6.2 tp -59.81 -25.99 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.33 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' A' ' 114' ' ' LYS . 10.1 mmpt? -73.32 -45.33 55.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.924 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.95 -22.44 60.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.917 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 112' ' ' MET . 37.0 mm -59.42 -44.29 92.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.641 HE21 ' HB ' ' A' ' 124' ' ' ILE . 65.0 mt-30 -68.01 -25.5 65.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.26 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.7 -46.75 16.52 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.025 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -78.44 -52.68 8.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.317 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.558 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -81.07 -19.34 43.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.367 -176.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.35 26.35 63.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.629 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.3 m -95.84 161.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.377 0.608 . . . . 0.0 112.109 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.808 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 6.7 mpt_? -108.68 135.15 50.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.716 HG21 HD11 ' A' ' 113' ' ' ILE . 43.2 mm -116.29 129.83 72.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 1.047 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -143.51 169.56 17.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.186 168.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -117.29 104.28 10.99 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.898 ' HD2' ' HG3' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -94.83 -12.91 26.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -165.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.898 ' HG3' ' HD2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.557 0 C-N-CA 123.675 0.79 . . . . 0.0 109.055 173.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 87.6 Cg_endo . . . . . 0 N--CA 1.462 -0.326 0 CA-C-O 120.963 0.318 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -130.89 156.43 45.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.932 0.396 . . . . 0.0 111.028 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.872 ' HG3' ' HG2' ' A' ' 99' ' ' ARG . 48.9 mttm -110.03 118.51 36.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.485 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 10.6 mm -77.34 120.53 28.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.041 0.448 . . . . 0.0 112.207 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.69 36.18 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.47 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 1.047 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 12.7 t-160 -85.15 104.71 15.28 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.953 HD12 HG21 ' A' ' 95' ' ' VAL . 60.5 mt -88.35 118.27 33.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.221 170.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.808 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 41.4 ttm -109.49 127.39 54.39 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 158.56 -160.59 31.12 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.478 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 16.3 Cg_exo -68.73 139.99 45.52 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.786 2.324 . . . . 0.0 110.855 174.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 143' ' ' PRO . 75.8 Cg_exo -50.56 -32.54 35.58 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.138 3.225 . . . . 0.0 114.139 -172.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.82 -44.61 66.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.789 0.328 . . . . 0.0 110.556 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.558 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 55.7 mtt-85 -70.76 -27.72 64.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.291 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.747 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 71.2 m -57.41 -56.05 26.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.27 175.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.08 -31.81 68.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.36 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 146' ' ' ARG . 30.9 t60 -55.95 -33.1 64.43 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.265 0.555 . . . . 0.0 110.313 173.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.702 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.24 -45.01 24.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.506 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.19 -24.56 67.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.403 0.621 . . . . 0.0 110.304 176.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -76.58 -26.27 54.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.106 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.575 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 68.5 mt -78.21 -40.89 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 73.6 mt -59.55 -43.17 90.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.064 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -57.06 -39.34 74.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.011 0.434 . . . . 0.0 110.666 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -69.91 -33.09 71.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.303 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 70.3 mt -66.61 -40.41 88.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.087 0.47 . . . . 0.0 110.335 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 56.3 mt . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.854 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.431 HG21 ' HA ' ' A' ' 57' ' ' PRO . 24.0 m . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 121.302 0.572 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 12.1 p -125.65 121.98 61.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.858 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -109.99 150.74 28.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.759 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 39.1 mt-10 -116.06 123.36 47.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.439 0.638 . . . . 0.0 111.959 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -114.11 144.46 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.992 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.406 ' SD ' ' HB2' ' A' ' 48' ' ' ASP . 33.3 tpp -87.91 124.11 33.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.963 0.411 . . . . 0.0 111.514 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.7 mp -104.24 109.05 61.94 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.86 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.586 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 52.7 Cg_exo -61.29 147.25 96.08 Favored 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 123.596 2.864 . . . . 0.0 112.962 175.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.7 124.92 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.65 -39.14 2.99 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -169.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -79.71 -31.75 41.23 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.104 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.673 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -53.67 -34.34 58.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.881 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.03 -39.12 91.53 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.581 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.1 pp -89.7 -22.84 22.03 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.553 -0.381 . . . . 0.0 111.075 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.557 HG21 HD12 ' A' ' 71' ' ' LEU . 96.6 t -78.52 -46.83 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.729 HG13 ' H ' ' A' ' 19' ' ' LYS . 22.0 pt -91.2 -21.14 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.086 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.479 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.78 -0.73 59.44 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.759 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.729 ' H ' HG13 ' A' ' 17' ' ' ILE . 15.6 tptp 70.0 -52.33 0.63 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.975 0.91 . . . . 0.0 110.557 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.72 8.68 73.99 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.16 5.4 76.54 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.194 -0.526 . . . . 0.0 113.082 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.918 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 10.2 pt-20 -73.31 -27.57 61.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.487 HG23 ' C ' ' A' ' 80' ' ' GLY . 90.3 m -77.43 -43.67 31.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.899 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.555 ' HA ' HD12 ' A' ' 27' ' ' LEU . 6.2 tp -62.81 -24.21 35.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 CA-C-O 120.834 0.349 . . . . 0.0 110.525 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.918 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 77.9 mttt -60.85 -50.66 72.55 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.141 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.463 ' CB ' ' HB2' ' A' ' 81' ' ' ASP . 39.2 mt-30 -71.54 -31.75 67.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.107 -177.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 24' ' ' ILE . 47.7 mt -68.44 -27.58 66.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 110.611 176.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.1 mt-30 -84.65 -47.55 10.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.295 0.569 . . . . 0.0 110.565 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -84.02 -53.37 5.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.206 -171.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.679 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 26.3 ttm180 -65.6 -44.47 86.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -80.66 -7.19 59.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.316 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.77 9.34 38.74 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.763 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.2 m -109.15 172.16 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.95 0.375 . . . . 0.0 110.362 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -113.43 109.98 19.56 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.867 ' HB3' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -95.19 112.82 24.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.499 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.1 tp -111.11 100.67 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 122.392 1.091 . . . . 0.0 110.667 -177.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.896 ' HG ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -134.38 143.91 47.9 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.634 178.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.0 mp -62.51 100.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.886 0.374 . . . . 0.0 110.237 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -87.36 -77.21 0.34 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -104.85 86.68 2.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.224 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . -144.28 163.12 27.85 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.021 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 m -62.54 -28.74 70.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -82.16 -78.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.39 . . . . 0.0 111.77 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.625 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 76.2 m-20 -110.34 56.25 0.63 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.874 -171.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 9.3 t -80.19 -45.43 18.08 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -94.01 -26.52 16.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.824 0.821 . . . . 0.0 109.026 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.625 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 57.3 t -78.89 159.86 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.009 -175.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 47' ' ' VAL . 3.3 p-10 -55.94 151.33 11.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -126.71 129.83 23.98 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.509 -166.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.06 112.99 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.846 2.364 . . . . 0.0 112.108 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.896 HD22 ' HG ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -81.37 110.52 16.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.973 -176.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.573 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.6 mpt_? -98.77 107.46 19.91 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.42 174.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.3 mt -91.43 113.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.053 176.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.0 mt -103.77 123.12 57.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.806 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.4 -171.45 44.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.267 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 9.7 t70 -71.34 139.14 84.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.431 ' HA ' HG21 ' A' ' 2' ' ' THR . 30.3 Cg_exo -34.82 -47.06 0.62 Allowed 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 124.07 3.18 . . . . 0.0 114.99 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -61.81 -40.64 95.95 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.821 0.344 . . . . 0.0 111.281 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 56' ' ' ASP . 19.7 ptpt -82.14 -31.04 30.76 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.95 -175.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.98 -30.68 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.546 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -52.21 14.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.919 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -65.59 -23.68 66.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.708 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -81.21 -51.32 8.55 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.997 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.501 ' SG ' HD12 ' A' ' 53' ' ' ILE . 94.5 m -54.11 -40.81 67.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.272 0.558 . . . . 0.0 109.978 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -58.54 -53.28 60.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.822 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.668 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 6.6 ptt? -64.43 -40.81 96.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.89 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 63' ' ' ALA . 86.9 t -56.53 -47.64 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.531 0.205 . . . . 0.0 110.812 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.1 mtt -69.87 -26.9 64.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.956 0.408 . . . . 0.0 110.89 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.544 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -85.36 -27.91 25.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.78 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.7 pp -90.14 -32.64 5.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 O-C-N 121.71 -0.619 . . . . 0.0 111.788 175.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.588 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 4.2 tt -71.98 -12.5 61.27 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.604 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -67.36 -10.42 50.91 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.256 -0.278 . . . . 0.0 111.22 177.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.927 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 9.2 tp10 -56.57 131.13 47.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.136 0.494 . . . . 0.0 110.297 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 31.0 ptt180 -66.67 -44.57 81.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.888 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 29.1 t0 172.88 92.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.869 0.73 . . . . 0.0 109.54 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -176.19 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.926 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.927 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . 160.78 131.25 1.2 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.169 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -87.89 58.55 4.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.154 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.608 ' HD2' HG22 ' A' ' 70' ' ' ILE . 78.5 m-85 57.72 8.84 0.73 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.212 0.605 . . . . 0.0 112.416 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.487 ' C ' HG23 ' A' ' 23' ' ' THR . . . 70.06 7.34 59.41 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.581 -0.342 . . . . 0.0 113.087 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.679 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.2 OUTLIER 170.71 -62.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.107 0.479 . . . . 0.0 109.781 -172.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.78 ' HA ' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER 163.71 -45.02 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.446 -173.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 57.63 72.37 0.52 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.388 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 1.04 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 24.8 tt0 -171.34 -68.56 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.749 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.34 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.691 ' H ' ' HD2' ' A' ' 82' ' ' ARG . 0.9 OUTLIER -136.18 -95.7 0.24 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.527 -0.733 . . . . 0.0 111.926 178.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.571 ' H ' ' HD2' ' A' ' 85' ' ' TYR . . . 84.96 92.03 0.79 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 38.0 t 65.49 6.34 3.7 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.709 0.404 . . . . 0.0 110.893 -175.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.755 ' HG3' ' HD2' ' A' ' 127' ' ' LYS . 3.0 mmp_? -132.66 171.61 13.62 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.102 -173.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.98 HD11 ' HG2' ' A' ' 125' ' ' GLN . 24.3 mm 28.95 -83.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 125.725 1.891 . . . . 0.0 115.144 169.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.53 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 86.49 36.18 9.85 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -172.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.18 98.23 0.11 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.802 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 112.0 161.66 16.22 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -174.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.04 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 40.0 pt -93.98 158.77 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -172.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CG ' HG21 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -102.55 108.07 19.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.015 179.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 27.5 t -101.11 105.12 37.07 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.43 ' CA ' HD13 ' A' ' 137' ' ' ILE . 56.9 Cg_endo -75.06 108.12 2.64 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.047 1.832 . . . . 0.0 111.885 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.685 HG13 HD21 ' A' ' 158' ' ' LEU . 47.2 t -101.65 127.76 30.58 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.997 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.626 ' HD2' HD22 ' A' ' 158' ' ' LEU . 74.3 Cg_exo -41.59 132.97 3.72 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.803 3.002 . . . . 0.0 112.734 171.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' A' ' 134' ' ' PRO . 32.6 ptt180 -51.34 -34.92 35.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.562 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -92.5 4.69 53.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.352 -177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.6 m -122.44 -18.55 6.68 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.586 ' HA ' HG11 ' A' ' 97' ' ' VAL . 14.2 p -59.1 -34.1 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.623 0.249 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.53 -30.0 75.74 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.798 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.78 -33.79 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.055 0.455 . . . . 0.0 109.868 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.53 -36.09 76.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.01 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.752 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 37.7 mm -75.23 -46.04 39.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.266 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.45 -127.19 7.49 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 108' ' ' ARG . 4.2 mmp_? -100.39 -65.38 0.97 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.7 m -105.64 -20.96 13.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.514 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.17 50.18 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.127 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -93.86 -57.78 2.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.703 0.287 . . . . 0.0 110.472 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.573 ' HA ' ' HD3' ' A' ' 115' ' ' LYS . 14.2 tpt -59.82 -36.43 76.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.367 -174.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.752 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.6 tp -65.78 -32.39 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -86.43 -19.76 29.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.308 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.573 ' HD3' ' HA ' ' A' ' 112' ' ' MET . 26.5 mtpp -66.79 -35.68 80.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.297 174.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 112' ' ' MET . 30.1 mm -62.89 -38.51 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.198 0.523 . . . . 0.0 109.629 175.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -64.69 -34.01 77.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.675 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -82.36 -38.64 23.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.277 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.9 -55.8 4.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.002 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.85 -25.38 22.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.558 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.97 32.9 19.77 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.981 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 m -114.69 164.1 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.094 0.473 . . . . 0.0 111.449 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -109.87 163.17 13.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.641 HG21 HD11 ' A' ' 113' ' ' ILE . 45.3 mm -123.76 124.36 69.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.048 0.452 . . . . 0.0 111.492 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.98 ' HG2' HD11 ' A' ' 89' ' ' ILE . 50.5 tp60 -115.18 112.96 23.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.034 177.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.433 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 35.7 m-85 -87.64 106.04 17.76 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.365 0.602 . . . . 0.0 109.566 173.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.755 ' HD2' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -107.46 -159.28 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.753 -178.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.431 ' H ' ' HB2' ' A' ' 127' ' ' LYS . 7.2 tp-100 . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 121.298 0.57 . . . . 0.0 112.099 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.547 ' HB2' ' HD3' ' A' ' 99' ' ' ARG . 92.4 Cg_endo . . . . . 0 N--CA 1.461 -0.39 0 CA-C-O 120.941 0.309 . . . . 0.0 112.771 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.557 ' OE1' ' HA ' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -75.37 149.24 38.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 111.131 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -124.93 123.16 39.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.996 -175.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.696 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 40.0 mm -65.43 111.25 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.954 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -90.84 91.07 8.2 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 164.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 28.0 t60 -71.18 115.86 10.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.228 0.537 . . . . 0.0 111.08 -169.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.771 HD11 HD12 ' A' ' 154' ' ' ILE . 96.4 mt -79.74 107.79 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.222 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.493 ' HB2' ' HD2' ' A' ' 139' ' ' HIS . 21.9 ttp -103.96 128.12 51.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.13 -172.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.26 -156.4 27.21 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.41 137.79 44.22 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.669 2.246 . . . . 0.0 111.705 177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -45.56 -55.07 3.81 Favored 'Trans proline' 0 N--CA 1.474 0.378 0 C-N-CA 123.543 2.828 . . . . 0.0 113.978 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -64.52 -32.86 74.68 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.798 0.333 . . . . 0.0 111.03 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -72.5 -36.06 68.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.802 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 74.5 m -60.72 -54.5 44.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.44 174.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.584 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 4.7 mm-40 -54.97 -42.04 71.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.739 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -59.65 -31.61 69.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.401 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.67 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.22 -35.15 42.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.365 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -70.71 -18.71 62.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.644 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 9.8 mpt_? -77.57 -17.3 58.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.977 0.418 . . . . 0.0 109.975 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.93 -50.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.913 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.771 HD12 HD11 ' A' ' 140' ' ' ILE . 38.7 mt -71.64 -57.18 8.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.734 -173.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.409 ' HA ' HD12 ' A' ' 158' ' ' LEU . 3.9 m-20 -59.07 -28.65 66.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.881 0.372 . . . . 0.0 110.813 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.93 -47.32 80.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.428 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 4.4 pp -76.59 -20.91 56.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.326 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.685 HD21 HG13 ' A' ' 97' ' ' VAL . 33.6 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.198 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 57' ' ' PRO . 6.6 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 29.3 m -130.98 124.56 56.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 0.0 110.8 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -105.42 153.75 21.26 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.608 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 51.9 mt-10 -123.86 109.06 13.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.457 0.646 . . . . 0.0 111.677 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -105.59 139.02 28.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.7 tpp -91.01 122.35 33.6 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.716 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.696 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -95.53 113.76 62.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.749 -177.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -61.78 153.87 64.72 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.628 2.886 . . . . 0.0 112.459 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.74 144.66 55.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 171.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.42 -53.15 3.46 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -170.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -63.36 -35.11 79.29 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.372 172.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.675 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -49.12 -34.37 13.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.839 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -60.06 -44.34 97.37 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.615 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 75' ' ' ASP . 4.1 pp -85.48 -23.95 27.58 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.081 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.696 HG11 HG12 ' A' ' 8' ' ' ILE . 97.7 t -73.69 -42.9 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.681 HG13 ' H ' ' A' ' 19' ' ' LYS . 21.2 pt -91.56 -25.24 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 121.679 -0.638 . . . . 0.0 111.083 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.612 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 100.49 3.77 55.17 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.904 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.681 ' H ' HG13 ' A' ' 17' ' ' ILE . 7.6 tptm 53.82 48.13 22.05 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.542 0.687 . . . . 0.0 110.462 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.57 -1.48 0.52 Allowed Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.945 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.34 26.46 13.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.605 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -84.11 -60.12 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.988 0.423 . . . . 0.0 110.555 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.612 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 54.4 m -61.33 -44.52 97.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.359 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.57 HD12 HE21 ' A' ' 28' ' ' GLN . 0.3 OUTLIER -60.69 -31.4 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.032 0.444 . . . . 0.0 110.19 -177.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -39.01 93.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.264 177.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 30' ' ' ARG . 24.3 mt-30 -77.85 -39.53 43.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.269 0.557 . . . . 0.0 109.61 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.625 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 74.8 mt -64.0 -23.85 67.49 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.81 0.338 . . . . 0.0 110.61 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.692 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 68.8 mt-30 -85.89 -58.37 2.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.808 0.337 . . . . 0.0 111.751 174.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -82.59 -42.26 18.51 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -172.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.57 ' HG3' HG13 ' A' ' 137' ' ' ILE . 1.9 mtp180 -73.7 -38.72 64.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.83 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -84.39 -12.22 54.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.209 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.75 75.09 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.992 175.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 23.3 m -128.15 153.15 37.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.844 0.354 . . . . 0.0 110.675 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -90.13 110.14 21.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 1.014 ' HB3' HD21 ' A' ' 51' ' ' LEU . 48.9 mtt -96.25 124.58 40.31 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.446 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 6.1 tp -119.09 111.12 32.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.776 0.798 . . . . 0.0 110.217 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.724 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -134.15 144.35 48.48 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.829 -174.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.492 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 43.8 mm -68.19 104.48 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.05 0.452 . . . . 0.0 111.207 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 1.3 pp0? -146.71 20.85 1.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.64 0.733 . . . . 0.0 109.868 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.27 23.15 0.29 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.702 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . 82.33 -55.59 4.96 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.223 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.4 t -90.53 -157.9 0.51 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 62.04 -132.27 0.59 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.304 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.477 ' H ' HG21 ' A' ' 38' ' ' ILE . 93.8 m-20 -80.88 69.51 7.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.487 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 4.0 t -79.58 -44.96 20.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.904 0.383 . . . . 0.0 110.801 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -93.27 -3.54 53.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.161 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.11 159.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.913 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.02 156.22 36.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 18.2 mttm -131.06 128.35 22.24 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.301 -161.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.53 125.35 8.25 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.435 2.09 . . . . 0.0 112.021 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.014 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.5 tm? -105.88 120.42 41.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.603 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.608 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.7 mpt_? -102.98 121.61 42.9 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.395 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.9 mt -90.5 109.92 21.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.465 HG12 HG12 ' A' ' 3' ' ' VAL . 36.8 mt -104.92 119.33 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.524 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.45 -170.74 43.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.921 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -67.24 142.03 96.55 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HA ' HG21 ' A' ' 2' ' ' THR . 87.4 Cg_exo -46.29 -47.68 14.6 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.129 2.553 . . . . 0.0 113.931 -172.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.483 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 46.1 t80 -59.23 -40.71 86.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.151 0.5 . . . . 0.0 110.647 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -67.99 -45.49 73.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.093 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.6 t -58.33 -34.08 49.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.558 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -73.99 -40.51 62.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.737 0.303 . . . . 0.0 111.377 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.646 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 13.4 mm100 -72.99 -29.02 62.73 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.139 0.495 . . . . 0.0 110.268 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -85.65 -36.59 20.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.8 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.7 p -55.56 -43.4 75.83 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.96 0.41 . . . . 0.0 111.146 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.53 -38.85 81.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.593 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.803 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 4.9 ptt? -71.49 -34.27 70.0 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.598 -176.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 63' ' ' ALA . 89.4 t -56.99 -36.17 49.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 174.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 36.2 mtm -82.0 -28.34 32.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.449 0.642 . . . . 0.0 110.19 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 36.5 t70 -75.87 -41.29 52.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.311 -171.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.909 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.8 pp -89.63 -26.3 5.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 8' ' ' ILE . 5.8 tt -69.6 -24.27 63.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.673 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -19.94 59.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.591 -177.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 12.5 tp10 -51.19 -90.31 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.561 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 61.9 ttt180 168.08 -82.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.1 p-10 -168.52 12.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.828 172.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -86.46 -76.26 0.36 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.501 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -140.43 83.65 0.23 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.792 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.561 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -91.83 24.07 22.85 Favored Glycine 0 C--O 1.226 -0.388 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 175.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.725 ' HD2' HG22 ' A' ' 70' ' ' ILE . 54.6 m-85 69.05 -23.86 0.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.394 1.078 . . . . 0.0 113.56 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.496 ' C ' HG23 ' A' ' 23' ' ' THR . . . 84.14 15.4 69.61 Favored Glycine 0 C--N 1.328 0.129 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.399 177.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.423 ' HA ' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER 173.89 -65.69 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -174.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.909 ' HA ' HG21 ' A' ' 70' ' ' ILE . 32.3 ttt180 166.88 -18.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.906 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 79' ' ' PHE . 0.3 OUTLIER 67.66 42.7 1.98 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.025 176.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 28.9 tt0 -160.64 -52.56 0.05 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.472 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 46.0 p90 -176.71 171.7 2.22 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 110.075 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.682 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -132.95 -11.13 1.88 Allowed Glycine 0 CA--C 1.523 0.57 0 O-C-N 123.726 0.641 . . . . 0.0 112.28 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.646 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 18.0 p 178.28 -55.97 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.62 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 1.4 mpt_? -70.08 179.1 2.46 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.752 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.666 HG23 ' CD2' ' A' ' 139' ' ' HIS . 54.2 mt 78.36 -74.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.64 0.587 . . . . 0.0 111.136 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 46.91 46.73 19.65 Favored Glycine 0 C--N 1.337 0.609 0 O-C-N 123.41 0.444 . . . . 0.0 112.582 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 142.85 99.88 0.34 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.673 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 113.69 166.11 16.03 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -174.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 2.8 pp -93.66 -178.43 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.223 0.535 . . . . 0.0 112.253 -173.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.565 ' OD2' ' HD3' ' A' ' 96' ' ' PRO . 1.7 p-10 -109.74 147.01 33.96 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.142 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.895 HG23 ' HB3' ' A' ' 138' ' ' ALA . 3.5 m -137.56 97.14 10.48 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 121.229 0.537 . . . . 0.0 111.666 173.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HD3' ' OD2' ' A' ' 94' ' ' ASP . 37.2 Cg_endo -67.04 108.55 1.53 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.155 2.57 . . . . 0.0 111.692 173.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 102' ' ' VAL . 99.0 t -103.52 120.1 52.78 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.818 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -46.32 128.02 11.77 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.768 2.312 . . . . 0.0 110.872 170.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.71 -31.5 37.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -173.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -82.12 -9.76 59.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.968 0.413 . . . . 0.0 110.809 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -107.06 -19.1 13.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.514 ' HA ' HG11 ' A' ' 97' ' ' VAL . 94.6 t -48.31 -45.39 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.491 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.87 -22.13 61.9 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.986 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.7 t -86.51 -38.78 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.89 0.376 . . . . 0.0 110.075 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.6 t -66.61 -38.77 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 121.345 0.593 . . . . 0.0 109.904 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.762 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 38.9 mm -70.54 -43.36 77.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.562 174.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.92 66.92 1.39 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.726 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 108' ' ' ARG . 4.0 mpt_? 57.81 -94.81 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.061 0.544 . . . . 0.0 112.055 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.1 m -77.21 -13.29 59.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.399 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' A' ' 106' ' ' ILE . . . 109.11 22.38 6.9 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.992 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 12.8 pt-20 -85.45 -10.81 55.63 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.737 -0.272 . . . . 0.0 111.689 -176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.9 tpt -89.94 -40.8 12.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 0.0 110.421 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.762 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 11.0 tp -62.19 -25.32 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.449 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 45.6 mtpt -85.93 -22.05 27.61 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.605 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 61.1 mttp -68.51 -32.95 73.28 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.533 HG23 HD12 ' A' ' 153' ' ' ILE . 29.8 mt -63.65 -37.02 78.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.505 0.669 . . . . 0.0 109.43 174.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -73.04 -26.33 61.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.858 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -87.56 -41.24 13.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.024 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.1 -51.33 10.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.185 -174.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.584 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -92.77 -11.05 34.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.084 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.42 31.65 68.37 Favored Glycine 0 C--O 1.229 -0.196 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.484 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.65 -177.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.036 0.446 . . . . 0.0 111.909 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.631 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 55.1 ttt180 -132.57 143.2 49.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.177 176.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.565 HG21 HD11 ' A' ' 113' ' ' ILE . 47.0 mm -110.86 142.84 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.041 0.448 . . . . 0.0 112.164 -171.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 2.2 tt0 -148.34 114.38 5.8 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.281 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.401 ' CE1' HD11 ' A' ' 106' ' ' ILE . 36.6 m-85 -79.45 111.21 15.48 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.803 -0.56 . . . . 0.0 109.635 175.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -121.34 112.91 19.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.369 -174.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 128' ' ' GLN . 9.2 mm100 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 121.224 0.535 . . . . 0.0 110.984 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.476 0.483 0 N-CA-C 115.249 1.211 . . . . 0.0 115.249 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -94.46 134.66 36.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.581 0.705 . . . . 0.0 112.358 -169.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -110.88 120.8 43.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.804 -177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.57 HG13 ' HG3' ' A' ' 30' ' ' ARG . 9.1 mm -72.34 116.37 14.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.808 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.895 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -105.09 143.12 33.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.199 0.523 . . . . 0.0 111.417 174.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.666 ' CD2' HG23 ' A' ' 89' ' ' ILE . 10.4 t-160 -86.38 125.58 33.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.902 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.675 HD12 HD11 ' A' ' 93' ' ' ILE . 30.6 mt -106.91 107.8 23.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.805 170.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.631 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 37.0 ttm -95.59 129.69 42.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.151 -175.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.64 -167.79 36.56 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.633 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.12 143.44 78.15 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.489 2.126 . . . . 0.0 110.811 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.32 -48.17 8.41 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 124.023 3.148 . . . . 0.0 113.758 -173.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -61.79 -47.81 83.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.32 0.581 . . . . 0.0 110.945 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 49.7 mtt180 -69.51 -22.38 63.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.307 -176.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.673 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 77.8 m -59.22 -52.31 66.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.249 0.547 . . . . 0.0 110.003 174.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -74.39 -31.71 62.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.731 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 146' ' ' ARG . 9.4 t60 -62.49 -29.91 70.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.243 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.556 ' HB3' HG21 ' A' ' 140' ' ' ILE . . . -80.17 -38.85 30.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.506 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.3 -23.82 66.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.302 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 149' ' ' HIS . 13.5 ptt180 -76.62 -25.14 53.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -174.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.568 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 62.5 mt -68.82 -41.46 82.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.529 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.8 -40.74 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.057 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -57.8 -45.79 85.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.458 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -57.84 -37.31 73.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.926 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 77.4 mt -65.36 -50.77 64.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.545 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 mt . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 121.217 0.532 . . . . 0.0 110.192 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.762 HG22 HG12 ' A' ' 54' ' ' ILE . 20.6 t -142.8 112.65 2.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.688 166.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 16.6 mm100 -123.85 159.59 29.27 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 176.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 48.7 mt-10 -116.88 129.15 55.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.17 0.51 . . . . 0.0 111.35 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.799 HD11 ' HA ' ' A' ' 64' ' ' CYS . 74.5 mt -111.43 145.97 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.54 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.21 110.29 20.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.835 0.35 . . . . 0.0 111.427 -175.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.9 mp -106.42 106.39 57.33 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.276 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.82 163.95 37.3 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.793 2.329 . . . . 0.0 111.342 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.85 145.3 56.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.47 -56.57 2.0 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -172.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -68.93 -27.91 66.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.827 0.346 . . . . 0.0 110.481 175.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.614 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -53.52 -35.37 60.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.133 174.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.705 ' HA3' ' HE3' ' A' ' 19' ' ' LYS . . . -63.37 -47.69 85.36 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.846 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 73' ' ' GLU . 2.7 pp -78.68 -19.16 53.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.2 0.5 . . . . 0.0 111.407 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.403 ' N ' HD12 ' A' ' 15' ' ' LEU . 74.8 t -78.41 -40.24 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.764 0.316 . . . . 0.0 111.151 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 13' ' ' ALA . 30.9 pt -88.86 -29.48 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.075 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.521 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.9 16.8 32.18 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.705 ' HE3' ' HA3' ' A' ' 14' ' ' GLY . 33.4 mmtp 55.44 47.07 21.93 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.006 0.522 . . . . 0.0 110.867 -175.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.11 -35.83 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.35 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 152.87 -12.43 0.62 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.295 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.526 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 20.1 mm-40 -45.26 -49.81 12.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.521 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 26.1 m -81.29 -34.89 31.69 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.435 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 21' ' ' GLY . 7.3 tp -64.91 -26.92 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.012 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 84.4 mttt -55.19 -53.6 54.0 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.913 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.511 HE21 ' HB2' ' A' ' 81' ' ' ASP . 23.2 mt-30 -66.14 -45.08 82.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.592 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.618 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 95.7 mt -59.87 -29.13 68.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.897 0.38 . . . . 0.0 111.124 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.712 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 27.5 mt-30 -85.89 -49.81 7.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.147 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.63 -51.78 5.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.656 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 15.2 ttm180 -65.14 -42.83 93.44 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -80.89 -29.66 35.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.557 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.73 0.92 85.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.351 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 34.6 m -112.87 151.45 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -91.39 109.66 20.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.607 ' HB3' HD21 ' A' ' 51' ' ' LEU . 41.6 mtt -95.61 114.05 25.77 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.625 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.5 tp -113.12 109.63 29.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.99 0.9 . . . . 0.0 109.532 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.86 HD13 HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -124.11 136.86 54.52 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.45 -174.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.697 HG22 ' HD2' ' A' ' 50' ' ' PRO . 10.8 tp -76.15 100.8 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 122.012 0.91 . . . . 0.0 110.014 -174.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 41' ' ' GLY . 21.6 tm0? -132.09 135.1 46.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.084 -173.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 t70 72.52 -23.81 0.2 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.82 0.848 . . . . 0.0 111.874 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 39' ' ' GLN . . . -68.24 155.81 53.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.203 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -74.28 76.17 1.84 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.066 0.46 . . . . 0.0 111.415 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -160.98 -62.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.158 176.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -131.68 53.71 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 110.439 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -83.08 -41.53 18.5 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.714 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -91.61 -4.2 55.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.386 0.612 . . . . 0.0 109.875 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 48' ' ' ASP . 40.3 t -108.45 165.03 5.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.519 -173.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.453 ' N ' HG12 ' A' ' 47' ' ' VAL . 5.0 p-10 -58.14 150.58 20.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.123 0.487 . . . . 0.0 110.289 171.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -126.99 127.43 24.37 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.101 -169.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.697 ' HD2' HG22 ' A' ' 38' ' ' ILE . 83.3 Cg_endo -81.18 108.18 1.98 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.74 2.294 . . . . 0.0 112.09 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.86 HD12 HD13 ' A' ' 37' ' ' LEU . 9.6 tt -84.17 117.55 23.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.841 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 36' ' ' ILE . 1.5 mpt_? -91.42 112.22 24.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.107 0.254 . . . . 0.0 110.964 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.751 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 62.5 mt -89.12 113.02 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.057 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.762 HG12 HG22 ' A' ' 3' ' ' VAL . 30.3 mt -104.55 118.17 51.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.493 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 176.52 -170.9 43.83 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.393 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.468 ' O ' HG23 ' A' ' 60' ' ' VAL . 9.3 m-20 -65.11 147.38 98.58 Favored Pre-proline 0 N--CA 1.462 0.156 0 C-N-CA 122.46 0.304 . . . . 0.0 110.507 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.89 -52.41 8.94 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.112 2.542 . . . . 0.0 114.613 -173.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.437 ' HE2' ' HG2' ' A' ' 88' ' ' ARG . 17.5 p90 -63.17 -27.07 69.12 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.949 0.404 . . . . 0.0 110.571 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 91.7 mttt -72.46 -50.52 25.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.555 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 56' ' ' ASP . 22.0 t -59.93 -34.95 57.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.03 -176.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -66.3 -51.19 59.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 12.2 mm100 -64.83 -37.71 88.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 110.38 -177.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.596 ' HB2' ' OG ' ' A' ' 87' ' ' SER . . . -69.19 -40.38 78.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.751 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.799 ' HA ' HD11 ' A' ' 6' ' ' ILE . 54.0 t -52.41 -43.4 64.77 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.209 0.528 . . . . 0.0 110.208 177.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 37.9 tt0 -71.1 -46.14 62.32 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.587 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.587 ' SD ' ' HA ' ' A' ' 63' ' ' ALA . 3.8 ptt? -65.35 -39.69 92.69 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.494 -171.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.774 ' HB ' HD13 ' A' ' 6' ' ' ILE . 90.4 t -62.32 -50.19 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.367 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.542 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 56.4 mtp -63.32 -30.29 71.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.05 0.452 . . . . 0.0 110.586 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -73.37 -40.24 64.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.898 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.855 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.9 pp -86.67 -24.29 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.684 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.751 HD23 HG12 ' A' ' 67' ' ' VAL . 3.6 pp -83.09 -0.38 48.83 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.37 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 11.9 ptm180 -50.92 -42.8 59.74 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.746 ' HB2' HD21 ' A' ' 15' ' ' LEU . 27.1 tt0 60.07 110.84 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 124.373 1.046 . . . . 0.0 113.107 174.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -107.67 -39.17 5.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -140.66 50.58 1.66 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 59.49 68.2 0.82 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.18 0.514 . . . . 0.0 111.571 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.32 -40.62 0.24 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.652 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 76.48 -96.7 1.15 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.182 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.596 ' HD2' ' HA ' ' A' ' 70' ' ' ILE . 97.2 m-85 -144.47 -29.95 0.47 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.851 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.72 100.48 0.64 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.511 ' HB2' HE21 ' A' ' 26' ' ' GLN . 27.1 t70 68.79 -72.75 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -169.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.855 ' HA ' HG21 ' A' ' 70' ' ' ILE . 26.6 ttt180 178.26 -29.36 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.483 169.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t30 66.96 16.04 10.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.195 0.998 . . . . 0.0 109.479 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.962 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 74.6 mt-10 -129.12 -31.29 2.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.787 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.729 ' CB ' ' HB ' ' A' ' 89' ' ' ILE . 30.0 p90 176.98 152.68 0.2 Allowed 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.385 172.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.559 ' C ' ' HA ' ' A' ' 31' ' ' ALA . . . -117.53 106.31 1.38 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.404 168.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.804 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 43.4 m 51.51 35.64 14.94 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.7 ' HB3' HD12 ' A' ' 89' ' ' ILE . 11.8 mtt180 -166.12 -162.36 0.54 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.729 ' HB ' ' CB ' ' A' ' 85' ' ' TYR . 2.8 mp 63.97 -77.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 124.039 0.837 . . . . 0.0 111.806 173.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 57.51 48.06 83.76 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.65 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 144.91 81.27 0.05 OUTLIER Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.292 -0.48 . . . . 0.0 111.92 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 141.37 -150.16 21.65 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.962 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 47.9 pt -136.56 167.34 24.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 116.9 0.35 . . . . 0.0 111.219 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.656 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 3.5 p30 -108.59 139.22 43.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 171.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.881 HG23 ' HB3' ' A' ' 138' ' ' ALA . 11.8 m -133.35 95.48 18.19 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 121.107 0.48 . . . . 0.0 111.277 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 19.9 Cg_endo -62.54 108.31 0.7 Allowed 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.692 2.261 . . . . 0.0 111.071 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.463 ' HA ' ' HD2' ' A' ' 98' ' ' PRO . 12.8 p -110.27 125.02 31.85 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.955 0.407 . . . . 0.0 111.102 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 97' ' ' VAL . 5.5 Cg_endo -48.64 124.06 10.4 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.221 2.614 . . . . 0.0 111.774 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -63.64 -20.94 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.706 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -83.7 -0.87 52.61 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.785 0.326 . . . . 0.0 110.775 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.9 m -129.63 -2.43 4.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.653 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.95 -24.78 24.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 110.592 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.96 -28.88 66.82 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.394 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.1 t -77.14 -37.61 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.083 0.468 . . . . 0.0 110.388 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.1 t -71.02 -37.31 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.609 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.6 mm -80.19 -38.87 18.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.52 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.68 -104.33 2.9 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.037 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -138.32 -66.58 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.704 0.288 . . . . 0.0 110.395 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.7 m -88.76 -3.78 58.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.344 0.592 . . . . 0.0 110.297 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.95 31.08 7.9 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.41 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -92.81 -26.81 17.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.765 0.317 . . . . 0.0 110.358 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.518 ' SD ' ' HD3' ' A' ' 115' ' ' LYS . 16.3 tpt -69.63 -36.55 76.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.375 0.607 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.427 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 4.6 tp -70.36 -32.93 52.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.913 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -73.53 -28.31 61.82 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.508 0.67 . . . . 0.0 109.421 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.518 ' HD3' ' SD ' ' A' ' 112' ' ' MET . 21.0 tttp -68.77 -31.87 71.21 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.65 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.5 mm -62.28 -36.87 76.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.679 0.752 . . . . 0.0 109.055 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.665 HE21 HG12 ' A' ' 124' ' ' ILE . 66.2 mt-30 -72.56 -22.19 61.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.557 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 115' ' ' LYS . 92.1 m-20 -79.52 -30.57 41.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.945 0.403 . . . . 0.0 110.803 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.36 -55.86 4.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.587 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -101.02 -28.97 12.43 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.922 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 117' ' ' GLN . . . 88.23 74.29 1.28 Allowed Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.681 -175.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 150' ' ' ALA . 18.6 m -134.23 166.95 27.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.683 0.278 . . . . 0.0 110.927 -175.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.816 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 23.5 ttt180 -122.27 138.81 54.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.665 HG12 HE21 ' A' ' 117' ' ' GLN . 50.8 mm -112.81 136.3 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -169.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.754 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 3.9 tp-100 -132.43 138.45 47.65 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.365 174.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -111.68 113.88 26.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.558 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -128.55 152.78 47.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.929 -173.127 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 . . . . . 0 C--O 1.235 0.316 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.723 177.32 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 C--O 1.234 0.293 0 CA-C-O 121.033 0.347 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 98' ' ' PRO . 3.0 mp0 -111.48 153.98 25.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.899 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.4 ' O ' HG12 ' A' ' 97' ' ' VAL . 22.7 mtpp -109.96 113.23 25.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.367 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.558 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 17.5 mm -68.86 105.71 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.113 0.482 . . . . 0.0 111.123 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.881 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -94.77 141.4 28.67 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.368 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -96.65 113.61 25.19 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.182 176.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.639 HD13 ' HB3' ' A' ' 150' ' ' ALA . 48.0 mt -93.22 119.6 41.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.634 173.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.816 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 38.0 ttm -105.89 137.77 43.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.445 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.48 179.34 26.17 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.318 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 74.1 Cg_exo -52.36 149.17 23.69 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.927 2.418 . . . . 0.0 111.824 175.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.6 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 76.8 Cg_exo -51.34 -27.69 24.58 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.684 2.923 . . . . 0.0 113.684 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 12.5 t70 -76.97 -46.42 24.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.06 0.457 . . . . 0.0 109.84 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -60.45 -47.3 86.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.912 -177.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 17.7 p -57.58 -56.5 21.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.777 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -68.45 -23.46 64.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.814 0.34 . . . . 0.0 111.463 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.477 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 4.6 t60 -70.41 -30.37 67.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.134 0.492 . . . . 0.0 109.673 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.639 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.09 -41.66 28.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.926 -177.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.22 -32.02 69.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.04 0.448 . . . . 0.0 110.857 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -76.98 -19.48 57.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.381 -177.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 149' ' ' HIS . 63.3 mt -81.08 -43.06 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.309 0.576 . . . . 0.0 109.575 174.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.3 mt -63.42 -46.94 93.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.572 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -60.14 -35.63 75.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.384 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.42 -40.45 86.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.14 0.495 . . . . 0.0 110.125 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.39 -41.0 81.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.625 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 51.2 mt . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 121.151 0.501 . . . . 0.0 110.579 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 57' ' ' PRO . 16.2 m . . . . . 0 C--O 1.223 -0.295 0 CA-C-O 121.189 0.519 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 17.9 m -101.06 134.58 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.34 0.591 . . . . 0.0 111.196 -177.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -125.63 155.39 40.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.904 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 46.8 mt-10 -113.45 117.27 31.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.328 0.585 . . . . 0.0 112.104 -173.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -105.68 142.4 18.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.754 175.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.527 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 48.0 tpp -91.94 125.51 36.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.681 0.277 . . . . 0.0 110.899 -176.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 51' ' ' LEU . 3.5 mp -96.84 106.02 27.6 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.644 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.801 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 23.9 Cg_exo -67.37 148.37 79.46 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.936 2.424 . . . . 0.0 111.531 175.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.59 134.39 54.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 76' ' ' GLN . . . 102.99 -36.25 4.44 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -170.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.944 ' HG3' HD12 ' A' ' 15' ' ' LEU . 12.6 mptt -82.42 8.46 11.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.961 0.41 . . . . 0.0 110.363 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -59.02 -39.84 83.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.914 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 18' ' ' GLY . . . -69.15 -15.34 69.68 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.265 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.944 HD12 ' HG3' ' A' ' 12' ' ' LYS . 16.2 mt -90.67 -40.93 11.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.917 -0.142 . . . . 0.0 111.235 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.711 HG21 HG13 ' A' ' 8' ' ' ILE . 61.8 t -92.84 -51.16 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.701 HG13 ' H ' ' A' ' 19' ' ' LYS . 17.3 pt -91.51 -28.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.075 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . 89.84 15.81 57.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.185 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.701 ' H ' HG13 ' A' ' 17' ' ' ILE . 66.6 mmtt 67.36 -58.28 0.42 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.417 0.687 . . . . 0.0 111.704 -177.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.19 -5.9 75.68 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.501 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.94 4.36 54.37 Favored Glycine 0 C--O 1.229 -0.213 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.757 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.747 ' HA ' ' CD ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -73.39 -28.77 62.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -175.148 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.615 HG21 ' O ' ' A' ' 15' ' ' LEU . 91.5 m -71.53 -41.27 69.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.252 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 35' ' ' MET . 6.9 tp -65.56 -27.45 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.151 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.747 ' CD ' ' HA ' ' A' ' 22' ' ' GLU . 11.9 mtpp -57.79 -49.5 76.42 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -72.84 -35.99 67.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.102 -175.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.485 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 98.1 mt -66.01 -27.69 68.31 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 121.837 -0.539 . . . . 0.0 110.382 176.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.752 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.6 mt-30 -84.88 -52.88 5.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.421 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -84.28 -56.38 3.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -174.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HE ' ' HB3' ' A' ' 30' ' ' ARG . 3.5 ttp180 -56.27 -42.28 77.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.864 0.364 . . . . 0.0 110.461 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -87.65 -29.83 20.88 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.368 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.47 10.37 70.76 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.26 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.6 m -117.31 152.04 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.743 0.306 . . . . 0.0 110.3 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -96.56 110.98 23.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 46.4 mtt -94.81 125.79 39.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.0 tp -117.6 114.5 45.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.886 0.85 . . . . 0.0 109.941 -177.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.656 HD22 ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -132.82 142.94 49.23 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.676 -175.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.43 HD13 ' HG2' ' A' ' 50' ' ' PRO . 2.0 mp -61.62 112.84 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.17 0.51 . . . . 0.0 110.882 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.427 ' OE1' HD13 ' A' ' 17' ' ' ILE . 22.2 mm-40 -125.26 -53.51 1.61 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.067 176.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.29 72.17 9.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.541 0.686 . . . . 0.0 109.588 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.13 106.02 0.24 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.563 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.9 t -79.2 65.22 4.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.588 0.708 . . . . 0.0 111.103 -173.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -131.41 -52.25 1.01 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.187 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.634 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.7 m-20 -113.32 47.09 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.358 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 p -78.37 -48.55 15.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.991 0.424 . . . . 0.0 110.825 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -93.23 -11.8 31.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.587 0.708 . . . . 0.0 109.417 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 50.1 t -88.92 162.65 2.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.815 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' N ' HG12 ' A' ' 47' ' ' VAL . 4.2 m-20 -61.85 154.12 26.9 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 39.4 mttp -127.28 144.31 50.25 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.874 -170.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HG2' HD13 ' A' ' 38' ' ' ILE . 83.3 Cg_endo -92.08 122.11 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.81 2.34 . . . . 0.0 112.886 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.941 ' HB2' HD11 ' A' ' 8' ' ' ILE . 8.4 tt -101.56 126.23 48.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.7 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 36' ' ' ILE . 3.3 mpt_? -107.92 121.1 44.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.691 0.282 . . . . 0.0 110.287 174.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 61.6 mt -89.47 117.3 32.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.174 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.4 mt -103.84 120.31 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.97 -171.05 43.93 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.336 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 18.9 m-20 -71.63 146.77 91.57 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 122.459 0.303 . . . . 0.0 110.504 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.582 ' HA ' HG21 ' A' ' 2' ' ' THR . 99.8 Cg_exo -44.33 -51.24 7.07 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.463 2.775 . . . . 0.0 113.7 -175.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -60.58 -49.61 76.85 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.756 0.312 . . . . 0.0 111.223 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.025 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 5.3 ptpp? -72.73 -23.55 60.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.926 -175.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 2' ' ' THR . 71.4 t -71.22 -43.04 74.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -58.17 9.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.78 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.72 -21.62 66.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.598 -174.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -85.36 -39.17 17.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.463 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 68' ' ' MET . 37.9 t -56.59 -50.56 71.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.606 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.54 -33.54 75.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.083 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.843 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 18.2 ptt? -79.57 -36.21 38.58 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.738 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 63' ' ' ALA . 69.9 t -56.27 -44.57 79.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 57.1 mtp -66.63 -32.57 73.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.566 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.456 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 35.2 t70 -85.24 -28.71 25.2 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -88.82 -21.69 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.098 -1.001 . . . . 0.0 110.438 173.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.499 HD12 ' CG2' ' A' ' 16' ' ' VAL . 5.8 tt -82.08 -26.29 33.78 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.354 178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -61.05 -13.95 20.3 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.67 ' HG3' ' H ' ' A' ' 75' ' ' ASP . 9.0 tp10 -55.47 135.28 50.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.217 0.532 . . . . 0.0 111.684 -175.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -75.72 -19.1 59.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.587 0.708 . . . . 0.0 109.578 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.67 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 10.8 m-20 -106.39 -174.8 2.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.632 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 11' ' ' GLY . 48.2 mt-30 -94.91 41.03 1.09 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.85 45.4 1.17 Allowed Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.705 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.707 ' H ' HD22 ' A' ' 15' ' ' LEU . . . -67.33 178.63 17.26 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 172.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.479 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 86.5 m-85 -68.32 -31.57 71.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.283 0.541 . . . . 0.0 111.581 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 23' ' ' THR . . . 101.45 -2.64 53.74 Favored Glycine 0 CA--C 1.508 -0.348 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 82' ' ' ARG . 1.6 p30 -179.17 -63.54 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.843 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 6.8 ttt85 173.41 -29.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.241 165.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.506 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 4.1 t30 52.33 65.77 1.41 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.937 0.399 . . . . 0.0 110.373 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 1.041 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 30.5 tt0 176.28 -47.54 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.754 0.787 . . . . 0.0 109.844 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.796 ' HA ' ' NE2' ' A' ' 139' ' ' HIS . 36.4 p90 -173.78 157.98 3.17 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.43 175.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -143.03 95.42 0.18 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 1.025 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 67.8 m 70.75 -52.64 0.67 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.691 ' HD3' HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -67.6 -82.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.078 0.466 . . . . 0.0 111.738 -175.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.691 HD13 ' HD3' ' A' ' 88' ' ' ARG . 41.3 mm -54.34 -88.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -168.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.42 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 89.73 78.42 1.33 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -169.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.24 94.2 2.1 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.232 -0.508 . . . . 0.0 112.063 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.725 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 148.94 -144.06 11.69 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.041 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 49.9 pt -152.43 158.13 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 117.476 0.638 . . . . 0.0 110.057 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -105.27 140.71 38.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.981 0.42 . . . . 0.0 110.53 175.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 2.8 t -137.45 116.72 10.17 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.659 -176.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.61 107.75 2.25 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.013 1.809 . . . . 0.0 111.629 169.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG13 HD21 ' A' ' 158' ' ' LEU . 40.9 t -99.17 126.14 39.05 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.945 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.691 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 74.1 Cg_exo -43.69 130.68 7.47 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.662 2.908 . . . . 0.0 113.13 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 33.1 ptt180 -60.24 -24.22 64.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.025 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 98' ' ' PRO . 12.6 p80 -92.81 20.34 6.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.729 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 105' ' ' VAL . 14.6 t -145.79 -31.46 0.38 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.126 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -49.38 -37.66 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.24 -28.95 63.06 Favored Glycine 0 C--O 1.235 0.178 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.925 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.7 t -75.11 -35.07 33.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.027 0.441 . . . . 0.0 109.873 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 101' ' ' SER . 66.9 t -59.59 -40.05 81.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.905 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.785 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.3 mm -72.95 -37.71 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.389 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.93 34.57 21.17 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 65.66 -76.73 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.514 0.725 . . . . 0.0 111.399 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.2 p -93.73 9.62 36.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.868 0.366 . . . . 0.0 111.662 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.411 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 94.34 8.12 60.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.892 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -65.26 -32.2 73.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 110.913 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.405 ' SD ' ' HD3' ' A' ' 115' ' ' LYS . 15.4 tpt -89.93 -37.85 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.817 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.785 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.2 tp -64.98 -27.97 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.084 0.469 . . . . 0.0 110.382 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -72.58 -21.86 61.08 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.182 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.405 ' HD3' ' SD ' ' A' ' 112' ' ' MET . 27.6 mtpp -71.57 -33.84 69.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.732 0.301 . . . . 0.0 110.543 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.576 HG23 HD12 ' A' ' 153' ' ' ILE . 32.3 mt -67.92 -40.38 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 0.0 109.469 176.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -70.02 -28.21 65.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.437 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -79.52 -37.52 36.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.9 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -79.57 -55.16 5.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.578 -176.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.96 -15.01 26.75 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.55 32.5 57.5 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.881 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.546 ' CG1' ' HB3' ' A' ' 146' ' ' ARG . 14.9 m -102.98 159.15 4.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.216 0.531 . . . . 0.0 112.103 -173.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.921 ' HB2' ' HB2' ' A' ' 141' ' ' MET . 65.3 mtm180 -101.26 144.09 30.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.223 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 113' ' ' ILE . 51.2 mm -116.79 121.54 67.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.584 ' HB2' ' SD ' ' A' ' 141' ' ' MET . 5.9 tp-100 -123.94 111.14 15.69 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.604 ' CE1' HD11 ' A' ' 106' ' ' ILE . 27.4 m-85 -87.53 133.26 33.8 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.561 0.696 . . . . 0.0 110.104 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.571 ' HD3' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -157.03 -166.25 2.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.381 -171.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.422 HE21 ' HB2' ' A' ' 128' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.491 0 O-C-N 123.426 0.454 . . . . 0.0 111.813 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 14.2 Cg_exo . . . . . 0 N--CA 1.464 -0.234 0 CA-C-O 120.893 0.289 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.691 ' OE2' ' HA ' ' A' ' 98' ' ' PRO . 1.3 mp0 -94.73 154.17 17.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.972 0.415 . . . . 0.0 111.248 -174.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.79 124.73 46.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.328 0.585 . . . . 0.0 111.359 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 44.8 mm -63.3 115.8 2.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.295 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.75 132.45 38.12 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 164.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.796 ' NE2' ' HA ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -108.34 115.24 29.74 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.676 -177.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.718 HG21 ' HA ' ' A' ' 147' ' ' CYS . 82.7 mt -83.85 137.58 20.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.522 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.921 ' HB2' ' HB2' ' A' ' 123' ' ' ARG . 31.2 mtp -120.42 129.26 53.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.066 -176.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.75 -167.03 28.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.635 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.763 ' HB2' ' HD3' ' A' ' 146' ' ' ARG . 32.8 Cg_exo -61.0 147.28 96.19 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.085 2.524 . . . . 0.0 112.195 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.773 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 52.0 Cg_exo -57.04 -18.65 29.46 Favored 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 123.955 3.104 . . . . 0.0 113.817 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.94 -30.17 26.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.326 0.584 . . . . 0.0 110.178 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.763 ' HD3' ' HB2' ' A' ' 143' ' ' PRO . 8.4 mpt_? -84.13 -44.12 14.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.408 -174.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.773 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 10.6 p -53.85 -55.1 29.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.011 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.431 ' OE2' HG21 ' A' ' 93' ' ' ILE . 38.5 mm-40 -62.65 -37.87 88.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.48 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.412 ' O ' HG13 ' A' ' 153' ' ' ILE . 15.7 t60 -65.49 -26.76 68.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.223 0.535 . . . . 0.0 110.316 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.708 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.98 -40.26 28.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.005 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.633 ' HB2' HD11 ' A' ' 93' ' ' ILE . . . -65.94 -24.92 66.92 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.366 0.603 . . . . 0.0 110.149 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -18.94 59.56 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.538 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.576 HD12 HG23 ' A' ' 116' ' ' ILE . 63.1 mt -81.76 -45.06 20.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.316 172.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.475 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.9 mt -62.21 -40.77 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.006 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -58.84 -37.33 76.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.71 -34.16 77.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 34.1 mt -68.87 -33.87 74.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.824 -178.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.511 HD22 ' HD2' ' A' ' 98' ' ' PRO . 18.4 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.357 0.599 . . . . 0.0 110.127 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 60' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.642 0 CA-C-O 120.944 0.402 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 27.7 m -123.5 130.39 74.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.159 175.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -118.47 142.72 47.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.625 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 45.3 mt-10 -108.01 116.74 32.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.361 0.6 . . . . 0.0 111.775 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 6' ' ' ILE . 3.9 mp -106.82 142.82 18.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.402 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 87.6 mmm -92.88 116.09 28.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.937 0.399 . . . . 0.0 110.704 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.499 HG12 HG11 ' A' ' 16' ' ' VAL . 1.8 mp -91.36 113.77 59.55 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.586 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 75.1 Cg_exo -55.77 152.15 36.51 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.425 2.75 . . . . 0.0 112.775 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.622 ' HA ' ' NZ ' ' A' ' 49' ' ' LYS . . . -59.62 129.93 44.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 172.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.58 -39.21 2.94 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.81 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.724 ' HG3' HD21 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -65.38 -19.68 66.05 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.805 0.335 . . . . 0.0 111.249 -177.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.665 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -58.38 -24.04 58.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.863 0.363 . . . . 0.0 110.374 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' CA ' ' HD3' ' A' ' 19' ' ' LYS . . . -61.29 -41.15 99.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.246 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.724 HD21 ' HG3' ' A' ' 12' ' ' LYS . 0.5 OUTLIER -90.42 -23.84 20.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.811 0.305 . . . . 0.0 110.992 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.6 HG21 HD12 ' A' ' 71' ' ' LEU . 77.1 t -82.63 -52.05 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.679 HD13 ' HG3' ' A' ' 39' ' ' GLN . 19.2 pt -91.53 -20.09 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 121.526 -0.734 . . . . 0.0 110.155 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.62 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.19 17.09 32.97 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -175.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HD3' ' CA ' ' A' ' 14' ' ' GLY . 13.6 tptp 55.66 31.81 18.08 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.421 0.688 . . . . 0.0 110.428 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.77 -40.17 0.3 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.551 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.594 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 158.1 -8.84 0.2 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.157 -1.02 . . . . 0.0 114.07 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.473 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 44.4 tt0 -58.64 -43.37 89.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.504 0.652 . . . . 0.0 112.377 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.62 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 55.2 m -78.3 -36.73 46.19 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.195 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 35' ' ' MET . 5.6 tp -64.6 -20.1 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.937 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 27.6 mtpp -58.36 -59.45 5.33 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.42 0.629 . . . . 0.0 109.503 170.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 48.6 mt-30 -67.22 -35.23 79.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.91 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 87.7 mt -65.1 -32.91 74.85 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 122.037 -0.415 . . . . 0.0 110.835 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.724 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 47.9 mt-30 -85.5 -46.61 10.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.062 0.458 . . . . 0.0 111.41 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -88.16 -35.36 17.45 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.519 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 5.5 ttm180 -82.87 -43.42 16.6 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.746 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -83.18 -22.29 33.26 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.982 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.69 68.16 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.097 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 34.2 m -128.15 150.69 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 110.846 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -90.72 109.99 21.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 1.056 ' HB3' HD11 ' A' ' 51' ' ' LEU . 48.4 mtt -100.29 123.31 44.36 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 tt -121.02 113.87 41.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.799 0.809 . . . . 0.0 110.768 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.691 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -134.86 143.57 47.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.948 -177.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 3.7 mp -73.34 101.18 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.307 0.575 . . . . 0.0 111.351 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.679 ' HG3' HD13 ' A' ' 17' ' ' ILE . 4.9 mm-40 -131.36 15.68 5.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.44 170.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.03 -30.74 62.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.825 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' A' ' 45' ' ' THR . . . 113.56 8.28 19.04 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.036 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 m -61.77 -49.9 74.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.678 0.275 . . . . 0.0 111.688 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -164.44 -42.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.851 0.358 . . . . 0.0 111.091 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.636 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 13.3 m120 -78.98 51.49 1.14 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.926 0.393 . . . . 0.0 111.266 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.536 ' CG2' ' HA2' ' A' ' 41' ' ' GLY . 14.3 p -86.09 -61.77 1.67 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.178 0.513 . . . . 0.0 110.867 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -92.33 -6.82 49.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.455 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 48.9 t -93.38 156.27 3.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.944 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.4 149.4 38.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.63 ' HE3' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -111.21 124.15 33.45 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.816 -174.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.12 112.89 2.34 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.452 2.101 . . . . 0.0 111.825 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.056 HD11 ' HB3' ' A' ' 35' ' ' MET . 21.2 tp -92.98 121.1 33.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.775 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.529 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 2.7 mpt_? -102.05 114.14 28.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.853 0.358 . . . . 0.0 110.657 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 70.0 mt -89.42 110.63 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.229 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.4 mt -106.13 122.08 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.376 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.402 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 173.87 -171.43 44.51 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.956 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . 3.2 m-20 -61.58 148.75 85.96 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 122.282 0.233 . . . . 0.0 110.536 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.65 -55.61 3.82 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.119 2.546 . . . . 0.0 114.188 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -66.73 -26.91 67.23 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.926 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.869 ' HG2' ' HB2' ' A' ' 87' ' ' SER . 93.2 mttt -66.67 -53.02 38.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.187 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 2' ' ' THR . 46.4 t -59.89 -32.51 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.589 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.22 -54.91 30.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.853 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -69.88 -34.1 73.12 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.051 -178.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -69.88 -47.5 62.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.431 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.2 t -55.95 -38.36 70.23 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.19 0.519 . . . . 0.0 109.862 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -64.53 -52.82 55.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.695 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.655 ' SD ' ' HA2' ' A' ' 86' ' ' GLY . 8.4 ptt? -65.69 -36.07 82.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.472 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 53' ' ' ILE . 53.5 t -57.06 -48.38 81.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.245 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 69.4 mtm -69.78 -25.35 63.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.184 0.516 . . . . 0.0 110.214 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.48 -37.82 42.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.926 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.566 ' HB ' ' H ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -90.22 -30.77 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.86 176.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.6 HD12 HG21 ' A' ' 16' ' ' VAL . 5.2 tt -70.93 -26.45 63.2 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -63.9 0.95 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.176 0.298 . . . . 0.0 110.404 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.961 ' HG2' ' H ' ' A' ' 74' ' ' ARG . 23.6 tt0 42.31 -159.83 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 169.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.961 ' H ' ' HG2' ' A' ' 73' ' ' GLU . 20.9 mmt180 -145.54 -47.06 0.22 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.807 0.843 . . . . 0.0 108.751 167.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -173.66 102.23 0.11 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.011 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 61.66 69.49 0.64 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.459 0.647 . . . . 0.0 111.399 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.41 -5.52 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.372 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.22 150.78 48.88 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.669 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.566 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 74.5 m-85 -76.99 3.53 12.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -170.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 23' ' ' THR . . . 73.14 4.13 62.62 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.723 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.5 OUTLIER 175.89 -62.91 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.736 ' CZ ' ' HB3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER 154.13 -35.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 O-C-N 125.1 1.5 . . . . 0.0 109.101 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 55.81 73.51 0.43 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.371 0.419 . . . . 0.0 110.399 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.934 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 70.4 tt0 -175.71 -51.13 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.665 -173.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.741 ' HA ' HD12 ' A' ' 89' ' ' ILE . 4.5 p90 -151.04 -75.89 0.14 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.655 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 101.15 -43.38 1.74 Allowed Glycine 0 C--O 1.229 -0.198 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.869 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 32.5 p -171.06 -57.16 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -69.98 -177.23 1.28 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.379 167.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 85' ' ' TYR . 59.8 mt 70.57 -74.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.09 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.417 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 51.12 47.21 49.92 Favored Glycine 0 C--N 1.336 0.552 0 O-C-N 123.727 0.642 . . . . 0.0 112.501 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.25 99.36 0.4 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -176.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.816 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 135.79 -138.51 9.98 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -174.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.934 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.8 pt -145.53 159.59 12.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 171.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.593 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . 1.9 p30 -99.22 132.58 44.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 31.3 t -126.65 106.2 23.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -171.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.419 ' HB2' ' HB3' ' A' ' 135' ' ' GLU . 42.8 Cg_endo -68.79 121.44 8.33 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.234 1.956 . . . . 0.0 111.389 171.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.633 HG13 HD21 ' A' ' 158' ' ' LEU . 51.3 t -117.71 124.9 28.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.653 0.263 . . . . 0.0 111.216 177.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 86.1 Cg_exo -44.62 130.51 9.54 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.753 2.968 . . . . 0.0 113.475 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 134' ' ' PRO . 35.2 mtp180 -51.63 -37.92 52.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.151 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.495 ' CE1' ' HB3' ' A' ' 98' ' ' PRO . 0.7 OUTLIER -92.26 6.43 46.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.655 -174.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 98' ' ' PRO . 9.8 m -130.03 -25.52 2.5 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.607 -173.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.4 p -53.15 -26.26 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.742 0.306 . . . . 0.0 111.592 172.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.3 -44.96 89.41 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.947 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 101' ' ' SER . 7.6 p -77.38 -25.23 15.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.208 0.528 . . . . 0.0 110.587 -178.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.1 t -69.68 -33.14 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.85 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.568 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 49.6 mm -87.12 -65.06 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.352 176.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.82 52.19 3.39 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.696 -173.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 108' ' ' ARG . 45.2 mtp180 54.77 -89.84 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.71 0.804 . . . . 0.0 112.375 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -72.75 -8.82 57.25 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.594 0.711 . . . . 0.0 110.348 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.26 45.72 2.52 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.587 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.37 -43.88 80.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.8 0.3 . . . . 0.0 110.942 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.466 ' O ' HG13 ' A' ' 116' ' ' ILE . 15.3 tpt -83.59 -38.55 21.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.848 0.356 . . . . 0.0 110.641 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 124' ' ' ILE . 8.9 tp -63.91 -31.08 51.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.5 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -82.73 -20.12 36.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.657 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -71.23 -37.44 72.01 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.467 HD12 HD12 ' A' ' 113' ' ' ILE . 23.1 mt -64.64 -37.27 79.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.201 0.524 . . . . 0.0 109.603 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 86.6 mt-30 -66.6 -27.36 67.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.724 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -85.65 -46.26 10.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.039 0.447 . . . . 0.0 111.045 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -79.33 -55.36 5.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.778 -173.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.14 -26.96 39.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.058 0.456 . . . . 0.0 110.293 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.96 19.98 62.02 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.138 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.76 144.88 9.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 111.879 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.786 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 7.7 tpp180 -91.34 143.41 26.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.723 HG21 HD11 ' A' ' 113' ' ' ILE . 34.3 mm -129.01 142.21 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -170.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 1.031 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 3.8 pt20 -149.54 167.8 25.29 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 167.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 106' ' ' ILE . 31.7 m-85 -121.95 133.55 54.83 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.535 ' O ' ' HB ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -152.66 128.16 10.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.352 -171.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 121.052 0.453 . . . . 0.0 111.216 179.664 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 15.0 Cg_exo . . . . . 0 CA--C 1.528 0.19 0 N-CA-C 114.734 1.013 . . . . 0.0 114.734 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 51.1 mt-10 -127.18 141.35 51.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -114.02 130.62 56.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.478 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 23.5 mm -74.62 131.54 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -105.88 141.47 37.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.358 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 1.031 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -89.27 110.15 20.96 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.187 175.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.753 HD13 ' HB3' ' A' ' 150' ' ' ALA . 68.5 mt -94.26 135.84 27.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.463 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.786 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 41.6 ttm -122.92 124.55 43.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.056 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.59 -170.66 34.11 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.91 149.02 91.54 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.713 2.276 . . . . 0.0 111.986 174.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.4 -50.71 6.53 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 123.314 2.676 . . . . 0.0 113.665 -177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.66 -47.53 79.6 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.13 0.49 . . . . 0.0 110.224 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -60.0 -41.93 93.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.631 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.816 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 66.7 m -56.26 -60.53 3.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.224 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.638 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 38.2 mt-10 -66.82 -33.17 75.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.287 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -26.88 68.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.753 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.13 -37.19 46.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.826 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.27 67.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.409 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -76.56 -31.48 57.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.287 -178.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.44 -44.58 83.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.197 0.522 . . . . 0.0 109.644 174.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.68 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 70.4 mt -63.03 -53.38 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.741 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.64 HD22 HD12 ' A' ' 158' ' ' LEU . 12.0 m120 -55.47 -38.29 68.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.476 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -59.87 -44.1 94.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 110.756 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.12 -39.48 89.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.594 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 68.4 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.941 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.407 ' O ' HG21 ' A' ' 60' ' ' VAL . 91.1 m . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.5 m -132.1 133.4 60.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.105 0.478 . . . . 0.0 111.179 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 5.4 mm-40 -108.09 145.08 34.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.909 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.74 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 42.1 mt-10 -112.05 104.28 12.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.329 0.585 . . . . 0.0 111.343 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.0 mp -105.65 141.97 19.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.01 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.518 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 45.5 ttm -100.56 114.58 28.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.911 0.386 . . . . 0.0 110.646 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.474 ' HA ' HD11 ' A' ' 71' ' ' LEU . 1.8 mp -83.22 110.07 21.46 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.043 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.854 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 31.3 Cg_exo -62.26 137.25 64.65 Favored 'Trans proline' 0 CA--C 1.519 -0.259 0 C-N-CA 122.81 2.34 . . . . 0.0 111.273 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.59 114.88 3.22 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.56 -34.78 3.66 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -169.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.854 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -89.29 3.78 50.97 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 172.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.506 ' HB1' HD11 ' A' ' 17' ' ' ILE . . . -60.73 -41.19 94.85 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.545 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.82 -14.29 50.94 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.702 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.655 ' O ' HG21 ' A' ' 23' ' ' THR . 22.6 mt -89.56 -57.04 3.01 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.539 0.169 . . . . 0.0 111.187 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.452 ' CG2' HD12 ' A' ' 71' ' ' LEU . 61.8 t -79.58 -54.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.506 HD11 ' HB1' ' A' ' 13' ' ' ALA . 12.7 pt -92.47 -10.7 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.699 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 69.64 31.47 70.65 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 tptt 73.27 -58.08 0.61 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.097 0.959 . . . . 0.0 111.356 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.2 24.48 5.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.874 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 24' ' ' ILE . . . 116.06 -13.21 16.86 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.684 174.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 35.8 mm-40 -56.95 -46.67 81.94 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.655 HG21 ' O ' ' A' ' 15' ' ' LEU . 55.4 m -80.33 -34.24 36.82 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.265 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.495 HD11 HD21 ' A' ' 37' ' ' LEU . 5.2 tp -62.28 -24.96 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 83.6 mttt -57.25 -58.89 6.25 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.102 170.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HB3' ' A' ' 81' ' ' ASP . 42.7 mt-30 -67.57 -20.25 65.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.206 -174.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 85.3 mt -79.74 -30.85 40.97 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.22 173.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 79.8 mt-30 -84.31 -32.26 24.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.569 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.62 -63.38 1.33 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.606 0.241 . . . . 0.0 111.285 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.509 ' HB3' HH22 ' A' ' 82' ' ' ARG . 10.6 ttm180 -66.66 -31.45 72.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.162 -172.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -96.38 -27.17 15.05 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.37 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' HA3' ' NE2' ' A' ' 128' ' ' GLN . . . 78.56 2.89 85.98 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.774 -0.726 . . . . 0.0 113.286 175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.683 HG23 ' SD ' ' A' ' 35' ' ' MET . 27.6 m -101.08 161.91 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -103.99 109.49 21.28 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.326 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.683 ' SD ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -92.12 121.09 33.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.2 tp -113.56 102.34 13.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.964 0.888 . . . . 0.0 109.219 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.751 HD13 HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -132.31 142.21 49.26 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.819 -176.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.681 HG21 ' H ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -60.77 122.24 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.403 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.2 -37.23 0.57 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.299 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.85 -48.11 55.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.121 0.486 . . . . 0.0 110.398 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.665 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 137.14 34.48 0.2 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.335 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -78.99 -22.32 45.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.037 0.446 . . . . 0.0 110.829 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.54 ' HB3' HG12 ' A' ' 38' ' ' ILE . 54.1 tp60 -136.72 -80.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.781 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.681 ' H ' HG21 ' A' ' 38' ' ' ILE . 96.7 m-20 -107.56 87.31 2.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.168 0.509 . . . . 0.0 110.757 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.665 ' HB ' ' HA2' ' A' ' 41' ' ' GLY . 1.8 t -81.51 -42.67 19.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.262 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -94.17 -35.45 12.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.746 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.72 160.33 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.386 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.637 ' OD1' ' HA ' ' A' ' 9' ' ' PRO . 61.7 m-20 -49.53 139.93 11.52 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.391 0.432 . . . . 0.0 111.05 177.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 65.2 mttt -113.06 128.52 25.52 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.163 -165.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -84.8 140.29 7.96 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.798 2.332 . . . . 0.0 113.376 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.751 HD12 HD13 ' A' ' 37' ' ' LEU . 9.0 tt -117.92 139.81 50.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.361 -174.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.58 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.3 mpt_? -123.35 123.42 40.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.453 0.168 . . . . 0.0 110.589 170.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.613 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.4 mt -93.82 116.77 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.7 mt -103.67 120.34 53.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.653 0.263 . . . . 0.0 111.281 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.09 -170.76 43.51 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.372 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.541 ' HB3' ' HE2' ' A' ' 59' ' ' LYS . 9.9 t70 -60.57 138.81 92.78 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.847 -0.677 . . . . 0.0 110.675 172.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.42 -28.83 9.06 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.967 3.111 . . . . 0.0 114.676 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -73.17 -52.05 15.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.949 0.404 . . . . 0.0 110.225 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HE2' ' HB3' ' A' ' 56' ' ' ASP . 0.3 OUTLIER -68.83 -30.14 68.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.468 -177.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 2' ' ' THR . 88.6 t -70.6 -32.87 51.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.448 175.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.443 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 0.8 OUTLIER -70.23 -52.45 23.1 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -65.01 -23.2 67.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.358 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.674 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -86.6 -43.97 12.25 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.949 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 68' ' ' MET . 30.4 p -61.9 -30.98 71.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.692 0.282 . . . . 0.0 111.447 -174.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -83.43 -30.51 27.24 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.794 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.82 ' HB2' ' HG3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -79.3 -34.34 42.5 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.326 -176.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.08 -27.45 42.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.924 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 44.8 mtm -82.95 -35.95 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 0.0 109.607 171.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 36.0 t70 -62.97 -43.76 97.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.782 -175.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.879 HG21 ' HA ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -87.05 -21.5 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.37 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 8' ' ' ILE . 3.5 tt -84.29 -24.69 29.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.64 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.406 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -60.6 -35.55 76.39 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.146 -0.222 . . . . 0.0 110.537 -177.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 1.1 pt-20 37.83 -145.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.199 0.937 . . . . 0.0 112.867 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 8.1 ptm180 173.26 -12.67 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.264 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -154.87 35.62 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.531 -173.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? 58.54 76.13 0.36 Allowed 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.614 0.721 . . . . 0.0 109.404 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.66 116.78 0.72 Allowed Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.257 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . -99.37 -75.32 1.18 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.264 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -144.53 -58.38 0.37 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.768 0.794 . . . . 0.0 109.028 176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.42 -91.3 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB3' ' CB ' ' A' ' 26' ' ' GLN . 5.7 p-10 -90.52 -44.75 9.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 164.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.879 ' HA ' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER 170.37 -51.46 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.689 -172.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.536 ' HA ' ' HB2' ' A' ' 94' ' ' ASP . 18.8 m120 57.45 53.41 7.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 171.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.712 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 0.7 OUTLIER -174.36 2.99 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 177.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.816 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -161.66 -71.53 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.987 -1.071 . . . . 0.0 110.959 174.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.524 ' H ' ' CD ' ' A' ' 82' ' ' ARG . . . 53.67 65.67 3.27 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.581 -174.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.511 ' C ' ' HD2' ' A' ' 88' ' ' ARG . 17.0 t 74.31 -21.62 0.27 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.692 0.797 . . . . 0.0 112.086 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.586 ' HG3' ' HB2' ' A' ' 127' ' ' LYS . 2.6 mmm180 -119.05 -166.32 1.24 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -172.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.816 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 55.6 mt 70.59 -83.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 167.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.575 ' HA2' ' HD2' ' A' ' 85' ' ' TYR . . . 62.87 54.97 29.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.126 -173.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 128.96 58.71 0.11 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.513 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.551 ' O ' HG21 ' A' ' 89' ' ' ILE . . . 164.59 163.28 17.34 Favored Glycine 0 C--O 1.207 -1.572 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.712 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.0 pt -90.31 154.26 3.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 119.14 1.47 . . . . 0.0 112.39 -169.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 83' ' ' ASN . 36.2 m-20 -90.38 117.48 29.13 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.836 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.685 HG21 HD12 ' A' ' 140' ' ' ILE . 1.3 t -116.69 95.1 45.48 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.874 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.17 108.53 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.52 2.146 . . . . 0.0 111.782 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.589 HG13 HD21 ' A' ' 158' ' ' LEU . 86.0 t -94.77 118.75 66.74 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.443 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.641 ' HD2' HD22 ' A' ' 158' ' ' LEU . 47.0 Cg_exo -38.11 123.6 0.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.014 2.476 . . . . 0.0 111.478 171.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -34.46 -58.55 0.48 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -168.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -71.92 -23.71 61.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 t -78.63 -15.1 58.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.594 0.235 . . . . 0.0 111.143 -172.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.556 ' HA ' HG11 ' A' ' 97' ' ' VAL . 58.1 t -54.82 -37.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.154 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.51 -36.03 82.87 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.701 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.18 -37.83 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.353 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.33 -34.28 69.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.346 0.593 . . . . 0.0 110.36 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.73 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 39.7 mm -76.45 -43.57 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.29 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.56 34.87 8.21 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.477 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 65.65 -75.28 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.357 0.663 . . . . 0.0 111.673 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 m -87.49 2.79 49.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.496 ' O ' ' HG2' ' A' ' 114' ' ' LYS . . . 92.52 14.08 56.06 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.877 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -65.89 -40.86 91.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.751 0.31 . . . . 0.0 111.297 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 55.7 tpp -78.23 -36.34 47.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.73 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.0 tp -68.18 -29.66 45.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.816 0.341 . . . . 0.0 110.157 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 110' ' ' GLY . 42.2 mmtm -70.16 -34.73 73.37 Favored 'General case' 0 CA--C 1.523 -0.086 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 173.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 112' ' ' MET . 25.5 mmmt -61.61 -38.7 88.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.981 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.12 -43.04 95.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.26 0.552 . . . . 0.0 109.552 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 60.5 mt-30 -69.04 -26.81 65.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.733 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -86.22 -45.54 11.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.073 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.17 -36.42 47.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.986 -173.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 146' ' ' ARG . . . -103.98 -20.35 13.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.96 37.96 31.81 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.886 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.406 HG11 HG23 ' A' ' 140' ' ' ILE . 33.1 m -112.79 154.23 14.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.959 0.409 . . . . 0.0 111.944 -173.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.553 ' HD3' ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -108.25 135.18 50.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.553 ' N ' ' HD3' ' A' ' 123' ' ' ARG . 45.3 mm -99.58 143.66 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.087 0.47 . . . . 0.0 111.957 -170.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 5.5 tt0 -147.79 104.95 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.682 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -74.29 111.42 9.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.061 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -125.22 156.32 38.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.181 -173.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.529 ' NE2' ' HA3' ' A' ' 32' ' ' GLY . 12.0 mm100 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.848 175.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.46 -0.494 0 CA-C-O 121.237 0.432 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -131.24 152.79 50.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.913 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HD2' HG21 ' A' ' 102' ' ' VAL . 82.8 mttt -110.7 113.36 25.91 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.513 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 1.7 mm -72.55 112.57 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.194 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -96.29 135.8 37.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.802 173.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.777 ' CE1' HG23 ' A' ' 89' ' ' ILE . 1.5 t60 -86.87 109.04 19.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.903 174.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' A' ' 150' ' ' ALA . 41.0 mt -91.19 123.25 43.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 170.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.449 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 13.9 ttp -112.53 131.41 55.61 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -171.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.32 -178.11 27.98 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.68 147.13 96.04 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.859 1.706 . . . . 0.0 110.764 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -41.16 -44.27 5.32 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.475 2.783 . . . . 0.0 112.834 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.31 -40.96 62.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.789 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 9.3 mtm180 -84.53 -38.89 19.48 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 140' ' ' ILE . 61.2 m -58.59 -61.32 2.69 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 111.002 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.686 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 6.2 mm-40 -58.02 -40.85 81.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.182 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -57.58 -31.96 66.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.903 0.382 . . . . 0.0 111.282 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.697 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.46 -36.79 44.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.972 0.415 . . . . 0.0 110.915 -176.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.408 ' HB3' HH11 ' A' ' 152' ' ' ARG . . . -66.17 -24.1 66.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.798 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.686 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 11.3 mpt_? -78.59 -28.04 45.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.755 0.312 . . . . 0.0 110.424 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.3 mt -70.15 -47.93 64.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.233 0.539 . . . . 0.0 109.551 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.517 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.0 mt -63.18 -42.99 98.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.705 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -57.84 -39.21 77.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.982 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.55 -32.58 74.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.772 0.32 . . . . 0.0 110.302 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 44.0 mt -67.64 -47.95 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.969 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.641 HD22 ' HD2' ' A' ' 98' ' ' PRO . 13.3 mt . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.896 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 57' ' ' PRO . 1.6 m . . . . . 0 N--CA 1.451 -0.409 0 CA-C-O 120.958 0.408 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 12.0 m -124.12 128.79 74.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.09 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -114.15 133.95 55.23 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.543 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 43.5 mt-10 -103.04 126.12 50.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.223 0.535 . . . . 0.0 111.869 -175.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -117.8 144.52 25.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 174.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.4 mtp -93.1 112.44 24.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.158 0.504 . . . . 0.0 110.777 -176.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.549 HG13 HG21 ' A' ' 16' ' ' VAL . 1.7 mp -95.21 114.93 64.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.706 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.54 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 41.8 Cg_exo -61.72 152.42 74.23 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.449 2.766 . . . . 0.0 112.815 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.73 131.51 45.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.61 -42.01 2.13 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -169.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 9' ' ' PRO . 13.1 tptt -68.7 -32.48 72.31 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.711 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -52.39 -31.75 35.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.315 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.661 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -59.0 -42.09 96.73 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.431 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.952 HD23 ' HA ' ' A' ' 76' ' ' GLN . 3.8 pp -89.67 -17.95 27.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.756 0.278 . . . . 0.0 111.663 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.549 HG21 HG13 ' A' ' 8' ' ' ILE . 82.9 t -83.5 -48.69 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.711 HG12 ' O ' ' A' ' 13' ' ' ALA . 13.3 pt -90.52 -24.79 5.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.516 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.515 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 100.91 11.58 39.66 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.669 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.661 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 5.4 tptm 52.33 44.2 30.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.324 0.583 . . . . 0.0 110.353 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.83 -24.4 0.55 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.474 -173.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.99 -11.53 7.34 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.331 175.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -59.32 -34.32 72.19 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -174.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.515 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 28.3 m -84.23 -41.57 16.8 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.316 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 35' ' ' MET . 8.3 tp -66.44 -32.4 57.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -47.91 -48.14 31.83 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.58 170.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.599 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 49.4 mt-30 -73.8 -42.07 61.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.657 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.544 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 81.6 mt -60.65 -28.1 68.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.179 0.514 . . . . 0.0 110.709 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 87.6 mt-30 -85.58 -53.75 4.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.567 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -82.23 -49.75 9.75 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -172.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.525 ' HD3' ' OD2' ' A' ' 81' ' ' ASP . 21.3 ttt180 -67.61 -51.75 46.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 110.01 -176.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.625 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -70.31 -29.05 65.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.934 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.07 3.23 87.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.832 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.1 m -103.44 -179.34 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.039 0.447 . . . . 0.0 110.376 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -121.5 114.25 20.97 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.676 ' HB2' HD11 ' A' ' 24' ' ' ILE . 51.6 mtt -100.66 121.1 41.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tp -114.02 110.99 34.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.915 0.864 . . . . 0.0 110.213 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.818 HD13 HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -133.22 144.42 49.78 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.319 -174.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.6 mm -60.76 100.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.134 0.492 . . . . 0.0 110.615 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.547 ' HG2' HG21 ' A' ' 17' ' ' ILE . 42.4 mt-30 -105.4 -42.73 5.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.526 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.74 -19.65 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.511 -177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.04 49.46 3.53 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.199 174.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 m -59.83 -71.37 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.832 0.349 . . . . 0.0 110.847 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -117.85 -26.0 6.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.146 0.498 . . . . 0.0 110.832 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -107.56 75.35 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.985 0.422 . . . . 0.0 110.823 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 p -83.29 -63.22 1.4 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.927 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -94.96 -4.47 46.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.289 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.24 158.21 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.004 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.46 144.77 16.13 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.49 0.494 . . . . 0.0 110.872 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -117.46 127.98 26.31 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.796 -171.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.88 116.76 3.49 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.248 1.966 . . . . 0.0 112.141 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.818 HD12 HD13 ' A' ' 37' ' ' LEU . 8.4 tt -98.48 119.89 37.95 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.483 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.602 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.4 mpt_? -100.11 116.27 31.75 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 176.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CG2' HG23 ' A' ' 60' ' ' VAL . 27.7 mt -89.43 118.37 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 3' ' ' VAL . 27.5 mt -104.67 121.32 56.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 177.49 -177.92 48.32 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.483 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.612 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 13.8 t70 -62.04 139.98 95.9 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.565 ' HA ' HG21 ' A' ' 2' ' ' THR . 69.7 Cg_exo -38.7 -45.86 2.51 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.912 3.075 . . . . 0.0 115.157 -175.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -74.43 -33.51 62.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.251 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 1.007 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 19.0 ptpt -79.2 -41.68 27.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -175.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.512 HG23 ' CG2' ' A' ' 53' ' ' ILE . 8.0 p -67.36 -24.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.503 0.668 . . . . 0.0 109.935 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -66.88 -57.89 6.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.24 178.066 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -61.45 -33.16 73.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -69.51 -45.73 68.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.745 177.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.455 ' HA ' HG22 ' A' ' 67' ' ' VAL . 42.8 t -58.97 -35.63 73.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.52 0.676 . . . . 0.0 109.632 177.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.25 -37.08 84.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.616 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.867 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 15.5 ptt? -84.95 -33.47 22.65 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.975 -176.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 35.1 m -62.37 -28.96 45.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.299 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.6 mtm -81.6 -21.03 38.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 110.32 174.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -83.2 -46.26 12.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.894 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.702 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.6 pp -83.22 -26.7 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.333 . . . . 0.0 111.743 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 6.0 tt -75.72 -18.35 59.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.876 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 5.8 ptm180 -53.39 -42.1 66.61 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.529 ' HG2' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER 56.07 137.73 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 170.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 72.7 mtp180 -112.43 -13.45 13.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 161.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.529 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 36.1 t70 -163.18 135.06 5.1 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.544 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.952 ' HA ' HD23 ' A' ' 15' ' ' LEU . 78.4 mt-30 -43.81 106.65 0.07 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.289 1.042 . . . . 0.0 112.188 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.483 ' N ' ' HB3' ' A' ' 15' ' ' LEU . . . 150.82 -34.38 0.95 Allowed Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.103 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.95 -111.23 3.61 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.702 ' HD1' HG22 ' A' ' 70' ' ' ILE . 97.3 m-85 -127.78 -13.77 5.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.74 0.305 . . . . 0.0 110.609 174.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 81.23 91.92 0.52 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -174.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.599 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 5.7 t70 71.22 -75.04 0.08 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -170.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.867 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 24.9 ttt180 173.17 -35.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 O-C-N 124.18 0.925 . . . . 0.0 110.332 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 69.19 13.54 8.62 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.65 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.808 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 84.9 tt0 -123.96 -34.43 2.99 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.631 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 25.6 p90 171.27 127.31 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.139 175.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.753 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -82.99 -66.69 1.51 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.946 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 1.007 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 45.2 m -144.98 22.56 1.57 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.776 0.798 . . . . 0.0 109.125 176.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 1.8 mpt_? -133.84 -164.16 1.46 Allowed 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.043 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' A' ' 85' ' ' TYR . 23.9 mt 64.71 -81.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.45 50.71 57.86 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 132.96 85.02 0.26 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.286 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 153.94 -143.76 10.48 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.808 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.9 pt -144.97 160.55 13.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 117.302 0.551 . . . . 0.0 110.844 175.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.491 ' HB3' ' HE ' ' A' ' 30' ' ' ARG . 5.0 m-20 -107.0 119.68 40.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.949 173.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.828 HG23 ' HB3' ' A' ' 138' ' ' ALA . 6.2 m -113.35 104.88 55.56 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.169 0.509 . . . . 0.0 112.172 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 51.8 Cg_endo -72.34 108.6 2.54 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.816 2.344 . . . . 0.0 111.634 173.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.678 HG13 HD21 ' A' ' 158' ' ' LEU . 46.9 t -102.35 124.92 37.87 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.071 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.552 ' HD2' HD22 ' A' ' 158' ' ' LEU . 78.7 Cg_exo -44.54 133.65 9.8 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.636 2.89 . . . . 0.0 112.783 173.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -58.59 -30.6 67.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.651 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -89.88 1.36 56.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.424 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 105' ' ' VAL . 25.1 m -119.56 -27.97 5.41 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.505 ' HA ' HG11 ' A' ' 97' ' ' VAL . 11.2 p -52.33 -34.43 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.38 -37.76 94.19 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.85 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.9 -37.14 53.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 0.0 110.36 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 101' ' ' SER . 48.0 t -65.35 -38.67 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.326 0.584 . . . . 0.0 110.669 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.814 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 13.7 mt -81.03 -26.33 10.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.238 0.542 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.4 48.44 5.94 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 59.02 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.83 0.852 . . . . 0.0 112.244 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.9 m -75.08 -24.49 58.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 111.065 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.413 ' HA2' ' CG2' ' A' ' 106' ' ' ILE . . . 130.41 50.7 0.11 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.725 177.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.563 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 40.4 mt-10 -93.42 -58.98 2.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.882 0.373 . . . . 0.0 110.302 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -68.37 -31.54 70.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.163 -173.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.814 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.0 tp -65.46 -22.88 31.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.253 0.549 . . . . 0.0 110.675 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -82.32 -26.06 33.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.046 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.563 ' HD3' ' O ' ' A' ' 111' ' ' GLU . 2.7 mptp? -65.24 -38.13 89.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.455 HD11 ' SD ' ' A' ' 112' ' ' MET . 28.9 mm -59.12 -43.12 88.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.491 175.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.499 HE21 HG12 ' A' ' 124' ' ' ILE . 59.7 mt-30 -67.04 -33.61 75.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.744 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -79.26 -42.32 26.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.613 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.64 -40.62 33.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.464 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.17 18.47 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.93 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.19 46.35 8.25 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.438 HG21 HG23 ' A' ' 140' ' ' ILE . 1.9 t -118.02 143.75 27.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.109 -0.546 . . . . 0.0 111.678 -169.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.475 ' HD3' ' SD ' ' A' ' 141' ' ' MET . 79.4 mtp180 -103.53 148.68 25.67 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.499 HG12 HE21 ' A' ' 117' ' ' GLN . 46.2 mm -114.63 135.03 55.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.189 0.519 . . . . 0.0 111.937 -171.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.586 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 24.1 tt0 -137.32 105.67 5.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.219 176.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.493 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 33.6 m-85 -80.76 106.53 12.84 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 121.942 -0.474 . . . . 0.0 109.949 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.832 ' O ' ' HE2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.47 127.28 48.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.235 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 . . . . . 0 N--CA 1.466 0.353 0 CA-C-O 121.384 0.612 . . . . 0.0 111.589 175.567 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 N--CA 1.476 0.445 0 N-CA-C 115.091 1.15 . . . . 0.0 115.091 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -132.74 146.35 51.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.358 0.599 . . . . 0.0 111.525 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -119.47 115.94 25.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.747 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.546 HG22 ' NZ ' ' A' ' 127' ' ' LYS . 18.0 mm -72.84 108.32 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.569 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.828 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -96.79 141.4 30.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.671 175.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.6 ' NE2' HG23 ' A' ' 89' ' ' ILE . 3.2 t-160 -91.52 117.52 29.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.879 0.371 . . . . 0.0 110.414 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.655 HD13 ' HB3' ' A' ' 150' ' ' ALA . 37.9 mt -97.17 118.24 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.248 171.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.475 ' SD ' ' HD3' ' A' ' 123' ' ' ARG . 46.3 ttm -102.13 121.61 42.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 -174.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 164.33 170.26 29.02 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.16 150.83 82.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.585 2.19 . . . . 0.0 111.6 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.775 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 87.2 Cg_exo -42.3 -40.02 6.65 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.931 3.087 . . . . 0.0 114.999 -172.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.3 -32.07 64.4 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.998 -0.439 . . . . 0.0 110.855 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 149' ' ' HIS . 92.7 mtt-85 -85.0 -35.17 22.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.778 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.775 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 27.7 p -62.99 -51.08 68.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.609 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 28.3 mt-10 -66.38 -29.01 69.09 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.935 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 4.4 t60 -55.49 -36.08 66.26 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.116 0.484 . . . . 0.0 110.136 175.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.655 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.14 -35.04 42.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.922 -174.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.473 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -67.15 -24.93 65.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.609 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 2.9 mpt_? -77.84 -18.5 56.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.981 0.42 . . . . 0.0 110.314 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.5 mt -82.41 -44.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 66.7 mt -65.94 -52.51 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.347 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -60.74 -30.21 69.85 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.251 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.63 -39.48 93.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.996 0.427 . . . . 0.0 110.013 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.424 HD11 ' CE ' ' A' ' 112' ' ' MET . 82.7 mt -67.07 -44.06 81.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.776 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.678 HD21 HG13 ' A' ' 97' ' ' VAL . 71.3 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.776 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.656 HG21 ' HA ' ' A' ' 57' ' ' PRO . 36.5 m . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 17.5 m -132.28 141.4 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.699 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -123.52 141.72 51.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.742 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 45.6 mt-10 -112.23 121.38 44.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.363 0.601 . . . . 0.0 111.703 -175.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.66 HG13 HG21 ' A' ' 67' ' ' VAL . 44.7 mm -110.52 150.08 13.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.665 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.489 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 50.4 tpp -101.37 117.03 34.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.881 0.372 . . . . 0.0 110.848 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.779 HG12 HG11 ' A' ' 16' ' ' VAL . 3.0 mp -99.37 104.39 26.56 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.185 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 7' ' ' MET . 21.2 Cg_exo -67.52 159.45 52.44 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 123.08 2.52 . . . . 0.0 111.82 177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.51 141.56 57.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.14 -51.42 1.89 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -172.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.78 -25.01 64.49 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.004 0.431 . . . . 0.0 110.411 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.748 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -52.11 -37.47 54.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.67 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA3' ' OE1' ' A' ' 76' ' ' GLN . . . -63.03 -38.46 96.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.984 -178.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.077 HD23 ' HA ' ' A' ' 76' ' ' GLN . 2.9 pp -89.93 -15.82 31.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.98 0.39 . . . . 0.0 111.656 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.779 HG11 HG12 ' A' ' 8' ' ' ILE . 70.8 t -90.2 -49.94 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.748 HG12 ' O ' ' A' ' 13' ' ' ALA . 17.6 pt -87.51 -23.42 6.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.321 -0.551 . . . . 0.0 109.895 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.761 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 89.92 17.95 52.33 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.719 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.452 ' H ' HG13 ' A' ' 17' ' ' ILE . 29.7 mmtp 65.05 -63.36 0.19 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.667 0.787 . . . . 0.0 111.658 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.75 19.35 47.56 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.257 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 92.82 8.04 62.33 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.025 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.605 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 28.6 tt0 -63.01 -48.34 79.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.687 0.28 . . . . 0.0 111.594 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.761 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 78.9 m -67.23 -39.45 86.23 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.204 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.667 HD12 HD12 ' A' ' 27' ' ' LEU . 1.3 tp -64.6 -22.1 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.67 0.272 . . . . 0.0 110.899 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.605 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 49.8 mttm -56.79 -57.86 10.62 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.619 0.723 . . . . 0.0 109.981 173.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -69.31 -26.98 65.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.963 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.667 HD12 HD12 ' A' ' 24' ' ' ILE . 36.6 mt -75.03 -30.14 61.0 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.045 -0.409 . . . . 0.0 111.019 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.706 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.2 mt-30 -84.83 -42.45 15.1 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.032 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -88.07 -62.1 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.66 HH21 ' HA3' ' A' ' 86' ' ' GLY . 2.2 ttp180 -58.47 -43.75 89.02 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.933 0.397 . . . . 0.0 110.891 -176.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -75.45 -22.39 57.36 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.356 0.598 . . . . 0.0 111.178 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.99 78.4 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.778 -0.647 . . . . 0.0 112.672 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 28.6 m -121.75 151.0 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.843 0.354 . . . . 0.0 110.455 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -89.19 109.49 20.36 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 1.044 ' HB3' HD11 ' A' ' 51' ' ' LEU . 59.4 mtt -98.2 114.43 26.67 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.707 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.9 tp -110.44 112.25 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 122.006 0.908 . . . . 0.0 109.677 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.638 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -132.29 143.38 49.85 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.95 -175.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 78.7 mt -54.37 107.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 124.01 0.819 . . . . 0.0 111.892 -173.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -126.37 -14.55 5.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.837 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.28 158.61 20.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.676 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.29 69.11 0.88 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.966 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.4 t -89.38 -62.89 1.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -175.6 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.393 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -86.75 62.5 7.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.114 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 p -83.29 -61.13 1.93 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.81 0.338 . . . . 0.0 111.347 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -93.39 -17.08 23.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.283 0.563 . . . . 0.0 109.819 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 11.9 t -79.15 166.17 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.886 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.4 p30 -47.84 140.91 6.13 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.159 0.504 . . . . 0.0 111.282 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 16.6 mtmm -130.1 137.46 30.92 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.087 -170.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.53 133.21 5.22 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.597 2.198 . . . . 0.0 112.4 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.044 HD11 ' HB3' ' A' ' 35' ' ' MET . 22.4 tp -108.05 120.18 41.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.813 -177.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.707 ' HB2' HG23 ' A' ' 36' ' ' ILE . 5.1 mpt_? -96.27 115.57 27.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.37 174.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.3 mt -91.47 110.1 22.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.786 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 3' ' ' VAL . 35.3 mt -108.06 121.04 60.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.452 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.544 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.86 -170.2 43.33 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.986 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.985 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . 2.1 m-20 -51.03 146.75 10.11 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.647 0.263 . . . . 0.0 110.514 175.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.656 ' HA ' HG21 ' A' ' 2' ' ' THR . 51.3 Cg_exo -54.72 -52.62 7.66 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 121.909 1.739 . . . . 0.0 112.773 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -61.03 -30.65 70.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.638 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.985 ' HG3' ' HB2' ' A' ' 56' ' ' ASP . 46.1 mttp -64.77 -47.97 76.22 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.294 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.31 -39.0 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.165 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.19 -51.88 67.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.564 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.912 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -68.7 -35.43 77.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 -178.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -72.31 -42.48 65.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.89 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 47.3 t -57.35 -36.76 71.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.358 0.599 . . . . 0.0 109.568 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -67.49 -45.63 75.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.21 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.633 ' O ' HG13 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -73.94 -37.7 64.48 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.837 -175.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.66 HG21 HG13 ' A' ' 6' ' ' ILE . 35.9 m -62.49 -35.18 68.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.678 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.726 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 66.2 mtt -71.24 -21.22 62.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.737 0.303 . . . . 0.0 110.632 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 8.9 t70 -85.59 -41.51 15.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.967 0.413 . . . . 0.0 111.04 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.812 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.1 pp -86.85 -23.99 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.922 0.392 . . . . 0.0 111.856 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.622 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 3.6 tt -86.47 -20.06 28.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.551 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.726 ' HB3' ' O ' ' A' ' 68' ' ' MET . 5.3 ptm180 -61.55 -11.36 10.81 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.85 0.357 . . . . 0.0 111.076 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 1.05 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 16.0 tp10 -50.98 138.79 18.65 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.401 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -66.7 -30.08 70.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.827 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 29.1 t70 -135.23 -89.32 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.716 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 1.077 ' HA ' HD23 ' A' ' 15' ' ' LEU . 9.3 tt0 -153.66 61.45 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.544 0.688 . . . . 0.0 110.296 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 1.05 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . -137.64 30.49 2.58 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.8 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.75 158.27 40.73 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.812 ' HD1' HG22 ' A' ' 70' ' ' ILE . 4.5 m-85 -60.59 -45.51 93.7 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.82 -75.49 0.42 Allowed Glycine 0 CA--C 1.496 -1.099 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 169.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.526 ' HA ' HD21 ' A' ' 27' ' ' LEU . 19.2 p-10 -92.33 -15.61 27.12 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.418 -0.891 . . . . 0.0 110.473 174.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.446 ' CB ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER 84.58 64.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.635 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 28.8 t-20 -49.54 102.93 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.709 176.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 1.065 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.7 tt0 162.65 -41.97 0.0 OUTLIER 'General case' 0 C--O 1.232 0.157 0 O-C-N 124.572 1.17 . . . . 0.0 108.32 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 53.2 p90 -175.03 151.27 1.3 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.449 -177.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.61 80.04 0.18 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.89 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 40.1 m 72.38 -20.41 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.107 0.479 . . . . 0.0 111.001 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.663 ' HD3' ' H ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -103.96 154.03 20.13 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.733 171.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.694 HG21 ' CE1' ' A' ' 139' ' ' HIS . 33.3 mm 62.58 -88.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.119 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.03 46.45 1.73 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.661 -172.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 151.71 164.82 12.48 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.739 -0.545 . . . . 0.0 111.739 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.748 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 86.13 -122.02 5.91 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.081 -0.581 . . . . 0.0 111.724 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 1.065 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 28.7 pt -155.43 178.5 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 122.921 0.489 . . . . 0.0 109.852 171.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -120.22 137.04 54.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.694 170.364 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 29.2 t -124.12 98.06 39.55 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.073 -175.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.441 ' CA ' HD13 ' A' ' 137' ' ' ILE . 38.2 Cg_endo -69.98 107.75 1.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.671 1.581 . . . . 0.0 110.92 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.672 HG21 HG21 ' A' ' 105' ' ' VAL . 14.8 p -116.02 126.75 27.35 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.014 0.435 . . . . 0.0 110.574 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.496 ' HA ' ' HG2' ' A' ' 135' ' ' GLU . 73.6 Cg_exo -46.96 136.17 17.54 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.499 2.799 . . . . 0.0 112.546 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -54.77 -29.13 53.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.343 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -92.29 10.55 29.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.895 0.379 . . . . 0.0 111.354 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 105' ' ' VAL . 46.1 m -128.64 -15.19 4.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.761 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 106' ' ' ILE . 7.6 p -64.51 -35.28 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.267 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.73 -28.56 73.5 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.184 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.29 -37.97 39.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.672 HG21 HG21 ' A' ' 97' ' ' VAL . 62.1 t -59.78 -41.09 84.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.919 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.784 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 46.0 mm -67.39 -46.3 83.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.245 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.06 33.26 9.02 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.611 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' A' ' 108' ' ' ARG . 27.9 mtp180 64.9 -78.28 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.264 0.626 . . . . 0.0 111.914 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.457 ' HB2' ' HG3' ' A' ' 111' ' ' GLU . 18.0 m -81.81 11.32 5.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.878 0.37 . . . . 0.0 110.815 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.407 ' O ' ' HG2' ' A' ' 114' ' ' LYS . . . 75.51 22.12 76.0 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.919 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 109' ' ' SER . 41.0 mt-10 -71.46 -50.47 31.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.895 0.378 . . . . 0.0 110.916 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.544 ' O ' HG12 ' A' ' 116' ' ' ILE . 13.6 tpt -68.49 -39.11 81.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.081 -173.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.784 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.3 tp -65.96 -32.37 57.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.608 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 110' ' ' GLY . 74.6 mmtt -81.41 -30.58 33.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.203 0.525 . . . . 0.0 109.731 176.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -66.15 -38.74 88.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.945 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 112' ' ' MET . 45.6 mm -62.15 -39.04 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.354 0.597 . . . . 0.0 109.651 174.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 77.6 mt-30 -65.8 -32.22 73.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.833 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -79.8 -42.4 24.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.567 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -79.46 -43.58 22.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.65 -18.94 20.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.929 0.395 . . . . 0.0 111.671 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.53 47.42 8.03 Favored Glycine 0 C--O 1.228 -0.223 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.886 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.459 ' HB ' HG23 ' A' ' 140' ' ' ILE . 27.1 m -122.17 179.58 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 111.653 -173.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.748 ' HB3' ' HG2' ' A' ' 141' ' ' MET . 43.1 ttt180 -145.68 145.78 31.04 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.558 HG13 HD11 ' A' ' 113' ' ' ILE . 44.9 mm -107.68 138.46 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -168.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.811 ' HA ' HE21 ' A' ' 125' ' ' GLN . 0.0 OUTLIER -138.48 94.92 2.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.866 175.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 138' ' ' ALA . 44.2 m-85 -73.72 105.97 5.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.776 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -102.04 -166.74 1.32 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.076 -173.451 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . 0.408 ' OE1' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -169.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--O 1.237 0.45 0 CA-C-O 121.519 0.55 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 98' ' ' PRO . 45.7 mt-10 -129.36 151.03 50.45 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.872 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.494 ' O ' HG12 ' A' ' 97' ' ' VAL . 66.9 mttm -109.38 113.82 26.97 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -175.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 14.9 mm -67.13 109.86 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.864 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 126' ' ' PHE . . . -97.79 135.14 39.98 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 170.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.694 ' CE1' HG21 ' A' ' 89' ' ' ILE . 13.2 t60 -86.69 123.43 31.85 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.979 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.551 HD13 ' HB3' ' A' ' 150' ' ' ALA . 32.3 mt -103.24 126.15 57.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.275 171.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.748 ' HG2' ' HB3' ' A' ' 123' ' ' ARG . 16.8 ptp -107.23 165.49 11.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.958 0.409 . . . . 0.0 110.665 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.76 172.96 13.26 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.503 ' HD2' ' HD3' ' A' ' 146' ' ' ARG . 38.1 Cg_exo -58.89 143.5 99.36 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.415 2.076 . . . . 0.0 111.765 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.747 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 72.5 Cg_exo -41.59 -43.97 6.24 Favored 'Trans proline' 0 N--CA 1.476 0.466 0 C-N-CA 124.006 3.137 . . . . 0.0 114.497 -173.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 11.4 t70 -57.59 -42.93 84.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.612 0.244 . . . . 0.0 111.417 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.503 ' HD3' ' HD2' ' A' ' 143' ' ' PRO . 18.3 mtp180 -79.75 -39.15 31.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.52 -172.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.747 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 12.2 p -63.11 -50.65 69.64 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.666 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 5.7 mm-40 -62.21 -38.88 90.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.664 0.269 . . . . 0.0 110.718 176.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 18.6 t60 -57.66 -32.31 67.18 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.953 0.406 . . . . 0.0 111.076 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.551 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -77.91 -34.02 51.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.778 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.512 ' HB3' HH11 ' A' ' 152' ' ' ARG . . . -67.47 -25.26 65.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.396 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.666 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 10.9 mpt_? -77.83 -32.73 52.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.845 0.355 . . . . 0.0 110.264 -177.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.44 ' O ' HD13 ' A' ' 157' ' ' LEU . 63.4 mt -65.4 -46.36 90.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.813 176.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.633 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 68.3 mt -62.41 -37.48 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.294 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.85 -31.3 69.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.462 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.08 -37.48 38.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.14 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 153' ' ' ILE . 7.8 mp -53.49 -42.29 67.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 25.5 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.424 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.807 0 N-CA-C 111.369 -0.692 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m -79.51 125.08 29.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.886 0.343 . . . . 0.0 110.201 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 15.0 m -133.54 115.18 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.502 0.668 . . . . 0.0 111.525 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -115.28 141.33 48.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.487 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 39.5 mt-10 -109.77 136.04 49.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.555 0.693 . . . . 0.0 112.504 -174.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -125.0 148.22 29.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.771 -1.104 . . . . 0.0 108.07 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 68.3 mtp -101.49 129.18 47.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.151 0.5 . . . . 0.0 111.56 -174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.688 HD11 ' HB2' ' A' ' 51' ' ' LEU . 3.9 mp -105.54 107.29 58.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.301 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.494 ' HD2' ' HG3' ' A' ' 12' ' ' LYS . 8.1 Cg_exo -74.64 152.23 42.43 Favored 'Trans proline' 0 C--O 1.236 0.413 0 C-N-CA 123.211 2.607 . . . . 0.0 111.429 177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.61 129.43 40.53 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.47 -15.4 24.77 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HD2' ' O ' ' A' ' 71' ' ' LEU . 71.0 mmtt -112.66 9.27 19.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.045 0.45 . . . . 0.0 110.132 175.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.417 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -62.92 -41.67 99.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.95 -177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.6 -15.72 66.72 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.12 -1.038 . . . . 0.0 112.175 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.862 HD11 ' HB2' ' A' ' 73' ' ' GLU . 24.7 mt -87.32 -58.61 2.52 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 120.81 0.338 . . . . 0.0 110.719 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.673 HG11 HG12 ' A' ' 8' ' ' ILE . 85.3 t -81.68 -48.83 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -172.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 13' ' ' ALA . 39.8 pt -91.52 -26.78 4.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.917 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.35 33.92 13.18 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.457 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm 57.65 29.66 17.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.977 0.511 . . . . 0.0 112.093 -178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.1 -33.47 0.61 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 119.951 -1.119 . . . . 0.0 113.304 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 157.07 -6.33 0.19 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 119.908 -1.139 . . . . 0.0 113.792 -176.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.74 -46.57 67.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.964 0.382 . . . . 0.0 111.549 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 81' ' ' ASP . 86.0 m -73.36 -42.9 61.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.23 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.731 HD11 ' HB2' ' A' ' 35' ' ' MET . 5.8 tp -62.35 -26.1 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.75 -174.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 89.3 mttt -53.54 -56.89 13.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.945 0.879 . . . . 0.0 109.96 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.731 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 22.8 mt-30 -73.96 -27.69 61.12 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.607 -174.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.579 HD12 HD12 ' A' ' 24' ' ' ILE . 91.8 mt -66.59 -27.64 67.88 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.236 0.541 . . . . 0.0 109.853 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.679 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.4 mt-30 -85.41 -46.42 10.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.019 174.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -79.82 -62.44 1.68 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.504 ' HG2' HH22 ' A' ' 82' ' ' ARG . 3.0 ttm180 -62.34 -38.37 89.23 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.395 -173.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -87.51 -26.46 23.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.825 0.345 . . . . 0.0 111.634 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.4 70.9 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.76 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.5 m -127.41 156.06 38.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -94.25 109.37 21.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.822 ' HB3' HD21 ' A' ' 51' ' ' LEU . 48.8 mtt -100.24 114.04 27.18 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.172 0.51 . . . . 0.0 109.64 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.4 tt -111.72 113.8 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.982 0.896 . . . . 0.0 109.932 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.742 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 1.1 pt? -132.6 141.19 48.56 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.197 -175.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.692 HD13 ' HG2' ' A' ' 50' ' ' PRO . 2.1 mp -59.43 102.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.421 0.629 . . . . 0.0 111.012 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 19.46 17.73 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.6 123.37 25.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.405 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.767 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . -79.59 -0.97 85.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.225 -175.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.6 m -90.09 -26.35 20.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.086 0.443 . . . . 0.0 110.865 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -115.79 -81.53 0.61 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.282 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.565 ' HB2' ' CG2' ' A' ' 38' ' ' ILE . 15.0 m120 -96.76 67.31 2.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.94 0.4 . . . . 0.0 110.994 -176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.767 ' HB ' ' HA2' ' A' ' 41' ' ' GLY . 1.9 t -83.44 -56.49 3.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.315 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -94.3 -21.8 18.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.124 0.488 . . . . 0.0 110.856 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.11 158.17 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.755 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.2 148.0 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.442 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -122.86 133.86 24.71 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.018 -174.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.692 ' HG2' HD13 ' A' ' 38' ' ' ILE . 94.7 Cg_endo -86.98 119.91 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.421 2.081 . . . . 0.0 112.649 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.0 tt -88.06 111.11 21.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.675 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 2.6 mtp85 -96.73 100.12 11.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.722 0.296 . . . . 0.0 110.544 177.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 59.9 mt -80.83 112.61 19.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.23 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 51.4 mt -104.43 121.24 55.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.34 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.63 -171.01 44.21 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.23 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -69.05 153.1 96.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.5 -54.98 4.36 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.217 2.612 . . . . 0.0 114.227 -174.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -65.68 -26.87 67.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 110.811 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.633 ' HG2' ' HB3' ' A' ' 87' ' ' SER . 87.6 mttt -69.67 -51.06 38.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.112 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -62.91 -29.0 46.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.321 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.36 -56.18 16.14 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.516 178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.924 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -65.04 -37.2 86.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.657 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -67.33 -46.67 72.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.356 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.9 t -55.68 -36.64 67.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.074 0.464 . . . . 0.0 110.447 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -63.95 -50.72 67.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.148 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 8.2 ptt? -68.69 -38.96 80.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.951 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 63' ' ' ALA . 61.6 t -57.53 -41.83 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.567 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.0 mtp -68.33 -25.71 65.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.306 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.671 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 11.8 t70 -84.54 -54.46 4.73 Favored 'General case' 0 C--O 1.219 -0.5 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.692 -176.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -71.51 -21.04 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.997 -174.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.624 HD12 HG21 ' A' ' 16' ' ' VAL . 5.1 tt -76.34 -16.82 59.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.069 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.736 ' HD2' ' HG2' ' A' ' 74' ' ' ARG . 10.9 ptp180 -56.7 -36.6 69.83 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.862 ' HB2' HD11 ' A' ' 15' ' ' LEU . 1.3 tm-20 65.85 98.98 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.853 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.736 ' HG2' ' HD2' ' A' ' 72' ' ' ARG . 43.2 mtt180 -96.36 -27.8 14.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.378 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -151.65 29.1 0.61 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.129 -172.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.762 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER 37.86 35.67 0.08 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.004 0.921 . . . . 0.0 112.827 -169.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.47 -44.26 0.79 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 65.03 25.57 70.93 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.698 -0.287 . . . . 0.0 112.876 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 67.8 -50.93 0.52 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.622 0.769 . . . . 0.0 111.889 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 111.34 99.15 2.48 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -174.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 26' ' ' GLN . 0.7 OUTLIER 72.59 -66.38 0.31 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.02 0.482 . . . . 0.0 109.91 -169.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.634 ' HB3' ' NH1' ' A' ' 82' ' ' ARG . 0.8 OUTLIER 170.17 -42.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.328 -178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 57.95 78.11 0.26 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.213 0.53 . . . . 0.0 110.765 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 1.056 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.6 tt0 -174.91 -68.27 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.288 -175.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.629 ' HB3' ' O ' ' A' ' 89' ' ' ILE . 1.1 p90 -141.32 -69.22 0.38 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 120.689 -1.257 . . . . 0.0 112.367 176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.428 ' H ' ' HD1' ' A' ' 85' ' ' TYR . . . 68.45 75.39 0.52 Allowed Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.288 -174.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.633 ' HB3' ' HG2' ' A' ' 59' ' ' LYS . 9.6 m 74.86 -38.74 0.39 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.541 0.736 . . . . 0.0 112.71 176.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.702 ' HG2' ' HD2' ' A' ' 127' ' ' LYS . 3.9 mpt_? -66.21 -88.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -173.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.629 ' O ' ' HB3' ' A' ' 85' ' ' TYR . 10.5 mm -111.65 88.82 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.1 -174.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.39 91.01 0.08 OUTLIER Glycine 0 CA--C 1.522 0.519 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.496 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.57 93.79 0.29 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.85 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 112.41 165.13 16.98 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.836 -0.905 . . . . 0.0 110.836 -174.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.056 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 45.6 pt -94.15 155.71 3.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 117.125 0.463 . . . . 0.0 111.967 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.496 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 2.1 p30 -96.35 147.16 24.1 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 175.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.656 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 40.6 t -136.51 99.72 10.52 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -171.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 95' ' ' VAL . 38.6 Cg_endo -71.07 106.7 1.95 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.113 1.875 . . . . 0.0 111.412 170.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.586 HG23 HD21 ' A' ' 158' ' ' LEU . 13.4 p -109.65 131.32 21.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.58 144.51 51.93 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.447 2.765 . . . . 0.0 112.747 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -64.49 -22.13 66.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.772 -172.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -86.35 -4.48 59.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 110.516 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 105' ' ' VAL . 16.4 m -114.85 -29.61 6.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.1 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 8.2 p -57.21 -39.96 70.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.12 -27.12 74.11 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.071 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.534 HG11 HD21 ' A' ' 161' ' ' LEU . 62.1 t -77.95 -33.62 18.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.08 0.467 . . . . 0.0 109.745 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 101' ' ' SER . 94.3 t -60.19 -39.8 81.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.171 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.411 HD11 ' CZ ' ' A' ' 126' ' ' PHE . 33.6 mm -72.2 -59.05 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.467 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.4 -137.72 14.26 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -98.42 -57.34 2.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.222 0.511 . . . . 0.0 110.014 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 m -105.65 -24.27 12.58 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.612 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 136.81 20.54 0.59 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.469 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 1.8 mp0 -49.75 -43.68 48.12 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.1 0.476 . . . . 0.0 110.991 -176.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.678 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.2 tpt -76.37 -52.7 9.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.584 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.669 HD11 HG21 ' A' ' 124' ' ' ILE . 20.1 tt -69.92 -26.26 29.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.743 -173.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -72.23 -29.28 63.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.552 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.678 ' HG2' ' O ' ' A' ' 112' ' ' MET . 16.5 ptpt -80.04 -22.59 42.2 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.265 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.36 -45.68 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -69.26 -25.29 64.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.625 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -79.39 -39.46 32.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.046 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -78.98 -54.08 6.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.404 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.446 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -88.23 -15.29 36.31 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.06 57.46 6.95 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.129 -175.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.9 m -131.62 174.21 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.872 0.368 . . . . 0.0 111.314 -172.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.803 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 86.6 mtt180 -125.04 151.41 45.65 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 173.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.669 HG21 HD11 ' A' ' 113' ' ' ILE . 47.8 mm -112.23 136.35 48.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.079 0.466 . . . . 0.0 111.155 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.664 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 3.9 tp-100 -130.72 110.99 11.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.309 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 52.1 m-85 -80.97 102.89 10.43 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.113 171.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.941 ' HE2' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -99.2 164.67 12.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.847 -178.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.44 ' CD ' HH21 ' A' ' 88' ' ' ARG . 4.9 pt20 -46.32 100.26 0.02 OUTLIER 'General case' 0 C--O 1.236 0.382 0 O-C-N 124.146 0.904 . . . . 0.0 110.52 173.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -64.35 149.06 49.02 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.754 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.81 116.45 2.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.323 -1.308 . . . . 0.0 109.189 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -71.87 75.43 0.74 Allowed Glycine 0 N--CA 1.45 -0.418 0 O-C-N 123.861 0.726 . . . . 0.0 113.555 -167.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.415 ' C ' ' HD2' ' A' ' 134' ' ' PRO . 20.2 p -124.63 -32.32 3.12 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.685 0.279 . . . . 0.0 110.765 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 123.33 -69.44 0.45 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.405 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.415 ' HD2' ' C ' ' A' ' 132' ' ' THR . 12.2 Cg_endo -55.22 -65.22 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.394 2.73 . . . . 0.0 114.393 -174.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -93.17 148.87 21.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.619 . . . . 0.0 111.757 -172.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.484 ' O ' HG12 ' A' ' 97' ' ' VAL . 60.3 mttm -127.46 123.21 35.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.894 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.941 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 6.4 mm -74.13 107.67 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.35 -175.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.656 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -99.4 104.71 16.6 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.664 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 60.7 t-80 -73.32 133.73 43.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.0 0.428 . . . . 0.0 111.485 -172.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.687 HD13 ' HB3' ' A' ' 150' ' ' ALA . 95.9 mt -101.2 111.83 32.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.887 175.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.803 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 37.6 ttm -97.19 137.36 36.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.936 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 152.82 -161.21 29.45 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.011 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -71.39 139.12 34.15 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.982 2.455 . . . . 0.0 111.344 175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -43.94 -47.21 10.3 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 124.037 3.158 . . . . 0.0 113.964 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -65.53 -39.6 91.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 111.155 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.446 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 57.7 mtt180 -76.16 -28.29 57.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.178 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.85 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 73.1 m -56.92 -59.74 4.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.202 174.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.698 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 31.3 mt-10 -61.58 -39.82 92.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.464 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -54.79 -31.41 58.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.393 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.687 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.34 -34.74 48.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.974 0.416 . . . . 0.0 110.635 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 93' ' ' ILE . . . -71.73 -21.39 61.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.286 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.698 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 8.2 mpt_? -76.74 -30.42 56.58 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.595 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 58.1 mt -70.13 -51.29 40.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.591 175.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.547 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 67.1 mt -59.04 -44.83 92.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.091 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -61.28 -32.2 72.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.386 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.86 -35.51 67.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 47.3 mt -62.0 -38.2 87.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.001 176.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.586 HD21 HG23 ' A' ' 97' ' ' VAL . 22.2 mt -61.08 -41.28 96.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.691 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.25 -32.13 66.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.949 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 34.7 t -64.84 -40.93 95.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.027 0.441 . . . . 0.0 109.906 175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.534 HD21 HG11 ' A' ' 104' ' ' VAL . 93.3 mt -74.19 -22.52 59.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.972 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -73.4 -22.1 60.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.429 173.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.3 m -93.05 93.93 8.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.859 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.443 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.504 -177.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.871 -0.491 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.441 ' HB ' HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -79.4 95.99 5.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.971 0.415 . . . . 0.0 111.405 179.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.572 HG22 HG12 ' A' ' 54' ' ' ILE . 38.0 t -125.03 113.62 36.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.5 175.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -107.32 146.98 30.86 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.449 176.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.595 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 42.5 mt-10 -109.03 120.49 42.69 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.136 0.493 . . . . 0.0 111.507 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 47.8 mm -108.55 127.17 65.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.038 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 ttm -79.64 119.85 23.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.137 0.494 . . . . 0.0 111.525 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.457 HG12 HG11 ' A' ' 16' ' ' VAL . 1.6 mp -100.48 119.01 59.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.171 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.657 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 50.4 Cg_exo -61.74 148.41 93.13 Favored 'Trans proline' 0 N--CA 1.476 0.451 0 C-N-CA 123.761 2.974 . . . . 0.0 112.609 172.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.99 135.45 52.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.7 -45.8 1.69 Allowed Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -170.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.836 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -71.41 -34.01 69.96 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.25 -41.27 60.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.106 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.845 ' HA3' ' HE3' ' A' ' 19' ' ' LYS . . . -61.19 -32.25 79.88 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.957 -0.565 . . . . 0.0 113.221 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.4 pp -91.59 -22.2 20.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.001 0.401 . . . . 0.0 111.401 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.457 HG11 HG12 ' A' ' 8' ' ' ILE . 70.6 t -81.32 -46.56 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.763 0.316 . . . . 0.0 111.656 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 13' ' ' ALA . 25.0 pt -91.6 -27.29 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.193 0.52 . . . . 0.0 110.383 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.7 132.6 6.43 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.845 ' HE3' ' HA3' ' A' ' 14' ' ' GLY . 30.9 mmtp -63.96 -17.81 63.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.122 0.461 . . . . 0.0 110.693 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.45 13.83 8.26 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.87 -1.09 74.07 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.977 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -53.9 -52.85 59.21 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -172.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 15' ' ' LEU . 19.2 m -62.32 -36.45 82.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.822 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.734 HD12 HD12 ' A' ' 27' ' ' LEU . 2.6 tp -66.7 -33.28 62.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.897 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -57.24 -41.7 80.06 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.433 0.635 . . . . 0.0 110.375 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 30' ' ' ARG . 10.7 mt-30 -71.86 -26.37 62.33 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.229 -176.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.734 HD12 HD12 ' A' ' 24' ' ' ILE . 74.2 mt -81.14 -34.36 32.53 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.08 0.467 . . . . 0.0 110.857 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.85 HE22 ' HB2' ' A' ' 35' ' ' MET . 18.6 mm-40 -84.83 -59.12 2.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.271 0.558 . . . . 0.0 110.843 -176.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -85.89 -46.17 10.84 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.722 -172.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.976 HH12 ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -65.84 -52.6 49.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 111.09 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -71.5 -28.95 64.26 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.642 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.72 17.36 54.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.054 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.5 m -118.39 171.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' HD2' ' OE1' ' A' ' 28' ' ' GLN . 52.7 tptt -114.53 109.47 18.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.832 0.825 . . . . 0.0 109.723 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.85 ' HB2' HE22 ' A' ' 28' ' ' GLN . 48.3 mtt -94.68 112.64 24.38 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.452 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.654 HG23 ' HB2' ' A' ' 52' ' ' ARG . 1.0 OUTLIER -111.01 104.13 16.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.905 0.859 . . . . 0.0 109.219 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.718 ' HB3' ' HA ' ' A' ' 51' ' ' LEU . 1.8 pt? -133.46 142.5 48.31 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.041 -173.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.524 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 3.2 mp -66.28 105.13 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.563 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.501 ' HG2' HG21 ' A' ' 17' ' ' ILE . 49.1 mt-30 -85.67 -57.84 2.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.925 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -174.43 118.59 0.22 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 160.86 -49.86 0.36 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.997 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.3 p -72.16 -75.51 0.13 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.904 0.352 . . . . 0.0 111.616 -176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -157.55 -35.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.189 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -79.62 67.32 5.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.443 0.639 . . . . 0.0 110.207 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.0 p -83.34 -57.76 3.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.918 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -93.19 -14.3 27.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.442 0.639 . . . . 0.0 110.239 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.04 158.16 3.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.7 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -56.89 150.36 16.71 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.394 0.434 . . . . 0.0 110.49 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 64.8 mttt -127.33 123.56 23.33 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.24 -167.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.19 124.44 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.81 2.34 . . . . 0.0 112.891 -178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.718 ' HA ' ' HB3' ' A' ' 37' ' ' LEU . 7.2 tt -98.98 118.6 36.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.697 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.654 ' HB2' HG23 ' A' ' 36' ' ' ILE . 3.9 mpt_? -97.52 119.4 36.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.644 0.259 . . . . 0.0 110.53 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 56.4 mt -92.46 110.16 22.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.021 176.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.572 HG12 HG22 ' A' ' 3' ' ' VAL . 27.5 mt -104.55 120.84 55.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.53 -171.08 44.09 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.946 -1.121 . . . . 0.0 113.028 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.479 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 9.5 t70 -60.73 135.49 92.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 O-C-N 123.786 0.345 . . . . 0.0 110.782 177.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -43.48 -46.73 9.73 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.174 2.582 . . . . 0.0 114.262 -174.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.48 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 87.3 t80 -64.81 -40.39 95.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.296 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 52.0 mttp -67.52 -42.26 83.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.281 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.441 HG21 ' HB ' ' A' ' 2' ' ' THR . 98.9 t -60.16 -33.49 53.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.674 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -68.71 -50.1 53.54 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.638 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 12.5 mm100 -65.37 -39.68 92.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.223 -178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.514 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -63.56 -43.45 97.02 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.773 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.2 m -56.93 -44.36 82.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.761 0.315 . . . . 0.0 110.356 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.99 -42.16 99.76 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.905 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.643 ' HB2' ' HB2' ' A' ' 82' ' ' ARG . 5.6 ptt? -77.51 -34.22 54.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.406 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 54.1 t -61.62 -38.69 80.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 110.243 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 67.8 mtt -69.98 -21.84 63.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.542 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.614 ' HB2' HH21 ' A' ' 82' ' ' ARG . 31.9 t70 -84.84 -59.25 2.4 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.789 -177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.753 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -68.44 -20.04 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.069 -174.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.836 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 6.5 tt -76.51 -10.26 59.26 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.309 175.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -65.58 -17.37 64.53 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.917 0.389 . . . . 0.0 110.351 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.497 ' HB3' HD22 ' A' ' 15' ' ' LEU . 10.5 tp10 -56.83 128.43 36.63 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.522 -174.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -96.7 -20.18 18.44 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.013 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -122.46 36.63 4.59 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.648 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 65.08 105.43 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.247 173.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.69 -104.23 0.22 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.753 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 91.26 33.43 8.11 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.541 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 83' ' ' ASN . 21.0 m-85 67.89 -56.68 0.47 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.215 0.606 . . . . 0.0 111.871 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.545 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 115.28 105.79 2.56 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -172.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 2.5 t70 73.39 -61.34 0.5 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.673 0.389 . . . . 0.0 110.354 -173.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.823 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 8.6 ttm180 169.72 -21.17 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.564 1.165 . . . . 0.0 108.712 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.6 ' HA ' ' OD1' ' A' ' 94' ' ' ASP . 0.2 OUTLIER 66.1 31.89 8.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.611 178.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 1.077 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 34.4 tt0 -141.07 -40.05 0.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.157 -173.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.605 ' CE1' ' HB3' ' A' ' 62' ' ' GLN . 20.0 p90 -159.98 -44.07 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.976 ' HA3' HH12 ' A' ' 30' ' ' ARG . . . 65.12 72.74 0.67 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.572 -175.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.774 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 49.7 m 67.67 -37.89 0.34 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 175.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.467 ' HD2' HD13 ' A' ' 89' ' ' ILE . 2.8 tmt_? -68.53 -81.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.981 HD11 ' HG2' ' A' ' 125' ' ' GLN . 31.5 mm -65.97 -80.35 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -168.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.4 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 109.96 73.47 0.75 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 -170.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.581 ' H ' ' HD2' ' A' ' 85' ' ' TYR . . . 118.75 161.12 11.66 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -174.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.812 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 89.34 -146.66 19.11 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.144 179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.077 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 43.4 pt -149.24 162.02 4.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 172.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.6 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 2.3 p-10 -107.4 140.51 40.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.815 HG23 ' HB3' ' A' ' 138' ' ' ALA . 17.2 m -132.91 95.24 19.4 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.466 0.65 . . . . 0.0 111.472 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HD2' ' HA ' ' A' ' 95' ' ' VAL . 12.3 Cg_endo -58.47 108.68 0.42 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.191 2.594 . . . . 0.0 111.899 173.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.731 HG13 HD21 ' A' ' 158' ' ' LEU . 89.8 t -98.2 118.64 63.32 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.447 176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.576 ' HD2' HD22 ' A' ' 158' ' ' LEU . 59.9 Cg_exo -41.35 132.57 3.38 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.518 2.812 . . . . 0.0 112.217 172.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -61.19 -26.47 67.74 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.019 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -92.21 6.73 45.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.639 ' HB3' HD21 ' A' ' 161' ' ' LEU . 22.4 m -122.63 -29.14 4.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.553 -176.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.422 ' HA ' HG11 ' A' ' 97' ' ' VAL . 14.1 p -51.55 -30.75 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.08 -44.7 96.14 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.098 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.08 -35.0 46.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.865 0.364 . . . . 0.0 110.448 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.93 -42.54 95.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.979 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.677 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 48.2 mm -75.49 -45.35 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.892 0.377 . . . . 0.0 110.612 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.12 -147.64 16.86 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.654 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.407 ' HG3' ' N ' ' A' ' 109' ' ' SER . 14.9 ptm180 -108.68 -44.52 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.056 0.455 . . . . 0.0 110.274 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.536 ' HB2' ' HG3' ' A' ' 111' ' ' GLU . 46.2 m -106.6 10.35 31.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.197 0.522 . . . . 0.0 109.748 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 77.03 28.05 59.23 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.325 -176.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -92.48 -20.35 21.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.362 0.125 . . . . 0.0 111.203 -178.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.435 ' HA ' ' HE2' ' A' ' 115' ' ' LYS . 16.7 tpt -74.41 -43.22 57.28 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.677 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 6.2 tp -63.84 -28.24 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.222 178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.718 ' HA ' ' HG2' ' A' ' 117' ' ' GLN . 98.8 mttt -78.68 -19.12 53.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.63 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 63.6 mttm -64.76 -31.82 73.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.8 mm -67.78 -38.61 80.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.245 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.718 ' HG2' ' HA ' ' A' ' 114' ' ' LYS . 2.7 mm100 -72.39 -27.23 62.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.04 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.18 -38.63 35.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.399 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -81.29 -54.99 5.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.357 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -93.0 -5.06 51.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -172.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.88 29.23 67.23 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.727 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.7 m -95.82 177.5 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.168 0.508 . . . . 0.0 111.549 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -129.41 133.87 47.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.062 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.545 HG12 HE22 ' A' ' 117' ' ' GLN . 47.7 mm -99.72 127.23 52.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.336 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.981 ' HG2' HD11 ' A' ' 89' ' ' ILE . 5.3 tp-100 -122.64 97.13 5.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.513 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -74.94 106.39 6.43 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.598 ' HE3' ' O ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -125.62 132.3 52.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.157 -177.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 54.66 -171.83 0.05 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 67.54 -34.9 0.25 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.302 1.041 . . . . 0.0 113.263 173.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -58.18 119.59 7.14 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.452 0.301 . . . . 0.0 110.599 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.87 -37.81 3.31 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.446 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.3 t -91.79 -13.43 31.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.931 0.396 . . . . 0.0 110.546 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -129.89 173.64 19.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.06 -27.11 4.76 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 123.113 2.542 . . . . 0.0 112.368 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.564 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 5.3 mp0 -114.24 161.95 17.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.962 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -110.46 110.93 21.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 34.1 mm -68.24 102.18 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.181 0.515 . . . . 0.0 111.287 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.815 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -80.82 141.05 35.07 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.738 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 57.7 t-80 -106.33 115.02 29.49 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.877 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 154' ' ' ILE . 83.7 mt -80.14 110.75 16.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 27.7 ttp -109.06 123.69 49.56 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.018 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.72 -161.12 34.9 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.43 ' HG2' ' CZ ' ' A' ' 146' ' ' ARG . 18.2 Cg_exo -67.58 141.14 54.23 Favored 'Trans proline' 0 CA--C 1.531 0.343 0 C-N-CA 122.689 2.259 . . . . 0.0 111.531 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -44.31 -51.11 7.2 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 123.799 2.999 . . . . 0.0 114.343 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.58 -38.31 86.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.411 0.624 . . . . 0.0 110.559 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.43 ' CZ ' ' HG2' ' A' ' 143' ' ' PRO . 12.1 ttm180 -72.49 -30.44 64.53 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.253 -176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.812 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 77.5 m -56.35 -57.97 10.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.913 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.49 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 6.4 mm-40 -64.28 -27.75 69.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.679 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -65.92 -29.78 70.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.176 0.512 . . . . 0.0 110.373 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.662 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.2 -34.97 49.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.261 0.553 . . . . 0.0 109.903 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -17.03 64.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.408 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -76.19 -42.1 47.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.861 0.362 . . . . 0.0 110.193 179.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.85 -42.28 82.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.952 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.775 HD12 HD11 ' A' ' 140' ' ' ILE . 73.4 mt -67.57 -34.96 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.472 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.589 ' O ' ' HG2' ' A' ' 159' ' ' GLN . 21.2 t-20 -62.46 -48.81 77.99 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.8 -44.58 70.29 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.094 176.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.2 mp -56.11 -52.95 62.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.415 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.731 HD21 HG13 ' A' ' 97' ' ' VAL . 86.1 mt -62.45 -29.5 70.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.372 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 155' ' ' ASN . 26.6 mm-40 -81.55 -42.94 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.963 0.411 . . . . 0.0 111.131 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.7 p -67.51 -43.39 80.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.912 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.639 HD21 ' HB3' ' A' ' 101' ' ' SER . 4.5 pp -70.48 -17.58 62.97 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -175.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 159' ' ' GLN . 3.4 ptm180 -100.44 12.25 37.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.05 0.452 . . . . 0.0 110.699 -178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.9 m -153.59 -167.97 2.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.286 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.673 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.64 93.48 7.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 47.5 t -126.95 112.72 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.676 171.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -113.41 144.91 42.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.056 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.582 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 41.2 mt-10 -109.52 111.77 23.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.243 0.544 . . . . 0.0 111.654 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.3 mp -105.2 139.07 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 173.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.401 ' HB3' ' OD2' ' A' ' 48' ' ' ASP . 54.2 mtp -95.71 123.73 39.41 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.265 0.555 . . . . 0.0 110.645 -174.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.758 HG12 HG11 ' A' ' 16' ' ' VAL . 1.6 mp -96.98 114.8 65.24 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.725 -175.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.84 147.94 92.06 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.771 2.981 . . . . 0.0 113.007 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.36 132.37 47.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 168.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.53 -44.16 1.59 Allowed Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -170.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -72.05 -26.32 62.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.008 0.432 . . . . 0.0 110.003 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.6 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.31 -32.55 25.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.472 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.445 ' O ' ' HA2' ' A' ' 18' ' ' GLY . . . -60.98 -38.53 95.65 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.566 -0.825 . . . . 0.0 112.903 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.777 HD21 ' HB2' ' A' ' 73' ' ' GLU . 3.5 pp -91.01 -27.23 18.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.405 0.602 . . . . 0.0 111.419 176.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.758 HG11 HG12 ' A' ' 8' ' ' ILE . 75.8 t -70.04 -58.93 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.645 HG13 ' H ' ' A' ' 19' ' ' LYS . 37.9 pt -91.77 -22.64 6.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.329 -0.549 . . . . 0.0 110.67 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . 84.42 19.41 60.43 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.645 ' H ' HG13 ' A' ' 17' ' ' ILE . 32.9 mmtp 65.6 -68.76 0.11 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.671 0.788 . . . . 0.0 111.314 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.55 5.9 79.47 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.69 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.78 10.09 58.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.769 177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 27.7 tt0 -66.25 -39.15 89.29 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.809 -0.23 . . . . 0.0 111.513 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.539 HG21 ' O ' ' A' ' 15' ' ' LEU . 20.5 m -77.25 -33.88 55.95 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.317 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.511 HD13 ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -67.06 -29.99 48.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.901 178.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.554 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 10.7 ttmm -49.68 -55.23 14.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.66 0.743 . . . . 0.0 109.098 168.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.581 HE21 ' NH1' ' A' ' 30' ' ' ARG . 35.9 mt-30 -70.32 -39.3 74.84 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.493 -176.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 32.1 mt -66.61 -25.61 66.69 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.945 -0.472 . . . . 0.0 111.488 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 43.8 mt-30 -85.73 -41.17 15.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.732 0.301 . . . . 0.0 111.352 173.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 25' ' ' LYS . 12.4 mm-40 -86.66 -55.25 3.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -175.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.695 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 6.9 ttm180 -67.1 -50.59 61.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.198 0.523 . . . . 0.0 110.865 -177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.659 ' O ' ' HB3' ' A' ' 87' ' ' SER . . . -70.13 -9.99 57.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.415 178.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.54 23.0 60.01 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.999 173.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.685 HG21 HG23 ' A' ' 53' ' ' ILE . 34.2 m -132.2 155.57 41.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -89.98 109.1 20.15 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.588 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 58.4 mtt -96.71 116.03 28.43 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.432 HD13 ' C ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -109.58 107.12 22.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 122.322 1.058 . . . . 0.0 108.79 178.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.997 HD13 HD12 ' A' ' 51' ' ' LEU . 1.3 pt? -133.47 144.85 49.71 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.013 -176.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.87 HG23 ' HB2' ' A' ' 42' ' ' SER . 2.5 mp -56.95 122.08 5.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 123.507 0.504 . . . . 0.0 110.145 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -129.91 -159.58 0.97 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.332 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.64 99.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.536 0.684 . . . . 0.0 110.346 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.84 -39.24 0.5 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.87 ' HB2' HG23 ' A' ' 38' ' ' ILE . 16.8 m -88.31 171.92 9.81 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 172.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -89.84 -13.74 35.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.884 0.373 . . . . 0.0 111.486 -171.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.827 ' HB2' HG21 ' A' ' 38' ' ' ILE . 94.8 m-20 -87.68 34.9 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -176.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -64.97 -46.13 82.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -85.26 -14.44 46.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.594 0.711 . . . . 0.0 109.76 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.52 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 35.5 t -79.66 156.69 4.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.462 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 7' ' ' MET . 11.2 t70 -66.81 131.13 45.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 173.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.675 ' HD2' ' O ' ' A' ' 38' ' ' ILE . 26.8 mtmm -121.68 125.97 26.59 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -165.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.525 ' HD2' HD13 ' A' ' 38' ' ' ILE . 88.3 Cg_endo -80.57 130.67 7.96 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.581 2.187 . . . . 0.0 112.313 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.997 HD12 HD13 ' A' ' 37' ' ' LEU . 6.8 tt -108.37 128.59 54.89 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.695 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.1 mpt_? -97.62 118.94 35.27 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.481 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.685 HG23 HG21 ' A' ' 33' ' ' VAL . 59.9 mt -88.08 109.51 19.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.476 HG12 HG22 ' A' ' 3' ' ' VAL . 29.4 mt -110.39 119.12 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.86 -170.61 43.54 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.895 -1.145 . . . . 0.0 112.834 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.457 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 7.5 t70 -64.72 137.79 97.25 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 122.781 0.432 . . . . 0.0 110.914 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -40.3 -49.13 3.97 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.601 2.867 . . . . 0.0 113.964 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -63.46 -45.42 90.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.765 0.317 . . . . 0.0 110.724 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 56' ' ' ASP . 46.2 mttm -62.95 -43.74 97.98 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.848 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 53' ' ' ILE . 90.9 t -63.52 -29.25 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.633 178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -80.5 -46.28 16.1 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -173.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -66.99 -32.57 73.89 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.46 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.744 ' HA ' ' SD ' ' A' ' 66' ' ' MET . . . -70.42 -45.02 66.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.513 ' SG ' ' HA ' ' A' ' 61' ' ' GLN . 26.5 p -63.02 -27.23 69.27 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.311 178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.05 -47.54 28.43 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.202 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.744 ' SD ' ' HA ' ' A' ' 63' ' ' ALA . 6.6 ptm -69.13 -38.58 78.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.439 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 26.9 m -63.4 -31.79 54.18 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.444 0 CA-C-N 117.961 0.346 . . . . 0.0 111.326 -178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.7 mtt -81.18 -20.75 40.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.402 0.62 . . . . 0.0 109.959 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 21.1 t70 -83.16 -52.62 6.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.214 -178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.858 HG22 ' HB2' ' A' ' 79' ' ' PHE . 2.7 pp -72.51 -21.43 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 111.363 -177.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 70' ' ' ILE . 6.1 tt -85.9 -4.18 59.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 12.3 ptm180 -51.87 -42.02 62.33 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 174.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.923 ' HG3' ' HA ' ' A' ' 76' ' ' GLN . 26.0 tt0 60.93 101.53 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.812 -1.086 . . . . 0.0 113.449 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.2 ttm105 -101.64 -36.92 8.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.037 170.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -119.81 8.32 11.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.128 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.923 ' HA ' ' HG3' ' A' ' 73' ' ' GLU . 44.6 tt0 68.57 12.29 8.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.789 0.804 . . . . 0.0 110.915 -176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.06 -19.56 6.74 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 64.15 -102.64 0.61 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.858 ' HB2' HG22 ' A' ' 70' ' ' ILE . 87.8 m-85 -135.83 -29.23 1.04 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.231 0.515 . . . . 0.0 110.624 173.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.42 79.91 1.47 Allowed Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.695 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER 71.18 -60.52 0.51 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 124.499 0.764 . . . . 0.0 110.353 -172.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 4.8 ttm-85 142.65 91.74 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 126.204 1.802 . . . . 0.0 108.117 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -67.92 52.04 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.038 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.953 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 33.4 mt-10 -152.13 -45.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.747 -176.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 88' ' ' ARG . 33.1 p90 -177.44 144.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.755 0.312 . . . . 0.0 111.306 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.522 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -128.51 -94.34 0.79 Allowed Glycine 0 C--O 1.221 -0.659 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 174.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.659 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 19.6 p -87.52 13.27 10.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.17 0.509 . . . . 0.0 110.2 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.667 ' CG ' ' HD3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -143.23 174.63 10.55 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.329 -170.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.779 HG12 ' CD2' ' A' ' 139' ' ' HIS . 8.9 mt 59.46 -80.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.768 173.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.73 41.07 89.73 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 141' ' ' MET . . . 151.38 66.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.736 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 168.22 -142.79 7.69 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.953 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 38.9 pt -142.7 143.83 25.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 117.277 0.538 . . . . 0.0 111.262 176.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.442 ' OD2' HG21 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -89.95 126.77 35.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.541 177.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 70.2 t -116.38 95.22 44.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -170.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.52 ' CA ' HD13 ' A' ' 137' ' ' ILE . 38.1 Cg_endo -71.28 106.51 1.94 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 121.4 1.4 . . . . 0.0 111.276 169.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 136' ' ' LYS . 10.7 p -104.47 129.39 25.12 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 121.229 0.538 . . . . 0.0 110.169 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.655 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 52.9 Cg_exo -52.79 128.83 30.04 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.221 2.614 . . . . 0.0 112.624 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.508 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 0.6 OUTLIER -57.43 -25.57 59.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.904 -177.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -92.09 16.36 11.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.605 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.542 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 2.7 p -155.97 12.55 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.7 p -77.01 -20.57 14.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.464 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.13 -33.59 86.31 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.92 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.8 ' HB ' HD11 ' A' ' 161' ' ' LEU . 7.3 p -74.99 -24.02 17.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.063 0.459 . . . . 0.0 110.412 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 97' ' ' VAL . 30.9 t -72.88 -37.62 54.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.064 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 46.7 mm -84.26 -38.99 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.425 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.29 -133.56 11.65 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.7 mtp180 -102.4 -74.03 0.64 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.915 0.388 . . . . 0.0 110.443 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.534 ' HB2' ' OE1' ' A' ' 111' ' ' GLU . 30.5 m -89.38 -4.73 57.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.894 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.494 ' O ' HG22 ' A' ' 113' ' ' ILE . . . 114.01 6.74 20.35 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.06 176.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' HB2' ' A' ' 109' ' ' SER . 1.1 mp0 -65.16 -24.02 67.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 104' ' ' VAL . 15.8 tpt -76.49 -40.61 49.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.402 . . . . 0.0 110.907 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.636 HD11 HG21 ' A' ' 124' ' ' ILE . 6.6 tp -70.02 -32.34 51.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 88.7 mttt -71.29 -29.32 64.91 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.429 0.633 . . . . 0.0 109.642 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.512 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 7.0 ttmt -66.28 -36.85 84.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.746 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.5 mt -65.1 -39.72 86.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.148 0.499 . . . . 0.0 109.709 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.639 HE21 ' HB ' ' A' ' 124' ' ' ILE . 79.2 mt-30 -63.93 -24.84 67.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.428 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -87.01 -50.54 6.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.235 -178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.02 -40.06 32.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.153 -172.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.58 -16.69 20.91 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.266 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.7 42.11 62.81 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.4 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.8 m -112.9 150.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.09 0.471 . . . . 0.0 111.628 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -96.74 122.35 39.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.56 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.639 ' HB ' HE21 ' A' ' 117' ' ' GLN . 50.0 mm -109.44 141.85 23.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.942 0.401 . . . . 0.0 111.998 -170.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.756 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 1.9 pt20 -158.89 144.13 16.19 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -96.82 107.5 19.99 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 121.744 -0.597 . . . . 0.0 109.741 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.667 ' HD3' ' CG ' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -112.55 134.0 54.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.458 -171.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 61.55 -78.83 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.962 0.789 . . . . 0.0 112.892 174.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HA ' ' OG1' ' A' ' 132' ' ' THR . 10.4 m-20 -76.59 72.01 3.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.32 0.581 . . . . 0.0 112.04 -171.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -142.06 98.6 3.36 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 171.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.07 -7.45 81.6 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.988 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' A' ' 129' ' ' ASP . 33.8 p -90.65 -38.01 13.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.171 0.51 . . . . 0.0 110.52 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -128.77 -178.11 15.21 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.532 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.508 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 20.5 Cg_endo -64.31 -61.96 0.1 Allowed 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.424 2.083 . . . . 0.0 112.508 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.655 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 0.4 OUTLIER -86.13 155.6 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.883 0.373 . . . . 0.0 110.833 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.617 ' O ' HG12 ' A' ' 97' ' ' VAL . 74.0 mttt -110.96 113.56 26.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.199 -175.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 4.9 mm -79.19 115.1 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.186 0.517 . . . . 0.0 111.711 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . . . -87.31 142.34 27.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.666 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.779 ' CD2' HG12 ' A' ' 89' ' ' ILE . 2.9 t-80 -86.95 107.69 18.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.12 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.557 HD13 ' HB3' ' A' ' 150' ' ' ALA . 23.1 mt -105.42 121.99 58.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 172.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 91' ' ' GLY . 43.7 ttp -129.82 139.71 51.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 -176.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 154.5 -155.01 25.92 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.3 139.25 37.93 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.475 2.117 . . . . 0.0 111.174 175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.29 -47.93 8.53 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 123.691 2.927 . . . . 0.0 113.229 -173.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -61.28 -48.2 82.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.484 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -66.86 -29.97 70.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.837 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.736 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 66.9 m -59.31 -62.43 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -58.72 -42.79 89.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.882 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.508 ' O ' HG13 ' A' ' 153' ' ' ILE . 11.9 t-160 -58.49 -24.75 61.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.235 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.557 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -81.06 -52.36 7.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.27 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.05 -26.14 68.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -79.66 -19.04 50.01 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.798 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 149' ' ' HIS . 78.4 mt -72.06 -42.53 67.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 167.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.686 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 71.1 mt -61.07 -49.95 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.358 176.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -53.12 -40.22 64.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.529 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.25 -43.73 95.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.883 0.373 . . . . 0.0 110.564 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.03 -39.81 94.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.406 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 33.3 mt -65.48 -36.57 84.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.564 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -79.36 -15.99 57.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.416 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 33.6 t -79.38 -36.43 39.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.131 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.8 HD11 ' HB ' ' A' ' 104' ' ' VAL . 38.5 mt -88.07 -41.36 13.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.852 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 68.93 -73.25 0.09 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.078 0.862 . . . . 0.0 110.451 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 32.7 t -136.87 126.23 24.93 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.677 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.622 179.101 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.593 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.429 ' HB ' HG21 ' A' ' 60' ' ' VAL . 9.9 m -85.81 119.97 26.71 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 78.8 t -127.91 125.95 65.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.077 0.465 . . . . 0.0 111.186 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -122.43 145.16 48.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.837 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 67.3 mt-10 -111.84 126.7 55.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.48 0.657 . . . . 0.0 112.222 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -119.74 126.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 173.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 42.5 ttm -82.34 125.08 30.6 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.019 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.642 HG12 HG11 ' A' ' 16' ' ' VAL . 1.6 mp -101.05 119.37 58.23 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.617 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.642 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 51.2 Cg_exo -60.27 154.5 52.04 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.582 2.854 . . . . 0.0 113.047 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.99 129.76 39.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.63 -38.6 3.04 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -170.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.66 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -70.6 -30.76 67.51 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.601 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -54.67 -35.08 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.618 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.51 -32.57 73.52 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.148 -0.549 . . . . 0.0 113.157 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.755 ' HB3' ' HA ' ' A' ' 76' ' ' GLN . 0.8 OUTLIER -91.48 -25.91 19.06 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 117.069 0.435 . . . . 0.0 111.433 177.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.642 HG11 HG12 ' A' ' 8' ' ' ILE . 85.5 t -77.32 -48.84 23.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.704 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.706 HG13 ' H ' ' A' ' 19' ' ' LYS . 36.8 pt -91.93 -15.42 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.199 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.528 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 90.51 5.47 69.3 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -176.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.706 ' H ' HG13 ' A' ' 17' ' ' ILE . 13.6 tptm 65.27 -64.4 0.18 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.31 1.044 . . . . 0.0 110.645 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.09 -6.76 88.77 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.872 -0.491 . . . . 0.0 111.872 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 108.11 3.14 33.8 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.663 174.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.72 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 34.9 tt0 -62.41 -45.37 93.44 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 117.434 0.617 . . . . 0.0 111.981 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.528 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 25.7 m -71.27 -37.81 71.89 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.566 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.714 HD12 HD12 ' A' ' 27' ' ' LEU . 4.9 tp -64.76 -25.55 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-O 120.802 0.334 . . . . 0.0 110.381 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.72 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 76.0 mttt -58.77 -46.95 86.32 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.63 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -68.33 -39.07 82.06 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.917 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.714 HD12 HD12 ' A' ' 24' ' ' ILE . 39.1 mt -66.63 -26.89 67.29 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.135 -0.353 . . . . 0.0 110.922 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.736 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 79.7 mt-30 -85.52 -52.1 6.07 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -86.58 -55.29 3.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.54 -176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.635 HH22 ' HA ' ' A' ' 83' ' ' ASN . 2.7 mtp180 -62.61 -47.88 81.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.169 0.509 . . . . 0.0 111.269 -177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -78.16 -2.81 39.41 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.695 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.12 22.02 41.27 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.765 174.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.736 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.3 m -133.74 153.66 37.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -93.55 109.24 20.86 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.956 ' HB3' HD21 ' A' ' 51' ' ' LEU . 46.9 mtt -93.47 113.89 26.14 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.413 HD13 ' C ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -109.96 107.96 24.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 122.46 1.124 . . . . 0.0 109.464 -177.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.705 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.1 pt? -133.36 142.81 48.59 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.014 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.9 mm -64.5 98.59 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.115 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.44 ' HG2' HG21 ' A' ' 17' ' ' ILE . 26.0 mt-30 -82.03 -59.8 2.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -122.12 -176.94 3.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.636 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.632 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . 105.6 157.37 22.49 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.3 m -82.24 28.97 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -173.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -105.41 -96.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -100.28 58.5 0.98 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.632 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 1.6 t -61.95 -61.19 2.66 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.508 -174.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.521 ' H ' HG23 ' A' ' 45' ' ' THR . 66.1 t30 -96.03 -22.43 17.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.834 -0.541 . . . . 0.0 111.316 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 m -83.85 -168.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -169.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -57.14 147.97 23.33 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.347 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -135.14 133.98 21.18 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.887 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.07 111.13 1.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.691 2.261 . . . . 0.0 111.578 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.956 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.0 tm? -88.46 111.76 22.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.239 -176.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 35' ' ' MET . 5.3 mpt_? -98.69 111.02 23.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.923 178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.2 mt -85.95 110.42 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.595 HG12 HG22 ' A' ' 3' ' ' VAL . 21.1 mt -110.18 119.93 60.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.202 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.522 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.72 -170.44 43.36 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.032 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.945 ' HB2' ' HE2' ' A' ' 59' ' ' LYS . 7.3 m-20 -61.56 141.9 94.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 122.487 0.315 . . . . 0.0 110.646 175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 54.1 Cg_exo -50.53 -51.69 10.54 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.403 2.736 . . . . 0.0 114.174 -169.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -57.02 -44.55 82.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.065 0.459 . . . . 0.0 110.44 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.945 ' HE2' ' HB2' ' A' ' 56' ' ' ASP . 42.1 mtmt -68.58 -40.57 80.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.759 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 2' ' ' THR . 88.3 t -61.93 -35.65 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.463 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.03 -54.25 28.27 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -65.43 -27.48 68.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.546 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.581 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -79.7 -36.53 37.39 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 178.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 68' ' ' MET . 38.1 t -56.82 -42.4 79.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.075 0.464 . . . . 0.0 110.005 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.47 -26.69 38.13 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.448 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.656 ' HA ' ' HE ' ' A' ' 82' ' ' ARG . 9.9 ptp -66.37 -48.02 71.49 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.462 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.635 ' N ' ' HG3' ' A' ' 66' ' ' MET . 91.9 t -59.83 -47.61 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.815 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 64' ' ' CYS . 19.9 ptp -70.57 -20.59 62.77 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.924 0.392 . . . . 0.0 111.12 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 25.3 t70 -85.98 -44.2 12.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -81.82 -21.37 10.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.901 -0.719 . . . . 0.0 111.053 -177.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.717 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.2 pp -77.02 -2.71 35.36 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.229 174.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 8.4 ptp180 -63.88 -19.95 65.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.278 0.561 . . . . 0.0 109.531 176.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.593 ' HG2' ' N ' ' A' ' 77' ' ' GLY . 9.5 tp10 -52.47 144.17 13.91 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.338 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.1 mtp85 -87.63 -60.1 2.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.013 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -113.61 55.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.7 -173.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.755 ' HA ' ' HB3' ' A' ' 15' ' ' LEU . 62.2 tt0 69.39 114.09 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.739 0.78 . . . . 0.0 112.545 173.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.593 ' N ' ' HG2' ' A' ' 73' ' ' GLU . . . 157.3 -96.35 0.15 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.476 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.7 -99.2 1.48 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.588 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -141.29 -41.42 0.38 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.868 0.366 . . . . 0.0 110.053 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 91.25 91.62 1.35 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -171.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.514 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 3.4 t70 70.57 -69.89 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -165.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.656 ' HE ' ' HA ' ' A' ' 66' ' ' MET . 20.8 ttm-85 171.62 -40.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.763 0.825 . . . . 0.0 109.129 174.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.635 ' HA ' HH22 ' A' ' 30' ' ' ARG . 4.7 t30 61.87 59.13 1.79 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.629 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 1.06 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 44.9 tt0 -173.95 -38.5 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.275 -173.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.434 ' CB ' ' H ' ' A' ' 90' ' ' GLY . 5.6 p90 -168.4 90.16 0.27 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.626 166.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.603 ' HA2' ' HE1' ' A' ' 66' ' ' MET . . . -83.87 96.94 2.01 Favored Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 170.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.617 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 61.3 p 66.84 -53.69 0.45 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.112 1.365 . . . . 0.0 111.896 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 89' ' ' ILE . 6.0 mmt180 -97.42 -167.2 1.5 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.019 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.661 HG23 ' ND1' ' A' ' 139' ' ' HIS . 71.0 mt 75.52 -66.44 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 O-C-N 124.083 0.864 . . . . 0.0 111.085 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.434 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 50.42 61.03 6.23 Favored Glycine 0 N--CA 1.451 -0.352 0 O-C-N 123.691 0.619 . . . . 0.0 112.497 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.34 88.89 1.02 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.878 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.625 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 154.36 -128.06 2.27 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.06 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 31.1 pt -148.37 154.39 10.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -89.03 128.05 35.71 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 53.5 t -119.1 96.72 50.3 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.872 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.512 ' CA ' HD13 ' A' ' 137' ' ' ILE . 60.1 Cg_endo -77.38 107.54 2.42 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.786 1.657 . . . . 0.0 110.941 174.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.404 HG11 ' HA ' ' A' ' 102' ' ' VAL . 21.7 t -100.64 124.43 42.4 Favored Pre-proline 0 C--N 1.319 -0.74 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.205 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -49.1 129.53 22.01 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.589 2.193 . . . . 0.0 110.742 171.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -57.57 -28.51 63.64 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -172.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -80.67 -7.26 59.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.752 0.311 . . . . 0.0 110.877 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.3 m -113.31 -27.27 8.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.71 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.404 ' HA ' HG11 ' A' ' 97' ' ' VAL . 12.1 p -57.44 -30.08 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.837 0.351 . . . . 0.0 111.596 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.49 -34.72 89.95 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.091 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.586 HG21 HD21 ' A' ' 161' ' ' LEU . 43.8 t -74.14 -29.42 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.024 0.44 . . . . 0.0 110.273 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 46.5 t -62.09 -34.99 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.149 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.9 mm -84.13 -47.89 17.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.2 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.39 -116.42 5.51 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.549 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -128.7 -54.31 1.23 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.141 0.496 . . . . 0.0 110.009 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 m -105.1 20.55 18.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.297 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.1 18.15 76.26 Favored Glycine 0 C--O 1.224 -0.475 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.46 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.484 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 6.0 tp10 -68.49 -37.06 79.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.993 0.425 . . . . 0.0 111.092 -174.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.6 tpt -69.68 -43.39 72.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.693 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.44 HD11 ' CB ' ' A' ' 124' ' ' ILE . 19.8 tt -67.31 -27.03 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.155 0.502 . . . . 0.0 111.032 -176.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 50.4 mtpt -65.12 -32.03 73.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.421 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -72.3 -32.33 66.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 113' ' ' ILE . 10.8 mm -63.98 -50.59 76.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -62.84 -29.72 70.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.287 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -79.84 -38.7 32.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.601 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -79.5 -38.91 33.31 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.786 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.456 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -96.65 -11.25 25.47 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 111.49 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.4 23.35 75.8 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.592 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.03 173.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.337 . . . . 0.0 111.425 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 31.6 mtp180 -136.24 141.04 43.91 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 173.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.44 ' CB ' HD11 ' A' ' 113' ' ' ILE . 36.5 mm -110.26 138.67 37.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.524 0.678 . . . . 0.0 112.561 -171.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 138.17 44.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.148 171.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -84.86 105.28 15.52 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.72 ' HE2' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -94.82 -166.13 1.42 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.298 -169.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.429 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 27.7 tp60 -69.17 75.55 0.34 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.618 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.497 ' OD2' ' HA ' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -163.79 81.35 0.43 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.377 172.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -87.51 53.8 2.92 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.743 0.783 . . . . 0.0 109.377 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.61 81.1 1.0 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.198 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.6 p -82.67 1.04 40.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.31 0.576 . . . . 0.0 110.662 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -96.48 -64.33 0.93 Allowed Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.608 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -87.56 -84.5 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.677 2.251 . . . . 0.0 113.185 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -143.8 165.84 26.57 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.356 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -123.08 118.21 27.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.728 0.299 . . . . 0.0 110.353 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.72 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 18.8 mm -70.14 124.22 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.257 0.551 . . . . 0.0 111.966 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -102.39 140.66 36.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.298 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.661 ' ND1' HG23 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -83.54 112.09 19.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.602 178.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.765 HD13 ' HB3' ' A' ' 150' ' ' ALA . 24.7 mt -91.81 123.76 44.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.66 169.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.492 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 44.5 ttm -102.71 136.75 41.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.75 -169.98 24.16 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.126 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 14.5 Cg_exo -70.29 139.1 37.61 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.109 2.539 . . . . 0.0 111.166 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 143' ' ' PRO . 87.0 Cg_exo -48.6 -32.92 22.52 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.24 3.293 . . . . 0.0 114.456 -174.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.1 -43.1 68.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.001 0.429 . . . . 0.0 110.781 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 49.8 mtt180 -72.36 -26.34 61.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.062 0.458 . . . . 0.0 110.03 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.612 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 92.7 m -55.91 -58.04 9.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.801 175.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.85 -30.02 71.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.911 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.428 ' O ' HG13 ' A' ' 153' ' ' ILE . 4.2 t60 -57.86 -35.73 71.36 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.311 0.577 . . . . 0.0 110.214 176.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.765 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.6 -38.35 40.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.905 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.82 -25.16 67.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.58 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -79.15 -25.0 42.91 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.237 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.44 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 42.1 mt -73.35 -37.74 52.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 57.3 mt -71.77 -33.33 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.176 176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -63.68 -40.52 97.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.746 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -63.29 -30.45 71.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.703 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 26.9 mt -66.08 -32.15 73.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.981 0.42 . . . . 0.0 110.096 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.44 -35.69 81.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.879 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -73.15 -36.97 66.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.921 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.6 p -71.34 -21.06 62.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.588 -178.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.586 HD21 HG21 ' A' ' 104' ' ' VAL . 70.1 mt -77.01 17.85 0.41 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -87.91 -5.06 58.75 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 173.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.8 t -122.44 144.34 49.12 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.522 -0.763 . . . . 0.0 108.956 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.731 -177.239 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.865 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.6 m -79.27 135.29 36.72 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 89.1 t -133.91 131.34 56.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.458 -176.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -134.52 149.2 50.65 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 172.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.698 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 46.4 mt-10 -106.49 135.76 47.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.23 0.538 . . . . 0.0 111.741 -176.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.0 mp -119.22 148.15 22.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 173.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mmt -92.33 114.25 26.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.707 0.289 . . . . 0.0 111.369 -177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.571 ' CD1' ' HB2' ' A' ' 51' ' ' LEU . 2.3 mp -100.14 108.01 50.11 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.101 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 12' ' ' LYS . 7.3 Cg_exo -75.92 155.0 38.65 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.939 2.426 . . . . 0.0 111.474 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.17 128.97 38.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.04 -34.56 5.36 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -169.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HA ' ' HG ' ' A' ' 15' ' ' LEU . 10.0 mptt -94.53 -4.39 48.09 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.129 0.49 . . . . 0.0 110.747 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.689 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -61.61 -43.06 99.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.548 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.25 -11.15 55.08 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.831 177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.609 ' CD1' ' HB3' ' A' ' 73' ' ' GLU . 34.1 mt -84.84 -47.8 9.99 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.485 HG21 ' CG1' ' A' ' 8' ' ' ILE . 65.1 t -78.06 -44.58 27.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.989 -176.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.847 HG13 ' H ' ' A' ' 19' ' ' LYS . 23.3 pt -90.77 -15.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 121.54 -0.725 . . . . 0.0 110.468 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.45 -1.19 89.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.783 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.847 ' H ' HG13 ' A' ' 17' ' ' ILE . 14.3 tptm 72.9 -44.04 0.58 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.015 0.926 . . . . 0.0 110.702 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -95.95 -11.04 55.72 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.914 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.81 -9.03 29.84 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.447 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 10.5 mp0 -54.09 -49.29 69.41 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 122.954 0.502 . . . . 0.0 112.33 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 15' ' ' LEU . 26.4 m -70.11 -43.42 71.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -172.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 24' ' ' ILE . 6.0 tp -61.99 -25.9 38.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.331 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 42.6 mttm -62.68 -42.59 99.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.496 175.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.503 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 49.2 mt-30 -83.55 -29.16 28.07 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.003 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.578 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 82.7 mt -65.89 -24.8 66.93 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.541 -0.725 . . . . 0.0 109.683 171.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.768 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.2 mt-30 -86.1 -55.42 3.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.618 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -80.76 -45.4 17.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.574 ' NH2' ' HA ' ' A' ' 83' ' ' ASN . 11.4 mtp180 -76.06 -42.08 48.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.631 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -82.87 -9.07 59.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.122 0.486 . . . . 0.0 110.425 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.04 20.95 71.32 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.456 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.768 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 31.4 m -134.7 163.1 37.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -100.24 110.28 22.52 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 1.0 ' HB3' HD11 ' A' ' 51' ' ' LEU . 51.4 mtt -93.59 114.52 26.88 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.412 HD13 ' C ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -110.85 108.02 24.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 122.399 1.095 . . . . 0.0 109.302 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.66 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.3 pt? -133.68 142.64 48.11 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.262 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 38' ' ' ILE . 3.5 mp -64.31 101.56 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.208 0.528 . . . . 0.0 111.107 -176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -99.29 -58.47 1.93 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -95.42 159.81 14.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.429 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.58 117.03 3.36 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.072 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 t -74.28 78.73 1.83 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.313 0.578 . . . . 0.0 110.775 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -142.65 -54.46 0.41 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.783 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 14.5 m120 -118.58 39.79 3.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.659 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 p -70.71 -61.5 1.74 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.832 0.349 . . . . 0.0 111.232 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -91.29 -4.08 56.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.498 0.666 . . . . 0.0 109.968 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.588 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 39.3 t -90.72 160.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.328 -177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 47' ' ' VAL . 3.8 p-10 -58.3 145.65 37.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.165 0.507 . . . . 0.0 109.706 171.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 128.21 26.04 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.704 -169.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.42 113.29 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.793 2.329 . . . . 0.0 112.13 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.0 HD11 ' HB3' ' A' ' 35' ' ' MET . 48.7 tp -85.58 105.34 16.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.294 -0.867 . . . . 0.0 111.226 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HD2' ' OE2' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -89.52 101.6 14.28 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.33 174.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.4 mt -83.63 109.61 17.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 175.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 3' ' ' VAL . 14.5 mt -107.95 119.47 57.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.152 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.525 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 171.77 -169.97 42.98 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.265 -1.445 . . . . 0.0 113.697 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' HB3' ' HD2' ' A' ' 59' ' ' LYS . 13.1 t70 -55.02 136.05 67.18 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 114.642 -0.779 . . . . 0.0 110.642 174.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 56' ' ' ASP . 33.0 Cg_exo -57.34 -34.32 97.7 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.496 2.797 . . . . 0.0 113.813 -173.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.461 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 68.4 t80 -72.37 -35.64 68.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.556 0.693 . . . . 0.0 109.419 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' HD2' ' HB3' ' A' ' 56' ' ' ASP . 53.3 mttp -76.84 -41.62 43.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.768 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG22 HG22 ' A' ' 53' ' ' ILE . 95.1 t -59.72 -36.61 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.11 176.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -56.55 17.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.45 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 12.4 mm100 -67.05 -34.52 77.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.067 -176.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 67' ' ' VAL . . . -69.98 -44.77 68.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.21 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 52.9 t -56.74 -35.05 68.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.498 0.666 . . . . 0.0 109.584 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' HG2' ' NH2' ' A' ' 82' ' ' ARG . 33.9 tt0 -72.61 -33.83 66.95 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.013 178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.769 ' HA ' ' HE ' ' A' ' 82' ' ' ARG . 0.6 OUTLIER -74.98 -37.52 61.87 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.347 177.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.616 ' N ' ' HG3' ' A' ' 66' ' ' MET . 85.0 t -56.34 -52.35 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.277 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 90.3 mtp -62.57 -21.01 65.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.892 0.377 . . . . 0.0 111.077 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 30.6 t70 -79.37 -56.18 4.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.614 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.908 HG21 ' H ' ' A' ' 82' ' ' ARG . 2.1 pp -81.7 -21.38 10.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.519 ' O ' HD23 ' A' ' 71' ' ' LEU . 6.4 tt -84.8 -10.64 57.0 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.333 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 4.4 ptp180 -66.15 -11.44 49.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.078 0.466 . . . . 0.0 110.342 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.609 ' HB3' ' CD1' ' A' ' 15' ' ' LEU . 10.0 tp10 -50.64 142.22 11.41 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.168 -0.923 . . . . 0.0 111.13 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 74' ' ' ARG . 11.4 mmt180 -80.77 -49.39 11.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.469 -175.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -171.98 20.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.828 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -109.6 -86.46 0.53 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.079 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -151.56 -24.56 0.05 OUTLIER Glycine 0 CA--C 1.521 0.458 0 C-N-CA 119.774 -1.203 . . . . 0.0 114.543 -173.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.37 -127.23 8.78 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.826 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.445 ' HD2' HG22 ' A' ' 70' ' ' ILE . 70.3 m-85 -133.1 -60.28 0.86 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.962 0.411 . . . . 0.0 110.121 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.52 76.78 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.503 ' OD2' ' HB2' ' A' ' 26' ' ' GLN . 3.9 m-20 54.6 44.38 28.77 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 122.119 0.962 . . . . 0.0 109.184 -175.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.908 ' H ' HG21 ' A' ' 70' ' ' ILE . 30.8 ttm-85 69.06 -45.52 0.55 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.624 -1.625 . . . . 0.0 112.353 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.574 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 6.2 t30 61.21 63.64 1.2 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.616 0.722 . . . . 0.0 109.233 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 1.045 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 37.0 tt0 -177.17 -41.72 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.428 -170.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.0 p90 175.08 151.36 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.643 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.34 -12.96 1.75 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.88 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 6.3 p -172.88 -57.68 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.809 0.814 . . . . 0.0 108.815 -174.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.47 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -73.5 -178.44 3.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.618 -1.173 . . . . 0.0 108.473 170.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.805 HG22 ' H ' ' A' ' 91' ' ' GLY . 68.1 mt 74.13 -82.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 167.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 58.03 41.49 94.49 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.649 -171.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.805 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 153.45 91.15 0.08 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.681 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.684 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 158.63 -132.96 3.25 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 175.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.045 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 27.7 pt -147.19 165.94 6.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 169.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.554 ' HB3' ' CG2' ' A' ' 137' ' ' ILE . 19.8 m-20 -111.36 132.18 54.62 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.86 HG23 ' HB3' ' A' ' 138' ' ' ALA . 2.6 m -120.86 95.28 48.97 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 120.965 0.412 . . . . 0.0 111.015 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.77 108.73 1.95 Allowed 'Trans proline' 0 N--CA 1.466 -0.098 0 C-N-CA 122.99 2.46 . . . . 0.0 110.946 173.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.648 HG21 HG21 ' A' ' 105' ' ' VAL . 14.0 p -116.64 127.58 26.63 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 120.861 0.363 . . . . 0.0 111.123 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.427 ' N ' ' HG2' ' A' ' 135' ' ' GLU . 6.9 Cg_endo -50.42 131.56 32.52 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.385 2.723 . . . . 0.0 112.406 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' O ' HG12 ' A' ' 102' ' ' VAL . 15.7 ptt180 -64.22 -25.45 68.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.51 -171.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.84 -4.77 57.28 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.373 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.0 m -123.82 -10.14 7.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.758 0.313 . . . . 0.0 111.548 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 99' ' ' ARG . 12.5 p -63.83 -28.07 44.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 110.387 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.66 -30.03 71.31 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.957 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.0 t -76.53 -36.44 28.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.96 0.41 . . . . 0.0 110.079 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.648 HG21 HG21 ' A' ' 97' ' ' VAL . 54.2 t -69.7 -37.45 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.446 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.736 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 45.7 mm -76.55 -46.92 30.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.177 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.28 170.23 25.91 Favored Glycine 0 N--CA 1.445 -0.752 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -70.94 -53.15 16.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.103 0.478 . . . . 0.0 110.188 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -87.88 -6.93 57.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.182 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 85.69 29.06 27.66 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.687 -176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 78.7 mm-40 -88.99 -25.73 21.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.659 0.266 . . . . 0.0 110.743 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.529 ' SD ' ' HD2' ' A' ' 115' ' ' LYS . 17.4 tpt -68.79 -40.61 79.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.902 0.382 . . . . 0.0 110.328 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.736 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.6 tp -65.79 -27.33 41.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.297 0.57 . . . . 0.0 109.912 177.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 111' ' ' GLU . 55.5 mtpt -76.41 -30.33 57.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.522 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.529 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 99.2 mttt -62.77 -35.87 81.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.191 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 20.2 mm -60.88 -45.45 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.491 0.662 . . . . 0.0 109.295 175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -68.34 -34.6 76.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.6 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -79.49 -42.17 25.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.729 -177.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -79.58 -54.26 6.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.34 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -85.44 -14.37 46.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.859 0.361 . . . . 0.0 111.466 -176.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.51 32.6 57.46 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.168 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.5 m -106.27 171.81 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.191 0.519 . . . . 0.0 111.532 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 27.2 mtm180 -122.13 140.49 52.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.354 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 113' ' ' ILE . 50.8 mm -103.45 141.57 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 111.653 -172.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 24.5 tt0 -144.08 106.92 4.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.794 177.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -82.82 148.54 27.7 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.623 ' HD2' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -151.07 93.43 1.92 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -168.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 45.26 40.73 5.42 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.539 1.136 . . . . 0.0 112.313 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.647 ' HB2' ' HA ' ' A' ' 136' ' ' LYS . 2.4 p30 -106.04 -6.06 19.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.607 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.632 ' HA ' ' HE3' ' A' ' 136' ' ' LYS . 29.9 t70 -78.8 92.82 4.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.048 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.36 -15.78 62.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.879 174.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.6 p -67.71 -32.23 72.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.785 0.326 . . . . 0.0 111.397 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -140.62 -176.73 15.45 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.307 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.62 -27.17 18.86 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.05 2.5 . . . . 0.0 111.736 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.427 ' HG2' ' N ' ' A' ' 98' ' ' PRO . 25.6 mt-10 -128.06 147.34 50.52 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.801 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.647 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 36.6 mtpt -109.38 118.13 35.85 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.614 -168.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.623 ' O ' ' HD2' ' A' ' 127' ' ' LYS . 5.5 mm -78.7 99.5 3.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.55 -175.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.86 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -91.95 141.94 28.09 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.878 176.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.528 ' CE1' HG23 ' A' ' 89' ' ' ILE . 6.7 t-160 -95.55 123.49 39.12 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.006 0.431 . . . . 0.0 110.504 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.612 ' HB ' ' CG1' ' A' ' 93' ' ' ILE . 37.0 mt -97.33 114.85 35.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.284 170.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.489 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 52.7 ttm -101.77 134.59 44.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.179 -175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.55 -165.24 31.39 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.459 ' HD2' ' HD2' ' A' ' 146' ' ' ARG . 20.5 Cg_exo -66.41 148.32 83.95 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.67 2.246 . . . . 0.0 111.658 176.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.39 -53.98 3.88 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.541 2.828 . . . . 0.0 113.645 -176.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -61.24 -44.77 96.71 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.084 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.459 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 53.8 mtt180 -64.84 -39.12 93.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.99 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.446 ' HA ' ' CG2' ' A' ' 140' ' ' ILE . 75.7 m -58.06 -59.21 5.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.003 0.43 . . . . 0.0 110.654 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.645 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 35.0 mm-40 -61.83 -34.73 76.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.836 -176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -67.95 -29.06 68.02 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.798 0.333 . . . . 0.0 110.73 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.552 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -77.72 -34.23 52.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.086 0.47 . . . . 0.0 110.3 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -60.87 -31.38 70.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.749 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.645 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 7.3 mpt_? -77.7 -19.94 54.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.723 -174.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.6 mt -73.22 -40.98 58.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 84.5 mt -68.96 -45.27 80.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.236 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -56.73 -32.39 65.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.789 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.39 -41.7 90.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.188 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.89 -44.58 92.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.223 0.535 . . . . 0.0 110.485 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.513 HD21 HG23 ' A' ' 97' ' ' VAL . 17.2 mt -69.27 -33.07 72.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.152 -177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -64.98 -29.62 70.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.939 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.5 t -66.31 -26.07 67.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.981 0.42 . . . . 0.0 110.322 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.6 mt -89.28 5.38 45.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.678 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -121.12 109.44 15.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.693 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.4 m -82.34 24.72 0.66 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.968 0.413 . . . . 0.0 111.859 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.978 -179.003 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.889 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 57' ' ' PRO . 10.7 m -81.48 105.78 12.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.099 0.476 . . . . 0.0 111.325 -173.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 44.5 t -132.16 113.02 20.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.609 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -108.64 142.25 39.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.964 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.592 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 48.7 mt-10 -104.27 129.58 52.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.416 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -115.9 141.42 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 96.6 mmm -90.69 104.84 17.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.973 0.416 . . . . 0.0 110.965 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.56 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -91.85 118.86 68.49 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.764 -177.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.458 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 43.4 Cg_exo -63.21 140.3 76.92 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.655 2.904 . . . . 0.0 112.809 176.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.94 123.61 21.08 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 170.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.08 -36.97 3.75 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -168.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.795 ' HE3' ' HA ' ' A' ' 74' ' ' ARG . 11.6 mptt -74.11 -19.48 60.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 171.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.567 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -47.53 -41.02 20.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.164 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 19' ' ' LYS . . . -60.24 -36.9 92.04 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.622 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' A' ' 73' ' ' GLU . 3.9 pp -91.42 -23.88 19.9 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.883 0.341 . . . . 0.0 111.518 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.56 HG11 HG12 ' A' ' 8' ' ' ILE . 86.7 t -82.24 -55.04 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.594 HG13 ' H ' ' A' ' 19' ' ' LYS . 40.6 pt -91.79 -14.99 8.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.367 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.738 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 92.18 6.56 64.72 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.858 ' HE2' ' HA ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER 64.98 -68.35 0.11 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.874 0.869 . . . . 0.0 110.204 -176.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.83 -1.09 90.13 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.237 -0.506 . . . . 0.0 111.918 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.59 -5.92 29.71 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.409 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.664 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 57.4 mm-40 -50.87 -51.95 46.42 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -176.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.738 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 27.6 m -71.87 -39.31 69.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -174.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 27' ' ' LEU . 2.6 tp -66.17 -27.64 41.34 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.08 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.338 -176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.664 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 22.0 mttm -56.29 -59.2 5.28 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.453 0.644 . . . . 0.0 109.561 172.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.609 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 18.9 mt-30 -63.51 -37.53 87.67 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.559 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.609 HD12 HD12 ' A' ' 24' ' ' ILE . 95.7 mt -63.2 -33.64 75.93 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 121.921 -0.487 . . . . 0.0 110.815 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.752 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 46.7 mt-30 -85.11 -44.77 12.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.905 0.384 . . . . 0.0 111.512 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.61 -51.47 5.88 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -65.78 -52.41 51.13 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.063 0.459 . . . . 0.0 109.975 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.57 -28.62 63.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.74 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.35 3.55 86.85 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.116 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.2 m -101.2 149.29 6.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -87.66 110.7 20.6 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.778 ' HE1' HD11 ' A' ' 51' ' ' LEU . 32.0 mmm -92.14 111.87 23.6 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.667 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tp -112.22 104.97 17.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.816 0.817 . . . . 0.0 109.379 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.721 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.2 pt? -132.76 127.25 34.24 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.561 -175.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.561 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.2 mp -68.78 99.84 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 172.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HA ' ' HD2' ' A' ' 49' ' ' LYS . 7.2 tp-100 -123.76 -34.06 3.08 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.049 0.452 . . . . 0.0 110.29 -174.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -127.85 42.54 3.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.545 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.17 -156.76 8.4 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.127 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -90.52 -164.42 1.17 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 122.164 0.186 . . . . 0.0 111.214 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 71.62 -79.47 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.229 0.612 . . . . 0.0 111.008 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.544 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 5.7 m-20 -116.74 94.65 4.69 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 p -85.53 -61.87 1.66 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.021 0.438 . . . . 0.0 111.615 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -94.33 -8.7 38.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.926 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.556 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 17.3 t -85.89 164.81 2.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.908 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.403 ' N ' HG12 ' A' ' 47' ' ' VAL . 4.1 m-20 -54.48 142.59 26.86 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.997 0.427 . . . . 0.0 110.29 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 46.1 mtmt -131.6 131.18 22.67 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.75 -167.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.58 131.86 9.61 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.858 2.372 . . . . 0.0 113.382 -175.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.778 HD11 ' HE1' ' A' ' 35' ' ' MET . 0.4 OUTLIER -111.73 124.59 52.66 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.494 178.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.667 ' HB2' HG23 ' A' ' 36' ' ' ILE . 4.7 mpt_? -101.11 119.69 39.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.017 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.543 HG12 ' SD ' ' A' ' 35' ' ' MET . 57.9 mt -91.19 115.28 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 173.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 53.1 mt -104.74 120.72 55.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.381 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.45 -170.92 43.94 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.495 -0.859 . . . . 0.0 113.149 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.721 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 13.8 t70 -72.12 143.5 86.21 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.529 ' HA ' HG21 ' A' ' 2' ' ' THR . 74.6 Cg_exo -40.49 -50.32 3.8 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 123.756 2.971 . . . . 0.0 114.983 -175.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -62.12 -38.94 90.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 111.221 -173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.917 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 19.4 ptmt -79.64 -35.42 39.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -175.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.17 -31.42 52.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.215 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -68.77 -55.84 9.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.806 0.336 . . . . 0.0 110.356 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 15.2 mm100 -59.55 -35.86 75.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.643 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.53 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -73.13 -43.61 61.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.614 ' O ' ' HG3' ' A' ' 68' ' ' MET . 36.0 t -59.11 -42.54 90.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.004 -177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -71.87 -32.54 67.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.599 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.948 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 14.7 ptt? -78.69 -38.67 38.64 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.91 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.516 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 33.7 m -61.8 -22.11 27.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 120.649 0.261 . . . . 0.0 110.602 178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 48.7 mtt -81.71 -39.94 23.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.069 0.462 . . . . 0.0 110.167 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.73 -26.58 29.61 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -171.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.534 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.2 OUTLIER -87.13 -20.93 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 120.865 -1.147 . . . . 0.0 109.714 173.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.491 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 5.2 tt -75.86 -18.04 59.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.045 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -60.5 -14.24 18.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.213 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.65 ' HB3' HD22 ' A' ' 15' ' ' LEU . 8.2 tp10 -47.01 -41.49 16.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.423 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.795 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 45.1 ttp180 74.62 -67.53 0.25 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.501 -178.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.46 62.05 0.77 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -171.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.412 HE22 ' HA3' ' A' ' 14' ' ' GLY . 6.8 tp-100 67.38 127.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.787 0.68 . . . . 0.0 112.63 170.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' A' ' 15' ' ' LEU . . . 137.84 -103.83 0.43 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.683 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.534 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . 73.6 24.8 73.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.368 174.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 68.4 -54.57 0.53 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.514 0.726 . . . . 0.0 111.962 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 110.91 102.45 2.68 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -173.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.703 ' H ' HG23 ' A' ' 23' ' ' THR . 2.7 t70 71.38 -69.37 0.19 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -169.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.948 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 50.9 ttt85 162.13 -33.54 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.846 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 63.35 32.93 14.31 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.33 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.902 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 23.5 tt0 -130.73 -57.97 1.04 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.869 -174.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 9.9 p90 -146.79 -26.32 0.41 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.202 -0.936 . . . . 0.0 113.149 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.584 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 65.63 -89.16 0.11 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.816 -176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.917 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 29.3 m -147.83 22.27 1.12 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.271 0.558 . . . . 0.0 109.606 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -96.41 -86.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.188 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.739 HD11 ' HG2' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -94.44 -164.08 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.251 175.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.597 ' H ' HG22 ' A' ' 89' ' ' ILE . . . -141.92 2.43 1.88 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.711 176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.82 125.17 3.34 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.852 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 103.5 163.34 25.32 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -176.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.902 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 46.3 pt -97.85 157.11 3.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.017 0.437 . . . . 0.0 111.732 -174.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.11 117.47 33.67 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.619 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 25.0 t -107.56 105.73 56.7 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -172.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.443 ' HA ' HD13 ' A' ' 137' ' ' ILE . 48.6 Cg_endo -72.48 108.02 2.43 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 121.826 1.684 . . . . 0.0 110.897 169.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.654 HG23 HD21 ' A' ' 158' ' ' LEU . 11.0 p -124.91 131.14 24.06 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.122 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 87.2 Cg_exo -45.52 134.01 12.83 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.389 2.726 . . . . 0.0 113.437 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 102' ' ' VAL . 10.3 ptm180 -55.85 -33.22 64.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.854 -174.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -86.04 -15.18 42.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.103 0.477 . . . . 0.0 110.416 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.471 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 16.0 m -95.28 -28.45 14.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.85 -176.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 106' ' ' ILE . 13.6 p -63.49 -28.21 44.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.399 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.84 -28.06 72.92 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.811 176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.06 -30.49 14.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.189 0.519 . . . . 0.0 109.765 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 34.6 t -68.82 -34.37 64.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.225 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 102' ' ' VAL . 37.0 mm -80.45 -50.25 17.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.166 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 106.59 -117.8 5.47 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -126.8 -53.97 1.42 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.1 m -102.18 -15.77 16.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.036 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.51 14.53 6.86 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -64.85 -24.61 67.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.873 0.368 . . . . 0.0 110.987 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.621 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 16.0 tpt -86.15 -42.82 13.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.882 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.627 HD11 HG13 ' A' ' 124' ' ' ILE . 15.5 tt -74.01 -35.85 43.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.572 -175.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -69.71 -23.87 63.49 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.495 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 112' ' ' MET . 16.9 ptpt -75.35 -21.96 57.96 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.364 175.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 mm -65.41 -40.94 89.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.636 ' HG3' ' O ' ' A' ' 122' ' ' VAL . 1.8 mp0 -63.78 -31.28 72.41 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.268 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.09 -53.43 7.01 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.541 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -79.4 -51.26 9.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.113 -172.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -84.08 -22.42 31.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.866 0.365 . . . . 0.0 111.425 -175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.01 41.42 40.37 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.088 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.636 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 27.4 m -121.08 160.23 22.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 111.72 -173.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.795 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 83.3 mtp180 -111.11 151.12 28.48 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.633 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.627 HG13 HD11 ' A' ' 113' ' ' ILE . 48.9 mm -114.4 130.99 67.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.082 0.468 . . . . 0.0 111.333 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.739 ' HG2' HD11 ' A' ' 89' ' ' ILE . 5.4 tp-100 -128.2 110.44 12.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.545 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -82.45 107.12 14.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.128 0.49 . . . . 0.0 110.014 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.507 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.15 -174.67 3.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.07 -174.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.4 ' O ' ' HE3' ' A' ' 127' ' ' LYS . 14.8 mm100 -49.94 131.37 22.67 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.442 0.464 . . . . 0.0 111.101 177.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.487 ' HA ' HG12 ' A' ' 137' ' ' ILE . 24.2 m-20 -87.7 -173.31 4.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.796 -176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -73.55 -8.52 56.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.007 0.432 . . . . 0.0 111.071 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 87.39 1.36 83.83 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.855 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.7 p -80.55 -66.72 0.85 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.923 0.392 . . . . 0.0 110.954 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 99' ' ' ARG . . . 134.18 -58.05 0.69 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.579 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.556 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 88.1 Cg_exo -49.15 -39.19 41.88 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.082 2.521 . . . . 0.0 113.501 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 98' ' ' PRO . 36.1 mt-10 -120.7 137.64 54.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.794 0.33 . . . . 0.0 111.101 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -110.97 133.11 53.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.128 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 6.8 mm -78.17 105.64 7.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.192 0.52 . . . . 0.0 111.45 176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.619 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -100.78 109.11 21.08 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 170.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 28.3 t60 -73.64 132.42 42.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.955 0.407 . . . . 0.0 111.119 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.616 HD13 ' HB3' ' A' ' 150' ' ' ALA . 80.5 mt -104.13 107.16 21.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.501 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.795 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 41.1 ttm -93.42 143.4 26.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.076 -174.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 142.44 -165.45 26.74 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 146' ' ' ARG . 32.2 Cg_exo -60.51 136.8 69.81 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.648 2.232 . . . . 0.0 110.523 172.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -52.9 -32.19 55.91 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.034 3.156 . . . . 0.0 113.236 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.09 -51.92 58.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.293 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.595 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 98.1 mtt180 -60.4 -40.73 92.01 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.479 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.852 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 73.2 m -52.33 -59.35 4.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.316 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.16 -39.61 93.19 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.871 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -56.6 -29.83 62.56 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.3 0.572 . . . . 0.0 110.558 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.616 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.97 -36.08 36.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.848 -175.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.75 -19.66 65.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.589 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -77.83 -36.66 49.85 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.9 mt -66.87 -40.49 85.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.833 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.601 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 54.3 mt -66.46 -41.74 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.456 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.559 ' O ' ' HG2' ' A' ' 159' ' ' GLN . 7.6 m-80 -60.31 -39.87 88.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.176 176.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -55.92 -41.01 73.94 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.955 0.407 . . . . 0.0 110.103 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.542 HD11 ' HE2' ' A' ' 112' ' ' MET . 96.5 mt -62.31 -47.57 83.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.266 175.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.654 HD21 HG23 ' A' ' 97' ' ' VAL . 24.8 mt -61.02 -23.83 65.71 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.798 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 155' ' ' ASN . 13.1 mm100 -83.36 -48.6 10.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.161 0.505 . . . . 0.0 110.556 175.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.1 m -67.48 -33.55 75.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.306 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 157' ' ' LEU . 4.4 pp -78.02 -6.07 53.35 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.145 -0.347 . . . . 0.0 111.897 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -68.28 -37.16 80.39 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.9 p -87.56 -51.63 5.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.456 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.501 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.868 176.444 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.571 -0.611 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 t -94.53 152.42 18.57 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 30.0 m -131.37 137.13 56.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.165 0.507 . . . . 0.0 111.417 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -130.35 150.65 51.49 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 73.8 mt-10 -106.19 123.86 48.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 111.57 -173.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -112.33 140.21 33.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 174.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.4 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 44.8 tpp -89.15 113.41 24.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.722 0.296 . . . . 0.0 110.909 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.754 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -98.61 111.14 59.48 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.065 0.459 . . . . 0.0 110.526 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.588 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 51.5 Cg_exo -60.22 139.6 87.9 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.307 2.672 . . . . 0.0 112.713 175.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.3 125.78 25.69 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 169.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.16 -46.25 1.2 Allowed Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -167.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.867 ' HG2' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.7 -32.7 64.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.661 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.21 -31.89 21.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.55 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.431 ' HA2' ' HE3' ' A' ' 19' ' ' LYS . . . -56.16 -44.99 88.75 Favored Glycine 0 C--O 1.223 -0.593 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.49 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 73' ' ' GLU . 3.3 pp -90.09 -18.13 26.45 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.69 -0.3 . . . . 0.0 111.651 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.754 HG11 HG12 ' A' ' 8' ' ' ILE . 91.6 t -82.73 -49.01 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.781 0.324 . . . . 0.0 111.682 178.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.661 HG12 ' O ' ' A' ' 13' ' ' ALA . 10.1 pt -91.36 -21.67 6.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.944 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.794 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 96.16 13.12 50.21 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.597 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.431 ' HE3' ' HA2' ' A' ' 14' ' ' GLY . 3.4 tppp? 67.36 -57.7 0.43 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.961 0.904 . . . . 0.0 110.922 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.53 2.58 46.11 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 175.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 109.39 13.23 17.7 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.088 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.731 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 33.7 tt0 -68.32 -43.59 77.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.841 0.353 . . . . 0.0 111.736 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.794 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 59.3 m -71.06 -40.34 71.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.502 -177.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 35' ' ' MET . 7.3 tp -64.08 -21.53 29.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 120.83 0.348 . . . . 0.0 110.529 -176.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.731 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 47.9 mttm -59.0 -48.31 82.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.288 0.566 . . . . 0.0 110.136 174.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -79.33 -29.83 42.49 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.505 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 92.9 mt -68.42 -27.25 66.03 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 121.844 -0.535 . . . . 0.0 110.449 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.4 mt-30 -84.27 -45.52 12.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.337 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' HB3' ' HA ' ' A' ' 130' ' ' ASP . 20.9 mt-10 -87.82 -39.23 15.03 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.514 ' HD3' ' OD2' ' A' ' 94' ' ' ASP . 4.0 ttm180 -75.29 -46.48 33.23 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.217 -176.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -81.56 -27.0 34.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.28 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.01 21.7 60.66 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.677 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.3 m -121.97 147.0 26.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.91 0.386 . . . . 0.0 111.195 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -90.54 110.38 21.52 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.771 ' HB2' HD11 ' A' ' 24' ' ' ILE . 60.3 mtt -95.09 124.0 38.9 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.3 tp -110.93 100.81 11.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 122.156 0.979 . . . . 0.0 110.451 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 51' ' ' LEU . 1.4 pt? -134.93 142.87 46.62 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.889 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.2 mp -65.83 99.94 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.15 0.5 . . . . 0.0 111.188 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -101.56 -29.04 12.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.004 176.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.19 175.03 7.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.524 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.12 48.13 3.28 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.363 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.0 t -90.21 -157.81 0.5 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -55.82 -61.37 2.41 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.578 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.6 m-20 -85.58 48.63 1.62 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.99 0.424 . . . . 0.0 111.218 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -76.95 -47.94 19.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -93.51 -17.01 23.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.419 0.628 . . . . 0.0 110.068 175.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.578 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 23.1 t -79.4 151.35 4.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.377 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.588 ' OD2' ' HA ' ' A' ' 9' ' ' PRO . 6.6 m-20 -58.97 145.14 42.75 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -114.63 125.72 28.78 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-O 121.029 0.442 . . . . 0.0 111.989 -162.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.8 125.5 3.23 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.825 2.35 . . . . 0.0 111.15 174.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 37' ' ' LEU . 7.3 tt -106.51 120.67 42.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.93 -172.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 36' ' ' ILE . 5.1 mpt_? -102.93 120.74 41.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 71.8 mt -91.1 115.47 30.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.108 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.467 HG12 ' CG1' ' A' ' 3' ' ' VAL . 24.7 mt -104.16 121.39 55.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.98 -170.83 43.76 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.37 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.827 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 1.9 m-20 -57.42 149.08 51.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 123.171 0.589 . . . . 0.0 110.472 175.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.13 -50.28 10.19 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.842 2.361 . . . . 0.0 113.332 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.44 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 50.4 p90 -67.89 -42.53 81.04 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.827 ' HG2' ' HB2' ' A' ' 56' ' ' ASP . 16.8 ptpt -72.12 -29.91 64.54 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.969 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.87 -34.57 70.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.447 . . . . 0.0 110.051 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.565 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 59.2 tp60 -77.03 -45.91 25.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.522 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 14.4 mm100 -63.0 -27.18 69.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.079 0.466 . . . . 0.0 110.131 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.628 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -84.6 -41.81 16.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.784 178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.603 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.8 p -61.1 -34.45 74.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.594 0.235 . . . . 0.0 111.595 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.77 -30.64 32.25 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.745 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.73 ' SD ' ' HD3' ' A' ' 82' ' ' ARG . 17.4 ptt? -76.02 -34.97 59.7 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.446 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 27.2 m -68.8 -22.68 26.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.636 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.603 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 49.3 mtt -82.21 -24.5 34.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.664 0.745 . . . . 0.0 109.394 172.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.463 ' CG ' HH21 ' A' ' 72' ' ' ARG . 10.0 t70 -84.58 -53.3 5.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.594 -171.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.012 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.6 pp -76.17 -20.77 15.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.412 0.625 . . . . 0.0 111.455 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.867 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 2.0 tt -76.06 -9.25 58.47 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.072 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 15.0 ptp180 -52.39 -53.5 44.15 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.604 ' O ' ' HD2' ' A' ' 74' ' ' ARG . 0.0 OUTLIER 53.97 144.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 176.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.604 ' HD2' ' O ' ' A' ' 73' ' ' GLU . 13.0 mmm180 -121.14 -30.31 4.36 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.723 -0.611 . . . . 0.0 110.247 172.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -147.19 41.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.643 -174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.475 ' H ' ' CG ' ' A' ' 73' ' ' GLU . 49.6 mt-30 62.77 30.73 16.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.373 0.606 . . . . 0.0 110.068 -175.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.68 82.7 0.35 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.199 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.36 175.94 44.69 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.646 ' CD1' HG22 ' A' ' 70' ' ' ILE . 92.8 m-85 -81.45 4.29 21.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.097 0.949 . . . . 0.0 112.348 -173.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 23' ' ' THR . . . 78.03 -3.94 59.72 Favored Glycine 0 N--CA 1.461 0.35 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.638 175.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.416 ' O ' HG12 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -177.49 -61.57 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -178.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 1.012 ' HA ' HG21 ' A' ' 70' ' ' ILE . 2.9 ttp-105 162.47 -34.59 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 124.616 1.197 . . . . 0.0 109.45 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.745 ' HA ' ' OD1' ' A' ' 94' ' ' ASP . 2.2 t-20 57.98 58.99 3.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.931 0.872 . . . . 0.0 110.173 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 1.065 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 0.8 OUTLIER -171.95 -136.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.878 -178.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.573 ' HB3' ' H ' ' A' ' 90' ' ' GLY . 1.3 p90 -59.19 -74.42 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.694 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 85.02 -38.57 2.97 Favored Glycine 0 C--O 1.226 -0.379 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 59' ' ' LYS . 13.0 t -170.92 -37.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.907 -0.647 . . . . 0.0 109.352 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.45 ' HG3' ' CB ' ' A' ' 127' ' ' LYS . 6.5 mmt180 -94.64 149.12 21.56 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.381 -176.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.754 HD12 ' HB2' ' A' ' 141' ' ' MET . 39.8 mm 75.48 -67.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 O-C-N 124.083 0.864 . . . . 0.0 111.377 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.573 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 72.11 43.6 47.53 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.46 -174.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 152.16 73.7 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 84' ' ' GLU . . . 147.8 159.37 8.37 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 -171.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.065 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 9.7 pt -91.14 165.86 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -167.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.745 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 0.6 OUTLIER -99.8 148.17 24.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.168 -0.923 . . . . 0.0 108.865 176.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 138' ' ' ALA . 38.7 t -135.0 96.18 14.63 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -174.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -69.48 107.2 1.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.549 1.5 . . . . 0.0 110.504 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.746 HG23 HD21 ' A' ' 158' ' ' LEU . 14.9 p -117.37 128.95 25.68 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 120.584 0.231 . . . . 0.0 110.683 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.451 ' HB2' ' OG ' ' A' ' 101' ' ' SER . 64.1 Cg_exo -39.25 132.84 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.997 3.131 . . . . 0.0 113.443 -178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -56.99 -30.13 63.86 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.476 -171.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -90.1 -12.17 39.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.839 0.352 . . . . 0.0 111.497 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 98' ' ' PRO . 14.8 m -96.57 -17.16 20.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.758 -173.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 106' ' ' ILE . 7.4 p -59.49 -34.7 55.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.13 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.38 -31.01 79.43 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.447 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.63 -37.05 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.012 0.434 . . . . 0.0 109.952 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 97' ' ' VAL . 52.9 t -63.27 -39.87 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.294 176.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.715 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.6 mm -72.41 -42.68 64.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.309 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.98 35.94 7.44 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.788 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 63.25 -78.06 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.03 0.532 . . . . 0.0 111.857 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -69.71 -15.28 63.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.768 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.462 ' HA2' HG22 ' A' ' 106' ' ' ILE . . . 90.99 17.26 52.1 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.839 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -7.9 51.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.865 0.364 . . . . 0.0 110.968 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 14.8 tpt -90.24 -41.43 11.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.966 0.412 . . . . 0.0 109.918 177.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.715 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 8.9 tp -64.31 -22.43 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.207 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 99.3 mttt -81.74 -21.79 37.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.029 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -67.74 -40.24 84.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.008 0.432 . . . . 0.0 109.901 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.536 HG23 HD12 ' A' ' 153' ' ' ILE . 22.1 mt -60.85 -43.65 96.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.78 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -73.71 -18.9 60.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.165 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -87.96 -45.39 10.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.824 0.345 . . . . 0.0 110.882 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -78.49 -46.67 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 146' ' ' ARG . . . -87.16 -17.46 32.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.842 0.354 . . . . 0.0 111.258 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.65 23.96 77.3 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.697 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.4 m -95.47 177.8 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.912 0.387 . . . . 0.0 111.273 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.698 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 98.5 mtt180 -129.24 131.93 47.13 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.606 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.676 HG21 HD11 ' A' ' 113' ' ' ILE . 47.0 mm -98.6 118.69 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 120.974 0.416 . . . . 0.0 111.02 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.69 ' HB3' HD11 ' A' ' 89' ' ' ILE . 50.6 tp60 -116.23 109.94 18.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.838 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -82.58 140.7 33.1 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HD2' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -146.61 -172.36 3.95 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.067 -171.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -52.23 121.3 6.61 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.859 0.361 . . . . 0.0 110.404 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.01 170.97 14.94 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 29' ' ' GLU . 5.0 p-10 -75.31 -45.07 41.95 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.278 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.8 -21.02 10.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.49 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 89.2 m -76.63 -38.54 54.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.158 0.504 . . . . 0.0 110.301 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -91.24 173.77 37.87 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -86.39 17.82 1.68 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.857 2.371 . . . . 0.0 112.661 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -125.83 155.82 40.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.038 0.447 . . . . 0.0 111.301 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.432 ' O ' HG12 ' A' ' 97' ' ' VAL . 23.8 mtpp -110.42 123.91 50.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.222 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.527 ' O ' ' HD2' ' A' ' 127' ' ' LYS . 15.2 mm -72.91 102.31 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.007 0.432 . . . . 0.0 112.005 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -92.72 140.96 28.99 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 169.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.508 ' HB3' ' CG1' ' A' ' 89' ' ' ILE . 2.2 m80 -106.33 138.24 42.87 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.197 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.845 HD13 ' HB3' ' A' ' 150' ' ' ALA . 87.8 mt -107.4 107.25 22.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.325 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.754 ' HB2' HD12 ' A' ' 89' ' ' ILE . 47.4 ttm -85.83 124.43 32.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.824 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.92 -177.82 34.49 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.131 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.64 147.74 86.45 Favored 'Trans proline' 0 C--O 1.224 -0.177 0 C-N-CA 122.913 2.409 . . . . 0.0 111.389 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.712 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 87.5 Cg_exo -45.16 -46.66 13.34 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 123.286 2.657 . . . . 0.0 114.132 -174.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -60.53 -34.55 74.29 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.764 0.316 . . . . 0.0 110.889 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 120' ' ' ALA . 7.0 mtm180 -86.79 -34.48 19.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.053 -0.522 . . . . 0.0 112.188 -176.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.712 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 25.7 p -61.42 -47.14 87.13 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 177.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -69.6 -35.64 75.48 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.597 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -54.56 -32.92 59.3 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.149 0.5 . . . . 0.0 110.942 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.845 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.86 -28.77 44.24 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.089 -176.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.77 -23.65 63.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.955 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -78.08 -25.02 47.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.775 0.322 . . . . 0.0 110.412 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.536 HD12 HG23 ' A' ' 116' ' ' ILE . 62.1 mt -73.87 -42.84 53.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.242 0.544 . . . . 0.0 109.868 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.3 mt -68.81 -39.39 80.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.469 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -58.86 -36.75 75.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.486 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.21 -42.03 93.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.007 0.432 . . . . 0.0 110.173 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.44 -35.23 80.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.49 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.746 HD21 HG23 ' A' ' 97' ' ' VAL . 35.5 mt -62.52 -28.95 70.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.219 0.533 . . . . 0.0 110.323 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -85.21 -47.19 10.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.705 175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.2 t -66.08 -22.62 66.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.477 -171.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 4.6 pp -63.62 -15.0 57.02 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -59.82 -34.92 73.7 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.285 0.564 . . . . 0.0 109.874 173.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 6.4 p -101.99 54.52 0.8 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.747 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.322 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.36 107.27 12.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.955 0.407 . . . . 0.0 111.589 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 38.5 t -130.35 112.52 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.439 173.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -110.87 146.93 35.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.613 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 38.4 mt-10 -110.91 116.9 32.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.219 0.533 . . . . 0.0 112.033 -175.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 49.2 mm -110.16 132.28 58.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 173.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 44.0 ttm -90.41 119.4 30.66 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.516 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.841 HG12 HG11 ' A' ' 16' ' ' VAL . 1.8 mp -92.95 115.63 65.24 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.252 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HA ' ' OD1' ' A' ' 48' ' ' ASP . 59.6 Cg_exo -57.12 142.14 94.32 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.598 2.865 . . . . 0.0 112.404 176.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.38 121.37 13.62 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.6 -54.2 0.6 Allowed Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -167.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.508 ' HE2' ' OE2' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -64.69 -29.77 70.77 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 172.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.702 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -50.33 -33.82 21.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.03 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.777 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -59.56 -41.47 97.27 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.731 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.798 HD22 ' HA ' ' A' ' 76' ' ' GLN . 0.5 OUTLIER -89.39 -31.07 17.93 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.957 179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.841 HG11 HG12 ' A' ' 8' ' ' ILE . 78.4 t -67.29 -47.91 79.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 112.071 0.396 . . . . 0.0 112.071 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.765 HG13 ' H ' ' A' ' 19' ' ' LYS . 21.6 pt -91.03 -21.68 6.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.281 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 98.4 -2.5 59.21 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.859 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.777 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 6.1 tptm 69.78 -50.59 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 111.047 -178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.57 4.96 69.92 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 172.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.7 3.62 64.25 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.801 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 46.7 mt-10 -65.05 -34.31 78.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.545 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 26.7 m -85.37 -40.93 15.94 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.92 -175.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.516 HG21 HE22 ' A' ' 39' ' ' GLN . 3.3 tp -67.19 -26.39 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 63.7 tttt -52.73 -50.99 62.32 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.83 169.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 28.4 mt-30 -74.43 -36.5 63.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.363 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.637 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 88.0 mt -66.13 -28.23 68.64 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.173 -0.329 . . . . 0.0 111.135 178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 24.3 mt-30 -85.6 -43.64 13.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.793 0.33 . . . . 0.0 111.503 176.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.59 -52.0 6.11 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.532 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 29.6 ttm180 -70.35 -53.35 17.03 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.765 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -65.68 -26.2 67.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.349 0.595 . . . . 0.0 110.711 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.93 0.38 75.29 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.998 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 35.3 m -103.88 151.38 6.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -92.51 110.3 21.72 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 1.025 ' HB3' HD21 ' A' ' 51' ' ' LEU . 56.8 mtt -97.24 115.38 27.5 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.361 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.93 104.42 17.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 122.334 1.064 . . . . 0.0 109.664 -177.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.717 ' H ' HD23 ' A' ' 37' ' ' LEU . 1.2 pt? -134.26 142.5 47.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.859 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.0 mp -69.29 100.11 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.516 HE22 HG21 ' A' ' 24' ' ' ILE . 70.2 mt-30 -80.76 -67.12 0.8 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -130.54 101.65 5.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.972 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 45' ' ' THR . . . -155.86 149.51 20.57 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 p -69.76 71.87 0.36 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.12 0.485 . . . . 0.0 111.58 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -169.85 -56.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.411 177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.528 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 90.1 m-20 -126.9 60.55 1.36 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.898 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 41' ' ' GLY . 2.2 p -83.86 -59.87 2.29 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.637 176.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -87.13 -14.92 39.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.354 0.597 . . . . 0.0 109.727 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 47.2 t -79.77 146.06 8.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.833 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.504 ' OD1' ' HA ' ' A' ' 9' ' ' PRO . 42.7 m-20 -58.81 149.91 25.33 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.565 0.541 . . . . 0.0 109.615 177.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -115.97 122.18 32.82 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.936 -166.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.43 121.34 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.47 2.113 . . . . 0.0 111.537 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.025 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.1 tm? -106.19 125.17 50.66 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.299 -174.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.613 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 1.7 mpt_? -103.42 121.25 42.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.378 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 62.9 mt -89.81 109.09 20.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.9 mt -105.94 119.7 55.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.992 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.525 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.18 -171.14 44.04 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.432 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -69.05 146.72 97.41 Favored Pre-proline 0 C--N 1.327 -0.397 0 O-C-N 123.67 0.276 . . . . 0.0 110.522 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.12 -51.89 8.68 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 123.367 2.711 . . . . 0.0 114.186 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -58.2 -44.19 87.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.233 0.54 . . . . 0.0 110.457 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 86.5 mttt -62.82 -46.72 86.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.486 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.13 -34.21 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.52 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -69.63 -50.04 48.1 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.828 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -65.88 -33.5 75.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.341 179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.56 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -69.7 -47.78 61.96 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.079 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 83.3 m -56.27 -37.82 70.32 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.171 0.51 . . . . 0.0 110.304 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -70.08 -41.92 73.45 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.888 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.936 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 10.5 ptt? -78.31 -35.69 47.44 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.425 -173.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.533 ' HA ' ' CD1' ' A' ' 70' ' ' ILE . 26.9 m -59.44 -47.02 92.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.492 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.1 mtm -65.16 -24.29 67.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 110.479 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 35.2 t70 -83.32 -41.97 17.65 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.514 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.695 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -86.99 -32.65 6.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.442 -179.235 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.622 ' HA ' HD11 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -82.66 -11.66 58.19 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.348 -175.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -62.75 -40.67 97.96 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 175.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.508 ' OE2' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 37.21 -156.2 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.622 1.201 . . . . 0.0 113.431 175.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -165.12 -19.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.492 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -163.2 63.93 0.18 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.894 169.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.798 ' HA ' HD22 ' A' ' 15' ' ' LEU . 65.2 tt0 70.94 -18.81 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.59 0.756 . . . . 0.0 112.619 177.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.09 86.03 0.58 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.327 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.695 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -121.25 35.29 3.68 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.468 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 65.97 -60.78 0.29 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.626 0.77 . . . . 0.0 112.258 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 106.62 107.53 3.22 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -172.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.571 ' HB3' ' O ' ' A' ' 80' ' ' GLY . 1.9 t70 70.64 -72.55 0.11 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -168.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.936 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 47.5 ttt-85 165.03 -27.79 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.825 1.25 . . . . 0.0 108.532 172.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 67.04 26.19 9.04 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.282 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 1.039 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 13.9 tt0 -130.52 -66.79 0.75 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.188 0.518 . . . . 0.0 110.191 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.498 ' HB2' ' O ' ' A' ' 89' ' ' ILE . 13.3 p90 -144.84 86.9 1.81 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.771 0.796 . . . . 0.0 110.348 176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -74.18 71.45 1.47 Allowed Glycine 0 C--N 1.315 -0.617 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.748 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.616 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 47.4 m 66.23 2.41 2.35 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.598 ' HD2' ' O ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -85.17 -86.11 0.14 Allowed 'General case' 0 CA--C 1.505 -0.766 0 CA-C-O 121.212 0.529 . . . . 0.0 110.448 174.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.908 HD11 ' HG2' ' A' ' 125' ' ' GLN . 1.7 mt -88.75 -167.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.805 ' H ' HG22 ' A' ' 89' ' ' ILE . . . -144.57 39.62 1.21 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.401 ' O ' ' HE1' ' A' ' 139' ' ' HIS . . . -177.42 124.41 0.94 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.654 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 96.9 165.41 32.84 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.039 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 43.3 pt -94.06 156.22 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 117.292 0.546 . . . . 0.0 112.412 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.496 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 2.2 m-20 -95.88 114.14 25.84 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 175.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.619 HG21 HD12 ' A' ' 140' ' ' ILE . 44.1 t -111.65 104.81 56.45 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HA ' HD13 ' A' ' 137' ' ' ILE . 46.1 Cg_endo -71.32 115.26 4.21 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.349 2.033 . . . . 0.0 112.341 171.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.674 HG23 HD21 ' A' ' 158' ' ' LEU . 10.5 p -117.43 126.22 27.55 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.398 0.618 . . . . 0.0 110.277 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 24.3 Cg_exo -61.79 143.06 95.7 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.306 2.671 . . . . 0.0 112.501 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -59.2 -33.96 71.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.273 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -85.27 20.94 1.83 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.1 p -149.55 -24.52 0.28 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.415 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 106' ' ' ILE . 10.6 p -60.57 -26.55 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 120.694 0.283 . . . . 0.0 110.696 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.84 -35.89 84.65 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.255 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.2 t -78.79 -35.18 17.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.079 0.466 . . . . 0.0 110.055 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 97' ' ' VAL . 41.5 t -63.25 -38.66 82.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.569 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.798 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 44.7 mm -73.87 -40.87 53.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.197 0.522 . . . . 0.0 110.07 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.46 -149.52 19.36 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -75.73 -83.27 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 m -95.92 21.74 8.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.214 0.53 . . . . 0.0 110.645 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.666 ' O ' ' HD3' ' A' ' 114' ' ' LYS . . . 91.79 47.67 3.36 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -170.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -94.26 -54.14 3.67 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.846 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.2 tpt -67.67 -34.29 76.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.882 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.798 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 7.9 tp -67.13 -31.96 55.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.546 -177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.688 ' HD2' HG23 ' A' ' 113' ' ' ILE . 5.7 mptp? -79.51 -23.47 42.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.124 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.422 ' HB3' ' HE3' ' A' ' 115' ' ' LYS . 22.9 mmmt -66.07 -37.27 85.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.8 mm -60.34 -42.87 92.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.519 0.675 . . . . 0.0 109.281 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -67.58 -33.13 74.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.916 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -79.29 -46.58 17.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.514 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -42.23 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.928 -172.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.54 -13.51 29.66 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.286 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.62 23.26 75.69 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.651 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.8 m -99.94 175.28 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.131 0.491 . . . . 0.0 111.432 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 71.1 mtm180 -129.0 141.36 51.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.039 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 113' ' ' ILE . 49.5 mm -102.38 130.0 52.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.024 0.44 . . . . 0.0 110.8 -175.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.908 ' HG2' HD11 ' A' ' 89' ' ' ILE . 6.1 tp-100 -126.62 96.86 4.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.868 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -75.55 112.78 12.25 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 169.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.781 ' NZ ' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -134.57 163.98 28.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.768 -168.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 40.76 -92.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.497 ' OD2' HG12 ' A' ' 137' ' ' ILE . 0.6 OUTLIER -58.87 123.54 16.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.399 0.618 . . . . 0.0 111.562 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -123.14 -68.65 0.87 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.804 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.49 44.56 1.48 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.2 p -67.62 -13.83 62.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.328 -0.436 . . . . 0.0 111.714 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 119.56 -103.19 0.95 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.679 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 36.6 Cg_endo -65.75 -43.69 9.38 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.052 2.501 . . . . 0.0 114.242 -173.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -133.61 148.52 51.57 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.391 0.615 . . . . 0.0 112.089 -168.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 97' ' ' VAL . 30.7 mttm -123.44 117.28 24.8 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.937 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.781 ' HB ' ' NZ ' ' A' ' 127' ' ' LYS . 12.2 mm -71.93 102.22 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.123 0.487 . . . . 0.0 110.676 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.538 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -87.37 98.26 11.26 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 63.9 t-80 -72.1 127.72 33.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.056 0.455 . . . . 0.0 110.634 -172.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 95' ' ' VAL . 93.9 mt -98.65 107.66 20.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.174 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.511 ' HA ' ' HA3' ' A' ' 92' ' ' GLY . 38.6 ttm -92.95 137.72 32.11 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.876 -176.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 149.26 -160.92 28.61 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.703 176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.83 140.6 35.6 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.739 2.293 . . . . 0.0 111.507 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -41.54 -49.64 5.07 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.891 3.061 . . . . 0.0 114.249 -174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -59.42 -52.1 67.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.335 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -61.61 -35.51 78.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.35 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.654 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 72.9 m -56.96 -59.46 5.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.856 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -66.92 -33.73 76.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.971 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.439 ' O ' HG13 ' A' ' 153' ' ' ILE . 4.2 t60 -60.02 -33.17 71.65 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.211 0.529 . . . . 0.0 110.018 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.559 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.09 -45.93 22.12 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.906 -176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.57 -20.74 66.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.06 0.457 . . . . 0.0 110.244 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.46 -28.2 52.3 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.089 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 149' ' ' HIS . 71.6 mt -77.62 -44.93 29.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.132 0.492 . . . . 0.0 109.829 175.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.488 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 73.2 mt -65.49 -41.15 90.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.01 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -57.04 -42.6 80.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.346 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -60.95 -36.87 80.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.92 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.15 -42.18 99.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 109.989 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.674 HD21 HG23 ' A' ' 97' ' ' VAL . 17.6 mt -66.55 -42.59 86.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.99 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -67.56 -34.81 77.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.888 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.2 t -65.83 -31.67 72.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.963 0.411 . . . . 0.0 110.377 178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.16 19.26 4.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.564 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -91.76 44.44 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.98 0.419 . . . . 0.0 110.052 176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.8 t -86.22 71.34 10.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.27 0.557 . . . . 0.0 109.718 -178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.4 -176.304 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.915 -0.474 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 m -79.57 111.51 15.92 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 18.6 m -123.47 120.6 60.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.327 0.584 . . . . 0.0 111.098 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 4' ' ' GLN . 11.7 mm-40 -106.32 139.13 41.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.844 174.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.805 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 61.9 mt-10 -110.99 116.11 30.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.28 0.562 . . . . 0.0 111.54 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.9 mp -105.79 140.13 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.425 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 86.7 mmm -87.02 106.31 17.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.996 0.426 . . . . 0.0 110.901 -176.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.477 ' CG1' HG21 ' A' ' 16' ' ' VAL . 1.8 mp -90.62 109.49 34.69 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.985 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 12' ' ' LYS . 13.3 Cg_exo -72.85 165.75 31.9 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 123.322 2.681 . . . . 0.0 111.695 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.97 148.78 34.07 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.59 ' O ' ' HB3' ' A' ' 76' ' ' GLN . . . 84.65 -58.1 5.0 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.145 -172.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.656 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 7.5 mptt -60.98 -31.0 70.6 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.644 0.259 . . . . 0.0 111.268 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -51.7 -38.03 53.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.686 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.59 ' HA2' ' HG2' ' A' ' 19' ' ' LYS . . . -63.26 -37.51 94.99 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.946 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 3.8 pp -80.97 -24.28 38.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.98 0.39 . . . . 0.0 110.133 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG21 ' CG1' ' A' ' 8' ' ' ILE . 96.2 t -79.77 -52.34 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.311 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.757 HG13 ' H ' ' A' ' 19' ' ' LYS . 27.8 pt -77.64 -27.45 15.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.154 0.502 . . . . 0.0 110.287 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 95.49 8.19 58.67 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.35 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.757 ' H ' HG13 ' A' ' 17' ' ' ILE . 54.3 mmtt 42.47 58.22 3.15 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.678 0.752 . . . . 0.0 110.955 -176.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.17 -27.52 1.56 Allowed Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.398 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.69 -8.02 10.18 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.127 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.716 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 32.8 tt0 -49.96 -59.21 4.09 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -176.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.487 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 23.5 m -67.27 -38.19 84.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 35' ' ' MET . 3.4 tp -65.25 -27.19 41.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.197 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.716 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 35.0 mttm -57.97 -54.46 46.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.19 0.519 . . . . 0.0 109.797 171.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.505 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 25.6 mt-30 -68.88 -34.28 75.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.475 -176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.69 HD13 ' HE2' ' A' ' 35' ' ' MET . 32.6 mt -70.69 -25.7 63.09 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.343 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.762 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 27.0 mt-30 -85.75 -44.07 12.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.691 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -86.11 -54.01 4.73 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.654 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 28.0 ttm180 -71.44 -42.18 68.55 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.972 0.415 . . . . 0.0 110.44 -175.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.666 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -83.32 -9.18 59.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.824 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.12 23.49 66.14 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.886 171.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 20.6 m -129.02 152.11 36.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.982 0.391 . . . . 0.0 110.426 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 49.9 tptt -87.74 110.19 20.27 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.69 ' HE2' HD13 ' A' ' 27' ' ' LEU . 27.9 mmm -92.7 116.39 28.97 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.526 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.7 tp -110.08 111.66 37.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.978 0.894 . . . . 0.0 110.214 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.549 HD13 HD23 ' A' ' 51' ' ' LEU . 3.1 mm? -99.29 135.68 40.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.426 -1.261 . . . . 0.0 109.759 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.484 HG21 ' HD2' ' A' ' 50' ' ' PRO . 13.0 tt -86.79 99.87 8.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.839 0.828 . . . . 0.0 109.755 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.49 32.88 0.13 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.761 -175.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.15 -29.27 16.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.444 -175.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.66 -177.82 16.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.26 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.5 m -79.37 69.85 5.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.329 0.585 . . . . 0.0 110.737 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -134.52 -63.32 0.72 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.036 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.482 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 13.1 m120 -124.78 28.2 6.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.532 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -82.1 -36.17 27.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.132 0.491 . . . . 0.0 109.768 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -93.72 -11.99 30.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.533 0.682 . . . . 0.0 109.676 176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 38.0 t -104.19 164.75 3.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.201 -173.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.446 ' N ' HG12 ' A' ' 47' ' ' VAL . 4.1 p30 -55.88 151.33 11.7 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.028 170.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 40.2 mttp -130.86 125.59 21.37 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.735 -168.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.484 ' HD2' HG21 ' A' ' 38' ' ' ILE . 66.3 Cg_endo -74.27 103.89 1.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.144 1.896 . . . . 0.0 110.831 172.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.805 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -84.7 127.46 34.11 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.975 -175.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.583 ' N ' HD22 ' A' ' 51' ' ' LEU . 3.5 mpt_? -102.42 113.39 26.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.004 0.43 . . . . 0.0 110.728 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 59.1 mt -83.84 112.41 21.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.512 172.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 34' ' ' LYS . 52.0 mt -104.22 120.28 54.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.17 -170.58 43.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.681 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.613 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 9.5 m-20 -68.12 152.57 96.37 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 122.688 0.395 . . . . 0.0 111.139 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.8 -54.71 3.92 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.256 2.637 . . . . 0.0 114.394 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -62.22 -48.46 79.87 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.707 0.289 . . . . 0.0 111.594 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.613 ' HD2' ' H ' ' A' ' 56' ' ' ASP . 16.8 ptpt -68.57 -34.11 75.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.771 -175.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 56' ' ' ASP . 76.7 t -65.3 -30.06 49.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.382 . . . . 0.0 110.189 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.23 -48.55 12.92 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -173.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 15.6 mm100 -63.35 -39.92 95.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.433 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.674 ' HA ' ' CG ' ' A' ' 66' ' ' MET . . . -70.02 -41.22 74.59 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.842 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.1 t -55.53 -43.5 75.82 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.47 0.652 . . . . 0.0 109.631 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -65.16 -48.56 73.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.232 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.674 ' CG ' ' HA ' ' A' ' 63' ' ' ALA . 2.0 ppp? -67.01 -42.56 84.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.472 -177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.645 HG12 HD23 ' A' ' 71' ' ' LEU . 75.3 t -58.47 -49.97 80.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 122.971 0.17 . . . . 0.0 110.924 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.414 ' HE3' HG13 ' A' ' 6' ' ' ILE . 64.4 mtt -58.64 -29.86 66.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.165 0.507 . . . . 0.0 110.425 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.537 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 8.7 t70 -85.54 -35.63 20.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.044 -173.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.731 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.7 pp -86.87 -21.57 7.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.985 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.645 HD23 HG12 ' A' ' 67' ' ' VAL . 3.0 pp -86.35 2.2 48.3 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.341 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 69' ' ' ASP . 7.4 ptp180 -64.07 -14.24 53.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.989 0.423 . . . . 0.0 109.86 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.506 ' HG2' ' C ' ' A' ' 77' ' ' GLY . 8.0 tp10 -51.57 146.75 7.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.452 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -64.01 -36.58 84.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.552 -174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -168.1 112.77 0.65 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.375 173.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.63 ' HA ' HD23 ' A' ' 15' ' ' LEU . 22.4 pt20 37.64 63.48 0.76 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.347 1.059 . . . . 0.0 113.84 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.506 ' C ' ' HG2' ' A' ' 73' ' ' GLU . . . -152.73 29.15 0.84 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.165 176.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.69 171.25 34.49 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.282 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.731 ' HD1' HG22 ' A' ' 70' ' ' ILE . 80.0 m-85 -65.81 -20.42 66.24 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 84.31 98.68 0.63 Allowed Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.654 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 4.0 t70 71.57 -82.94 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -168.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.651 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 44.4 ttt85 169.36 -36.23 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.197 0.599 . . . . 0.0 109.616 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 62.38 36.34 14.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.515 0.674 . . . . 0.0 110.218 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 1.002 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.6 tt0 -142.35 -49.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.455 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.583 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 13.1 p90 -177.04 135.47 0.2 Allowed 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.96 172.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -115.27 -72.49 0.53 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.704 174.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.628 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 18.5 t -108.08 -4.83 17.38 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.16 0.505 . . . . 0.0 110.429 176.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.589 ' HG2' ' HB2' ' A' ' 127' ' ' LYS . 1.4 mpt_? -129.81 172.52 11.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.662 -172.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.609 HG12 ' HB2' ' A' ' 139' ' ' HIS . 35.7 mt 73.21 -78.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 123.813 0.695 . . . . 0.0 112.243 171.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 59.27 44.54 96.42 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.231 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.409 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 151.28 78.05 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.162 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.713 ' HA3' ' O ' ' A' ' 140' ' ' ILE . . . 158.56 -129.28 2.24 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.002 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 29.4 pt -149.99 160.79 4.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 117.081 0.44 . . . . 0.0 109.847 173.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -99.5 125.73 45.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.342 176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 39.9 t -126.2 101.88 27.96 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.65 107.36 2.45 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.021 1.814 . . . . 0.0 112.057 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.512 HG23 HG12 ' A' ' 95' ' ' VAL . 37.8 t -98.89 128.51 32.16 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 121.006 0.432 . . . . 0.0 111.449 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.555 ' HA ' ' HG3' ' A' ' 135' ' ' GLU . 5.5 Cg_endo -47.4 129.26 16.02 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.852 3.034 . . . . 0.0 112.215 174.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.727 ' HD3' ' HB2' ' A' ' 134' ' ' PRO . 23.1 ptt180 -57.49 -32.06 66.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.372 -174.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -87.92 11.34 16.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.734 0.302 . . . . 0.0 111.196 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.656 ' HB3' HD21 ' A' ' 161' ' ' LEU . 9.3 m -127.89 -30.14 2.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.383 -176.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.39 -33.13 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.45 -29.36 66.31 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.533 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.69 -37.1 12.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.08 0.467 . . . . 0.0 110.08 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.97 -41.79 93.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.713 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.652 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 34.1 mm -77.1 -45.69 29.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.518 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 100.64 -124.79 8.36 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.553 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -112.36 -70.39 0.81 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.028 0.442 . . . . 0.0 110.1 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.7 m -99.04 20.4 13.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.172 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 76.56 37.2 35.89 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.794 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -93.88 -33.4 13.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.643 0.258 . . . . 0.0 110.466 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 17.1 tpt -68.43 -41.84 79.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.403 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.1 tp -63.65 -21.69 29.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.614 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -80.61 -19.22 45.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.985 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -68.2 -28.97 67.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.167 0.508 . . . . 0.0 110.166 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.647 HD12 HD12 ' A' ' 113' ' ' ILE . 27.1 mt -71.67 -33.64 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.682 0.754 . . . . 0.0 109.172 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -72.18 -23.93 61.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.292 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -79.86 -40.93 27.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.564 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.4 -56.27 4.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.469 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.487 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -86.94 -23.73 25.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 111.597 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.16 26.65 43.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.703 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 141' ' ' MET . 29.8 m -95.2 164.22 2.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.669 0.271 . . . . 0.0 111.225 -175.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.435 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 13.8 mmt180 -118.33 139.1 51.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 139' ' ' HIS . 48.5 mm -114.64 141.88 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -168.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.666 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 1.1 tp-100 -155.23 106.06 2.56 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.248 178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CE1' HD11 ' A' ' 106' ' ' ILE . 18.2 m-85 -73.39 105.0 4.58 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.888 176.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.589 ' HB2' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -107.25 96.25 6.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.119 -174.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 65.83 -168.63 0.21 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.759 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 136' ' ' LYS . 1.0 OUTLIER -111.26 -179.6 3.77 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.447 ' HA ' HD11 ' A' ' 137' ' ' ILE . 13.5 t70 -67.32 -40.6 85.96 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.307 0.575 . . . . 0.0 110.46 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 98.27 -44.69 1.75 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 -174.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.6 m -66.1 -36.06 82.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.358 0.599 . . . . 0.0 110.281 175.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -146.15 178.86 23.57 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.727 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.727 ' HB2' ' HD3' ' A' ' 99' ' ' ARG . 5.8 Cg_exo -79.61 19.93 0.92 Allowed 'Trans proline' 0 CA--C 1.528 0.177 0 C-N-CA 123.551 2.834 . . . . 0.0 112.414 -178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.555 ' HG3' ' HA ' ' A' ' 98' ' ' PRO . 1.4 mp0 -83.92 147.59 27.41 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.273 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 129' ' ' ASP . 81.7 mttt -108.91 120.9 43.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.555 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 7.0 mm -73.55 123.61 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.016 0.436 . . . . 0.0 111.294 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 126' ' ' PHE . . . -99.0 126.77 44.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.608 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.666 ' HB3' ' O ' ' A' ' 125' ' ' GLN . 1.5 t60 -73.87 126.85 31.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.229 174.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.713 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 82.9 mt -113.98 142.74 25.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.281 -0.872 . . . . 0.0 108.78 172.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 122' ' ' VAL . 51.0 ttm -132.09 131.35 42.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.552 0.215 . . . . 0.0 110.562 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.8 -167.97 30.52 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.82 142.63 76.87 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.537 2.158 . . . . 0.0 111.477 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.91 -46.69 18.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.215 2.61 . . . . 0.0 113.529 -172.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -60.46 -36.87 79.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.083 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.513 ' HA ' ' HB3' ' A' ' 149' ' ' HIS . 53.1 mtt180 -80.1 -26.43 39.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.86 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.59 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 69.9 m -60.65 -56.1 25.35 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 173.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.68 -31.42 72.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.599 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.537 ' O ' HG13 ' A' ' 153' ' ' ILE . 11.9 t60 -59.75 -33.38 71.6 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.145 0.497 . . . . 0.0 110.258 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.713 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.37 -42.39 30.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.388 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 93' ' ' ILE . . . -63.53 -28.42 69.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.08 0.466 . . . . 0.0 110.275 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -25.71 52.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.297 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 149' ' ' HIS . 75.3 mt -74.64 -47.6 38.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.676 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.1 mt -61.36 -46.18 97.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.822 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -54.45 -44.06 72.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.356 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.39 -36.13 83.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.405 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 73.5 mt -63.54 -45.55 90.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.085 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 20.7 mt -62.57 -30.02 71.01 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.442 HE21 ' NE ' ' A' ' 162' ' ' ARG . 27.7 tp60 -79.63 -33.72 41.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.881 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.3 t -79.06 -29.06 43.26 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.271 -172.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 101' ' ' SER . 3.2 pp -81.01 19.8 0.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -172.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.442 ' NE ' HE21 ' A' ' 159' ' ' GLN . 66.0 mtm180 -78.55 47.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.796 0.331 . . . . 0.0 111.459 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.8 m -122.99 -7.23 8.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.756 0.313 . . . . 0.0 110.636 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.785 -177.437 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 5.0 m -111.83 110.6 21.03 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 4.2 p -140.79 140.52 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.519 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -125.69 140.66 52.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.258 176.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 13.0 mp0 -102.39 119.99 39.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.168 0.508 . . . . 0.0 111.623 -178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.695 HG13 HG21 ' A' ' 67' ' ' VAL . 39.1 mm -113.08 146.62 17.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.027 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.455 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 42.3 mtp -105.38 116.46 31.99 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.482 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.697 HG12 HG11 ' A' ' 16' ' ' VAL . 2.1 mp -97.39 109.14 48.72 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.883 -176.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.823 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 50.8 Cg_exo -61.4 152.78 70.53 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.364 2.709 . . . . 0.0 112.558 175.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.67 144.39 57.06 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.17 -45.54 2.64 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -171.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.823 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -69.19 -15.65 63.44 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.946 0.403 . . . . 0.0 110.274 174.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.555 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -54.23 -38.64 65.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.511 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 18' ' ' GLY . . . -65.89 -31.17 78.81 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.925 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.697 ' CD1' ' HA ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -91.92 -29.48 16.65 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.446 -0.443 . . . . 0.0 112.157 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.697 HG11 HG12 ' A' ' 8' ' ' ILE . 89.2 t -83.78 -56.66 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 13' ' ' ALA . 32.0 pt -93.05 -21.12 6.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.136 -0.625 . . . . 0.0 110.864 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . 103.77 -61.74 0.43 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 23.1 tptp 169.31 -35.91 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 170.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.92 -0.36 7.08 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.224 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.648 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 133.11 0.54 4.21 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.189 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HB2' ' HA3' ' A' ' 18' ' ' GLY . 36.3 mp0 -51.08 -54.7 22.5 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.072 0.549 . . . . 0.0 112.08 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.565 HG21 ' O ' ' A' ' 15' ' ' LEU . 87.3 m -81.67 -26.12 34.97 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.508 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.733 HD12 HD12 ' A' ' 27' ' ' LEU . 2.7 tp -67.75 -22.9 28.76 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.156 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.648 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 7.8 mtpm? -56.03 -54.76 41.07 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.555 169.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 45.0 mt-30 -60.6 -44.12 96.65 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.659 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.733 HD12 HD12 ' A' ' 24' ' ' ILE . 50.7 mt -64.38 -28.59 69.8 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.264 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.738 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 47.1 mt-30 -86.88 -49.09 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.921 0.391 . . . . 0.0 111.664 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.41 -54.24 4.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.707 -171.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 94' ' ' ASP . 10.5 ttt180 -63.8 -51.82 63.06 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.793 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -70.9 -26.79 63.38 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.754 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.79 16.83 80.43 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.876 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.9 m -120.11 160.7 20.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -98.11 110.44 23.02 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.677 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 1.048 ' HB3' HD11 ' A' ' 51' ' ' LEU . 43.5 mtt -101.43 125.75 48.11 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.614 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tt -122.53 115.09 44.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.856 0.836 . . . . 0.0 110.733 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.693 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -134.69 145.18 48.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.332 -175.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.798 HG23 ' HB2' ' A' ' 42' ' ' SER . 33.5 mm -59.9 99.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.469 0.652 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -155.45 23.47 0.41 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.972 175.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -111.34 -63.78 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.269 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.43 20.67 0.27 Allowed Glycine 0 CA--C 1.517 0.206 0 C-N-CA 119.924 -1.131 . . . . 0.0 113.736 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.798 ' HB2' HG23 ' A' ' 38' ' ' ILE . 54.6 m -90.95 -166.22 1.53 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 117.279 0.539 . . . . 0.0 110.781 177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -86.28 -27.25 24.5 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -174.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.541 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.4 m-20 -79.58 56.58 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.028 0.442 . . . . 0.0 110.698 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.9 p -83.1 -50.98 7.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.425 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -90.55 -21.47 21.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.525 0.678 . . . . 0.0 109.683 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 23.0 t -79.15 158.82 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.267 -177.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -60.32 153.53 22.41 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.184 0.516 . . . . 0.0 110.525 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -123.88 135.05 25.83 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.766 -163.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.22 104.0 0.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.891 2.394 . . . . 0.0 111.843 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.048 HD11 ' HB3' ' A' ' 35' ' ' MET . 29.5 tp -87.6 129.44 35.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.027 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.614 ' HB2' HG23 ' A' ' 36' ' ' ILE . 7.7 mpt_? -106.73 117.61 34.5 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.407 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.1 mt -92.79 109.34 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.851 175.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.9 mt -106.11 121.54 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.72 -177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 177.82 -171.21 43.75 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.668 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.733 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 11.4 m-20 -64.78 156.28 79.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 C-N-CA 122.412 0.285 . . . . 0.0 110.882 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -48.03 -54.85 4.64 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.148 2.565 . . . . 0.0 113.851 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -63.57 -31.54 72.73 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.946 0.403 . . . . 0.0 110.287 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 56' ' ' ASP . 89.7 mttt -66.84 -52.39 44.26 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.566 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.31 -28.76 45.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.299 -175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -79.85 -41.65 25.89 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.438 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.839 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -72.52 -25.21 61.31 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.831 178.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.712 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -83.42 -40.43 19.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.114 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.61 -33.29 72.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.574 0.702 . . . . 0.0 109.246 174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.27 -47.22 62.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.681 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.712 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 2.3 ppp? -66.91 -42.13 85.93 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.58 -176.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.695 HG21 HG13 ' A' ' 6' ' ' ILE . 27.0 m -59.63 -42.84 89.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.469 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.927 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.3 mtt -68.75 -24.76 64.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.029 0.442 . . . . 0.0 110.629 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.734 ' HA ' ' HE ' ' A' ' 72' ' ' ARG . 52.3 m-20 -81.67 -40.91 22.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.818 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.868 HG22 ' HD2' ' A' ' 79' ' ' PHE . 2.8 pp -88.07 -31.58 5.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.697 ' HA ' ' CD1' ' A' ' 15' ' ' LEU . 1.6 tt -75.71 -15.26 60.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.849 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.734 ' HE ' ' HA ' ' A' ' 69' ' ' ASP . 16.4 ptp180 -60.94 -53.6 55.23 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.541 ' HG2' ' CD2' ' A' ' 15' ' ' LEU . 0.7 OUTLIER 40.35 -169.73 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 174.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -162.09 -30.25 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.0 -1.455 . . . . 0.0 109.214 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -129.16 32.66 4.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.556 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.508 ' HA ' ' CD2' ' A' ' 15' ' ' LEU . 39.4 mt-30 64.42 16.74 10.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.062 0.458 . . . . 0.0 111.351 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -114.11 86.44 0.42 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.464 -0.655 . . . . 0.0 111.464 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 80' ' ' GLY . . . -98.82 40.61 2.41 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.183 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.868 ' HD2' HG22 ' A' ' 70' ' ' ILE . 24.7 m-85 69.28 -32.11 0.22 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.918 0.887 . . . . 0.0 112.818 174.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 93.83 95.95 1.55 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 4.1 t70 72.31 -67.15 0.27 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -170.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.794 ' HA ' HG21 ' A' ' 70' ' ' ILE . 48.0 ttt-85 178.03 -1.93 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.214 169.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 47.5 t30 67.85 -58.65 0.44 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.213 0.605 . . . . 0.0 111.64 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.867 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 36.1 mt-10 -72.92 -23.19 60.67 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -174.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.609 ' CB ' ' HB ' ' A' ' 89' ' ' ILE . 44.7 p90 172.12 140.17 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 122.912 0.485 . . . . 0.0 111.136 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.793 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -112.25 97.33 0.9 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 168.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.495 ' HB2' ' HB1' ' A' ' 31' ' ' ALA . 21.8 t 71.62 -38.15 0.41 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.447 ' HG3' HH11 ' A' ' 88' ' ' ARG . 0.2 OUTLIER -89.73 -167.87 1.98 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.751 HG13 ' CG ' ' A' ' 139' ' ' HIS . 1.5 mp 67.19 -75.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 123.671 0.607 . . . . 0.0 112.3 171.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.428 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 80.23 -31.91 2.32 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.459 -0.401 . . . . 0.0 112.781 -176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.414 ' N ' HG22 ' A' ' 89' ' ' ILE . . . -148.42 118.61 0.99 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.01 -146.18 17.57 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.867 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 44.4 pt -140.98 160.61 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.904 0.352 . . . . 0.0 110.258 174.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 85' ' ' TYR . 32.8 m-20 -108.04 117.88 35.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.03 174.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.799 HG23 ' HB3' ' A' ' 138' ' ' ALA . 20.7 m -117.03 106.03 48.22 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -176.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 32.4 Cg_endo -66.29 107.83 1.25 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.455 2.103 . . . . 0.0 111.311 172.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.412 ' HA ' ' HD2' ' A' ' 98' ' ' PRO . 10.7 p -102.85 127.96 28.89 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.936 0.398 . . . . 0.0 110.85 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.658 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 7.3 Cg_endo -52.73 129.3 31.92 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.185 2.59 . . . . 0.0 112.677 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.603 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -44.77 -40.9 6.46 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 113.988 -1.46 . . . . 0.0 113.268 -176.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.499 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 16.6 p80 -82.45 -4.87 58.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.732 -173.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.526 ' O ' HG12 ' A' ' 104' ' ' VAL . 22.6 t -124.49 8.18 8.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.327 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.45 -26.39 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.155 0.503 . . . . 0.0 110.224 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.63 -39.58 67.26 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.906 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 101' ' ' SER . 6.0 p -64.35 -24.71 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.083 0.468 . . . . 0.0 110.458 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 101' ' ' SER . 48.9 t -74.23 -45.47 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.46 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.19 -36.4 37.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.428 0.633 . . . . 0.0 110.578 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.07 -72.68 2.55 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -175.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -171.2 -71.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.8 m -95.66 20.63 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.442 0.639 . . . . 0.0 110.088 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.42 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 84.96 2.37 88.44 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.876 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -57.4 -24.8 57.67 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 15.1 tpt -89.54 -51.51 5.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.69 0.281 . . . . 0.0 110.852 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.885 HD11 HG13 ' A' ' 124' ' ' ILE . 19.5 tt -67.68 -31.54 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.735 -174.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.557 ' HA ' ' HG2' ' A' ' 117' ' ' GLN . 98.0 mttt -68.65 -19.16 64.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.673 0.273 . . . . 0.0 111.201 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -74.65 -31.06 61.83 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.107 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 25.0 mm -63.37 -38.4 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.716 HE22 HG12 ' A' ' 124' ' ' ILE . 4.9 mm100 -64.1 -32.21 73.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.629 -1.168 . . . . 0.0 110.704 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -87.16 -41.9 13.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.458 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.15 -48.09 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -89.13 -16.22 31.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.152 0.501 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 53.79 6.31 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.122 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 141' ' ' MET . 29.1 m -133.46 170.81 19.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -172.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.669 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 85.9 mtt180 -132.36 153.27 50.93 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.885 HG13 HD11 ' A' ' 113' ' ' ILE . 49.6 mm -114.71 140.44 35.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -172.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.984 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 52.0 tp60 -143.95 101.19 3.7 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.521 175.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -73.14 116.35 13.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.997 0.427 . . . . 0.0 110.574 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.672 ' O ' ' HB ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -139.03 129.42 25.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.689 -177.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 61.53 -171.23 0.15 Allowed 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 172.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -148.17 168.63 21.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.141 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.23 -11.54 54.65 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -171.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.44 -46.07 3.36 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.862 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.8 t -83.89 -1.36 54.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.362 0.601 . . . . 0.0 109.846 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -156.21 177.92 32.99 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.384 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.448 ' HG2' ' HD2' ' A' ' 99' ' ' ARG . 10.3 Cg_endo -93.43 30.27 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.711 2.94 . . . . 0.0 112.143 177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.658 ' OE2' ' HA ' ' A' ' 98' ' ' PRO . 0.8 OUTLIER -81.52 152.27 27.38 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.256 0.551 . . . . 0.0 111.026 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' O ' HG12 ' A' ' 97' ' ' VAL . 59.0 mttm -110.53 114.8 28.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.582 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.672 ' HB ' ' O ' ' A' ' 127' ' ' LYS . 12.5 mm -70.32 105.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.306 0.574 . . . . 0.0 110.357 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.799 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -94.3 126.95 39.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.68 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.984 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 7.3 t-160 -77.8 117.37 19.11 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.099 173.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.609 ' HB ' ' CG1' ' A' ' 93' ' ' ILE . 48.7 mt -97.98 106.57 18.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.669 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 52.9 ttm -85.73 126.63 34.12 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.219 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.15 157.81 8.5 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.496 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.98 149.78 19.92 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.699 2.266 . . . . 0.0 111.741 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.837 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 50.7 Cg_exo -39.12 -44.42 2.64 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 124.037 3.158 . . . . 0.0 114.457 -175.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -59.32 -40.77 87.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.079 0.466 . . . . 0.0 111.484 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -78.62 -50.61 11.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.512 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.837 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 18.8 p -61.33 -52.36 64.99 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.667 -175.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.56 -30.47 71.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.735 0.302 . . . . 0.0 111.685 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -70.83 -25.08 62.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.231 0.539 . . . . 0.0 110.461 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.28 -42.91 24.76 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.964 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.89 -30.23 68.87 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -19.95 54.44 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.915 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.5 mt -80.18 -45.13 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 174.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.6 mt -64.11 -45.01 97.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.342 177.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -56.06 -37.35 69.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.305 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.85 -43.61 90.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 110.305 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 70.3 mt -63.14 -40.33 97.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.425 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 7.7 mt -62.5 -40.83 97.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.039 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.44 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . 17.9 mt-30 -68.37 -28.9 67.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.855 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.7 t -73.72 -33.16 64.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.376 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 43.1 mt -92.15 19.62 6.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.391 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 159' ' ' GLN . 39.8 mmt180 -79.76 68.64 5.9 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.4 p -69.72 93.72 0.75 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.33 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.348 -175.209 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.868 0 N-CA-C 112.222 -0.351 . . . . 0.0 112.222 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 57' ' ' PRO . 37.1 m -152.67 96.21 2.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.869 0.366 . . . . 0.0 110.155 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 70.5 t -122.52 116.63 49.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.044 0.449 . . . . 0.0 111.027 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -107.77 163.03 13.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 49.0 mt-10 -127.82 120.09 27.08 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.079 0.466 . . . . 0.0 111.768 -174.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 6' ' ' ILE . 3.7 mp -111.36 140.52 30.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.535 -0.757 . . . . 0.0 108.969 175.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.498 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 39.0 ttm -90.12 122.44 33.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.811 0.339 . . . . 0.0 110.808 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.589 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.7 mp -95.88 110.78 53.4 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.751 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.784 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 32.6 Cg_exo -65.82 146.66 83.95 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.463 2.775 . . . . 0.0 111.909 172.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.42 130.72 44.84 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.63 -40.31 2.59 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -168.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.784 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 1.3 mptm? -84.36 -30.68 25.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.069 -0.566 . . . . 0.0 109.952 173.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.604 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -49.54 -45.45 47.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.855 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -58.0 -39.59 92.12 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.467 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 76' ' ' GLN . 3.5 pp -84.87 -36.39 21.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.069 0.434 . . . . 0.0 110.918 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.658 HG21 HD12 ' A' ' 71' ' ' LEU . 59.9 t -65.94 -42.79 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.682 0.277 . . . . 0.0 111.727 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.895 HG13 ' H ' ' A' ' 19' ' ' LYS . 13.9 pt -92.25 -27.13 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.033 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.587 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 99.88 0.17 56.33 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.643 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.895 ' H ' HG13 ' A' ' 17' ' ' ILE . 7.2 tptm 74.28 -35.66 0.31 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.139 0.975 . . . . 0.0 111.423 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.99 2.55 17.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.945 173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.78 -2.76 38.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.608 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 6.8 mp0 -55.52 -44.94 77.15 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.587 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 88.5 m -74.16 -46.95 39.1 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.496 -177.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.643 HD11 ' HB2' ' A' ' 35' ' ' MET . 7.6 tp -62.83 -26.58 41.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 22' ' ' GLU . 1.3 tmtm? -55.41 -44.83 76.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.212 173.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.414 ' HG3' ' HD2' ' A' ' 25' ' ' LYS . 20.7 mt-30 -85.36 -20.55 29.75 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.707 -177.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.703 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 33.8 mt -79.38 -24.25 42.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.44 0.638 . . . . 0.0 109.494 176.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.701 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 23.5 mt-30 -86.03 -38.88 17.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.892 174.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -86.73 -63.06 1.37 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.431 ' HD3' ' CG ' ' A' ' 94' ' ' ASP . 13.7 ttm180 -65.96 -34.21 77.59 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 110.778 -174.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -87.63 -9.74 53.38 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.024 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.01 22.7 55.84 Favored Glycine 0 C--N 1.33 0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 113.484 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 30.6 m -126.95 148.99 31.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -177.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -89.75 109.01 20.03 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.922 ' HB3' HD11 ' A' ' 51' ' ' LEU . 7.4 mtm -98.29 117.26 32.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.1 tp -111.29 104.7 17.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.928 0.87 . . . . 0.0 110.5 -173.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -133.98 142.28 47.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.915 -178.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.699 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 3.9 mp -68.31 100.44 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.159 0.504 . . . . 0.0 110.604 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 12.2 mt-30 -96.58 -56.05 2.72 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -121.54 95.9 4.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.089 -179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -176.44 158.56 24.95 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.829 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.7 t -88.82 85.35 6.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.972 0.415 . . . . 0.0 110.453 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -164.46 -79.07 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.021 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 3.2 m-20 -118.52 66.2 0.77 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.51 -56.3 3.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.717 -174.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -93.73 -6.01 47.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.208 1.004 . . . . 0.0 108.519 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 56.5 t -86.42 158.74 3.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.952 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -60.32 148.79 35.66 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 110.323 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.699 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 52.0 mttt -128.62 134.73 26.6 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.024 -166.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.7 121.64 3.34 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.665 2.244 . . . . 0.0 112.125 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.922 HD11 ' HB3' ' A' ' 35' ' ' MET . 53.3 tp -98.03 111.68 23.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.794 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.9 mpt_? -98.22 116.22 29.98 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.506 175.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 49.8 mt -92.14 111.19 23.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.553 177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.9 mt -106.6 120.26 57.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.767 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.428 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 173.15 -171.51 44.51 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.42 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.648 ' HB2' ' HE3' ' A' ' 59' ' ' LYS . 3.7 m-20 -65.14 141.69 98.35 Favored Pre-proline 0 C--N 1.33 -0.239 0 C-N-CA 122.149 0.18 . . . . 0.0 111.332 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.496 ' HA ' HG21 ' A' ' 2' ' ' THR . 96.7 Cg_exo -43.39 -54.2 3.73 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.873 3.049 . . . . 0.0 114.234 -174.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -61.13 -41.82 97.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.666 0.27 . . . . 0.0 111.579 -174.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.991 ' HB2' ' HB2' ' A' ' 87' ' ' SER . 18.3 ptpt -77.44 -27.16 52.09 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.381 -173.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 56' ' ' ASP . 91.4 t -64.56 -32.06 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.986 175.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -73.04 -52.81 12.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -61.98 -37.84 86.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.554 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.562 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -72.25 -39.15 68.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.725 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.413 ' HA ' HG22 ' A' ' 67' ' ' VAL . 42.5 t -57.73 -35.29 70.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.268 0.556 . . . . 0.0 110.076 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.63 -40.93 76.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.774 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.562 ' HG3' ' O ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -78.11 -34.95 49.8 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.494 -176.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 33.1 m -67.92 -26.3 34.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-O 120.811 0.338 . . . . 0.0 110.614 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 66.3 mtt -81.4 -21.36 39.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.011 0.434 . . . . 0.0 109.897 173.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.85 -55.31 4.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.944 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.658 ' HB ' ' H ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -70.01 -19.71 22.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.397 0.617 . . . . 0.0 110.48 -177.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.658 HD12 HG21 ' A' ' 16' ' ' VAL . 3.1 tt -85.77 -16.33 39.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.19 174.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.432 ' HB3' ' O ' ' A' ' 68' ' ' MET . 8.2 ptm180 -69.83 -8.29 47.16 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.902 -0.136 . . . . 0.0 111.306 -174.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 10.3 tp10 -59.21 -94.87 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 O-C-N 123.586 0.554 . . . . 0.0 111.99 -172.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 73' ' ' GLU . 37.8 ttp180 159.59 -59.74 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -86.97 147.15 25.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.272 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.664 ' HA ' HD23 ' A' ' 15' ' ' LEU . 29.7 tt0 -54.12 99.87 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.162 0.506 . . . . 0.0 110.834 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.39 -78.6 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.308 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 59.48 -117.26 10.57 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.658 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 90.7 m-85 -127.73 -55.32 1.31 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.496 ' O ' HG13 ' A' ' 70' ' ' ILE . . . 135.98 -79.97 0.31 Allowed Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 170.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 82' ' ' ARG . 6.2 p-10 -103.25 2.78 34.74 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.828 0.823 . . . . 0.0 109.237 170.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 20.4 ttt180 86.86 -31.21 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.587 -176.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.4 t30 51.5 71.99 0.41 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.729 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 18.0 tt0 -176.36 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.003 -171.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.854 ' HA ' HD12 ' A' ' 89' ' ' ILE . 34.8 p90 -171.88 -37.63 0.02 OUTLIER 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 175.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 72.57 -91.69 0.58 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.818 -175.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.991 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 46.1 p -117.16 -11.68 10.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.588 0.708 . . . . 0.0 111.01 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.712 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 46.9 mtt180 -113.65 -163.98 0.9 Allowed 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.571 -169.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.854 HD12 ' HA ' ' A' ' 85' ' ' TYR . 75.6 mt 60.66 -84.2 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.678 0.611 . . . . 0.0 112.274 168.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.17 45.4 81.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.857 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.492 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 150.82 90.62 0.08 OUTLIER Glycine 0 CA--C 1.518 0.261 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.46 -149.64 18.71 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 23.7 pt -136.77 167.14 24.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 117.605 0.703 . . . . 0.0 111.107 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.537 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . 2.1 p30 -105.43 141.8 36.3 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.373 173.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.851 HG23 ' HB3' ' A' ' 138' ' ' ALA . 6.2 m -136.92 102.86 9.14 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 121.076 0.465 . . . . 0.0 111.451 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HB3' HD13 ' A' ' 137' ' ' ILE . 36.1 Cg_endo -67.2 107.86 1.44 Allowed 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.893 2.395 . . . . 0.0 111.739 173.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 105' ' ' VAL . 7.6 p -105.79 131.2 21.95 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.247 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.467 ' HG3' ' NH2' ' A' ' 162' ' ' ARG . 84.6 Cg_exo -45.28 125.91 7.66 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.673 2.915 . . . . 0.0 113.104 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -61.46 -21.03 63.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.947 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -92.04 8.11 39.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.704 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 105' ' ' VAL . 41.7 m -141.88 0.44 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 106' ' ' ILE . 10.1 p -66.84 -33.37 62.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.393 -176.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.18 -29.9 76.49 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.894 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.08 -40.22 58.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.049 0.452 . . . . 0.0 109.988 177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 97' ' ' VAL . 40.4 t -64.22 -41.6 92.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.303 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.738 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.1 mm -67.07 -49.28 74.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.487 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 80.38 69.16 1.42 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.126 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 57.43 -88.85 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.522 0.729 . . . . 0.0 112.309 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.0 t -97.69 18.81 14.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.987 0.422 . . . . 0.0 110.971 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.66 22.92 41.16 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.057 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -72.91 -43.91 61.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.047 0.451 . . . . 0.0 110.839 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.4 ' SD ' ' HD2' ' A' ' 115' ' ' LYS . 16.6 tpt -74.05 -40.29 62.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.632 -177.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.738 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.5 tp -66.47 -32.67 59.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.815 -178.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -80.85 -22.63 39.72 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.991 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.4 ' HD2' ' SD ' ' A' ' 112' ' ' MET . 0.0 OUTLIER -66.76 -37.25 84.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.9 mt -63.28 -40.97 91.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 75.1 mt-30 -63.05 -32.85 74.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.29 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -84.6 -40.1 17.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.987 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.78 -42.04 28.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.361 -172.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.66 2.41 47.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.513 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.98 32.49 82.31 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.464 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.91 171.6 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.008 0.432 . . . . 0.0 111.263 -175.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.844 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 3.2 mmp_? -124.1 152.28 42.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 49.6 mm -117.08 133.47 63.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.087 0.47 . . . . 0.0 111.65 -175.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.585 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 23.8 tp60 -139.37 99.63 3.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.368 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -74.9 140.6 43.91 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 121.932 -0.48 . . . . 0.0 109.792 175.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.616 ' HD3' HH11 ' A' ' 88' ' ' ARG . 0.7 OUTLIER -153.11 138.2 17.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.146 -175.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.412 ' HB2' ' NH1' ' A' ' 88' ' ' ARG . 14.2 mm100 51.48 -164.65 0.06 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.438 0.461 . . . . 0.0 111.254 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 46.28 39.63 6.52 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.024 0.827 . . . . 0.0 111.777 169.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -102.0 80.54 2.01 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.812 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.09 -14.9 44.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.051 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 21.8 p -64.06 -66.62 0.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.133 0.492 . . . . 0.0 111.125 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -99.24 -174.03 31.41 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.494 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.69 -21.61 14.45 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.858 2.372 . . . . 0.0 112.204 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HG3' ' N ' ' A' ' 98' ' ' PRO . 5.3 mp0 -121.86 159.93 25.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.043 0.449 . . . . 0.0 111.019 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -121.77 117.53 26.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.542 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.537 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 30.1 mm -71.42 102.45 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.244 0.545 . . . . 0.0 111.968 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.851 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -90.5 142.48 27.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.558 176.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.588 ' NE2' HG23 ' A' ' 89' ' ' ILE . 6.0 t-160 -91.23 115.66 28.2 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.658 HD13 ' HB3' ' A' ' 150' ' ' ALA . 47.3 mt -94.15 113.98 29.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.25 172.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.844 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 43.8 ttm -98.95 132.84 43.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.575 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 153.17 -175.14 31.74 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.617 -0.802 . . . . 0.0 111.925 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.93 145.91 75.9 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.681 2.254 . . . . 0.0 111.592 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.685 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 96.8 Cg_exo -44.68 -48.63 10.23 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.523 2.816 . . . . 0.0 113.869 -173.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.9 -38.69 79.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.936 0.398 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -84.56 -37.33 21.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.874 -174.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 29.4 p -57.74 -47.83 81.34 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -69.22 -32.95 72.54 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.683 0.277 . . . . 0.0 110.655 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -64.69 -27.78 69.16 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.658 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -77.19 -29.77 54.52 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.9 0.381 . . . . 0.0 110.704 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.69 -25.32 66.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.839 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -78.29 -20.32 51.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.469 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 61.5 mt -79.77 -39.89 20.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.28 0.562 . . . . 0.0 109.56 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.568 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 53.2 mt -71.17 -51.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.824 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -58.07 -32.21 67.82 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.995 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.24 -32.29 72.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.245 0.545 . . . . 0.0 110.462 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.8 -44.44 23.13 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.814 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.827 ' HA ' HD21 ' A' ' 161' ' ' LEU . 57.6 mt -64.12 -26.61 68.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.117 -174.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -74.22 -15.28 61.0 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.831 0.348 . . . . 0.0 110.732 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.572 ' HB3' HD13 ' A' ' 161' ' ' LEU . 20.5 t -79.68 -60.3 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.464 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.827 HD21 ' HA ' ' A' ' 158' ' ' LEU . 0.0 OUTLIER -73.98 21.51 0.09 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.467 ' NH2' ' HG3' ' A' ' 98' ' ' PRO . 35.1 mmt180 -97.63 40.66 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 169.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.3 m -67.23 132.87 48.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.806 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.316 178.21 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 14.0 m -92.86 89.38 6.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.853 0.358 . . . . 0.0 110.148 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 22.4 m -124.85 145.77 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.27 -178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 73.1 mm-40 -130.42 150.78 51.49 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.55 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 43.6 mt-10 -111.21 121.93 46.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.908 0.385 . . . . 0.0 111.505 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.4 mp -106.06 140.58 23.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.404 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -87.37 110.09 20.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.444 -177.612 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.69 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -98.36 111.48 59.9 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.151 0.5 . . . . 0.0 111.084 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 7' ' ' MET . 37.1 Cg_exo -62.55 151.87 80.83 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.707 2.938 . . . . 0.0 112.789 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.36 133.45 46.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.4 -49.9 1.02 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -167.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 13.9 mptt -69.08 -32.71 72.35 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 170.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.677 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -50.99 -35.09 31.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.415 176.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.415 ' CA ' ' HG2' ' A' ' 19' ' ' LYS . . . -64.3 -38.05 95.34 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.489 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.3 pp -89.06 -21.17 23.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.711 0.255 . . . . 0.0 111.18 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.69 HG11 HG12 ' A' ' 8' ' ' ILE . 96.6 t -82.58 -41.35 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 175.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.828 HG21 ' HG3' ' A' ' 39' ' ' GLN . 11.2 pt -92.25 -22.68 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 O-C-N 121.52 -0.738 . . . . 0.0 110.912 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.676 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 92.69 16.55 48.37 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.377 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.415 ' HG2' ' CA ' ' A' ' 14' ' ' GLY . 66.0 mmtt 48.64 50.82 16.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.911 0.484 . . . . 0.0 111.297 -177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.91 -28.49 1.57 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.096 -177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.25 -13.94 2.78 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.387 -0.911 . . . . 0.0 113.006 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.812 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 1.2 mm-40 -43.7 -55.28 4.49 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -177.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.676 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 73.8 m -75.11 -35.11 61.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.49 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.78 HD11 HD21 ' A' ' 37' ' ' LEU . 1.7 tp -68.35 -26.78 34.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.613 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.812 ' HD3' ' HA ' ' A' ' 22' ' ' GLU . 14.3 mtpp -55.04 -51.89 64.88 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.483 0.659 . . . . 0.0 109.998 174.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.442 ' HB2' ' CG ' ' A' ' 81' ' ' ASP . 23.1 mt-30 -81.63 -31.72 32.27 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.887 -172.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.634 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 83.8 mt -66.83 -23.43 66.04 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 121.742 -0.599 . . . . 0.0 110.479 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 24.1 mt-30 -84.81 -46.46 11.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.13 173.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.737 ' HB3' ' O ' ' A' ' 130' ' ' ASP . 15.2 mm-40 -86.44 -56.69 3.31 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -175.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HA ' ' OE1' ' A' ' 128' ' ' GLN . 0.7 OUTLIER -57.87 -41.97 83.58 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.144 0.497 . . . . 0.0 110.223 -178.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -86.79 -6.46 58.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.533 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.23 23.22 52.46 Favored Glycine 0 CA--C 1.517 0.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 113.52 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.0 m -132.21 153.88 39.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.893 0.377 . . . . 0.0 110.449 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -90.93 109.52 20.75 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.634 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 47.8 mtt -95.37 113.51 25.19 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 tp -110.96 106.87 21.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 122.027 0.918 . . . . 0.0 110.152 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.844 HD22 ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -132.99 142.12 48.67 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.55 -1.204 . . . . 0.0 109.254 -177.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.778 HG21 ' HB2' ' A' ' 43' ' ' GLN . 71.8 mt -86.14 101.6 10.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.726 0.298 . . . . 0.0 111.09 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.828 ' HG3' HG21 ' A' ' 17' ' ' ILE . 0.1 OUTLIER -134.69 -26.51 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.291 177.018 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -88.16 -34.13 17.95 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.4 146.78 34.88 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.75 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -79.71 38.8 0.39 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.778 ' HB2' HG21 ' A' ' 38' ' ' ILE . 48.8 mt-30 -106.38 -49.6 3.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.111 0.482 . . . . 0.0 110.345 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -131.45 30.96 4.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.488 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -70.58 -40.28 73.37 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.022 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -93.84 -26.17 17.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.094 0.473 . . . . 0.0 110.288 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 48' ' ' ASP . 40.0 t -79.3 169.57 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.629 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' N ' HG12 ' A' ' 47' ' ' VAL . 3.4 p30 -60.28 151.95 26.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.985 0.421 . . . . 0.0 110.415 172.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' ILE . 11.6 mptt -108.64 130.87 22.22 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.024 -171.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -88.88 103.95 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.685 2.257 . . . . 0.0 111.4 174.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.844 ' HG ' HD22 ' A' ' 37' ' ' LEU . 5.7 tt -87.92 109.7 19.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.868 -174.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.55 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.3 mpt_? -97.23 115.43 27.6 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 120.697 0.284 . . . . 0.0 110.51 175.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 72.7 mt -87.71 115.67 28.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.054 175.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.431 HG12 ' CG1' ' A' ' 3' ' ' VAL . 32.5 mt -104.13 120.74 54.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 172.22 -170.78 43.76 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.62 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.437 ' HB3' ' HD2' ' A' ' 59' ' ' LYS . 5.5 t70 -65.79 140.42 97.29 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.229 174.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -43.39 -49.45 7.52 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.252 2.635 . . . . 0.0 114.308 -176.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -63.38 -36.55 84.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.409 0.623 . . . . 0.0 110.204 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.577 ' HG2' ' HB2' ' A' ' 87' ' ' SER . 45.8 mttp -68.95 -44.0 73.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.9 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.5 t -59.3 -34.41 53.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.047 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.579 HE21 ' C ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -72.15 -52.2 17.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.545 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.798 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -59.93 -32.35 70.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.251 0.548 . . . . 0.0 110.477 -178.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.73 -44.54 14.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.057 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.649 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.9 p -59.5 -33.9 71.92 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 111.272 -175.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -75.28 -32.78 61.13 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.239 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.593 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 14.2 ptt? -84.4 -32.82 23.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.344 -175.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.655 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 34.9 m -61.0 -31.79 50.81 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.425 175.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.649 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 36.6 mtm -81.26 -35.36 31.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 175.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.593 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 30.8 t70 -64.66 -40.66 95.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.205 -175.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 66' ' ' MET . 0.2 OUTLIER -87.79 -22.21 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.009 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.655 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -83.93 -24.41 30.72 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.298 -178.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.4 1.17 3.2 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.892 0.377 . . . . 0.0 111.372 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 9.8 tp10 -58.07 150.5 20.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.799 173.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 74' ' ' ARG . 44.3 ttt-85 -79.49 59.43 2.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.312 0.577 . . . . 0.0 110.187 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 64.38 75.79 0.37 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.439 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -156.98 -71.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.931 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.474 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . -172.93 -36.53 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.768 -177.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.01 -97.99 2.22 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.988 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -130.51 -35.31 1.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.872 0.368 . . . . 0.0 111.039 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.55 67.61 0.64 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.442 ' CG ' ' HB2' ' A' ' 26' ' ' GLN . 5.8 m-20 61.97 30.7 18.09 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 122.026 0.917 . . . . 0.0 109.998 -174.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.534 ' HG2' ' HB3' ' A' ' 84' ' ' GLU . 35.5 ttt85 73.99 -40.23 0.45 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.035 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 t30 66.79 11.56 8.33 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.383 0.611 . . . . 0.0 110.601 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.721 ' HG3' ' O ' ' A' ' 92' ' ' GLY . 42.7 tt0 -115.83 -39.49 3.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.033 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.636 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 4.7 p90 -176.13 -157.1 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.697 175.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.675 ' HA3' ' HA ' ' A' ' 31' ' ' ALA . . . -176.2 -28.58 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.577 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 20.4 p -165.41 -48.63 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.593 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . 0.4 OUTLIER -73.66 173.36 9.88 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.034 169.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.8 ' HA ' ' CE1' ' A' ' 139' ' ' HIS . 65.5 mt 74.49 -77.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 O-C-N 123.538 0.524 . . . . 0.0 111.539 178.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.71 40.94 49.55 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.367 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.67 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 144.93 98.79 0.25 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.747 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 135.9 -138.79 10.19 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.706 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 29.6 pt -143.67 158.35 16.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 117.109 0.454 . . . . 0.0 110.493 173.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.585 ' OD2' HG21 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -93.4 117.84 30.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 175.021 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.953 HG21 HD12 ' A' ' 140' ' ' ILE . 75.2 t -116.8 95.29 46.19 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.719 -168.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.479 ' HA ' HD13 ' A' ' 137' ' ' ILE . 50.8 Cg_endo -72.22 113.51 3.72 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.037 1.825 . . . . 0.0 111.893 172.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.609 HG21 HG21 ' A' ' 105' ' ' VAL . 10.4 p -116.84 133.84 23.03 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -48.43 128.98 18.75 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.202 2.602 . . . . 0.0 112.226 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.872 ' HG2' ' HG3' ' A' ' 136' ' ' LYS . 14.7 mtp180 -63.5 -44.1 95.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.414 -171.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.02 6.44 3.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.871 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 104' ' ' VAL . 4.4 m -132.51 1.92 3.77 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.834 0.35 . . . . 0.0 110.761 -175.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 99' ' ' ARG . 10.9 p -75.42 -19.7 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 110.671 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.77 -40.67 95.3 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.842 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 101' ' ' SER . 8.5 p -73.15 -29.03 27.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.909 0.385 . . . . 0.0 110.337 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.609 HG21 HG21 ' A' ' 97' ' ' VAL . 64.6 t -66.94 -41.75 87.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.775 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.76 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 40.7 mm -72.51 -38.11 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.935 175.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.5 38.65 5.24 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.039 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 38.7 ttp-105 66.33 -75.36 0.05 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.215 0.606 . . . . 0.0 111.821 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.3 p -99.99 12.5 36.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.091 0.472 . . . . 0.0 110.694 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.72 40.49 7.18 Favored Glycine 0 C--O 1.224 -0.514 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.203 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -91.91 -32.07 15.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.116 0.484 . . . . 0.0 110.412 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.552 ' O ' HG12 ' A' ' 116' ' ' ILE . 5.9 tpt -89.64 -41.56 11.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.521 -171.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.76 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 6.2 tp -59.81 -25.99 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.33 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' A' ' 114' ' ' LYS . 10.1 mmpt? -73.32 -45.33 55.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.924 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.95 -22.44 60.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.917 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 112' ' ' MET . 37.0 mm -59.42 -44.29 92.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 172.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.641 HE21 ' HB ' ' A' ' 124' ' ' ILE . 65.0 mt-30 -68.01 -25.5 65.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.26 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.7 -46.75 16.52 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.025 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -78.44 -52.68 8.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.317 -175.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.558 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -81.07 -19.34 43.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.367 -176.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.35 26.35 63.86 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.629 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.3 m -95.84 161.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.377 0.608 . . . . 0.0 112.109 -172.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.808 ' HB2' ' HB3' ' A' ' 141' ' ' MET . 6.7 mpt_? -108.68 135.15 50.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 172.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.716 HG21 HD11 ' A' ' 113' ' ' ILE . 43.2 mm -116.29 129.83 72.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -170.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 1.047 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -143.51 169.56 17.47 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.186 168.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -117.29 104.28 10.99 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 168.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.898 ' HD2' ' HG3' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -94.83 -12.91 26.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -165.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.898 ' HG3' ' HD2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER 166.73 140.45 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.675 0.79 . . . . 0.0 109.055 173.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.573 ' OD2' ' HG2' ' A' ' 136' ' ' LYS . 1.3 m-20 -90.59 46.29 1.32 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 122.987 0.179 . . . . 0.0 111.059 -174.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.737 ' O ' ' HB3' ' A' ' 29' ' ' GLU . 30.8 t70 56.57 -90.98 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -167.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 139.79 -22.66 2.81 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.499 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.5 p -113.22 -36.4 5.04 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.802 0.334 . . . . 0.0 110.334 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -87.31 159.24 30.8 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.393 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.401 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 87.6 Cg_endo -87.73 36.53 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.321 2.68 . . . . 0.0 112.656 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -130.89 156.43 45.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.932 0.396 . . . . 0.0 111.028 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.872 ' HG3' ' HG2' ' A' ' 99' ' ' ARG . 48.9 mttm -110.03 118.51 36.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.485 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 10.6 mm -77.34 120.53 28.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.041 0.448 . . . . 0.0 112.207 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -94.96 135.69 36.18 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.47 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 1.047 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 12.7 t-160 -85.15 104.71 15.28 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.953 HD12 HG21 ' A' ' 95' ' ' VAL . 60.5 mt -88.35 118.27 33.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.221 170.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.808 ' HB3' ' HB2' ' A' ' 123' ' ' ARG . 41.4 ttm -109.49 127.39 54.39 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 158.56 -160.59 31.12 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.478 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 16.3 Cg_exo -68.73 139.99 45.52 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.786 2.324 . . . . 0.0 110.855 174.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 143' ' ' PRO . 75.8 Cg_exo -50.56 -32.54 35.58 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 124.138 3.225 . . . . 0.0 114.139 -172.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.82 -44.61 66.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.789 0.328 . . . . 0.0 110.556 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.558 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 55.7 mtt-85 -70.76 -27.72 64.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.291 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.747 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 71.2 m -57.41 -56.05 26.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.27 175.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -71.08 -31.81 68.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.36 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.558 ' HB3' ' HA ' ' A' ' 146' ' ' ARG . 30.9 t60 -55.95 -33.1 64.43 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.265 0.555 . . . . 0.0 110.313 173.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.702 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.24 -45.01 24.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.506 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.19 -24.56 67.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.403 0.621 . . . . 0.0 110.304 176.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -76.58 -26.27 54.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.106 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.575 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 68.5 mt -78.21 -40.89 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 73.6 mt -59.55 -43.17 90.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.064 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -57.06 -39.34 74.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.011 0.434 . . . . 0.0 110.666 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -69.91 -33.09 71.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.303 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 70.3 mt -66.61 -40.41 88.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.087 0.47 . . . . 0.0 110.335 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 56.3 mt -66.56 -28.73 68.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.854 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -83.36 -16.12 47.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.673 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 44.4 m -73.25 -20.6 60.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.557 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.43 0.46 1.04 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.845 -177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -68.92 -50.81 46.13 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.6 m -162.81 117.27 1.73 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.514 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.474 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.318 -179.65 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 112.071 -0.412 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.431 HG21 ' HA ' ' A' ' 57' ' ' PRO . 24.0 m -82.05 92.88 6.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.302 0.572 . . . . 0.0 110.945 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 12.1 p -125.65 121.98 61.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.858 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -109.99 150.74 28.06 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.759 -178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 39.1 mt-10 -116.06 123.36 47.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.439 0.638 . . . . 0.0 111.959 -176.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.3 mp -114.11 144.46 21.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.992 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.406 ' SD ' ' HB2' ' A' ' 48' ' ' ASP . 33.3 tpp -87.91 124.11 33.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.963 0.411 . . . . 0.0 111.514 -176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.616 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.7 mp -104.24 109.05 61.94 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.86 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.586 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 52.7 Cg_exo -61.29 147.25 96.08 Favored 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 123.596 2.864 . . . . 0.0 112.962 175.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.7 124.92 24.95 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.65 -39.14 2.99 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -169.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -79.71 -31.75 41.23 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.104 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.673 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -53.67 -34.34 58.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.881 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.03 -39.12 91.53 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.581 177.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 12' ' ' LYS . 4.1 pp -89.7 -22.84 22.03 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.553 -0.381 . . . . 0.0 111.075 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.557 HG21 HD12 ' A' ' 71' ' ' LEU . 96.6 t -78.52 -46.83 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.729 HG13 ' H ' ' A' ' 19' ' ' LYS . 22.0 pt -91.2 -21.14 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.086 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.479 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.78 -0.73 59.44 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.759 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.729 ' H ' HG13 ' A' ' 17' ' ' ILE . 15.6 tptp 70.0 -52.33 0.63 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.975 0.91 . . . . 0.0 110.557 -178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.72 8.68 73.99 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.16 5.4 76.54 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.194 -0.526 . . . . 0.0 113.082 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.918 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 10.2 pt-20 -73.31 -27.57 61.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -173.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.487 HG23 ' C ' ' A' ' 80' ' ' GLY . 90.3 m -77.43 -43.67 31.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.899 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.555 ' HA ' HD12 ' A' ' 27' ' ' LEU . 6.2 tp -62.81 -24.21 35.07 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.168 0 CA-C-O 120.834 0.349 . . . . 0.0 110.525 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.918 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 77.9 mttt -60.85 -50.66 72.55 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.141 175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.463 ' CB ' ' HB2' ' A' ' 81' ' ' ASP . 39.2 mt-30 -71.54 -31.75 67.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.107 -177.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 24' ' ' ILE . 47.7 mt -68.44 -27.58 66.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.933 0.397 . . . . 0.0 110.611 176.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.1 mt-30 -84.65 -47.55 10.38 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.295 0.569 . . . . 0.0 110.565 175.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.951 ' HB3' ' HA3' ' A' ' 131' ' ' GLY . 21.4 mm-40 -84.02 -53.37 5.6 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.206 -171.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.679 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 26.3 ttm180 -65.6 -44.47 86.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -80.66 -7.19 59.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.316 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.77 9.34 38.74 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.763 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.2 m -109.15 172.16 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.95 0.375 . . . . 0.0 110.362 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -113.43 109.98 19.56 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 171.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.867 ' HB3' HD11 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -95.19 112.82 24.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.499 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.1 tp -111.11 100.67 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 122.392 1.091 . . . . 0.0 110.667 -177.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.896 ' HG ' HD22 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -134.38 143.91 47.9 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.634 178.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 38' ' ' ILE . 4.0 mp -62.51 100.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.886 0.374 . . . . 0.0 110.237 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -87.36 -77.21 0.34 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -104.85 86.68 2.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.224 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . -144.28 163.12 27.85 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.021 -177.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 m -62.54 -28.74 70.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -82.16 -78.67 0.19 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.39 . . . . 0.0 111.77 -174.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.625 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 76.2 m-20 -110.34 56.25 0.63 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.874 -171.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 9.3 t -80.19 -45.43 18.08 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -94.01 -26.52 16.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.824 0.821 . . . . 0.0 109.026 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.625 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 57.3 t -78.89 159.86 4.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.009 -175.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 47' ' ' VAL . 3.3 p-10 -55.94 151.33 11.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -126.71 129.83 23.98 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.509 -166.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -83.06 112.99 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.846 2.364 . . . . 0.0 112.108 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.896 HD22 ' HG ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -81.37 110.52 16.88 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.973 -176.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.573 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.6 mpt_? -98.77 107.46 19.91 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.42 174.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.3 mt -91.43 113.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.053 176.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.0 mt -103.77 123.12 57.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.806 -177.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.4 -171.45 44.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.267 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 9.7 t70 -71.34 139.14 84.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 174.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.431 ' HA ' HG21 ' A' ' 2' ' ' THR . 30.3 Cg_exo -34.82 -47.06 0.62 Allowed 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 124.07 3.18 . . . . 0.0 114.99 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -61.81 -40.64 95.95 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.821 0.344 . . . . 0.0 111.281 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 56' ' ' ASP . 19.7 ptpt -82.14 -31.04 30.76 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.95 -175.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.6 t -64.98 -30.68 51.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.546 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -52.21 14.67 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.919 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -65.59 -23.68 66.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.708 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -81.21 -51.32 8.55 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.997 178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.501 ' SG ' HD12 ' A' ' 53' ' ' ILE . 94.5 m -54.11 -40.81 67.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.272 0.558 . . . . 0.0 109.978 177.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -58.54 -53.28 60.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.822 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.668 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 6.6 ptt? -64.43 -40.81 96.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.89 -176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 63' ' ' ALA . 86.9 t -56.53 -47.64 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 120.531 0.205 . . . . 0.0 110.812 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 58.1 mtt -69.87 -26.9 64.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.956 0.408 . . . . 0.0 110.89 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.544 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -85.36 -27.91 25.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.78 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.7 pp -90.14 -32.64 5.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 O-C-N 121.71 -0.619 . . . . 0.0 111.788 175.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.588 ' HG ' ' HG2' ' A' ' 12' ' ' LYS . 4.2 tt -71.98 -12.5 61.27 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.604 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -67.36 -10.42 50.91 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 122.256 -0.278 . . . . 0.0 111.22 177.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.927 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 9.2 tp10 -56.57 131.13 47.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.136 0.494 . . . . 0.0 110.297 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 31.0 ptt180 -66.67 -44.57 81.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.888 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 74' ' ' ARG . 29.1 t0 172.88 92.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 O-C-N 123.869 0.73 . . . . 0.0 109.54 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -176.19 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.926 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.927 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . 160.78 131.25 1.2 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.169 178.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -87.89 58.55 4.31 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.154 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.608 ' HD2' HG22 ' A' ' 70' ' ' ILE . 78.5 m-85 57.72 8.84 0.73 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.212 0.605 . . . . 0.0 112.416 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.487 ' C ' HG23 ' A' ' 23' ' ' THR . . . 70.06 7.34 59.41 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.581 -0.342 . . . . 0.0 113.087 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.679 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.2 OUTLIER 170.71 -62.63 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.107 0.479 . . . . 0.0 109.781 -172.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.78 ' HA ' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER 163.71 -45.02 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.446 -173.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 57.63 72.37 0.52 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.388 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 1.04 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 24.8 tt0 -171.34 -68.56 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.749 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.34 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.691 ' H ' ' HD2' ' A' ' 82' ' ' ARG . 0.9 OUTLIER -136.18 -95.7 0.24 Allowed 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.527 -0.733 . . . . 0.0 111.926 178.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.571 ' H ' ' HD2' ' A' ' 85' ' ' TYR . . . 84.96 92.03 0.79 Allowed Glycine 0 CA--C 1.52 0.372 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' ALA . 38.0 t 65.49 6.34 3.7 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.709 0.404 . . . . 0.0 110.893 -175.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.755 ' HG3' ' HD2' ' A' ' 127' ' ' LYS . 3.0 mmp_? -132.66 171.61 13.62 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.102 -173.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.98 HD11 ' HG2' ' A' ' 125' ' ' GLN . 24.3 mm 28.95 -83.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 125.725 1.891 . . . . 0.0 115.144 169.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.53 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 86.49 36.18 9.85 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -172.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.18 98.23 0.11 Allowed Glycine 0 CA--C 1.518 0.26 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.802 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 112.0 161.66 16.22 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -174.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.04 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 40.0 pt -93.98 158.77 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -172.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.484 ' CG ' HG21 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -102.55 108.07 19.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.015 179.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 27.5 t -101.11 105.12 37.07 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' CA ' HD13 ' A' ' 137' ' ' ILE . 56.9 Cg_endo -75.06 108.12 2.64 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.047 1.832 . . . . 0.0 111.885 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.685 HG13 HD21 ' A' ' 158' ' ' LEU . 47.2 t -101.65 127.76 30.58 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.997 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.626 ' HD2' HD22 ' A' ' 158' ' ' LEU . 74.3 Cg_exo -41.59 132.97 3.72 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.803 3.002 . . . . 0.0 112.734 171.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' A' ' 134' ' ' PRO . 32.6 ptt180 -51.34 -34.92 35.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.562 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -92.5 4.69 53.03 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.352 -177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.6 m -122.44 -18.55 6.68 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.586 ' HA ' HG11 ' A' ' 97' ' ' VAL . 14.2 p -59.1 -34.1 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.623 0.249 . . . . 0.0 111.138 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.53 -30.0 75.74 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.798 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.78 -33.79 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.055 0.455 . . . . 0.0 109.868 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.53 -36.09 76.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.01 176.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.752 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 37.7 mm -75.23 -46.04 39.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.266 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 115.45 -127.19 7.49 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 108' ' ' ARG . 4.2 mmp_? -100.39 -65.38 0.97 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.7 m -105.64 -20.96 13.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.514 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 143.17 50.18 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.127 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -93.86 -57.78 2.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.703 0.287 . . . . 0.0 110.472 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.573 ' HA ' ' HD3' ' A' ' 115' ' ' LYS . 14.2 tpt -59.82 -36.43 76.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.367 -174.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.752 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.6 tp -65.78 -32.39 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -86.43 -19.76 29.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.308 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.573 ' HD3' ' HA ' ' A' ' 112' ' ' MET . 26.5 mtpp -66.79 -35.68 80.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.297 174.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 112' ' ' MET . 30.1 mm -62.89 -38.51 82.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.198 0.523 . . . . 0.0 109.629 175.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -64.69 -34.01 77.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.675 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -82.36 -38.64 23.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.277 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -78.9 -55.8 4.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.002 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.85 -25.38 22.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.558 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.97 32.9 19.77 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.981 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 31.4 m -114.69 164.1 11.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.094 0.473 . . . . 0.0 111.449 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -109.87 163.17 13.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.641 HG21 HD11 ' A' ' 113' ' ' ILE . 45.3 mm -123.76 124.36 69.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.048 0.452 . . . . 0.0 111.492 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.98 ' HG2' HD11 ' A' ' 89' ' ' ILE . 50.5 tp60 -115.18 112.96 23.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.034 177.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.433 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 35.7 m-85 -87.64 106.04 17.76 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.365 0.602 . . . . 0.0 109.566 173.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.755 ' HD2' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -107.46 -159.28 0.69 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.753 -178.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.431 ' H ' ' HB2' ' A' ' 127' ' ' LYS . 7.2 tp-100 -71.65 63.66 0.43 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.298 0.57 . . . . 0.0 112.099 -176.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.512 ' OD2' ' HG2' ' A' ' 136' ' ' LYS . 0.9 OUTLIER 48.84 -163.82 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 170.035 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.567 ' OD2' HG22 ' A' ' 132' ' ' THR . 16.3 t70 -88.05 -65.53 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.368 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.951 ' HA3' ' HB3' ' A' ' 29' ' ' GLU . . . 132.3 -48.12 0.98 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.775 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.567 HG22 ' OD2' ' A' ' 130' ' ' ASP . 13.9 t -72.57 -12.23 60.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.413 0.607 . . . . 0.0 111.11 -173.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -163.92 -156.15 8.64 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.779 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.547 ' HB2' ' HD3' ' A' ' 99' ' ' ARG . 92.4 Cg_endo -81.33 9.49 3.84 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.802 2.335 . . . . 0.0 112.771 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.557 ' OE1' ' HA ' ' A' ' 98' ' ' PRO . 0.5 OUTLIER -75.37 149.24 38.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.186 0.517 . . . . 0.0 111.131 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.512 ' HG2' ' OD2' ' A' ' 129' ' ' ASP . 60.1 mttm -124.93 123.16 39.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.996 -175.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.696 ' HB ' ' HE2' ' A' ' 127' ' ' LYS . 40.0 mm -65.43 111.25 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.954 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.506 ' O ' ' HB ' ' A' ' 95' ' ' VAL . . . -90.84 91.07 8.2 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 164.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 28.0 t60 -71.18 115.86 10.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.228 0.537 . . . . 0.0 111.08 -169.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.771 HD11 HD12 ' A' ' 154' ' ' ILE . 96.4 mt -79.74 107.79 12.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.222 174.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.493 ' HB2' ' HD2' ' A' ' 139' ' ' HIS . 21.9 ttp -103.96 128.12 51.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.13 -172.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.26 -156.4 27.21 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.41 137.79 44.22 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.669 2.246 . . . . 0.0 111.705 177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -45.56 -55.07 3.81 Favored 'Trans proline' 0 N--CA 1.474 0.378 0 C-N-CA 123.543 2.828 . . . . 0.0 113.978 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -64.52 -32.86 74.68 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.798 0.333 . . . . 0.0 111.03 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -72.5 -36.06 68.28 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.802 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 74.5 m -60.72 -54.5 44.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.44 174.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.584 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 4.7 mm-40 -54.97 -42.04 71.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.739 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -59.65 -31.61 69.69 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.401 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.67 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.22 -35.15 42.1 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.365 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -70.71 -18.71 62.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.644 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 9.8 mpt_? -77.57 -17.3 58.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.977 0.418 . . . . 0.0 109.975 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.93 -50.9 15.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.913 173.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.771 HD12 HD11 ' A' ' 140' ' ' ILE . 38.7 mt -71.64 -57.18 8.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.734 -173.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.552 ' O ' ' HG2' ' A' ' 159' ' ' GLN . 3.9 m-20 -59.07 -28.65 66.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.881 0.372 . . . . 0.0 110.813 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.93 -47.32 80.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.428 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 4.4 pp -76.59 -20.91 56.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.326 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.685 HD21 HG13 ' A' ' 97' ' ' VAL . 33.6 mt -67.91 -33.64 75.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.198 176.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 155' ' ' ASN . 61.9 mm-40 -67.66 -30.49 70.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 109.67 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 157' ' ' LEU . 49.8 m -64.12 -23.08 67.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.596 175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.5 mt -111.1 2.77 18.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.934 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -111.24 59.38 0.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.095 0.474 . . . . 0.0 110.783 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.1 m -83.96 -10.49 57.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.341 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.0 176.49 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 57' ' ' PRO . 6.6 m -129.31 104.35 7.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 29.3 m -130.98 124.56 56.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.026 0.441 . . . . 0.0 110.8 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -105.42 153.75 21.26 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.608 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 51.9 mt-10 -123.86 109.06 13.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.457 0.646 . . . . 0.0 111.677 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -105.59 139.02 28.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.7 tpp -91.01 122.35 33.6 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.716 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.696 HG12 HG11 ' A' ' 16' ' ' VAL . 1.7 mp -95.53 113.76 62.49 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.749 -177.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -61.78 153.87 64.72 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.628 2.886 . . . . 0.0 112.459 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.74 144.66 55.32 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 171.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.42 -53.15 3.46 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -170.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 74' ' ' ARG . 0.9 OUTLIER -63.36 -35.11 79.29 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.584 -0.308 . . . . 0.0 110.372 172.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.675 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -49.12 -34.37 13.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.839 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.509 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -60.06 -44.34 97.37 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.615 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 75' ' ' ASP . 4.1 pp -85.48 -23.95 27.58 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.081 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.696 HG11 HG12 ' A' ' 8' ' ' ILE . 97.7 t -73.69 -42.9 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.681 HG13 ' H ' ' A' ' 19' ' ' LYS . 21.2 pt -91.56 -25.24 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 121.679 -0.638 . . . . 0.0 111.083 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.612 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 100.49 3.77 55.17 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.904 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.681 ' H ' HG13 ' A' ' 17' ' ' ILE . 7.6 tptm 53.82 48.13 22.05 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.542 0.687 . . . . 0.0 110.462 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.57 -1.48 0.52 Allowed Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.945 -174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.34 26.46 13.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.605 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -84.11 -60.12 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.988 0.423 . . . . 0.0 110.555 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.612 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 54.4 m -61.33 -44.52 97.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.359 -178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.57 HD12 HE21 ' A' ' 28' ' ' GLN . 0.3 OUTLIER -60.69 -31.4 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-O 121.032 0.444 . . . . 0.0 110.19 -177.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HG2' ' HA3' ' A' ' 131' ' ' GLY . 0.1 OUTLIER -64.25 -39.01 93.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.264 177.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 30' ' ' ARG . 24.3 mt-30 -77.85 -39.53 43.19 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.269 0.557 . . . . 0.0 109.61 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.625 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 74.8 mt -64.0 -23.85 67.49 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.81 0.338 . . . . 0.0 110.61 176.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.692 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 68.8 mt-30 -85.89 -58.37 2.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.808 0.337 . . . . 0.0 111.751 174.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -82.59 -42.26 18.51 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -172.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.57 ' HG3' HG13 ' A' ' 137' ' ' ILE . 1.9 mtp180 -73.7 -38.72 64.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.83 -177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.629 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . . . -84.39 -12.22 54.86 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.209 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.32 10.75 75.09 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.992 175.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 23.3 m -128.15 153.15 37.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.844 0.354 . . . . 0.0 110.675 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -90.13 110.14 21.17 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 1.014 ' HB3' HD21 ' A' ' 51' ' ' LEU . 48.9 mtt -96.25 124.58 40.31 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.446 ' CG2' ' HB2' ' A' ' 52' ' ' ARG . 6.1 tp -119.09 111.12 32.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.776 0.798 . . . . 0.0 110.217 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.724 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -134.15 144.35 48.48 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.829 -174.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.492 ' O ' ' HD3' ' A' ' 49' ' ' LYS . 43.8 mm -68.19 104.48 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.05 0.452 . . . . 0.0 111.207 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 37' ' ' LEU . 1.3 pp0? -146.71 20.85 1.3 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.64 0.733 . . . . 0.0 109.868 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.27 23.15 0.29 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.702 -172.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 45' ' ' THR . . . 82.33 -55.59 4.96 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.223 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.4 t -90.53 -157.9 0.51 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 62.04 -132.27 0.59 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.304 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.477 ' H ' HG21 ' A' ' 38' ' ' ILE . 93.8 m-20 -80.88 69.51 7.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.91 0.386 . . . . 0.0 110.487 178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.436 ' HB ' ' O ' ' A' ' 41' ' ' GLY . 4.0 t -79.58 -44.96 20.08 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.904 0.383 . . . . 0.0 110.801 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -93.27 -3.54 53.44 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.161 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.11 159.73 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.913 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -67.02 156.22 36.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 38' ' ' ILE . 18.2 mttm -131.06 128.35 22.24 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.301 -161.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.53 125.35 8.25 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.435 2.09 . . . . 0.0 112.021 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.014 HD21 ' HB3' ' A' ' 35' ' ' MET . 2.5 tm? -105.88 120.42 41.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.603 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.608 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.7 mpt_? -102.98 121.61 42.9 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.395 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.9 mt -90.5 109.92 21.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.465 HG12 HG12 ' A' ' 3' ' ' VAL . 36.8 mt -104.92 119.33 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.524 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.45 -170.74 43.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.921 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -67.24 142.03 96.55 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HA ' HG21 ' A' ' 2' ' ' THR . 87.4 Cg_exo -46.29 -47.68 14.6 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.129 2.553 . . . . 0.0 113.931 -172.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.483 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 46.1 t80 -59.23 -40.71 86.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.151 0.5 . . . . 0.0 110.647 -178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -67.99 -45.49 73.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.093 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.6 t -58.33 -34.08 49.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.558 178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -73.99 -40.51 62.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.737 0.303 . . . . 0.0 111.377 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.646 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 13.4 mm100 -72.99 -29.02 62.73 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.139 0.495 . . . . 0.0 110.268 -178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -85.65 -36.59 20.22 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.8 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 68' ' ' MET . 31.7 p -55.56 -43.4 75.83 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.96 0.41 . . . . 0.0 111.146 -175.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.53 -38.85 81.22 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.593 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.803 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 4.9 ptt? -71.49 -34.27 70.0 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.598 -176.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 63' ' ' ALA . 89.4 t -56.99 -36.17 49.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 174.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 36.2 mtm -82.0 -28.34 32.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.449 0.642 . . . . 0.0 110.19 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 36.5 t70 -75.87 -41.29 52.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.311 -171.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.909 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.8 pp -89.63 -26.3 5.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 8' ' ' ILE . 5.8 tt -69.6 -24.27 63.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.673 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -19.94 59.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.591 -177.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 74' ' ' ARG . 12.5 tp10 -51.19 -90.31 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.561 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 61.9 ttt180 168.08 -82.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -171.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HA ' HD23 ' A' ' 15' ' ' LEU . 7.1 p-10 -168.52 12.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.828 172.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -86.46 -76.26 0.36 Allowed 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.501 -175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -140.43 83.65 0.23 Allowed Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.792 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.561 ' O ' ' HB ' ' A' ' 70' ' ' ILE . . . -91.83 24.07 22.85 Favored Glycine 0 C--O 1.226 -0.388 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 175.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.725 ' HD2' HG22 ' A' ' 70' ' ' ILE . 54.6 m-85 69.05 -23.86 0.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.394 1.078 . . . . 0.0 113.56 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.496 ' C ' HG23 ' A' ' 23' ' ' THR . . . 84.14 15.4 69.61 Favored Glycine 0 C--N 1.328 0.129 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.399 177.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.423 ' HA ' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER 173.89 -65.69 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 -174.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.909 ' HA ' HG21 ' A' ' 70' ' ' ILE . 32.3 ttt180 166.88 -18.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.906 174.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.656 ' HB2' ' HB3' ' A' ' 79' ' ' PHE . 0.3 OUTLIER 67.66 42.7 1.98 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.025 176.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 28.9 tt0 -160.64 -52.56 0.05 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.472 -173.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.654 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 46.0 p90 -176.71 171.7 2.22 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.114 0.566 . . . . 0.0 110.075 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.682 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -132.95 -11.13 1.88 Allowed Glycine 0 CA--C 1.523 0.57 0 O-C-N 123.726 0.641 . . . . 0.0 112.28 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.646 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 18.0 p 178.28 -55.97 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.62 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 1.4 mpt_? -70.08 179.1 2.46 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.752 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.666 HG23 ' CD2' ' A' ' 139' ' ' HIS . 54.2 mt 78.36 -74.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 123.64 0.587 . . . . 0.0 111.136 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 46.91 46.73 19.65 Favored Glycine 0 C--N 1.337 0.609 0 O-C-N 123.41 0.444 . . . . 0.0 112.582 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 142.85 99.88 0.34 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.673 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 113.69 166.11 16.03 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -174.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 2.8 pp -93.66 -178.43 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.223 0.535 . . . . 0.0 112.253 -173.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.565 ' OD2' ' HD3' ' A' ' 96' ' ' PRO . 1.7 p-10 -109.74 147.01 33.96 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.142 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.895 HG23 ' HB3' ' A' ' 138' ' ' ALA . 3.5 m -137.56 97.14 10.48 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 121.229 0.537 . . . . 0.0 111.666 173.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.565 ' HD3' ' OD2' ' A' ' 94' ' ' ASP . 37.2 Cg_endo -67.04 108.55 1.53 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.155 2.57 . . . . 0.0 111.692 173.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 102' ' ' VAL . 99.0 t -103.52 120.1 52.78 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.818 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -46.32 128.02 11.77 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.768 2.312 . . . . 0.0 110.872 170.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.71 -31.5 37.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -173.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -82.12 -9.76 59.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.968 0.413 . . . . 0.0 110.809 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -107.06 -19.1 13.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -176.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.514 ' HA ' HG11 ' A' ' 97' ' ' VAL . 94.6 t -48.31 -45.39 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.491 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.87 -22.13 61.9 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.986 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.7 t -86.51 -38.78 12.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.89 0.376 . . . . 0.0 110.075 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.6 t -66.61 -38.77 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-O 121.345 0.593 . . . . 0.0 109.904 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.762 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 38.9 mm -70.54 -43.36 77.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.562 174.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.92 66.92 1.39 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.726 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 108' ' ' ARG . 4.0 mpt_? 57.81 -94.81 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.061 0.544 . . . . 0.0 112.055 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.1 m -77.21 -13.29 59.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.18 0.514 . . . . 0.0 110.399 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' A' ' 106' ' ' ILE . . . 109.11 22.38 6.9 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.992 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 12.8 pt-20 -85.45 -10.81 55.63 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.737 -0.272 . . . . 0.0 111.689 -176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 16.9 tpt -89.94 -40.8 12.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.389 . . . . 0.0 110.421 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.762 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 11.0 tp -62.19 -25.32 37.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.449 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 110' ' ' GLY . 45.6 mtpt -85.93 -22.05 27.61 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.605 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 111' ' ' GLU . 61.1 mttp -68.51 -32.95 73.28 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 177.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.533 HG23 HD12 ' A' ' 153' ' ' ILE . 29.8 mt -63.65 -37.02 78.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.505 0.669 . . . . 0.0 109.43 174.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -73.04 -26.33 61.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.858 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -87.56 -41.24 13.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.024 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.1 -51.33 10.45 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.185 -174.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.584 ' O ' ' HD3' ' A' ' 146' ' ' ARG . . . -92.77 -11.05 34.8 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.084 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.42 31.65 68.37 Favored Glycine 0 C--O 1.229 -0.196 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.484 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.65 -177.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.036 0.446 . . . . 0.0 111.909 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.631 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 55.1 ttt180 -132.57 143.2 49.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.177 176.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.565 HG21 HD11 ' A' ' 113' ' ' ILE . 47.0 mm -110.86 142.84 22.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.041 0.448 . . . . 0.0 112.164 -171.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 2.2 tt0 -148.34 114.38 5.8 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.281 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.401 ' CE1' HD11 ' A' ' 106' ' ' ILE . 36.6 m-85 -79.45 111.21 15.48 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.803 -0.56 . . . . 0.0 109.635 175.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -121.34 112.91 19.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.369 -174.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 128' ' ' GLN . 9.2 mm100 59.69 -167.46 0.17 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.224 0.535 . . . . 0.0 110.984 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.582 ' OD1' ' HG2' ' A' ' 136' ' ' LYS . 5.7 m-20 -135.93 171.68 14.11 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.525 ' HB2' HD11 ' A' ' 137' ' ' ILE . 15.5 t70 -84.72 139.6 31.88 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 173.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.415 ' HA3' ' HG2' ' A' ' 25' ' ' LYS . . . -63.08 -10.46 33.7 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 114.268 -171.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.635 HG23 ' HD2' ' A' ' 134' ' ' PRO . 14.5 t -77.44 -26.28 51.41 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 117.566 0.683 . . . . 0.0 110.358 176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 118.67 -70.61 0.32 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.714 -0.755 . . . . 0.0 114.267 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.635 ' HD2' HG23 ' A' ' 132' ' ' THR . 9.3 Cg_endo -51.67 -50.1 15.08 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.708 2.939 . . . . 0.0 115.249 -171.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -94.46 134.66 36.75 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.581 0.705 . . . . 0.0 112.358 -169.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HG2' ' OD1' ' A' ' 129' ' ' ASP . 48.3 mttm -110.88 120.8 43.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.804 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.57 HG13 ' HG3' ' A' ' 30' ' ' ARG . 9.1 mm -72.34 116.37 14.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.808 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.895 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -105.09 143.12 33.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.199 0.523 . . . . 0.0 111.417 174.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.666 ' CD2' HG23 ' A' ' 89' ' ' ILE . 10.4 t-160 -86.38 125.58 33.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.902 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.675 HD12 HD11 ' A' ' 93' ' ' ILE . 30.6 mt -106.91 107.8 23.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.805 170.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.631 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 37.0 ttm -95.59 129.69 42.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.151 -175.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.64 -167.79 36.56 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.633 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.12 143.44 78.15 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.489 2.126 . . . . 0.0 110.811 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.32 -48.17 8.41 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 124.023 3.148 . . . . 0.0 113.758 -173.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -61.79 -47.81 83.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.32 0.581 . . . . 0.0 110.945 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.584 ' HD3' ' O ' ' A' ' 120' ' ' ALA . 49.7 mtt180 -69.51 -22.38 63.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.307 -176.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.673 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 77.8 m -59.22 -52.31 66.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.249 0.547 . . . . 0.0 110.003 174.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -74.39 -31.71 62.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.731 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.577 ' HB3' ' HA ' ' A' ' 146' ' ' ARG . 9.4 t60 -62.49 -29.91 70.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.243 175.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.556 ' HB3' HG21 ' A' ' 140' ' ' ILE . . . -80.17 -38.85 30.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.506 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.3 -23.82 66.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.302 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 149' ' ' HIS . 13.5 ptt180 -76.62 -25.14 53.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -174.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.568 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 62.5 mt -68.82 -41.46 82.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.529 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 65.5 mt -71.8 -40.74 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.057 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -57.8 -45.79 85.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.458 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -57.84 -37.31 73.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.926 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 77.4 mt -65.36 -50.77 64.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.545 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 mt -63.91 -37.13 86.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.217 0.532 . . . . 0.0 110.192 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -69.86 -34.1 73.14 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.799 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.2 t -69.12 -22.64 63.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.985 0.421 . . . . 0.0 110.492 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 81.9 mt -84.05 -4.33 58.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.248 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -76.2 135.6 39.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.6 t -73.92 103.17 4.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.101 0.477 . . . . 0.0 109.833 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.244 -174.846 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 112.187 -0.365 . . . . 0.0 112.187 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 54' ' ' ILE . 0.9 OUTLIER -161.32 -42.01 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.384 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.762 HG22 HG12 ' A' ' 54' ' ' ILE . 20.6 t -142.8 112.65 2.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.688 166.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 16.6 mm100 -123.85 159.59 29.27 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 176.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 48.7 mt-10 -116.88 129.15 55.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.17 0.51 . . . . 0.0 111.35 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.799 HD11 ' HA ' ' A' ' 64' ' ' CYS . 74.5 mt -111.43 145.97 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.54 177.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.21 110.29 20.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.835 0.35 . . . . 0.0 111.427 -175.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 51' ' ' LEU . 1.9 mp -106.42 106.39 57.33 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.276 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -70.82 163.95 37.3 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.793 2.329 . . . . 0.0 111.342 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.85 145.3 56.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.47 -56.57 2.0 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 -172.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -68.93 -27.91 66.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.827 0.346 . . . . 0.0 110.481 175.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.614 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -53.52 -35.37 60.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.133 174.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.705 ' HA3' ' HE3' ' A' ' 19' ' ' LYS . . . -63.37 -47.69 85.36 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.846 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 73' ' ' GLU . 2.7 pp -78.68 -19.16 53.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.2 0.5 . . . . 0.0 111.407 -177.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.403 ' N ' HD12 ' A' ' 15' ' ' LEU . 74.8 t -78.41 -40.24 24.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.764 0.316 . . . . 0.0 111.151 175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 13' ' ' ALA . 30.9 pt -88.86 -29.48 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.075 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.521 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.9 16.8 32.18 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 -177.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.705 ' HE3' ' HA3' ' A' ' 14' ' ' GLY . 33.4 mmtp 55.44 47.07 21.93 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.006 0.522 . . . . 0.0 110.867 -175.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.11 -35.83 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.35 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 152.87 -12.43 0.62 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.239 -0.981 . . . . 0.0 113.295 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.526 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 20.1 mm-40 -45.26 -49.81 12.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.521 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 26.1 m -81.29 -34.89 31.69 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.435 -174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 21' ' ' GLY . 7.3 tp -64.91 -26.92 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.012 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.526 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 84.4 mttt -55.19 -53.6 54.0 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.913 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.511 HE21 ' HB2' ' A' ' 81' ' ' ASP . 23.2 mt-30 -66.14 -45.08 82.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.592 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.618 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 95.7 mt -59.87 -29.13 68.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.897 0.38 . . . . 0.0 111.124 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.712 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 27.5 mt-30 -85.89 -49.81 7.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.147 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.63 -51.78 5.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.656 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 15.2 ttm180 -65.14 -42.83 93.44 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -80.89 -29.66 35.6 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.557 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.73 0.92 85.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.351 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 34.6 m -112.87 151.45 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -91.39 109.66 20.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.607 ' HB3' HD21 ' A' ' 51' ' ' LEU . 41.6 mtt -95.61 114.05 25.77 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.625 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.5 tp -113.12 109.63 29.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.99 0.9 . . . . 0.0 109.532 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.86 HD13 HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -124.11 136.86 54.52 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.45 -174.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.697 HG22 ' HD2' ' A' ' 50' ' ' PRO . 10.8 tp -76.15 100.8 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 122.012 0.91 . . . . 0.0 110.014 -174.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 41' ' ' GLY . 21.6 tm0? -132.09 135.1 46.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.084 -173.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.9 t70 72.52 -23.81 0.2 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.82 0.848 . . . . 0.0 111.874 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 39' ' ' GLN . . . -68.24 155.81 53.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.203 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -74.28 76.17 1.84 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.066 0.46 . . . . 0.0 111.415 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -160.98 -62.19 0.06 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.158 176.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -131.68 53.71 1.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 110.439 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.8 t -83.08 -41.53 18.5 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.714 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -91.61 -4.2 55.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.386 0.612 . . . . 0.0 109.875 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 48' ' ' ASP . 40.3 t -108.45 165.03 5.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.519 -173.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.453 ' N ' HG12 ' A' ' 47' ' ' VAL . 5.0 p-10 -58.14 150.58 20.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.123 0.487 . . . . 0.0 110.289 171.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -126.99 127.43 24.37 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.101 -169.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.697 ' HD2' HG22 ' A' ' 38' ' ' ILE . 83.3 Cg_endo -81.18 108.18 1.98 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.74 2.294 . . . . 0.0 112.09 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.86 HD12 HD13 ' A' ' 37' ' ' LEU . 9.6 tt -84.17 117.55 23.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.841 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 36' ' ' ILE . 1.5 mpt_? -91.42 112.22 24.04 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.107 0.254 . . . . 0.0 110.964 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.751 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 62.5 mt -89.12 113.02 25.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.057 176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.762 HG12 HG22 ' A' ' 3' ' ' VAL . 30.3 mt -104.55 118.17 51.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.493 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 176.52 -170.9 43.83 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.393 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.468 ' O ' HG23 ' A' ' 60' ' ' VAL . 9.3 m-20 -65.11 147.38 98.58 Favored Pre-proline 0 N--CA 1.462 0.156 0 C-N-CA 122.46 0.304 . . . . 0.0 110.507 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 1' ' ' GLY . 83.2 Cg_exo -49.89 -52.41 8.94 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.112 2.542 . . . . 0.0 114.613 -173.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.437 ' HE2' ' HG2' ' A' ' 88' ' ' ARG . 17.5 p90 -63.17 -27.07 69.12 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.949 0.404 . . . . 0.0 110.571 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 87' ' ' SER . 91.7 mttt -72.46 -50.52 25.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.555 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 56' ' ' ASP . 22.0 t -59.93 -34.95 57.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.03 -176.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -66.3 -51.19 59.79 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 58' ' ' TYR . 12.2 mm100 -64.83 -37.71 88.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.936 0.398 . . . . 0.0 110.38 -177.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.596 ' HB2' ' OG ' ' A' ' 87' ' ' SER . . . -69.19 -40.38 78.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.751 178.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.799 ' HA ' HD11 ' A' ' 6' ' ' ILE . 54.0 t -52.41 -43.4 64.77 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.209 0.528 . . . . 0.0 110.208 177.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 69' ' ' ASP . 37.9 tt0 -71.1 -46.14 62.32 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.587 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.587 ' SD ' ' HA ' ' A' ' 63' ' ' ALA . 3.8 ptt? -65.35 -39.69 92.69 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.494 -171.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.774 ' HB ' HD13 ' A' ' 6' ' ' ILE . 90.4 t -62.32 -50.19 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.367 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.542 ' HA ' ' HG ' ' A' ' 71' ' ' LEU . 56.4 mtp -63.32 -30.29 71.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.05 0.452 . . . . 0.0 110.586 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -73.37 -40.24 64.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.898 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.855 HG21 ' HA ' ' A' ' 82' ' ' ARG . 2.9 pp -86.67 -24.29 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.684 -177.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.751 HD23 HG12 ' A' ' 67' ' ' VAL . 3.6 pp -83.09 -0.38 48.83 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.37 175.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HG3' ' N ' ' A' ' 73' ' ' GLU . 11.9 ptm180 -50.92 -42.8 59.74 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.746 ' HB2' HD21 ' A' ' 15' ' ' LEU . 27.1 tt0 60.07 110.84 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 124.373 1.046 . . . . 0.0 113.107 174.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -107.67 -39.17 5.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 170.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -140.66 50.58 1.66 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 59.49 68.2 0.82 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.18 0.514 . . . . 0.0 111.571 171.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 167.32 -40.62 0.24 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.652 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . 76.48 -96.7 1.15 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.182 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.596 ' HD2' ' HA ' ' A' ' 70' ' ' ILE . 97.2 m-85 -144.47 -29.95 0.47 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.851 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.72 100.48 0.64 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.511 ' HB2' HE21 ' A' ' 26' ' ' GLN . 27.1 t70 68.79 -72.75 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -169.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.855 ' HA ' HG21 ' A' ' 70' ' ' ILE . 26.6 ttt180 178.26 -29.36 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.483 169.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t30 66.96 16.04 10.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 122.195 0.998 . . . . 0.0 109.479 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.962 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 74.6 mt-10 -129.12 -31.29 2.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.128 -1.397 . . . . 0.0 108.787 175.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.729 ' CB ' ' HB ' ' A' ' 89' ' ' ILE . 30.0 p90 176.98 152.68 0.2 Allowed 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.385 172.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.559 ' C ' ' HA ' ' A' ' 31' ' ' ALA . . . -117.53 106.31 1.38 Allowed Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.404 168.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.804 ' HB3' ' HB3' ' A' ' 59' ' ' LYS . 43.4 m 51.51 35.64 14.94 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.7 ' HB3' HD12 ' A' ' 89' ' ' ILE . 11.8 mtt180 -166.12 -162.36 0.54 Allowed 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.729 ' HB ' ' CB ' ' A' ' 85' ' ' TYR . 2.8 mp 63.97 -77.8 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 124.039 0.837 . . . . 0.0 111.806 173.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 57.51 48.06 83.76 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 112.102 -0.399 . . . . 0.0 112.102 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.65 ' H ' HG22 ' A' ' 89' ' ' ILE . . . 144.91 81.27 0.05 OUTLIER Glycine 0 CA--C 1.519 0.322 0 C-N-CA 121.292 -0.48 . . . . 0.0 111.92 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 141.37 -150.16 21.65 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.962 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 47.9 pt -136.56 167.34 24.3 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-N 116.9 0.35 . . . . 0.0 111.219 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.656 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 3.5 p30 -108.59 139.22 43.68 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 171.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.881 HG23 ' HB3' ' A' ' 138' ' ' ALA . 11.8 m -133.35 95.48 18.19 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 121.107 0.48 . . . . 0.0 111.277 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 19.9 Cg_endo -62.54 108.31 0.7 Allowed 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.692 2.261 . . . . 0.0 111.071 172.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.463 ' HA ' ' HD2' ' A' ' 98' ' ' PRO . 12.8 p -110.27 125.02 31.85 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 120.955 0.407 . . . . 0.0 111.102 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 97' ' ' VAL . 5.5 Cg_endo -48.64 124.06 10.4 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.221 2.614 . . . . 0.0 111.774 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -63.64 -20.94 66.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.706 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -83.7 -0.87 52.61 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.785 0.326 . . . . 0.0 110.775 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.667 ' HB3' HD21 ' A' ' 161' ' ' LEU . 18.9 m -129.63 -2.43 4.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.653 -175.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.95 -24.78 24.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.907 0.384 . . . . 0.0 110.592 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.96 -28.88 66.82 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.394 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.1 t -77.14 -37.61 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.083 0.468 . . . . 0.0 110.388 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.1 t -71.02 -37.31 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.609 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 50.6 mm -80.19 -38.87 18.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.52 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.68 -104.33 2.9 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.037 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -138.32 -66.58 0.48 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.704 0.288 . . . . 0.0 110.395 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.7 m -88.76 -3.78 58.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.344 0.592 . . . . 0.0 110.297 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.95 31.08 7.9 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.41 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -92.81 -26.81 17.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.765 0.317 . . . . 0.0 110.358 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.518 ' SD ' ' HD3' ' A' ' 115' ' ' LYS . 16.3 tpt -69.63 -36.55 76.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.375 0.607 . . . . 0.0 110.277 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.427 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 4.6 tp -70.36 -32.93 52.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.913 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -73.53 -28.31 61.82 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.508 0.67 . . . . 0.0 109.421 173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.518 ' HD3' ' SD ' ' A' ' 112' ' ' MET . 21.0 tttp -68.77 -31.87 71.21 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.65 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.5 mm -62.28 -36.87 76.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.679 0.752 . . . . 0.0 109.055 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.665 HE21 HG12 ' A' ' 124' ' ' ILE . 66.2 mt-30 -72.56 -22.19 61.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.557 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 115' ' ' LYS . 92.1 m-20 -79.52 -30.57 41.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.945 0.403 . . . . 0.0 110.803 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.36 -55.86 4.76 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.587 -175.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 146' ' ' ARG . . . -101.02 -28.97 12.43 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.922 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 117' ' ' GLN . . . 88.23 74.29 1.28 Allowed Glycine 0 C--O 1.228 -0.239 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.681 -175.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 150' ' ' ALA . 18.6 m -134.23 166.95 27.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.683 0.278 . . . . 0.0 110.927 -175.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.816 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 23.5 ttt180 -122.27 138.81 54.37 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.665 HG12 HE21 ' A' ' 117' ' ' GLN . 50.8 mm -112.81 136.3 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -169.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.754 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 3.9 tp-100 -132.43 138.45 47.65 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.365 174.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -111.68 113.88 26.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.558 ' HD3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -128.55 152.78 47.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.929 -173.127 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.478 ' HB3' ' H ' ' A' ' 129' ' ' ASP . 13.1 mm100 67.73 -146.71 0.14 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.723 177.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' A' ' 128' ' ' GLN . 2.4 m-20 -45.27 106.02 0.07 Allowed 'General case' 0 CA--C 1.52 -0.18 0 O-C-N 124.214 0.946 . . . . 0.0 112.0 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -103.58 11.07 36.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.156 -174.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 151.43 -14.21 0.82 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.132 -174.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.9 p -60.64 -57.22 13.64 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.013 0.435 . . . . 0.0 109.852 172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.85 175.19 55.12 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 171.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.94 -33.71 19.23 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.546 2.164 . . . . 0.0 112.178 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 98' ' ' PRO . 3.0 mp0 -111.48 153.98 25.38 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.899 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 129' ' ' ASP . 22.7 mtpp -109.96 113.23 25.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.367 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.558 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 17.5 mm -68.86 105.71 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.113 0.482 . . . . 0.0 111.123 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.881 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -94.77 141.4 28.67 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.368 175.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.754 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -96.65 113.61 25.19 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.182 176.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.639 HD13 ' HB3' ' A' ' 150' ' ' ALA . 48.0 mt -93.22 119.6 41.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.634 173.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.816 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 38.0 ttm -105.89 137.77 43.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.445 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.48 179.34 26.17 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.318 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.422 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 74.1 Cg_exo -52.36 149.17 23.69 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.927 2.418 . . . . 0.0 111.824 175.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.6 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 76.8 Cg_exo -51.34 -27.69 24.58 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.684 2.923 . . . . 0.0 113.684 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 12.5 t70 -76.97 -46.42 24.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.06 0.457 . . . . 0.0 109.84 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -60.45 -47.3 86.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.912 -177.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 17.7 p -57.58 -56.5 21.13 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.777 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -68.45 -23.46 64.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.814 0.34 . . . . 0.0 111.463 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.477 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 4.6 t60 -70.41 -30.37 67.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.134 0.492 . . . . 0.0 109.673 175.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.639 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.09 -41.66 28.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.926 -177.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.22 -32.02 69.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.04 0.448 . . . . 0.0 110.857 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -76.98 -19.48 57.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.381 -177.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 149' ' ' HIS . 63.3 mt -81.08 -43.06 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.309 0.576 . . . . 0.0 109.575 174.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 69.3 mt -63.42 -46.94 93.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.572 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -60.14 -35.63 75.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.384 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.42 -40.45 86.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.14 0.495 . . . . 0.0 110.125 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 81.5 mt -68.39 -41.0 81.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.625 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 51.2 mt -67.1 -30.0 69.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.151 0.501 . . . . 0.0 110.579 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 30.0 tt0 -83.16 -28.74 29.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.208 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.0 p -80.22 -22.89 41.32 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.667 HD21 ' HB3' ' A' ' 101' ' ' SER . 3.5 pp -87.74 20.82 2.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 -175.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 159' ' ' GLN . 52.6 mtp180 -46.17 130.4 10.28 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.538 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.4 p -92.54 166.99 12.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.278 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.675 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.554 -179.192 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.861 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 57' ' ' PRO . 16.2 m -83.49 73.05 10.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.189 0.519 . . . . 0.0 109.896 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 17.9 m -101.06 134.58 40.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.34 0.591 . . . . 0.0 111.196 -177.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -125.63 155.39 40.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.904 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 46.8 mt-10 -113.45 117.27 31.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.328 0.585 . . . . 0.0 112.104 -173.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.1 mp -105.68 142.4 18.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.754 175.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.527 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 48.0 tpp -91.94 125.51 36.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.681 0.277 . . . . 0.0 110.899 -176.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.941 HD11 ' HB2' ' A' ' 51' ' ' LEU . 3.5 mp -96.84 106.02 27.6 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.644 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.801 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 23.9 Cg_exo -67.37 148.37 79.46 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 122.936 2.424 . . . . 0.0 111.531 175.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.59 134.39 54.25 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 76' ' ' GLN . . . 102.99 -36.25 4.44 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -170.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.944 ' HG3' HD12 ' A' ' 15' ' ' LEU . 12.6 mptt -82.42 8.46 11.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.961 0.41 . . . . 0.0 110.363 176.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -59.02 -39.84 83.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.914 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.465 ' O ' ' HA2' ' A' ' 18' ' ' GLY . . . -69.15 -15.34 69.68 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.265 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.944 HD12 ' HG3' ' A' ' 12' ' ' LYS . 16.2 mt -90.67 -40.93 11.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.917 -0.142 . . . . 0.0 111.235 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.711 HG21 HG13 ' A' ' 8' ' ' ILE . 61.8 t -92.84 -51.16 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.701 HG13 ' H ' ' A' ' 19' ' ' LYS . 17.3 pt -91.51 -28.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.075 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 14' ' ' GLY . . . 89.84 15.81 57.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.185 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.701 ' H ' HG13 ' A' ' 17' ' ' ILE . 66.6 mmtt 67.36 -58.28 0.42 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.417 0.687 . . . . 0.0 111.704 -177.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -88.19 -5.9 75.68 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.501 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.94 4.36 54.37 Favored Glycine 0 C--O 1.229 -0.213 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.757 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.747 ' HA ' ' CD ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -73.39 -28.77 62.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -175.148 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.615 HG21 ' O ' ' A' ' 15' ' ' LEU . 91.5 m -71.53 -41.27 69.38 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.252 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 35' ' ' MET . 6.9 tp -65.56 -27.45 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.151 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.747 ' CD ' ' HA ' ' A' ' 22' ' ' GLU . 11.9 mtpp -57.79 -49.5 76.42 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 174.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -72.84 -35.99 67.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.102 -175.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.485 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 98.1 mt -66.01 -27.69 68.31 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 121.837 -0.539 . . . . 0.0 110.382 176.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.752 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.6 mt-30 -84.88 -52.88 5.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.421 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -84.28 -56.38 3.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -174.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HE ' ' HB3' ' A' ' 30' ' ' ARG . 3.5 ttp180 -56.27 -42.28 77.19 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.864 0.364 . . . . 0.0 110.461 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -87.65 -29.83 20.88 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.368 -178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.47 10.37 70.76 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.26 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.6 m -117.31 152.04 19.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.743 0.306 . . . . 0.0 110.3 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -96.56 110.98 23.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 27' ' ' LEU . 46.4 mtt -94.81 125.79 39.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.0 tp -117.6 114.5 45.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.886 0.85 . . . . 0.0 109.941 -177.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.656 HD22 ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -132.82 142.94 49.23 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.676 -175.442 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.43 HD13 ' HG2' ' A' ' 50' ' ' PRO . 2.0 mp -61.62 112.84 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.17 0.51 . . . . 0.0 110.882 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.427 ' OE1' HD13 ' A' ' 17' ' ' ILE . 22.2 mm-40 -125.26 -53.51 1.61 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.067 176.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.29 72.17 9.04 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.541 0.686 . . . . 0.0 109.588 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.13 106.02 0.24 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.563 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.9 t -79.2 65.22 4.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.588 0.708 . . . . 0.0 111.103 -173.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -131.41 -52.25 1.01 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.187 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.634 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 2.7 m-20 -113.32 47.09 1.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.358 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 p -78.37 -48.55 15.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.991 0.424 . . . . 0.0 110.825 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -93.23 -11.8 31.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.587 0.708 . . . . 0.0 109.417 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.634 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 50.1 t -88.92 162.65 2.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.815 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.426 ' N ' HG12 ' A' ' 47' ' ' VAL . 4.2 m-20 -61.85 154.12 26.9 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 176.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 39.4 mttp -127.28 144.31 50.25 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.874 -170.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HG2' HD13 ' A' ' 38' ' ' ILE . 83.3 Cg_endo -92.08 122.11 0.6 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.81 2.34 . . . . 0.0 112.886 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.941 ' HB2' HD11 ' A' ' 8' ' ' ILE . 8.4 tt -101.56 126.23 48.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.7 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB2' HG23 ' A' ' 36' ' ' ILE . 3.3 mpt_? -107.92 121.1 44.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.691 0.282 . . . . 0.0 110.287 174.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 61.6 mt -89.47 117.3 32.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.174 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.4 mt -103.84 120.31 53.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.97 -171.05 43.93 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.336 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.58 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 18.9 m-20 -71.63 146.77 91.57 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 122.459 0.303 . . . . 0.0 110.504 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.582 ' HA ' HG21 ' A' ' 2' ' ' THR . 99.8 Cg_exo -44.33 -51.24 7.07 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.463 2.775 . . . . 0.0 113.7 -175.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -60.58 -49.61 76.85 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.756 0.312 . . . . 0.0 111.223 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.025 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 5.3 ptpp? -72.73 -23.55 60.86 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.926 -175.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 2' ' ' THR . 71.4 t -71.22 -43.04 74.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -58.17 9.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.78 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.72 -21.62 66.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.598 -174.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.653 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -85.36 -39.17 17.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.463 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.472 ' O ' ' HG3' ' A' ' 68' ' ' MET . 37.9 t -56.59 -50.56 71.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.606 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.54 -33.54 75.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.083 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.843 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 18.2 ptt? -79.57 -36.21 38.58 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.738 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 63' ' ' ALA . 69.9 t -56.27 -44.57 79.91 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 57.1 mtp -66.63 -32.57 73.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.566 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.456 ' HA ' ' HG2' ' A' ' 72' ' ' ARG . 35.2 t70 -85.24 -28.71 25.2 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -169.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG23 ' O ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -88.82 -21.69 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 O-C-N 121.098 -1.001 . . . . 0.0 110.438 173.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.499 HD12 ' CG2' ' A' ' 16' ' ' VAL . 5.8 tt -82.08 -26.29 33.78 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.354 178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 69' ' ' ASP . 0.3 OUTLIER -61.05 -13.95 20.3 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.213 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.67 ' HG3' ' H ' ' A' ' 75' ' ' ASP . 9.0 tp10 -55.47 135.28 50.66 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.217 0.532 . . . . 0.0 111.684 -175.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.8 tpt180 -75.72 -19.1 59.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.587 0.708 . . . . 0.0 109.578 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.67 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 10.8 m-20 -106.39 -174.8 2.62 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.632 176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 11' ' ' GLY . 48.2 mt-30 -94.91 41.03 1.09 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 171.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -124.85 45.4 1.17 Allowed Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.705 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.707 ' H ' HD22 ' A' ' 15' ' ' LEU . . . -67.33 178.63 17.26 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 172.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.479 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 86.5 m-85 -68.32 -31.57 71.08 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 117.283 0.541 . . . . 0.0 111.581 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 23' ' ' THR . . . 101.45 -2.64 53.74 Favored Glycine 0 CA--C 1.508 -0.348 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 177.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 82' ' ' ARG . 1.6 p30 -179.17 -63.54 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.843 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 6.8 ttt85 173.41 -29.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.241 165.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.506 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 4.1 t30 52.33 65.77 1.41 Allowed 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.937 0.399 . . . . 0.0 110.373 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 1.041 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 30.5 tt0 176.28 -47.54 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.754 0.787 . . . . 0.0 109.844 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.796 ' HA ' ' NE2' ' A' ' 139' ' ' HIS . 36.4 p90 -173.78 157.98 3.17 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.43 175.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -143.03 95.42 0.18 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 1.025 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 67.8 m 70.75 -52.64 0.67 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.691 ' HD3' HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -67.6 -82.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.078 0.466 . . . . 0.0 111.738 -175.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.691 HD13 ' HD3' ' A' ' 88' ' ' ARG . 41.3 mm -54.34 -88.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -168.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 89.73 78.42 1.33 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -169.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.24 94.2 2.1 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.232 -0.508 . . . . 0.0 112.063 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.725 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 148.94 -144.06 11.69 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -177.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.041 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 49.9 pt -152.43 158.13 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 117.476 0.638 . . . . 0.0 110.057 174.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -105.27 140.71 38.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.981 0.42 . . . . 0.0 110.53 175.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 2.8 t -137.45 116.72 10.17 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.659 -176.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.61 107.75 2.25 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.013 1.809 . . . . 0.0 111.629 169.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.409 HG13 HD21 ' A' ' 158' ' ' LEU . 40.9 t -99.17 126.14 39.05 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.768 -0.197 . . . . 0.0 110.945 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.691 ' HA ' ' OE2' ' A' ' 135' ' ' GLU . 74.1 Cg_exo -43.69 130.68 7.47 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.662 2.908 . . . . 0.0 113.13 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 134' ' ' PRO . 33.1 ptt180 -60.24 -24.22 64.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.025 -176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 98' ' ' PRO . 12.6 p80 -92.81 20.34 6.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.729 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 105' ' ' VAL . 14.6 t -145.79 -31.46 0.38 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.126 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -49.38 -37.66 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.24 -28.95 63.06 Favored Glycine 0 C--O 1.235 0.178 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.925 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.7 t -75.11 -35.07 33.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.027 0.441 . . . . 0.0 109.873 177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 101' ' ' SER . 66.9 t -59.59 -40.05 81.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.905 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.785 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 41.3 mm -72.95 -37.71 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.389 177.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.93 34.57 21.17 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -175.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 65.66 -76.73 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.514 0.725 . . . . 0.0 111.399 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.2 p -93.73 9.62 36.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.868 0.366 . . . . 0.0 111.662 -174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.411 ' HA2' HG22 ' A' ' 113' ' ' ILE . . . 94.34 8.12 60.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.892 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -65.26 -32.2 73.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.808 0.337 . . . . 0.0 110.913 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.405 ' SD ' ' HD3' ' A' ' 115' ' ' LYS . 15.4 tpt -89.93 -37.85 14.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.817 -176.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.785 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.2 tp -64.98 -27.97 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.084 0.469 . . . . 0.0 110.382 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -72.58 -21.86 61.08 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.182 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.405 ' HD3' ' SD ' ' A' ' 112' ' ' MET . 27.6 mtpp -71.57 -33.84 69.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.732 0.301 . . . . 0.0 110.543 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.576 HG23 HD12 ' A' ' 153' ' ' ILE . 32.3 mt -67.92 -40.38 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.343 0.592 . . . . 0.0 109.469 176.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -70.02 -28.21 65.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.437 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -79.52 -37.52 36.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.9 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -79.57 -55.16 5.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.578 -176.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -92.96 -15.01 26.75 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.55 32.5 57.5 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.881 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.546 ' CG1' ' HB3' ' A' ' 146' ' ' ARG . 14.9 m -102.98 159.15 4.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.216 0.531 . . . . 0.0 112.103 -173.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.921 ' HB2' ' HB2' ' A' ' 141' ' ' MET . 65.3 mtm180 -101.26 144.09 30.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.223 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.511 HG21 HD11 ' A' ' 113' ' ' ILE . 51.2 mm -116.79 121.54 67.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.986 0.422 . . . . 0.0 110.745 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.584 ' HB2' ' SD ' ' A' ' 141' ' ' MET . 5.9 tp-100 -123.94 111.14 15.69 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.604 ' CE1' HD11 ' A' ' 106' ' ' ILE . 27.4 m-85 -87.53 133.26 33.8 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.561 0.696 . . . . 0.0 110.104 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.571 ' HD3' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -157.03 -166.25 2.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.825 -1.079 . . . . 0.0 108.381 -171.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.422 HE21 ' HB2' ' A' ' 128' ' ' GLN . 0.0 OUTLIER -47.96 125.81 9.58 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.426 0.454 . . . . 0.0 111.813 -177.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 136' ' ' LYS . 7.6 p-10 -104.15 -164.0 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.824 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -62.45 -38.03 88.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.918 0.39 . . . . 0.0 110.287 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.53 -59.79 1.85 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.567 177.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.5 t -96.64 -23.65 16.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.096 0.474 . . . . 0.0 110.133 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.07 148.84 43.41 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 172.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 14.2 Cg_exo -69.47 -19.68 37.19 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.829 2.352 . . . . 0.0 112.452 -176.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.691 ' OE2' ' HA ' ' A' ' 98' ' ' PRO . 1.3 mp0 -94.73 154.17 17.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.972 0.415 . . . . 0.0 111.248 -174.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.455 ' HA ' ' HB2' ' A' ' 129' ' ' ASP . 0.9 OUTLIER -119.79 124.73 46.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.328 0.585 . . . . 0.0 111.359 -178.039 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 44.8 mm -63.3 115.8 2.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.295 177.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -93.75 132.45 38.12 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 164.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.796 ' NE2' ' HA ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -108.34 115.24 29.74 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.676 -177.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.718 HG21 ' HA ' ' A' ' 147' ' ' CYS . 82.7 mt -83.85 137.58 20.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.522 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.921 ' HB2' ' HB2' ' A' ' 123' ' ' ARG . 31.2 mtp -120.42 129.26 53.83 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.066 -176.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.75 -167.03 28.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.635 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.763 ' HB2' ' HD3' ' A' ' 146' ' ' ARG . 32.8 Cg_exo -61.0 147.28 96.19 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.085 2.524 . . . . 0.0 112.195 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.773 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 52.0 Cg_exo -57.04 -18.65 29.46 Favored 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 123.955 3.104 . . . . 0.0 113.817 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.94 -30.17 26.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.326 0.584 . . . . 0.0 110.178 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.763 ' HD3' ' HB2' ' A' ' 143' ' ' PRO . 8.4 mpt_? -84.13 -44.12 14.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.408 -174.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.773 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 10.6 p -53.85 -55.1 29.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.011 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.431 ' OE2' HG21 ' A' ' 93' ' ' ILE . 38.5 mm-40 -62.65 -37.87 88.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.48 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.412 ' O ' HG13 ' A' ' 153' ' ' ILE . 15.7 t60 -65.49 -26.76 68.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.223 0.535 . . . . 0.0 110.316 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.708 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.98 -40.26 28.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.005 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.633 ' HB2' HD11 ' A' ' 93' ' ' ILE . . . -65.94 -24.92 66.92 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.366 0.603 . . . . 0.0 110.149 177.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -18.94 59.56 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.538 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.576 HD12 HG23 ' A' ' 116' ' ' ILE . 63.1 mt -81.76 -45.06 20.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.316 172.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.475 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.9 mt -62.21 -40.77 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.006 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -58.84 -37.33 76.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.71 -34.16 77.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 153' ' ' ILE . 34.1 mt -68.87 -33.87 74.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.824 -178.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.511 HD22 ' HD2' ' A' ' 98' ' ' PRO . 18.4 mt -67.08 -28.68 68.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.357 0.599 . . . . 0.0 110.127 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -85.45 -28.56 24.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.58 0.705 . . . . 0.0 110.416 172.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.456 ' HB3' ' HA ' ' A' ' 157' ' ' LEU . 22.4 t -75.48 -20.38 58.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.997 -173.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 3.4 pp -59.57 -9.9 2.99 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -68.2 -17.57 64.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.345 0.593 . . . . 0.0 110.02 174.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 21.1 t -140.41 -166.11 2.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.63 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.319 -178.911 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 60' ' ' VAL . 0.9 OUTLIER -112.05 67.42 0.65 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.944 0.402 . . . . 0.0 111.143 -178.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 27.7 m -123.5 130.39 74.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.159 175.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -118.47 142.72 47.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.625 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 45.3 mt-10 -108.01 116.74 32.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.361 0.6 . . . . 0.0 111.775 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 6' ' ' ILE . 3.9 mp -106.82 142.82 18.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.402 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 87.6 mmm -92.88 116.09 28.72 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.937 0.399 . . . . 0.0 110.704 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.499 HG12 HG11 ' A' ' 16' ' ' VAL . 1.8 mp -91.36 113.77 59.55 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.586 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 75.1 Cg_exo -55.77 152.15 36.51 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.425 2.75 . . . . 0.0 112.775 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.622 ' HA ' ' NZ ' ' A' ' 49' ' ' LYS . . . -59.62 129.93 44.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 172.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.58 -39.21 2.94 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.81 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.724 ' HG3' HD21 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -65.38 -19.68 66.05 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.805 0.335 . . . . 0.0 111.249 -177.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.665 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -58.38 -24.04 58.79 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.863 0.363 . . . . 0.0 110.374 176.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' CA ' ' HD3' ' A' ' 19' ' ' LYS . . . -61.29 -41.15 99.43 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.246 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.724 HD21 ' HG3' ' A' ' 12' ' ' LYS . 0.5 OUTLIER -90.42 -23.84 20.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.811 0.305 . . . . 0.0 110.992 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.6 HG21 HD12 ' A' ' 71' ' ' LEU . 77.1 t -82.63 -52.05 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.521 0.564 . . . . 0.0 112.521 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.679 HD13 ' HG3' ' A' ' 39' ' ' GLN . 19.2 pt -91.53 -20.09 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 121.526 -0.734 . . . . 0.0 110.155 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.62 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 97.19 17.09 32.97 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -175.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HD3' ' CA ' ' A' ' 14' ' ' GLY . 13.6 tptp 55.66 31.81 18.08 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.421 0.688 . . . . 0.0 110.428 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 164.77 -40.17 0.3 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.551 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.594 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 158.1 -8.84 0.2 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.157 -1.02 . . . . 0.0 114.07 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.473 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 44.4 tt0 -58.64 -43.37 89.71 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.504 0.652 . . . . 0.0 112.377 -175.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.62 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 55.2 m -78.3 -36.73 46.19 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.195 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 35' ' ' MET . 5.6 tp -64.6 -20.1 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 120.683 -0.407 . . . . 0.0 109.937 -178.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 27.6 mtpp -58.36 -59.45 5.33 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.42 0.629 . . . . 0.0 109.503 170.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 48.6 mt-30 -67.22 -35.23 79.14 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.91 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 87.7 mt -65.1 -32.91 74.85 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 122.037 -0.415 . . . . 0.0 110.835 177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.724 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 47.9 mt-30 -85.5 -46.61 10.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.062 0.458 . . . . 0.0 111.41 177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -88.16 -35.36 17.45 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.519 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 5.5 ttm180 -82.87 -43.42 16.6 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.746 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -83.18 -22.29 33.26 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.982 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.69 68.16 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.097 176.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 34.2 m -128.15 150.69 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.906 0.384 . . . . 0.0 110.846 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -90.72 109.99 21.18 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 1.056 ' HB3' HD11 ' A' ' 51' ' ' LEU . 48.4 mtt -100.29 123.31 44.36 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 tt -121.02 113.87 41.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.799 0.809 . . . . 0.0 110.768 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.691 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -134.86 143.57 47.08 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.948 -177.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 3.7 mp -73.34 101.18 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.307 0.575 . . . . 0.0 111.351 -175.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.679 ' HG3' HD13 ' A' ' 17' ' ' ILE . 4.9 mm-40 -131.36 15.68 5.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.44 170.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -74.03 -30.74 62.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.825 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' A' ' 45' ' ' THR . . . 113.56 8.28 19.04 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.036 -176.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 m -61.77 -49.9 74.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.678 0.275 . . . . 0.0 111.688 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -164.44 -42.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.851 0.358 . . . . 0.0 111.091 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.636 ' HA ' ' HB ' ' A' ' 47' ' ' VAL . 13.3 m120 -78.98 51.49 1.14 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.926 0.393 . . . . 0.0 111.266 -176.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.536 ' CG2' ' HA2' ' A' ' 41' ' ' GLY . 14.3 p -86.09 -61.77 1.67 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.178 0.513 . . . . 0.0 110.867 175.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -92.33 -6.82 49.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.455 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 44' ' ' ASN . 48.9 t -93.38 156.27 3.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.944 176.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.4 149.4 38.49 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.63 ' HE3' ' O ' ' A' ' 47' ' ' VAL . 0.7 OUTLIER -111.21 124.15 33.45 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.816 -174.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.12 112.89 2.34 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.452 2.101 . . . . 0.0 111.825 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.056 HD11 ' HB3' ' A' ' 35' ' ' MET . 21.2 tp -92.98 121.1 33.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.775 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.529 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 2.7 mpt_? -102.05 114.14 28.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.853 0.358 . . . . 0.0 110.657 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 70.0 mt -89.42 110.63 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.229 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.4 mt -106.13 122.08 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.376 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.402 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 173.87 -171.43 44.51 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.956 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . 3.2 m-20 -61.58 148.75 85.96 Favored Pre-proline 0 C--N 1.331 -0.21 0 C-N-CA 122.282 0.233 . . . . 0.0 110.536 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.65 -55.61 3.82 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.119 2.546 . . . . 0.0 114.188 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -66.73 -26.91 67.23 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.926 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.869 ' HG2' ' HB2' ' A' ' 87' ' ' SER . 93.2 mttt -66.67 -53.02 38.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.187 178.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 2' ' ' THR . 46.4 t -59.89 -32.51 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.589 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.22 -54.91 30.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.853 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -69.88 -34.1 73.12 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.051 -178.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.568 ' O ' ' HG2' ' A' ' 66' ' ' MET . . . -69.88 -47.5 62.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.431 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 50.2 t -55.95 -38.36 70.23 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.19 0.519 . . . . 0.0 109.862 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -64.53 -52.82 55.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.695 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.655 ' SD ' ' HA2' ' A' ' 86' ' ' GLY . 8.4 ptt? -65.69 -36.07 82.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.472 -175.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 53' ' ' ILE . 53.5 t -57.06 -48.38 81.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.245 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 69.4 mtm -69.78 -25.35 63.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.184 0.516 . . . . 0.0 110.214 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -78.48 -37.82 42.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.926 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.566 ' HB ' ' H ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -90.22 -30.77 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.86 176.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.6 HD12 HG21 ' A' ' 16' ' ' VAL . 5.2 tt -70.93 -26.45 63.2 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.22 -63.9 0.95 Allowed 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.176 0.298 . . . . 0.0 110.404 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.961 ' HG2' ' H ' ' A' ' 74' ' ' ARG . 23.6 tt0 42.31 -159.83 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 169.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.961 ' H ' ' HG2' ' A' ' 73' ' ' GLU . 20.9 mmt180 -145.54 -47.06 0.22 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.807 0.843 . . . . 0.0 108.751 167.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -173.66 102.23 0.11 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.011 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 61.66 69.49 0.64 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.459 0.647 . . . . 0.0 111.399 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.41 -5.52 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.372 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.22 150.78 48.88 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.669 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.566 ' H ' ' HB ' ' A' ' 70' ' ' ILE . 74.5 m-85 -76.99 3.53 12.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -170.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 23' ' ' THR . . . 73.14 4.13 62.62 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.723 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 0.5 OUTLIER 175.89 -62.91 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 -178.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.736 ' CZ ' ' HB3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER 154.13 -35.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 O-C-N 125.1 1.5 . . . . 0.0 109.101 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 t30 55.81 73.51 0.43 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.371 0.419 . . . . 0.0 110.399 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.934 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 70.4 tt0 -175.71 -51.13 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.665 -173.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.741 ' HA ' HD12 ' A' ' 89' ' ' ILE . 4.5 p90 -151.04 -75.89 0.14 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.655 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . 101.15 -43.38 1.74 Allowed Glycine 0 C--O 1.229 -0.198 0 N-CA-C 111.873 -0.491 . . . . 0.0 111.873 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.869 ' HB2' ' HG2' ' A' ' 59' ' ' LYS . 32.5 p -171.06 -57.16 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -69.98 -177.23 1.28 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.379 167.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 85' ' ' TYR . 59.8 mt 70.57 -74.64 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.09 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.417 ' H ' ' CB ' ' A' ' 85' ' ' TYR . . . 51.12 47.21 49.92 Favored Glycine 0 C--N 1.336 0.552 0 O-C-N 123.727 0.642 . . . . 0.0 112.501 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.25 99.36 0.4 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -176.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.816 ' HA2' ' SG ' ' A' ' 147' ' ' CYS . . . 135.79 -138.51 9.98 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -174.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.934 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.8 pt -145.53 159.59 12.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 171.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.593 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . 1.9 p30 -99.22 132.58 44.44 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 31.3 t -126.65 106.2 23.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -171.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.419 ' HB2' ' HB3' ' A' ' 135' ' ' GLU . 42.8 Cg_endo -68.79 121.44 8.33 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.234 1.956 . . . . 0.0 111.389 171.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.633 HG13 HD21 ' A' ' 158' ' ' LEU . 51.3 t -117.71 124.9 28.46 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.653 0.263 . . . . 0.0 111.216 177.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 134' ' ' PRO . 86.1 Cg_exo -44.62 130.51 9.54 Favored 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.753 2.968 . . . . 0.0 113.475 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 134' ' ' PRO . 35.2 mtp180 -51.63 -37.92 52.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.151 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.495 ' CE1' ' HB3' ' A' ' 98' ' ' PRO . 0.7 OUTLIER -92.26 6.43 46.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.655 -174.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 98' ' ' PRO . 9.8 m -130.03 -25.52 2.5 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.607 -173.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.4 p -53.15 -26.26 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 120.742 0.306 . . . . 0.0 111.592 172.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.3 -44.96 89.41 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.947 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 101' ' ' SER . 7.6 p -77.38 -25.23 15.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.208 0.528 . . . . 0.0 110.587 -178.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 41.1 t -69.68 -33.14 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.85 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.568 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 49.6 mm -87.12 -65.06 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.352 176.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.82 52.19 3.39 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.696 -173.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 108' ' ' ARG . 45.2 mtp180 54.77 -89.84 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.71 0.804 . . . . 0.0 112.375 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -72.75 -8.82 57.25 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.594 0.711 . . . . 0.0 110.348 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.26 45.72 2.52 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.587 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.37 -43.88 80.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.8 0.3 . . . . 0.0 110.942 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.466 ' O ' HG13 ' A' ' 116' ' ' ILE . 15.3 tpt -83.59 -38.55 21.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.848 0.356 . . . . 0.0 110.641 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 124' ' ' ILE . 8.9 tp -63.91 -31.08 51.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.5 -178.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -82.73 -20.12 36.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.657 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.562 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -71.23 -37.44 72.01 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 172.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.467 HD12 HD12 ' A' ' 113' ' ' ILE . 23.1 mt -64.64 -37.27 79.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.201 0.524 . . . . 0.0 109.603 176.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 86.6 mt-30 -66.6 -27.36 67.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.724 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -85.65 -46.26 10.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.039 0.447 . . . . 0.0 111.045 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -79.33 -55.36 5.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.778 -173.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.14 -26.96 39.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.058 0.456 . . . . 0.0 110.293 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.96 19.98 62.02 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.138 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.76 144.88 9.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.117 0.484 . . . . 0.0 111.879 -174.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.786 ' HB3' ' HB3' ' A' ' 141' ' ' MET . 7.7 tpp180 -91.34 143.41 26.66 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.723 HG21 HD11 ' A' ' 113' ' ' ILE . 34.3 mm -129.01 142.21 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -170.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 1.031 ' HG2' ' HB3' ' A' ' 139' ' ' HIS . 3.8 pt20 -149.54 167.8 25.29 Favored 'General case' 0 C--O 1.219 -0.501 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 167.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 106' ' ' ILE . 31.7 m-85 -121.95 133.55 54.83 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.535 ' O ' ' HB ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -152.66 128.16 10.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.352 -171.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 58.31 -166.64 0.15 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.052 0.453 . . . . 0.0 111.216 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.417 ' HA ' ' H ' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -145.33 -175.09 4.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.363 176.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.48 ' OD2' ' HB ' ' A' ' 132' ' ' THR . 51.2 p-10 -70.42 -11.49 60.95 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -172.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.73 7.55 87.3 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.328 -176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.48 ' HB ' ' OD2' ' A' ' 130' ' ' ASP . 34.6 m -113.34 -41.78 3.61 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 137.67 -58.82 0.63 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.447 -0.883 . . . . 0.0 113.75 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 98' ' ' PRO . 15.0 Cg_exo -69.52 -17.18 38.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.795 2.33 . . . . 0.0 114.734 -170.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 51.1 mt-10 -127.18 141.35 51.76 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -114.02 130.62 56.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.478 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 94' ' ' ASP . 23.5 mm -74.62 131.54 34.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -175.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -105.88 141.47 37.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.358 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 1.031 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -89.27 110.15 20.96 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.187 175.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.753 HD13 ' HB3' ' A' ' 150' ' ' ALA . 68.5 mt -94.26 135.84 27.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.463 172.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.786 ' HB3' ' HB3' ' A' ' 123' ' ' ARG . 41.6 ttm -122.92 124.55 43.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.056 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 156.59 -170.66 34.11 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.91 149.02 91.54 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.713 2.276 . . . . 0.0 111.986 174.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -43.4 -50.71 6.53 Favored 'Trans proline' 0 N--CA 1.475 0.42 0 C-N-CA 123.314 2.676 . . . . 0.0 113.665 -177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -56.66 -47.53 79.6 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.13 0.49 . . . . 0.0 110.224 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -60.0 -41.93 93.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.631 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.816 ' SG ' ' HA2' ' A' ' 92' ' ' GLY . 66.7 m -56.26 -60.53 3.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.224 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.638 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 38.2 mt-10 -66.82 -33.17 75.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.287 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -26.88 68.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.753 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.13 -37.19 46.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.826 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.48 -26.27 67.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.409 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -76.56 -31.48 57.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.287 -178.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.44 -44.58 83.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.197 0.522 . . . . 0.0 109.644 174.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.68 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 70.4 mt -63.03 -53.38 47.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.741 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.64 HD22 HD12 ' A' ' 158' ' ' LEU . 12.0 m120 -55.47 -38.29 68.89 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.476 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -59.87 -44.1 94.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 110.756 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.12 -39.48 89.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.594 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 68.4 mt -61.25 -52.03 66.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.941 -178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 155' ' ' ASN . 10.5 mm100 -67.39 -21.75 65.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.072 0.463 . . . . 0.0 111.028 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 61.6 m -73.3 -22.46 60.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.835 177.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 73.5 mt -103.91 -49.65 3.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.252 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 68.56 -63.13 0.36 Allowed 'General case' 0 N--CA 1.466 0.351 0 O-C-N 124.026 0.829 . . . . 0.0 109.313 -172.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 18.4 m -86.46 -90.25 0.11 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.51 175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.368 -179.505 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.407 ' O ' HG21 ' A' ' 60' ' ' VAL . 91.1 m -104.85 140.67 37.78 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.5 m -132.1 133.4 60.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.105 0.478 . . . . 0.0 111.179 178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 5.4 mm-40 -108.09 145.08 34.57 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.909 175.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.74 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 42.1 mt-10 -112.05 104.28 12.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.329 0.585 . . . . 0.0 111.343 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.0 mp -105.65 141.97 19.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.01 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.518 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 45.5 ttm -100.56 114.58 28.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.911 0.386 . . . . 0.0 110.646 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.474 ' HA ' HD11 ' A' ' 71' ' ' LEU . 1.8 mp -83.22 110.07 21.46 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.043 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.854 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 31.3 Cg_exo -62.26 137.25 64.65 Favored 'Trans proline' 0 CA--C 1.519 -0.259 0 C-N-CA 122.81 2.34 . . . . 0.0 111.273 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.59 114.88 3.22 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.56 -34.78 3.66 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -169.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.854 ' HD3' ' HB2' ' A' ' 9' ' ' PRO . 0.8 OUTLIER -89.29 3.78 50.97 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 172.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.506 ' HB1' HD11 ' A' ' 17' ' ' ILE . . . -60.73 -41.19 94.85 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.545 176.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.82 -14.29 50.94 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.702 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.655 ' O ' HG21 ' A' ' 23' ' ' THR . 22.6 mt -89.56 -57.04 3.01 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 116.539 0.169 . . . . 0.0 111.187 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.452 ' CG2' HD12 ' A' ' 71' ' ' LEU . 61.8 t -79.58 -54.86 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.506 HD11 ' HB1' ' A' ' 13' ' ' ALA . 12.7 pt -92.47 -10.7 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.699 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 69.64 31.47 70.65 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.726 -0.949 . . . . 0.0 110.726 -175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 tptt 73.27 -58.08 0.61 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.097 0.959 . . . . 0.0 111.356 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.2 24.48 5.64 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.874 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.47 ' O ' HG22 ' A' ' 24' ' ' ILE . . . 116.06 -13.21 16.86 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.684 174.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 35.8 mm-40 -56.95 -46.67 81.94 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.655 HG21 ' O ' ' A' ' 15' ' ' LEU . 55.4 m -80.33 -34.24 36.82 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.265 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.495 HD11 HD21 ' A' ' 37' ' ' LEU . 5.2 tp -62.28 -24.96 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.496 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 83.6 mttt -57.25 -58.89 6.25 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.102 170.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' CB ' ' HB3' ' A' ' 81' ' ' ASP . 42.7 mt-30 -67.57 -20.25 65.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.206 -174.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 85.3 mt -79.74 -30.85 40.97 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.22 173.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 79.8 mt-30 -84.31 -32.26 24.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.569 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -85.62 -63.38 1.33 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.606 0.241 . . . . 0.0 111.285 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.509 ' HB3' HH22 ' A' ' 82' ' ' ARG . 10.6 ttm180 -66.66 -31.45 72.12 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.162 -172.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 27' ' ' LEU . . . -96.38 -27.17 15.05 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.37 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' HA3' ' NE2' ' A' ' 128' ' ' GLN . . . 78.56 2.89 85.98 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.774 -0.726 . . . . 0.0 113.286 175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.683 HG23 ' SD ' ' A' ' 35' ' ' MET . 27.6 m -101.08 161.91 3.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -103.99 109.49 21.28 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.326 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.683 ' SD ' HG23 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -92.12 121.09 33.34 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 172.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 52' ' ' ARG . 6.2 tp -113.56 102.34 13.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 121.964 0.888 . . . . 0.0 109.219 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.751 HD13 HD12 ' A' ' 51' ' ' LEU . 0.7 OUTLIER -132.31 142.21 49.26 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.819 -176.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.681 HG21 ' H ' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -60.77 122.24 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.403 179.237 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.2 -37.23 0.57 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.299 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.85 -48.11 55.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.121 0.486 . . . . 0.0 110.398 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.665 ' HA2' ' HB ' ' A' ' 45' ' ' THR . . . 137.14 34.48 0.2 Allowed Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.335 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -78.99 -22.32 45.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.037 0.446 . . . . 0.0 110.829 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.54 ' HB3' HG12 ' A' ' 38' ' ' ILE . 54.1 tp60 -136.72 -80.19 0.39 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.781 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.681 ' H ' HG21 ' A' ' 38' ' ' ILE . 96.7 m-20 -107.56 87.31 2.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.168 0.509 . . . . 0.0 110.757 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.665 ' HB ' ' HA2' ' A' ' 41' ' ' GLY . 1.8 t -81.51 -42.67 19.88 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.262 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -94.17 -35.45 12.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.746 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.72 160.33 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.386 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.637 ' OD1' ' HA ' ' A' ' 9' ' ' PRO . 61.7 m-20 -49.53 139.93 11.52 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.391 0.432 . . . . 0.0 111.05 177.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 44' ' ' ASN . 65.2 mttt -113.06 128.52 25.52 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.163 -165.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -84.8 140.29 7.96 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.798 2.332 . . . . 0.0 113.376 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.751 HD12 HD13 ' A' ' 37' ' ' LEU . 9.0 tt -117.92 139.81 50.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.361 -174.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.58 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 3.3 mpt_? -123.35 123.42 40.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.453 0.168 . . . . 0.0 110.589 170.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.613 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 64.4 mt -93.82 116.77 35.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.7 mt -103.67 120.34 53.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.653 0.263 . . . . 0.0 111.281 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.09 -170.76 43.51 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.329 -0.939 . . . . 0.0 113.372 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.541 ' HB3' ' HE2' ' A' ' 59' ' ' LYS . 9.9 t70 -60.57 138.81 92.78 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.847 -0.677 . . . . 0.0 110.675 172.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.42 -28.83 9.06 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.967 3.111 . . . . 0.0 114.676 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -73.17 -52.05 15.6 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.949 0.404 . . . . 0.0 110.225 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HE2' ' HB3' ' A' ' 56' ' ' ASP . 0.3 OUTLIER -68.83 -30.14 68.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.468 -177.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 2' ' ' THR . 88.6 t -70.6 -32.87 51.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.448 175.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.443 ' HA ' ' SG ' ' A' ' 64' ' ' CYS . 0.8 OUTLIER -70.23 -52.45 23.1 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -65.01 -23.2 67.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.358 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.674 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -86.6 -43.97 12.25 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.949 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 68' ' ' MET . 30.4 p -61.9 -30.98 71.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.692 0.282 . . . . 0.0 111.447 -174.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -83.43 -30.51 27.24 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 120.255 -0.578 . . . . 0.0 109.794 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.82 ' HB2' ' HG3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -79.3 -34.34 42.5 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.326 -176.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.08 -27.45 42.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.924 176.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 64' ' ' CYS . 44.8 mtm -82.95 -35.95 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 0.0 109.607 171.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 36.0 t70 -62.97 -43.76 97.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.782 -175.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.879 HG21 ' HA ' ' A' ' 82' ' ' ARG . 0.2 OUTLIER -87.05 -21.5 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.37 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 8' ' ' ILE . 3.5 tt -84.29 -24.69 29.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.64 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.406 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -60.6 -35.55 76.39 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 121.146 -0.222 . . . . 0.0 110.537 -177.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 74' ' ' ARG . 1.1 pt-20 37.83 -145.73 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.199 0.937 . . . . 0.0 112.867 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 8.1 ptm180 173.26 -12.67 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.264 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -154.87 35.62 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.531 -173.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? 58.54 76.13 0.36 Allowed 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.614 0.721 . . . . 0.0 109.404 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 151.66 116.78 0.72 Allowed Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.257 -176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 70' ' ' ILE . . . -99.37 -75.32 1.18 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.264 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -144.53 -58.38 0.37 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.768 0.794 . . . . 0.0 109.028 176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.42 -91.3 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB3' ' CB ' ' A' ' 26' ' ' GLN . 5.7 p-10 -90.52 -44.75 9.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 164.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.879 ' HA ' HG21 ' A' ' 70' ' ' ILE . 0.0 OUTLIER 170.37 -51.46 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.689 -172.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.536 ' HA ' ' HB2' ' A' ' 94' ' ' ASP . 18.8 m120 57.45 53.41 7.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 171.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.712 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 0.7 OUTLIER -174.36 2.99 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 177.559 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.816 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -161.66 -71.53 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.987 -1.071 . . . . 0.0 110.959 174.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.524 ' H ' ' CD ' ' A' ' 82' ' ' ARG . . . 53.67 65.67 3.27 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.581 -174.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.511 ' C ' ' HD2' ' A' ' 88' ' ' ARG . 17.0 t 74.31 -21.62 0.27 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.692 0.797 . . . . 0.0 112.086 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.586 ' HG3' ' HB2' ' A' ' 127' ' ' LYS . 2.6 mmm180 -119.05 -166.32 1.24 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -172.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.816 ' HB ' ' HA ' ' A' ' 85' ' ' TYR . 55.6 mt 70.59 -83.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 167.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.575 ' HA2' ' HD2' ' A' ' 85' ' ' TYR . . . 62.87 54.97 29.54 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.126 -173.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 128.96 58.71 0.11 Allowed Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.513 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.551 ' O ' HG21 ' A' ' 89' ' ' ILE . . . 164.59 163.28 17.34 Favored Glycine 0 C--O 1.207 -1.572 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.712 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.0 pt -90.31 154.26 3.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 119.14 1.47 . . . . 0.0 112.39 -169.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.536 ' HB2' ' HA ' ' A' ' 83' ' ' ASN . 36.2 m-20 -90.38 117.48 29.13 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.836 173.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.685 HG21 HD12 ' A' ' 140' ' ' ILE . 1.3 t -116.69 95.1 45.48 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 121.041 -0.263 . . . . 0.0 110.874 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.17 108.53 2.69 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.52 2.146 . . . . 0.0 111.782 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.589 HG13 HD21 ' A' ' 158' ' ' LEU . 86.0 t -94.77 118.75 66.74 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.443 177.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.641 ' HD2' HD22 ' A' ' 158' ' ' LEU . 47.0 Cg_exo -38.11 123.6 0.64 Allowed 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.014 2.476 . . . . 0.0 111.478 171.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -34.46 -58.55 0.48 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -168.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -71.92 -23.71 61.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.1 t -78.63 -15.1 58.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.594 0.235 . . . . 0.0 111.143 -172.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.556 ' HA ' HG11 ' A' ' 97' ' ' VAL . 58.1 t -54.82 -37.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.154 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.51 -36.03 82.87 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.701 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 161' ' ' LEU . 61.4 t -73.18 -37.83 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.353 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 21.7 t -66.33 -34.28 69.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.346 0.593 . . . . 0.0 110.36 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.73 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 39.7 mm -76.45 -43.57 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.29 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.56 34.87 8.21 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.477 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 65.65 -75.28 0.05 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.357 0.663 . . . . 0.0 111.673 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 m -87.49 2.79 49.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.071 0.462 . . . . 0.0 110.708 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.496 ' O ' ' HG2' ' A' ' 114' ' ' LYS . . . 92.52 14.08 56.06 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.877 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -65.89 -40.86 91.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.751 0.31 . . . . 0.0 111.297 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 55.7 tpp -78.23 -36.34 47.16 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.73 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 10.0 tp -68.18 -29.66 45.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.816 0.341 . . . . 0.0 110.157 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 110' ' ' GLY . 42.2 mmtm -70.16 -34.73 73.37 Favored 'General case' 0 CA--C 1.523 -0.086 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 173.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 112' ' ' MET . 25.5 mmmt -61.61 -38.7 88.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.981 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.12 -43.04 95.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.26 0.552 . . . . 0.0 109.552 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.535 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 60.5 mt-30 -69.04 -26.81 65.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.733 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -86.22 -45.54 11.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.073 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.17 -36.42 47.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.986 -173.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 146' ' ' ARG . . . -103.98 -20.35 13.9 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.96 37.96 31.81 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.886 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.406 HG11 HG23 ' A' ' 140' ' ' ILE . 33.1 m -112.79 154.23 14.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.959 0.409 . . . . 0.0 111.944 -173.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.553 ' HD3' ' N ' ' A' ' 124' ' ' ILE . 0.0 OUTLIER -108.25 135.18 50.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.553 ' N ' ' HD3' ' A' ' 123' ' ' ARG . 45.3 mm -99.58 143.66 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.087 0.47 . . . . 0.0 111.957 -170.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 139' ' ' HIS . 5.5 tt0 -147.79 104.95 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.682 175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -74.29 111.42 9.45 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.061 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.586 ' HB2' ' HG3' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -125.22 156.32 38.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.181 -173.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.529 ' NE2' ' HA3' ' A' ' 32' ' ' GLY . 12.0 mm100 69.08 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.848 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 136' ' ' LYS . 24.3 m-20 -90.48 104.82 17.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.112 0.482 . . . . 0.0 111.285 -171.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.403 ' O ' ' HE2' ' A' ' 136' ' ' LYS . 16.4 t70 -132.6 -49.16 0.9 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.514 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -97.82 19.78 53.23 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.3 t -161.08 158.37 27.6 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.92 160.39 36.35 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.856 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.27 -14.85 10.45 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.575 2.183 . . . . 0.0 111.682 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -131.24 152.79 50.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.913 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HD2' HG21 ' A' ' 102' ' ' VAL . 82.8 mttt -110.7 113.36 25.91 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.513 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 1.7 mm -72.55 112.57 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.194 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 95' ' ' VAL . . . -96.29 135.8 37.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.802 173.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.777 ' CE1' HG23 ' A' ' 89' ' ' ILE . 1.5 t60 -86.87 109.04 19.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.903 174.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' A' ' 150' ' ' ALA . 41.0 mt -91.19 123.25 43.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 170.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.449 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 13.9 ttp -112.53 131.41 55.61 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -171.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 150.32 -178.11 27.98 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.68 147.13 96.04 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.859 1.706 . . . . 0.0 110.764 174.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -41.16 -44.27 5.32 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.475 2.783 . . . . 0.0 112.834 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -52.31 -40.96 62.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.789 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 120' ' ' ALA . 9.3 mtm180 -84.53 -38.89 19.48 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 140' ' ' ILE . 61.2 m -58.59 -61.32 2.69 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.036 0.446 . . . . 0.0 111.002 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.686 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 6.2 mm-40 -58.02 -40.85 81.86 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.182 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -57.58 -31.96 66.69 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.903 0.382 . . . . 0.0 111.282 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.697 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -78.46 -36.79 44.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.972 0.415 . . . . 0.0 110.915 -176.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.408 ' HB3' HH11 ' A' ' 152' ' ' ARG . . . -66.17 -24.1 66.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.798 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.686 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 11.3 mpt_? -78.59 -28.04 45.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.755 0.312 . . . . 0.0 110.424 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 58.3 mt -70.15 -47.93 64.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.233 0.539 . . . . 0.0 109.551 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.517 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 61.0 mt -63.18 -42.99 98.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.705 178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -57.84 -39.21 77.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.982 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.55 -32.58 74.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.772 0.32 . . . . 0.0 110.302 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 44.0 mt -67.64 -47.95 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.969 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.641 HD22 ' HD2' ' A' ' 98' ' ' PRO . 13.3 mt -59.69 -40.56 88.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.896 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -68.02 -31.18 70.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.452 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 64.1 m -79.29 -27.03 42.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.266 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.646 HD11 HG21 ' A' ' 104' ' ' VAL . 82.6 mt -86.17 -34.49 20.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.483 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 43.4 mtm-85 65.67 95.53 0.06 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.555 0.693 . . . . 0.0 111.614 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.7 m -97.05 68.85 2.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.356 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.58 178.402 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 57' ' ' PRO . 1.6 m -81.45 85.33 6.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.958 0.408 . . . . 0.0 110.25 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 12.0 m -124.12 128.79 74.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.09 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -114.15 133.95 55.23 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.543 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HG2' ' HG3' ' A' ' 52' ' ' ARG . 43.5 mt-10 -103.04 126.12 50.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.223 0.535 . . . . 0.0 111.869 -175.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 6' ' ' ILE . 4.2 mp -117.8 144.52 25.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 174.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 54.4 mtp -93.1 112.44 24.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.158 0.504 . . . . 0.0 110.777 -176.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.549 HG13 HG21 ' A' ' 16' ' ' VAL . 1.7 mp -95.21 114.93 64.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.706 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.54 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 41.8 Cg_exo -61.72 152.42 74.23 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.449 2.766 . . . . 0.0 112.815 177.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.73 131.51 45.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.61 -42.01 2.13 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -169.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.54 ' HB2' ' HB2' ' A' ' 9' ' ' PRO . 13.1 tptt -68.7 -32.48 72.31 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 173.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.711 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -52.39 -31.75 35.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.315 176.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.661 ' HA2' ' HD3' ' A' ' 19' ' ' LYS . . . -59.0 -42.09 96.73 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.431 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.952 HD23 ' HA ' ' A' ' 76' ' ' GLN . 3.8 pp -89.67 -17.95 27.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.756 0.278 . . . . 0.0 111.663 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.549 HG21 HG13 ' A' ' 8' ' ' ILE . 82.9 t -83.5 -48.69 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 177.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.711 HG12 ' O ' ' A' ' 13' ' ' ALA . 13.3 pt -90.52 -24.79 5.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.516 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.515 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 100.91 11.58 39.66 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.669 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.661 ' HD3' ' HA2' ' A' ' 14' ' ' GLY . 5.4 tptm 52.33 44.2 30.06 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.324 0.583 . . . . 0.0 110.353 178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.83 -24.4 0.55 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.474 -173.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.99 -11.53 7.34 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.566 -0.826 . . . . 0.0 113.331 175.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -59.32 -34.32 72.19 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -174.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.515 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 28.3 m -84.23 -41.57 16.8 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.316 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 35' ' ' MET . 8.3 tp -66.44 -32.4 57.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.7 tttp -47.91 -48.14 31.83 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.58 170.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.599 ' HB3' ' HB2' ' A' ' 81' ' ' ASP . 49.4 mt-30 -73.8 -42.07 61.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.657 -178.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.544 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 81.6 mt -60.65 -28.1 68.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.179 0.514 . . . . 0.0 110.709 178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 87.6 mt-30 -85.58 -53.75 4.98 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.567 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -82.23 -49.75 9.75 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -172.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.525 ' HD3' ' OD2' ' A' ' 81' ' ' ASP . 21.3 ttt180 -67.61 -51.75 46.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.971 0.415 . . . . 0.0 110.01 -176.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.625 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -70.31 -29.05 65.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.934 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.07 3.23 87.77 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.832 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 33.1 m -103.44 -179.34 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.039 0.447 . . . . 0.0 110.376 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -121.5 114.25 20.97 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.676 ' HB2' HD11 ' A' ' 24' ' ' ILE . 51.6 mtt -100.66 121.1 41.07 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.7 tp -114.02 110.99 34.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.915 0.864 . . . . 0.0 110.213 -178.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.818 HD13 HD12 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -133.22 144.42 49.78 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.319 -174.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.6 mm -60.76 100.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.134 0.492 . . . . 0.0 110.615 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.547 ' HG2' HG21 ' A' ' 17' ' ' ILE . 42.4 mt-30 -105.4 -42.73 5.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.526 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.74 -19.65 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.511 -177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.04 49.46 3.53 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.199 174.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 m -59.83 -71.37 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.832 0.349 . . . . 0.0 110.847 176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -117.85 -26.0 6.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.146 0.498 . . . . 0.0 110.832 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -107.56 75.35 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.985 0.422 . . . . 0.0 110.823 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 p -83.29 -63.22 1.4 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.927 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -94.96 -4.47 46.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.289 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.4 t -97.24 158.21 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.004 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.46 144.77 16.13 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.49 0.494 . . . . 0.0 110.872 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -117.46 127.98 26.31 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.796 -171.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.88 116.76 3.49 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.248 1.966 . . . . 0.0 112.141 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.818 HD12 HD13 ' A' ' 37' ' ' LEU . 8.4 tt -98.48 119.89 37.95 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.483 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.602 ' HG3' ' HG2' ' A' ' 5' ' ' GLU . 4.4 mpt_? -100.11 116.27 31.75 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 176.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.512 ' CG2' HG23 ' A' ' 60' ' ' VAL . 27.7 mt -89.43 118.37 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 3' ' ' VAL . 27.5 mt -104.67 121.32 56.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' A' ' 2' ' ' THR . . . 177.49 -177.92 48.32 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.483 174.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.612 ' HB3' ' HE3' ' A' ' 59' ' ' LYS . 13.8 t70 -62.04 139.98 95.9 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.565 ' HA ' HG21 ' A' ' 2' ' ' THR . 69.7 Cg_exo -38.7 -45.86 2.51 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.912 3.075 . . . . 0.0 115.157 -175.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -74.43 -33.51 62.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.251 -174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 1.007 ' HB2' ' HB3' ' A' ' 87' ' ' SER . 19.0 ptpt -79.2 -41.68 27.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -175.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.512 HG23 ' CG2' ' A' ' 53' ' ' ILE . 8.0 p -67.36 -24.51 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.503 0.668 . . . . 0.0 109.935 178.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -66.88 -57.89 6.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.24 178.066 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -61.45 -33.16 73.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.72 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HA ' ' HG2' ' A' ' 66' ' ' MET . . . -69.51 -45.73 68.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.745 177.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.455 ' HA ' HG22 ' A' ' 67' ' ' VAL . 42.8 t -58.97 -35.63 73.5 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.52 0.676 . . . . 0.0 109.632 177.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -66.25 -37.08 84.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.616 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.867 ' HB2' ' HD2' ' A' ' 82' ' ' ARG . 15.5 ptt? -84.95 -33.47 22.65 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.975 -176.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 71' ' ' LEU . 35.1 m -62.37 -28.96 45.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.299 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 70.6 mtm -81.6 -21.03 38.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.142 0.496 . . . . 0.0 110.32 174.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -83.2 -46.26 12.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.894 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.702 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.6 pp -83.22 -26.7 7.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.8 0.333 . . . . 0.0 111.743 -177.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 6.0 tt -75.72 -18.35 59.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.876 175.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 73' ' ' GLU . 5.8 ptm180 -53.39 -42.1 66.61 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' HG2' ' N ' ' A' ' 75' ' ' ASP . 0.0 OUTLIER 56.07 137.73 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 170.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 72.7 mtp180 -112.43 -13.45 13.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 161.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.529 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 36.1 t70 -163.18 135.06 5.1 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.544 174.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.952 ' HA ' HD23 ' A' ' 15' ' ' LEU . 78.4 mt-30 -43.81 106.65 0.07 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.289 1.042 . . . . 0.0 112.188 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.483 ' N ' ' HB3' ' A' ' 15' ' ' LEU . . . 150.82 -34.38 0.95 Allowed Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.103 -173.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 60.95 -111.23 3.61 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.702 ' HD1' HG22 ' A' ' 70' ' ' ILE . 97.3 m-85 -127.78 -13.77 5.21 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.74 0.305 . . . . 0.0 110.609 174.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 81' ' ' ASP . . . 81.23 91.92 0.52 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -174.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.599 ' HB2' ' HB3' ' A' ' 26' ' ' GLN . 5.7 t70 71.22 -75.04 0.08 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -170.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.867 ' HD2' ' HB2' ' A' ' 66' ' ' MET . 24.9 ttt180 173.17 -35.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 O-C-N 124.18 0.925 . . . . 0.0 110.332 174.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 69.19 13.54 8.62 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.65 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.808 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 84.9 tt0 -123.96 -34.43 2.99 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.631 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 25.6 p90 171.27 127.31 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.139 175.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.753 ' HA2' ' SD ' ' A' ' 66' ' ' MET . . . -82.99 -66.69 1.51 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.946 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 1.007 ' HB3' ' HB2' ' A' ' 59' ' ' LYS . 45.2 m -144.98 22.56 1.57 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.776 0.798 . . . . 0.0 109.125 176.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 85' ' ' TYR . 1.8 mpt_? -133.84 -164.16 1.46 Allowed 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.043 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' A' ' 85' ' ' TYR . 23.9 mt 64.71 -81.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 64.45 50.71 57.86 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 89' ' ' ILE . . . 132.96 85.02 0.26 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.286 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 153.94 -143.76 10.48 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.808 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 35.9 pt -144.97 160.55 13.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 117.302 0.551 . . . . 0.0 110.844 175.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.491 ' HB3' ' HE ' ' A' ' 30' ' ' ARG . 5.0 m-20 -107.0 119.68 40.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.949 173.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.828 HG23 ' HB3' ' A' ' 138' ' ' ALA . 6.2 m -113.35 104.88 55.56 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.169 0.509 . . . . 0.0 112.172 -176.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HB3' ' CD1' ' A' ' 137' ' ' ILE . 51.8 Cg_endo -72.34 108.6 2.54 Favored 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.816 2.344 . . . . 0.0 111.634 173.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.678 HG13 HD21 ' A' ' 158' ' ' LEU . 46.9 t -102.35 124.92 37.87 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.071 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.552 ' HD2' HD22 ' A' ' 158' ' ' LEU . 78.7 Cg_exo -44.54 133.65 9.8 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.636 2.89 . . . . 0.0 112.783 173.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -58.59 -30.6 67.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.651 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -89.88 1.36 56.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.424 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 105' ' ' VAL . 25.1 m -119.56 -27.97 5.41 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.505 ' HA ' HG11 ' A' ' 97' ' ' VAL . 11.2 p -52.33 -34.43 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.38 -37.76 94.19 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.85 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.9 -37.14 53.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.808 0.337 . . . . 0.0 110.36 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 101' ' ' SER . 48.0 t -65.35 -38.67 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.326 0.584 . . . . 0.0 110.669 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.814 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 13.7 mt -81.03 -26.33 10.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.238 0.542 . . . . 0.0 111.113 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 81.4 48.44 5.94 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -174.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 59.02 -91.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.83 0.852 . . . . 0.0 112.244 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.9 m -75.08 -24.49 58.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 111.065 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.413 ' HA2' ' CG2' ' A' ' 106' ' ' ILE . . . 130.41 50.7 0.11 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.725 177.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.563 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 40.4 mt-10 -93.42 -58.98 2.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.882 0.373 . . . . 0.0 110.302 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -68.37 -31.54 70.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.163 -173.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.814 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.0 tp -65.46 -22.88 31.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.253 0.549 . . . . 0.0 110.675 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -82.32 -26.06 33.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.046 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.563 ' HD3' ' O ' ' A' ' 111' ' ' GLU . 2.7 mptp? -65.24 -38.13 89.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.455 HD11 ' SD ' ' A' ' 112' ' ' MET . 28.9 mm -59.12 -43.12 88.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.491 175.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.499 HE21 HG12 ' A' ' 124' ' ' ILE . 59.7 mt-30 -67.04 -33.61 75.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.744 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -79.26 -42.32 26.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.613 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.64 -40.62 33.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.464 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.17 18.47 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.93 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 79.19 46.35 8.25 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.438 HG21 HG23 ' A' ' 140' ' ' ILE . 1.9 t -118.02 143.75 27.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.109 -0.546 . . . . 0.0 111.678 -169.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.475 ' HD3' ' SD ' ' A' ' 141' ' ' MET . 79.4 mtp180 -103.53 148.68 25.67 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 171.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.499 HG12 HE21 ' A' ' 117' ' ' GLN . 46.2 mm -114.63 135.03 55.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.189 0.519 . . . . 0.0 111.937 -171.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.586 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 24.1 tt0 -137.32 105.67 5.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.219 176.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.493 ' CZ ' HD11 ' A' ' 106' ' ' ILE . 33.6 m-85 -80.76 106.53 12.84 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 121.942 -0.474 . . . . 0.0 109.949 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.832 ' O ' ' HE2' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -123.47 127.28 48.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.235 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 63.81 -170.3 0.19 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.384 0.612 . . . . 0.0 111.589 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -138.57 -168.3 2.37 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -68.81 -27.5 65.91 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 173.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 132.73 -20.94 4.28 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.453 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.907 HG23 ' HD2' ' A' ' 134' ' ' PRO . 6.2 t -136.62 -27.21 1.05 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 146.87 -47.74 0.68 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 119.368 -1.396 . . . . 0.0 115.465 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.907 ' HD2' HG23 ' A' ' 132' ' ' THR . 51.0 Cg_exo -37.76 -47.76 2.02 Favored 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 123.777 2.984 . . . . 0.0 115.091 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 130' ' ' ASP . 20.1 mt-10 -132.74 146.35 51.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.358 0.599 . . . . 0.0 111.525 -177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -119.47 115.94 25.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.747 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.546 HG22 ' NZ ' ' A' ' 127' ' ' LYS . 18.0 mm -72.84 108.32 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.569 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.828 ' HB3' HG23 ' A' ' 95' ' ' VAL . . . -96.79 141.4 30.05 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.671 175.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.6 ' NE2' HG23 ' A' ' 89' ' ' ILE . 3.2 t-160 -91.52 117.52 29.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.879 0.371 . . . . 0.0 110.414 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.655 HD13 ' HB3' ' A' ' 150' ' ' ALA . 37.9 mt -97.17 118.24 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.248 171.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.475 ' SD ' ' HD3' ' A' ' 123' ' ' ARG . 46.3 ttm -102.13 121.61 42.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 -174.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 164.33 170.26 29.02 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -61.16 150.83 82.65 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.585 2.19 . . . . 0.0 111.6 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.775 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 87.2 Cg_exo -42.3 -40.02 6.65 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.931 3.087 . . . . 0.0 114.999 -172.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.3 -32.07 64.4 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.998 -0.439 . . . . 0.0 110.855 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 149' ' ' HIS . 92.7 mtt-85 -85.0 -35.17 22.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.778 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.775 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 27.7 p -62.99 -51.08 68.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.609 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 28.3 mt-10 -66.38 -29.01 69.09 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.006 -0.278 . . . . 0.0 110.935 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.409 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 4.4 t60 -55.49 -36.08 66.26 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.116 0.484 . . . . 0.0 110.136 175.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.655 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -79.14 -35.04 42.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.922 -174.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.473 ' HB2' ' CD1' ' A' ' 93' ' ' ILE . . . -67.15 -24.93 65.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.609 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 2.9 mpt_? -77.84 -18.5 56.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.981 0.42 . . . . 0.0 110.314 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.5 mt -82.41 -44.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 66.7 mt -65.94 -52.51 48.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.347 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -60.74 -30.21 69.85 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.251 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -64.63 -39.48 93.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.996 0.427 . . . . 0.0 110.013 177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.424 HD11 ' CE ' ' A' ' 112' ' ' MET . 82.7 mt -67.07 -44.06 81.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.776 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.678 HD21 HG13 ' A' ' 97' ' ' VAL . 71.3 mt -63.1 -33.8 76.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.776 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -73.34 -37.66 66.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.447 177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 29.8 t -71.04 -38.57 72.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.685 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 163' ' ' SER . 74.1 mt -80.36 -78.36 0.17 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 56.29 -77.45 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.093 0.871 . . . . 0.0 113.099 174.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 161' ' ' LEU . 38.5 t 169.96 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -173.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.818 178.571 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.437 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.656 HG21 ' HA ' ' A' ' 57' ' ' PRO . 36.5 m -137.09 94.91 3.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.051 0.453 . . . . 0.0 109.986 177.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 17.5 m -132.28 141.4 45.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.699 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -123.52 141.72 51.73 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.742 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 45.6 mt-10 -112.23 121.38 44.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.363 0.601 . . . . 0.0 111.703 -175.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.66 HG13 HG21 ' A' ' 67' ' ' VAL . 44.7 mm -110.52 150.08 13.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.665 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.489 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 50.4 tpp -101.37 117.03 34.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.881 0.372 . . . . 0.0 110.848 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.779 HG12 HG11 ' A' ' 16' ' ' VAL . 3.0 mp -99.37 104.39 26.56 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.185 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 7' ' ' MET . 21.2 Cg_exo -67.52 159.45 52.44 Favored 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 123.08 2.52 . . . . 0.0 111.82 177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.51 141.56 57.64 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.14 -51.42 1.89 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.976 -0.849 . . . . 0.0 110.976 -172.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.78 -25.01 64.49 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.004 0.431 . . . . 0.0 110.411 175.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.748 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -52.11 -37.47 54.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.67 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.556 ' HA3' ' OE1' ' A' ' 76' ' ' GLN . . . -63.03 -38.46 96.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.984 -178.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.077 HD23 ' HA ' ' A' ' 76' ' ' GLN . 2.9 pp -89.93 -15.82 31.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.98 0.39 . . . . 0.0 111.656 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.779 HG11 HG12 ' A' ' 8' ' ' ILE . 70.8 t -90.2 -49.94 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.748 HG12 ' O ' ' A' ' 13' ' ' ALA . 17.6 pt -87.51 -23.42 6.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.321 -0.551 . . . . 0.0 109.895 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.761 ' HA3' ' H ' ' A' ' 23' ' ' THR . . . 89.92 17.95 52.33 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.719 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.452 ' H ' HG13 ' A' ' 17' ' ' ILE . 29.7 mmtp 65.05 -63.36 0.19 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.667 0.787 . . . . 0.0 111.658 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.75 19.35 47.56 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.257 178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 25' ' ' LYS . . . 92.82 8.04 62.33 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.025 176.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.605 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 28.6 tt0 -63.01 -48.34 79.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.687 0.28 . . . . 0.0 111.594 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.761 ' H ' ' HA3' ' A' ' 18' ' ' GLY . 78.9 m -67.23 -39.45 86.23 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.204 -177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.667 HD12 HD12 ' A' ' 27' ' ' LEU . 1.3 tp -64.6 -22.1 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.67 0.272 . . . . 0.0 110.899 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.605 ' HD2' ' HA ' ' A' ' 22' ' ' GLU . 49.8 mttm -56.79 -57.86 10.62 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.619 0.723 . . . . 0.0 109.981 173.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -69.31 -26.98 65.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.963 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.667 HD12 HD12 ' A' ' 24' ' ' ILE . 36.6 mt -75.03 -30.14 61.0 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.045 -0.409 . . . . 0.0 111.019 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.706 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 48.2 mt-30 -84.83 -42.45 15.1 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.032 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -88.07 -62.1 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.66 HH21 ' HA3' ' A' ' 86' ' ' GLY . 2.2 ttp180 -58.47 -43.75 89.02 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.933 0.397 . . . . 0.0 110.891 -176.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.671 ' HA ' ' O ' ' A' ' 86' ' ' GLY . . . -75.45 -22.39 57.36 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 121.356 0.598 . . . . 0.0 111.178 178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.02 16.99 78.4 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.778 -0.647 . . . . 0.0 112.672 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 28.6 m -121.75 151.0 25.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.843 0.354 . . . . 0.0 110.455 179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -89.19 109.49 20.36 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 1.044 ' HB3' HD11 ' A' ' 51' ' ' LEU . 59.4 mtt -98.2 114.43 26.67 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.707 HG23 ' HB2' ' A' ' 52' ' ' ARG . 4.9 tp -110.44 112.25 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 CA-C-O 122.006 0.908 . . . . 0.0 109.677 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.638 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -132.29 143.38 49.85 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.95 -175.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 78.7 mt -54.37 107.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 124.01 0.819 . . . . 0.0 111.892 -173.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -126.37 -14.55 5.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.837 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.28 158.61 20.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.676 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.29 69.11 0.88 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.279 -0.486 . . . . 0.0 112.966 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.4 t -89.38 -62.89 1.38 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -175.6 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.393 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -86.75 62.5 7.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.114 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 p -83.29 -61.13 1.93 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.81 0.338 . . . . 0.0 111.347 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -93.39 -17.08 23.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.283 0.563 . . . . 0.0 109.819 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 11.9 t -79.15 166.17 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.886 -177.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 1.4 p30 -47.84 140.91 6.13 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.159 0.504 . . . . 0.0 111.282 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 47' ' ' VAL . 16.6 mtmm -130.1 137.46 30.92 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.087 -170.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.53 133.21 5.22 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.597 2.198 . . . . 0.0 112.4 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.044 HD11 ' HB3' ' A' ' 35' ' ' MET . 22.4 tp -108.05 120.18 41.6 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.813 -177.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.707 ' HB2' HG23 ' A' ' 36' ' ' ILE . 5.1 mpt_? -96.27 115.57 27.64 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.37 174.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 63.3 mt -91.47 110.1 22.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.786 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 3' ' ' VAL . 35.3 mt -108.06 121.04 60.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.452 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.544 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.86 -170.2 43.33 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.986 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.985 ' HB2' ' HG3' ' A' ' 59' ' ' LYS . 2.1 m-20 -51.03 146.75 10.11 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.647 0.263 . . . . 0.0 110.514 175.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.656 ' HA ' HG21 ' A' ' 2' ' ' THR . 51.3 Cg_exo -54.72 -52.62 7.66 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 121.909 1.739 . . . . 0.0 112.773 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -61.03 -30.65 70.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.638 176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.985 ' HG3' ' HB2' ' A' ' 56' ' ' ASP . 46.1 mttp -64.77 -47.97 76.22 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.294 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.31 -39.0 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.165 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.19 -51.88 67.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.564 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.912 ' HA ' HE21 ' A' ' 62' ' ' GLN . 0.0 OUTLIER -68.7 -35.43 77.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 -178.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 66' ' ' MET . . . -72.31 -42.48 65.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.89 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 47.3 t -57.35 -36.76 71.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.358 0.599 . . . . 0.0 109.568 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -67.49 -45.63 75.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.21 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.633 ' O ' HG13 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -73.94 -37.7 64.48 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.837 -175.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.66 HG21 HG13 ' A' ' 6' ' ' ILE . 35.9 m -62.49 -35.18 68.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.678 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.726 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 66.2 mtt -71.24 -21.22 62.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.737 0.303 . . . . 0.0 110.632 175.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 8.9 t70 -85.59 -41.51 15.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.967 0.413 . . . . 0.0 111.04 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.812 HG22 ' HD1' ' A' ' 79' ' ' PHE . 2.1 pp -86.85 -23.99 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.922 0.392 . . . . 0.0 111.856 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.622 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 3.6 tt -86.47 -20.06 28.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.551 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.726 ' HB3' ' O ' ' A' ' 68' ' ' MET . 5.3 ptm180 -61.55 -11.36 10.81 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.85 0.357 . . . . 0.0 111.076 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 1.05 ' HG2' ' H ' ' A' ' 77' ' ' GLY . 16.0 tp10 -50.98 138.79 18.65 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.401 -177.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -66.7 -30.08 70.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.827 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' H ' ' HG3' ' A' ' 73' ' ' GLU . 29.1 t70 -135.23 -89.32 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.716 175.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 1.077 ' HA ' HD23 ' A' ' 15' ' ' LEU . 9.3 tt0 -153.66 61.45 0.74 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.544 0.688 . . . . 0.0 110.296 -176.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 1.05 ' H ' ' HG2' ' A' ' 73' ' ' GLU . . . -137.64 30.49 2.58 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.8 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.75 158.27 40.73 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.812 ' HD1' HG22 ' A' ' 70' ' ' ILE . 4.5 m-85 -60.59 -45.51 93.7 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.82 -75.49 0.42 Allowed Glycine 0 CA--C 1.496 -1.099 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 169.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.526 ' HA ' HD21 ' A' ' 27' ' ' LEU . 19.2 p-10 -92.33 -15.61 27.12 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.418 -0.891 . . . . 0.0 110.473 174.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.446 ' CB ' ' HB2' ' A' ' 66' ' ' MET . 0.0 OUTLIER 84.58 64.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.635 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 28.8 t-20 -49.54 102.93 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.709 176.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 1.065 ' HA ' ' HA ' ' A' ' 93' ' ' ILE . 41.7 tt0 162.65 -41.97 0.0 OUTLIER 'General case' 0 C--O 1.232 0.157 0 O-C-N 124.572 1.17 . . . . 0.0 108.32 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 88' ' ' ARG . 53.2 p90 -175.03 151.27 1.3 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.449 -177.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.61 80.04 0.18 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.89 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 40.1 m 72.38 -20.41 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.107 0.479 . . . . 0.0 111.001 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.663 ' HD3' ' H ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -103.96 154.03 20.13 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.733 171.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.694 HG21 ' CE1' ' A' ' 139' ' ' HIS . 33.3 mm 62.58 -88.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.119 176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.03 46.45 1.73 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.09 -0.576 . . . . 0.0 111.661 -172.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 85' ' ' TYR . . . 151.71 164.82 12.48 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.739 -0.545 . . . . 0.0 111.739 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.748 ' O ' ' HG3' ' A' ' 84' ' ' GLU . . . 86.13 -122.02 5.91 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.081 -0.581 . . . . 0.0 111.724 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.065 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 28.7 pt -155.43 178.5 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 122.921 0.489 . . . . 0.0 109.852 171.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -120.22 137.04 54.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.694 170.364 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 137' ' ' ILE . 29.2 t -124.12 98.06 39.55 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.073 -175.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.441 ' CA ' HD13 ' A' ' 137' ' ' ILE . 38.2 Cg_endo -69.98 107.75 1.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.671 1.581 . . . . 0.0 110.92 169.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.672 HG21 HG21 ' A' ' 105' ' ' VAL . 14.8 p -116.02 126.75 27.35 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.014 0.435 . . . . 0.0 110.574 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.496 ' HA ' ' HG2' ' A' ' 135' ' ' GLU . 73.6 Cg_exo -46.96 136.17 17.54 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.499 2.799 . . . . 0.0 112.546 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -54.77 -29.13 53.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.343 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -92.29 10.55 29.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.895 0.379 . . . . 0.0 111.354 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.465 ' HB3' HD21 ' A' ' 161' ' ' LEU . 46.1 m -128.64 -15.19 4.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.761 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 106' ' ' ILE . 7.6 p -64.51 -35.28 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.267 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.73 -28.56 73.5 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.184 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.29 -37.97 39.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.672 HG21 HG21 ' A' ' 97' ' ' VAL . 62.1 t -59.78 -41.09 84.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.919 175.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.784 ' HA ' ' HB ' ' A' ' 113' ' ' ILE . 46.0 mm -67.39 -46.3 83.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.245 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.06 33.26 9.02 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.611 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' A' ' 108' ' ' ARG . 27.9 mtp180 64.9 -78.28 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.264 0.626 . . . . 0.0 111.914 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.457 ' HB2' ' HG3' ' A' ' 111' ' ' GLU . 18.0 m -81.81 11.32 5.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.878 0.37 . . . . 0.0 110.815 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.407 ' O ' ' HG2' ' A' ' 114' ' ' LYS . . . 75.51 22.12 76.0 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.919 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 109' ' ' SER . 41.0 mt-10 -71.46 -50.47 31.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.895 0.378 . . . . 0.0 110.916 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.544 ' O ' HG12 ' A' ' 116' ' ' ILE . 13.6 tpt -68.49 -39.11 81.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.081 -173.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.784 ' HB ' ' HA ' ' A' ' 106' ' ' ILE . 9.3 tp -65.96 -32.37 57.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.608 -177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 110' ' ' GLY . 74.6 mmtt -81.41 -30.58 33.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.203 0.525 . . . . 0.0 109.731 176.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -66.15 -38.74 88.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.945 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 112' ' ' MET . 45.6 mm -62.15 -39.04 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.354 0.597 . . . . 0.0 109.651 174.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 113' ' ' ILE . 77.6 mt-30 -65.8 -32.22 73.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.833 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -79.8 -42.4 24.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.567 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -79.46 -43.58 22.97 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.65 -18.94 20.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.929 0.395 . . . . 0.0 111.671 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.53 47.42 8.03 Favored Glycine 0 C--O 1.228 -0.223 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.886 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.459 ' HB ' HG23 ' A' ' 140' ' ' ILE . 27.1 m -122.17 179.58 2.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 111.653 -173.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.748 ' HB3' ' HG2' ' A' ' 141' ' ' MET . 43.1 ttt180 -145.68 145.78 31.04 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.558 HG13 HD11 ' A' ' 113' ' ' ILE . 44.9 mm -107.68 138.46 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -168.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.811 ' HA ' HE21 ' A' ' 125' ' ' GLN . 0.0 OUTLIER -138.48 94.92 2.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.866 175.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 138' ' ' ALA . 44.2 m-85 -73.72 105.97 5.26 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 174.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.776 ' HD3' ' H ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -102.04 -166.74 1.32 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.076 -173.451 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . 0.408 ' OE1' ' HG2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -70.44 48.65 0.11 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 -169.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -135.97 66.32 1.5 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 170.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -105.3 -48.16 3.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.952 -174.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -111.97 1.9 27.14 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.605 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.4 t -100.0 40.6 1.23 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.587 0.708 . . . . 0.0 110.775 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 170.88 165.84 28.83 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.925 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.41 -11.18 17.4 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 122.844 2.363 . . . . 0.0 111.231 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 98' ' ' PRO . 45.7 mt-10 -129.36 151.03 50.45 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.872 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.494 ' O ' HG12 ' A' ' 97' ' ' VAL . 66.9 mttm -109.38 113.82 26.97 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -175.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 14.9 mm -67.13 109.86 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.864 178.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 126' ' ' PHE . . . -97.79 135.14 39.98 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 170.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.694 ' CE1' HG21 ' A' ' 89' ' ' ILE . 13.2 t60 -86.69 123.43 31.85 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.979 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.551 HD13 ' HB3' ' A' ' 150' ' ' ALA . 32.3 mt -103.24 126.15 57.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.275 171.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.748 ' HG2' ' HB3' ' A' ' 123' ' ' ARG . 16.8 ptp -107.23 165.49 11.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.958 0.409 . . . . 0.0 110.665 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.76 172.96 13.26 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.503 ' HD2' ' HD3' ' A' ' 146' ' ' ARG . 38.1 Cg_exo -58.89 143.5 99.36 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.415 2.076 . . . . 0.0 111.765 175.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.747 ' HA ' ' SG ' ' A' ' 147' ' ' CYS . 72.5 Cg_exo -41.59 -43.97 6.24 Favored 'Trans proline' 0 N--CA 1.476 0.466 0 C-N-CA 124.006 3.137 . . . . 0.0 114.497 -173.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 11.4 t70 -57.59 -42.93 84.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.612 0.244 . . . . 0.0 111.417 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.503 ' HD3' ' HD2' ' A' ' 143' ' ' PRO . 18.3 mtp180 -79.75 -39.15 31.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.52 -172.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.747 ' SG ' ' HA ' ' A' ' 144' ' ' PRO . 12.2 p -63.11 -50.65 69.64 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.666 ' O ' ' HD3' ' A' ' 152' ' ' ARG . 5.7 mm-40 -62.21 -38.88 90.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.664 0.269 . . . . 0.0 110.718 176.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 18.6 t60 -57.66 -32.31 67.18 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.953 0.406 . . . . 0.0 111.076 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.551 ' HB3' HD13 ' A' ' 140' ' ' ILE . . . -77.91 -34.02 51.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.778 -177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.512 ' HB3' HH11 ' A' ' 152' ' ' ARG . . . -67.47 -25.26 65.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.396 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.666 ' HD3' ' O ' ' A' ' 148' ' ' GLU . 10.9 mpt_? -77.83 -32.73 52.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.845 0.355 . . . . 0.0 110.264 -177.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.44 ' O ' HD13 ' A' ' 157' ' ' LEU . 63.4 mt -65.4 -46.36 90.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.813 176.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.633 ' O ' ' HG ' ' A' ' 158' ' ' LEU . 68.3 mt -62.41 -37.48 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.294 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -59.85 -31.3 69.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.462 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 159' ' ' GLN . 15.6 t70 -79.08 -37.48 38.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.001 0.429 . . . . 0.0 110.14 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 153' ' ' ILE . 7.8 mp -53.49 -42.29 67.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.852 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 154' ' ' ILE . 25.5 mt -62.22 -36.65 82.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.424 -176.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 156' ' ' ASP . 21.3 pt20 -84.21 -25.47 29.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.666 0.27 . . . . 0.0 111.31 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 59.3 m -79.64 -26.78 41.0 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -175.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.465 HD21 ' HB3' ' A' ' 101' ' ' SER . 3.5 pp -81.36 19.94 0.92 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -173.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 159' ' ' GLN . 38.4 mmt180 -73.98 -26.5 60.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.262 0.554 . . . . 0.0 109.967 177.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.9 t -159.29 110.93 2.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.471 0 C-N-CA 120.111 -1.043 . . . . 0.0 113.279 -174.823 . . . . . . . . 0 0 . 1 stop_ save_